<SEC-DOCUMENT>0001193125-14-172070.txt : 20140430
<SEC-HEADER>0001193125-14-172070.hdr.sgml : 20140430
<ACCEPTANCE-DATETIME>20140430161140
ACCESSION NUMBER:		0001193125-14-172070
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20140625
FILED AS OF DATE:		20140430
DATE AS OF CHANGE:		20140430
EFFECTIVENESS DATE:		20140430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEKTAR THERAPEUTICS
		CENTRAL INDEX KEY:			0000906709
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943134940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24006
		FILM NUMBER:		14798834

	BUSINESS ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		4154825300

	MAIL ADDRESS:	
		STREET 1:		455 MISSION BAY BOULEVARD SOUTH
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS INC
		DATE OF NAME CHANGE:	19980723

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INHALE THERAPEUTIC SYSTEMS
		DATE OF NAME CHANGE:	19940303
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d716112ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities
Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No.<U></U>&nbsp;&nbsp;&nbsp;&nbsp;) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a
Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B> </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167;240.14a-12 </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>Nektar Therapeutics </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter)
</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if
other than the Registrant) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules&nbsp;14a-6(i)(1) and 0-11. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&nbsp;0-11 (set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE 25, 2014 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the 2014 Annual Meeting of
Stockholders of Nektar Therapeutics, a Delaware corporation. The 2014 Annual Meeting will be held on Wednesday, June&nbsp;25, 2014, at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158, for
the following purposes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect three directors with terms to expire at the 2017 Annual Meeting of Stockholders. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to our Employee Stock Purchase Plan, as amended and restated, to increase the aggregate number of shares of common stock available for issuance
under the plan by 1,000,000 shares for a total reserve of 2,500,000 shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2014.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148; vote). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conduct any other business properly brought before the 2014 Annual Meeting. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">These items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. The record date for the 2014 Annual Meeting is April&nbsp;28, 2014. Only
stockholders of record at the close of business on that date are entitled to notice of, and to vote at, the 2014 Annual Meeting or any adjournment thereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Your vote is very important. Whether or not you attend the 2014 Annual Meeting in person, it is important that your shares be represented. You may vote your proxy on the Internet, by phone or by mail in
accordance with the instructions in the Notice of Availability of Proxy Materials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On behalf of the Board of Directors, thank
you for your participation in this important annual process. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel
and</I> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Secretary</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">May&nbsp;16, 2014 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Y<SMALL>OU</SMALL> <SMALL>ARE</SMALL> <SMALL>CORDIALLY</SMALL> <SMALL>INVITED</SMALL> <SMALL>TO</SMALL> <SMALL>ATTEND</SMALL>
<SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> <SMALL>IN</SMALL> <SMALL>PERSON</SMALL>. W<SMALL>HETHER</SMALL> <SMALL>OR</SMALL> <SMALL>NOT</SMALL> <SMALL>YOU</SMALL> <SMALL>EXPECT</SMALL> <SMALL>TO</SMALL> <SMALL>ATTEND</SMALL>
<SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>, <SMALL>PLEASE</SMALL> <SMALL>VOTE</SMALL> <SMALL>ON</SMALL> <SMALL>THE</SMALL> <SMALL>INTERNET</SMALL>, <SMALL>BY</SMALL> <SMALL>PHONE</SMALL> <SMALL>OR</SMALL> <SMALL>BY</SMALL>
<SMALL>MAIL</SMALL> <SMALL>AS</SMALL> <SMALL>INSTRUCTED</SMALL> <SMALL>IN</SMALL> <SMALL>THE</SMALL> N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> A<SMALL>VAILABILITY</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> M<SMALL>ATERIALS</SMALL>,
<SMALL>AS</SMALL> <SMALL>PROMPTLY</SMALL> <SMALL>AS</SMALL> <SMALL>POSSIBLE</SMALL> <SMALL>IN</SMALL> <SMALL>ORDER</SMALL> <SMALL>TO</SMALL> <SMALL>ENSURE</SMALL> <SMALL>YOUR</SMALL> <SMALL>REPRESENTATION</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL>
<SMALL>MEETING</SMALL>. E<SMALL>VEN</SMALL> <SMALL>IF</SMALL> <SMALL>YOU</SMALL> <SMALL>HAVE</SMALL> <SMALL>VOTED</SMALL> <SMALL>BY</SMALL> <SMALL>PROXY</SMALL>, <SMALL>YOU</SMALL> <SMALL>MAY</SMALL> <SMALL>STILL</SMALL> <SMALL>VOTE</SMALL>
<SMALL>IN</SMALL> <SMALL>PERSON</SMALL> <SMALL>IF</SMALL> <SMALL>YOU</SMALL> <SMALL>ATTEND</SMALL> <SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>. P<SMALL>LEASE</SMALL> <SMALL>NOTE</SMALL>, <SMALL>HOWEVER</SMALL>,
<SMALL>THAT</SMALL> <SMALL>IF</SMALL> <SMALL>YOUR</SMALL> <SMALL>SHARES</SMALL> <SMALL>ARE</SMALL> <SMALL>HELD</SMALL> <SMALL>OF</SMALL> <SMALL>RECORD</SMALL> <SMALL>BY</SMALL> <SMALL>A</SMALL> <SMALL>BROKER</SMALL>, <SMALL>BANK</SMALL>
<SMALL>OR</SMALL> <SMALL>OTHER</SMALL> <SMALL>NOMINEE</SMALL> <SMALL>AND</SMALL> <SMALL>YOU</SMALL> <SMALL>WISH</SMALL> <SMALL>TO</SMALL> <SMALL>VOTE</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>,
<SMALL>YOU</SMALL> <SMALL>MUST</SMALL> <SMALL>OBTAIN</SMALL> <SMALL>A</SMALL> <SMALL>PROXY</SMALL> <SMALL>ISSUED</SMALL> <SMALL>IN</SMALL> <SMALL>YOUR</SMALL> <SMALL>NAME</SMALL> <SMALL>FROM</SMALL> <SMALL>THAT</SMALL> <SMALL>RECORD</SMALL>
<SMALL>HOLDER</SMALL>. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TABLE OF <A NAME="toc"></A>CONTENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_1">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_2">PROPOSAL 1: ELECTION OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_3">PROPOSAL 2: APPROVAL OF AN AMENDMENT TO OUR EMPLOYEE STOCK PURCHASE PLAN</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_4">PROPOSAL 3: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_5">PROPOSAL 4: ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_6">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_7">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_8">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_9">INFORMATION ABOUT THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_10">THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_11">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2015 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_12">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2016 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_13">CURRENT DIRECTORS NOMINATED FOR REELECTION TO SERVE UNTIL THE 2017 ANNUAL MEETING</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_14">MEETINGS OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_15">CORPORATE GOVERNANCE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_16">BOARD LEADERSHIP STRUCTURE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_17">RISK OVERSIGHT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_18">INDEPENDENCE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_19">INFORMATION REGARDING THE COMMITTEES OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_20">STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_21">CODE OF BUSINESS CONDUCT AND ETHICS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_22">ORGANIZATION AND COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_23">DIRECTOR COMPENSATION TABLE</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_24">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_25">COMPENSATION COMMITTEE REPORT</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_26">SUMMARY COMPENSATION TABLE&#151;FISCAL 2011-2013</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_27">DESCRIPTION OF EMPLOYMENT AGREEMENTS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_28">GRANTS OF PLAN BASED AWARDS IN 2013</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_29">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END FOR 2013</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_30">OPTION EXERCISES AND STOCK VESTED IN 2013</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_31">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_32">INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_33">PRE-APPROVAL POLICIES AND PROCEDURES</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_34">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_35">OTHER MATTERS</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#toc716112_36">ADDITIONAL INFORMATION</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112g36i66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">455 Mission Bay Boulevard South </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">San Francisco, California 94158 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">TO BE HELD ON JUNE 25, 2014 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">AT 2:00 P.M. PACIFIC TIME </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_1"></A>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING PROCEDURES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HY</SMALL> <SMALL>AM</SMALL> I <SMALL>RECEIVING</SMALL> <SMALL>THESE</SMALL> <SMALL>MATERIALS</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We sent you a Notice of Availability of Proxy Materials (the &#147;Notice&#148;) because the board of directors of Nektar Therapeutics (&#147;Nektar,&#148; the &#147;Company,&#148; &#147;we&#148; or
&#147;us&#148;) is soliciting your proxy to vote at our 2014 annual meeting of stockholders (the &#147;Annual Meeting&#148;) to be held on June&nbsp;25, 2014 at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San
Francisco, California 94158. We invite you to attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may vote by proxy over the Internet
or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials by mail, you may vote by mail. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Notice was first sent or made available on or about May&nbsp;16, 2014 to all stockholders of record entitled to vote at the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>CAN</SMALL> <SMALL>VOTE</SMALL> <SMALL>AT</SMALL> <SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on April&nbsp;28, 2014 will be entitled to vote at the Annual Meeting. On this record
date, there were 126,977,078&nbsp;shares of common stock outstanding and entitled to vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares
Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on April&nbsp;28, 2014, your shares were registered directly in your name with our transfer
agent, Computershare Investor Services, LLC, then you are a stockholder of record. The Notice will be sent to you by mail directly by us. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you
plan to attend the Annual Meeting, we urge you to vote on the Internet or by phone as instructed in the Notice or by proxy by mail by requesting a paper copy of the proxy materials as instructed in the Notice to ensure your vote is counted.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on April&nbsp;28, 2014, your shares were held in an account at a brokerage firm, bank or other agent, then you are the beneficial
owner of shares held in &#147;street name&#148; and the Notice is being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a
beneficial owner, you have the right to direct your broker, bank or other agent on how to vote the shares in your account. Your brokerage firm, bank or other agent will not be able to vote in the election of directors unless they have your voting
instructions, so it is very important that you indicate your voting instructions to the institution holding your shares. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are also invited to attend the Annual Meeting. However, since you are not the
stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker, bank or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>AM</SMALL> I <SMALL>VOTING</SMALL> <SMALL>ON</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">There are four matters scheduled for a vote: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: To elect three directors with terms to expire at the 2017 Annual Meeting of Stockholders. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: To approve an amendment to our Employee Stock Purchase Plan, as amended and restated, to increase the aggregate number of shares of common
stock available for issuance under the plan by 1,000,000 shares for a total reserve of 2,500,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: To ratify the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for our fiscal year ending
December&nbsp;31, 2014. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: To approve a non-binding advisory resolution regarding our executive compensation (a &#147;say-on-pay&#148; vote).
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>PROXY</SMALL> <SMALL>MATERIALS</SMALL> <SMALL>DISTRIBUTED</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under rules adopted by the Securities and Exchange Commission (&#147;SEC&#148;), we are sending the Notice to our
stockholders of record and beneficial owners as of April&nbsp;28, 2014. Stockholders will have the ability to access the proxy materials, including this proxy statement and our Annual Report on Form 10-K for the fiscal year ended December&nbsp;31,
2013, on the Internet at <I><U>www.nektar.com</U></I> or to request a printed or electronic set of the proxy materials at no charge. Instructions on how to access the proxy materials over the Internet and how to request a printed copy may be found
on the Notice. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, any stockholder may request to receive proxy materials in printed form by mail or electronically
by email on an ongoing basis. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact of annual meetings on the environment. A stockholder who chooses to
receive future proxy materials by email will receive an email prior to next year&#146;s annual meeting with instructions containing a link to those materials and a link to the proxy voting website. A stockholder&#146;s election to receive proxy
materials by email will remain in effect until the stockholder terminates it. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>DO</SMALL> I <SMALL>VOTE</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may either vote &#147;For&#148; or &#147;Against&#148; or abstain from voting with respect to each nominee to the
board of directors. For each of the other matters to be voted on, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are: </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a
stockholder of record as of April&nbsp;28, 2014, you may vote in person at the Annual Meeting, vote by proxy over the Internet or by phone by following the instructions provided in the Notice or, if you request printed copies of the proxy materials
by mail, you may vote by mail. If your proxy is properly executed in time to be voted at the Annual Meeting, the shares represented by the proxy will be voted in accordance with the instructions you provide. Whether or not you plan to attend the
Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person if you have already voted by proxy. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote on the Internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the 12-digit control number from the Notice and
follow the instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;24, 2014 to be counted. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by phone, request a paper or email copy of the proxy materials by following the instructions on the Notice and call the number provided with the proxy materials
to transmit your voting instructions. Your vote must be received by 11:59 p.m. Eastern Time on June&nbsp;24, 2014 to be counted. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote by mail, request a paper copy of the proxy materials by following the instructions on the Notice and complete, sign and date the proxy card enclosed with the
paper copy of the proxy materials and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received a Notice and
voting instructions from that organization rather than from us. Simply follow the instructions to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow
the instructions from your broker, bank or other agent included with the Notice, or contact your broker, bank or other agent. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We provide Internet proxy voting to allow you to vote your shares on-line, with procedures designed to ensure the authenticity and
correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers and telephone companies. </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>DO</SMALL> I <SMALL>HAVE</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of common stock you owned as of April&nbsp;28, 2014. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> <SMALL>THE</SMALL> <SMALL>QUORUM</SMALL> <SMALL>REQUIREMENT</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to take any action at the meeting (other than to adjourn the meeting). The presence, in person or by
proxy duly authorized, of the holders of a majority of the outstanding shares of stock entitled to vote will constitute a quorum. On April&nbsp;28, 2014, there were 126,977,078&nbsp;shares outstanding and entitled to vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your shares will be counted towards the quorum only if you submit a valid proxy or vote in person at the Annual Meeting. Even if your
valid proxy card indicates that you abstain from voting or if a broker indicates on a proxy that it lacks discretionary authority to vote your shares on a particular matter, commonly referred to as &#147;broker non-votes,&#148; your shares will
still be counted for purposes of determining the presence of a quorum at the Annual Meeting. If there is no quorum, the chairman of the Annual Meeting or a majority of the votes present at the Annual Meeting may adjourn the Annual Meeting to another
date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IF</SMALL> I <SMALL>RETURN</SMALL> <SMALL>A</SMALL> <SMALL>PROXY</SMALL> <SMALL>CARD</SMALL>
<SMALL>BUT</SMALL> <SMALL>DO</SMALL> <SMALL>NOT</SMALL> <SMALL>MAKE</SMALL> <SMALL>SPECIFIC</SMALL> <SMALL>CHOICES</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record and you return a proxy card without marking any voting selections, your shares will be voted:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: &#147;For&#148; election of all three nominees for director. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: &#147;For&#148; the increase to the aggregate number of shares of common stock authorized for issuance under the Employee Stock Purchase Plan.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: &#147;For&#148; the ratification of the audit committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm
for our fiscal year ending December&nbsp;31, 2014. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: &#147;For&#148; the approval of the resolution regarding executive compensation. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any other matter is properly presented at the meeting, your proxy (one of the individuals
named on your proxy card) will vote your shares using his best judgment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered
in the name of your broker, bank or other agent, your shares are held by your broker, bank or other agent as your nominee (that is, in &#147;street name&#148;) and you will need to obtain a proxy form from the organization that holds your shares and
follow the instructions included on that form regarding how to instruct the organization to vote your shares. If you do not give instructions to your broker, bank or other agent, it can vote your shares with respect to &#147;discretionary&#148;
items but not with respect to &#147;non- discretionary&#148; items. Discretionary items are proposals considered routine under the rules of various national securities exchanges, and, in the absence of your voting instructions, your broker, bank or
other agent may vote your shares held in street name on such proposals. Non-discretionary items are proposals considered non-routine under the rules of various national securities exchanges, and, in the absence of your voting instructions, your
broker, bank or other agent may not vote your shares held in street name on such proposals and the shares will be treated as broker non-votes. Proposals 1, 2, and 4 are matters considered non-routine under the applicable rules. If you do not give
your broker specific instructions, the broker will not vote your shares on Proposals 1, 2, and 4 and your shares will constitute broker non-votes which will be counted for purposes of determining whether a quorum exists but will not affect the
outcome of these proposals. Proposal 3 involves a matter we believe to be routine and thus if you do not give instructions to your broker, the broker may vote your shares in its discretion on Proposal 3 and therefore no broker non-votes are expected
to exist in connection with Proposal 3. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>ARE</SMALL> <SMALL>VOTES</SMALL> <SMALL>COUNTED</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will count, with respect to Proposals 1, 2, 3,
and 4 &#147;For&#148; votes, &#147;Against&#148; votes and abstentions, and with respect to Proposals 1, 2, and 4, broker non-votes. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>WILL</SMALL> <SMALL>SERVE</SMALL> <SMALL>AS</SMALL> <SMALL>INSPECTOR</SMALL> <SMALL>OF</SMALL> <SMALL>ELECTIONS</SMALL>?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A representative of Broadridge Financial Solutions, Inc. will serve as the inspector of elections. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>MANY</SMALL> <SMALL>VOTES</SMALL> <SMALL>ARE</SMALL> <SMALL>NEEDED</SMALL> <SMALL>TO</SMALL> <SMALL>APPROVE</SMALL>
<SMALL>EACH</SMALL> <SMALL>PROPOSAL</SMALL>? </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 1 electing three members of the board of directors, each director must receive a &#147;For&#148; vote from a majority of the votes cast at
the Annual Meeting on the election of directors. A majority of votes cast shall mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty percent (50%)&nbsp;of the number of votes cast with respect to that
director&#146;s election, with votes cast including votes &#147;Against&#148; in each case and excluding abstentions with respect to that director&#146;s election. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 2 approving an amendment to our Employee Stock Purchase Plan to increase the aggregate number of shares of common stock authorized for
issuance under the plan, the proposal must receive a &#147;For&#148; vote from the majority of the shares present and entitled to vote and cast either in person or by proxy. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 3 ratifying the audit committee&#146;s selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for
our fiscal year ending December&nbsp;31, 2014, the proposal must receive a &#147;For&#148; vote from the majority of the shares present and cast either in person or by proxy. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Proposal 4 approving the resolution regarding executive compensation, the proposal must receive a &#147;For&#148; vote from the majority of the
shares present and entitled to vote and cast either in person or by proxy. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HO</SMALL> <SMALL>IS</SMALL>
<SMALL>PAYING</SMALL> <SMALL>FOR</SMALL> <SMALL>THIS</SMALL> <SMALL>PROXY</SMALL> <SMALL>SOLICITATION</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will pay
for the entire cost of soliciting proxies. In addition to the Notice and the proxy materials, our directors and employees may also solicit proxies in person, by telephone or by other means of communication.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
We will not pay our directors and employees any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding the Notice
and any other proxy materials to beneficial owners. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>DOES</SMALL> <SMALL>IT</SMALL> <SMALL>MEAN</SMALL>
<SMALL>IF</SMALL> I <SMALL>RECEIVE</SMALL> <SMALL>MORE</SMALL> <SMALL>THAN</SMALL> <SMALL>ONE</SMALL> N<SMALL>OTICE</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you receive more than one Notice, your shares are registered in more than one name or are registered in different accounts. Please vote
by proxy according to each Notice to ensure that all of your shares are voted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>AN</SMALL> I <SMALL>CHANGE</SMALL>
<SMALL>MY</SMALL> <SMALL>VOTE</SMALL> <SMALL>AFTER</SMALL> <SMALL>SUBMITTING</SMALL> <SMALL>MY</SMALL> <SMALL>PROXY</SMALL>? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes, you can revoke your proxy at any time before the final vote at the Annual Meeting. If you are a stockholder of record, you may revoke
your proxy in any one of three ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A duly executed proxy card with a later date or time than the previously submitted proxy; </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A written notice that you are revoking your proxy to our Secretary, care of Nektar Therapeutics, at 455 Mission Bay Boulevard South, San Francisco, California 94158; or
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A later-dated vote on the Internet or by phone or a ballot cast in person at the Annual Meeting (simply attending the Annual Meeting will not, by itself, revoke your
proxy). </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner, you may revoke your proxy by submitting new instructions to your broker,
bank or other agent, or if you have received a proxy from your broker, bank or other agent giving you the right to vote your shares at the Annual Meeting, by attending the meeting and voting in person. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HEN</SMALL> <SMALL>ARE</SMALL> <SMALL>STOCKHOLDER</SMALL> <SMALL>PROPOSALS</SMALL> <SMALL>DUE</SMALL> <SMALL>FOR</SMALL> <SMALL>NEXT</SMALL>
<SMALL>YEAR</SMALL>&#146;<SMALL>S</SMALL> A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to Rule 14a-8 under the
Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), some stockholder proposals may be eligible for inclusion in our 2015 proxy statement. Any such proposal must be submitted in writing by January&nbsp;16, 2015, to our
Secretary, care of Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. If we change the date of our 2015 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline
shall be a reasonable time before we begin to print and send our proxy materials. Stockholders interested in submitting such a proposal are advised to contact knowledgeable counsel with regard to the detailed requirements of the applicable
securities laws and our bylaws. The submission of a stockholder proposal does not guarantee that it will be included in our proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alternatively, under our bylaws, if you wish to submit a proposal that is not to be included in next year&#146;s proxy statement or nominate a director, you must provide specific information to us no
earlier than March&nbsp;27, 2015 and no later than the close of business on April&nbsp;27, 2015. If we change the date of our 2015 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline shall be
changed to not later than the sixtieth day prior to such annual meeting and no earlier than the close of business on the ninetieth day prior to such annual meeting. In the event we provide less than 70 days&#146; notice or prior public disclosure of
the date of the annual meeting, the stockholder proposal or nomination must be received not later than the tenth day following the day on which such notice of the date of the annual meeting was mailed or such public disclosure was made. The public
announcement of an adjournment or postponement of the 2015 annual meeting does not commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described in this proxy statement. You are advised to review
our bylaws, which contain additional requirements with respect to advance notice of stockholder proposals and director nominees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A stockholder&#146;s submission must include certain specific information concerning the proposal or nominee, as the case may be, and information as to the stockholder&#146;s ownership of our common
stock. Proposals or nominations not meeting these requirements will not be entertained at any annual meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In relation to stockholder proposals and nominations, in certain instances we may exercise
discretionary voting authority under proxies held by the board of directors. For instance, if we do not receive a stockholder proposal by April&nbsp;27, 2015, we may exercise discretionary voting authority under proxies held by the board of
directors on such stockholder proposal. If we change the date of our 2015 annual meeting by more than 30 days from the date of the previous year&#146;s annual meeting, the deadline will change to a reasonable time before we begin to print and send
our proxy materials. In addition, even if we are notified of a stockholder proposal within the time requirements discussed above, if the stockholder does not comply with certain requirements of the Exchange Act, we may exercise discretionary voting
authority under proxies held by the board of directors on such stockholder proposal if we include advice in our proxy statement on the nature of the matter and how we intend to exercise our discretion to vote on the matter. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>W<SMALL>HAT</SMALL> <SMALL>IS</SMALL> &#147;<SMALL>HOUSEHOLDING</SMALL>&#148; <SMALL>AND</SMALL> <SMALL>HOW</SMALL> <SMALL>DOES</SMALL>
<SMALL>IT</SMALL> <SMALL>AFFECT</SMALL> <SMALL>ME</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a procedure approved by the SEC called
&#147;householding.&#148; Under this procedure, stockholders who have the same address may receive only one copy of the Notice, unless one or more of these stockholders notifies us that they wish to receive individual copies of the Notice and, if
requested, other proxy materials. This process potentially means extra convenience for stockholders and cost savings for companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of our common stock, once you receive notice from your broker, bank or other agent that they will be householding communications to your address, householding will continue
until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive separate Notices or other proxy materials, please notify your broker, bank or other
agent, direct your written request to Nektar Therapeutics, Secretary, 455 Mission Bay Boulevard South, San Francisco, California 94158 or contact our Secretary at (415)&nbsp;482-5300. Stockholders who currently receive multiple copies of the Notice
or other proxy materials at their address and would like to request householding of their communications should contact their broker, bank or other agent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OW</SMALL> <SMALL>CAN</SMALL> I <SMALL>FIND</SMALL> <SMALL>OUT</SMALL> <SMALL>THE</SMALL> <SMALL>RESULTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> <SMALL>VOTING</SMALL> <SMALL>AT</SMALL>
<SMALL>THE</SMALL> <SMALL>ANNUAL</SMALL> <SMALL>MEETING</SMALL>? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the
Annual Meeting. Final voting results will be published in a Current Report on Form 8-K filed with the SEC within four business days following the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_2"></A>PROPOSAL 1 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our board of directors is presently comprised of nine (9)&nbsp;directors and is divided into three (3)&nbsp;classes. Each class consists of one third of the total number of directors, and each class has a
three (3)&nbsp;year term. There are three (3)&nbsp;current directors in Class I, whose term of office expires in 2014: Joseph J. Krivulka, Howard W. Robin and Dennis L. Winger. Each of the current directors in Class I has been nominated for
reelection at the Annual Meeting. Messrs. Krivulka, Robin and Winger were all previously elected by the stockholders. Vacancies on the board, including vacancies created by an increase in the number of directors, are filled only by persons elected
by a majority of the remaining directors. A director elected by the board to fill a vacancy in a class serves until the earlier of the remainder of the full term of that class, that director&#146;s successor is elected and qualified or their death,
resignation or removal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are elected by a majority of the votes cast at the Annual Meeting on the election of
directors. A majority of votes cast shall mean that the number of shares voted &#147;For&#148; a director&#146;s election exceeds fifty percent (50%)&nbsp;of the number of votes cast with respect to that director&#146;s election, with votes cast
including votes &#147;Against&#148; in each case but excluding abstentions with respect to that director&#146;s election. Shares represented by executed proxies by stockholders of record will be voted for the election of the three&nbsp;nominees
named below, unless the &#147;Against&#148; or &#147;Abstain&#148; voting selection has been marked on the proxy card. Neither abstentions nor broker non-votes will have an effect on the outcome of the vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would otherwise be voted for such
nominee will be voted for the election of a substitute nominee proposed by the nominating and corporate governance committee and nominated by the board of directors. Each person nominated for election has agreed to serve if elected. Our management
has no reason to believe that any nominee will be unable to serve. If elected at the Annual Meeting, each of the nominees will serve until the earliest of the 2017 annual meeting of our stockholders, his successor is elected and qualified or his
death, resignation or removal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each nominee. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Joseph J. Krivulka, </I>age 62, has served as our director since March 2005. Mr.&nbsp;Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals, LLC, an emerging branded pharmaceutical
company, and has served in that capacity since its inception in February 2007.&nbsp;He is also the founder and chairman of Rouses Point Pharmaceuticals LLC, a generic pharmaceutical products company, as well as the founder and chairman of MIST
Pharmaceuticals, LLC, a cardiovascular pharmaceutical products company. Mr.&nbsp;Krivulka was the founder and President of Triax Pharmaceuticals, a dermatology products company, a position he held from November 2004 through the sale of the company
to PreCision Dermatology in April 2012. Mr.&nbsp;Krivulka was a co-founder and President of Reliant Pharmaceuticals, LLC, a company that markets pharmaceutical products, from 1999 until 2004. Mr.&nbsp;Krivulka was formerly Chief Executive Officer of
Bertek, Inc., a generic pharmaceutical products company that is a subsidiary of Mylan Inc., and Corporate Vice President of Mylan Inc., a generic pharmaceutical products company. He holds a B.S. from West Virginia Wesleyan College.<I>
</I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Howard W. Robin</I>, age 61, has served as our President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr.&nbsp;Robin served
as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served as their Chief Operating Officer, President and as
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
director. From 1991 to 2001, Mr.&nbsp;Robin was Corporate Vice President and General Manager at Berlex Laboratories, Inc., a pharmaceutical products company that is a subsidiary of Schering, AG,
and from 1987 to 1991 he served as Vice President of Finance and Business Development and Chief Financial Officer. From 1984 to 1987, Mr.&nbsp;Robin was Director of Business Planning and Development at Berlex. He was a Senior Associate with Arthur
Andersen&nbsp;&amp; Co. prior to joining Berlex. He received his B.S. in Accounting and Finance from Fairleigh Dickinson University in 1974. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L. Winger </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dennis L. Winger</I>, age 66, has served as our
director since December 2009. Mr.&nbsp;Winger was Senior Vice President and Chief Financial Officer of Applera Corporation, a life sciences company, from 1997 through December 2008. From 1989 to 1997, Mr.&nbsp;Winger served as Senior Vice President,
Finance and Administration, and Chief Financial Officer of Chiron Corporation. From 1982 to 1989, Mr.&nbsp;Winger was with The Cooper Companies, Inc., where he held positions of increasing responsibility, including that of Chief Financial Officer.
Mr.&nbsp;Winger currently serves on the board of directors of Accuray Incorporated (NASDAQ: ARAY), a radiosurgery company. Mr.&nbsp;Winger recently served on the board of directors of each of Vertex Pharmaceuticals Incorporated, a pharmaceutical
company, until May 2012, Cephalon, Inc. a pharmaceutical company, until its merger with Teva Pharmaceuticals Industry Limited in October 2011 and Cell Genesys, Inc. until its merger with BioSante Pharmaceuticals in October 2009. Mr.&nbsp;Winger
received a B.A. from Siena College and an M.B.A. from the Columbia University Graduate School of Business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF
DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF EACH NAMED NOMINEE. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_3"></A>PROPOSAL 2 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO OUR EMPLOYEE STOCK PURCHASE PLAN </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 1994, our board of directors adopted, and our stockholders subsequently approved, The Employee Stock Purchase Plan, as
amended and restated (the &#147;Purchase Plan&#148;). The Purchase Plan was amended and restated in May 2002, and the amended and restated version of the Purchase Plan was approved by our stockholders in June 2002. The amended and restated Purchase
Plan was amended in March 2010, and such amendment was approved by our stockholders in June 2010. On April&nbsp;11, 2014, subject to stockholder approval, our board of directors amended the Purchase Plan to increase the number of shares of common
stock available for issuance under the Purchase Plan by an additional 1,000,000 shares. Our board of directors adopted this amendment in order to ensure that a sufficient reserve of shares of common stock remains available for the grant of purchase
rights under the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, 1,500,000 shares of common stock are authorized for issuance under the Purchase
Plan. As of March&nbsp;31, 2014, 294,054 shares of common stock remain available for future issuance under the Purchase Plan. If stockholders approve the amendment to the Purchase Plan, the maximum number of shares authorized for issuance under the
Purchase Plan will increase from 1,500,000 shares to 2,500,000 shares. If approved, the additional 1,000,000 shares would bring the total number of shares currently available for grant under the Purchase Plan to 1,294,054 shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders are requested in this Proposal 2 to approve the amendment to the Purchase Plan. The affirmative vote of the holders of a
majority of the shares present in person or represented by proxy at the Annual Meeting and cast on this proposal will be required to approve the amendment to the Purchase Plan. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 2. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The essential features of the Purchase Plan, as amended and restated, are outlined below: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SUMMARY OF PURCHASE PLAN (AS PROPOSED TO BE AMENDED) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The principal terms of the Purchase Plan, as proposed to be amended, are summarized below. The following summary is qualified in its entirety by the full text of the Purchase Plan, in its current form,
which appears as Exhibit 1 to this proxy statement and can be reviewed on the SEC&#146;s website at http://www.sec.gov. You may also obtain, free of charge, a copy of the Purchase Plan by writing to Investor Relations at 455 Mission Bay Boulevard
South, San Francisco, California 94158. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PURPOSE </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The purpose of the Purchase Plan is (i)&nbsp;to provide a means by which our employees (and employees of any of our subsidiaries designated by the board of directors to participate in the Purchase Plan)
may be given an opportunity to purchase our common stock through payroll deductions, (ii)&nbsp;to assist us in retaining the services of our employees and secure and retain the services of new employees, and (iii)&nbsp;to provide incentives for such
persons to exert maximum efforts for our success. All of our employees employed in the United States are eligible to participate in the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The rights to purchase common stock granted under the Purchase Plan are intended to qualify as options issued under an &#147;employee stock purchase plan&#148; as that term is defined in
Section&nbsp;423(b) of the U.S. Internal Revenue Code. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADMINISTRATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors administers the Purchase Plan and has the final power to construe and interpret both the Purchase Plan and the
rights granted under it. The board of directors has the power, subject to the provisions </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of the Purchase Plan, to determine when and how rights to purchase common stock will be granted, the provisions of each offering of such rights (which need not be identical), and whether
employees of any of our subsidiaries will be eligible to participate in the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors has the
power, which it has not yet exercised, to delegate administration of the Purchase Plan to a committee composed of not fewer than two members of the board of directors. As used herein with respect to the Purchase Plan, the &#147;board of
directors&#148; refers to any committee the board of directors appoints and to the board of directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>STOCK SUBJECT TO PURCHASE PLAN
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, a maximum of 1,500,000 shares of common stock are authorized for issuance under the Purchase Plan. If
stockholders approve the amendment to the Purchase Plan, the maximum number of shares authorized for issuance under the Purchase Plan will increase from 1,500,000 shares to 2,500,000 shares (an increase of 1,000,000 shares). If rights granted under
the Purchase Plan expire, lapse or otherwise terminate without being exercised, the shares of common stock not purchased under such rights again become available for issuance under the Purchase Plan. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OFFERINGS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Purchase
Plan is implemented by offerings of rights to all eligible employees from time to time by the board of directors. The maximum length for an offering under the Purchase Plan is twenty-seven months. Currently, under the Purchase Plan, each offering is
twenty- four months long and is divided into four shorter &#147;purchase periods&#148; approximately six months long. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELIGIBILITY
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise determined by the board of directors in accordance with the terms of the Purchase Plan, any person who is
customarily employed at least twenty hours per week and five months per calendar year by us (or by any of our parent or subsidiary designated by the board of directors) on the first day of an offering is eligible to participate in that offering,
provided that such employee has been continuously employed by us or the designated parent or subsidiary corporation for at least six months preceding the first day of the offering. Officers who are &#147;highly compensated&#148; as defined in the
U.S. Internal Revenue Code may be eligible to participate in the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">However, no employee is eligible to
participate in the Purchase Plan if, immediately after the grant of purchase rights, the employee would own, directly or indirectly, stock possessing 5% or more of the total combined voting power or value of all classes of our stock or of any parent
or subsidiary (including any stock which such employee may purchase under all outstanding rights and options). In addition, no employee may accrue rights to purchase more than $25,000 worth of common stock (determined at the fair market value of the
shares at the time such rights are granted) under all of our employee stock purchase plans and the employee stock purchase plans of any of our parent or subsidiary corporations in any calendar year. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;31, 2014, approximately 360 individuals employed by the Company and participating subsidiaries are eligible to
participate in the Purchase Plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PARTICIPATION IN THE PURCHASE PLAN </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eligible employees enroll in the Purchase Plan by delivering to us, prior to the date selected by the board of directors for the offering,
an agreement authorizing payroll deductions of up to 15% of such employees&#146; total compensation during the offering. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PURCHASE PRICE </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The purchase price per share at which shares of common stock are sold in an offering under the Purchase Plan is the lower of (i)&nbsp;85% of the fair market value of a share of common stock on the first
day of the offering or (ii)&nbsp;85% of the fair market value of a share of common stock on the applicable purchase dates. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PAYMENT OF
PURCHASE PRICE; PAYROLL DEDUCTIONS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The purchase price of the shares is accumulated by payroll deductions over the
offering. At any time during the offering, a participant may reduce or terminate his or her payroll deductions as the board of directors provides in the offering. A participant may increase or decrease such payroll deductions after the beginning of
the offering as the board of directors provides in the offering. Further, in the case of an employee who first becomes eligible to participate as of a date specified during the offering, such employee may make payroll deductions after the beginning
of the offering. All payroll deductions made for a participant are credited to his or her account under the Purchase Plan and deposited with our general funds. A participant may not currently make additional payments into such account. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PURCHASE OF STOCK </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon
execution of an agreement to participate in the Purchase Plan by an employee, shares of common stock are automatically purchased on the employee&#146;s behalf under the Purchase Plan. In connection with offerings made under the Purchase Plan, the
board of directors specifies a maximum number of shares of common stock an employee may be granted the right to purchase and the maximum aggregate number of shares of common stock that may be purchased pursuant to such offering by all participants.
If the aggregate number of shares to be purchased upon exercise of rights granted in the offering would exceed the maximum aggregate number of shares of common stock available, the board of directors would make a pro rata allocation of available
shares in a uniform and equitable manner. Unless the employee&#146;s participation is discontinued, his or her right to purchase shares is exercised automatically at the end of the offering at the applicable price. See &#147;Withdrawal&#148; below.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>WITHDRAWAL </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While each participant in the Purchase Plan is required to sign an agreement authorizing payroll deductions, the participant may withdraw
from a given offering by terminating his or her payroll deductions and by delivering to us a notice of withdrawal from the Purchase Plan. Such withdrawal may be elected at any time prior to the end of the applicable offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon any withdrawal from an offering by the employee, we will distribute to the employee his or her accumulated payroll deductions
without interest, less any accumulated deductions previously applied to the purchase of shares of common stock on the employee&#146;s behalf during such offering, and such employee&#146;s interest in the offering will be automatically terminated.
The employee is not entitled to again participate in that offering. However, an employee&#146;s withdrawal from an offering will not have any effect upon such employee&#146;s eligibility to participate in subsequent offerings under the Purchase
Plan. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TERMINATION OF EMPLOYMENT </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Rights granted pursuant to any offering under the Purchase Plan terminate immediately upon cessation of an employee&#146;s employment for any reason, and we will distribute to such employee all of his or
her accumulated payroll deductions, without interest. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RESTRICTIONS ON TRANSFER </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rights granted under the Purchase Plan are not transferable, other than by will or the laws of descent and distribution or by a
beneficiary designation by the employee in the event of the employee&#146;s death, and may be exercised only by the person to whom such rights are granted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADJUSTMENT PROVISIONS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Transactions not involving receipt of consideration by us, such as a merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock
split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by us, will result in appropriate changes to the type(s), class(es) and number of
shares of common stock subject to the Purchase Plan and to outstanding purchase rights. In that event, the Purchase Plan will be appropriately adjusted in the type(s), class(es) and maximum number of shares subject to the Purchase Plan and the
outstanding purchase rights granted under the Purchase Plan will be appropriately adjusted in the type(s), class(es), number of shares and purchase limits of such purchase rights. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>EFFECT OF CERTAIN CORPORATE TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event of (i)&nbsp;the
sale, lease, license or other disposition of all or substantially all of our assets, (ii)&nbsp;the sale or other disposition of at least 90% of our outstanding securities, (iii)&nbsp;a merger, consolidation or similar transaction following which we
are not the surviving corporation or (iv)&nbsp;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately preceding the merger, consolidation or similar
transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property (collectively, &#147;corporate transaction&#148;), any surviving or acquiring corporation may continue or assume rights
outstanding under the Purchase Plan or may substitute similar rights. If any surviving or acquiring corporation does not continue or assume such rights or substitute similar rights, then the participants&#146; accumulated payroll deductions will be
used to purchase shares of common stock within ten days prior to the corporate transaction under the ongoing offering and the participants&#146; rights under the ongoing offering will terminate immediately after such purchase. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DURATION, AMENDMENT AND TERMINATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors may suspend or terminate the Purchase Plan at any time. Unless terminated earlier, the Purchase Plan will terminate at the time that all of the shares of common stock reserved for
issuance under the Purchase Plan, as increased and/or adjusted from time to time, have been issued under the terms of the Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors may amend the Purchase Plan at any time. Any amendment of the Purchase Plan must be approved by the stockholders if the amendment is necessary for the Purchase Plan to satisfy
Section&nbsp;423 of the U.S. Internal Revenue Code or other applicable laws and regulations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rights granted before amendment
or termination of the Purchase Plan will not be altered or impaired by any amendment or termination of the Purchase Plan without consent of the employee to whom such rights were granted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>FEDERAL INCOME TAX INFORMATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following is a general summary of the
current federal income tax principles applicable to the Purchase Plan. The following summary is not intended to be exhaustive and does not describe state, local or international tax consequences. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Purchase Plan is intended to qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the U.S. Internal
Revenue Code. Participant contributions to the Purchase Plan are made on an after-tax basis. That is, a participant&#146;s Purchase Plan contributions are deducted from compensation that is taxable to the participant and for which the Company is
generally entitled to a tax deduction. Generally, no taxable income is recognized by a participant with respect to either the grant or exercise of his or her Purchase Plan option. The Company will have no tax deduction with respect to either of
those events. A participant will generally recognize income (or loss) only upon a sale or disposition of any shares that the participant acquires under the Purchase Plan. The </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
particular tax consequences of a sale of shares acquired under the Purchase Plan depends on whether the participant has held the shares for a &#147;Required Holding Period&#148; before selling or
disposing of the shares. The Required Holding Period starts on the date that the participant acquires the shares under the Purchase Plan and ends on the later of (1)&nbsp;two years after the grant date of the offering period in which the participant
acquired the shares, or (2)&nbsp;one year after the exercise date on which the participant acquired the shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the
participant holds the shares for the Required Holding Period and then sells the shares at a price in excess of the purchase price paid for the shares, the gain on the sale of the shares will be taxed as ordinary income to the participant to the
extent of the lesser of (1)&nbsp;the amount by which the fair market value of the shares on the grant date of the offering period in which the participant acquired the shares exceeded the purchase price of the shares (calculated as though the shares
had been purchased on the grant date), or (2)&nbsp;the gain on the sale of the shares. Any portion of the participant&#146;s gain on the sale of the shares not taxed as ordinary income will be taxed as long-term capital gain. If the participant
holds the shares for the Required Holding Period and then sells the shares at a price less than the purchase price paid for the shares, the loss on the sale will be treated as a long-term capital loss to the participant. The Company will not be
entitled to a tax deduction with respect to any shares held by the participant for the Required Holding Period, regardless of whether the shares are eventually sold at a gain or a loss. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The participant has a &#147;Disqualifying Disposition&#148; if the participant disposes of the shares before the participant has held the
shares for the Required Holding Period. If the participant sells the shares in a Disqualifying Disposition, the participant will realize ordinary income in an amount equal to the difference between the purchase price paid for the shares and the fair
market value of the shares on the exercise date on which the participant acquired the shares, and the Company generally will be entitled to a corresponding tax deduction. In addition, if the participant makes a Disqualifying Disposition of the
shares at a price in excess of the fair market value of the shares on the exercise date, the participant will realize capital gain in an amount equal to the difference between the selling price of the shares and the fair market value of the shares
on the exercise date. Alternatively, if the participant makes a Disqualifying Disposition of the shares at a price less than the fair market value of the shares on the Exercise Date, the participant will realize a capital loss in an amount equal to
the difference between the fair market value of the shares on the exercise date and the selling price of the shares. The Company will not be entitled to a tax deduction with respect to any capital gain realized by a participant. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITIES UNDERLYING AWARDS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The closing price of a share of the Company&#146;s common stock as of April&nbsp;28, 2014 was $11.49&nbsp;per share. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>SPECIFIC BENEFITS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The benefits that will be received by or allocated to
eligible participants under the Purchase Plan in the future cannot be determined at this time because the amount of contributions set aside to purchase shares of common stock under the Purchase Plan (subject to the limitations discussed above) is
entirely within the discretion of each participant. If the amended and restated version of the Purchase Plan had been in effect for the year ended December&nbsp;31, 2013, we do not expect that the number of shares purchased by participants in the
plan during that year would have been materially different than the numbers of shares purchased as set forth in the table below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As of March&nbsp;31, 2014, 1,205,946 shares of our common stock had been purchased under the Purchase Plan. For information regarding stock-based awards granted to the Named Executive Officers during
fiscal 2013, see the material under the heading &#147;Executive Compensation Plan Information&#148; below. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Aggregate Past Purchases Under Purchase Plan </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Position</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate&nbsp;Number&nbsp;of&nbsp;Shares<BR>Purchased Under the Plan in<BR>the&nbsp;Year&nbsp;Ended&nbsp;December&nbsp;31,<BR>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate&nbsp;Number&nbsp;of&nbsp;Shares<BR>Purchased&nbsp;Under&nbsp;the&nbsp;Plan&nbsp;in<BR>All Completed Offering<BR>Periods</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Group:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Finance and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Scientific Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rinko Ghosh</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and Chief Business Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President and General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Non-Executive Director Group:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis L. Winger</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All employees, including all current officers who are not executive officers, as a group:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">140,231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,205,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Chess participated in the Purchase Plan while employed by the Company. </FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>EQUITY COMPENSATION PLAN INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company currently maintains five
equity compensation plans: the 2012 Plan, the 2008 Plan, the 2000 Non-Officer Plan, the 2000 Plan and the Purchase Plan. With the exception of the 2000 Non-Officer Plan, these plans have each been approved by the Company&#146;s stockholders.
Stockholders are being asked to approve an amendment to the Purchase Plan, as described above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets
forth, for each of the Company&#146;s equity compensation plans, the number of shares of common stock subject to outstanding awards, the weighted-average exercise price of outstanding options, and the number of shares remaining available for future
award grants as of December&nbsp;31, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:46pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;shares&nbsp;of<BR>Common&nbsp;Stock&nbsp;to&nbsp;be<BR>issued&nbsp;upon&nbsp;
exercise&nbsp;of<BR>outstanding&nbsp;options,<BR>warrants&nbsp;and&nbsp;rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise&nbsp;price&nbsp;of<BR>outstanding&nbsp;
options,<BR>warrants&nbsp;and&nbsp;rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;shares&nbsp;of&nbsp;Common<BR>Stock&nbsp;remaining&nbsp;available&nbsp;
for<BR>future&nbsp;issuance&nbsp;under&nbsp;equity<BR>compensation&nbsp;plans&nbsp;(excluding<BR>shares&nbsp;reflected&nbsp;in&nbsp;the&nbsp;first&nbsp;column)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,936,311</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.76</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,954,265</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by stockholders</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,718,904</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">5</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.84</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,655,215</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.06</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,954,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of these shares, 3,781,991 shares were subject to options then outstanding under the 2012 Plan. In addition, 3,957,282 shares were subject to options
then outstanding under the 2008 Plan, and 7,197,038 shares were subject to options then outstanding under the 2000 Plan. The Company&#146;s authority to grant new awards under the 2000 Plan terminated on February&nbsp;9, 2010, and the Company&#146;s
authority to grant new awards under the 2008 Plan terminated on June&nbsp;28, 2012. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This weighted-average exercise price does not reflect the shares that will be issued upon the payment of outstanding restricted stock units.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This number of shares is presented after giving effect to the 67,056 shares purchased under the Purchase Plan for the purchase period that ended
November&nbsp;30, 2013. Of the aggregate number of shares that remained available for future issuance, 7,660,211 shares were available under the 2012 Plan, and 294,054 shares were available under the Purchase Plan. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">This row reflects information for the 2000 Non-Officer Plan. The 2000 Non-Officer Plan was adopted by our board of directors on August&nbsp;18, 1998,
and was amended and restated in its entirety on June&nbsp;6, 2000. The purpose of the 2000 Non-Officer Plan is to attract and retain qualified personnel, to provide additional incentives to employees and consultants and to promote the success of our
business. Pursuant to the 2000 Non-Officer Plan, we may grant or issue non-qualified stock options, rights to acquire restricted stock and stock bonuses to employees and consultants who are neither officers nor directors of the Company. The maximum
term of a stock option under the 2000 Non-Officer Plan is eight years. The exercise price of stock options granted under the 2000 Non-Officer Plan is determined by our board of directors by reference to the closing price of our common stock on the
Nasdaq Global Market on the date of grant. The Company&#146;s authority to grant new awards under the 2000 Non-Officer Plan terminated on June&nbsp;28, 2012. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">5</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Of these shares, 5,718,904 were subject to options then outstanding under the 2000 Non-Officer Plan. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_4"></A>PROPOSAL 3 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee of the board of directors has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting
firm for the fiscal year ending December&nbsp;31, 2014, and has further directed that management submit the selection of our independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. Ernst&nbsp;&amp;
Young LLP has audited our financial statements since our inception in 1990. Representatives of Ernst&nbsp;&amp; Young LLP are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will
be available to respond to appropriate questions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neither our bylaws nor other governing documents or law require stockholder
ratification of the selection of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. However, the audit committee is submitting the selection of Ernst&nbsp;&amp; Young LLP to the stockholders for ratification as a matter
of good corporate practice. If the stockholders fail to ratify the selection, the audit committee will reconsider whether or not to retain Ernst&nbsp;&amp; Young LLP. Even if the selection is ratified, the audit committee, in its discretion, may
direct the appointment of a different independent registered public accounting firm at any time during the year if the committee determines that such a change would be in our best interests and our stockholders&#146; best interest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares of our common stock present in person or represented by proxy at the
Annual Meeting and cast on this proposal will be required to ratify the selection of Ernst&nbsp;&amp; Young LLP for our fiscal year ending December&nbsp;31, 2014. Abstentions are treated as shares represented in person or by proxy and entitled to
vote at the Annual Meeting and, therefore, will have the effect of a vote against the ratification of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm. No broker non-votes are expected to exist in connection with this
proposal. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 3. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_5"></A>PROPOSAL 4 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors is committed to excellence in governance and is aware of the significant interest in executive compensation matters by investors and the general public. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have designed our executive compensation program to attract, motivate, reward and retain the senior management talent required to
achieve our corporate objectives and increase stockholder value. We believe that our compensation policies and procedures are centered on pay-for-performance principles and are strongly aligned with the long-term interests of our stockholders.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We urge you to carefully review the Compensation Discussion and Analysis section of this proxy statement for details on our
executive compensation, including our compensation philosophy and objectives and the 2013 compensation of the Named Executive Officers described in &#147;Information About the Executive Officers&#151;Compensation Discussion and
Analysis&#151;Introduction.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are presenting this proposal, which gives you as a stockholder the opportunity to
endorse or not endorse our compensation program for the Named Executive Officers by voting for or against the following resolution (a &#147;say-on-pay&#148; vote), as required pursuant to Section&nbsp;14A of the Exchange Act: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;RESOLVED, that the compensation paid to the Company&#146;s Named Executive Officers, as disclosed pursuant to Item&nbsp;402 of
Regulation S-K promulgated by the SEC, including the Compensation Discussion and Analysis, compensation tables and related narrative discussion contained in the proxy statement for the Company&#146;s 2014 Annual Meeting is hereby APPROVED.&#148;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While the vote on the resolution is advisory in nature and therefore will not bind us to take any particular action, our
board of directors and our organization and compensation committee intend to carefully consider the stockholder vote resulting from the proposal in making future decisions regarding our compensation program. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the results of voting at our 2011 annual meeting of stockholders, we have determined to hold a non-binding advisory vote on the
compensation of Named Executive Officers every year, until the next non-binding advisory vote on the frequency of future advisory votes on the compensation of our Named Executive Officers. Accordingly, we expect that our next say-on-pay vote will be
held at the 2015 annual meeting of stockholders. An advisory vote on the frequency of future advisory votes on the compensation paid to our Named Executive Officers is required to be held at least once every six years. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of a majority of the votes cast by holders of the shares of common stock present in person or represented by proxy
at the Annual Meeting is required (on a non-binding advisory basis) for approval of this proposal. Abstentions are treated as shares represented in person or by proxy and entitled to vote at the Annual Meeting and, therefore, will have the effect of
a vote against this proposal. Broker non-votes will have no effect on the outcome of the vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS
RECOMMENDS A VOTE IN FAVOR OF PROPOSAL 4. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_6"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of our common stock as of April&nbsp;15, 2014,
by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of our Named Executive Officers; (iii)&nbsp;all of our executive officers and directors as a group; and (iv)&nbsp;all those known by us to be beneficial owners of more than five
percent of our common stock. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Ownership&nbsp;**</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:59pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">OppenheimerFunds, Inc. and related entities (1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">PRIMECAP Management Company (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,498,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">BlackRock, Inc. and certain subsidiaries (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,065,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Vanguard Group (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,527,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.93</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">511,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">209,999</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">206,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">236,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">225,616</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,387,492</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wang (11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">206,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield (12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">206,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Winger (13)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">176,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D. (14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">685,830</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rinko Ghosh (15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">695,275</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie (16)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">953,734</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson (17)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">989,788</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers and directors as a group (16 persons)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,655,091</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denotes ownership percentage less than 1%. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This table is based upon information supplied by officers, directors and principal stockholders and Schedules 13G filed with the SEC. Unless otherwise indicated in the
footnotes to this table, and subject to community property laws where applicable, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable
percentages are based on 126,936,564 shares outstanding on April&nbsp;15, 2014, adjusted as required by rules promulgated by the SEC. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;16) filed with the SEC on February&nbsp;7, 2014 by OppenheimerFunds, Inc., a registered investment adviser under
Section&nbsp;203 of the Investment Advisers Act of 1940, and Oppenheimer Global Opportunities Fund, an investment company registered under Section&nbsp;8 of the Investment Company Act of 1940. Oppenheimer Global Opportunities Fund has sole voting
and shared dispositive power with respect to 23,000,000 shares of our common stock. OppenheimerFunds, Inc. has shared voting and dispositive power with respect to the 23,000,000 shares of our common stock beneficially owned by Oppenheimer Global
Opportunities Fund. OppenheimerFunds, Inc. disclaims beneficial ownership as an investment adviser pursuant to Rule 13d-4 of the Exchange Act. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;4) filed with the SEC on February&nbsp;14, 2014 by PRIMECAP Management Company, a registered investment adviser
under Section&nbsp;203 of the Investment Advisers Act of 1940. PRIMECAP Management Company has the sole voting power with respect to 10,496,486 shares of our common stock and sole dispositive power with respect to 12,498,386 shares of our common
stock. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;4) filed with the SEC on January&nbsp;30, 2014 by BlackRock, Inc., a parent holding company or control person in
accordance with Rule 13d-1(b)(1)(ii)(G). BlackRock, Inc. has the sole voting power with respect to 7,668,936 shares of our common stock and the sole dispositive power with respect to 8,065,265 shares of our common stock. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based solely on the Schedule 13G/A (Amendment No.&nbsp;1) filed with the SEC on February&nbsp;12, 2014 by The Vanguard Group, a registered investment adviser under
Section&nbsp;203 of the Investment Advisers Act of 1940. The Vanguard Group has the sole voting power with respect to 167,931 shares of our common stock, sole dispositive power with respect to 7,365,907 shares of our common stock and shared
dispositive power with respect to 161,531 shares of our common stock. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;251,166 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014, and (ii)&nbsp;4,914 shares issued pursuant to our
401(k) Retirement Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 159,166 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 186,666 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 216,666 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 209,166 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;3,377,082 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014 and (ii)&nbsp;410 shares owned by
Mr.&nbsp;Robin&#146;s wife. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 186,666 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;186,666 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014 and (ii)&nbsp;20,000 shares held in trust for
Mr.&nbsp;Whitfield&#146;s children under which Mr.&nbsp;Whitfield is the sole trustee. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 160,416 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 685,830 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(15)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;685,522 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014, (ii)&nbsp;3,153 shares issued pursuant to our
401(k) Retirement Plan, and (iii)&nbsp;1,500 shares issued pursuant to our Employee Stock Purchase Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(16)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;949,983 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014, (ii)&nbsp;997 shares issued pursuant to our 401(k)
Retirement Plan, and (iii)&nbsp;250 shares issued pursuant to our Employee Stock Purchase Plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(17)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 979,788 shares issuable upon exercise of options exercisable within 60 days of April&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_7"></A>S<SMALL>ECTION</SMALL>&nbsp;16(<SMALL>A</SMALL>) B<SMALL>ENEFICIAL</SMALL> O<SMALL>WNERSHIP</SMALL> R<SMALL>EPORTING</SMALL>
C<SMALL>OMPLIANCE</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires our directors and executive officers, and
persons who beneficially own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers,
directors and greater than ten percent beneficial owners are required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To our knowledge, based solely on our review of Forms 3, 4 and 5, and any amendments thereto, furnished to us or written representations that no Form 5 was required, we believe that during the fiscal year
ended December&nbsp;31, 2013, all filing requirements applicable to our executive officers and directors under the Exchange Act were met in a timely manner. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_8"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We review all relationships and transactions between us and (i)&nbsp;any of our directors or executive officers,
(ii)&nbsp;any nominee for election as a director, (iii)&nbsp;any security holder who is known to us to own beneficially or of record more than five percent of our common stock or (iv)&nbsp;any member of the immediate family of any of the foregoing.
Our legal staff is primarily responsible for the development and implementation of processes and controls to obtain information with respect to related person transactions and for then determining, based on the facts and circumstances, whether the
Company or a related person has a direct or indirect material interest in the transaction. In addition, the audit committee reviews and approves or ratifies any related person transaction that is required to be disclosed. In the course of its review
and approval or ratification of a disclosable related party transaction, the committee considers: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the nature of the related person&#146;s interest in the transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the material terms of the transaction, including, without limitation, the dollar amount and type of transaction; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the related person; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the importance of the transaction to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether the transaction would impair the judgment of a director or executive officer to act in the best interest of the Company; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other matters the committee deems appropriate. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any member of the audit committee who is a related person with respect to a transaction under review may not participate in the deliberations or vote respecting approval or ratification of the
transaction, provided, however, that such director may be counted in determining the presence of a quorum at a meeting where the audit committee reviews the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As required under SEC rules, related party transactions that are determined to be directly or indirectly material to us or the related party are disclosed in our proxy statement. Historically, we have not
entered into transactions with related parties. Michael Robin, the son of Howard W. Robin, our President and Chief Executive Officer and one of the Class I directors nominated for election at the 2014 Annual Meeting, is employed by the Company in a
non-executive officer capacity as a manager in our business development group.&nbsp;During 2013, Michael Robin&#146;s total compensation was approximately $137,000 including base salary, target bonus, stock options (based on grant date fair value),
and benefits. Michael Robin&#146;s compensation was established by the Company in accordance with its compensation practices applicable to employees with equivalent qualifications and responsibilities and holding similar positions, without the
direct involvement of Howard W. Robin. During the 2013 fiscal year, there were no other relationships or transactions between us and any related party for which disclosure is required under the rules of the SEC. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_9"></A>INFORMATION ABOUT THE BOARD OF DIRECTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a brief biography of each current director, including each nominee for reelection at the Annual Meeting to a new term of
office and each director whose current term of office continues through the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_10"></A>THE BOARD OF
DIRECTORS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_11"></A>D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> <SMALL>IN</SMALL> O<SMALL>FFICE</SMALL>
U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2015 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Robert B. Chess</I>, age 57, is the Chairman of our board of directors and has served as a director since May 1992.
From March 2006 until January 2007, Mr.&nbsp;Chess served as our Acting President and Chief Executive Officer, and from April 1999 to January 2007, served as Executive Chairman.&nbsp;He also served as our Co-Chief
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Executive Officer from August 1998 to April 2000, as President from December 1991 to August 1998, and as Chief Executive Officer from May 1992 to August 1998. Mr.&nbsp;Chess was previously the
co-Founder and President of Penederm, Inc., a publicly-traded dermatological pharmaceutical company that was sold to Mylan Laboratories. He has held management positions at Intel Corporation and Metaphor Computer Systems (now part of IBM), and was a
member of the first President Bush&#146;s White House staff as a White House Fellow and Associate Director of the White House Office of Economic and Domestic Policy.&nbsp;From 1997 until his retirement in 2009, Mr.&nbsp;Chess served on the board of
directors of the Biotechnology Industry Organization (BIO).&nbsp;Mr. Chess served as Chairman of BIO&#146;s Emerging Companies Section&nbsp;and Co-Chairman of BIO&#146;s Intellectual Property Committee. Mr.&nbsp;Chess was the initial Chairman of Bio
Ventures for Global Health and continues to serve on its board.&nbsp;He also serves on the Board of Trustees of the California Institute of Technology where he chairs the Technology Transfer Committee and as a trustee of the Committee for Economic
Development. Mr.&nbsp;Chess is currently the Chairman of OPX Biotechnologies, a private company in the renewable fuels and chemicals field and also serves as a director of Pelvalon, Inc., a private medical device company. He is currently a member of
the faculty of the Stanford Graduate School of Business, where he teaches courses in the MBA program on starting technology-based businesses and the healthcare industry.&nbsp;Mr. Chess received his B.S. degree in Engineering with honors from the
California Institute of Technology and an M.B.A. from Harvard University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Susan Wang</I>, age 63, has served as our director since December 2003. Ms.&nbsp;Wang, who retired from Solectron Corporation in May
2002, served in various management positions there from 1984 to June 2002. Her final position at Solectron, an electronics manufacturing services and supply chain solutions company, was Executive Vice President for Corporate Development and Chief
Financial Officer, a position she held from September 2001 to June 2002. Prior to joining Solectron, Ms.&nbsp;Wang held financial and managerial positions with Xerox Corporation and Westvaco Corporation. She began her career with Price
Waterhouse&nbsp;&amp; Co. in New York and was a certified public accountant. Ms.&nbsp;Wang is also a director of Cirrus Logic, Inc. (NASDAQ: CRUS), an analog chip company, and Premier, Inc. (NASDAQ: PINC), a healthcare information technology and
hospital supply chain company. She serves as Chair of the audit committees of both Cirrus Logic, Inc. and Premier, Inc. and is a member of the compensation committee of Cirrus Logic. In addition, Ms.&nbsp;Wang served as a director of Suntech Power
Holdings Co., Ltd., a solar energy company, from 2009 to August 2013, a director of Altera Corporation, a programmable semiconductor company from 2002 to May 2013, a director of Calpine Corporation, an independent power generation company, from 2003
to 2009, Avanex Corporation, a telecommunications component and sub-systems provider, from 2002 to 2009 and Rae Systems Inc., a developer of sensory technology for hazardous materials from 2009 to 2011. Ms.&nbsp;Wang holds an M.B.A. from the
University of Connecticut and a B.S. in accounting from the University of Texas. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Roy A. Whitfield</I>, age 60, has served as our director since August 2000. Mr.&nbsp;Whitfield is the former Chairman of the Board and
Chief Executive Officer of Incyte Corporation, a drug discovery and development company he co-founded in 1991. From January 1993 to November 2001, Mr.&nbsp;Whitfield served as its Chief Executive Officer and from November 2001 until June 2003 as its
Chairman. He also served as a director of Incyte from 1991 to January 2014. From 1984 to 1989, Mr.&nbsp;Whitfield held senior operating and business development positions with Technicon Instruments Corporation, a medical instrumentation company, and
its predecessor company, Cooper Biomedical, Inc., a biotechnology and medical diagnostics company. Prior to his work at Technicon, Mr.&nbsp;Whitfield spent seven years with the Boston Consulting Group&#146;s international consulting practice. He
currently serves as a director of Illumina, Inc., a developer, manufacturer and marketer of integrated systems for analysis of genetic variations and biological functions, and Station X, Inc. a private company. Since February 2008, he has also
served as Executive Chairman of the board of directors of Bioseek. Mr.&nbsp;Whitfield received a B.S. in mathematics from Oxford University and an M.B.A. from Stanford University. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_12"></A>D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> <SMALL>IN</SMALL>
O<SMALL>FFICE</SMALL> U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2016 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R.
Scott Greer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>R. Scott Greer</I>, age 55, has served as our director since February 2010. Mr.&nbsp;Greer currently serves
as Managing Director of Numenor Ventures, LLC, a venture capital firm. In 1996, Mr.&nbsp;Greer co-founded Abgenix, Inc., a company that specialized in the discovery, development and manufacture of human therapeutic antibodies, and from June 1996
through May 2002, he served as its Chief Executive Officer. He also served as a director of Abgenix from 1996 and Chairman of the board of directors from 2000 until the acquisition of Abgenix by Amgen, Inc. in April 2006. Prior to Abgenix&#146;s
formation, Mr.&nbsp;Greer held senior management positions at Cell Genesys, Inc., a biotechnology company, initially as Chief Financial Officer and Vice President of Corporate Development and later as Senior Vice President of Corporate Development,
and various positions at Genetics Institute, Inc., a biotechnology research and development company. Mr.&nbsp;Greer served as a member of the board of directors of Sirna Therapeutics, Inc., a biotechnology company, from 2003, and as its Chairman of
the board of directors from 2005, through the closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. From 2001 to 2005, Mr.&nbsp;Greer served as a member of the board of directors of Illumina, Inc., a provider of
integrated systems for the analysis of genetic variation and biological function, and from 2001 to 2004, he served as member of the board of directors of CV Therapeutics, Inc., a biotechnology company. He currently serves as a member of the board of
directors of StemCells, Inc. (NASDAQ: STEM), a biopharmaceutical company focused on stem cell therapeutics, and as chairman of the board of directors of Ablexis LLC, a private development-stage biotechnology company. Mr.&nbsp;Greer received a B.A.
in Economics from Whitman College and an M.B.A. degree from Harvard University. He also was a certified public accountant. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Christopher A. Kuebler</I><B></B>, age 60, has served as our director since December 2001. Mr.&nbsp;Kuebler also currently serves on the board of directors of Waters Corporation, an analytical
technologies products and services company. From January 1997 to December 2005, Mr.&nbsp;Kuebler served as Chairman of the Board of Covance Inc., a drug development services company, and from November 1994 to December 2004, served as its Chief
Executive Officer. From March 1993 through November 1994, he was the Corporate Vice President, European Operations for Abbott Laboratories, a diversified health care company. From January 1986 until March 1993, Mr.&nbsp;Kuebler served in various
commercial positions for Abbott Laboratories&#146; Pharmaceutical Division and was that Division&#146;s Vice President, Sales and Marketing prior to taking the position of Corporate Vice President, European Operations. Before that, he held positions
at Squibb Inc. and Monsanto Health Care. Mr.&nbsp;Kuebler holds a B.S. in Biological Science from Florida State University.<B> </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Lutz Lingnau</I>, age 71, has served as our director since
August 2007. Mr.&nbsp;Lingnau retired from Schering AG Group, Germany, in December 2005 as a member of Schering AG&#146;s Executive Board and as Vice Chairman, President and Chief Executive Officer of Schering Berlin, Inc., a United States
subsidiary. Prior to his retirement, Mr.&nbsp;Lingnau was responsible for Schering AG&#146;s worldwide specialized therapeutics and dermatology businesses. He joined Schering AG&#146;s business trainee program in 1966. Throughout his career at
Schering AG, he served in various capacities and in a number of subsidiaries in South America and the United States, including his roles as President of Berlex Laboratories, Inc., from 1983 to 1985, as the Head of Worldwide Sales and Marketing in
the Pharmaceutical Division of Schering AG, from 1985 to 1989, and as Chairman of Berlex Laboratories, Inc. from 1985 to 2005. Mr.&nbsp;Lingnau was a member of the Supervisory Board of LANXESS AG, a specialty chemicals company listed on the
Frankfurt Stock Exchange from 2005 to May 2010. From December 2006 through September 2009, he served as Chairman of the board of directors of Micropharma Limited, a private biotechnology company, and was a member of was a member of the board of
directors of Sirna Therapeutics, Inc., a biotechnology company, from February 2006 through the closing of the acquisition of Sirna by Merck&nbsp;&amp; Co., Inc. in December 2006. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_13"></A>C<SMALL>URRENT</SMALL> D<SMALL>IRECTORS</SMALL> N<SMALL>OMINATED</SMALL>
F<SMALL>OR</SMALL> R<SMALL>EELECTION</SMALL> <SMALL>TO</SMALL> S<SMALL>ERVE</SMALL> U<SMALL>NTIL</SMALL> <SMALL>THE</SMALL> 2017 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Joseph J. Krivulka, </I>age 62, has served as our director since March 2005. Mr.&nbsp;Krivulka is the founder and current Chairman of Akrimax Pharmaceuticals, LLC, an emerging branded pharmaceutical
company, and has served in that capacity since its inception in February 2007.&nbsp;He is also the founder and chairman of Rouses Point Pharmaceuticals LLC, a generic pharmaceutical products company, as well as the founder and chairman of MIST
Pharmaceuticals, LLC, a cardiovascular pharmaceutical products company. Mr.&nbsp;Krivulka was the founder and President of Triax Pharmaceuticals, a dermatology products company, a position he held from November 2004 through the sale of the company
to PreCision Dermatology in April 2012. Mr.&nbsp;Krivulka was a co-founder and President of Reliant Pharmaceuticals, LLC, a company that markets pharmaceutical products, from 1999 until 2004. Mr.&nbsp;Krivulka was formerly Chief Executive Officer of
Bertek, Inc., a generic pharmaceutical products company that is a subsidiary of Mylan Inc., and Corporate Vice President of Mylan Inc., a generic pharmaceutical products company. He holds a B.S. from West Virginia Wesleyan College.<I>
</I></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Howard W. Robin</I>, age 61, has served as our President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr.&nbsp;Robin served
as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served as their Chief Operating Officer, President and as director. From
1991 to 2001, Mr.&nbsp;Robin was Corporate Vice President and General Manager at Berlex Laboratories, Inc., a pharmaceutical products company that is a subsidiary of Schering, AG, and from 1987 to 1991 he served as Vice President of Finance and
Business Development and Chief Financial Officer. From 1984 to 1987, Mr.&nbsp;Robin was Director of Business Planning and Development at Berlex. He was a Senior Associate with Arthur Andersen&nbsp;&amp; Co. prior to joining Berlex. He received his
B.S. in Accounting and Finance from Fairleigh Dickinson University in 1974. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L. Winger </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dennis L. Winger</I>, age 66, has served as our director since December 2009. Mr.&nbsp;Winger was Senior Vice President and Chief
Financial Officer of Applera Corporation, a life sciences company, from 1997 through December 2008. From 1989 to 1997, Mr.&nbsp;Winger served as Senior Vice President, Finance and Administration, and Chief Financial Officer of Chiron Corporation.
From 1982 to 1989, Mr.&nbsp;Winger was with The Cooper Companies, Inc., where he held positions of increasing responsibility, including that of Chief Financial Officer. Mr.&nbsp;Winger currently serves on the board of directors of Accuray
Incorporated (NASDAQ: ARAY), a radiosurgery company. Mr.&nbsp;Winger recently served on the board of directors of each of Vertex Pharmaceuticals Incorporated, a pharmaceutical company, until May 2012, Cephalon, Inc. a pharmaceutical company, until
its merger with Teva Pharmaceuticals Industry Limited in October 2011 and Cell Genesys, Inc. until its merger with BioSante Pharmaceuticals in October 2009. Mr.&nbsp;Winger received a B.A. from Siena College and an M.B.A. from the Columbia
University Graduate School of Business. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_14"></A>M<SMALL>EETINGS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL>
B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors met thirteen (13)&nbsp;times during
2013. Each board member attended 75% or more of the aggregate of the meetings of the board and of the committees on which he or she served held during the period of the 2013 fiscal year for which he or she was a director or committee member, as
applicable. All of our directors then serving on our board except for Mr.&nbsp;
Krivulka attended our 2013 annual meeting of stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_15"></A>C<SMALL>ORPORATE</SMALL> G<SMALL>OVERNANCE</SMALL>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors has documented our governance practices in our Corporate Governance Policy Statement to assure that
the board will have the necessary authority and practices in place to review and evaluate our business operations as needed and to make decisions that are independent of our management. The guidelines
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
are also intended to align the interests of directors and management with those of our stockholders. The Corporate Governance Policy Statement sets forth certain practices the board will follow
with respect to board composition, board committees, board nomination, director qualifications and evaluation of the board and committees. The Corporate Governance Policy Statement, as well as the charters for each committee of the board, may be
viewed at <I><U>www.nektar.com</U></I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_16"></A>B<SMALL>OARD</SMALL> L<SMALL>EADERSHIP</SMALL> S<SMALL>TRUCTURE</SMALL>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The positions of Chief Executive Officer and Chairman of the board of directors are currently held by Howard W. Robin and
Robert B. Chess, respectively. The board of directors believes at this time having a separate chairman provides a more effective channel for the board of directors to express its views on management, by enhancing the board&#146;s oversight of, and
independence from, management, and allows the Chief Executive Officer to focus more on the strategy and operations of the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_17">
</A>R<SMALL>ISK</SMALL> O<SMALL>VERSIGHT</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors monitors and assesses key business risks directly
through deliberations of the board of directors and also by way of delegation of certain risk oversight functions to be performed by committees of the board of directors.&nbsp;The board of directors regularly reviews and assesses, among other
matters, the following important areas that present both opportunities and risk to the Company&#146;s business: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of the Company&#146;s annual operating and capital spending plan and review of management&#146;s updates as to the progress against
plan and any related risks and uncertainties. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic consideration of the balance of risk and opportunities presented by the Company&#146;s medium to long-term strategic plan and the potential
implications of success and failure in one or more of the Company&#146;s key drug development programs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular consideration of the risks and uncertainties presented by alternative clinical development strategies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the progress and results of the Company&#146;s clinical development programs and early research efforts including but not limited to
the strengths, weaknesses, opportunities and threats for these programs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review and oversight of material outstanding litigation or threatened litigation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Review and approval of material collaboration partnerships for the further development and commercial exploitation of the Company&#146;s proprietary
drug development programs and technologies. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review and approval of the annual corporate goals and an assessment of the Company&#146;s level of achievement against these established goals.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Regular review of the Company&#146;s financial position relative to the risk and opportunities for the Company&#146;s business.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic review of the Company&#146;s intellectual property estate. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review and assessment of CEO succession planning. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Periodic&nbsp;review of the Company&#146;s compensation programs. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The discussion above of risk oversight matters reviewed by the board of directors is intended to be illustrative only and not a complete
list of all important matters reviewed and considered by the board of directors in providing oversight and direction for the Company&#146;s senior management and business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The risk oversight function of the board of directors is also administered through various board committees.&nbsp;The audit committee oversees the management of financial, accounting, internal controls,
disclosure controls and the engagement arrangement and regular oversight of the independent auditors.&nbsp;The audit committee </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
also periodically reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies, information technology infrastructure and general fraud monitoring practices
and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions.&nbsp;To assist the audit committee in its risk management oversight function, the
internal auditor has a direct reporting relationship to the audit committee.&nbsp;The Company&#146;s internal audit function is focused on internal control monitoring and activities in support of the audit committee&#146;s risk oversight function.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee is responsible for the design and oversight of the Company&#146;s compensation
programs.&nbsp;As discussed below, this committee has recently considered whether the Company&#146;s compensation policies and practices create risks that could have a material adverse impact on the Company&#146;s business and has concluded that
these policies and practices do not create such risks.&nbsp;The organization and compensation committee also regularly reviews and reports to the board of directors on contingency succession planning for the Chief Executive Officer and certain other
select senior management positions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance committee periodically reviews the Company&#146;s
corporate governance practices, including certain risks that those practices are intended to address.&nbsp;This committee periodically reviews the composition of the board of directors to help ensure that a diversity of skills and experiences is
represented by the members of the board of directors taking into account the stage of growth of the Company and its strategic direction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In carrying out their risk oversight functions, the board of directors and its committees routinely request and review management updates, reports from the independent auditors and legal and regulatory
advice from outside experts, as appropriate, to assist in discerning and managing important risks that may be faced by the Company.&nbsp;The board of directors is committed to continuing to ensure and evolve its risk oversight practices as
appropriate given the stage of the Company&#146;s evolution as a drug development company and the fast-paced changes in the biopharmaceutical industry. In that regard, in 2013 the Company maintained a risk management committee composed of senior
managers in charge of important functional areas that regularly reported to the board of directors or one of its designated committees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_18">
</A>I<SMALL>NDEPENDENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As required under the NASDAQ Global Select Market listing standards, a majority of the members of a listed company&#146;s board of directors must qualify as &#147;independent,&#148; as affirmatively
determined by the board of directors. Our board consults with counsel to ensure that its determinations are consistent with all relevant securities and other laws and regulations regarding the definition of &#147;independent,&#148; including those
set forth in pertinent NASDAQ listing standards, as in effect from time to time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with these standards, after
review of all relevant transactions (if any) or relationships between each director, or any of his or her family members, and us, our senior management and our independent registered public accounting firm, the board has affirmatively determined
that all of our directors are independent directors within the meaning of the applicable NASDAQ listing standards, except for Mr.&nbsp;Robin, our President and Chief Executive Officer. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under applicable NASDAQ listing standards, in the 2013 fiscal year, our independent directors met at least four times in
regularly scheduled executive sessions at which only independent directors were present.&nbsp;The independent directors regularly rotate responsibility for presiding over the executive sessions such that no single independent director presides over
more than one executive session per year. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_19"></A>I<SMALL>NFORMATION</SMALL> R<SMALL>EGARDING</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMMITTEES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors has three regularly constituted committees: an audit committee, an organization and compensation committee, and a nominating and corporate governance committee. The following table
provides membership and meeting information as of December&nbsp;31, 2013, for each of the board committees: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Organization&nbsp;and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nominating</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Governance</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert B. Chess</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz Lingnau</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Susan Wang</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roy A. Whitfield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;X</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis L. Winger</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">X&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Total meetings in the 2013 fiscal year</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Committee Chairperson. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below
is a description of each committee of the board of directors. The board of directors has determined that each member of each committee meets the applicable rules and regulations regarding &#147;independence&#148; and that each member is free of any
relationship that would interfere with his or her individual exercise of independent judgment with regard to us. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B><I>A<SMALL>UDIT</SMALL> C<SMALL>OMMITTEE</SMALL></I></B><B><SMALL></SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee of the board of directors oversees our corporate accounting and financial reporting process. For this purpose, the
audit committee performs several functions. The audit committee: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates the performance of and assesses the qualifications of our independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">determines whether to retain or terminate our independent registered public accounting firm or to appoint and engage a new independent registered
public accounting firm; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and determines the engagement of the independent auditors, including the overall scope and plans for their respective audits, the adequacy of
staffing and compensation, and negotiates and executes, on behalf of the Company, engagement letters with the independent auditors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes guidelines and procedures with respect to the rotation of the lead or coordinating audit partners having primary responsibility for the
audit and the audit partner responsible for reviewing the audit; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the retention of the independent registered public accounting firm for any permissible non-audit services and, at least annually,
discusses with our independent registered public accounting firm, and reviews, that firm&#146;s independence; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">obtains and reviews, at least annually, a formal written statement prepared by the independent registered public accounting firm delineating all
relationships between the independent registered public accounting firm and the Company and discusses with the independent registered public accounting firm, and reviews, its independence from management and the Company;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with the independent registered public accounting firm any management or internal control letter issued or, to the extent practicable, proposed
to be issued by the independent registered public accounting firm and management&#146;s response; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm the scope, adequacy and effectiveness of our financial reporting
controls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management, the Company&#146;s risk management committee, the internal auditor and the independent registered public
accounting firm, as appropriate, the Company&#146;s major financial risks, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and maintains procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls or
auditing matters, including procedures for the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">investigates and resolves any disagreements between our management and the independent registered public accounting firm regarding our financial
reporting, accounting practices or accounting policies and reviews with the independent registered public accounting firm any other problems or difficulties it may have encountered during the course of the audit work; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">meets with senior management and the independent registered public accounting firm in separate executive sessions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the financial statements to be included in our quarterly reports on Form 10-Q and our annual reports on Form 10-K;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm the results of the independent registered public accounting firm&#146;s
review of our quarterly financial statements and the results of our annual audit and the disclosures contained under the caption &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in our periodic
reports; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the independent registered public accounting firm any material financial arrangements of the Company which do
not appear on the financial statements of the Company and any significant transactions or courses of dealing with parties related to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews with management and the independent registered public accounting firm significant issues that arise regarding accounting principles and
financial statement presentation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the Company&#146;s internal audit function; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discusses with management and the independent registered public accounting firm any correspondence from or with regulators or governmental agencies,
any employee complaints or any published reports that raise material issues regarding the Company&#146;s financial statements, financial reporting process or accounting policies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the audit committee report to be included in the Company&#146;s annual report or proxy statement; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s investment policy for its cash reserves, corporate insurance policies, information technology infrastructure and general
fraud monitoring practices and procedures, including the maintenance and monitoring of a whistleblower hotline and the segregation of duties and access controls across various functions. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has the authority to retain special legal, accounting or other professional advisors to advise the committee as it
deems necessary, at our expense, to carry out its duties and to determine the compensation of any such advisors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Four
directors comprised the audit committee at the end of the 2013 fiscal year: Ms.&nbsp;Wang, who chairs the committee, and Messrs. Greer, Krivulka, and Winger. The board of directors annually reviews the NASDAQ listing standards definition of
independence for audit committee members and has determined that all members </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of our audit committee are independent. The board of directors has determined that Ms.&nbsp;Wang and Mr.&nbsp;Winger each qualify as an &#147;audit committee financial expert&#148; as defined in
applicable SEC rules. The board of directors made a qualitative assessment of Ms.&nbsp;Wang&#146;s level of knowledge and experience based on a number of factors, including her formal education and experience as a Chief Financial Officer of a public
reporting company. In addition to our audit committee, Ms.&nbsp;Wang also serves on the audit committees of Cirrus Logic, Inc. (NASDAQ: CRUS) and Premier, Inc. (NASDAQ: PINC). The board of directors does not believe that such simultaneous service
impairs Ms.&nbsp;Wang&#146;s ability to effectively serve on our audit committee and as the chairwoman of such committee. The board of directors made a qualitative assessment of Mr.&nbsp;Winger&#146;s level of knowledge and experience based on a
number of factors, including his formal education and experience as a Chief Financial Officer of a public reporting company. In addition to our audit committee, Mr.&nbsp;Winger also serves on the audit committee of Accuray Incorporated (NASDAQ:
ARAY). The board of directors does not believe that such simultaneous service impairs Mr.&nbsp;Winger&#146;s ability to effectively serve on our audit committee. The audit committee has adopted a written audit committee charter that is available on
our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>O<SMALL>RGANIZATION</SMALL> <SMALL>AND</SMALL> C<SMALL>OMPENSATION</SMALL>
C<SMALL>OMMITTEE</SMALL> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee of the board of directors administers the
variable compensation programs and reviews management&#146;s recommendations for organization structure and development of the Company. Additionally, the organization and compensation committee reviews and in some cases approves the type and level
of cash and equity-based compensation for officers, employees and consultants of the Company, and recommends certain compensation actions to the board of directors for review and approval. The organization and compensation committee: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and approves the structure and guidelines for various incentive compensation and benefit plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">grants equity awards under the various equity incentive compensation and benefit plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approves the compensation for the executive officers of the Company, including the President and Chief Executive Officer, and those vice-president
level employees that report directly to the President and Chief Executive Officer, including, but not limited to, annual salary, bonus, equity compensation and other&nbsp;benefits; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">recommends the compensation levels for the members of the board of directors who are not employed by us or our subsidiaries (&#147;non-employee
directors&#148;) for approval by the independent members of the board of directors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the operation of the Company&#146;s executive compensation programs to determine whether they remain supportive of the Company&#146;s business
objectives and are competitive relative to comparable companies and establishes and periodically reviews policies for the administration of executive compensation programs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the Company&#146;s executive compensation arrangements to evaluate whether incentive and other forms of compensation do not encourage
inappropriate or excessive risk taking and reviews and discusses, at least annually, the relationship between risk management policies and practices, corporate strategy and the Company&#146;s executive compensation arrangements;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the organization and compensation committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">oversees the preparation of the organization and compensation committee report to be included in the Company&#146;s annual proxy statement;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews management recommendations on organization structure and development, including succession planning; and </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews performance of the executive officers and vice-president level employees that report directly to the Chief Executive Officer.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee takes into account our President and Chief Executive
Officer&#146;s recommendations regarding the compensatory arrangements for our executive officers, although our President and Chief Executive Officer does not participate in the deliberations or determinations of his own compensation. In particular,
the organization and compensation committee considered our President and Chief Executive Officer&#146;s recommendations for 2013 regarding the increase in annual base compensation, award of annual performance-based bonus compensation and the number
of stock options granted to our executive officers excluding himself. While the organization and compensation committee considers and appreciates the input and expertise of management in making its decisions, it does ensure that an executive session
where no management is present is included in the agenda for every committee meeting.&nbsp;The organization and compensation committee&#146;s charter gives the committee the sole authority to retain independent counsel, compensation and benefits
consultants or other outside experts or advisors that it believes to be necessary or appropriate. During 2013, the organization and compensation committee retained Frederic W. Cook&nbsp;&amp; Co. (&#147;FW Cook&#148;), a nationally recognized
executive compensation consulting firm that performs compensation benchmarking, analysis and design services.&nbsp;FW Cook was engaged in 2013 to provide regulatory, legislative updates and market trend analysis, to provide analysis on our
compensation programs, to provide recommendations and advice on the structure, elements and amounts of compensation provided to our non-employee directors, to review the Compensation Discussion and Analysis, and to provide executive compensation
analysis as needed.&nbsp;FW Cook does not provide any other services to us other than the executive and director compensation services it performs at the request of the organization and compensation committee, and after consideration of such
services and other factors prescribed by the SEC for purposes of assessing the independence of compensation consultants, we have determined that no conflicts of interest exist between the Company and FW Cook (or any individuals providing such
services to the committee on FW Cook&#146;s behalf). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee may delegate to its
subcommittees such authority as it deems appropriate, except for the authority the committee is required to exercise by applicable law or regulation. The organization and compensation committee has delegated certain limited authority to grant stock
option awards under our stock incentive plan to a committee comprised of management representatives, and with respect to certain limited authority to grant restricted stock unit awards, to a committee of the board of directors, with Mr.&nbsp;Robin
serving as the sole member of that committee. These committees may not approve award grants to anyone serving as an executive officer or director of the Company. Other than the authority delegated to these committees, the organization and
compensation committee has no current intention to delegate any of its authority to any other committee or subcommittee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Four
directors comprised the organization and compensation committee at the end of the 2013 fiscal year: Mr.&nbsp;Lingnau, who chaired the committee, and Messrs. Greer, Krivulka and Kuebler. The board of directors annually reviews the NASDAQ listing
standards definition of independence for organization and compensation committee members and has determined that all members of our organization and compensation committee are independent. The organization and compensation committee charter can be
found on our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>N<SMALL>OMINATING</SMALL> <SMALL>AND</SMALL> C<SMALL>ORPORATE</SMALL>
G<SMALL>OVERNANCE</SMALL> C<SMALL>OMMITTEE</SMALL> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance committee: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes criteria for board membership, including standards for independence, and considers and assess the independence of the directors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">evaluates board composition and performance; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">identifies, reviews and recommends the board&#146;s selected candidates to serve as directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">considers stockholder recommendations for director nominations and other proposals submitted by stockholders; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews the adequacy of and compliance with our Code of Business Conduct and Ethics; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">administers and oversees all aspects of our corporate governance functions on behalf of the board; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">monitors regulatory and legislative developments in corporate governance, as well as trends in corporate governance practices, and makes
recommendations to the board regarding the same; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviews and discusses with management and the Company&#146;s risk management committee, as appropriate, the Company&#146;s major risks relating to the
purview of the nominating and corporate government committee, the Company&#146;s policies for assessment and management of such risks, and the steps to be taken to control such risks; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establishes and oversees procedures for the receipt, retention and treatment of complaints received by the Company with respect to legal and regulatory
compliance (except for compliance relating to accounting, internal accounting controls, auditing matters and financial disclosure and reporting); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">provides recommendations to the board of directors to establish such special committees as may be desirable or necessary from time to time in order to
address ethical, legal, business or other matters that may arise. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and corporate governance
committee believes that candidates for director should possess the highest personal and professional ethics, integrity and values, be committed to represent our long-term interests and those of our stockholders, possess diverse experience at
policy-making levels in business, science and technology, possess key personal characteristics such as strategic thinking, objectivity, independent judgment, intellect and the courage to speak out and actively participate in meetings, as well as
have sufficient time to carry out the duties and responsibilities of a board member effectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Three directors comprised
the nominating and corporate governance committee at the end of the 2013 fiscal year: Mr.&nbsp;Whitfield, who chairs the committee, and Messrs. Kuebler and Winger. The board of directors annually reviews the NASDAQ listing standards definition of
independence for the nominating and corporate governance committee and has determined that all members of our nominating and corporate governance committee are independent. The nominating and corporate governance committee charter can be found on
our corporate website at <I>www.nektar.com</I>. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The current members of our board of directors represent a desirable mix of
backgrounds, skills and experiences, and are all believed to share the key personal characteristics described above.&nbsp;Below are some of the specific experiences and skills of our directors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Chess is our Chairman and former President and Chief Executive Officer and has a deep understanding of our business. Having founded and led private and public companies, Mr.&nbsp;Chess has strong
experience leading growing companies in our industry. Due to his long association with the Company as a co-founder, director and senior executive leader at various times, he possesses significant knowledge and perspective on the history and
development of the Company. Mr.&nbsp;Chess is a prominent participant in our industry, was a long-time member of the board of our industry association, and is on the board of trustees and faculty of leading academic institutions. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Wang has a strong financial and business background as a senior executive of Solectron Corporation, an electronics manufacturing services and supply chain solutions company. She is an audit
committee financial expert as a result of her prior experience as Chief Financial Officer of Solectron, has extensive experience on the audit committees of other U.S. public companies, and is a certified public accountant.&nbsp;Ms. Wang has
extensive corporate governance experience through service on other public company boards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Whitfield has a strong strategy development and leadership background in the biotechnology and medical industries. He is a former
strategy consultant from a major consulting firm, was the founder and chief executive officer of a public biotechnology company, and has held executive positions in various segments of the health care industry. He has extensive corporate governance
experience through his service on other public company boards in the pharmaceutical and life sciences industries. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph
J. Krivulka </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Krivulka has a strong operational and leadership record in the pharmaceutical industry with strong
expertise in product evaluation, development, and marketing.&nbsp;Mr. Krivulka has founded and served as chief executive officer of several successful pharmaceutical companies and is currently the Chairman of Akrimax Pharmaceuticals. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin is our President and Chief Executive Officer. Mr.&nbsp;Robin has over 25 years of experience in the pharmaceutical and biotechnology industries in a variety of roles of increasing
responsibility and, prior to becoming our chief executive officer, was the chief executive officer and president and a director of Sirna Therapeutics, a development stage biotechnology company. The board of directors has determined that
Mr.&nbsp;Robin&#146;s position as president and chief executive officer provides him with important insight into the Company&#146;s opportunities, risks, strengths and weaknesses, as well as its organizational and operational capabilities, which is
valuable to the board of directors in making strategic decisions and performing its oversight responsibilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L.
Winger </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Winger has a strong operational and finance background with over 20 years of experience as a financial and
administrative senior executive in the life sciences and pharmaceutical industries. Most recently, he was Chief Financial Officer of Applera Corporation, a life sciences company, and prior to that was a senior financial and administrative executive
at Chiron Corporation, a biotechnology company, for eight years. Mr.&nbsp;Winger has corporate governance and audit committee experience through service on other public company boards in the pharmaceutical and life sciences industries. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer has a proven track record as an entrepreneur and senior executive with extensive experience in the biotechnology industry, most recently with Abgenix, Inc., until its acquisition by Amgen,
Inc. in 2006. Mr.&nbsp;Greer has held senior executive and finance positions at other companies in our industry and currently serves as a director of several other companies in the biopharmaceutical and medical device industries. He possesses strong
expertise in biotech industry strategy, business models, and finance and has served on compensation and audit committees. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Kuebler is a former chief executive officer of Covance Inc., a drug development services company. Prior to that, he had diverse management experience in positions of increasing responsibility
with Abbott Laboratories and other large health care companies. As a result of his experiences, Mr.&nbsp;Kuebler possesses valuable knowledge and insight regarding both the development and commercial aspects of the biopharmaceutical industry as well
as leadership experience in running a significant public company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Lingnau has a strong management background in the pharmaceutical industry as a senior executive and member of the executive board of Schering AG Group. He has international sales and operations
experience as former head of worldwide sales and marketing in the pharmaceutical division of Schering, and in operational roles in South America and the U.S., and also as a member of the supervisory board of a German specialty chemicals company.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Candidates for director nominees are reviewed in the context of the current composition of the board, our operating
requirements and the long-term interests of stockholders. In conducting this assessment, the committee considers diversity, age, skills and such other factors as it deems appropriate given our current needs and those of our board to maintain a
balance of knowledge, experience and capability. The nominating and corporate governance committee also periodically reviews the overall effectiveness of the board, including board attendance, level of participation, quality of performance,
self-assessment reviews and any relationships or transactions that might impair director independence. In the case of new director candidates, the nominating and corporate governance committee also determines whether the nominee must be independent
for NASDAQ purposes, which determination is based upon applicable NASDAQ listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The committee then uses its network of contacts to compile a list of potential
candidates, but may also engage, if it deems appropriate, a professional search firm. The committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and
needs of the board. The nominating and corporate governance committee meets to discuss and consider such candidates&#146; qualifications and then selects a nominee for recommendation to the board by majority vote. We have paid fees to third party
search firms in the past to assist in our process of identifying or evaluating director candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The nominating and
corporate governance committee of our board of directors will consider for nomination any qualified director candidates recommended by our stockholders. Any stockholder who wishes to recommend a director candidate is directed to submit in writing
the candidate&#146;s name, biographical information, relevant qualifications and other information required by our bylaws to our Secretary at our principal executive offices before the deadline set forth in our bylaws. All written submissions
received from our stockholders will be reviewed by the nominating and corporate governance committee at the next appropriate meeting. The nominating and corporate governance committee will evaluate any suggested director candidates received from our
stockholders in the same manner as recommendations received from management, committee members or members of our board. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_20">
</A>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The board of directors will consider any written or electronic communication from our stockholders to the board, a committee of the board or any individual director. Any stockholder who wishes to
communicate to the board of directors, a committee of the board or any individual director should submit written or electronic communications to our Secretary at our principal executive offices, which shall include contact information for such
stockholder. All communications from stockholders received will be forwarded by our Secretary to the board of directors, a committee of the board or an individual director, as appropriate, on a periodic basis, but in any event no later than the
board of director&#146;s next scheduled meeting. The board of directors, a committee of the board, or individual directors, as appropriate, will consider and review carefully any communications from stockholders forwarded by our Secretary.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_21"></A>C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> B<SMALL>USINESS</SMALL> C<SMALL>ONDUCT</SMALL> <SMALL>AND</SMALL>
E<SMALL>THICS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a code of business conduct and ethics that applies to all employees, including our
principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The code of business conduct and ethics is available on our website at <I><U>www.nektar.com</U></I>.
Amendments to, and waivers from, the code of business conduct and ethics that apply to any director, executive officer or persons performing similar functions will be disclosed at the website address provided above and, to the extent required by
applicable regulations, on a Current Report on Form 8-K filed with the SEC. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_22"></A>O<SMALL>RGANIZATION</SMALL> <SMALL>AND</SMALL> C<SMALL>OMPENSATION</SMALL>
C<SMALL>OMMITTEE</SMALL> I<SMALL>NTERLOCKS</SMALL> <SMALL>AND</SMALL> I<SMALL>NSIDER</SMALL> P<SMALL>ARTICIPATION</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee consisted of four independent directors at the end of 2013: Messrs. Greer, Krivulka, Kuebler
and Lingnau. No director who served on the organization and compensation committee in 2013 was, or has been, an officer or employee of us, nor has any director had any relationships requiring disclosure under the SEC rules regarding certain
relationships and related-party transactions. None of our executive officers served on the board of directors or the compensation committee (or other board committee performing equivalent functions) of another entity, one of whose executive officers
served on our board of directors or organization and compensation committee. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_23"></A>D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL>&#151;F<SMALL>ISCAL</SMALL> 2013
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of our non-employee directors participates in our Amended and Restated Compensation Plan for Non-Employee Directors
(the &#147;Director Plan&#148;). Only our non-employee directors are eligible to participate in the Director Plan. The following table shows compensation awarded or paid to our non-employee directors for the fiscal year ended December&nbsp;31, 2013.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:29pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or&nbsp;Paid&nbsp;
in</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash&nbsp;($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)(2)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)(3)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Compensation</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total&nbsp;($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Robert B. Chess</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">414,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R. Scott Greer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">82,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">383,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Joseph J. Krivulka</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">376,055</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christopher A. Kuebler</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">368,930</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lutz Lingnau</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">382,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Susan Wang</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">390,930</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Roy A. Whitfield</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">370,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis L. Winger</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">301,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">376,180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Robin, our President and Chief Executive Officer, is not included in this table as he was an employee of us in 2013 and received no additional compensation for
his services in his capacity as a director.</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">No restricted stock units or other stock awards were awarded as part of the annual equity compensation for non-employee directors in 2013. As of December&nbsp;31, 2013,
none of our directors held restricted stock units. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of awards computed in accordance with FASB ASC Topic 718 (formerly SFAS No.&nbsp;123R), which excludes
the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form 10-K for the
fiscal year ended December&nbsp;31, 2013.&nbsp;Each of our non-employee directors received 40,000 options for their annual stock option grant on September&nbsp;9, 2013. The grant date fair value of the stock options awarded to each of our
non-employee directors for their annual stock option grant in 2013 was $301,180. As of December&nbsp;31, 2013, each of our non-employee directors had the following number of outstanding stock options: Robert B. Chess: 335,333; R. Scott Greer:
172,500; Joseph J. Krivulka: 200,000; Christopher A. Kuebler: 230,000; Lutz Lingnau: 222,500; Susan Wang: 200,000; Roy A. Whitfield: 200,000; and Dennis L. Winger: 173,750.</FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the Director Plan, each non-employee director is eligible to receive an annual retainer of $30,000 for serving on the board of
directors, an additional annual retainer of $50,000 for serving as the chair or lead director of the board of directors, an additional annual retainer of $20,000 for serving as chair of the audit committee, an additional annual retainer of $15,000
for serving as chair of the organization and compensation committee, an additional annual retainer of $10,000 for serving as chair of the nominating and corporate governance committee, and an additional annual retainer of $5,000 for serving as chair
of any other committee. In addition, each non-employee director is entitled to $2,000 for each in-person or telephonic board meeting he or she attends and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
$1,000 for each in-person board meeting he or she attends by telephone. Each non-employee director is also entitled to $1,750 for each in-person or telephonic committee meeting he or she attends
and $875 for each in-person committee meeting he or she attends by telephone.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September of each year, each non-employee
director is eligible to receive an equity award consisting of either all stock options or a combination of stock options and restricted stock units, as determined by the board. These equity awards vest over a period of one year and will have a total
value or cover a number of shares as determined annually by the board of directors. Upon initial appointment to the board of directors, each non-employee director is eligible to receive an equity award consisting of either all stock options or a
combination of stock options and restricted stock units. These initial equity awards vest over a period of three years from the date of appointment and will be at a level based on 150% of the most recent annual equity compensation grant to
non-employee directors, as determined annually by the board of directors. Non-employee directors are also eligible to receive discretionary equity-based awards under our stock incentive plans from time to time as determined by the board of
directors. The exercise price of stock options granted is equal to the closing price of the Company&#146;s common stock on the grant date<B>.</B> Following completion of a non-employee director&#146;s service on the board of directors, his or her
stock options will remain exercisable for a period of eighteen months (or, if earlier, the end of the maximum term of the option). The term of stock options granted to non-employee directors is eight years. In the event of a change of control, the
vesting of each option or restricted stock unit award held by each non-employee director will accelerate in full as of the closing of such transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Director Plan includes ownership guidelines for non-employee directors, stating that each non-employee director should own shares of our common stock equal to at least three times the value of the
annual board retainer. The minimum stock ownership level should be achieved by each non-employee director by January&nbsp;1, 2015 or within five years of the date of his or her first appointment to the board of directors. Each non-employee director
currently meets the minimum stock ownership guidelines. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INFORMATION ABOUT THE EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_24"></A>C<SMALL>OMPENSATION</SMALL> D<SMALL>ISCUSSION</SMALL> <SMALL>AND</SMALL> A<SMALL>NALYSIS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Introduction </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Compensation Discussion and Analysis is designed to provide our stockholders with an understanding of our executive compensation philosophy and decision making process. It discusses the principles underlying the structure of the compensation
arrangements for our Chief Executive Officer, our Chief Financial Officer, and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2013 (the &#147;Named Executive Officers&#148;).
Unless noted otherwise, any references within the Compensation Discussion and Analysis to decisions made by the board of directors, refers to the independent members of the board of directors only. This Compensation Discussion and Analysis primarily
focuses on the compensation of our Named Executive Officers for 2013 that are identified in the table below. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="57%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Title</B></FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President &amp; Chief Executive Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President &amp; Chief Financial Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen&nbsp;K.&nbsp;Doberstein,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior&nbsp;Vice&nbsp;President&nbsp;&amp;&nbsp;Chief&nbsp;Scientific&nbsp;Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rinko Ghosh*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President &amp; Chief Business Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President &amp; General Counsel</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Ghosh&#146;s last day of employment with the Company was March&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current compensation programs for the Named Executive Officers are determined and approved by the organization and compensation
committee. None of the Named Executive Officers are members of the organization and compensation committee. As described in more detail above under the caption &#147;Information About the Board of Directors-Information Regarding the Committees of
the Board of Directors&#151;Organization and Compensation Committee,&#148; the organization and compensation committee takes into account Mr.&nbsp;Robin&#146;s recommendations regarding the compensatory arrangements for our executive officers,
although Mr.&nbsp;Robin does not participate in the deliberations or determinations of his own compensation. For example, during 2013, the organization and compensation committee considered Mr.&nbsp;Robin&#146;s recommendations regarding the
increase in annual base compensation, award of annual performance-based bonus compensation, and the number of stock options to be granted to our executive officers other than himself. The other Named Executive Officers do not currently have any role
in determining or recommending the form or amount of compensation paid to any of our executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Company Performance Highlights
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In assessing the appropriate level of compensation for our executive officers, in particular the short-term incentive
compensation to be awarded for a particular year, we take into account the over-all performance of the Company against the specific annual corporate objectives established by the board of directors at the beginning of that year. The biotechnology
industry is characterized by high stock price volatility and, as a result, our focus on pay-for-performance is based on an assessment of the level of the Company&#146;s achievement against those specific objectives rather than the stock price at any
given point in time. Some of the significant accomplishments achieved by the Company in 2013 are summarized below. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our collaboration partner, AstraZeneca, announced that the United States Food and Drug Administration (FDA) accepted the New Drug Application (NDA),
and the European Medicines Agency (EMA) accepted the Marketing Authorisation Application (MAA), for naloxegol, a peripherally-acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Bayer AG initiated a Phase 3 clinical study for BAY41-6551 (Inhaled Amikacin) in mechanically ventilated patients with gram-negative pneumonia&#151;a
development program in which we have a significant royalty interest. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We negotiated an amendment to our worldwide naloxegol license agreement with AstraZeneca to provide for a risk-benefit sharing arrangement that
resulted in a commitment by AstraZeneca to submit an NDA with the FDA and an MAA with the EMA and the subsequent payment of $95 million in milestones to us in the fourth quarter of 2013 after these filings were accepted by these governmental health
authorities. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our collaboration partner, Baxter Healthcare, announced that it completed enrollment in its Phase 3 clinical trial for BAX 855 (a longer-acting
(PEGylated) form of a full-length recombinant factor VIII (rFVIII) protein) in patients with hemophilia A. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We completed enrollment five months ahead of schedule in the etirinotecan pegol (NKTR-102) Phase 3 BEACON clinical study in patients with metastatic
breast cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An investigator sponsored clinical study was initiated at the Abramson Cancer Center of the University of Pennsylvania to evaluate etirinotecan pegol
as a third-line treatment in patients with metastatic and recurrent non-small cell lung cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">An investigator sponsored clinical study was initiated at Roswell Park Cancer Institute to evaluate etirinotecan pegol as a second-line treatment in
patients with relapsed or refractory small cell lung cancer. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We reported positive data from a human abuse liability study for NKTR-181, a novel investigational opioid to treat chronic pain, demonstrating that
drug abusers rated NKTR-181 similar to placebo in &#147;drug liking&#148; and &#147;feeling high&#148; scores and had highly statistically significant lower &#147;drug liking&#148; scores and reduced &#147;feeling high&#148; scores as compared to
oxycodone at all doses tested. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We reported Phase 2 efficacy study results for NKTR-181 in chronic pain patients with osteoarthritis of the knee and showed that patients achieved an
average 40% reduction in pain even though the primary end point in the study was not met as a result of the unusual lack of rebound in pain scores for the placebo arm of the study. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We presented preclinical data for NKTR-214, an investigational cancer immunotherapy which targets the IL-2 receptor complex and is being developed as a
potential treatment for multiple cancers, which demonstrated improved efficacy and better tolerability in aggressive and resistant preclinical melanoma models. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to considering the Company&#146;s accomplishments and progress each year, we also think it is important in making
compensation decisions to take into account the long-term performance of the executive leadership team. We believe that the skills, creativity and dedication of executive leadership have led to numerous significant accomplishments including the
following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Over the past seven years, our business has been transformed from a drug delivery service provider to a drug development company which included a
significant change in the mix of senior leadership and the skills and experience of personnel in key functional areas, a reprioritization of resource allocation, and building a more efficient and productive organization.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2012, we closed a $125 million secured debt financing that was a very unique transaction (and in our view, on very attractive terms) for a
development stage biotechnology company such as Nektar. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2012, we successfully completed of the sale of the Company&#146;s CIMZIA and MIRCERA royalty rights for $124 million.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In October 2010, we negotiated a revised supply agreement with Amgen, Inc. which resulted in a $50 million up-front payment and the potential to
receive significant additional payments that may be received by us in future years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2009, we received a payment of $31 million from the negotiation of a license extension with F. Hoffmann- La&nbsp;Roche Ltd and Hoffmann-La
Roche Inc. related to certain PEGASYS manufacturing rights. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2009, we entered into a license agreement with AstraZeneca AB for naloxegol (formerly known as NKTR-118) and naloxegol fixed-dose
combination products (formerly known as NKTR-119). AstraZeneca announced positive Phase 3 clinical trial results for naloxegol in November 2012 and February 2013. AstraZeneca agreed to pay us an up-front payment of $125 million and assumed all
future development costs for naloxegol and the naloxegol fixed-dose combination products.&nbsp;For naloxegol, we have received $95 million in regulatory milestones to date and we are eligible to receive up to an additional $175 million in regulatory
and launch milestones and up to $375 million in additional sales milestones.&nbsp;In relation to the naloxegol fixed-dose combination products, for each of the first two initial fixed-dose combination products, we are eligible to receive for each of
such products up to $75 million in development milestones and up to $310 million in additional sales milestones.&nbsp;For both naloxegol and the naloxegol fixed-dose combination products, we are also eligible to receive significant and escalating
royalty payments. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">At the end of 2008, we completed the sale and transfer of certain pulmonary technology assets to Novartis Pharma AG in consideration for a payment to
us of $115 million. In addition, we retained rights to certain important assets including the inhaled Amikacin program with Bayer, certain patent rights specific to inhaled insulin and certain rights to receive royalties on net sales Cipro DPI which
entered Phase 3 clinical development in 2012. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following the execution of the Novartis pulmonary asset purchase agreement in the fourth quarter of 2008, we repurchased approximately
$100&nbsp;million in par value of our 3.25% convertible subordinated notes for an aggregate purchase price of $47.8&nbsp;million. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The above accomplishments directly resulted in the Company (1)&nbsp;building and advancing a significant drug candidate pipeline; (2)&nbsp;building an organization and infrastructure designed to execute
on our mission of being a leading drug development company; (3)&nbsp;receiving over $750 million in capital from transactions that did not involve the issuance of equity securities; (4)&nbsp;avoiding significant future financial commitments in
certain cases; and (5)&nbsp;establishing collaboration and proprietary product opportunities that have significant future economic potential based on milestone payments, royalties and sales. We believe that the compensation programs and awards to
our Named Executive Officers should be evaluated within the context of these significant accomplishments and performance over a sustained period of time. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Compensation Program Objectives and Philosophy </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to continue
the execution and growth of our business as described above, we believe that it is vital that we continue to retain and attract highly experienced and skilled senior leadership by offering competitive base compensation and benefits, significant
performance-based incentives, and the potential for long-term equity compensation. Our goal is to structure a meaningful portion of executive compensation such that it will only have value if the senior leadership is successful in building
significant long-term value for us and our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our current executive compensation programs are intended to achieve
the following four fundamental goals and objectives: (1)&nbsp;to incent and reward sustained long-term performance by aligning significant elements of executive compensation with our stockholders&#146; interests, (2)&nbsp;to attract and retain an
experienced, highly qualified and motivated executive management team to lead our business, (3)&nbsp;to provide appropriate economic rewards for achieving high levels of our performance and individual contribution, and (4)&nbsp;to pay compensation
that is competitive, taking into account the experience, skills and performance of the executives required to build and maintain the organization necessary to support our mission to be a leading drug development company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">When structuring our executive compensation programs to achieve our goals and objectives, we are guided by the following basic
philosophies: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Alignment with Stockholders&#146; Interests</I>. Our compensation model should be designed to align the economic interests of our executives with
those of our stockholders. In 2012, we established a performance-based stock option award program for our executive officers. Under this program, 50% of the stock options granted to our executive officers for both 2012 and 2013 were made in the form
of </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
performance-based stock option awards that vest based on the standard four-year monthly vesting schedule plus a separate performance condition that must also be achieved before the executive
officer is permitted to exercise any of the shares under the performance-based stock option. The performance condition would be met only if, within five years from the grant date, the Company or one of its collaboration partners files a new drug
application or biologics license application with the FDA (or the equivalent new drug registration with the EMA) for any &#147;Proprietary Company Program&#148; which is defined to include any drug candidate that is wholly-owned by the Company (e.g.
NKTR-102 or NKTR-181) or where the Company is entitled to an average royalty interest equal to or greater than 7.5%. We believe that this performance condition is rigorous and objective as it has been achieved only twice in the history of the
Company&#151;most recently with the filing of regulatory approval applications for naloxegol in the second half of 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Pay for Performance</I>. Our compensation model should deliver compensation above industry median for exceptional performance and deliver
compensation below the median for years in which the Company does not perform. In 2013, a study performed by the organization and compensation committee&#146;s independent consultant showed that the value of total direct target compensation for our
Named Executive Officers, including our CEO, was below the median for similarly situated executives of our peer group. As used in this discussion, &#147;total direct compensation&#148; means base salary, annual bonus and the value of equity awards
granted to the executive as determined under the principles used to value equity awards in the Company&#146;s financial reporting. In addition, to the extent that a peer company&#146;s market capitalization is higher or lower than that of the
Company, the data regarding this difference was taken into account as one factor in evaluation of the size of equity awards. In 2012, 2013, and 2014, we also tied 50% of each Named Executive Officer&#146;s equity award to the achievement of a
rigorous and objective performance milestone in addition to standard time-based vesting requirements as described above. We currently intend to continue this performance-based equity program on a go forward basis. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Total Rewards Program.</I> The total compensation program must balance pay for performance elements with selected static non-performance
based elements in order to create a total rewards program that is competitive and will help us attract and retain highly qualified and motivated executives. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Flexible Approach</I>. The level of compensation provided to executives must take into account each executive&#146;s role, experience,
tenure, performance and expected contribution to our future success. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Focus on Achievement of Fundamental Business Goals.</I> The compensation program should be structured so that executives are appropriately
incentivized to achieve our short- and long-term goals that are fundamental to driving value in our business. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that each element of our executive compensation program helps us to achieve one or more of our compensation goals and
objectives. For example, we believe that performance-based short-term cash incentive opportunities in combination with equity incentive awards that are earned over time and increase in value only if we become more valuable is the best way to align
our executives&#146; interests with those of our stockholders and pay for performance. The long-term vesting schedules applicable to equity awards also serve as a significant retention incentive. Providing base salaries, occasional discretionary
bonus opportunities and certain severance protections helps us ensure that we are providing a competitive compensation package that will permit us to attract and retain qualified, experienced and highly skilled executives. We believe that we have
created a total compensation program that combines short- and long-term components, cash and equity, and fixed and contingent payments, in proportions that are appropriate to achieve each of our fundamental goals and objectives as described above.
We also believe that the structure of our compensation program provides appropriate incentives to reward our executives for achieving our long-term goals and objectives, some of the most important of which are building and advancing a robust drug
candidate pipeline, entering into new collaboration partnerships and executing on our current collaborations, increasing the skill level and efficiency of our organization and improving our financial performance. We believe that our compensation
program has helped us both recruit and retain superior executive talent to continue to build an organization capable of executing on our mission to become a leading drug development company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Relationship between Company Performance and Executive Pay </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The biotechnology industry is generally thought to be characterized by a higher risk profile than more established industries which
historically has let to high stock volatility for biotechnology companies. The Company ended 2013 with a closing stock price of $11.35 which represented a five-year company annual stockholder return of 15%, a two year compound stockholder annual
return of 42%, and a one year annual return of 53%. Mr.&nbsp;Robin&#146;s total compensation, as reported below in the Summary Compensation Table, increased by 10% from 2012 to 2013, while the stock price increased by 53% over the same period. The
graph below demonstrates that even with high levels of volatility in stock price, the total direct compensation for Mr.&nbsp;Robin has been generally aligned with our stock price performance since he joined the Company as our Chief Executive Officer
in 2007. We believe this alignment is due in large part to our commitment to the principle of pay for performance and that we review data from the adjusted market capitalization of the Company&#146;s peer group as one component of our equity award
determinations rather than relying simply on grant date fair value. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112g78h81.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr. Robin&#146;s compensation for 2007 reflects his new-hire stock option grant. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In 2011, 2012 and 2013, the stock option awards made to Mr.&nbsp;Robin accounted for 55%, 47% and 58%, respectively, of his total direct compensation. This substantial portion of the compensation awarded
to Mr.&nbsp;Robin has been made in the form of stock options to ensure that value is delivered only if the stock price increases after the grant date. In addition, one-half of Mr.&nbsp;Robin&#146;s stock options awarded in 2012, 2013, and 2014
include performance-based vesting and have value only if a NDA or MAA approval filing was made for a significant drug development program in the Company&#146;s pipeline. This performance hurdle is in addition to the value of the stock options being
directly linked to an increase in stock price following the grant date. We believe these performance based stock option grants served to further align Mr.&nbsp;Robin&#146;s interests with those of our stockholders and create appropriate additional
incentives to achieve performance objectives we consider critical to the long-term growth of the Company. The business milestone that we have established for this performance based equity program has been met only twice in the history of the
Company. Most recently, in September 2013, the EMA accepted the MAA for naloxegol and a NDA was also subsequently accepted by the FDA. These regulatory approval filings for naloxegol, a significant drug development program in the Company&#146;s
late-stage pipeline, met the rigorous and objective performance milestone for the 2012 and 2013 performance stock grants made to Mr.&nbsp;Robin. As discussed further below, in 2014 we continued the performance-based equity award program for the
stock option award made to Mr.&nbsp;Robin in 2014. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Executive Compensation Practices </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below we provide a summary of our executive compensation practices, including both the practices that we follow and those that we do not
follow, in each case based on whether we believe they serve the long-term interests of our stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation and Governance
Practices We Are Proud Of </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Pay-for-Performance</I>. A substantial majority of the compensation awarded to our Named Executive Officers is either tied to specific company-wide and individual
performance objectives or has been made in the form of stock option awards that will only have value if the price of our stock increases after the grant date. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Performance-Based Equity Grants</I>. In 2012, 2013 and 2014, we awarded 50% of each executive officer&#146;s equity compensation in the form of performance-based
stock options that only vest and become exercisable upon the achievement of specified significant accomplishments in addition to satisfying our typical 4-year time-based vesting requirement. We continued this performance-based equity program for
executive officers in 2014 and currently intend to continue this program in future years. We believe this program is important in that it even more tightly aligns the economic interests of our senior leadership team with those of our stockholders.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Double Trigger</I>. Our change of control severance benefit plan (CIC Plan) only provides our executive officers with acceleration of unvested equity awards held by
them if they are terminated (without cause or constructively) in connection with a change of control transaction or within 12 months following a change of control transaction. We do not provide accelerated vesting of equity awards on a change in
control alone. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Modest Perquisites</I>. We provide only modest perquisites and nearly all of those perquisites are in the form of insurance benefits that we believe are in line with
industry practice for executive compensation. We do not provide perquisites such as personal travel reimbursement, tax services or financial planning. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Reasonable Post-Employment and Change of Control Severance Arrangements</I>. We believe that our severance arrangements with our executive officers are reasonable
and in line with industry practice. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Review Tally Sheets</I>. We review tally sheets for our Named Executive Officers prior to making annual executive compensation decisions. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Claw-Back Policy</I>. We have implemented a claw-back policy which permits us to require reimbursement or cancellation of all or a portion of any
performance-based cash awards or equity incentive payments to the extent based on financial results that are subsequently revised. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Regular Review of Share Utilization for Equity Compensation</I>. We regularly evaluate equity incentive plan share reserve pool utilization by reviewing overhang
levels (the dilutive impact of equity compensation on stockholders) and annual run rates (the aggregate shares awarded as a percentage of total outstanding shares). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Mitigate Undue Risk</I>. We mitigate undue risk associated with compensation by implementing the following: multiple performance targets and caps on potential
payments of short-term incentive compensation (i.e. annual bonuses), awarding a substantial portion of executive compensation in the form of long-term compensation (i.e. stock options with multi-year vesting requirements), and compensation claw-back
provisions. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Utilize Independent Compensation Consulting Firm</I>. The organization and compensation committee regularly consults with an independent compensation consulting firm
which provides no other services to the Company. For more information on our independent compensation consultant, please see &#147;Organization and Compensation Committee&#148; under &#147;Information About Our Board of Directors&#148; above.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Shareholder Outreach</I>. We regularly meet with our shareholders to get feedback and discuss items of concern to them, including executive compensation. We describe
shareholder outreach efforts on executive compensation in more detail below in &#147;The Role of Stockholder Say-on-Pay Votes.&#148; </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Stock Option Repricing</I>. Our equity incentive plans prohibit us from repricing, exchanging or otherwise providing value for underwater stock options.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Elimination of Excise Tax Gross-Ups on Change of Control Payments</I>. On April&nbsp;5, 2011, we amended our change of control severance benefit plan to eliminate
any &#147;gross up&#148; payments for any excise taxes imposed on participants who became eligible to participate in the plan after January&nbsp;1, 2010. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Full Value Equity Awards</I>. We have not awarded &#147;full value&#148; restricted stock units to our Named Executive Officers during the last six years. Stock
options are our preferred form of long-term incentive compensation because we believe they are more performance based than other equity vehicles, with value delivered only if the stock price of our common shares appreciates following the stock
option grant date. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Accelerated Vesting of Equity Awards on Termination</I>. Whether one of our Named Executive Officers is terminated by the Company without cause or resigns for a
good reason, our severance arrangements do not provide for accelerated vesting of outstanding equity awards (other than a qualifying termination after a change in control as provided in the CIC Plan). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Inclusion of the Value of Equity Awards in Severance Calculations.</I> Our post-termination and change of control severance arrangements do not include the value
of equity awards in annual compensation for purposes of determining cash severance amounts. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Employment Contracts</I>. We do not have employment contracts with our executive officers that provide for a guaranteed term of employment.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Funded Pension or Retirement Plans</I>. We do not provide any guaranteed or funded retirement plan benefits other than a matching contribution up to $3,000 for
401(k) plan participation that we make available to all employees. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No Hedging Transactions, Share Pledging, or Short Sales by Executive Officers or Directors</I>. Our security trading policy prohibits any employee or director from
engaging in hedging transactions, short sales or trading in any derivative security of the Company. This policy also prohibits pledging our shares on margin. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Role of Stockholder Say-on-Pay Votes </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We provide our stockholders
with the opportunity to cast an annual advisory vote on our executive compensation program (referred to as a &#147;say-on-pay vote&#148;). At our annual meeting of stockholders held in June 2013, approximately 89% of the votes cast on the say-on-pay
proposal were voted in favor of the proposal. Although we believe this result affirms stockholders&#146; support of our approach to executive compensation, we continue to seek feedback on our program from our stockholders. The board of directors and
organization and compensation committee will continue to consider the outcome of our say-on-pay proposals when making future compensation decisions for the Named Executive Officers.</FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In May and June of 2013 we contacted a substantial majority of our top 20 stockholders to discuss executive compensation and the
management say-on-pay proposal that was to be voted upon at the June 2013 annual meeting of stockholders. In these discussions, management reviewed peer group design, the adoption of performance vesting based on the important achievement of an NDA
or MAA filing for significant drug development programs, and equity grants that took into account data that adjusted the Company&#146;s market capitalization relative to the peer group. The stockholders provided consistent feedback supporting our
executive pay program and this support was ultimately manifested in an 89% approval of the management say-on-pay proposal in 2013. Specifically, the stockholders indicated strong support for the performance-based equity program which they agreed was
established based on clear and objective value enhancing performance milestones for the Company. They also affirmed their support of our practice of reviewing market capitalization adjusted peer group data as one component of equity award
decision-making process particularly given the volatility of stock prices in the biotechnology sector. In addition, based on feedback from certain stockholders that they would value more detailed information on the annual corporate goals that are
the basis of the short-term annual incentive compensation program, we have included greater detail in this year&#146;s proxy statement regarding </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the corporate goal achievement for performance period ending December&nbsp;31, 2013. Although not specifically requested by stockholders, we reviewed our peer group companies and adjusted this
group removing 3 peer group companies and adding 5 new peer group companies with market capitalizations closer to that of the Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Design and Elements of Our Compensation Program </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The material elements of our current executive compensation programs for Named Executive Officers consist primarily of the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary.</I> Each Named Executive Officer earned an annual base salary during 2013. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> Each Named Executive Officer was eligible to earn an incentive cash compensation payment for the 2013 performance period based
on a combination of the Company&#146;s achievement of corporate performance objectives and their individual performance. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Long-Term Incentive Compensation.</I> Each Named Executive Officer was awarded stock option grants during 2013, with 50% of each grant being subject to a rigorous
and objective performance-based vesting condition as well as a time-based vesting schedule. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we review
peer group company data regarding the mix of current and long-term incentive compensation and between cash and non-cash compensation, we have not adopted any formal policies or guidelines for allocations among these various compensation elements.
However, consistent with our philosophy of paying for performance, we believe that a greater component of overall direct compensation for the Named Executive Officers relative to other employees should be performance-based; therefore, in 2013
approximately 59% to 76% of the total direct compensation of the Named Executive Officers was tied to Company and individual performance objectives or linked to the value of our stock price. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As illustrated in the accompanying chart, in 2013, approximately 76% of total direct compensation to Mr.&nbsp;Robin was performance-based
and not guaranteed. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112g45r25.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">50% of the stock options granted to Mr.&nbsp;Robin in 2013 was contingent upon achievement of a performance-based milestone. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Use of Peer Company Data </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We regularly review the compensation practices of our peer group companies identified below in response to the fast moving nature of the
biotechnology industry, including merger and acquisition activity, and changes in product pipeline and business stage.&nbsp;In determining the appropriate peer companies, we consider the following factors: business model, business stage and
complexity, therapeutic area similarity, status of the drug candidate pipeline, manufacturing activity (if any), technology platform, product focus and company size based on the number of employees, revenue and market capitalization. As a result of
the Company having a combination of multiple drug candidates in diverse therapeutic areas (and, in the case of Amikacin Inhale and Cipro DPI, drug candidates based on different technologies), a mix of wholly-owned and partnered drug candidates, a
technology platform with the potential to enable multiple drug candidates in future years, and a significant legacy proprietary manufacturing operation, it is very challenging to identify truly comparable companies. Prior to the February 2013
compensation decisions for the Named Executive Officers, our last review of the composition of our peer group companies was conducted in September 2012. As a result of this review, Human Genome Sciences, Inc. was removed from the peer group due to
its acquisition by GlaxoSmithKline. No other peer group changes were made. The peer group of companies used in the deliberations when determining the structure and amounts of total compensation for the Named Executive Officers as part of our annual
compensation review in the first quarter of 2013 included: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acorda Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Affymetrix, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alkermes, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Auxilium Pharmaceuticals</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">BioMarin Pharmaceutical Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cubist Pharmaceutical Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Incyte Corporation</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Isis Pharmaceuticals,&nbsp;Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jazz Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Onyx Pharmaceuticals Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Seattle Genetics</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Theravance</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">United Therapeutics Corp.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Viropharma, Inc.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2013, we modified our peer group companies with the objective of more closely aligning the
Company&#146;s market capitalization and business model with that of the peer group. As a result of this review, Affymetrix, Inc., BioMarin Pharmaceutical, Inc., and Onyx Pharmaceuticals, Inc. were removed from the peer group. We also determined
that we would add certain companies to the peer group including Arena Pharmaceuticals, Inc., ImmunoGen, Inc., Ironwood Pharmaceuticals, Inc., NPS Pharmaceuticals, Inc. and Questcor Pharmaceuticals, Inc. The median market capitalization of these
newly added peer group companies was approximately 130% of our market capitalization at the time of our review and modification of the peer group. The revised peer group, referred to in this discussion as the 2014 Peer Group, was used as a reference
point in making our most recent executive compensation decisions in early 2014. The updated peer group of companies used as a reference point in our deliberations regarding total compensation for the Named Executive Officers in early 2014 included:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acorda Therapeutics, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Alkermes, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arena Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Auxilium Pharmaceuticals</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Cubist Pharmaceutical Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exelixis, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">ImmunoGen, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ironwood Pharmaceuticals, Inc.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Incyte Corporation</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Isis Pharmaceuticals,&nbsp;Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jazz Pharmaceuticals, Inc.</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NPS Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Questcor Pharmaceuticals, Inc.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Seattle Genetics</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Theravance</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">United
Therapeutics Corp.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Viropharma, Inc.</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Given that certain of our peer group companies have larger market capitalizations than the Company, we
also review equity and total direct compensation data for our executives against the compensation for similarly situated executives with the peer companies as adjusted for differences in market capitalization to help further
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
inform our decision-making process. Although the board of directors and organization and compensation committee reviewed and discussed the compensation data for the peer group companies to help
inform executive compensation decisions, we do not set compensation at any specific level or percentile based on the peer group data (i.e., we do not &#147;benchmark&#148; our executive compensation levels). The peer group data is used by us as only
one reference point taken into account in making compensation decisions. We do not use peer group or industry survey data as a standalone tool for setting compensation due to the unique aspects of our business and the need to attract and retain
particular expert managers with unique experience, skills and other individual circumstances. However, we generally believe that reviewing and analyzing this information is an important component of our executive compensation decision-making
process. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Base Salary </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Base salary is the initial building block of compensation for the Named Executive Officers because it provides the executives with a specified minimum level of cash compensation which we believe is an
important part of attracting and retaining the executives. When determining the amount of each Named Executive Officer&#146;s base salary, we consider competitive pay practices, cost of labor and compensation trends, individual performance and
promotions, level and scope of responsibility, experience and internal pay equity. However, we do not use a formula or assign a particular weight to any one factor in determining base salary levels. Rather, the determination of base salary levels is
subjective, and the board of directors and organization and compensation committee set salaries at levels they believe in their judgment are reasonably competitive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In February 2013, base salaries for the Named Executive Officers were reviewed by us and were increased between 2.9% to 6.3% based on labor cost and compensation trends, competitive considerations, and a
subjective assessment of each executive&#146;s role and performance during the previous year. The base salary earned by each Named Executive Officer during 2013 is reported below in the Summary Compensation Table.</FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Short-Term Incentive Compensation </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Incentive Compensation Policy.</I> We believe that the short-term incentive compensation program (&#147;Incentive Compensation Policy&#148;) for the Named Executive Officers is important to our
business as it provides a mechanism to reward achievement of short-term objectives that advance us toward our long-term strategic objectives. Our Incentive Compensation Policy applies to all employees and all executive officers other than
Mr.&nbsp;Robin, who is subject to his own separate annual performance-based bonus compensation arrangement with a combination of corporate and personal objectives established and evaluated by the board of directors. However, Mr.&nbsp;Robin&#146;s
bonus arrangement for 2013 was based on substantially the same corporate objectives as applied to the other Named Executive Officers under the Incentive Compensation Policy. Consistent with our compensation philosophy of paying for performance and
maintaining a flexible approach, we use the Incentive Compensation Policy to provide Named Executive Officers with an incentive to contribute to the achievement of corporate objectives and goals while at the same time encouraging and rewarding
excellent individual performance and recognizing differences in performance between individual executives. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Plan
Design.</I> The board of directors establishes a number of annual corporate goals each year that include clinical development, research, manufacturing, organizational and financial goals which we believe are essential to building long-term
stockholder value and are used to assess corporate performance for the year under the Incentive Compensation Policy. These corporate goals are designed to be achieved during the annual performance period and their relative weighting is based upon
our assessment of the importance of each goal in creating long-term value for the Company and our stockholders. If we achieve the target level of performance for all of the stated goals, the overall corporate performance rating should be
approximately 100%.&nbsp;Each corporate goal is designed so that significant levels of achievement are required to meet the goal. Following the conclusion of the annual performance period, the level of achievement for each corporate goal is assessed
by the board of directors. The board determines whether each corporate goal has been met, exceeded, or not satisfied. In addition, in assessing corporate performance, the determination of corporate performance may be adjusted upward or
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
downward as deemed appropriate to factor in other significant corporate events that occurred during the performance period. After taking into account the level of attainment of each corporate
goal and such other corporate performance factors as the board may determine appropriate in reviewing performance for a particular year, the board of directors assigns an overall corporate performance rating for the year, which may range from 0% to
200%. The organization and compensation committee then confirms the corporate performance rating for purposes of the Incentive Compensation Policy. The total available bonus pool under the Incentive Compensation Policy is determined by multiplying
the corporate performance rating by the aggregate target bonus of all eligible participants. The aggregate of all individual bonuses awarded under the policy cannot exceed the total available bonus pool so that the total cost of bonuses ultimately
reflects our assessment of overall performance and is not inflated by the sum of individual performance ratings. Mr.&nbsp;Robin does not participate in the final determination of corporate goals or determining the corporate performance rating for
purposes of the Incentive Compensation Policy. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After the corporate performance rating is determined, the individual
performance of each Named Executive Officer (other than Mr.&nbsp;Robin) is reviewed by the organization and compensation committee in consultation with Mr.&nbsp;Robin in order to determine the appropriate individual performance percentage rating to
be assigned to the executive for the performance period. Mr.&nbsp;Robin&#146;s individual performance is reviewed by the organization and compensation committee for purposes of determining his annual bonus compensation.&nbsp;Each Named Executive
Officer&#146;s actual annual bonus is based on a combination of the corporate performance rating and his or her individual performance rating. The Incentive Compensation Policy does not provide for a specific allocation or weighting of each Named
Executive Officer&#146;s actual bonus amount between our corporate performance and individual performance.&nbsp;The actual annual bonus awarded for each Named Executive Officer is determined by us in our sole discretion, and the maximum payout for
each Named Executive Officer, including Mr.&nbsp;Robin, could be up to 200% of his or her target annual performance-based compensation target (or, by the same token, an individual executive&#146;s award could be reduced to 0% based on individual
performance regardless of the corporate performance rating). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I></I></B><I>Target Annual Short-Term Incentive Compensation
for 2013.</I><B><I></I></B> The Named Executive Officers were each assigned a target annual incentive for 2013 ranging from 50% to 75% of base salary. The table below shows the target annual incentive assigned by us to each Named Executive Officer
for 2013 both as a dollar amount and as a percentage of base salary. <B><I> </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Annual</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive&nbsp;for</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%&nbsp;of&nbsp;Base</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Salary)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">624,953</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">262,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">231,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rinko Ghosh</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">227,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">252,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Company Performance Objectives.</I> As a result of feedback from our stockholder outreach effort in
2013, below we have provided greater detail on the corporate performance objectives upon which the short-term incentive compensation is based. Specifically, we have expanded our disclosures below to provide the name of the individual development
program associated with each corporate goal and its relative weighting. The 2013 corporate objectives and relative weightings assigned to each objective were as follows: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective of achieving successful efficacy, safety and tolerability results from the NKTR-181 (our novel opioid pain drug candidate) Phase 2
clinical study as well as the successful results from the NKTR-181 human abuse liability clinical study (30%). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective to achieve a minimum year-end patient enrollment in the etirinotecan pegol Phase 3 BEACON (NKTR-102) Study in metastatic breast cancer
(10%). </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A clinical development objective of achieving successful results from the NKTR-192 (novel short-acting opioid drug candidate) Phase 1 clinical study (10%).
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A research and clinical development objective to complete IND enabling work (GLP manufacturing and toxicology studies) for NKTR-171 sufficient to advance it into
clinical studies (10%). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A research objective related to completing IND enabling work (GLP manufacturing) for NKTR-214 (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A research objective to advance multiple molecules into development candidate status (i.e. ready for IND enabling toxicology work) (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A manufacturing objective to complete nebulizer device stability work and meet minimum manufacturing quantities to enable Bayer to start the Phase 3 clinical studies
for BAY41-6551 (Inhaled Amikacin Solution formally known as NKTR-061) (10%). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A manufacturing objective to meet predefined quality, performance and on-time delivery targets for our significant proprietary pegylation reagent customers (5%).
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A business development objective to complete a new transaction with a minimum financial target (5%). </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">A financial objective that cash used in operations (excluding budgeted new transaction revenue in the goal specified above) plus capital expenditures not exceed $200
million (10%). </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These performance objectives served as the corporate performance objectives under the
Company&#146;s Incentive Compensation Policy and were also used as one data point for purposes of the organization and compensation committee determining Mr.&nbsp;Robin&#146;s performance-based incentive compensation for 2013. The aggregate
weighting of the 2013 target corporate objectives was set at 100%.&nbsp;However, the maximum potential corporate performance rating is limited to 200% in any case. A corporate performance rating in excess of 100% can only be achieved if the board of
directors determines that the goal achievement for one or many of the goals substantially exceeded the target metrics, or the board uses its discretion to factor in other significantly positive corporate events that occurred during the performance
period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Research and development goals comprised 70% of the corporate performance objectives for 2013, with an additional 15%
relating to manufacturing objectives that we believe are critical to our business, and the remaining 15% relating to financial objectives. This weighting of objectives is a reflection of our long-term focus as a drug development company with the
goal of building a broad, robust and diverse pipeline of proprietary drug candidates.&nbsp;We believe this mix of corporate goals was not only an appropriate measure of achievement in 2013, but also represents objectives important to building the
long-term foundation of our business. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Actual Annual Incentives Earned for 2013 </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A report of the achievement of the 2013 corporate objectives was prepared by the executive committee and then reviewed and assessed by the
board of directors. The board of directors determined that seven of the corporate goals identified above were met (including the financial objective), one was partially met, and one was exceeded which resulted in an 85% achievement level as compared
to target. One goal was not met and therefore received no credit. The board of directors also recognized that in 2013 there were significant accomplishments outside of the established corporate objectives including the favorable results from the
long-term comparative controlled safety study of naloxegol versus usual care (KODIAC-08) and the regulatory filings for naloxegol in the United States and European Union which triggered a total of $95 million in milestone payments in the second half
of 2013 under the Company&#146;s license agreement with AstraZeneca. In recognition of these accomplishments, the board of directors concluded a discretionary upward adjustment of 5% would be appropriate which resulted in a final corporate
performance rating of 90% for 2013 which was used to set the aggregate bonus pool under the Incentive Compensation Policy. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following the corporate performance rating determination, the organization and compensation
committee, in consultation with Mr.&nbsp;Robin, determined an individual performance rating for each of the Named Executive Officers excluding Mr.&nbsp;Robin, whose performance is determined independently by the organization and compensation
committee without his participation. As with our other employees and consistent with our philosophy of pay for performance, these executives are eligible to receive awards that exceed the corporate performance rating if their rating is
&#147;exceptional&#148; and &#147;exceeds expectations.&#148; Employees with ratings of &#147;solid performer&#148;, &#147;needs improvement&#148; and &#147;does not meet expectations&#148; received awards below the corporate performance rating
level, and in some cases they received bonuses significantly below that level or no bonus award at all. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After considering
input from Mr.&nbsp;Robin, the organization and compensation committee considered the following individual performance factors in determining each executive&#146;s actual bonus for 2013: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Dr.&nbsp;Doberstein, specific performance factors considered by us included his effective leadership of the Company&#146;s scientific function and
development of his leadership team, the continued advancement of the research development pipeline, his input on the strategic direction of the business, and his ability to effectively work with other members of the management team.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Mr.&nbsp;Nicholson, specific performance factors considered by us included his operational leadership across functional areas, his management of
high quality finance, information technology and quality departments, and his ability to effectively work with other members of the management team. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">For Mr.&nbsp;Labrucherie, specific performance factors considered by us included his exceptional performance within his functional area including his
leadership and skills in corporate governance and risk management, the negotiation of a revised collaboration agreement with AstraZeneca that resulted in regulatory filings being made for naloxegol, his management of a high quality legal and patent
department, his input on the strategic direction of the business, and his ability to effectively work with other members of the management team. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In the case of Mr.&nbsp;Ghosh, we entered into an employment transition and general release agreement with him in February 2014 which included lump sum severance payments, of which $204,795 related to
compensation for the 2013 annual performance period. This compensation was paid to Mr.&nbsp;Ghosh as an integrated component of his severance arrangement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In determining Mr.&nbsp;Robin&#146;s 2013 bonus, the organization and compensation committee took into account a combination of the corporate achievements identified above and its subjective assessment of
his individual performance. Specific performance factors considered for Mr.&nbsp;Robin included his superb leadership in setting and executing on the long-term strategy of the Company, the negotiation of a revised collaboration agreement with
AstraZeneca that resulted in regulatory filings being made for naloxegol, the overall execution of the business plan including advancing the Company&#146;s development pipeline of proprietary and partnered programs, the effective public
communication of the Company&#146;s business strategy and future potential. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The bonuses awarded to the Named Executive Officers for 2013 fell within the guidelines we
established for all of our employees under the Incentive Compensation Policy who received the individual performance ratings assessed and approved for these executives by the organization and compensation committee. In other words, although the
bonus awards to the Named Executive Officers may be higher than the 90% corporate performance rating, these bonus awards (expressed as a percentage of the participant&#146;s target bonus) were substantially consistent with the bonus awards made to
participants in the Incentive Compensation Policy with a similar individual performance rating. The following table lists the actual annual performance-based incentive compensation awarded to each Named Executive Officer as a percentage of his 2013
target bonus. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Actual&nbsp;Bonus</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>as a</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage&nbsp;of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Target&nbsp;Bonus<BR>for&nbsp;Entire<BR>2013&nbsp;Year</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(%)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Howard W. Robin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Nicholson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen K. Doberstein, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rinko Ghosh</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">110</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Discretionary Bonuses Earned in 2013.</I> No discretionary bonuses were awarded to the Named Executive
Officers in 2013. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts of each Named Executive Officer&#146;s bonuses for the 2013 fiscal year are reported in the
Summary Compensation Table below. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Long-Term Incentive Compensation: Equity Awards </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Overview.</I> In accordance with our objective of aligning executive compensation with our stockholders&#146; interests, our current
long-term incentive program for the Named Executive Officers generally consists of one annual award of equity compensation that is typically subject to a multi-year vesting schedule. We believe that equity compensation is a very effective tool to
align the interests of our Named Executive Officers, who have significant responsibility for driving our success, with the interests of our stockholders. Stock options are our preferred form of long-term incentive compensation because we believe
they are inherently performance-based with value delivered only if the price of our common shares appreciates following the grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Performance-Based Equity Compensation Program</I>. In 2012, we established a performance-based stock option award program for our executive officers. Under this program, 50% of the stock options
granted to our executive officers each year have been made in the form of performance-based stock option awards that vest based on the standard four-year monthly vesting schedule plus a separate performance condition that must also be achieved
before the executive officer is permitted to exercise the performance-based stock option. The performance condition will be met only if, within five years from the grant date, the Company or one of its collaboration partners files a new drug
application or biologics license application with the FDA (or the equivalent new drug registration with the European Medicines Agency) for any &#147;Proprietary Company Program&#148; which includes any drug candidate that is wholly-owned by the
Company (e.g. NKTR-102 or NKTR-181) or where the Company is entitled to an average royalty interest equal to or greater than 7.5% of net sales. In setting this performance hurdle, the organization and compensation committee believed it would be
challenging to achieve and, if achieved, would help create long-term stockholder value. For example, this performance condition has only been achieved twice in the history of the Company. The remaining 50% of the stock option grants awarded to our
executive officers in each year are subject to our standard time-based vesting requirements. In September 2013, the EMA accepted the MAA for naloxegol. This regulatory filing acceptance for naloxegol met the performance condition for the 2012 and
2013 performance stock option grants, which remain also subject </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
to the standard four-year monthly vesting schedule from the date of grant. We currently intend to continue the performance-based stock option award program in future years, with 50% of equity
awards vesting only if performance milestones based on corporate accomplishments are achieved that we believe are significant and further align the economic interests of our executives with those of our stockholders. At this point in the
Company&#146;s evolution as a drug development company, we believe that the advancement of the late stage drug candidate pipeline is critical to potential stockholder value creation. As such, the performance condition for our 2014 performance-based
stock option awards is also based on a future regulatory approval filing with the FDA or EMA for a Proprietary Company Program. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Actual Long-Term Incentives Awarded</I>. The Named Executive Officers received an annual equity award during the first portion of 2013
in connection with the annual performance review process. Our view is that the equity awards granted early in each year primarily represent compensation earned for performance during the preceding year, even though SEC proxy rules require that the
grant date fair value be included as compensation in the annual period in which the equity grant is awarded (i.e. 2013 instead of 2012 which is differs from the way annual cash bonus awards are categorized&#151;in 2012&#151;even though both
compensation awards are made on the same day). In determining the grant levels for these awards, we consider a number of factors including an assessment of individual performance, competitive market practices, the number of unvested stock options
held by the executive and average exercise price (i.e. the retention value) of these options, the individual&#146;s overall contribution, and stockholder dilution. However, we do not use a formula or assign a particular weight to any one factor in
determining equity award levels. Rather, the determination of equity grant levels is subjective, and the organization and compensation committee awards equity grants at levels it believes in its judgment are reasonably competitive and consistent
with our philosophy that a substantial portion of our executives&#146; compensation should be performance-based and help to further link the interests of our executives with those of our stockholders. These annual stock option awards vest monthly
over a period of four years and thus provide a retention incentive for the executive as well as an additional incentive to help create value for our stockholders. Our independent consultant provided data that indicated that the grant date value of
the stock options granted to Mr.&nbsp;Robin in 2013 were almost 50% below the unadjusted median for chief executive officers of our peer group and approximately median of our peer group after adjusting for market capitalization as described above.
For these purposes, the grant-date value of equity awards is determined using the same stock option valuation methodology used for the Company&#146;s financial reporting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The number of shares of common stock subject to stock options granted to each Named Executive Officer during 2013 and the grant-date fair value of these equity awards is presented in the Grants of Plan
Based Awards in 2013 table below. A description of the material terms of the 2013 stock option awards is presented in the narrative section following that table. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Grant Date Practices.</I> The grant date for equity awards is typically the date of approval by the organization and compensation committee or, if later the date an executive officer commences
employment for new hire grants. To streamline the administration of our equity plans, the organization and compensation committee will generally approve equity awards to newly hired executives at the time their other compensation arrangements are
approved, but provide that the grant date will be the date that they actually begin employment. This approach also permits us to match the grant date with the service period of the stock option recipient. Meetings of the organization and
compensation committee at which equity grants are reviewed and approved generally are scheduled well in advance. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance and Change
of Control Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the employment of a Named Executive Officer is terminated by us without cause or by the
executive for a designated good reason outside of the context of a change of control transaction, the executive would be entitled to severance benefits under the executive&#146;s agreements with the Company. These severance benefits include a cash
severance payment based on the executive&#146;s then current base salary and the amount of his or her target annual incentive bonus, payment of COBRA premiums for one year, and an additional 12 month period to exercise vested options (an 18 month
period for Mr.&nbsp;Robin).&nbsp;In order to attract and retain these Named Executive </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Officers in a competitive environment for highly skilled senior executive talent in the biotechnology and pharmaceutical industry and to provide an incentive to obtain a broad release of claims
in favor of the Company, we determined it was necessary to offer each of them severance benefits in the case of a termination without cause or constructive termination outside the context of a change of control transaction. Many of our peer
companies provide severance benefits for similar types of terminations of employment, and we believe that it is important for us to offer these severance benefits in order to continue to provide a competitive total compensation program. These Named
Executive Officers would also be entitled to certain termination benefits upon a termination of employment because of death or disability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We also maintain a Change of Control Severance Benefit Plan (the &#147;CIC Plan&#148;) that provides the Named Executive Officers with certain severance benefits if their employment is terminated in
connection with a change of control. The CIC Plan was originally established in 2006, and no amendments have been made to the plan since that time that would increase the severance benefits available under the CIC Plan. Severance benefits under the
CIC Plan are structured on a &#147;double-trigger&#148; basis, meaning that the executive must experience a termination without cause or resign for a specifically defined good reason in connection with the change of control in order for severance
benefits to become payable under the CIC Plan. Like the severance benefits under the letter agreements, we believe that these change of control severance benefits are an important element of a competitive total compensation program. Additionally, we
believe that providing change of control benefits should eliminate, or at least reduce, any reluctance of our Named Executive Officers and other key employees covered by the CIC Plan to diligently consider and pursue potential change of control
opportunities that may be in the best interests of our stockholders. At the same time, by providing change of control benefits only upon the occurrence of an additional triggering event occurring in connection with the change of control transaction
resulting in a job loss, we believe that this CIC Plan helps preserve the value of our key personnel for any potential acquiring company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under the CIC Plan, the executive would be entitled to accelerated equity award vesting upon a termination described above. The other severance benefits under the CIC Plan are generally similar to the
severance benefits described above; however Mr.&nbsp;Robin&#146;s cash severance would be increased to cover the two-year period following termination and Company-paid COBRA coverage would be increased to eighteen months. Outplacement services
received within twelve months following separation, up to a maximum of $5,000, are provided to all participants. In addition, each of the Named Executive Officers would be entitled to full equity vesting and, except for Dr.&nbsp;Doberstein, a
&#147;gross up&#148; payment for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code once a 10% cutback threshold is exceeded and outplacement benefits. We determined that Mr.&nbsp;Robin should be entitled to increased
severance benefits for a termination in connection with a change of control because of his role in the Company and the likelihood that a change of control would result in his termination of employment.&nbsp;The excise tax gross-up was included in
the CIC Plan as originally adopted in 2006 to make the participants whole for any adverse tax consequences to which they may become subject under Section&nbsp;4999 of the Internal Revenue Code and to avoid unintended differences in net severance
based on individual factors like the date of hire and past option exercise decisions, which preserves the level of change of control severance protections that we have determined to be appropriate.&nbsp;At the time the CIC Plan was established, we
believed this excise tax gross-up protection was a reasonable part of a competitive total compensation package and generally consistent with industry practice at the time. On April&nbsp;5, 2011, the board of directors amended the CIC Plan to
eliminate any &#147;gross up&#148; payments for any excise taxes imposed under Section&nbsp;4999 of the Internal Revenue Code for participants who became eligible to participate in the CIC Plan on or after January&nbsp;1, 2010. The board of
directors decided to eliminate this tax gross-up provision under the plan for new participants based on its review of current industry practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The &#147;Potential Payments Upon Termination or Change of Control&#148; section below describes and quantifies the severance and other benefits potentially payable to the Named Executive Officers.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Other Benefits </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We believe that establishing competitive benefit packages for employees is an important factor in attracting and retaining highly-qualified personnel, including the Named Executive Officers. The Named
Executive Officers are eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
disability insurance, commuting benefits, employee stock purchase plan and the 401(k) plan, in each case generally on the same basis as other employees. We do not offer a tax-qualified
defined-benefit pension plan or any non-qualified defined benefit retirement plans, nor do we provide material perquisites to our executives. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Assessment of Compensation-Related Risk </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">As with other companies that utilize pay-for-performance based compensation elements, our focus on a pay-for-performance compensation model inherently presents certain risks as our executive officers and
employees strive to achieve high levels of performance to build and expand our business.&nbsp;However, we recognize the need to strike a balance between pay-for-performance and calculated business risk taking, and believe that our compensation
program, including the compensation opportunities for our executive officers, should not encourage inappropriate or excessive risk-taking.&nbsp;Several design features of our compensation program that we believe reduce the likelihood of excessive
risk-taking include the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation plan design provides a mix of base salary, short-term incentive compensation opportunity and equity compensation earned over
multiple-year periods. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The determination of the corporate performance rating under the annual bonus plan is based on our achievement of a diversified mix of development,
research, organizational and financial objectives. Thus, the achievement of any single corporate objective does not have a disproportionate impact on the aggregate annual bonus awarded. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each employee&#146;s annual cash bonus is determined by a combination of the corporate performance rating and a subjective determination of individual
performance. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The maximum payout levels for annual incentive bonuses are capped at 200% of each employee&#146;s annual target bonus. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A substantial portion of each executive&#146;s compensation opportunity is in the form of long-term equity incentives, which help to further align the
long-term interests of our executives with those of our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">All employees are subject to our security trading policy which prohibits trading in derivative securities (i.e. puts or calls), short selling, and any
trading in the Company&#146;s securities on margin. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each executive officer is subject to our claw-back policy which provides that any compensation received by an executive officer based upon the
achievement of financial results that are subsequently revised is subject to cancellation or a reimbursement obligation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Based on a review of our compensation program, in particular the compensation opportunities for our executive officers, we have concluded that it should not encourage inappropriate or excessive
risk-taking that may have a material adverse effect on the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Section&nbsp;162(m) Policy </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;162(m) of the U.S. Internal Revenue Code limits our deduction for federal income tax purposes to $1 million of compensation
paid to certain Named Executive Officers in a taxable year. Compensation above $1 million may be deducted if it is &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m). While we consider the compensation limits of
Section&nbsp;162(m) when designing our executive compensation programs, we reserve discretion to grant compensation from time to time that may not be deductible under the Section&nbsp;162(m) limits in situations where we have determined the
compensation to be appropriate to satisfy our compensation and other objectives. We intend to continue to evaluate the effects of the compensation limits of Section&nbsp;162(m) and to grant compensation awards in the future in a manner we believe is
consistent with the best interests of our Company and stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_25"></A>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL>
R<SMALL>EPORT</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in this report is being furnished and shall not be deemed &#147;filed&#148; with
the SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that section, nor shall the material in this section be deemed to be &#147;soliciting material&#148; or incorporated by reference in any
registration statement or other document filed with the SEC under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the Exchange Act, except as otherwise expressly stated in such filing. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The organization and compensation committee has reviewed the Compensation Discussion and Analysis and discussed it with management. Based
on its review and discussions with management, the committee recommended to our board of directors that the Compensation Discussion and Analysis be included in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 and in
our 2013 proxy statement. This report is provided by the following independent directors, who currently comprise the committee: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Lutz
Lingnau&#151;Chairman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher A. Kuebler
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_26"></A>S<SMALL>UMMARY</SMALL> C<SMALL>OMPENSATION</SMALL>
T<SMALL>ABLE</SMALL>&#151;F<SMALL>ISCAL</SMALL> 2011-2013 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended
December&nbsp;31, 2013, compensation awarded to or earned by our Chief Executive Officer, our Chief Financial Officer and our other three most highly compensated executive officers who were serving as executive officers on December&nbsp;31, 2013
(the &#147;Named Executive Officers&#148;). To the extent any Named Executive Officers were also named executive officers for the fiscal years ended December&nbsp;31, 2012 or December&nbsp;31, 2011, compensation information for our 2012 and 2011
fiscal years is also presented for such executives. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year<BR>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>($)(1)<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<BR>($)(2)<BR>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<BR>($)(2)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive Plan</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation<BR>($)(3)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>831,247</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,067,165</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>656,200</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15,039<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,569,652</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>President and Chief<BR>Executive Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>807,196</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>500</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,510,160</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>910,125</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14,351</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,242,332</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>785,131</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,732,530</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>650,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10,599</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3,178,261</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>524,264</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>849,835</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>276,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,112<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,662,210</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR>Chief Financial Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>509,529</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>500</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>377,540</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>357,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12,225</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,256,794</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>495,583</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>363,831</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>260,925</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,717</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,130,056</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>459,722</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>459,370</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>231,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,513<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,159,605</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR>Chief Scientific Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>433,605</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>377,540</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>260,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,613</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,080,758</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>420,167</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>20,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>346,506</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>221,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9,057</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,017,280</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rinko Ghosh (7)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>453,994</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>459,370</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>204,795<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,436<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,125,595</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR>Chief Business Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>440,840</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>377,540</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>265,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,772</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,091,152</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>428,333</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,000</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>577,510</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>225,750</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8,426</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,241,020</B></FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>504,195</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>689,055</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>278,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,238<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,478,488</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Senior Vice President and<BR>General Counsel</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2012</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>488,270</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>566,310</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>330,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6,503</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,391,083</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>468,083</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>519,759</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>306,150</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7,249</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,301,241</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported in this column represent discretionary bonuses awarded in 2012 to Mr.&nbsp;Robin and Mr.&nbsp;Nicholson upon achievement of five years of service with
the Company, and in 2011 represent a bonus of $20,000 for Dr.&nbsp;Doberstein in connection with our removing the opportunity for participants in the CIC Plan hired after January&nbsp;1, 2010 to receive &#147;gross up&#148; payments for any excise
taxes imposed under Section&nbsp;4999 of the Internal Revenue Code under the plan and a discretionary bonus for Mr.&nbsp;Ghosh under our Service Award Policy upon his achievement of ten years of service with the Company. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported represent the aggregate grant date fair value of awards granted in the applicable year computed in accordance with FASB ASC Topic 718 (formerly SFAS
No.&nbsp;123R), which excludes the effects of estimated forfeitures. For a complete description of the assumptions made in determining the valuation, please refer to (i)&nbsp;Note 11 (Stock-Based Compensation) to our audited financial statements in
our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 and (ii)&nbsp;similar footnotes to our audited financial statements in our annual reports on Form 10-K for prior years when the awards were granted.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As noted in the Compensation Discussion and Analysis above, certain options granted to the Named Executive
Officers in 2012 and 2013 were subject to performance-based vesting requirements. The amounts reported in the &#147;Option Awards&#148; column of the table for 2012 and 2013 above include the grant date fair value of these performance-based stock
options based on the probable outcome (determined as of the grant date in accordance with applicable accounting rules) of the performance-based conditions applicable to the awards. The probable grant date fair value for these awards was determined
assuming that the highest level of the performance conditions would be achieved. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts reported for 2011, 2012 and 2013 represent amounts earned under the Incentive Compensation Policy for that year or, for Mr.&nbsp;Robin, under
his amended and restated offer letter effective as of </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
December&nbsp;1, 2008. As noted in the &#147;Compensation Discussion and Analysis&#148; above, Mr.&nbsp;Robin&#146;s annual bonus opportunity for 2013 was similar in structure to the bonus
opportunities for the other Named Executive Officers under the Incentive Compensation Policy. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $10,668, (ii)&nbsp;a $3,000 contribution to a 401(k) plan, and (iii)&nbsp;a $1,370 for parking. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $9,068, (ii)&nbsp;a $3,000 contribution to a 401(k) plan, and (iii)&nbsp;a $44 for parking. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $3,657, (ii)&nbsp;a $3,000 contribution to a 401(k), (iii)&nbsp;$2,244 for parking and $12 for a tax gross up on parking,
and (iv)&nbsp;a $600 public transit match. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ghosh&#146;s last day of employment at the Company was March&nbsp;15, 2014. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This compensation was paid to Mr.&nbsp;Ghosh as an integrated component of his severance arrangement. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $2,615, (ii)&nbsp;a $3,000 contribution to a 401(k) plan, and (iii)&nbsp;$1,821 for parking. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (i)&nbsp;life insurance premiums of $1,590, (ii)&nbsp;a $3,000 contribution to a 401(k), (iii)&nbsp;$2,360 for parking and $122 for a tax gross up on parking,
and (iv)&nbsp;a $165 public transit pass. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_27"></A>Description of Employment Agreements
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the Named Executive Officers has entered into our standard form of employment agreement and an offer letter or
letter agreement. The form of employment agreement provides for protective covenants with respect to confidential information, intellectual property and assignment of inventions and also sets forth other standard terms and conditions of employment.
The offer letter entered into by Messrs. Robin, Nicholson, and Dr.&nbsp;Doberstein provide for a minimum base salary and target annual short-term incentive compensation amounts, as well as other additional terms and conditions of employment. Each of
these letters specifies an initial base salary that may be increased in our discretion, but which may not be decreased. The current base salary level for Mr.&nbsp;Robin is $862,434, for Mr.&nbsp;Nicholson is $544,000 and for Dr.&nbsp;Doberstein is
$479,000. Under the offer letter agreements, Mr.&nbsp;Robin&#146;s annual target bonus is 65% of his base salary, and the minimum target bonus levels for Mr.&nbsp;Nicholson and Dr.&nbsp;Doberstein is 50% of the executive&#146;s base salary. The
offer letter agreements do not provide for any minimum or guaranteed term of employment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The letter agreements entered into
by each of the Named Executive Officers establish the compensation arrangements following separation from us under certain circumstances. Please see &#147;Potential Payments upon Termination or Change in Control&#148; below for more information on
these separation arrangements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_28"></A>GRANTS OF PLAN BASED AWARDS IN 2013 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows, for the fiscal year ended December&nbsp;31, 2013, certain information regarding grants of plan-based awards to
the Named Executive Officers. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="8" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="8" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>

<TD VALIGN="bottom" ROWSPAN="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ROWSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Possible
Payouts</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Under Non-Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive Plan Awards(1)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="7"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ROWSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated Future
Payouts</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Under Equity</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Incentive Plan Awards(2)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="7"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="8" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Awards:</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of Shares</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or Units</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="8" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;
Other</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards:</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options<BR>(#)(3)</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="8" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or&nbsp;Base<BR>Price&nbsp;of<BR>Option</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($/sh)<BR>(k)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="8"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="8" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fair&nbsp;
Value</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of
Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>and&nbsp;
Option</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)(4)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(l)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="8"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Threshold<BR>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Maximum<BR>(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>624,953</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,249,905</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,033,583</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>225,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>1,033,583</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>262,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>525,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>92,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>424,917</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>92,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>92,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>424,917</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>231,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>462,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>229,685</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>229,685</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Rinko Ghosh</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>227,550</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>455,100</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>229,685</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>50,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>229,685</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Annual Incentive Award</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>252,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>505,500</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>75,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>344,528</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1">Stock Options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2/6/2013</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>75,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>75,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>8.80</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>344,528</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Amounts reported represent the potential short-term incentive compensation amounts payable for our 2013 fiscal year under our Incentive Compensation Policy (or for
Mr.&nbsp;Robin, the potential amounts payable under his offer letter). The amounts reported represent each Named Executive Officer&#146;s target and maximum possible payments for the entire 2013 calendar year Because actual payments to the Named
Executive Officers could range from 0% to 200% of their target bonus, no threshold payment amount has been established for the Named Executive Officers. The actual short-term incentive bonus amount (if any) earned by each Named Executive Officer for
2013 is reported in Column (g)&nbsp;(Non-Equity Incentive Plan Compensation) of the Summary Compensation Table above. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These grants are subject to both a 4-year time-based vesting requirement and the achievement of specified performance criteria. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">These grants are subject to a 4-year time-based vesting requirement. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Refer to Note 11 (Stock-Based Compensation) to our audited financial statements in our annual report on Form 10-K for the fiscal year ended December&nbsp;31, 2013 for
the relevant assumptions used to determine the grant date fair value of the stock options granted during 2013. The amounts reflected in this column for stock options granted during 2013 that are subject to performance-based vesting conditions
represent the grant date fair value of these awards based on the probable outcome (determined as of the grant date in accordance with applicable accounting rules) of the performance-based conditions applicable to the awards.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Description of Plan-Based Awards </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stock Options.</I> Each stock option granted to the Named Executive Officers during 2013 may be exercised to purchase the designated
number of shares of our common stock at an exercise price equal to the closing price of the underlying common stock on the grant date. During 2013, the Named Executive Officers were granted only non-qualified stock options. Each Named Executive
Officer&#146;s stock option award granted in 2013 has a maximum term of eight years and is subject to a vesting schedule that requires the executive&#146;s continued service through the vesting date. For the stock option awards granted to Named
Executive Officers in February 2013, 50% of the options granted will vest and become exercisable on a monthly </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
pro-rata basis over a four-year period following the grant date, and 50% of the options granted will vest and become exercisable after achievement of specified performance criteria described
further below as well as also being subject to vesting on a monthly pro-rata basis over a four-year period following the grant date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under our performance-based stock option award program for our executive officers, 50% of the stock options granted to our executive officers in February 2013 were made in the form of performance-based
stock option awards that vest based on the standard four-year monthly time-based vesting plus a separate performance condition that must also be achieved before the executive officer is permitted to exercise the performance-based stock option. The
performance condition will be met only if within five years from the grant date, the Company or one of its collaboration partners files a new drug application or biologics license application with the FDA (or the equivalent new drug registration
with the European Medicines Agency) for any &#147;Proprietary Company Program&#148; which is defined to include any drug candidate that is wholly-owned by the Company (e.g. NKTR-102 or NKTR-181) or where the Company is entitled to an average royalty
interest equal to or greater than 7.5% of net sales. In September 2013, the European Medicines Agency (EMA) accepted the Marketing Authorization Application (MAA) for naloxegol. This regulatory filing acceptance met the performance condition for the
2013 performance equity grants, which are now only subject to the standard four-year monthly vesting schedule from the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Any stock options that are unvested upon a Named Executive Officer&#146;s termination of continuous employment or services will be forfeited without any value, unless the termination of continuous service
is a result of death, in which event, subject to any restrictions in the stock option agreement or equity incentive plan, the option would become fully vested and exercisable as of the date of termination. For Messrs. Robin, Nicholson and
Dr.&nbsp;Doberstein, in accordance with their letter agreements if any stock options that are unvested upon a their termination of continuous employment as a result of a disability, 50% of the unvested options would become fully vested and
exercisable as of the date of termination. In accordance with the letter agreements for the Named Executive Officers described above, any stock options that are vested upon termination of continuous service by us without cause or by the executive
for a good reason resignation (as defined in the CIC Plan) will generally remain outstanding and exercisable for 12 months following termination (18 months for Mr.&nbsp;Robin). This exercise period is also 12 months if the termination of employment
or continuous services is because of disability and is 18 months if the termination is a result of death. We also have the discretion to extend the applicable exercise period in connection with other terminations of employment. Any vested options
that are not exercised within the applicable post-termination of employment exercise period will terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the terms
of the 2012 Plan, if there is a change in control of the Company, outstanding awards granted under the plan will generally become fully vested and, in the case of options, exercisable, unless the organization and compensation committee provides for
the substitution, assumption, exchange or other continuation of the outstanding awards. Any options that become vested in connection with a change in control generally must be exercised prior to the change in control, or they will be cancelled in
exchange for the right to receive a cash payment in connection with the change in control transaction. In addition, outstanding awards held by our Named Executive Officers may vest, upon certain terminations of the Named Executive Officer&#146;s
employment without cause or for a good reason resignation in connection with a change of control and in connection with terminations of employment resulting from disability or death. Please see the &#147;Potential Payments Upon Termination or Change
of Control&#148; section below for a description of the vesting that may occur in such circumstances. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each Named Executive
Officer&#146;s stock option award was granted under, and is subject to the terms of, the 2012 Equity Incentive Plan. The plans are administered by the organization and compensation committee, and this committee has the ability to interpret and make
all required determinations under the plans. This authority includes making required proportionate adjustments to outstanding stock options to reflect certain corporate transactions and making provision to ensure that participants satisfy any
required withholding taxes.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Named Executive Officers are not entitled to any dividend equivalent rights on their stock
option awards, and stock option awards are generally only transferable to a beneficiary of a Named Executive Officer upon his death. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Short-Term Incentive Compensation.</I> All of the Named Executive Officers were eligible
to earn a short-term incentive compensation payment under the Incentive Compensation Policy or, for Mr.&nbsp;Robin, under an arrangement that mirrors the Incentive Compensation Policy. These opportunities are reflected in the &#147;Estimated
Possible Payouts Under Non-Equity Incentive Plan Awards&#148; columns of the table above. Please see &#147;Compensation Discussion and Analysis&#151;Current Executive Compensation Program Elements&#151;Short-Term Incentive Compensation and
Discretionary Bonuses&#148; for a description of the material terms of the Incentive Compensation Policy and Mr.&nbsp;Robin&#146;s related short-term incentive compensation arrangement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_29"></A>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END FOR 2013
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the value of all unexercised options and stock awards
previously awarded to the Named Executive Officers as of December&nbsp;31, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have Not<BR>Vested<BR>(#)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares/<BR>Units
etc.<BR>That<BR>Have&nbsp;Not<BR>Vested</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Payout<BR>value
of<BR>Unearned<BR>Shares/<BR>Units etc.<BR>That<BR>Have Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(k)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/16/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,435</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/16/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">565,565</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">14.52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">700,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">479,166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">20,834<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">212,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">87,500<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">91,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">108,334<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">91,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">108,334<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">178,125<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">46,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">178,125<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/2/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">45,092</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/2/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">154,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10/1/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">85,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/10/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/9/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/18/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/17/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">155,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,000<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">44,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">18,375<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">73,230<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">19,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">73,230<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/6/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">528,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11,250<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/5/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">42,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">17,500<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Rinko Ghosh</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3,600<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,860</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8/15/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">16.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8/14/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/20/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/19/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">60,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/11/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/10/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">57,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,500<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/1010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">57,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2,500<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/22/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">93,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6,250<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/21/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">29,167<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">22,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">27,084<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,416</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">39,584<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>

<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="16" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable<BR>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable<BR>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options<BR>(#)(1)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(f)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(2)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(g)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have Not<BR>Vested<BR>(#)</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(h)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That<BR>Have
Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(i)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number&nbsp;of<BR>Unearned<BR>Shares/<BR>Units
etc.<BR>That<BR>Have&nbsp;Not<BR>Vested</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(#)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(j)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Payout<BR>value of<BR>Unearned<BR>Shares/<BR>Units
etc.<BR>That<BR>Have Not<BR>Vested<BR>($)(3)</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(k)</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/16/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">3/15/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/2/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">13.02</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4/1/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/21/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">200,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">12/20/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/25/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/24/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/23/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">120,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">4.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/22/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/10/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">6/9/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/18/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">0<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">9.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11/17/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">115,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">5,000<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">11.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">1/31/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">63,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">26,250<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">10.69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,625<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/8/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">34,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">40,625<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">7.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/7/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">59,375<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/6/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">15,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">59,375<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">8.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1">2/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options subject to achievement of specified performance criteria. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">For all Named Executive Officers, the expiration date shown is the normal expiration date occurring on the eighth anniversary of the grant date, which is the latest
date that the options may be exercised. Options may terminate earlier in certain circumstances, such as in connection with a Named Executive Officer&#146;s termination of employment or in connection with certain corporate transactions, including a
change of control. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Restricted stock unit value is calculated based on the December&nbsp;30, 2013, closing price of our common stock of $11.35. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest over a five year period, with the first 20% of the options vesting one year from the date of grant and the remaining portion of the options vesting
pro-rata on a monthly basis over the following four years. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest over a four year period, with the first 25% of the options vesting one year from the date of grant and the remaining portion of the options vesting
pro-rata on a monthly basis over the following three years. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest pro-rata on a monthly basis over a period of four years from the date of grant. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest pro-rata on a monthly basis over a twelve month period. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest pro-rata on a monthly basis over a period of five years from the date of grant. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">This restricted stock unit award vests based upon achievement of a regulatory filing for a proprietary drug candidate development program before the eighth anniversary
of the grant date. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest upon achievement of specified performance criteria, and additionally once the applicable performance goal has been achieved, will vest pro-rata on a
monthly basis over a period of four years from the date of grant. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_30"></A>OPTION EXERCISES AND STOCK VESTED IN 2013 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table includes certain information with respect to the exercise of stock options by the Named Executive Officers during the
fiscal year ended December&nbsp;31, 2013, and on the vesting during our 2013 fiscal year of stock awards held by the Named Executive Officers. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:20pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(a)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;
of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares<BR>Acquired</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on&nbsp;Exercise&nbsp;
(#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on Exercise
($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(c)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acquired&nbsp;
on</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting (#)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(d)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Vesting
($)</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(e)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rinko Ghosh</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">37,948</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_31"></A>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following section describes the benefits that may become payable to the Named Executive Officers in connection with their termination
of employment with us or in connection with a change of control. Please see &#147;Compensation Discussion and Analysis&#151;Severance and Change of Control Benefits&#148; for a discussion of how the payments and benefits presented below were
determined. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;No Change of Control </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the Named Executive Officers is a party to certain letter agreements and our standard form executive employment agreement, and
these agreements include provisions for severance benefits upon certain terminations of employment that are not related to a change of control. Upon a termination of employment by us without cause or by the executive for a good reason resignation
(as defined in the CIC Plan and described below), the executive would be entitled to the following severance benefits: (i)&nbsp;a cash severance payment equal to his or her total annual cash compensation target (including base salary and the target
value of his or her annual incentive bonus, as such bonus target may be adjusted downward to take into account our performance through the fiscal quarter preceding termination), (ii)&nbsp;an extension of the exercise period for the vested and
unexercised portion of all outstanding stock options held by him or her for up to 12 months (18 months for Mr.&nbsp;Robin) following termination and (iii)&nbsp;payment of all applicable COBRA premiums for the executive for up to one year following
the termination date. In order to receive the severance benefits described above, each executive must first execute an effective waiver and release of claims in favor of us. Each executive&#146;s cash severance payment would ordinarily be paid in a
lump-sum within 60 days following the executive&#146;s separation from service, although payment will be delayed to the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a Named Executive Officer&#146;s employment with us terminates due to death, the executive&#146;s outstanding unvested stock options
will become fully vested and will be exercisable for up to 18 months following termination pursuant to the terms of the Company&#146;s equity incentive compensation plans. In addition, in the case of Messrs. Robin, Nicholson and Dr.&nbsp;Doberstein,
the executive&#146;s estate would be entitled to a pro-rata portion of the target annual incentive bonus for the year in which his death occurred. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If a Named Executive Officer terminates employment with us as a result of disability, vested options will be exercisable for up to twelve months following termination pursuant to the terms of the
Company&#146;s stock option agreement. Each Named Executive Officer is entitled to have 100% of his stock options become fully vested </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
upon disability for all outstanding stock options other than those under the 2012 Plan. For Messrs. Robin, Nicholson and Dr.&nbsp;Doberstein, they are each also entitled to have 50% of
outstanding unvested stock options become fully vested upon disability for stock options under the 2012 Plan in accordance with the terms and conditions of their letter agreements. In addition, pursuant to their offer letter agreements, Messrs.
Robin, Nicholson and Dr.&nbsp;Doberstein would each be entitled to receive a pro-rata portion of the executive&#146;s target annual incentive bonus for the year of termination in the event of a disability. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our standard form employment agreement, following a termination of employment, each Named Executive Officer will be subject
to an indefinite restriction on the disclosure of our confidential information and a one-year non-solicitation restriction covering our customers and employees, as well as certain other restrictions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table lists the estimated amounts that would become payable to each of the Named Executive Officers under the circumstances
described above, assuming that the applicable triggering event occurred on December&nbsp;31, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Executive &amp;</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:58pt"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Triggering Event</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of&nbsp;Cash<BR>Severance</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value&nbsp;of<BR>COBRA<BR>Benefits<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR>Vesting<BR>Acceleration<BR>($)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of<BR>Pro-Rata<BR>Bonus</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,458,223</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>28,737</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,486,959</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,409,183</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>624,953</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,034,135</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,863,401</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>624,953</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,488,354</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>788,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>32,680</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>820,930</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>423,170</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>262,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>685,920</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>609,906</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>262,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>872,656</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>693,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>20,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>713,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>336,745</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>231,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>567,745</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>458,159</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>231,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>689,159</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rinko Ghosh</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>682,650</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>19,617</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>702,267</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>243,556</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>243,556</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>445,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>445,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Without Cause or Good Reason</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>758,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>28,737</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>786,987</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Disability</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>353,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>353,750</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Death</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>656,653</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>656,653</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The value of COBRA benefits are based upon actual rates that were in place effective as of December 2013. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of this table, we have assumed that (i)&nbsp;the price per share of our common stock is equal to the closing price per share on the last trading day of the
fiscal year ended December&nbsp;31, 2013 ($11.35), and (ii)&nbsp;the value of any stock options or restricted stock units that may be accelerated is equal to the full value of such awards on that date (i.e., the full &#147;spread&#148; value for
stock options and the full value of the shares underlying restricted stock unit awards). No value is attributed to any stock options with an exercise price greater than or equal to $11.35. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Severance Benefits&#151;Change of Control </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each of the Named Executive Officers is covered under the CIC Plan. The CIC Plan provides for certain severance benefits to these
executives and our other employees covered by the plan upon certain terminations of employment occurring in connection with a change of control of us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If a change of control of the Company occurs, each Named Executive Officer will be entitled to severance benefits under the CIC Plan if the executive&#146;s employment is terminated by us or a successor
company without cause or by the executive for a good reason resignation, in each case within a period generally beginning on the date the agreement providing for a change of control is executed and ending twelve months following the change of
control. Severance benefits under the CIC Plan include: (i)&nbsp;a cash severance payment equal to 12 months of base salary (24 months for Mr.&nbsp;Robin) and the target value of the executive&#146;s annual incentive bonus, (ii)&nbsp;payment by us
of the same portion of the executive&#146;s COBRA premiums as we pay for active employees&#146; group health coverage for up to 12 months (18 months for Mr.&nbsp;Robin) following termination, (iii)&nbsp;provision of up to $5,000 for outplacement
services received within 12 months following termination, (iv)&nbsp;accelerated vesting of all outstanding stock options, restricted stock units and other outstanding equity awards; and (v)&nbsp;other than in the case of Dr.&nbsp;Doberstein, a
&#147;gross up&#148; payment to compensate the executive for excise taxes (if any) imposed under Section&nbsp;4999 of the Internal Revenue Code, but only to the extent the excise taxes cannot be avoided by reducing the severance benefits by an
amount not exceeding 10% such that the executive receives a greater-after tax amount as a result of the &#147;cut-back&#148; in benefits. In April 2011, the board of directors amended the CIC Plan so that this &#147;gross up&#148; benefit is not
available for new hires following January&nbsp;1, 2010 but is grandfathered for employees who joined the CIC Plan before that date so long as they are not promoted to a position such that he or she would be entitled to additional benefits under the
plan. Accordingly, Dr.&nbsp;Doberstein is not entitled to this &#147;gross up&#148; benefit as he joined the CIC Plan after January&nbsp;1, 2010. In order to receive the severance benefits described above, each executive must first execute an
effective waiver and release of claims in favor of us pursuant to a separation and release agreement. Each executive&#146;s cash severance payment will ordinarily be paid in a lump-sum within 60 days following the executive&#146;s separation from
service, although payment will be delayed to the extent required to comply with Section&nbsp;409A of the Internal Revenue Code. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For the purposes of the CIC Plan, a good reason resignation means a resignation upon the occurrence of one or more of the following
events: (i)&nbsp;assignment of any authority, duties or responsibilities that results in a material diminution in the executive&#146;s authority, duties or responsibilities as in effect immediately prior to the change of control,
(ii)&nbsp;assignment to a work location more than 50 miles from the executive&#146;s immediately previous work location, unless such reassignment of work location decreases the executive&#146;s commuting distance from his or her residence to the
executive&#146;s assigned work location, (iii)&nbsp;a material diminution in the executive&#146;s monthly base salary as in effect on the date of the change of control or as increased thereafter, (iv)&nbsp;notice to the executive by us or the
successor company during the 12-month period following the change of control that the executive&#146;s employment will be terminated under circumstances that would trigger severance benefits under the CIC Plan but for the designation of a date for
termination that is greater than 12 months following the change of control and (v)&nbsp;for Mr.&nbsp;Robin, if he does not serve in his same position in the successor company or is not appointed to the board of directors of the successor company. In
order for a good reason resignation to occur, the executive must first give us timely written notice of the grounds for good reason resignation, and we must have failed to cure such condition after a period of 30 days. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the CIC Plan, the separation and release agreement that each of the Named Executive Officers will be required to execute to
receive severance benefits under the plan will also require each executive to agree to continue to be subject to the restrictions on the disclosure of our confidential information in his or her employment agreement, to non-solicitation restrictions
and to certain other restrictions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Had a change of control occurred during the 2013 fiscal year and had the employment of each
of the Named Executive Officers terminated on December&nbsp;31, 2013 under one of the qualifying circumstances described above, each executive would have been entitled to receive the estimated benefits set forth in the table below. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:31pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name (1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cash</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Severance&nbsp;($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>COBRA and</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outplacement</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Benefits ($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated<BR>Value of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Acceleration<BR>($)(2)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Value&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Excise Tax</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Gross-Up ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Howard W. Robin</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2,916,445</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>48,105</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,863,401</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,872,952</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>John Nicholson</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>788,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>37,680</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>609,906</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,435,836</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stephen K. Doberstein, Ph.D.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>693,000</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>25,166</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>458,159</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,176,325</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Rinko Ghosh</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>682,650</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>24,617</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>445,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,152,701</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Gil M. Labrucherie</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>758,250</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>33,737</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>656,563</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1,448,549</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">This amount includes estimated COBRA premiums based upon actual rates as of December 2013 and up to $5,000 for outplacement services. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the terms of our equity compensation plans, these Named Executive Officers would also have been entitled to this same full equity acceleration (i)&nbsp;if a
corporate transaction (as defined in the applicable plan) occurred and the surviving or acquiring corporation refused to assume outstanding equity awards or substitute similar replacement awards for outstanding equity awards or (ii)&nbsp;upon the
acquisition by any person of beneficial ownership of 50% or more of the combined voting power of our shares in a transaction that is not a corporate transaction as defined in the applicable plan. See note (2)&nbsp;to the table above for the
calculation of these amounts. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_32"></A>INFORMATION ABOUT OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>I<SMALL>NDEPENDENT</SMALL> R<SMALL>EGISTERED</SMALL> P<SMALL>UBLIC</SMALL> A<SMALL>CCOUNTING</SMALL>
F<SMALL>IRM</SMALL> F<SMALL>EES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table represents
aggregate fees billed to us for fiscal years ended December&nbsp;31, 2013 and December&nbsp;31, 2012 by Ernst&nbsp;&amp; Young LLP, our independent registered public accounting firm. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal Year Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">930,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,179,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">164,742</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">942,036</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,343,905</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Audit Fees</I>. This category consists of fees related to the audit of our annual consolidated
financial statements and our internal control over financial reporting, review of interim condensed consolidated financial statements included in our quarterly reports on Form&nbsp;10-Q, and services that are normally provided by the independent
registered public accounting firm in connection with statutory audit, registration statements and other regulatory filings. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Tax Fees.</I> This category consists of fees related to services provided for international tax compliance and tax consultation
services. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee approved all fees described above. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_33"></A>P<SMALL>RE</SMALL>-A<SMALL>PPROVAL</SMALL> P<SMALL>OLICIES</SMALL> <SMALL>AND</SMALL> P<SMALL>ROCEDURES</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has adopted policies and procedures for the pre-approval of audit and non-audit services rendered by our independent
registered public accounting firm, Ernst&nbsp;&amp; Young LLP. The policy generally requires pre-approval for specified services in the defined categories of audit services, audit-related services and tax services up to specified amounts.
Pre-approval may also be given as part of the audit committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual explicit case-by-case basis before the independent registered
public accounting firm is engaged to provide each service. The pre-approval of services may be delegated to one or more of the audit committee&#146;s members, but the decision must be reported to the full audit committee at its next scheduled
meeting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Prior to Ernst&nbsp;&amp; Young LLP rendering services other than audit services, the audit committee would review
and approve such non-audit services only if such services were compatible with maintaining Ernst&nbsp;&amp; Young LLP&#146;s status as our independent registered public accounting firm.</FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_34"></A>R<SMALL>EPORT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>UDIT</SMALL> C<SMALL>OMMITTEE</SMALL>
<SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>The material in
this report is being furnished and shall not be deemed &#147;filed&#148; with the SEC for purposes of Section&nbsp;18 of the Exchange Act or otherwise subject to the liability of that section, nor shall the material in this section be deemed to be
&#147;soliciting material&#146; or incorporated by reference in any registration statement or other document filed with the SEC under the Securities Act or the Exchange Act, except as otherwise expressly stated in such filing. </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee is currently comprised of four non-employee directors, Susan Wang, who
chairs the committee, and R. Scott Greer, Joseph J. Krivulka, and Dennis L. Winger. Our board of directors has determined that Ms.&nbsp;Wang and Messrs. Greer. Krivulka, and Winger meet the independence requirements set forth in Rule 10A-3(b)(1)
under the Exchange Act and in the applicable NASDAQ rules. In addition, the board of directors has determined that Ms.&nbsp;Wang and Mr.&nbsp;Winger each qualify as audit committee financial experts as defined by SEC rules. The audit committee has
the responsibility and authority described in the Nektar Therapeutics Audit Committee Charter, which has been approved by the board of directors. A copy of the Audit Committee Charter is available on our website at <I><U>www.nektar.com</U></I>.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee is responsible for assessing the information provided by management and our independent registered public
accounting firm in accordance with its business judgment. Management is responsible for the preparation, presentation and integrity of our financial statements and for the appropriateness of the accounting principles and reporting policies that are
used. Management is also responsible for testing the system of internal controls and reports to the audit committee on any deficiencies found. Our independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP, is responsible for auditing
the annual financial statements and for reviewing the unaudited interim financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In fulfilling its oversight
responsibilities, the audit committee has reviewed and discussed the audited financial statements in the annual report on Form 10-K for the year ended December&nbsp;31, 2013 with both management and our independent registered public accounting firm.
The audit committee&#146;s review included a discussion of the quality and integrity of the accounting principles, the reasonableness of significant estimates and judgments and the clarity of disclosures in the financial statements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee reviewed with our independent registered public accounting firm the overall scope and plan of the audit. In addition,
it met with our independent registered public accounting firm, with and without management present, to discuss the results of our independent registered public accounting firm&#146;s examination, the evaluation of our system of internal controls,
the overall quality of our financial reporting and such other matters as are required to be discussed under generally accepted accounting standards in the United States. The audit committee has also received from, and discussed with, our independent
registered public accounting firm the matters required to be discussed by Auditing Standard No.&nbsp;16, &#147;<I>Communications with Audit Committees&#148;</I> issued by the Public Company Accounting Oversight Board (PCAOB). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The audit committee has discussed with Ernst&nbsp;&amp; Young LLP that firm&#146;s independence from management and our Company,
including the matters in the written disclosures and the letter regarding independence from Ernst&nbsp;&amp; Young LLP required by applicable requirements of the PCAOB. The audit committee has also considered the compatibility of audit related and
tax services with the auditors&#146; independence. Based on its evaluation, the audit committee has selected Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2014.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In reliance on the reviews and discussions referred to above, the audit committee recommended to the board of directors, and
the board of directors approved, the inclusion of the audited financial statements and management&#146;s assessment of the effectiveness of our internal controls over financial reporting in the annual report on Form 10-K for the year ended
December&nbsp;31, 2013 filed with the SEC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Audit Committee </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Susan Wang&#151;Chairwoman </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Joseph J. Krivulka </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis L. Winger</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_35"></A>OTHER MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The board of directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc716112_36"></A>ADDITIONAL INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our website address is
<I>http://www.nektar.com</I>. The information in, or that can be accessed through, our website is not deemed to be incorporated by reference into this proxy statement. Our annual reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT>
quarterly reports on Form 10-Q and current reports on Form 8-K and amendments to those reports are available, free of charge, on or through our website as soon as reasonably practicable after we electronically file such material with, or furnish it
to, the SEC. The public may read and copy any materials we file with the SEC at the SEC&#146;s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. Information on the operation of the Public Reference Room can be obtained by calling
1-800-SEC-0330. The SEC maintains an internet site that contains reports, proxy and information statements and other information regarding our filings at <I>www.sec.gov</I>. In addition, a copy of our Annual Report on Form 10-K for the fiscal year
ended December&nbsp;31, 2013 filed with the SEC is available without charge upon written request to: Secretary, Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, California 94158. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Gil M. Labrucherie </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Senior Vice President, General Counsel
and </I></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Secretary </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">May&nbsp;16, 2014 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">66 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibit 1 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>N<SMALL>EKTAR</SMALL> T<SMALL>HERAPEUTICS</SMALL> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>MPLOYEE</SMALL> S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL> P<SMALL>LAN</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
F<SMALL>EBRUARY</SMALL>&nbsp;10, 1994 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
F<SMALL>EBRUARY</SMALL>&nbsp;18, 1994 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
M<SMALL>AY</SMALL>&nbsp;10, 2002 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
J<SMALL>UNE</SMALL>&nbsp;25, 2002 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
S<SMALL>EPTEMBER</SMALL>&nbsp;15, 2009 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDED</SMALL> <SMALL>AND</SMALL> R<SMALL>ESTATED</SMALL>
M<SMALL>ARCH</SMALL>&nbsp;23, 2010 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> S<SMALL>TOCKHOLDERS</SMALL>
J<SMALL>UNE</SMALL>&nbsp;29, 2010 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>URPOSE</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The purpose of the Plan is to provide a means by which Employees of the Company and certain designated Related Corporations may
be given an opportunity to purchase shares of the Common Stock of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The Company, by means of the Plan,
seeks to retain the services of such Employees, to secure and retain the services of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>The Company intends that the Purchase Rights be considered options issued under an Employee Stock Purchase Plan. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>EFINITIONS</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B><B><I>&#147;Board&#148;</I></B> means the Board of Directors of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B><B><I>&#147;Code&#148;</I></B> means the Internal Revenue Code of 1986, as amended<I>.</I> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B><B><I>&#147;Committee&#148;</I></B> means a committee appointed by the Board in accordance with Section&nbsp;3(c) of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B><B><I>&#147;Common Stock&#148;</I></B> means the common stock of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) </B><B><I>&#147;Company&#148;</I></B> means Nektar Therapeutics, a Delaware corporation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(f) </B><B><I>&#147;Contributions&#148;</I></B> means the payroll deductions, and other additional payments specifically provided for
in the Offering, that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account, if specifically provided for in the Offering, and then only if the Participant has not
already had the maximum permitted amount through payroll deductions withheld during the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(g)
</B><B><I>&#147;Corporate Transaction&#148;</I></B> means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>a sale or other disposition of at least ninety percent (90%)&nbsp;of the outstanding securities of the Company; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>a merger, consolidation or similar transaction following which the Company is
the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property,
whether in the form of securities, cash or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(h) </B><B><I>&#147;Director&#148;</I></B> means a member of the
Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B><B><I>&#147;Eligible Employee&#148;</I></B> means an Employee who meets the requirements set forth in the
Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility to participate set forth in the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(j) </B><B><I>&#147;Employee&#148;</I></B> means any person, including Officers and Directors, who is employed for purposes of Section&nbsp;423(b)(4) of the Code by the Company or a Related
Corporation. Neither service as a Director nor payment of a director&#146;s fee shall be sufficient to make an individual an Employee of the Company or a Related Corporation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(k) </B><B><I>&#147;Employee Stock Purchase Plan&#148;</I></B> means a plan that grants Purchase Rights intended to be options issued under an &#147;employee stock purchase plan,&#148; as that term is
defined in Section&nbsp;423(b) of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(l) </B><B><I>&#147;Exchange Act&#148;</I></B> means the Securities Exchange
Act of 1934, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(m) </B><B><I>&#147;Fair Market Value&#148;</I></B> means the value of a security, as determined
in good faith by the Board. If the security is listed on any established stock exchange or traded on the Nasdaq National Market or the Nasdaq SmallCap Market, the Fair Market Value of the security, unless otherwise determined by the Board, shall be
the closing sales price (rounded up where necessary to the nearest whole cent) for such security (or the closing bid, if no sales were reported) as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in
the relevant security of the Company) on the Trading Day of the relevant determination date, as reported in <I>The Wall Street Journal</I> or such other source as the Board deems reliable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(n) </B><B><I>&#147;Offering&#148;</I></B> means the grant of Purchase Rights to purchase shares of Common Stock under the Plan to
Eligible Employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(o) </B><B><I>&#147;Offering Date&#148;</I></B> means a date selected by the Board for an Offering to
commence. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(p) &#147;</B><B><I>Officer</I></B><B>&#148;</B> means a person who is an officer of the Company within the
meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations promulgated thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(q)
</B><B><I>&#147;Participant&#148;</I></B> means an Eligible Employee who holds an outstanding Purchase Right granted pursuant to the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(r) </B><B><I>&#147;Plan&#148;</I></B> means this Nektar Therapeutics Employee Stock Purchase Plan, as amended and restated March&nbsp;23, 2010. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(s) </B><B><I>&#147;Purchase Date&#148;</I></B> means one or more dates during an Offering established by the Board on which Purchase
Rights shall be exercised and as of which purchases of shares of Common Stock shall be carried out in accordance with such Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(t) </B><B><I>&#147;Purchase Period&#148;</I></B> means a period of time specified within an Offering beginning on the Offering Date or on the next day following a Purchase Date within an Offering and
ending on a Purchase Date. An Offering may consist of one or more Purchase Periods. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(u) </B><B><I>&#147;Purchase
Right&#148;</I></B> means an option to purchase shares of Common Stock granted pursuant to the Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B><B><I>&#147;Related Corporation&#148;</I></B> means any parent corporation or
subsidiary corporation, whether now or hereafter existing, as those terms are defined in Sections&nbsp;424(e) and (f), respectively, of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(w) </B><B><I>&#147;Securities Act&#148;</I></B> means the Securities Act of 1933, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(x) &#147;</B><B><I>Trading Day</I></B><B>&#148;</B> means any day the exchange(s) or market(s) on which shares of Common Stock are listed, whether it be any established stock exchange, the Nasdaq
National Market, the Nasdaq SmallCap Market or otherwise, is open for trading. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DMINISTRATION</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Board shall administer the Plan unless and until the Board delegates administration to a Committee, as provided in Section&nbsp;3(c). Whether or not the Board has delegated administration,
the Board shall have the final power to determine all questions of policy and expediency that may arise in the administration of the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The Board (or the Committee) shall have the power, subject to, and within the limitations of, the express provisions of the Plan: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>To determine when and how Purchase Rights to purchase shares of Common Stock shall be granted and the provisions of each
Offering of such Purchase Rights (which need not be identical). </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>To designate from time to time which Related
Corporations of the Company shall be eligible to participate in the Plan. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>To construe and interpret the Plan and
Purchase Rights, and to establish, amend and revoke rules and regulations for the administration of the Plan. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent it
shall deem necessary or expedient to make the Plan fully effective. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>To amend the Plan as provided in
Section&nbsp;15. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B>Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to
promote the best interests of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>The Board may delegate administration of the Plan to a Committee of the Board composed of two (2)&nbsp;or more members of the Board. If administration is delegated to a Committee, the Committee
shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board.
The Board may abolish the Committee at any time and revest in the Board the administration of the Plan. If administration is delegated to a Committee, references to the Board in this Plan and in the Offering document shall thereafter be deemed to be
to the Board or the Committee, as the case may be. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.
</B></FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the provisions of Section&nbsp;14 relating to adjustments upon changes in securities, the shares
of Common Stock that may be sold pursuant to Purchase Rights shall not exceed in the aggregate one million five hundred thousand (1,500,000)&nbsp;shares of Common Stock. If any Purchase Right granted under the Plan shall for any reason terminate
without having been exercised, the shares of Common Stock not purchased under such Purchase Right shall again become available for issuance under the Plan. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; O<SMALL>FFERING</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Board may from time to time grant or provide for the grant of Purchase Rights to purchase shares of Common Stock under the
Plan to Eligible Employees in an Offering (consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering shall be in such form and shall contain such terms and conditions as the Board shall
deem appropriate, which shall comply with the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
requirement of Section&nbsp;423(b)(5) of the Code that all Employees granted Purchase Rights shall have the same rights and privileges. The terms and conditions of an Offering shall be
incorporated by reference into the Plan and treated as part of the Plan. The provisions of separate Offerings need not be identical, but each Offering shall include (through incorporation of the provisions of this Plan by reference in the document
comprising the Offering or otherwise) the period during which the Offering shall be effective, which period shall not exceed twenty-seven (27)&nbsp;months beginning with the Offering Date, and the substance of the provisions contained in
Sections&nbsp;6 through 9, inclusive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>If a Participant has more than one Purchase Right outstanding under the
Plan, unless he or she otherwise indicates in agreements or notices delivered hereunder: (i)&nbsp;each agreement or notice delivered by that Participant shall be deemed to apply to all of his or her Purchase Rights under the Plan, and (ii)&nbsp;a
Purchase Right with a lower exercise price (or an earlier-granted Purchase Right, if different Purchase Rights have identical exercise prices) shall be exercised to the fullest possible extent before a Purchase Right with a higher exercise price (or
a later-granted Purchase Right if different Purchase Rights have identical exercise prices) shall be exercised. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>LIGIBILITY</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>Purchase Rights may be granted only to Employees of the Company or, as the Board may designate as provided in Section&nbsp;3(b), to Employees of a Related Corporation. Except as provided in
Section&nbsp;6(b), an Employee shall not be eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee has been in the employ of the Company or the Related Corporation, as the case may be, for such continuous
period preceding such Offering Date as the Board may require, but in no event shall the required period of continuous employment be greater than two (2)&nbsp;years. In addition, the Board may provide that no Employee shall be eligible to be granted
Purchase Rights under the Plan unless, on the Offering Date, such Employee&#146;s customary employment with the Company or the Related Corporation is more than twenty (20)&nbsp;hours per week and more than five (5)&nbsp;months per calendar year.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee
shall, on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter, receive a Purchase Right under that Offering, which Purchase Right shall thereafter be
deemed to be a part of that Offering. Such Purchase Right shall have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>the date on which such Purchase Right is granted shall be the &#147;Offering Date&#148; of such Purchase Right for all
purposes, including determination of the exercise price of such Purchase Right; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>the period of the Offering with
respect to such Purchase Right shall begin on its Offering Date and end coincident with the end of such Offering; and </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>the Board may provide that if such person first becomes an Eligible Employee within a specified period of time before the
end of the Offering, he or she shall not receive any Purchase Right under that Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>No Employee shall be
eligible for the grant of any Purchase Rights under the Plan if, immediately after any such Purchase Rights are granted, such Employee owns stock possessing five percent (5%)&nbsp;or more of the total combined voting power or value of all classes of
stock of the Company or of any Related Corporation. For purposes of this Section&nbsp;6(c), the rules of Section&nbsp;424(d) of the Code shall apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under
all outstanding Purchase Rights and options shall be treated as stock owned by such Employee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>As specified by
Section&nbsp;423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights under the Plan only if such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related
Corporations, do not permit such Eligible Employee&#146;s rights to purchase stock of the Company or any Related Corporation to accrue at a rate which exceeds twenty five </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
thousand dollars ($25,000) of Fair Market Value of such stock (determined at the time such rights are granted, and which, with respect to the Plan, shall be determined as of their respective
Offering Dates) for each calendar year in which such rights are outstanding at any time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) </B>Officers of the Company
and any designated Related Corporation, if they are otherwise Eligible Employees, shall be eligible to participate in Offerings under the Plan. Notwithstanding the foregoing, the Board may provide in an Offering that Employees who are highly
compensated Employees within the meaning of Section&nbsp;423(b)(4)(D) of the Code shall not be eligible to participate. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL>; P<SMALL>URCHASE</SMALL> P<SMALL>RICE</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, shall be granted a Purchase Right
to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the Board, but in either case not exceeding fifteen percent (15%), of such Employee&#146;s Earnings (as
defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular Offering) and ends on the date stated in the Offering, which date shall be no later than the end
of the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The Board shall establish one (1)&nbsp;or more Purchase Dates during an Offering as of which
Purchase Rights granted pursuant to that Offering shall be exercised and purchases of shares of Common Stock shall be carried out in accordance with such Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>In connection with each Offering made under the Plan, the Board may specify a maximum number of shares of Common Stock that may be purchased by any Participant on any Purchase Date during such
Offering. In connection with each Offering made under the Plan, the Board may specify a maximum aggregate number of shares of Common Stock that may be purchased by all Participants pursuant to such Offering. In addition, in connection with each
Offering that contains more than one Purchase Date, the Board may specify a maximum aggregate number of shares of Common Stock that may be purchased by all Participants on any given Purchase Date under the Offering. If the aggregate purchase of
shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence of any Board action otherwise, a pro rata allocation of the shares of Common Stock
available shall be made in as nearly a uniform manner as shall be practicable and equitable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>The purchase price of
shares of Common Stock acquired pursuant to Purchase Rights shall be not less than the lesser of: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>an amount equal
to eighty-five percent (85%)&nbsp;of the Fair Market Value of the shares of Common Stock on the Offering Date; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii)
</B>an amount equal to eighty-five percent (85%)&nbsp;of the Fair Market Value of the shares of Common Stock on the applicable Purchase Date. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>ARTICIPATION</SMALL>; W<SMALL>ITHDRAWAL</SMALL>; T<SMALL>ERMINATION</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>A Participant may elect to authorize payroll deductions pursuant to an Offering under the Plan by completing and delivering to
the Company, within the time specified in the Offering, an enrollment form (in such form as the Company may provide). Each such enrollment form shall authorize an amount of Contributions expressed as a percentage of the submitting Participant&#146;s
Earnings (as defined in each Offering) during the Offering (not to exceed the maximum percentage specified by the Board). Each Participant&#146;s Contributions shall be credited to a bookkeeping account for such Participant under the Plan and shall
be deposited with the general funds of the Company except where applicable law requires that Contributions be deposited with a third party. To the extent provided in the Offering, a Participant may begin such Contributions after the beginning of the
Offering. To the extent provided in the Offering, a Participant may thereafter reduce (including to zero) or increase his or her Contributions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>During an Offering, a Participant may cease making Contributions and withdraw
from the Offering by delivering to the Company a notice of withdrawal in such form as the Company may provide. Such withdrawal may be elected at any time prior to the end of the Offering, except as provided otherwise in the Offering. Upon such
withdrawal from the Offering by a Participant, the Company shall distribute to such Participant all of his or her accumulated Contributions (reduced to the extent, if any, such deductions have been used to acquire shares of Common Stock for the
Participant) under the Offering, and such Participant&#146;s Purchase Right in that Offering shall thereupon terminate. A Participant&#146;s withdrawal from an Offering shall have no effect upon such Participant&#146;s eligibility to participate in
any other Offerings under the Plan, but such Participant shall be required to deliver a new enrollment form in order to participate in subsequent Offerings. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>Purchase Rights granted pursuant to any Offering under the Plan shall terminate immediately upon a Participant ceasing to be an Employee for any reason or for no reason (subject to any
post-employment participation period required by law) or other lack of eligibility. The Company shall distribute to such terminated or otherwise ineligible Employee all of his or her accumulated Contributions (reduced to the extent, if any, such
deductions have been used to acquire shares of Common Stock for the terminated or otherwise ineligible Employee) under the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>Purchase Rights shall not be transferable by a Participant otherwise than by will or the laws of descent and distribution, or by a beneficiary designation as provided in Section&nbsp;13 and,
during a Participant&#146;s lifetime, shall be exercisable only by such Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) </B>Unless otherwise specified in
an Offering, the Company shall have no obligation to pay interest on Contributions. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>XERCISE</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>On each Purchase Date during an Offering, each Participant&#146;s accumulated Contributions shall be applied to the purchase of
shares of Common Stock up to the maximum number of shares of Common Stock permitted pursuant to the terms of the Plan and the applicable Offering, at the purchase price specified in the Offering. No fractional shares shall be issued upon the
exercise of Purchase Rights unless specifically provided for in the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>If any amount of accumulated
Contributions remains in a Participant&#146;s account after the purchase of shares of Common Stock and such remaining amount is less than the amount required to purchase one share of Common Stock on the final Purchase Date of an Offering, then such
remaining amount shall be held in such Participant&#146;s account for the purchase of shares of Common Stock under the next Offering under the Plan, unless such Participant withdraws from such next Offering, as provided in Section&nbsp;8(b), or is
not eligible to participate in such Offering, as provided in Section&nbsp;6, in which case such amount shall be distributed to such Participant after the final Purchase Date, without interest. If the amount of Contributions remaining in a
Participant&#146;s account after the purchase of shares of Common Stock is at least equal to the amount required to purchase one (1)&nbsp;whole share of Common Stock on the final Purchase Date of the Offering, then such remaining amount shall be
distributed in full to such Participant at the end of the Offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>No Purchase Rights may be exercised to any
extent unless the shares of Common Stock to be issued upon such exercise under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable federal, state,
foreign and other securities and other laws applicable to the Plan. If on a Purchase Date during any Offering hereunder the shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights or any Offering shall
be exercised on such Purchase Date, and the Purchase Date shall be delayed until the shares of Common Stock are subject to such an effective registration statement and the Plan is in such compliance, except that the Purchase Date shall not be
delayed more than twelve (12)&nbsp;months and the Purchase Date shall in no event be more than twenty-seven (27)&nbsp;months from the Offering Date. If, on the Purchase Date under any Offering hereunder, as delayed to the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
maximum extent permissible, the shares of Common Stock are not registered and the Plan is not in such compliance, no Purchase Rights or any Offering shall be exercised and all Contributions
accumulated during the Offering (reduced to the extent, if any, such deductions have been used to acquire shares of Common Stock) shall be distributed to the Participants. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company shall seek to obtain from each federal, state, foreign or other regulatory commission or agency having jurisdiction over the
Plan such authority as may be required to issue and sell shares of Common Stock upon exercise of the Purchase Rights. If, after commercially reasonable efforts, the Company is unable to obtain from any such regulatory commission or agency the
authority that counsel for the Company deems necessary for the lawful issuance and sale of shares of Common Stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell shares of Common Stock upon exercise of
such Purchase Rights unless and until such authority is obtained. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>U<SMALL>SE</SMALL> <SMALL>OF</SMALL> P<SMALL>ROCEEDS</SMALL> <SMALL>FROM</SMALL> S<SMALL>HARES</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>.
</B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights shall constitute general funds
of the Company. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R<SMALL>IGHTS</SMALL> <SMALL>AS</SMALL> <SMALL>A</SMALL> <SMALL>STOCKHOLDER</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A Participant shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common Stock
subject to Purchase Rights unless and until the Participant&#146;s shares of Common Stock acquired upon exercise of Purchase Rights are recorded in the books of the Company (or its transfer agent). </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>ESIGNATION</SMALL> <SMALL>OF</SMALL> B<SMALL>ENEFICIARY</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>A Participant may file a written designation of a beneficiary who is to receive any shares of Common Stock and/or cash, if any, from the Participant&#146;s account under the Plan in the event
of such Participant&#146;s death subsequent to the end of an Offering but prior to delivery to the Participant of such shares of Common Stock or cash. In addition, a Participant may file a written designation of a beneficiary who is to receive any
cash from the Participant&#146;s account under the Plan in the event of such Participant&#146;s death during an Offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The Participant may change such designation of beneficiary at any time by written notice to the Company. In the event of the
death of a Participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Participant&#146;s death, the Company shall deliver such shares of Common Stock and/or cash to the executor or
administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or cash to the spouse or
to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>14.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> S<SMALL>ECURITIES</SMALL>; C<SMALL>ORPORATE</SMALL>
T<SMALL>RANSACTIONS</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>If any change is made in the shares of Common Stock, subject to the
Plan, or subject to any Purchase Right, without the receipt of consideration by the Company (through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split,
liquidating dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt of consideration by the Company), the Plan shall be appropriately adjusted in the type(s), class(es) and
maximum number of shares of Common Stock subject to the Plan pursuant to Section&nbsp;4(a), and the outstanding Purchase Rights shall be appropriately adjusted in the type(s), class(es), number of shares and purchase limits of such outstanding
Purchase Rights. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. (The conversion of any convertible securities of the Company shall not be treated as a &#147;transaction not involving the receipt
of consideration by the Company.&#148;) </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>In the event of a Corporate Transaction, then: (i)&nbsp;any surviving or
acquiring corporation may continue or assume Purchase Rights outstanding under the Plan or may substitute similar rights (including a right to acquire the same consideration paid to stockholders in the Corporate Transaction) for those outstanding
under the Plan, or (ii)&nbsp;if any surviving or acquiring corporation does not continue or assume such Purchase Rights or does not substitute similar rights for Purchase Rights outstanding under the Plan, then, the Participants&#146; accumulated
Contributions shall be used to purchase shares of Common Stock within ten (10)&nbsp;business days prior to the Corporate Transaction under the ongoing Offering, and the Participants&#146; Purchase Rights under the ongoing Offering shall terminate
immediately after such purchase. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>15.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>MENDMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Board at any time, and from time to time, may amend the Plan. However, except as provided in Section&nbsp;14 relating to
adjustments upon changes in securities and except as to amendments solely to benefit the administration of the Plan, to take account of a change in legislation or to obtain or maintain favorable tax, exchange control or regulatory treatment for
Participants or the Company or any Related Corporation, no amendment shall be effective unless approved by the stockholders of the Company to the extent stockholder approval is necessary for the Plan to satisfy the requirements of Section&nbsp;423
of the Code or other applicable laws or regulations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>It is expressly contemplated that the Board may amend the
Plan in any respect the Board deems necessary or advisable to provide Employees with the maximum benefits provided or to be provided under the provisions of the Code and the regulations promulgated thereunder relating to Employee Stock Purchase
Plans and/or to bring the Plan and/or Purchase Rights into compliance therewith. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>The rights and obligations under
any Purchase Rights granted before amendment of the Plan shall not be impaired by any amendment of the Plan except: (i)&nbsp;with the consent of the person to whom such Purchase Rights were granted, or (ii)&nbsp;as necessary to comply with any laws
or governmental regulations (including, without limitation, the provisions of the Code and the regulations promulgated thereunder relating to Employee Stock Purchase Plans). </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>16.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Board in its discretion may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate
at the time that all of the shares of Common Stock reserved for issuance under the Plan, as increased and/or adjusted from time to time, have been issued under the terms of the Plan. No Purchase Rights may be granted under the Plan while the Plan is
suspended or after it is terminated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>Any benefits, privileges, entitlements and obligations under any Purchase
Rights while the Plan is in effect shall not be impaired by suspension or termination of the Plan except (i)&nbsp;as expressly provided in the Plan or with the consent of the person to whom such Purchase Rights were granted, (ii)&nbsp;as necessary
to comply with any laws, regulations, or listing requirements, or (iii)&nbsp;as necessary to ensure that the Plan and/or Purchase Rights comply with the requirements of Section&nbsp;423 of the Code. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>17.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Plan shall become effective as determined by the Board, but no Purchase Rights shall be exercised unless and until the Plan has been
approved by the stockholders of the Company within twelve (12)&nbsp;months before or after the date the Plan is adopted by the Board. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>M<SMALL>ISCELLANEOUS</SMALL> P<SMALL>ROVISIONS</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering shall in any way alter the at will nature of a Participant&#146;s employment or be deemed
to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Corporation, or on the part of the Company or a Related Corporation to continue the employment of a Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>The provisions of the Plan shall be governed by the laws of the State of California without resort to that state&#146;s conflicts of laws rules. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112pc_001.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NEKTAR
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ATTN: SECRETARY </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">455 MISSION BAY BOULEVARD SOUTH
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">SAN FRANCISCO, CA 94158 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY INTERNET - www.proxyvote.com </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use the
Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on June&nbsp;24, 2014. Have your proxy card in hand when you access the web site and follow the instructions to obtain your
records and to create an electronic voting instruction form. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">If you would like to reduce the costs incurred by Nektar Therapeutics in mailing proxy materials, you can
consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted,
indicate that you agree to receive or access stockholder communications electronically in future years. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE
BY PHONE - 1-800-690-6903 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions up until 11:59
P.M. Eastern Time on June&nbsp;24, 2014. Have your proxy card in hand when you call and then follow the instructions. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY MAIL </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Mark, sign and date your proxy card
and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M75485-P50759-Z62736 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">KEEP THIS PORTION FOR YOUR
RECORDS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">DETACH AND RETURN THIS PORTION ONLY </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Board of Directors
recommends a vote &#147;FOR&#148; each nominee listed in Proposal 1 and &#147;FOR&#148; Proposals 2, 3 and 4. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Vote on Directors </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. To elect three directors with terms to expire at the 2017 Annual Meeting of Stockholders; </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Nominees: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For Against Abstain </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1a. Joseph J. Krivulka </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1b. Howard W. Robin </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1c. Dennis L. Winger
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Vote on Other Proposals </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For Against Abstain </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2. To approve an amendment to
our Employee Stock Purchase Plan, as amended and restated, to increase the aggregate number of shares of common stock available for issuance under the plan by 1,000,000 shares for a total reserve of 2,500,000 shares. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">3. To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal
year ending December 31, 2014. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">4. To approve a non-binding advisory resolution regarding our executive
compensation (a &#147;say-on-pay&#148; vote). </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For address changes and/or comments, please check this box and
write them on the back where indicated. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Yes No </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">MATERIALS ELECTION </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">As of July&nbsp;1, 2007, SEC rules permit companies to send you a notice that proxy information is available on the Internet (the &#147;Notice&#148;), instead of mailing you a complete set
of materials. Check the box to the right if you want to receive a complete set of future proxy materials by mail, at no cost to you. If you do not take action you may receive only a Notice. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please indicate if you plan to attend this meeting. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other
fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Date </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature (Joint Owners) </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Date </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g716112pc_002.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Notice and Proxy Statement
and Annual Report are available at www.proxyvote.com. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M75486-P50759-Z62736 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NEKTAR THERAPEUTICS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">PROXY SOLICITED BY THE BOARD OF DIRECTORS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">FOR THE
ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">TO BE HELD ON JUNE 25, 2014 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned hereby appoints Howard W. Robin and Gil M. Labrucherie, and each of them, as attorneys-in-fact and proxies
of the undersigned, with full power of substitution, to vote all of the shares of stock of Nektar Therapeutics which the undersigned may be entitled to vote at the annual meeting of stockholders of Nektar Therapeutics to be held on Wednesday,
June&nbsp;25, 2014 at 2:00 p.m. local time at Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA 94158 (and at any and all postponements, continuations and adjournments thereof), with all powers that the undersigned would
possess if personally present, upon and in respect of the matters listed on the reverse side and in accordance with the instructions specified on the reverse side, with discretionary authority as to any and all matters that may properly come before
the meeting. You hereby revoke all proxies previously given. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Unless a contrary direction is indicated, this
Proxy will be voted FOR all nominees listed in Proposal 1, FOR Proposals 2, 3 and 4, as more specifically indicated in the Proxy Statement, and at the discretion of the proxies with regard to any other matter that may properly come before the
meeting or any continuation, adjournment or postponement thereof. If you vote by telephone or Internet, you do not need to mail back this Proxy. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Address Changes/Comments: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">(If you noted any
Address Changes/Comments above, please mark corresponding box on the reverse side.) </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Continued and to be signed
on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g716112g36i66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g716112g36i66.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0@<4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````)P```,`````&`&<`,P`V
M`&D`-@`V`````0`````````````````````````!``````````````#`````
M)P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!8`````!````<````!<`
M``%0```>,```!60`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``7`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#HL7)LQ,AE]>I8=6\;F_GL784W5WU,NJ.YE@#FGR*YCI.(W,=DX[C&
MZH%KO!P=['*WT+,?CY#^GY'MEQV`GZ-@^G7_`-<^FS_U(DI%]9#&<P^%(_ZI
MZ)_S;R#K]H9_FG_R2']9(^W,GCT1_P!4]%_9O7_^Y7_@KO\`R"2F&3TRS`Z?
MDE]C;/5=2!M!$;7N\2?WT7I.;3A=*LNMU_3.#&#ESMK?:U-ET9M'1K6YEGJV
M&YI:=Q=#98(EP;^<LRG%RKZ;+:VEU6."XGM)@O;6/SK-OO?_`.<(J;-.-G=9
MOLO>X-:--Y!+1X4U-_ZM0ZATRS`;67V-L]0D`-!$0)[DK2^K_4&OJ^Q/@/K$
MU$:;F?\`DV*/UF^AC?UG?D04U,?H%^5BLN;<UHN9(!:3$_VD+JMSLG/L#)<S
M':6"/"O6Y_\`GK8Q\D8O0*[^[*1M'BX^U@_SUE='MP:#<[-L@V,](`AQEKM;
M7'8UWTO:DIU^@Y/K8#:W&7T'TS\!K7_X&L1]!R>KVXX=L-E]@W1,?2=]&6_N
MHW0;QCY_H[MU=P+`[@%S)=6_7]YN]!><@=7M.,)O%]GIC3GW?O[6_114VLGZ
MOW44/N;>+#6"XMV%I@:G:[>_W(G2'/ZA0_&R+'N%#FOK?,NAV[VESOW=OM0<
MVWKXQGC+:64.]KRT,X/9WIN>YK7*]]76XWV5[JMWJET7;HY`]@9'^#VN]J"G
M_]#L_JW_`$R[_BA_U2GU_'J-[+\>QHR06LLK:X>I.GH6-9]/U&_^07SHDDI]
M^ZM=9D64OO8:K?1VV-<"W4.=[F[OS'JZ.I=>C3'T_P")?_Y)?.B2*GZ(RLKJ
M.1@9`S:O3:TU&L[',DE_N^F3N5WZM_T%_P#QKOR,7S4D@I^@,VEM&>Q_3K&V
M!YWTBHAY:X?3KVLGV?\`HO\`1JSUN]V1B8EKZW5/+G!];P00X#W?2_-_=7SL
MDBI^@\ZVS]D8-0:[T@P/>^#MF-M;-WT=WT_:KF-@]#&/7]HLJ==M!L/JQ[C]
M+Z+U\X)(*?H#J--%&94[ISFO:=IK:QV^+&NXY<[W^Q2Q';^NM?!;NN>[:X01
M(?[7#^2OGU))3]1Y[0[!R&D@`U/$DP/HGDK(^K#O=D@@ZBL\:?GKYS224__9
M.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`#8`
M+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N``Y!9&]B90!D0`````'_
MVP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__`
M`!$(`"<`P`,!$0`"$0$#$0'_W0`$`!C_Q`"6```"`P`#`0$````````````)
M"@8'"`(#!0`!`0`#`0$``````````````````P0!`A```00!`P("!0@%"`L`
M`````@$#!`4&`!$'$@@A$S$B%':VM!5UM18V-SA!83+4"2.4-5:6%U<847%2
M8C/3)"55E281``("`04!`0$!`0`````````!$0(Q(5$2,@-Q84$B0O_:``P#
M`0`"$0,1`#\`*[JLF#+]B/.RYIB;O%61S2=R;"88.T#\AU3=M,/;)J.U'0C4
MB-_'7G`9VW3_`*5QE!39LUTCTK#E8&TM*AY"":6,/M`"T?*_XI<D^_V8_$5C
MJI81/;+^GA1<1RR=':EPL8R&9$?!'&)46ELI$=X%540VGFHQMN`JIZ454T2M
MS(>QW_8;-OZGY3_9^V_=-$K<(>QIWLWQ3**WN1XYFV.-W]?#9^U_G2YM/8Q8
MK7F8'E#3?FOOQFVF_,=<$1W5-R)$3Q77-VN+U.J)\EH9BSG[[9A[TY!];2]=
M+".7EA].UK\O?%/NLQ\JE:GOV8^O5&:.\#NT'"FK#BWC.R7[9NHL7*,BAEX8
MM'<;$CK:R2V>WVC>$]G'!W]B'=$V?7=GJE)U>#F]HT601];17MWYY5%/;6_D
M*'M)5M?,G^23W6K?GK%9=\M7?++IZMNKI7;T+IPH]%S"<R:`W7<2R=MML"<<
M<<H;4`;`$4C,S*(@B`BFZJO@B:)6X0]B,:T"4#A&:$*$.(900DB$)#06RB0J
MFZ*BI$V5%362MPA[!&>Q"1)XSQ?N$RS,*JUI:RDIL.NG5LH,FN.5'J(N>RI+
M,/VUI@7Y!;@`B.ZJXX`^DDW7Z:NJ0RFBLV#=RK([+,,FO\KN7$=M<CN+&ZGF
M/5T)*LI;LMT&1)54&&B=Z6Q]``B"G@FF)0DA;<N0E'\.;DA`>S/B>:YLCZ?;
M>AZC5$\UM(-1?110O!3-KV-T!%?0#I;+XJBO188SS>4%4TH:+1\K_BER3[_9
MC\16.JEA$]LOZ<J?B7E7(:V+<T'&7(-Y43@-R%:T^&9'9ULP&W39,XLZ%6OQ
M9``\T0*H$J(0JGI1=$K=!#V.NZXJY0QJ`[:Y%QOGM!5L;>?976'Y#50&=UV3
MS9DZN8CM[KZ-R31*>&9#646QP=W0<C<.7M>JW-KDF$^>`7&'V<]V7#.$:JCS
ME*4PGEIK%I#ZP)E0;<,41T3#PUS:BM].JV:^!*N4^)LMY=R?&N0,,L1D4=M2
M0K7'K=+UZM6OC6L'&W*89<9$,F:ZAD1Y%W&=B-R94F7*<87V=/+D@I-)0QC3
M>J/_T"NZK)BQJ.WS+A#DV-9,M.5&88#D+S,F'(0D!9$)UR'95LI`45>K[**3
MC+BBNSC#JJ)>*+K-++\-UJ_T8<XVY`H>4<)H,XQUU#KKR$#Y1U<!R16S@_DY
M]5,\OP&972A)H_!$51ZD]5459FFG#'IRI)SK#1:/E?\`%+DGW^S'XBL=5+")
M[9?T-YVR9?B4#@3BZ'.RC'8<N/C##;\67=UD>0R?M,E>AUAZ2#K9[+Z%1%TB
MR?)Z#JM<5J7M]N\(_KEBO]H:C]\US#V-E;GJ5E_171/#3753;%'0"?&LLH<\
MF!<4D;)Y(KSJMH:@NREMOLNWHUAHM'G/WVS#WIR#ZVEZJ6$3/+"`V_=:WQ?V
MW\7\>\?6#3O(MAA\5;.TCJQ(;PN"[+D$GF"XV\P=_/9W1IDDZHS1><:(I,H:
M^$V;>!G**I+)C#B'B/,><\V;QG'?6=<5;'(;Z>9.1:>M)\1EVLXR-'I;YNN[
M-M"JN/O$B;HG48]MJJEG"3LP^W$_%6*\.8;7X;B<90C1MY%A8OBVMC=VCHBD
MJULG0$4<D/**"(IZC+0BV"(`HFI[-V<L>DDH1(,[^Y&9>ZN0_5$S0LH'ABQV
MJB<:&HOZ$IOHJO\`DC.I7EE)A;^(+R2N-\95.`07^BRS^S0YX@:HX&.8^Y'F
MRA7H)"#VRV<B`F_JN-@Z.R^.W?FI<[''HX4`WN"^$;+F4.23@B__`/%X'97L
M$6`)PYV2JO504J"*HO5:C$DHB[+XM[;>.Z-M;C`JJF2*<+<@/<7<I85G#9F,
M>ENF/G4`]+U'.$ZZ\81.DT4W*J6\@>"])]*IXHFBRE-`G#3&167FI++4B.X#
MS#[3;S+S1(;;K3HH;;C9BJB8&!(J*G@J+J8H%J.5_P`4N2??[,?B*QU4L(GM
ME_0Y7:%^7#B[Z*M?B2ZU/?LQU.J-$S&8DF)*CSVHS\!^,^S-8F-M.Q'HCK1!
M):E-/(3+D9QDB0Q-%%1547PUR="Q64)3CDN1#CRFM`-[;)1JXNYK3I/D)6*:
M_I-871O^O52P3/+C`PMVYU\^KX)XGAV2.#+'!Z)\@=14=:9F0PF1&'!55)LV
M(D@`45V4>G9414V2>W9E%>J/_]$KNJR8+%W^<$K/AL\W8U#4IE>U%K,\88$B
M<D5P^7$I\@\M$7J*O]6+)+Q7R%9+9`:,M)\[?\L;Z5_Z*-[&.=$X_P`X/CG(
M9GE8EG\QAN`X^9(Q3Y@HA&@/IZ1;9O@$(;R[?\48Y*H@!JO7I65*R<TM#C^!
MJ]('"T?*_P"*7)/O]F/Q%8ZJ6$3VR_I)J#MZYKRFFK\@Q_CG(K6EM8Z2JZQB
M,,%'EQR(A1UHBD"2@I"J>*)Z-9RJM&PXM_P]C_*WW!_X495_-XW[SHYUW#C;
M8W]V'<4<C<;6W)+^=8C;8PU;5V,M5KEFVTV,QR))N3D@SY;KFZLC(!5WV_:3
M2_1II0QE$U,H%;G/WVS#WIR#ZVEZ:L(4\L_,9PK*\S*W'%J"RO%H*>;?W/L#
M"NC75%>VKLJ9(+<1$1$=A!%5QTO5`2+PT-I98)-X)3PYRM?\-9[49O0F3BQ2
M*)<5BN$W'NZ.23?SA5RMO!1=1L7&B5%\J0VVXB*H)K++DH-3AR,185F-!R!B
MM'F6,3$G4>006YT)[U$=;0E4'XDML#<%B=`D@;+[74JM/-D*KNFIVFG#'IRI
M1QSO[D9E[JY#]43-"R@>&+':J)QH:B_H2F^BJ_Y(SJ5Y92`:[P>2/[Q^<LH=
MBOJ]2XB0X73;*JMJW1NOA:R`VV!P95\]*,'$_;9\OQ5$1=/HHJA%W-F$:[&<
M5I\&X5BW-A,K8EYGME)R&8C\R.U+;JF"*MH8KHFX*HTL6.<MM-M]IB[K^A%^
MCFWX,HH0+#N*PF-@',^>8_7$P=.5R[<T912;.*E1?"-O#C1S:(@(*X9BQ5_W
MF%TVKFJ%64-H,%V9<C?W@\%XXS*D>=<X2IX7:(1)YBM5+;14;RIX$H'0OQ@4
MUWZW6C\55%TFZBPZCFJ`H<K_`(I<D^_V8_$5CIZPA-LOZ2+'.X#F?$*2!CF-
M<B9#34=6VXU7UD-]@8T1MU]V2X#0DP9(AOO&2[JOB2ZQUJ]6@Y-89RR'N#YK
MRJHF4-_R7E5A46#:LSH!6"L,S&"\#CRO908-^,XB[&V2J!IX$BZ%6JU2!V;R
MR0]M&+\4Y=RA14_*MU,KJZ3,CM5-6,/_`+5D5LZZ+<.GM;EN8#]2Q*?(139@
MA?5>A76MT4BTI.#:I-J1A1IIMEMMEEL&F6@!IIIH!;;:;;%!!ML!1!``%$1$
M1$1$34P\_](KNJR8:-LZV!<UT^HM8C%A66D.376,&4VCL:9!F,G'E17VR]5Q
ME]APA)%]*+J0I%Y^X7ANRX.Y+M,87VEVBDE\\8?;.>F=12736.!O"J(MA5/"
M4:1X`JN->8@H#@;TU?)23V7%A=NT3G0>9>.&HMS*1W.L,"+49*CA)Y]G'5LA
MJ<CV01%?G-E@P?V]$IEQ=A$PW3>O%_@ZEI7Z!3Y7_%+DGW^S'XBL=/6$)ME_
M0YW:_;U+';_Q6R_:5S+K>+L"XT[-C-N`7M4I=C`W4(5_UIJ>R_TQU>J+Y^?:
M3_S-5_[")_SM9#V.CL:N*E]P&6+2N>=<7I;::FQG'#+_`&0`'5(E_4B:R&`L
M]G/WVS#WIR#ZVEZJ6$3/+#H=GN(8YC?`V$SZ:JC0Y^5U@W>13A%3EVU@X_):
M%R6^XI&;49@4;::14;;'?I%%(E)%VW9CZ+_*!E]XO;^7#^<ED6/0U;X^S25(
ME5`LM[1Z"X+=^QQPNA$!EA%4GX2;#O&56TZE8,E;2W):Y%WK#E8)-V5=Q*\9
MY0/'>5S4#!,QL&QBRY+JBSC&2R$"/'FJ9;@U5VZBVQ*ZND&C1MY2`0=Z\O65
M*R%+0X>`PV=_<C,O=7(?JB9I*RAKPQ8[51.,4\M\B#Q7P5>YH+HMV%=B<.+1
M[[*IW]K&C5E+LVHGYHLV$H'3'9?Y)LE79$54F2FT%%G";%[Z.CO,MNX-%0U\
MR[OKB5Y$&!$`I$R;*<0G"045=R+I$B(B79$12541%75&/A/DN3_*WW!_X495
M_-XW[SK.==S>-MB*9CPEROQ_4)?9G@E]CU.LMF#\XSV&QC)+D`Z;#)&TZXH$
MZ+);*J(FZ;;[JFA63PP=6LHU%_#^Y'^S'*UA@LMQ!K>1*M6HZ$I(@9!CK4RR
MKUW\0`9%:Y-:7?93<)M-]T1%Y]%*G8Z\W#@R5RO^*7)/O]F/Q%8Z[6$<VR_H
M<KM"_+AQ=]%6OQ)=:GOV8ZG5%OY[@&*\E8U98KEU3%M*RQBR(Z$\PPY+KWGV
MU`+"KD.MN'!L8I[&TZ&Q"8IZ4\-8FTY1K2:ABT]E!D4]I/K7RZ9=7/E07B;)
M/5D09#C#A`0$J>#C2[*BK^I=4DXRGQC>R\HXVX]R:>O5/R+!\3O9I?Z9=O0P
M+"2OALGB](+4ST;10M4F?__3*[JLF&F]2%)COO0PG`\WXT2-D&4XCBN:5"3[
MK`)&39!3T#MJ_#:8^>J*(Y:2(YR6+.,;0$+:](2DC&:H*>/=&T\:'%TFLZ@I
M^VK+N0<&Y0J\DP'&LHS#V(.C*\<Q:HL+F59XI(?89LFWHM?'D$VK9F#D=UQ$
M!N4+>Z[;HKK)-0V*JVG*16W)<D)O(_($QMN0TW+S;*I+;4R+(A2VP?O9[H-R
MH4MMF5$D`)[&TZ`N-DBB2(J*FM6$#RR$ZTP^T`7[VM_F#XH]ZH_R:3KF_5FU
M[(JS.DVS?,47;=,JR%/!45/"WF>A4545/UIK5A&/+#Y]K7Y>^*?=9CY5*U/?
MLQ]>J)#SGCG'V7<:WV.<E7E)C6/6H-QX]_>65?4L5%YZSE//BS;*1%C#.CR@
MZA;ZT\X$-M=P(D4JVG*1MH:U%UKVI.ANK2E.=5V95<^5!6RI+"-;4\](SQ-#
M,K+*(;D>;!DB*&VX*^(JFZ(NZ)03AHNWO/N1<DX)RW%^3L1S*CO<4PNT9JLB
MR3&[NKB97CCM+,&N?;LK"#'C2[2N;$6G=C4WV5:>W,E>(4V25DTQU6^+30$C
M3Q(4KO\`LAR0L0XNQ2'378XHU$AY!>9`E9/^S[MT]!=KL?I_GA&$KOG)B*S/
M?.,KBN*#C9]*(B*JO.);_HSTG1?PJ?\`A]4./3>7K"_N;:FC6='0R(V*T\VR
M@1K:UN;AN0$N33US[PS;$*O'X4SVA6`+R1?$C44].^D\3//(:G2!Q1G<I08[
MD_"6?4F2VU/1QI=.3E79WEG7T\%C)(3K<_'&BL;-^-%CE,N(K3*[F*F#A"G[
M6VNJRK*#FT-.1?\`PB?D55F6*VF)19D[**W(*B?C\*!$>GS)EO#GL2($6/!C
MMO/37)$EL0\H0)7-^G9=]M4.(<X$+*@[<^GN6N=YK:.P9=8[99;D<]RMGM&Q
M.KW)EQ,D'!FL.@VZS+B$YY;@$(D)BJ*B+X:%A`\L.YVA?EPXN^BK7XDNM3W[
M,?3JC26N3H6VYOKXM7S#R?"@S8EA"#.LF=B2X,B-*CN1I=M*EL@+T-QV.KK#
M;Z-N"*HH."0J@DBBE-<(GMEAS.URTE6W`'%KLR#8U\B)BL"K\FRA383CL6L!
@8==.B^VM-K+KK&L:9D1WFE-EQIQ.@O#9$7[,=7JC_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g716112g45r25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g716112g45r25.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0K"4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!+````>,````&`&<`-``U
M`'(`,@`U`````0`````````````````````````!``````````````'C```!
M+``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````""4````!````<````$8`
M``%0``!;X```"`D`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!&`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#TZFFDTUDUM^B.P\%/T*/]&W[@E1_,5_U1^1$24U\@8V/CVWO96UE3
M'/<Y^UC0&C<2^Q_L8W^6Y8U'UFZ9:YH=CMK#WTU[B^F`;VO<S=[]WTJ_T?\`
MIZOUFG]7_2+:&=A'_#LDG;!<`9_=VG^LDW-PW.#!=7O<=H87`.G]W8?=N24X
M=GUJZ97@49IQ?;?19D!I-8$5/;0]K+'.V6_I'[OT?\WC_IK?3_1[S.^L&`VK
M-M.,",(M:Z"S4N>*-UO'V6G>[U&WY/IUOP_UW^86Y`^Y*`DIQ1]8>C;Q4:RZ
M[<&.954;`'.]/_"5MV.9ZE]5>_\`]%?I%%OUG^K[S%8=82YS&AE+B7.:6,VL
M]OY[[JF?V_TFQ;D!`8_%HC&H8`6<55-$-GW:[?95NG\])3E6_6;H#&[F`VDB
M6L97[B-M5^[])Z>QGHY#;-UFSZ%BE7]8NB/>VK:?5+F,<UM3G!IL,-<]^S;L
M_?>KM^3FUV"&4M8\M:QEK]KG%P^@'-]1N_<KC-^QOJ`!\>X#43Y)*<%_UFZ7
M7<ZFS&<PUV65W.+!#-EK<>IWLW.L^U,<^_']+?[*O?LL6OBNP\O&JRJ&-=3>
MQME;BV):X;F.VN&YOM5E))2/T*/]&W[@HW4TBIY%;?HGL/!&4+OYFS^J?R)*
M?__0]1H_F*_ZH_(GLL94PO>8:('CJ3M'":C^8K_JC\BF0'`APD'0@\)*<FS*
MQA<\TW8C6S[=S"7"=A?.US=VY_N4J<VAMQ-]V,6@;CL80[>3IR7;?H6>W^<5
M[(QWV,`H>*+!(;9L#X![;7?R]C_["E3265@6D6ODDV;0TG66DM;^<DI("'`.
M:9!U!'@N>ZQ]<,?$L?C8+!E7LT?83%3'?N[A[K7M_.;7_P!NH?UNZ@W!J;C8
MA]+*S`3:]AVD5#Z;G?\`"6.]E=G\XS]+L>N.````$`:`!%3;ZK]9.OWXF2\9
MCZ7>F\L%`%8:0TQM=#K?_!%U[,O(H.RI^UC>&0(7`Y`G'M'BQP_`KN'?2*2'
M1IS\?((KRZV[CH'$!S29!_.^A[FJX,EKW[:FNM;,.>V-H_MN+=__`%O>L%:O
M2LDO8:'F75B6GQ;_`.8()9.RLNJN<EM%)#9W&T[2X1/TZV>Q%HLRWD&RNL5N
M$[F6%W(G@UL]O]I$LHIM@V,#XT$B>8/_`'U28QE;&UUM#&-$-:!``'8!)3)0
MN_F;/ZI_(IJ%W\S9_5/Y$E/_T?4:/YBO^J/R(B'1_,5_U1^1$24I))))3R76
MRW)ZA>VUH>QA#&M=K`:)T_MN>LBWI=+M:G&L^!]S?_)+8ZQ6:^IWCL\M>/@Y
MH_[\URIHJ<3*P\BJM^]DM@C>W4<?]'^TNOL+0XR0/B0%F)H'@DAT#?0.;&_+
M7\B+@YM3<VD-))>[9QI[M%E*UTNLV=2QVCL[>?@T%R2GKDDDD$J4+OYFS^J?
MR*:A=_,V?U3^1)3_`/_2]1H_F*_ZH_(IDP)\%"C^8K_JC\B(DIJV=1QZG-;:
M'L<X`M!8XSINV^T.]R@>K88V$^H&O^B[TK(G<ZLL=#/:]KF.4[<)UEKK!D75
M[H]K'`-$1^:YK_W54]-]N2VN<VH#V&T%H82T>TN=[G>[9^YZ:2FMUCT<ZOU\
M9KS;C@%\L<V:W`._/:W^;W-?_P!N+%YU'"["C$=39O-]MHB-EA!$Z>[1K?!4
M.H]!;>\W8A;58[5[#]!Q_>T_FW)*>>25JSIG4:W%KL=YCNV'#_HE)G3.HV.V
MMQGB>[H:/^D44-5=!]7L(UU.R[&D/M]M8.A#!^=_UUW_`'Q+I_0&U.%V86V/
M&K*Q]`']YT_SCEL()4DDDDI2A=_,V?U3^134+OYFS^J?R)*?_]/U"EQ]&OVG
MZ+?#P^*GN/[I_#^]?*Z22GZHW']T_A_>EN/[I_#^]?*Z22GZHW']T_A_>EN/
M[I_#^]?*Z22GZHW']T_A_>EN/[I_#^]?*Z22GZHW']T_A_>EN/[I_#^]?*Z2
M2GZHW']T_A_>EN/[I_#^]?*Z22GZHW']T_A_>H7./HO]I^B?#P^*^6DDE/\`
M_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`
M;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@
M`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N``Y!9&]B90!D0```
M``'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`__``!$(`2P!XP,!$0`"$0$#$0'_W0`$`#W_Q`"V``$``@,!`0$!`0$`````
M````"`D&!PH%!`,"`0L!`0$!`0$````````````````!`@,$$```!@(!`0,$
M$`(&!@,1`0`!`@,$!08`!P@1$A,)(3$4&$$BU!6U%I:F1U=W.&C(*8E1%S(C
M)':W"F%Q0E(S0X$EMI%B4V-SDT2$M#5E==4W*'@9.1$!``$"`P<%``("`P$`
M``````$1`D%A$B$Q47'!(C*!4H(#(Q,SL4*1H=%B_]H`#`,!``(1`Q$`/P#L
M+XW<;M!6;06H+#8=0:^F9R9U]69&6EI&LQKI_(OW4:@JY>/'*J!E5W"ZIA,8
MQA$1$>HYTOONBZZ(NFE6;;8I&QNSU4>-7U&ZR^243[GS.N_W2NFWA!ZJ/&KZ
MC=9?)*)]SXUW^Z33;P@]5'C5]1NLODE$^Y\:[_=)IMX0>JCQJ^HW67R2B?<^
M-=_NDTV\(/51XU?4;K+Y)1/N?&N_W2:;>$'JH\:OJ-UE\DHGW/C7?[I--O"#
MU4>-7U&ZR^243[GQKO\`=)IMX0>JCQJ^HW67R2B?<^-=_NDTV\(/51XU?4;K
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M\:[_`'2:;>$'JH\:OJ-UE\DHGW/C7?[I--O"#U4>-7U&ZR^243[GQKO]TFFW
MA!ZJ/&KZC=9?)*)]SXUW^Z33;P@]5'C5]1NLODE$^Y\:[_=)IMX0>JCQJ^HW
M67R2B?<^-=_NDTV\(/51XU?4;K+Y)1/N?&N_W2:;>$'JH\:OJ-UE\DHGW/C7
M?[I--O"#U4>-7U&ZR^243[GQKO\`=)IMX0>JCQJ^HW67R2B?<^-=_NDTV\(/
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MNLODE$^Y\:[_`'2:;>$'JH\:OJ-UE\DHGW/C7?[I--O"#U4>-7U&ZR^243[G
MQKO]TFFWA!ZJ/&KZC=9?)*)]SXUW^Z33;P@]5'C5]1NLODE$^Y\:[_=)IMX0
M>JCQJ^HW67R2B?<^-=_NDTV\(/51XU?4;K+Y)1/N?&N_W2:;>$'JH\:OJ-UE
M\DHGW/C7?[I--O"#U4>-7U&ZR^243[GQKO\`=)IMX0>JCQJ^HW67R2B?<^-=
M_NDTV\(/51XU?4;K+Y)1/N?&N_W2:;>$'JH\:OJ-UE\DHGW/C7?[I--O"#U4
M>-7U&ZR^243[GQKO]TFFWA"$_P#(K3?\QO>S^65+][_78^(WH7O"Q]&^)WJK
M?&WXL]UW78]Y?C/_`&_T?IW?I?\`6=.UY<Z:KJ;_`/7JQ2*[L>C_T.W?BC]V
MK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W
M`OR:YUP^/5C'UZ/_T>W?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!
M@,!@,"IKG%=_%Q=[8+K?@#JK0$?K>-UK#6V>W=NV766>2]VDINSM%=?4R%;S
M!&K9VPC(-NJX4>QCI`?3DA,Y;`)>W-K4:<4.?#2\:"\[SXO\VMF\OZ17JW>.
M!\/'SU[=4!FYAFMVC9:*OHQ4$E"2<O-(QUZ5L>MWD>H*3@D>LL\;B1-$H'#%
M5FW;%,46YGQ4/%]H7'"D^)O>=3<5%>%ESMT.S/H^(4N:>X(?7<];'==A;:YL
M3E8&+=Q-N$DFC1_Z4Z*9=RW<*0J2"A@(K.]=-M=.*SGQ$_$GW5H'05=V%Q"X
MSVG=DA=M%N^0RNU[2Q][](Z>U0VB&<XI/WIZA,1RTY;W$8\*=G7F[UHLX#JH
MFLN*?HRQF(B9VRDIX?O)O:_*'P^-0<G+?7*Y-;>O=`NMB7JM2(K5:].6.O6B
MX0<)#1IIB0FC0I)D(%LD=99=5-)54RGD)T*%28I,PI;Y?<^/&]X%U+7_`"LY
M(4'A<325NV##TJ:T-1'5JF+E3U)=C+3;2'G[6I(*-O?YW#03M$DG$RLY')O4
MP4.T[DQ4S3:U$6SLB9JZ@Z?9&MRJ56M[%NY:,K77(2R,VKU,4GC9K.1C64;M
MW:0]!3<HI.@*H7V#@(96'/[MWQ).<?*3FIMGA%X6](TRT2X[F?1N\^16_0FG
M-6A;5$2YH*5AH1I!F?`T:,[$@O%D`8N8D))RU=*HMV[1J=R><FZ1$1-S,=P\
MS_$WXD>'7S`W1RBUEH2,Y!\?+%J.)U;=:8C.3NH=MUC8FR:!2I.TJ0?QBCYA
M"0A$+0Z(*1S10^DD2,=F1,!*JVI$1,Q3<^GACL_QQ-W&XT[HV43@@EQFV[#:
MRV?94J\UV.QV:GJ:_0<5:Q)%LEG+V+9W(E>EB`1(ZRK9-W[4QS)@)A;5G3%:
M;WG<E/$@YB;?YN6OP]O#'U[J66OFIX0TGOK?N\5)ISKW7RRJ$4"S"+:0"X*$
M<0$A-M6;A11I,NG4@9=!&-[MHLY%R(B*5N8OI[Q&^=W&+FWI_@YXG=(TC+!R
M..@RTIR#T*YF&%=?V&0>+0\7#2L;-I,ADT)&SE;Q?=C&PK]BY>H*G3=-UTSE
M<R8B8K:Z`;A;*]0:E:;U;9)&&JE+KDW;+-,.0.+>)KU<C'4Q-22X)%.H*+&-
M9J*F[)1-V2#T`1RL.:W37/3QAO$H/L+<_`?7G&+2?&&D6^4K=&<\BBV1Y>-L
MNH0&SEU&+.((+"P2D%&;IN+@&[>*CF2K@S4DHZ5055+-LMTMMV3O76ZTY+2]
M%XIT?=O/XVLN)]\%N]BMIQ5@N45#46!N#*P3D*T8UV<F9Z10D4K0RB"/XULB
M^?K+HN"E24<=.V:LTV[&7\?^9G%7E2I,MN.^_=9;<D*ZW3>3T+4+,R>6"(8*
MKE;(R4C75C-YQI%K.3`D1T=N#<Z@]D#B;R8)B8WPPZZ>(?P8UY#S,]<N5^BX
M.-K]_G-63!EMA0+EXRV'6?0QLE3-%L73J45EJ\600,^*FB<K0JQ#*B0#`."D
M\'Z7WQ"^#.L$:`YOG++0E<:[2B65@H+MWLJLKL['6Y(_=L+0U=LG[ILWJSQ0
M#%3DW!DF!C)G`%>J9P**3P;INV_M'ZU=ZZ8[`VWKNFNMNOCQNKDK';H2)^/[
MY-JT>G0J2CQXDE.&*TD&ZG5`QR]E=,>OMR]24:ZTOS:XC<B[E8=>Z*Y&:BVM
M=JLW</9FLTJZ0\W*IQS1PDS=R[!NV<&&;A&CIPDFJ]9"X:)G53`R@"H3M%F)
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M>Q<&X<M54R/G1$6AC(J`"GM#=!$3.Z&0[8Y<\7=%4BL[(V]R!U%0*/=XY&7H
MMDL%\KS9A?(MRR:23>0HG=OE5[JT7C9!!R0\61V4S=8B@>T,4PBD\'DT+FMQ
M)VAJVX[LU_R+U%:M5:[;BZV#=XNZPQX>B(]T9<IKF95RDYJYED"B=(KY-`RI
M/*0#!Y<%)W40.\.?QB].^(,%XJ*;:@:.W2POELJ&L-4S.VV-^L>SX"MU-.T!
ML*'C$JQ0Y56&*@F[,Y;-D7/=(,%3@Y'VW=RJS;3DVIX8N[MW[+XX;#V)RDY-
M\4.0,K7-IW-F&R^,MEAY+6=/IL#6JQ++P-ML32*K4,SEX;TQ>1.*B!3I0[QH
MLNNIWG4B"Z(KLANC7?B.\#MM;&::EUMRUT3<]B23X(R%K4'L"#=.+))&Z]W'
M55YZ06,M;Y8`$4T8U=THH`")0$`'*E)WT;6V#RKXT:FM,Y2=H;[U)KRVUJAE
MV?8*]=+[6ZU*0VOE)A*OHVV1:R\@T.UAG$XNFT25-T[UPH4A`,8Q0$4G@_;0
M?)_CUREKDG;./&X:'MZ!A)`L5..Z7.MI-:"D5"**-V<Y'`*<G#+/$4C*(`Y1
M2](2*)T^T3RX)B8WH*>,US?V[P!X>(;PTE&4J2O$CMNDZ_3^/L3)S<*RBIZ-
MM$O(/$HZ+FX%5:0$*X1$@G6%,A%CCV!,!1+)6V*S27A>#_XA>Q^<^M-T5OD'
M7:G3.3'&_:K[7>TZS3F3^*B31COTPM8GBP\K,SDA'.7$G!3$<X)WYT3K19E4
MQ*"O=)H+HI.S<JQW5X[/*%EXB<=IG2E,U(^XE-N6U#XHJ6ZQ5FQR-FN-@1L%
M=@-LNX:S,;BQBDW4<]EEQ8'19J((-#L%E4UA6.!U6HMBFW>M_:;YWG`>)3NN
MDWOE%Q'9<3J'H!/82&AB3[!'DE2_>ZMU"3G]A7=BI&-WT97F+]22>*NE9%1B
M2#>,1!J"IS+D8LTC3NVIAMN7O%I[I1]R0:<@M1.-"1C[WKD=NHWNOGH+"4&:
M:UTL8]L97HQ[614G'R#4J!SE5.JNF`%'MDZU*36E-K>E>L$);("#M-9E6,[6
M[+#QE@K\W%N$W<;,PDRR0D8J5CG:(F2=,9!@Y3614*(E.F<!#R#A'L8#`8#`
M8#`8#`8#`8%?OTJ?N!?DUSKA\>K&/KT?_]+MWXH_=JT;]F52^"6^:O\`.[FE
MOC')(',J8#`8#`8#`8#`8#`I5\6[Q.3<2H6O\9N/Z32X<V>0C$836D+[Z1$?
M&ZJB9]9:%0VE=)"7=-HN+*BX*N,2F\40:&5:+.W:J;1HH"TF6K;:[9W*\%N!
M6O.*/@<\V]4Z[VI0MU<CKQK5MN3D3:M?VZ-M!5E:=882RNH"*"-=N94:?3*M
M&2"*+EV0AY!XN]=G*B5R#9!@M:W1P:XY0<D-+RO^6*U=4&%^KCFV6_6_''4$
M+6$IF)4L"M[U;MZC3%TBEX9-\>1;^]45K:3<F$R?4$`2.8I2JE'&"Q'>M8Y%
MP2FHO`@GM3W=VT@;I4?#3@*'(0<NY:QLL>PU+0D%7IA@E'+.3+'=M9)H9,Z:
M8J"0_M>H^3JP9C;=7-[G@J7VCU?PDN,\W9;E5H"&H>L-BV>[RLS/Q4;'T^MP
M^R-BRLM/V=V\=(H0,-&1;=1RX<NC)(HH$,<Q@*`CB-Q=Y2HP\:#1+G2]/USS
M'4\0@_-"":\A$;91.+&_K+%;%U+(LK(M-3:"M,JU6N+>+GH"IM`1:.T2LTD%
MXE7L&723`&SA/-JWA2CKNXU;0EMW<=M$;EGJHK19K:^G];[&E::J<#C67]TJ
M$18G4*F83"J+=@K(BFEWQ4W`)`4%DTE>VF6L3LF8<TO@@;(I'&_GAXJ'&+>M
MEAJ+NNX;X+9:PK<Y!O!N=D1E4M^VUY$\1(3AFBTNLI&71C-L$N]56>QTDJ[2
M(*::RF2,6[ML6S"=GCF[BU1LOPIN<];UUL>E7N<UVYXX,;U&U"R1-B7J+^<Y
M):C=Q,?8/>ET[3C)!\U9*J$05,57L%[0E`!#JG<S;'=#6'A/\9J31J9PGW@M
MXGW)2^RDAH'6<D3B)<.3\--Z7CY;8&DV<2EKAIJ-1V=TA$ZY>V(`@XPI2K1[
MJ,:``=41**.:W3OC2CAX:5WJ7&KQL/%?U)O:QPE%NV\-AS=_U6\NLBA`)V6`
MF=EV38,+`0$C."W1?/I2F[)C'+9JDMVG"#!042*%0'NT;Y6[;;;1_?BSW2J<
MM/%=\)KCAH2PP]ZV'I7;K[8FTY"ER#2PDH]=>WK4ER?A,NHI84&<I4J?J"5E
MEFAW)%DTET>T"0K)F.G?!;LMNF5_/B`T:V[-X,\OM?41%Z[N-PXW;D@*[&QQ
M7)WTU*2%"G4&]?:I-.KA=:PB;T$$P`P*>D=D0,41`:Q&R850?Y=[DUH5YX;-
M!U.K?Z16-B:,L.UV>SJ[/6"%K\VV0LNS+=?X6VNV<BX9.EH%>NV=NT*_,!T2
MJL%414`41(61N:OB:HQ>)SL32W)OQ-O"2@;_`'>D;$X(W!W?I)C+!.QDIIV_
M;2A;M/TV9B).537<UVS,4K;5Z_#+IK=XV%-\N@!^[=*B*<"W9%W%]V_]>:DT
MU_F$?#_@^(E3I5"M\WKJR^L'2M31,17:\E6%X/8Q5GUPK-708PK"9=4ENLY4
M!=,JRA&D<X,03>C*'8D;;)JB_P"'EQ*XY<@[/X[5SW9J2H;-LE'V9NF%HLG;
MHXDLK1BS$KOB;DIBGE<"9.NVE:2KK`Y)9L"<BV!J4B"R9#JE41BMTS&FC2/%
M?A_QKM/^7MY4<C+/J&H6/>B$A?7\-M2;CB2-VJP4&QU9I6X^H3SCMOJM$I)&
M5]*;,3H)2`.%"N@6()2EF"S,ZXC!^7.)U5K;X>?^7U3W5,JCKM^^>5O8\L^D
M'C'T36#.1U76IXJTFQ,1^R:1E&:G1!5(05212`2CV@`<801Y7)G<E-;<6=-^
M-'X3#+@1`:JJLW-M0_F3!Z(+`I5MYK-WZ:R9VB72IYO>^0EI_6[FQJ.Y%=59
MW(L6R*S@RA`(=2XPD5TW51HX3U?ECO[E3XHZ->T3P0Y`;8LF][C4]RPG-&1M
M1M@5VK-+/=8!"N:_AH-M)*Q=#:@U]`7.V.3N#1[%'M@5NUZ3BLTB+=K^.:W&
MG;_$3P`J3I/;]_U[?)JM<Y6SVLOM67%Q=:K7:Y(16PEU:TWG%8R(!*3C[B26
M7=-TTQ!LNY$IC=X!REN"1,3?L;W\2/BGQYX@[9\#VR<:M4U/3]E><@:+#SMD
MIT>6/L%N08VS1\JV=W:8ZJ/[C+)O)IY_:Y([EP9!T=`3BAV4RN!$S.J);E\0
M3C_N#BURTY9^)YI1EQ)Y?ZG>4VJ0/*[CWR`)7[%<=7QD+5J3#N(RO+2!G"<0
MM*5R%:N&C=1PD[,@^*W]Z9-,K<<9I$Q,1;+(=U<Q]#[ZO/A@:7X]^'UQYV7O
MK?'&=M=="Q/*$C&,T=QJU7(1,^T/5&D+'5F18SZ4*&F)`C4(]HT<(L(UN6/2
M,I()H%<"DQJF9V-#>$]J]G->+!XG^@MR:^XUJ5FPZ;3B]J:?T"T>3'&-Q,L[
M;K=&2AJU"V:*C71FL:]F'R;UJY9H&9RBKQ$$R`0`!&*W;K99O_EK=2\=E(GD
M3>YZDZO'D'KWE%>*OK>?E&$"79]3J3_7C1B\AZL=STGXZ'=1YIA(Y$"E(9('
M91]J54`07UV<%2.FK-L*M_Y;KD\G15Y!I%V3Q&&%9V6ZCA.F=/7K_5.A'*R#
MIRDHDJWCY2X,(9FN`=2KIN!0.`IJG#)@L^<<EDGC%Z)X):K\*?B7>.-M5U/6
M-DK6;2RF@MA:P90$=LZ_M'%6?/K5+.+/6VK:TW#O5"$D)!VY.<R$X#<QS)N5
M"$/9W);75-6:;OTK4>1W^8$X=:_Y046(OK-]PAJ%IV#1;$W[ZN2UXK%.V]8Q
M:S\.DJ#26BX^XLBKJ,%^\9N10*FNFJB)TSL2M+-C;OABT6HZ2\='Q1=,ZFK\
M90-4LM:5F>C]?UAJE%U2,D57^K)E+WJAFQ2,XQE'O;Q*@S;(%3;,T7AD42$2
M`I"HWREWC:V]_F>__P#-R#__`&7U?_V4V5B=Q9Y*XN;.Z;CX0'/^U\F*#"NS
MT7GGP;?MXYM'%;HP\5R(K-*B(>)LJD:J8&[]W7KO#PDM(J'*)CM;6^[':4,(
M"W+$:HIPEHO9W&!?BYQT\`N&GVJJ&Q=O\OC<@MH.'7>C).K3M6X<?I:*1EO2
M2`[),0=!0AHUX543'!VS5'KY>@3@L36;EJ^NT&KG_,X\E&SY%NX8N.%T4@\0
M=IIJM5VJM.T8FX1<I+`9%1NHB80.4X"42B(#Y,N+/^GJYW5%M7P7*65UFSG=
MBD\%"T>)<Q,_DV[=,=8REPJC$`7A4YI)4@KTTE;F4B'.*HO'%2;-GH%,^;E$
ML_PWMI_]4?\`1^:(-6S5LV8HMV[%NW109H-$TTFJ#5),J;=%LDB!44VZ:)0`
MA2`!0*``'DS3B^C`8#`8#`8#`8#`8#`K]^E3]P+\FN=</CU8Q]>C_]/MWXH_
M=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`8#`8#`KOY,^%%P"YA[-4W'R
M+T"EL+9"T#$UE:R)[-W)33K0L&+GWJ:KQ=!V'5H195H5V<H+F;"X.3LE,<Q2
M$`JBQ=,;I>SQA\,'@KPWG[E9N.FAF-$F-@U%>AW):0O>T=@M9ZGNGK:0=P#N
M*V7>+C%)L7CIHF*P)()F6*7L'$Q.I<4)NF=\M14?P3/#%UWMQANNK<6ZXVN,
M/,M['!L9"V;!G:1!S[5SZ8WE8W7TY;)"FIG;.@*H@@=DHS:G(0R"*1BE$)2%
MU7;JMY\L/#>X7<X9^I6CE%IDNSYVBP[^!JK_`/F%M6E&BXF3>IR+UF*&N[S4
MFK\JKQ,#@=R190GE`IB@(@-2)F-TL5X_^%-P!XO?S-+I/CS&5=ON77LMJC9S
M"8OFU=@Q5QUW/>2:JDG$['O5NC"QDJ3VCCN4DE%4Q$AC"01+BA-TSOEI"H>`
M_P"%72KVWV!%<5XF0D6,@VE(V`M5_P!IW*D,GK8Y%>JE,M-VEZ_-,UUB"8[.
M20>LNAA*5$I`*4)2%U7<5NZ:::*::**9$DDB%3223*4B::9"@4B:9"@!2$(4
M```````#*RK^Y8^%KP6YLV-M=N0FB8BR7YJT;1X7^O3MHH=P>L&94TFC*<F*
M5-01[.W9M4P1;A)E>"U1]J@*8=.BBQ=,;G[U3PN>!U)XW;`XDUKC["1NAMK/
MH24V54T[5L`9>ZR=;F(BP0,A.7X;9_,)5Q#S,$U7:]W*ID;"F)$BD3.<AE#5
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MML;7,'9Y!XN#IV]E:W1K;`03=\]<F44<.62#1RZ56.HLHH<0,64AK5=&*0&T
M?#=X1[CT'2.,=\X]TU[I?67?GUM5HE6;K3R@N7:CA=\\JEHKLK%VJ*<RKMT=
M=^)7HEDEA[;P%QRI6:UKM>;Q%\,[A3P:DIJP\;]+1U0M]A8J14O=YB>L]UN"
M\.JX0<JPS.=N$Q-.86'66:(F5;,/147!T4SK%4.0#8H3=,[VQ=2<(^+^BC;_
M`#:JU<E5AY1STO9M[`%OOLV6]34\-B&5="2Q6F7)6DG/QLD.B$.$>W2]('NR
M%["?8%9FCQ:;P`XCZ_XP6CAG4=2$B>-ET)/)V;7`WC9,A[YEL[M!]-B:X2EQ
M>WUJ=XZ;)G`R$HD9'L`"0D#R8*S6N*I/Q1/#0LNP4?"RTUQ9T`E;.._&[>!V
MNPZ>YLT7)P]1U'(3^M'#]">/LZV*3UJAWT1#2@.0,K(K*$*)%.HJIE/):MG?
M,RLKXN^%CP3X;;'GMM\>]%1U-V%/-Y!@6R/[/<[>ZK\1*'$[^'J2-OL,XUK#
M%T`B1069$EU41[HZAD@*0+1F;IG?+&.37A`^'KRZV(XVUNOC_'R>QY([8U@M
MM4MMXU_(6L&C=)HD:THTFQP<?.O`:MTDO35T3/\`NDB$!<"%`N2BQ=,;I;$L
MGAH\(+9QDJ_#B;T3'*<;J;9$[A7-;1]TV5!IL;.FXFG?OVK:H.YQUXDGRSFQ
M/3JF=2:W?F7'O`-T+V;1-4UK7:V7NWAGQJY%R6CY?<NM$KC(<;[4RNVEU_C7
M>*^6F66.<0#IG(`WJUF@VU@227K#`1;2I'S4_HX`9,0,<#")F*HT;^\'?P[N
M3NZ'^_\`<V@$K/LV<<,'5JEF>P-FUN.MZ\3',(J*5L5?K=QBH1RJR81J*8G1
M00.Y*7LN16+T`)18NF(I5L7DEX9W"CE=":R@]O:4BU4M,1#6N:ID*--V364O
M0ZTQ3;(LZQ`OZ!+UXZ=;9HM"%;L%05:M1#MHD34'MY:)$S#V^-GAU\,>(%VF
M=B\;]'Q.KKE8J4RU[.3$5:+[+!*U5@_8RB+5['66US<4O)KR,<@LYDA0]\W9
MT^J[A3J/43,SOEB>N_"XX,ZGY2/.9&N](,JMOMY(6V9^,<;:[L6"93]\CI:(
MN$[%4=6Q*TV*D)Z*GGC=4J#%-N0KE0R22:AA/BAJFE*[&<ZA\/KASHK0NP.+
M^M-'5^,T)M.<FK+?]:V":N&P(6RS=@AZ]`R;]VXV%8[3+MSFC:G'%0(@Y23:
M*LTUFY4E@%01,S,UKM1OTMX)?AH:"VC%;@UYQO8ENM<E$)NIJVR\[%OD+4Y9
MHY!XQDH6O7*US<,,C'.2)J-7+I%RX:*)%.B=,X=H92%FZ9BE4Q93B#QUF>3M
M<YE26NB.>252I2^NZ_LCXTW9$T?3W*$ZU6B?BDWLB5$=G.WLSXGI2\6H\`J_
M0%0["?8J5FE,"C<0>.NMN0VU.5E*UT2%WYNR&85_9M]"TW9^-EB(Q.`29-`K
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M]G\BYG6;LVZMQZEE=';#OT9L3:4!)S.LIF%BZ](0+%I`7:,B*P^4B(5JBG*Q
M+9C,(=T!TG1#B8PBLTI@PYUX9W!I[Q=C^&#G0$&IQMB[&-O8:]"T;`3=-[6,
MF\EC60M\3MI-CGG#.7ZR0NC2YEA9J"T$WHO1'%#5-:UVI@T2E5S6M)I^NZ>T
M=L*E0ZQ`TZKL'\S-V)ZQKU9BVL-"LW<_9)&7L,TX:QS),AW3YTY=KB7MJJG.
M)C"1E>`P&`P&`P&`P&`P&!7[]*G[@7Y-<ZX?'JQCZ]'_U.W?BC]VK1OV95+X
M);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@87L'8^O]3U61O.S[M5=>TV),V))6FYS\96X%FL^<I,F#9:4EW+1H
M#N1?+IH-T0.*KA=0J:93',4HAY>N-QZFW!5D;QJO95&V)4%Y9>ODL=.M$-8(
M@E@:+IM7E></8UXX1:V!DZ6(DLQ5$CI%4P$.F4P],#(H&Y5>SRETA(":92LK
MKJS-:;=V+4QS+UNT/J=4]@M(61`Q"E(]7I=ZB)$H%$P>COTAZ]1$`#)L!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@5^_2I^X%^37.N'QZL8^O1__5[=^*/W:M
M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P(W;$YD\0M06AU2-L\JN-VK[HQ1;N7U0V)O+6-)M#-N[(*C1
M=U`66T1DJW1=)AVDS'2`IP\H"(86DS@C]R/V=K-W8.%7)!>RP=]XP5G9=VL<
MMLJFF)L?7E;FI_4%ZK>L]M2,O4$YY@2IQ$FZD(@)PHJ,8Q]-(*K*(D`7"(C&
M,4$N0<91]P'W5R*@)G8E1XW.^6O`*2<;+HDI>]8Q=ND*%;(6M[BWFTE(`(:6
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M%50K<KA9PJK4G>EKA#`8#`8#`8#`8#`8#`8#`8#`8#`8#`K]^E3]P+\FN=</
MCU8Q]>C_UNW?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,#%+Q>:AK2
MHV"^WZQ1=3IU6CEI:?L,TY(TCHUBAV2BHLJ;J8ZJRIRI(I$`ZRZQR)IE.H<I
M1#6]4Y)::NA=?>\%J?*+[1L]EIE*82M-O-;EG]HJ%5E[M8H64AK)6HF5JSN/
MJT$Y>?\`6J+(JR9"@D)SJI%.6DMYX1^2ZZ+9%9RY62;MVZ2BZZZZA$D4$4B"
MHJLLJH)2)I)D*)C&,(``!U'`\->V5M"J+7D)EB[J"->4M@6&+5]]XUS6TXT9
M@)F.7B@>!*,5HP._1.V!7OTQ`4^UV@ZAH_4G+OCIO6T25,U/LIE<;-#HO%Y:
M+:0-L8'C08$C5':+YQ,0,<S:O449AJH+<Z@+BFN0X$$H]<+2821PA@,!@,!@
M,!@,!@,!@,!@,!@,!@14V3S#U-1[D]U-4DK/O7>K-NFNMI'1\2C=;I$`X-V6
MBM_EU'L7K[3L<Z'RIO;C-0#18`$$E%#]D@EI_P`,(_E/R;W_`/VC?NQ?Y!ZW
M=>V_D/QLM,JE=9=D?_T/9_)OT*`MJ/?I"`JL*(QJZC-8#)^_<FW'J8;(W)/:
MPU)K'2M5;TG4U$K&OJLW<+O1AZO$M8M!Y)O#`H_F955!,',S/2BW]:[?NSKO
M':PBHLJ<XB82-B8&,W"Z4[7M>?VZ_6RLT>J17HWOI9[A/1=9KT;Z8Z18M/3Y
MJ:=,HUGZ4]<IHI]XJ7MJJ%(7J8P`(>'+[:U?`7ZN:JF]A4V)V7;V:DA5Z'(V
M.*:6R?9)HR[@'$7!+NB2+PB[>NR2B/83$5TXQX9,#%:.!2#)("TURUHR;BLS
MD7/MX:>FJM*N(AZ@_;L+'7'RL788-RLV.HDG*0<H@HU=H"/>-G*1TE`*H0Q0
M#WL!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C'UZ/_U^W?
MBC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,#0/**%UY8=#W^(VJRV$\H
MCEM!J3*VJ(&Z638\$NSL\(^@[A3XG7D1/W0\S1["V:3*:[!DZ59@Q%P*1R)'
M#"QO5LQM/V?RCE>-$1N9AMW8NJJ/RNW*P@-L25`V!QZN6T-&DXG6A:LW7<%;
M@(S7\A3FDIL^R/JHJJ1A7X:X-XUNY28E92Y6JD7=5AS2"E(F"T?7.7%:Y6SN
MBJY1N3U.JD748KDI9+"WV#6^2#^"U"KL)#4176S9*P+Z&BXXM$FIH%FZI?3'
M";L'KE!58<:,]T5QWVSM%S:9?E$RW9+7B+X)<:Z;!)3E_P!C5J!+LZW:_P!X
MP6YUBDK%B@Z7+;@7;O8II8Y%N9PNP=G(9NJ@18BB@F8V4XMW\#ZSL&`XT\48
M?51F]*H%>US3HG>5,WQK[D`.WD]A1=9@V%YBJ?(;*N-<4K#&+G6J[0B8Q<A#
M(JHG(R`$B=V%2=\U8G>ZGO.-T9XD(:XA;O`7.V\E59^INXJNVLUEL&MEM9\:
MXG8$[K=C`R56M-ID5ZA#V!I%C`2+20<RS86[%V@](0Z<796&HXW2%AN%?UU5
M(?8.S;SJ2[<U*/,7BL:RU/R>XTU>C4&*X^;"1M<``WW8]PN*FK+C;HR(&=(V
MDVU?&8>+M5$B/7+D#"O^'ZVKC/;K!L6UV-9OR7;*AX@5$HT(Y@ME;X@V$?Q2
M=Z'US!W%A74(6RLV,;JV=ESOTY:7:E)WLDCWAWA7;1$Z`K_A//AS4[)0*=M:
M@RS&Y1M7IO(3;,/JAE=7%DD';;5:LHSEZRW@IJVK.YN:J#9Q*.TXM8[AR@BT
M(5LW.#=!)-.I*7.$,!@,!@,!@,!@,!@,!@1*VIS)U;0;<[U128^U<@=]MDDC
M*:.T;',[=;X/TKM%9N]D3CF0BJ!IJ$<'`.R^MLO#(JEZ]QWY^B8EI_PUQ_)7
ME'R+_M7)39_\B-9O/;>KGQ@M4PRLDLP4\OO?MGD]Z'7[P_[]!02.8^D,ZHBD
M<#)FDY%$>T85B-R6NJ]0:MT?46E#U#0*KKFH,E57*<%4H9G#M'#]QT%Y*R)F
MR95Y:;D5`[QT^='6=NE1$ZRASB)A(V/@,!@5S^*8XUBCP^V>E?89A-65Y6K.
MQU$BO4)"WRS;8SZL2[)HXJZ,=#S#B'GU(1P\0(\*"!RHK*I@H`*F*9*V[VL^
M1.NVNY]DZNV=QZV%;#V_=$94IU!K&0<>6&@JWH)KM!",WF9Q;(M"7A9:G*;R
M7:Q<,J3T2P6Q2`(Z30BTIQ5>+&S>VKX;NTY._P"D_BV:D5FI5S6\?KR(@!J*
M5E28,GMGUQ6KM;]<VE>WOY*PS6V]3VJ><Q%OE7*B2\I-@JX=-63\SQFA4E8?
MA#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8%?OTJ?N!?DUSKA\>K&/KT?__0[=^*
M/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&!C,S<JO7IRH5N:FF4=.WV
M3DX:G1C@QP<V"4AJ_*6J491Y2D,4ZS*O0CMV<#"4`20,/7KT`0R;`8#`PVP;
M"IE8C;=*2U@9`A0H]&4N+6-!Q/3%?9.6IGK160K\$C)3I#OF9!5;IE;&47(`
MF3*8,#,L!@,!@,!@,!@,!@,#RYJ<A*W%O)RQ3$7`0L<B9Q(3$U(-(J+8-R>4
MZ[R0?+(-&J)`\YCG*4/XX%<NWO%AXBZO5=1T)99K;<VV,JB9IK:+*^B"."&[
M)>W:IES#5]VU/Y^^8+/B]D.H`/D`>D?5=.3.J%<6P_&_VI(JK(ZMTW1JFU'M
M)I.[K+3=UD!+YBN"(Q!Z6R:K"'E`AP<D*/D$3AY^D?3&,IKG@AU:O%"YN6HZ
MI1W(I7FBG:[+&JU*EPQ$>T(]>ZD"0"TWY`$`#M.C=.GD\O41U'UV<$U3Q4^<
M[_$&YVQ]EK<;$\O^1%?AY^NO%9.,JVU[E54'3A.4=%6,J%<EHP>X<(.@2,B7
MLI"F0"B42]`#A]T1;-M';ZML35T">$M;+17.!&@W$!8IN&6FX^W3LT>,DWK(
M9F;=WZU).IB7!NL0LG)N4T"%477!14X$*`F'H'2VQ&F-CC]DS%]VU9NRW=M>
M/$!0NTNIT'J'IH-)(/Z7:\H2+9T!@Z^P/L>3S9=,<&-5W%L&(Y3[(8"4LDA`
M3B?7VYG4>HR<B7KUZ)JQKAJW(/3R=11-_JR:(77+<U=Y9U5Z)$K+7Y6"4'L@
M+ABLE-,@'S&.I[1@\3*/GZ%25$/-Y?.,T3A+4?9&,)#UJ\5&XH]]6K!&RW0O
M;.@@OV'J)?)[9Q'K@B_;`/7_`)B9<S,3&^&XF)W2RK(I@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C'UZ/__1[=^*/W:M&_9E4O@E
MOFK_`#NYI;XQR2!S*F`P&`P&`P&!$_>E<L,OR!X2S43`S,G#U3;&V9&TRT=%
MOGL;6H^2XU[=@HY_/OVR"K6'9/YR3;,T57!TR*NW":)1%0Y2B7"56-"T]R8U
M;QWTO-:OCN2A-W;.\(;=$ONES:+)L^QVX_+.!K_#]76<;(ALF5?QU'WI%A;;
MXRKD>O[W+B9HN@HF=&-,#>+LK/-FU[A*G)Q>FD>/K+=U-XOEO^Q!W`KNS2?-
M[8,,YV0KK:MI4&1E]9V*^:KVT-'`#S"3^225&KH7@J"SM!29`72(_P`OYO7'
MG9MJIMZ;2ULY);7<:O\`#3K[O25UC$^0NH'%EY"14OOMU6K"A0EK2I9WF\X2
M-:P":;6:<2EC*"Z1G7>*NNT<5_R\_8FM;%`7+Q!+'6ZCR&0Y";5XR:WM>MY>
ML-=_OHBPR2E`]Z[VA6S01W6M(R[Q=RCT448LA6TPP!0`8H)H+&[8X<&Z)&K\
MKR<GKQH^L)[*0UA4[=M7F;K?;4L[GUZ'8WE\UJXJE)XQS5K>G58+EKO)*Z6&
MW^\)5/1V==AHI)1,K8Y$EALI7%Z?AVTRWP\BRL5DV1<7,X[T?58;:NL+'Q_Y
M':U?)[5:O(MS)7'8=\W3M7957MFUF*YY&/>KPI69IILN1UVEV+=B*8E:_E9,
M!@,!@,!@>/8+#`U.%DK):)J+KM?AFJCZ6FYM^UC(J-9I=.\<OG[Q5%LV1*(@
M':.8`ZB`><<;]PI)Y/>,M4ZRI(5/C+7D+Q+I"NU6V1;$'K.H-%2&,D*E>KQ3
M,IBQB'E,1PY48MRG*403<IFSM;]4[[F)NX*)MQ\B=V;_`)8)C;NQ[)<U4U3K
M,HUZ[*TKL4<Y0*<8:L1J;*O1`G(4`.+9LF93H`G$P^7.T6Q;NAF9F=[2V5#`
M8%;/B`->R\U8][77OFUQ:B7L=.SZ,K652F%3KY>WZ6/0.@=.R(^7KY//]_\`
MJ[_3_LZA_"O^X%QP_NU9O\0;?BWQAQ^W^RY8'FG,P&!^[9RY9KI.F;A=JY0,
M!T7#951!=$X>8Z2R1BJ)F#KYP$!P)'43DU<ZX9%G9@"W11>R05'2@-YM`@`!
M>TE(E(8KP0#VP@X(<YQ\G>%\^8FV)W-Q?,;TVZ/LFH["9BYKDF15PDF4[R*<
M@#>58]H>S_:&AC&$4^UY`43$Z0CY`,(YB8F-[K$Q.YGF13`8#`8#`H[X/\N-
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M]XW#5(QI`HN*/.-*K<Z1LAW,:]83";I2?3@(.1G^T1GV$CQ_OB0PBGJQZ^<X
M(+6,_I&(2G-)['INUYOCC5*[9`Y"5V(WG?&W(:W5'7E3V=2M#1>NU8VUTLT[
M<V+]ZY0G(L"Q9'SINV%-JDFX%&K&G,RX:<X]6/9-MD=/6APQY#^(Q$@MO+D/
M'Z*D'];T7S&W?4*'0==D6UW>SW:?;4.";1K%H)&*+=*/0(NY`5RFR+3:V1*\
MW[^]>;BE-:\<UKSK[2.BZAN^RSCW9R->NMF3O>LI'9U>HNOM?,*':B3UL",B
MSMW0/)6,;$67;`W4<F45(A4INVI'Z>Y#5K>%SV;#4-F$M2==Q6ISH[%;2)'$
M99++LVDALQ>ML8XK0IFIJUKRQ5>247,X.9?XPE3[I+T?MK"8HD'A#`8#`8#`
M8#`8%?OTJ?N!?DUSKA\>K&/KT?_2[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S
M*F`P&`P&!X-IM-:H]:G[E<I^'JM2JL/(V"RV6P2+6(@X"#B&JKZ4EY>4?*H,
MX^.CV:!U5EE3E(F0HB(@`8&O=2;ZU1O-M,.=8VA2=&`-'#,,9&NVFI3+)K,@
M]-"2IX&Y0E?FE(&>+&N1CY`C<S%^#946ZJG=G[):3#<&$,!@,!@?,]>LXUF[
MD9%VV81[!LN]?OWJZ35FR9M4CKNG;MTN=-!LV;()F.HH<Q2$(41$0`,#'VUU
MK#V=B*XRE2/I.?JSNZPQF+9Z]BI&L,GD.Q6E6T^U;*P)B'<3[3ND_206<)JB
MHD0Z9%#E#*<!@,!@,!@1-Y6\Q]1\2:F$Q>7XR]OE&RBE/UQ#.$!LUE6`QTB.
M3E/VR0E>173,#B1<%[H@$,1(JZ_80/JVR;IV;DF8ARJ\H^:&Z^5\\9W?9P8R
MG,G:B];UO7U5VE3A"=HX-UW#<3]Y/S9$3B!W[P5%NIC@B"*1@2+Z;;(MW;W.
M9F42\TA@,!@,"O[GVU$]:UV\ZFZ-YV;:].SU*(NV#-4!$_\`LF#T+R![/4?X
M9P^_=:[?3ON=,7A7_<"XX?W:LW^(-OR6^,.7V_V7+`\TYF`P&`P/NC9.0AWS
M:3BGKJ.D&B@*MGC-91NX1.`"'5-5,Q3!VBB("'F,41`>H#A4Y-2\E&LP9M7]
MA*MX^4.)$6EC`I&T:_./0I22A"]E&-<G'_FE`K<PCY03Z!VN<V\'2V_"4N@'
MKY0\H#Y0$/9S#H8$<-Q<K])Z3F&=-LEC?6?:DLT(]KVD]8P,OLS<]A:K*IMT
M'S#6].:RMB90)G"I2*3$@DRA6G7MN7B*8&.!:2U4TE.>.XG1)6(B=4<.J.D#
MA1A$;+A1Y';NL9N\,FS-9H6@[#H^J-8M!;J=Z=LRL%Q<J*%*4R[;VY!&R,V[
M-4T_D+7)F1=;@WA1-HPB\8+>,B*IHYSJUY'ROI3=0))S+K[9V`60;`T(HEZ,
M#9$>VH!^]]IV##9P:*K?AV\?H.L2E*EY#;5^ISK4VQ-'055OFTK-,0-$UGM:
M(1K][@:+&LEHMO`NYF!;)LBR7164:-2F3;N$BJK@J*RS:#XDL*V:XS4+O7?;
M/8U];:^C[1M0\QK-]:G\1K)I<(VK0:5<DM6/-41\,E&79XDNW;UM)-=4J;LP
M>G=XZ4%<G\5+AIKS6BM3#4%SVEJ)A7-=:YU1+Q%,L$"[C[[1M4I2#>D1UM&Z
MU6WOVTM%M9=VB>8A%X>:<H+]VJ[.1)`J0JVAN'3`[=)`@EMG=6JEH,LPV6<Z
M>O):@>P14^FP3DXN>0=Q,VQ7,`1J8LY%NBVFHHQE18/6HKKBH(FF#2"7`;1T
M?)5\M;>W^H42OR?'"?)J.LV5HQUY*6/B8ZIRNAYF6*O#.[FL2EM-?0K88Q&9
M1@WQ(Y%9TR6=E])P5E]=AX+ZBFDR)Q=AV;2CN2\EXZQ.J?:6+-]:ZCRXVXYW
M?O&D2;^5@9EY$0EBV$N5RU>0IXJ=BTD2)-)!(G;`XJW=K31M!U._L,C46LBF
MXM%>UU6)8)*0/((JQ.K:J6FU1--)5,I4U4X0O9<&\O?J>V'IYL%:M3<'.,#+
MB'QRI^FTRP8S320LEGM:U:4DUX`L]:9QY*$A*^YF4T)5>K4:!48UV%%=)!0D
M+$-""DEV>[*)FLI<X0P&`P&`P&`P&!7[]*G[@7Y-<ZX?'JQCZ]'_T^W?BC]V
MK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@1*YPU>QVOCC8V]9JTQ>G5;V#H+
M94W1*\Q+*S]\HFHN0.K]J;*HT'#G.F$U+W+7E-E(QLQZB+U9T5``,*@%$L;T
M=>0V\(#>=+UC(U>L<FU]`US>U.4Y0&AM*<C]8VR7U3)ZWW"FRBXF`4J%/VS;
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M&<.9<B@`3A5M*L:)G;@IH"DN;WL_96CK%RFVU9+=%42@<D.-^OZ9KSU6II*+
MUJY9VS85FN;W4+_;\?[Y)F6FQK[J6FCPZ"144/0\%=_%A!(39],KW%69G8S;
M.QK=KJZ;&UQ%Z!O]4Y%J2DQ11Y9NJYK?9E1W!74_>>N;-H&KZ['+@[N)I%"6
MJ8]ZX>1C-TZD78XL9N59V+N?<6P8>$T]LVF1ETJG.VA;1@8T>31I.851-,DT
M^^O^U;"O":Y<)WZ8@FDM48R!54;0,6^+%L'9HT_87+N>S&0.V8_0U%9<9('D
MK#0\?X=FVHAW'O6.[X*YL-NDV%H<+/"UTVW08SL9N,L`VM"50**B2B*R9@BS
M$;)]2DV5V\7UR-.D[9%;>@.+</RJK/'>T["\->+71D4N3%#N*=S6YN0*?**P
MZX/LGWKV]78F.X_'8FO$LV]&BDR-U%Q5%=&85*.>]-G1+JK<58WF07:5J/I_
MCIKCDI7D]4VO>%VD86BP.NKCQQXM/W@0&Q-J3`(.J@^Y!W"S,6QQD5FR<ZJX
MCD3%41]'3J3MIQ;UUCRWXI;LL1JAIGDWQ[VW;"LEY$U7UCNC6]]L18]KT%R_
M-"56R2LD#)N!@[Q7NNP3KY1#!28P2$PA@5W<[N?=0XD5X*Y`I,+=NVQ,%%J]
M4SN!%A6V:Y%$T+7<?1Q[Y*.(L7JV9%,FXD3$$I3I)@=8F[+)NY,S-.;DTV%L
M2Z[6N$W?MAV.1M5NL+D'4K-2BH*.%S$(5%!!)-,J;=FR9MTRI(-T2)H()$*1
M,I2E``]41$12-SGO87@,!@,!@,"$?/!J*FJZP[#MB+:_,$C`4O4H)NJ_8Q%0
MY@_H@51N4H>P(G_CTSC]_C'-U^GRGDZ/?"O^X%QP_NU9O\0;?F;?&'/[?[+E
M@>:<S`8#`8#`8$AJ#R7L.MZS)QTC6)[924='*&JE?A)*L1E@<2!>A6D&E,76
M>K-::QKA0X!W[]^@FS(`B!C$`J88NMQC>Z674V3.QFB6K^6W((B3W=FUF?&O
M7+XC-TGIKBW874EL>1:"'?'9WOE)+Q$3*,T7A3$[UM1X.O.VAR&*E/.TS=L>
M;M6(W)(::X_:7X^0+JNZ;UU7**RDG)I">?1S=5Y9K;+',<ZL[>+E+KR-OO5C
M<'4,*LC,/GSY41]NJ;!,S.]N+"&`P&!`[F5*['IK_5]HUIOJ]52^6;8^JM<Z
MMT+#0>L)2E[8LLC>/3]A&NJ<_KVP;"=UYKJ0)-Y,.(R9BR0$/#+2*`E=$`YB
MQCL8WM*[[(U[S$T-%--N[E^*>T]F2-9L=/MNO*-'\9V5,/IJ[2D54ZML)EK=
MM<%MRR.PX*.>QI'%E74=D-(-C)>C$103&$H@5'E+R5HGHNJ^1%[N-%MUH:::
MGMGV^?IE8L%DU4]"MVJ7Y!0^FJKK&IR#RR4Z_P!CICR-UNY?,)%TVAHJSV!5
M5TRKBJ8QJD;X7B1,K&3T5&SD)(,Y:&F8]G*Q$K'.47D?)QDBV3>,)!@\;G40
M=,WK58BB2A#&(<A@,`B`AE8>A@,!@,!@,!@,!@,!@5^_2I^X%^37.N'QZL8^
MO1__U.W?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,#'[95:W>ZM
M9:1<H.,L]0N5?F:K:ZW--$G\-8:W88YS$3L'+,5RG0>QDM%O%6ZZ1P$BB2AB
MB`@.!C3C;NKVVT(W2BU]JP;<EJM)7=EKDDPT6MYJA$NV+![9'$(BHH]8PP/9
M%)))=<J:;A3ME2$XI*]@4QP:[:\L>/3NQVFKALJ.:/J=';%E9F2EHFR0E059
M:@?#%[9-7[[,0K&CV]QJ^3(=O8D(F1?+PBZ2B;PB)TU`*6DO<KO(S3-J@ZS8
M(:Z)':6^^_RN@(Z1@[+!VAUL,J#I\O4'5*G(:.N$3-LH=BM).4GC%`6T0D>0
M5$C(HKX*-VX0P&`P-0;ET'ISD'76M7W)KZOWJ-C7I92!<R**[.Q5*:)V!2L-
M'M\0O'6RBV9OW9>ZDX=ZQ?I=/:+%PL3,;D;SZXY?:`=$<Z;V*VY2:L0[)5--
M\B9X(3<5?8)A_P`'7?)*/B'IKD=(IA%-E?HU^_=G`H+65`GE`;):?WKXHFO-
M7:OMI_B)LJC<B(TS6&8:+W#2W]3L$9)RY7Y&=K7FF*LU0KSK]B6-74]]:O-3
M4:[<)%9E<I+'.*.[+=<Y,W31RUWN]6[9MOL%]ODZ^LMNM$@I)SDW(J`=R\='
M*1,@`4A2(MFK5ND1%N@D4B+=!,B21")D*4/5$1$4C<Y,2P&`P&`P&`P(D<UV
M@N-(N%@!0?0+37W8B0O4H`<SMCU5'H/93ZO>@#Y/;B4/9Z#R^[P]77ZO-T,>
M%?\`<"XX?W:LW^(-OS%OC#G]O]ERP/-.9@,!@,!@,!@3!XZ;F/'.&FOK0[[4
M:Y4*A69%P<1%@Z4-T3AW"AQ'^Q.3B`-Q_P"4H/8_H&+W>+K<8=++L)3KSFZF
M`P&`P(L;2XETW:FXZYO1UL/=%+OE6HPZ[AU-?7\]>AVU:<V)6S3"*42O%R2+
M-[9GX-22J[84%)%M&L4EQ.5FAV"UP>E(\8*O.[7A=I6?8.X+6UJUQ/L2I:ML
M=W+):JK%\&'E8-O9XN!-$ISBZL8SFG)V#!Y)NH>-=&(Y:,T7"22A!5YEXXAZ
MUO3"4%Y.7J&N$GMJ:W,39D#+0J-]C+=-:_M&GC-XYY)UV5@2P,7I:X/ZBR:K
M1ZWHT.KWA3^^/5\(JD/4:K`42J5BD56/2B*O3:]"U6MQ2)E#HQD!7HUM$0\>
MD=8ZBITF4<S33*)C&,(%\HB/EPC(<!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/
M5C'UZ/_5[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&!7#M6[
M5B"Y_P#'8K'6NZ%E&-0W/5K[>ZEQ<Y`6'7Q;=MH./$9KA6R;AJFJI/6[ALI%
M4]=![*KS!V%>;1XDDW#(B0`!8W2@EIW2\UL_:D75[]&;/G:)O=KS2HFZ>,EG
MU3M&F4[A55>0,5<[#>+#K?:\ZQ;UZ>D[W:FK6OJ%6=R:4B6TKR%13BH-O(-%
MHU78]PT3R`TQL&O[WHE<ONQE-F/MRS.OG6V=1S=TN]FGSV#1=3@D;E$:EA=8
MU;2-]Y4TU%\HULDG#M6-/IE%BVSUJW?O[`5T-D[)7WY6#`8#`8&$;)V'5-34
M*V;)N\B6*JE,A'D[,O!`IE?1FB?4C5FB8Z?I<E(.#$;M4"B!W#E4B9?;&`,L
M1,S$1O-SBHY.\B+CR?V]8]IV]11`CY3WOJ]?!<RS.IU-FJL,/`,A[)"&[@BI
ME7"H%+Z0[556$`$_0/7;;%L4ARF:RC[E0P&`P&`P&`P(V\N6GI6@+P8H*&.T
M4K3LA4^@]>Q:H5)45`[(B*:;=8YAZ=.G9Z]>@"`\_M_KET^OSA?GX5_W`N.'
M]VK-_B#;\YV^,,?;_9<L#S3F8#`8#`8#`8'^@/3RAY!#R@(>Q@63<?=IC?*Z
M:%F'(JVJNI)INE%3=596+Z@DTD^HCVE5TQZ).1\H]YV3B/54`#E=%)R=K+JQ
MMWI"YELP&`P&`P&`P&`P&`P&`P&`P&`P&!7[]*G[@7Y-<ZX?'JQCZ]'_UNW?
MBC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,!@<XWC
M*<I%)VT0W%ZI2!@AJF9C:MGJ-EO:2-G>-2N:S6EQ2,';;P$6Z].73-VDSN7:
M'4"J-<[_`%6_[2Q=."BC.S!@,!@,!@,!@,#27)!IZ;HW92/8,?L5U1WT(/00
M]`=M7W;'_O4_1NT;^(`.8^SPNY-_7YVKSO"O^X%QP_NU9O\`$&WYRM\89^W^
MRY8'FG,P&`P&`P&`P&!F%#N#^B6J)LS#M',P7`';4#=DKZ.6_JGS(X^4H=^W
M,/8$0$"*`4_3J4,DQ6*+$TF)6VQ4FRFHUA+QRQ7#"39MWS-<OF4;NDBK)&Z>
M<IA(<.H#Y0'R#Y<XO1O??@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YU
MP^/5C'UZ/__7[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P
M&`P&`P&`P-<;?V/':AU=?=FRC99\TI-8E9X(YL!C.95XS;'&-AVH$*<WI4O(
MF2;)CT$`.J`CY,L168@G8X7KO;;!?KC:;O:W2CVRVVP2]BGG2G>`965EWR[Y
MZ)2*G4.DD5=8Q2$$1[L@`4/(&>R(I%(<6+X#`8#`8#`8#`8&M]QM/3M2;.:@
M05#J4"W"BF!NR)G"<"_5;AUZE#_CD+YQZ#[/DS-^VR[DU;Y6\UU/A7_<"XX?
MW:LW^(-OSC;XPGV_V7+`\TYF`P&`P&`P&`P&!/OBK=1E*[)4MXKVG5=5].C`
M,81,>(D%3"LD0!$1$K&0,(B/D``<$`/-G.^-M76R=E$L<PZ&`P&`P&`P&`P&
M`P&`P&`P&`P&!7[]*G[@7Y-<ZX?'JQCZ]'__T.W?BC]VK1OV95+X);YJ_P`[
MN:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,"N?Q%-@&B:+4]=,UQ(XMTNK-2Q
M$SB`C"UP$A;MW"8>=)Y,/4E2=?\`;9#_``SK]<;9ES^R=D0I%M&N:9<0,:=@
MVB[HP=`D6Y19R1>@`!1%ZU%)98"=/(503D#_`'?/G9RJC?:>,CY$5'%/FDWB
M7E,6-FNC=T`>40(E(-TQ;+G'S!VTD0#V39:K5'.P5*RU5?T>P0K^+/VA*11P
MB(M5A#S^CO4A49N0#^*9S!E:8[@,!@,!@,!@8Y<6GOA4+4P[OOO3:W.-.Z[?
M=][Z3&.D>[[SM$[';[?3KU#IU\X9)W2L;X7">%?]P+CA_=JS?X@V_.%OC!]O
M]ERP/-.9@,!@,!@,!@,!@;8TC:1J>RJV^.H*;*0=>\<C[82$%I+B5J4ZP_\`
M@FKPR2X_^2S-T5B6K9I="U3.3N8#`8#`8#`8#`8#`8#`8#`8#`8%?OTJ?N!?
MDUSKA\>K&/KT?__1[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`
MP&`P&`P&`P&`P*)N<]N&S\@9U@FKWC2FQ$)5VPE,`I]X1L,U(=``>@*)R4TJ
MD<1\O5+IY@#/1]<4M<+Y[D/<VR8'X.6K5Z@HU>-D';98HD6;N44UT%2#YRJ(
MJE.F<H_P$!#`T=:>/5&GN]7BB.*P^/U,!X[HO'"<?94BUS@0I`]@J"B`9:K6
M4;;5H6^UP%'#5FG8V!.IN_A1.LZ*0`$0%6,4*1YV^@>4$@6*'^]EJM8:8525
M04.BLFHBLD82*)*D,FHF<H]#$.0X`8ABCYP$.H85^>`P&`P/S52372505*!T
MEDSI*$$1`#IJ%$ARB("`@!BB(>3`MJ\+9%1MP(X[-U0`JJ%?M2*A0$#`"B6Q
M+@0X`8.H"`&*/E#//;XPOV>=R?V:<S`8#`8#`8#`8#`_TIC%,!BB)3%$#%,4
M1`Q3`/4!`0\H"`X%PU-FPLM3K<_VBF/+PD:^6[/3H1TNT2.[2\GD[2+GMD'I
MY.I<XSLF7HB:Q$LER*8#`8#`8#`8#`8#`8#`8#`8#`K]^E3]P+\FN=</CU8Q
M]>C_TNW?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!
M@,#FBVM.FL^SMAV$3]L)FZV>12'R]`;NIEXHV3)U,<032;F*4H=1Z%`/*.>J
M-D0\\S69E@.5#`8#`8&)V6C5.WI"G8(-D_4[/9([$@H2"(>P",@W%)XF4!`!
M[('[(]/*`X*HXVKC'_Q'--F_XF"+G`_UCV49)JE_T%*HC_K/EJM4<++1K94%
M13L$&]8)]KLD>"F"\>L/L`C(-Q59J&$!`>R!^V'7R@&5IB>`P&!<1X<K3WOX
M::=8`4A`9&V(T["8B*9?1MK7E'LD$0`1(7L=`_T9P@O\I3<RL&`P&`P&`P&`
MP/\`#&*0HF.8I2AYS&$"E#V/*(]`#RX'CN+'7VG7TF;B4!#_`&5)!H4_L>8@
MJ]L?/[`8I(M`XNV=A:-/PBL>]2?I1,A,PRBZ1NT4#HOU7J:0CU\Z35^F`>0/
M:]/]8\KXI<[V>,)"YEHP&`P&`P&`P&`P&`P&`P&`P&!7[]*G[@7Y-<ZX?'JQ
MCZ]'_]/MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`8#`8#`8#`8#
M`8'R/W(LF+UX!`4%HT<N03$>R!Q01.J!!-T'L@;L=.O0>F!RXG.=0YE%#&.<
MYC'.<YA,<YS"(F,8PB(F,81ZB(^41SUO,_G`8#`8#`8#`_-5))=,Z*R::R2A
M1(HDJ0JB:A#!T,4Y#@)3%$/.`ATP-,VG0M"L8J.&K-2N/S]3>D0HD1:F./40
M%6,4*=GV.H^4$@1,/^]BJUE&RT\>KS`]ZO%$;V=B3J8#QW5"1`@>RI%KF$YC
MC[!4%%QS55K#1[EJZ9+J-7C9=HY1,)%F[E%1!=(X><JB*I2*$,'\!`!PJZ7@
MLT]!XOZ_;`"92%F=I*)$2Z@0B+C;M\<()@`E+T$B*I0$.G0!#H'4/+G'&>:7
M;_2/\);X9?X8Q2%$QS%*4/.8P@4H>QY1'H`>7`\=Q8Z^TZ^DS<2@(?[*D@T*
M?V/,05>V/G]@,4D>"XV-3&W4#322IO8*W;/''7S>8Z3<R?F'V3!EI(\%QN"K
MI=010EG0^P*;5!,GL><5W29P\_\`NCYL:9'@N-U(AU!I7U3_`,#.)`B73S>=
M--HMU]G_`&@RZ1X+C<M@/U!M'1+<!]E0CMP</-YA!RB3_NE'&F!X3C:%S7Z@
M632;%'SE;L68?P\QU4%E`\H>P;+2!X+BWVAUU[Z?EA`?.5-ZN@0?-YR('3(/
MF_ABD#PEG+AR;M.%UES?[RRIU3>8`\YS&'S!E'XX%S/ASO3JZ>MK$_;$K/8T
M@LD<R@F`I'E;K/5%-,0Z)$(HV,?R#T,90?(`]1'A]N^.3K]>Z>:P+.;H8#`8
M#`8#`8#`8#`8#`8#`8#`K]^E3]P+\FN=</CU8Q]>C__4[=^*/W:M&_9E4O@E
MOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P&`P&`P&!Y4[_`.Y)G_Y5(?\`LBV6
M-\#EYSU/,8#`8#`8#`8#`8#`QVP5*M6I#T>P0K"4)V>R11PB`.D0'S^CO4A3
M>-A'^*9RC@9A1Y23UU4HRDU-Z>/@(A2349(&09.'!1EI=]-N^VZ6:F54[3^1
M5$!$>UT'VPB/41E()FKU7%OM#KKWT_+"`^<J;U=`@^;SD0.F0?-_#%('A+.7
M#DW:<+K+F_WEE3JF\P!YSF,/F#*/QP&`P&`P&`P&`P+C/#B_^UMY_O\`'_[.
MPN<?MWPZ_7NGFL/SDZ&`P&`P&`P&`P&`P&`P&`P&`P*_?I4_<"_)KG7#X]6,
M?7H__]7MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`8#`8#`8#`8#
M`8'\*)D5(=)4A%$U"&3434*!R*$.`E.0Y#`)3$,4>@@/D$,#EUDV*L7)2$8O
MU[Z.?.V*W4O9'O6BZC=3J7J;LCVTQ\G4>F>IYGPY0P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&!=-X=\89II.>?J)]D\ML28614_K?ZQFT@JVS3#H<"I^T=I+
M^4G7KUZ"/4.A>'V>7H[?7X^J>N<VS`8#`8#`8#`8#`8#`8#`8#`8%?OTJ?N!
M?DUSKA\>K&/KT?_6[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`
MP&`P&`P&`P&`P.<KD171JN\MIPW=@BF2Z3,BU2#M=$V,ZY&=CR%$WMA*5C))
M@'7J/3V1\^>FV:VP\]WE+3.:0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!?_
M`,.:\-<XZZ\24)V7$NUD["X'L%(*@3<P_>LCB`>4W2+.@4#"(B(%]@.@!YKY
MK=+O9LMA)S,M&`P&`P&`P&`P&`P&`P&`P&`P*_?I4_<"_)KG7#X]6,?7H__7
M[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P&`P&`P&`P*7?
M$+IIH3;L+;DDQ*TNU8;BJJ)1`%)>MJ!%O"@;S&[N*58?Z0[7^K._USLHX_9&
MV)0&SHP8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'I0T2]GYB)@HQ+OI&:DF,3
M'H^V_K7LBZ29M4O:E,;^L76*'D`1\OFR3LVCIOK<$SJ]=@*U'AT85V%BH)B'
M9`G1G$L4&#8.R`B!>B+<OD#S9Y9VS5Z8V;'M8#`8#`8#`8#`8#`8#`8#`8#`
M8%?OTJ?N!?DUSKA\>K&/KT?_T.W?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@
M,!@,!@,!@,!@,!@,!@,!@,"%_.O7A[II)U/,FXK2NOI)"RI]V7M+&AE"&CYY
M(/(/1!)LX([4'R="L^O7V!W]<TNYL7Q6U1IGH<3`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`F/P<UT:[[OC)IR@92'U\T5M+LXA_5#*%'T.OMQ-UZE6"06]**'
MLE:&#.?V32WFU9%;EZF<'<P&`P&`P&`P&`P&`P&`P&`P&`P*_?I4_<"_)KG7
M#X]6,?7H_]'MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`8#`8#`8
M#`8#`8#`^.1CV4O'OXJ2;)/(Z39NH]^S6`3(NF3U`[9TV5*`@(I+H*&*8/X#
M@<WNX];O]2[(M-$?=\HG#R!QBGBR8D&2@W8`ZAY`H]DJ9S+L52=YV.I2+E.3
MKU*.>FV:Q$O/,4F8:RS2&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P+VN%&ICZUT
M^SEI-MW%DV$HWL\D4Y1*NVB3("6M1RH"("`I1ZIG)BB4ITU7AR#_`$<\]\UN
MRAVLBD)@YALP&`P&`P&`P&`P&`P&`P&`P&`P*_?I4_<"_)KG7#X]6,?7H__2
M[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P&`P&`P&`P&!`
M#GEI%2ZTQMM"`:"M8Z$T6)-I(E`59"FB=1TY5'R=HZE=<G.Y*`"``W5<"/40
M*&=/KNI-,)<[[:Q53'G=R,!@,!@,!@,!@,!@,!@,!@,!@,!@,"3W%#22NY]G
M,49%J*M*JAVT[;U5$S&;N4$UA-'5\3!T**L\Y1$AB]HI@:IKG*/:(`#B^[3&
M;5EM9R7^%*4I2E*4"E*`%*4H`!2E`.@%*`>0``/,&>=W?[@,!@,!@,!@,!@,
M!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C'UZ/_3[=^*/W:M&_9E4O@EOFK_`#NY
MI;XQR2!S*F`P&`P&`P(F;CY;5G3>W=?ZBE*3;YZ0O3VAMC3L,K7"Q$.EL6R6
M6HPB[LS^::F:>]TQ7#+/1DABT5H]0QHM64>MW#!(L16*I9X159Q(\0Z.W+H-
M_P`CME[0XM256C=7:GN]IUYQSN,[M/;6JK;MQNT&LZMV/5(]S,2K:^RD\X4@
M(^+39I/Y&<;JMD41.4Q"QJ8VT2LI/,;2]X?-H1NI>:U:3[8AM'25/O&O+=4;
M-`;2G=:O]ML*Q,QTQ%H$2(I1(X[TL@@HO%KD,GW+E4%4Q-4I+#=D<T:/3BR$
MW`*NK9%5>N\J',]3XNEW:0O-@LW&"<JM;ML;55HUBY8-H^&G)E5%VJNV<"Z2
M52<-1%%!<1%'W4?G1I*SZ_=7RT#<=5EA>.Q^3]GA=D4BW5-[$:HCE9MK9+`R
M-/0<6,^TKCJ".*QFJ8J':O&#DJ?<OVQCBDLZY%;PF=4Z3+>Z#6$;9L6Z2VOZ
M-I^BV59U6T['L?:UCA:M3XRQ"JD62AHF)<30R,V;N^_813!XJ)0%$>@B-K"]
M<\U=3VC6.FKS<W;N@2^U='[`W,[@)6,E3(50NE6M8)O*IRTN1F9@WL^N)JPJ
M-E6!S@\<DCGBJ*9R-5C$%)VLDK?,'25WA:U-:_DK3L,MPTC1^0E;BJ/1[38Y
MN3UILF<1K=(D1C&,89:/D)R9.ND9L[[A1@FQ>+O?1F[-RJF*2Q-USKTLS3J[
M%:&VVK>;7LBX:C8ZKC=56N;V.RV#0H:/M5KA)>%@VDDQCFT72Y5O.>^)G8Q:
M\4L1=%RIVBE$4EBMYYPUYONO4.G-<P]AF36WDD^T3<KQ,ZXO`ZU4=5K6VS;5
M>J[2-DMBL*FO?:;9:@R8O$EU5D>V$@V137<LGGH(HD5I3>5,Y#U(ERI$+<0H
MTW%P\Y4[):ZF\@X#8E+M3%5[7[?3W+SO$Y>O3L>052$6!!ZFBHD==LD1=`RI
M)A4/RVX]N-*W8\I!-%!UU;'*SFO+D`ZB4*^,!EGE8<JFZB0[7H91H)QZJM.@
M`8YTE1#T67:HS<+[:3DB3FV3`8#`8#`8#`8#`8#`8#`8#`8#`]VLUJ;N$_$U
M>N,%Y2<G'J+".8MR]5%EUA\YA_HI((D`3JJ&$")IE,<P@4HB$F:;3?L="VA=
M-P^D->QE18"DZE5/^LK1,D3[)YB><$(#E8!$`.5DT(4J#8@].RBF`CU.8YC>
M>Z[5-7HMC3%&Z,RI@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C
M'UZ/_]3MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`^1=@Q=.&3QR
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MAVPK4Z=KI_5JNW4VWJC7>L35:%-*;`M,BU95H:%Z:#Q8RZC\78D,D@).V<3+
M\XCAGM&*V12%DMY5,FB-;\JML<LJSKXFH7RFQ9"U[K=[EL5PIT]LQ79WO-\6
M8F\[NF9*.7;UTCL4%46:PB5MWRXKEM;/XP<:Y_0]DVW99:>H#=KM$].=&UOI
MNDV/7&H8*TU]6X.KALJ#H]AOU_)7KEMMY:D#3B3!=!F<D,R.<'+TSQ\Z$S5(
MW8%"K6S:E+TNVL0?0TPW%)3LB!'3)R3V[22CUQ*;T:08+@"B1^@AV@Z&`Q!,
M4;$S$UAF8B8I+G]WCI*U:-N+FMSZ)W,6Y.X<5BQIHB1C8(HBG9(NF/4Y6\@W
M*<A7383"=!00Z"9,R:A_1;=%T5<+K9MFC3.:0P&`P&`P&`P&`P&`P&`P&`P/
MJ9,GDD\:QT<U</G[YPBS9,F:*CEV[=N5"HMVS9NB4ZJZZZIP*0A0$QC"``'7
M`N]XC\84=-PWQOM[9!?9<ZT`BJ?:2<HU.+6Z']Z&:Q2B49-P'3TU8AC$$0!)
M,1(4QU?/?=JFD;G:RVFV=Z:F8;,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/
MW`OR:YUP^/5C'UZ/_]7MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#
M`8$?]^;-L-`-I6M4XD<-OW/OFC:NB595N9ZT:PC>/LFT]H.B,4W;)9S(HZ:U
MC8_0C%.)6SWN7"I%445$CE1<I/,Z\/VO*6_6V/UPM6..@[C8S&@J6UO,ER?J
MKW7%N?Q='EKI$J)NV<A6]PTJ*4GV3MA$(LVC-TV,U=2[?OG28IN;(C>=NLWF
MO=4W%37^]G%GVQ2)/8<5J>O:7V'8=E1=.KAH%O:;;*UQ*OLWK2HQDA962+-\
ML1$9T7*?O8DZ,82%%-[-F7,33$_:*!6*,I>MF%V%5=8WEI9=::XN=UJ%8INZ
M'+QIJNRWNP0L0X;5&+N)X]=5,SH"G8LD3O7Y6C(HN,%&.</>5\/R4U_2CO5F
M*^UC:IHNP=J1].K]C3HE+E+TS%_$5D]AD5):+961_'`#\D(I)N99O&*H.W"9
M&[IHHN)BG)J^]<D>3SV.W_M?2M$TU+Z<XYV.^5MU6KO+VQ#9N['>H8[O=JFJ
M4]"JDJ>KO>JQLI&%ARR;.<&5=QYEG'O<W53/@I&SBV*]Y\<?V5F3K?:V0\0:
MO]3QUKN$=JVZO=?:]6WG$5"6U2K>;PC%&KT.VMA;S&H@<BRX,#K"H^]&;D.N
M`I+%JESH@MA#<F\94+GK9:B<I*9QV=R>T-:[&:U^VJV/8<+2"EJ\D6$A&Y+-
M+J20D21,HX1B#JMW#[JW5#J*-JU/F)INY[*B];0WQ\(-EM-WH='V!*:[ML3J
MC8=^UL2QJWJE4;8+^,0A+!.0#>F3*H"0Q6D@C$/5&"[HC942BC7M+\1?C+=J
MI(WQO*;"K=(0T7+\DX*T7C5%_J$;?--5I&M#:[AKU&:@FTG;D:P]N42U=-VK
M<SDZ\HT%NFNDZ044%)9M+<@;`A>^-(_%*QU"E;EO^Q--6:O[$K)Z[<8"\M-8
M6;;%"GB.@DW42>ONXW5DQ&#Z.=XD]?33(A%4UD%$3"F]+/"->;/U=4-O5-[3
M[FP%W'N1!9H[;BFE*0\@0IBMY2(=G26!J^0`XAU$IDU"&,10ITS&*-B9MFL)
M,1,4E1+OGCO==$3HMIA$\K57[@Y*];V:!RQTB3H90C1Z7J?WKF4TBB)VZAA[
M79,9(RA`[6>BVZ+N;A=;-O)H'-(8#`8#`8#`8#`8#`8#`8'LU^O3EKF8^O5N
M*>S4W*N"M8^-CT#N'3E8P"(@4A0Z%33(43J',($3(43&$"@(A)FFV3?N74\7
M.)$7IU%O<KF#2:V6Y;""0)B5S%U!%P4Q5&L4<Q`!S+JHG[#AYYB@)DD/ZL3J
M+<;K]6R-SM;93;.]-G.;9@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR
M:YUP^/5C'UZ/_];MWXH_=JT;]F52^"6^:O\`.[FEOC')(',J8#`8#`8#`8$8
M.2U'MEAD>-=\I<(XL<UI'DS3+\ZA6B[)!TM4[E2MC<>M@2J(2+IFT7+4J#O"
M3FE4NV*ZB,<<K<BCD44SEC%JB7XF[-V9M5]L+=6T=9RB,/J3=FF**ZU;IJ6H
M%[=5/=(0R#HFR[;.[3O;:SQ]790R2J$2P8Q<>YF0"2,5(2(M$15XT-Q:Y*5!
MOIVUTW>^GF&WM>Z4=\>;5+S&B;9+Z[MNOVLI`2--L,=44MX1UBKU\J:T&HLH
M;W[<QDG[X+HJ-D@3;+(BL<'U:?X<;'XXV2H(:0W-5FFMU:!H.C;:A]B:M?VV
M[6A71C1W#.['2+1![%IT%3I/:-9>"SDD7</+-(MPF5TP2+U,W$5KOA[G#GA8
M/#9L>N4S9AYK7LW2JXE<J,M43QD?(;I@D6D/)[FJ3CXV284OX^5ADBA8(,$7
MS=](LV\BDX;N3R'O@)FKP+EQ*WD[+O37.MN0%0HF@.15CMEDN,,\U%*SNX:`
MMLUDFWV\RU1L1KM""JK'X]/UGLBQ=2M;D5Z_)R3A<OIR?<-VXK&S9M:M>\/-
MSV_;/)>I1]MJVL.+6PME\:G:]67UZ:Q6ZU4?3>I]-M9"/UO=&NP8QK2VU@DZ
M2-<?FE8246:M6AG+#NEC`H:+7=Q;I]4&Y.)B^L7FTZV&O9_EKK3EE58Q#74D
M-QAYRJ76GWBUTR=L9]@EA9B'G7]0!&/=H13->/3="98CP4@!2I5YVO.'>Q*E
M:=404_N"K6#0&@ML7W<&IJ4PUG(0NRE9FWQVSHJO5N_[$/L"3@YNN:Y9[5?^
MB*1\!&/I4[5D+Q402=`^%<MKZZ;PJ?4.D<9JS&WVHVEYQMX*WWA<DWOVK5IV
MD;*+=V7%UDO<[946]^8JHUX6_&XR3NN@^<^F(SQB"_(#00=BN_FPBB\3KWKF
M9XNZ]3=LI?7^O>0FV.2,T6N-Y2&UOJN#:Z@MVLM=Z,UK"V:U6RT1=?&T;4)-
MM&Y7)F2014DFD1BS.TCRQ:[Y67963`\:P5Z#M<,_KUDBF,W"2B`MW\9)-TW+
M1REVBG+VTU`$`424*4Z9R]#IJ%`Y1`P`(-VV#?O5-;ZX&3]>4?6;3/I%D@>I
MW"U,<*]Y8XLG](Y(ARJ8"S[1/R]E,PE>@7LE`'!NIL[6_9$[+G*ZS&%=+IJY
M8N5V;UNNS>-5E&[IJZ14;N6SA$XIK(+H*E(JBLDH42F*8`,40Z"&=7-^&`P&
M`P&`P&`P&`P&!(?2O&39N['*+B%C1A*F"O8>7*:250B2%(8`53C$NA7$V\*'
M4`(@`IE-T!51(!`<S==%O-J+9GDN>TEQXU]HR*[BMLO?"Q.VY$IJWR:::DS)
M"'9.HB@(=HD5%BJ4!*U0$"CV2BH94Y>V/"ZZ;M[K%L1N;VS+1@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@5^_2I^X%^37.N'QZL8^O1__7[=^*/W:M&_9E4O@E
MOFK_`#NYI;XQR2!S*F`P&`P&`P&`P&`P&!71O+F'9=;\L(_CVC<^,VKX!?66
MFKTPG^0%KL=9E=A3>S]B;IILI3M=J,E64`XEZTSU6Q-W;A8RR[RP-$BDZG(!
MXU$;*OADN9UW;<RO5M;,]>@Y2VK!TA'4;N-M1=TV#4DKI=ILF2Y40]G+,$IJ
M&JJY;5G->7;>]+I`[R/.V-+H2RZ4244V5:WT=XAE^W#&1]=9UK6[K:M\/JZ0
MJD?&/9-"MZJ:6V"2LFYZ=N\#S\H];7GBDS791]D!-Q%A+6.PPD41O&+R)#%$
MQ1;;E9,!@,!@,!@,#2&V..^JMR('-;JZDG-=WW:%IAN[C+(W[).PF!I!-)0D
M@DB']!)VFX1+[!0'-1=-NZ69MB=ZL_9WA^[,K!G#_7LDPV#$E$QR,3"C!69%
M/RF$@M'BYHI^"1?)VTG1%53?T4`Z],ZQ]D3OV.<_7,;D(K'5+-3Y`\3:J_,U
MR23$X"RFHYW&N#`0W9,=,CM)(5DNOF.3M$,`@("("&;B8G=+%*;W@90P&`P&
M`P/[224643113.JLJ<B2221#***J*&`I$TR%`3'.<P@```"(B.!)G7'$+>>Q
MCMUT:FO5(982":;N?>P*!4C]1!5"-62/.O2'(41(9)J9(WDZG`#`.8F^V,6H
MLNG!8YJ/@EJZAF;2MU.?9-@2[M0J<HV*TJS18`*8>Y@2JK^^/9,(E$7JJR1R
M]![D@YSN^R9W;(=(LB-Z;K=NW:((M6B"+9LW2(BW;MTB(H((I%`B:2**92II
M))D``*4H```'0,YMOVP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*_?I4_<"
M_)KG7#X]6,?7H__0[=^*/W:M&_9E4O@EOFK_`#NYI;XQR2!S*F`P&`P&`P&`
MP&`P&!#WDUHG=G(.!NFH6FU=7U;C_M:HN:1L2(?Z=L=AVXTKTRU4C;@A2+\E
MM^&J49(V&(7.E'O75:<.*^[ZNR>FG[E-N6)IMQ:BD>#%BE=H.+.]NNLW$$IR
MGKO*9M>%=4R)N1\:_K<Y%3#76$?M4M\)&H5-:*BOBH=U[U"8:"Z<08M!,K[X
M%%=CT-]<')'>:LU;)VY4>;V&\V6I/QK;8^M5[YJA#547KG:VKZ5J.4U_\;8)
MS*1E=3VN[N2KH9`JCN]HI/!*FS;L6C,1-$WM=U`NOM?T:A$F)2Q$I%.K-0+8
M)Q8'$W.EK4*RABS$PN'D7E),&7?N#_[2QS#[.$9C@,!@,!@,!@,!@>5,04)8
MF2D98(:*G8U7_BQ\Q'M)-DIU*)1[QH]170/U*80\I1\@XW;A&VU\,./-J,HM
M\21KCM41ZNJI*/X<I>O7R)QG?.(-,`$>OD:@/_1Y,W%]T8LS9;.#1$UX;U!<
M&,->V);HH!$>R68CX:>[/D\PBS3KHF`#?ZO)Y/\`3FOY9X,_QQQ8$X\-62*I
MT:;?8K)=D!$[BD+M5.WU'J7NT[2[+V0#IT'M]1_AE_ER3^/-^'_\UYOZVHKY
M(N__`*_C^6.!_'FRJ,\->#2.49G;,J_3[?4Q(RHLXDXI]"="%4=3TT4I^H&]
MMV1#RA[7R>6?RY+_`!YMQ5K@-H*#,DI*MK5;E"``G+.V`[5N=0`#J)4JVV@5
M`2[?E`IE#^3R")O+US/V7+HM28I^K-;T`"_$RCUFN+%(*8O8V(9HR:A#%[)B
MKRHI&DG("7R#WBINH9F9F=\M1$1NAGV13`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`K]^E3]P+\FN=</CU8Q]>C_T>W?BC]VK1OV95+X);YJ_P`[N:6^
M,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C'UZ/_TNW?
MBC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"OW
MZ5/W`OR:YUP^/5C'UZ/_T^W?BC]VK1OV95+X);YJ_P`[N:6^,<D@<RI@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,"OWZ5/W`OR:YUP^/5C'UZ/_U.I_17K\_P`F]9?R
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M/U*OPR?.S'Y9G?D?J5?AD^=F/RS._(_4J_#)\[,?EF=^2*'_`.9/QX^ACXP>
IM=_\=][OYP^KQ_YWXF?RQ_\`6/?7_P`7F^RF--/_`%5GNKA6O3_Q_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g716112g78h81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g716112g78h81.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0L24&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!(0```C$````&`&<`-P`X
M`&@`.``Q`````0`````````````````````````!``````````````(Q```!
M(0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"'8````!````<````#H`
M``%0``!,(```"%H`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``Z`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#T^JFDUL]C?HCL/!9C;Z3L(S:W!S''6@`.@.]\_O,C=M5NZX5W].KF
M#<]S8W.`(%-EA]K7-8]VYC?YQMB`<QI<TMZ@"US7.`-4@@!SMV\`>ZI)2;$-
M3ZY#VY,V;=WIAD:`[8A2%G^43B/QF-J-7J57R"7D$-NK]+;[/3WU>[=^>EC6
M^K6#Z_VB+0-Q9LCV_1VZ(F<Q_I"ZHGU,=PM``G<!/J5;?^%J<]C?Y:2DWHT_
MZ-OW!+T:?]&W[@GKL9;6VVMP<QX#F.'!!$M<I)*8>C3_`*-OW!"+L,7MH+6^
MHX$@;=--8+HVM=M2]9U[G,QS#6DMLNYAP^DRL'Z5G\K^;9_+^@I.QJ_1-=8#
M#.]KHF'SN]1T_3=N^DDIGZ-/^C;]P2]&G_1M^X)J;1;6'<.!+7M\'#1[?\Y$
M24P]&G_1M^X)>C3_`*-OW!2)#07.,`:DG@!`:;<A[;`YU5+3+0-'/T_PC7M]
ME?\`TTE+/K#K+*V"MFUC'-<6`ZN+QKJW]Q2=34*#+6N(:9=M&NG*'>&FV^:C
M;^CK]C="?=;INT3,R7/MR<8LV"FMA;Q)W-=/YWT6[=J2G__0]&R7[;NEC7WW
M$0./Z/D.]W^:@?;-6?Y0!EKN:=#M#O?N_>9MWH]_](Z;()][@(B`?1M.]VG[
MHV?]<03EP\`Y_9Y@TZ:!WNW1]*K_`*:2FQC6^K6#Z_VB+0-Q9LCV_1VZ(]F3
M76\L>U\``EX8XMU_EM!0,:WU:P?7.1%H&XLV1[?H[8:KJ2FEA6L8^[&WL<QA
M]6DM(_FGD^W_`*U:VQG_`!?I(IW90T);CGN-#8/+]VK^5_A/^+_G*_5Z+7UT
MW48PR[:;&GTBX,ECM+/TC_W/9;_UI'8>H/)WMJI':'.M/S]N.DI.`RMD"&,8
M/@``J1ZFYUK31COOPP'^KE,_-<WZ+:J(];*:_P#TF/O_`+:>GIUCMQZC?]M/
MJ&RII8&5L'^#9Z+2YMGI_FVW;WJ\DIJLOI<]N12\647PQQ;J`_\`,<[]W=_-
M/_ZTC67UUD-)E[OHL:)<?E^[_+0<K`IR-[V_HLAS"QM[-'`'@.C;ZK&_Z.Q0
MJZ<^MFT9=TG5Q`K$N/TG']%N_P"DDI*UEUSR<A@;4T@UUATDG]^[3;N;^8SW
ML_[X<D#GOPJE/3S79:^S*ON%I!:Q[X#(&V*_2%?TDG])P++JKK*W664/]2IS
MWO?M=QN;O>Y)3*S^D6?I?2THUT_TC_9[O]-_,H%3W.ZCU$;8:RND!^NIVVN<
MW4[/;N9]!6+-_P!ILVUBWVTZ$@?X2S<_4?X)OZ55ZAD?M'J+GAXH].D5%WT2
M0VTV^EK_`"V;_:DI_]'T]E-+_1N<QKK*FQ6\@$MW`;]COS=T*#J,TD$9(`UT
M],=_H'Z7YB-5_-,_JC\BFDIJG?56'7W"P!XE\!H`^C!C^6B?;,3_`$S/\X(R
MK?9LGU`\Y3MHB6!K0#'IZ_\`@=G_`&\DIG]LQ/\`3,_S@E]LQ/\`3,_S@ED4
MW6[?2N-($SM`)),;?I?NJ3:[&T"HV%U@;M]4@23'T]K8:DIC]LQ/],S_`#@E
M]LQ/],S_`#@HX]%]3G&W(=<"(`<&B->?:/[*K9.4VOJ%=#LBVMUCFAE;:7.:
M[0;F^LUCZV_RG/24V_MF)_IF?YP2^V8G^F9_G!/?798T-KL-1!DN`!)'[NJE
M4Q[&P]_J&2=T1H3(;_924P^V8G^F9_G!+[9B?Z9G^<$U-%]=A=9>;6D:,+0-
M?BE=3>^UKV7&MC1JP-!D^924B-]#[['"WVQ0-S#.IL?M;[9^FYVQ_P#(5FW^
M:?\`U3^12:"&@$R0-3XJ-O\`-/\`ZI_(DI__TO4JOYIG]4?D4U39]!O\_P`#
M\BE_V^DIM*OFY3L7'=<VBS)+=?3I`+SK'M:YS5'_`+?2_P"WTE+G+>'AGV:X
MR)F&QVTW;_Y2;[<Z8^S72"`X[1'_`%7O_L)?]OI?]OI*7&:3MBB[5S6F6Q`<
M-^_^HW\]%MN-9:/3>_<0V6"8G][7VM0?^WTO^WTE,FY1-A8:+1[BW<6C;`CW
M[MWT?<DW+W`D4VB!NU9$B8_SOY*C_P!OI?\`;Z2DE&0;20:K*M`X%X`F>VA/
MN;^<C*K_`-OI?]OI*;2A;_-/_JG\B!_V^HO^@[^?X/Y$E/\`_]DX0DE-!"$`
M`````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'``
M```3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!
M`#A"24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("
M`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!(0(Q
M`P$1``(1`0,1`?_=``0`1__$`)T``0`!!0$!`0$````````````(!08'"0H$
M`@,!`0$!`0$!`````````````````0(#!!````8"`0("!`P%`P0!!`,``0(#
M!`4&``<($1(3%"$5&`DBU!8VEE=WE]=8>+@Q([87.$$R)%%A0C,94C24UB6U
M61$!``(!!`$$`@(#`0$```````$"$2$Q41)!87$R4B(#@1.1L4(C8O_:``P#
M`0`"$0,1`#\`[*M&<;M!SND]/3<SJ#7\G+S&K-?2LK)/:U&KO)"2D*E$.WSY
MVNH@)UG+MTL910YA$3&,(CG2U[1:T=IW9BL8C2-F4_99XX_4EK;Z*17Q?,][
M_:5ZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B#V6
M>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*
M17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3
MK7B#V6>./U):V^BD5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M>(/99XX_
M4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%
M\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7
MB#V6>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4E
MK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=
M[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M>(/9
M9XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOH
MI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`
M:3K7B#V6>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99X
MX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%
M?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M
M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]2
M6MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7Q
MWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(
M/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC]26M
MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO
M]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EG
MCC]26MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD
M5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I
M.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC
M]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B#V6>./U):V^BD5\
M7QWO]I.M>(/99XX_4EK;Z*17Q?'>_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX
M@]EGCC]26MOHI%?%\=[_`&DZUX@]EGCC]26MOHI%?%\=[_:3K7B#V6>./U):
MV^BD5\7QWO\`:3K7B#V6>./U):V^BD5\7QWO]I.M>(/99XX_4EK;Z*17Q?'>
M_P!I.M>(/99XX_4EK;Z*17Q?'>_VDZUX@]EGCC]26MOHI%?%\=[_`&DZUX@]
MEGCC]26MOHI%?%\=[_:3K7B#V6>./U):V^BD5\7QWO\`:3K7B'+1GM>9_]#N
M6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F5,!@,#5+`<V;ZXWE76,]L/0+2GV?
MESM+B@IQQ3BI!KR&JK&CRNQ:I4=KO+"XV2L$R>]3=-CIT8\*HT9HT^R,UDW1
MUD#+/8UC1(K<^P^0<]N=QHSCI/:JIE@JFE"[IL5AVI1K-L)E8'UAM<W4M<4)
MC$UZ_:W&`B9>1ILNK,2PO'SE!NF@DW:D.J*Y*D8WE$:+YV[TVAIZW<L=9DU;
M6M*:6J?'6T7_`%K:J=:;)>K^AM?0^C.3.R"0E\8WJL1E&/3]3[YCD8,@P<UY
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M<NO>3&^YRU:&V787NK%M`<D]Y[-TK5Z!#TJSL]C4&.K<+N>7UI?I+8[R]NXB
MW.[F&GNDO%EK486,]>H)H+*^KG"[\8C7ELMRLJ9(S4-$*Q2$M+1D6O.R9(6$
M1D7[5DK,S*C-[(IQ,4FY52/(29X^-<+@@B!U11;J'[>TAA`*G@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M#`D-RDXZ6+:;C2,#N?7LQMQI+3D"ZU[&V-B\L[>:K+%])6&*6C4%#JIR$(QC
M'"CI(>AT00/W``E$,+B=V:IA:4;1,HX@V#25FD(Y\M#Q;^14AV,E*)-E3Q[!
M[+I1\LK%M'CLI$U')6KDR!#"<$E!+V"1"'7'*ZVL..FR]M[R@JLM>:'N[;NF
M(NEZD)-&;7FW5C<4MJ;6-#IIK4\6DIBV7N?+'QB+A8C)%R^=>.+9DB)DDBXV
MPR5PUVMM+<VB&EPW6PHL9M**VOR0U;<&FM&TZTHWK#1G(_;&DD'-?1LLO.3@
MMW\?KU%=11=P(JN%%#E31(8J*8G2=$I<(8#`8'';GO>5_]'N6X[_`./^B_L=
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M_@(@6#$L4[49^*Z<-F"*`#*W)CAUN"]PS>7LO(^3J&P=M<=:-H?EL]JE%J[U
MOL9M6R71TZG]:N^V#9ZPNK5?:%@8-YDL?(D/'*M.]D"K)N<@SZ*^?@^BWM\F
MP@MK2U?XZS^WM:;WG-`L:I%'`^P]4DUT\KD=#;$6?FE(C6DO:M5Q$W-09F+E
M:2?^;)YY)F\7:F&?354M><-GE)O5)=R&X9NR:=U!LW9VWM*Z>/5(>)&G7+:*
M6Q6+EK8[LW>N'MWIU"A]L3C.KQAF3$8U-9L=RN]78M54QGTU3APB&W++Y[<(
M/UDP7[?.1.%CRF3A#`UR^\+Y>[*XF0VKI'7,)1YI:[2=J92I;K&S\BDW2@VL
M&NT-'E@K-6SI**'DU/$%0RH"`%[0+T'KNE8MG+%[37&$,N-'O2-^[CWQK'6%
MJIVGV5?NED3A91W7X&Z,YEN@JT=*E58.9&_2[)-8BJ)1'Q&RI1+U#H`B!@U;
M]<1$SF68O,S$-\^<G4P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P(;<)OF3O#]9/,/]P=[PL^$MIIK(OH:690\KZBE
MWD8_:Q4WY%"3]3R+AJJDQE?5KHQ&TAZO<G*MX"@@FKV=IA`!'"(.Z[X*PC2E
MW/7_`""O7M'U6R[>F=Z0D?,TV/UVK3]E6J?NEDM<Y&/Z/+M7[CUF_N:I6Z9U
M2E8HIB0G<"AA`N>&9^,'&/7O%&@6#7FN"O1B+%M7;FU'BK]T^<KD>[3V-9;R
ME#D%Z^?F!E4XN<;PS90#`HY;QY%U^YRJL<XF<I'80P&`P..W/>\K_]+N6X[_
M`./^B_L=UE_14)FK_*WNE?C'LS%F5,!@,#%)-ZZ84V9_9E/:="4VL)ED@U\2
MT1![7YQM"_*9Q%^IRNA=>NT*O_\`RAV/;YPL7_S!2!M_-PN)W?GM;?6D=$M8
M1]NG;FN-4,[&[<LH%UL.Y0%10EEV*:*\D+%2<?LBN&\2V7(L\6+_`"6:)@47
M,F3X6$Q,[/-9^1&A:3=ZCK6X;GU?6-@WU*,7I=+G;S6XNRV=&;>J1D"M#0[R
M11>O4K!*(G:QYB$$'[HAD6_B*E$H%Q/#]6?('1<AM1YHQAN'6CW<L>BHN^U<
MUNU=7OC0$(U*:<HKUA*0-+IO6D(Y2?+-Q2\=%BLDX.0J*J9S$Q.YLSD#HO2\
MA68G;NX=::RE+FLLA58Z]W:NU9[/BU79M72T8VF9!FLY9-'DDU06<`'@).':
M"1SE472*<8DE^0.BZ_L^'TG.[AUI#[?L*+9>$UE)76O,KS*$>HNW$>5G67$@
MG+++2;:/<JM4P2\1TDU7.D4Y451(7$[D1R!T78-GS&DX+<.M)C;]>1<KS>LH
MVZUY[>8LC)%HXD"O*RWD%)9%:,;2#95TF*7B-4G2!U2D*LD)QB=V7L(AMRR^
M>W"#]9,%^WSD3A8\IDX0P-<WO"^(6R.6<+J^/US.4B%<4F4M+R4&ZR,]'(N$
M9QI"(-@8'@JW8SJ*I'C#^("A$@`#!T$?2`;I:*YRQ>LVQAJ+T%QPNO'?WA.E
MM7;-EJM'2[*58VN-F6+V57KEG8N(.7<,6]?>O8:->*NWTBR7CTRN6[8IGR!T
M@,(BF*G2;1-)F&(B8O$2ZC<X.Q@,!@,!@,!@,!@,!@,!@,!@,!@,"*O*W=G]
MK*.>(@)$K>\VLIF44+99/SL-&_PD9T4^HJHF!,!0;'Z%'QS]Y!'PC!FZ5[3K
MLQ>V(]5W<<MN)[>US'RCM9(;1"^'#6I`HE*<9!!(/`DP2#H)$)AL`+`(`!`5
M\0A?]@Y+UZSZ+6>T>K/F9:,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0VX3?
M,G>'ZR>8?[@[WA9\)DX0P&`P&`P&!QVY[WE?_]/N6X[_`./^B_L=UE_14)FK
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M_"9K0#J,-XCD4D'`]8VPO?24K%S<IPXT;%1TF7D%HCF-R3V#O>-)6))F^H<$
M]AN6\5<=BVF348MF:-3W98MB1GJ1X4YRV,9]LZ0(9-)=5J)\\-U^5E#;EE\]
MN$'ZR8+]OG(G"QY3)PA@,#59[T[3TI,ZTJ7(>C$4:;"X_P!@83OK-BCW2!:L
MO)LECNR]H"*QJO86[1^3O*8C=`71_0`GZ]/USK-9VEB\:9\PG7QYW#$[[TS0
M-K1/AI!:H-%658IB/2*L;!12,LL3T,(J>''SC-=-(QN@JH@10`Z'#,6C$S#4
M3F(EFC(I@,!@,!@,!@,!@,!@,!@,!@,")N\N3+*BO`H6O&9;GM&06"/1CF:9
MW[*!=+"!"%?I-1%5]+&,;^6R3$!+Z3+&(`%(INM,ZSLQ:V-(W8RIO#I>YH.K
MCORS6&3NU@.1XX914DU3&+(8O4K9\]59/$EW*9!`@(MBIM6Q2^&GWE`!#4_L
MQI6-$BF=;;K0TS$H\<^34]KJ;</205XC/)4^3<+]C-\DY?%>UU1^3PDD7+X!
M;KQWBE`H%>"<I2]BG4%OSI$QNE?QOALNSDZF`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P(;<)OF3O#]9/,/\`<'>\+/A+B8DTX6(E)A9K(OD8F.?2:K*'CW4M
M+O$V#95T=K%Q3%-9[)R+@J0D0;HD.JLJ)2$`3"`81&/7G(VX;;TU9=CT#0]I
M^6\%L^]:M+J2Z7*C5F7:2]"V*_H$U(6FU14I:ZQ$1[`(U5^Z+&J3:Y$B"DV(
M\5[0,7&NZ_\`CYN-7>6NU+B^J3FB3\/>=F:UMU2<3#.QHPMRU-L*R:WM3>,L
ML<@U8V&&4FZPLHT=D10.=`Y06107*J@F)C#-V$,!@,#CMSWO*__4[EN._P#C
M_HO['=9?T5"9J_RM[I7XQ[,Q9E4=MR\H]2:+NNFM;W63D5;_`+[O4/0M;5*$
M8%>RDN\D9%HQD9M=1TX81S2O59!V#N24%<7)&I#"@@NH`)B7"-6HO>>Z#V_O
MR0T='UO9]1BWMCV92]5[QN\#"0FD=Z773=EB:CLJJ:LM9+([D):6A)R9(FU\
MRQ:HR8(K>6.<Q4R*LG68C+8]A'XN6Z3MNNU7`XHN456ZP)JJH*"DL0R:@)KH
M'271/V&'H<ABG*/I`0'TX%*K5;@:;7("H56)8P%8JL)%5NN046@1K&PL#!L4
M(R'B8YLF`)MF,='M4T44R^@B9``/0&!6\#PRD:RF8R1AY%(R\?*L7<:_0*LN
MW,LR?-U&KI(KAJHBY0,H@J8`.F<AR]>I1`0`<#\H6&B:Y#1->@(UE#P4#&,(
M:%B(YNFTCXJ)BVJ3&.C6#5$I$6S)BS0(DDF0`*0A0``Z!@5/`8#`AMRR^>W"
M#]9,%^WSD3A8\IDX0P&!29Z#BK/!S-;G6:4C"6&)D8.8CUNO@OHJ69K,)!FK
MVB4WA.6C@Y#=!`>AL;#3CP!G);C7R1W=PANCM7U>K,/KGJMZ]6]$D5%FW=B1
ML'0$E'%FHQVD@8B0%(@M&N2&$3CT#K?\JQ:'.NDS5NDSDZ&`P&`P&`P&`P&`
MP&`P&`P/A55-!-1990B**)#JJJJG*FFDFF43J***'$"D(0H"(B(@``&!`O9O
M(6U[-L2FH^.**TD_<',WF[ZU$4V;-H!@2=K13X2^&QCD#&[3R1O2<?@M0,8R
M2AND5BL=K.<VF9Q5FS1G'6L:>:!*.3$L=^?)G&6M3I,3&0.Y]+AE"$6$ZC1F
M(F$#JB/F'(]3'$I1*D26M-O9JM8K[I%YAI%?EAJA;8%!"R0*:I;GK\RT]#*M
M`,#UVP2!-:5CD3)AXQEP3;%<-P+U/XZ`%+Z5!S=+8G$[2Q>,QGRO;CUMA#;N
MN(N<652^448!8:U-BB4IDYAHD3J]*D'02-I9`2N$^@=A1.9,!$4S9+UZSZ+6
M>T>K.69:,!@,!@,!@,!@,!@,!@,!@,!@,#$6S=U4S5,C3HVSN3)KV^8+'IBF
M=,"Q3`.B;B>DN\P"E&-7*R29A_W#WF,7J"9^FHK,YPS-HC&67`$!`!`0$!#J
M`AZ0$!_@(#_J`YEI_<!@:U^%>AM4+6/<^\U:KW;3:<P^8K=O:/7ED+X:)MR[
M"K!B>I"S`5T_6#='0ZF:"/PN_KX@`<"SXAL5FE9E"&EEZZPC)6P(QC]6"C)J
M6=0$-(S*;54\8PEIUC"V1["QCQZ!$UW:,<_5;)&,H1LN8H)&(UK4C6'O`*;H
M'D-3ZY7.+M&W#L#<%\V3K6P1>_\`:%OK\9';LVI9+GL-K*2<MQ,KSBKVJ@UN
M9*A6WY86R,9*5,#A\P;MVXM'<:TS'"7O&"AV75VE:AKVT4.EZZ?5-)Y&H05'
MVU;-WL7R"KM60<6F<V3=]5Z=LUDNENEGKF2F7+J&\9Q(N55SN%U%3GRI+/\`
MA#`8#`X[<][RO__5[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q9E6"^1N@M-<D
MM5S&M=[0GK>A><B[4HZ0LLY2Y2KS=2=EFH6WP=RK4M!SM7EJ\[;>,1VW=H]$
MP.FKWH**IG+$X:YN/UA]SAM._P#&_1/'R[Z+V-9N,<'L*-X]:J@IM_<(6MA(
M*1ECNUMBV,P61AK5;$EZJ61)/N%GK\BHN':+CQ%U53S19[:S+<;E9:]]B7?D
M]4>6FA=5US;^M+56=NVR_P!RL>NU='/&$[0..^N(3S%DL#S8:&X'1GDR:Z66
ML5Q@L,$FFY=S)G`I%3:JD$NF)7EN:Z;^MV[W>B=`WFC:RDZAHY'<TW9+E0W.
MP0L<[:;=/U'7%.".+9*RA$5-1Y2)=:=<I**22B1VR;0[4W>J81C>4.8;F_OW
M;&DKIR\U_+4.F:JT?4..%JMVHY:D/;%-[%3V=Q[T'RBVDB-V-9XQ:JGAM9[\
M9Q]<*U:+@698J+/CN4%0;)1<1LS'6>1._9"RZOW'(V>BKZ+VORRV5QH;:B:4
M5VWLE<J=:MFX-94;8Z.QE;*=S*7&>O&M63^48*QJ4<WAY91JB7S+(';P8C6/
M*Z>16W^1)KSOZ`T/;]?TEIQAX[5;=LFVN=$>W0VUKO<3;B?1.OY-ZC9:^:ET
MB/A-2$\T_8INI)=S-E.F9$D>=%]4C&F6+2<M-Y6V(E>351GZ7#Z#J/(72&EE
M=-R=&<R5KM5-V//Z9IUYO,AL,+*Q5A;I6[#MITO$Q[6//&JLX1,C@RJC\5&D
M7'CRNG77(G?LQ9N/FVK#9Z*^TGR8WSL[2\5JF-HKMC8->5Z$A-V2^K;JWV"K
M9575ELDX.GFY;`T<QR#)$)PX,RD\@!WE3$:\MG.$0VY9?/;A!^LF"_;YR)PL
M>4R<(8#`8&G_`-Z!KVP4>0U'S,UNF5O<=/62&BK.JF@<Q'4&K*><K+R3\+L`
M\8TF5EHUT4XB*Z,L1/T%*(9T_7.<UG9SO&UH;1]9;!@-K:]INR*NJ*L%=*]&
MV"/`YBF6;$?MR*K,'?8(E(^C7/>W7+_X+)&+_IF)C$S#<3F,KYR*8#`8#`8#
M`8#`8#`8#`H5ELT#3X5]8K-*-(:&C4A6=OGBG8F0/X$23*'51=RN<0*FDF!E
M%#B!2E$P@&(C.D$S$:RU\S5MV?S`FW=3H*;RE::8.RH3UA>IG(K,`F8JH$?>
M"<OG7)D^ATHM%3PRB8AW*@`*8DZQ$?KUGY.69OI'Q3=UEJNGZFKR5>J4>"!#
M=BDE)N.U65F7A2]IG<D[`I14-_'L3*!44@'H0I0ZYSFTVW=(B(C$,C9%,!@:
MYW'7BQR/(Y+T9:CV\806`0[&$,[,X`5!Z@)$T@K<J\`X>CM3C'HE`#'+U#K\
MZ>L.?PMZ2V+@("`"`@("'4!#T@(#_`0'_4!SDZ/[@,!@,!@,!@,!@,!@,!@,
M!@,#&^T-IU/4E9<62TO2IAVJIQ42B<@RDX^(4!*QCFYC`)S=3%\10>B2)1[C
MB`=.MBLVG$),Q$9EJVM^O^0W)295VJUH;@\++)D:UQNK-0,6W90;03>308I3
MTM&O738YE3JF<@D"3A90YR="B!2]HFM-,ZN4Q:VN&R?0*.R8_6\3![3A5(FR
M5TPPR"RDI$RQY>%:)(^JWZKB(D)%,KE)$_EE`4/XAS(>(/7OSE;&<Q.CI7.-
M=V:LRT8$-N$WS)WA^LGF'^X.]X6?"9.$,!@,!@,!@<=N>]Y7_];N6X[_`./^
MB_L=UE_14)FK_*WNE?C'LS%F58ZW!$5V?U+M&!M[R#CJE-ZZNT1:)"S@N-:8
MUV2K4FSFWEA!K)PCH8-K&+*G=@F]:*>7*?M62'H<H<^GNH=TV(NT]-Z.6Y4T
MRZ:XAM6R4)J*#FO=Z7GC7.;RIE*IZ#:*G-7;EL\@VCK6C78A-K(/">7&0D(]
M,ZQD3`*SE.0W:/.'2AE886B=,PT!N?9?(#S\W9;U>*+2M>1D;*.&"4/4*90E
M['-M:U4R(LT#L2VBV6EY(RCIPHNLZ6\L0Q@09MTTQG3".R_%/;5LB]=7>;Y'
M7+7&_1TZ\U5NBXZ^@J%-,+A#6.9);G<;#)6BGF;14GKJ?=OF]6FDFB)T&KQP
M=RS7.L`)%SZ:/`Y]W]4&:KVJTC9]ZH6AK5&Z<CMEZ+B&%4?05W1T;5J?0JDD
MG;9:%=W&N-+#K_7L%`V,C9R924BXI!-%1FH*ZJPS_E7XGAVI4;BC9(_9]UM>
MN:1M79G(?5_'J0;TZ#JT1N78Y[W,2POKTQK9K;(4UM9]D33Z(BW!SMHEX^34
M-YE-DR10&5LRW"V^WJ#C7MOY(7RNWS8O'NE:%Y6R5(@:(#/<L/72VYX\?U]Q
M*U=5UKBQD>[*L;-K+QI"N"1C],OAE<-&CA`9]%RK<(H4MWD7$3M.ZP6D)W;&
MN-Z3W'J.BJ@%4?;.U4CK]2IKL[8O"*W6)I2U@U?"34E"(NP3D)9JH8ZQ6KMZ
MT<#/^7OU_P`-&E&OU3FE]NWJRZPU=L?9NV=-Z8D8NGLZ]K^\;7)L!M..%[+&
M0;:V6R!J\9M.?95N->N?+Q3:0`%/-*-&"C09]$U,(AMRR^>W"#]9,%^WSD3A
M8\IDX0P&`P+,V)1(#9]$MVN[2@9Q7[G7Y.NRI$Q`JY&TFU4;"Y:J&`P(O69S
M@L@ITZIK$*8/2&6)Q.28S&&JOW8M\GM<6/<?"O8SE-*T:JLDS.5`JBJGAO8@
M\@5K9FL4540)ZN\\NVEFI2_S%DY1940[2&$-WC.+0YTG&:RW#YS=#`8#`8#`
M8#`8#`8#`Q?M7;M-U!7SS=J>_P`]8%"1$(T$BDO-.B%Z^`R;B8H$1(/3Q5U!
M*BD`AU-W"4IK%9MLDS$1JAC7:#LOEG/,[UM-5W5-3LW)EZS4F2BC=62;@)BD
M,S*H4%#%7)Z'$FL3Q%@$2-BD3$/"Z9BD8KNYXF^L[-@\#`0M7B&$!7HQI#PT
M8@5NQCV*)46Z"0")AZ%#TG55.83J*&$QU%#"8XB81$>4S,ZRZXQLJ^`P&`P,
M*[]U4WV[KB7KA2)A.LP]<5=T?M**$VR34%%`5!_V-Y)$YVRHCZ"E5[^G4A>F
MJVZSEFT9C#''$K:KB[T96G6)15.ZZZ,G!2:#P3$?.HI$3MHQXL14WCG<M?+F
M:.1'J8%4BF./54,MZXG,;2E)S&)WA+',-F`P&`P&`P&`P&`P&`P&`P,-[FW;
M4]+UX9.;4*^FWB:H5^LMURIR$PX()2B83"17R4:@8P>,Y.0Q2!Z"E.H)2&U6
MLVEFUHJB[J_2]PWC9T-T;^!4\8<Q'-1H3A,Q&)XXW_(9"X8*G-Y*OI]Y3$;'
M`5GYNJC@1((^/NUHK'6K,5FT]K-@:22:"::**9$442$2222(5--)-,H$3333
M(`%(0A0```````,Y.C[P&`P(;<)OF3O#]9/,/]P=[PL^$P'KUG&LW<C(NVS"
M/8-EWK]^]72:LV3-JD==T[=NESIH-FS9!,QU%#F*0A"B(B`!A$?VG++CO):B
M=[WA]GP]@U0WM#NDM;96H^?LI+!;VMK&C)5JF0T#$R-AO<W+VWM81C:%:/U9
M9=1/R0.`4()BXG;"_M3[?U]NZJ&N>MYE[*PR$S,5N4;3-:M-)M%<LU?=F8SE
M8M]'O,+6[K3;-$.0`KB.E8]F]2`Q#&2`IR"8DQA$KF;3^<=MOF@(_B;R2IW'
MJD3,I=J_N66L.I]?;9FD%E*]Z[H,_`UN]6&IGF&A96%<1;YK'ORO4QDT'16[
MA%!<4BQC7,,><,=:\JZUR2WC;MZ<NZWS!HSO3^I:-6;C3*I2]50%/V!5[[N.
M3NU'?:EI-]NS%C9V$/88ETZG''EG3]%XBS,`ECB=(LXQI#:'E9,#CMSWO*__
MU^Y;CO\`X_Z+^QW67]%0F:O\K>Z5^,>S,695'[DI98B)URI4K%J';>YJSN%Y
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M.$C*,H]*ZS!19PIG2J(2[L!1:>,J`DP8EZ&/)/0LGMEQHJ/VQ2GFW&JSYFK1
M6\R@I,C*1<1\H96!1[?^(YLT17A]8.XM-4\@U8"#E5$B(]^#$XSC0VOR3T+H
MR2@8C;VV*5KV3LJ+AY$L[+,H,%CQ;1TV8O)Y\`]P0]99/WJ""\H\%"/17633
M.L4YRE$1$SM!-<D]"US:D7I&<VQ2HO:TRM&M&%)=S*"<L:2FFBS^"A7(^EG'
MS]@8-SKQT>X52>OT0[VZ2A>@X3$D'R3T+9=IR>DH';%*EMJPYY9!]2F4R@K*
ME?5]-!6QQ+4P?\.1G*TBY(>38-U57D<0W<Y22#TX,2S=@0VY9?/;A!^LF"_;
MYR)PL>4R<(8#`8#`TO\`O#*],<>-_:0YQ4=DL9-C-1U.V>T8I@091)!JZ0;&
M>'Z]!4LU+.]B#+*"5-`6C0`^&8,ZT_*)I+G?28LW#5NPP]NKL#:Z\\3D8&RP
M\9/PK](#`F]BI=FC(1[HA3`!RE7:N"&Z"`"'7H(=<Y.BM8#`8#`8#`8#`8'F
M>O&D<S=R#]PBT8L&R[QZ[<'*D@U:-4CKN'"ZAA`J:**)!,8P^@"@(X$9MS\H
M*CKJ+9LZLJUNUVL#)DZKL/&*B\9IH2R1%8R3E5V@F."#I)8BB#9,?,N@,3H!
M"'\4-UI,[[,6M$;;L::KXXV*[6`NW.1;A6<L3Q1)U%4IYVBPC4$Q\1H29:D_
MXR:*`FZIQB8`B3IU<>(8ZB1;:^/QKLD5SK;=.LI2D*4A"E(0A0*0A0`I2E*'
M0I2E#H!2E`.@`'\,YNCZP&`P&`P&!KSWC'ON/N[JWONO-US56W.QB+['-2B"
M:CIPF`R)1*!TDQ5EV2'G6Y3#T]8,S'./0P!G6OY5FL[N=OQM%HV3_C9%C,1S
M"6C'23V-DV;:08/$#=R+ID\1(X;.$C=`$4UD5"F#_L.<G1[<!@,!@,!@,!@,
M!@,!@,"/>^.05=TS%%;D*C.7B32*,'5TU3=_:J<Z9).5%'N5:QI#D$"@'15P
MH'8GT#O43U6O;V9M:*^[#6F>/UBMM@#<_((RLU:7YP=0E1E4TU&D0WZB=DM*
M,#=S=`6P*"+:.`H)M>O<J`K")4]6M$?C79FM9F>UMTZ<YNA@,!@,#6OPKUK<
MU+'N?8Q.0>WD*>AS#YBI*Z#2A="#J5X<=R;"AP<N9E?2"V]2K%D%BRH`C=4D
M_/I%()19"=F<L^-&PVRN6#*N3[R5BW<W%M(25<R4*PAW%B?2[!!BNJ\BV5?:
M-W;J==R#<ADDV:22JCHYP3*0PF`!(TQTV:N#W7Z-R#2/(QDQT][R"\<C;;59
MK1.S8>U6;3NW+]O)C!62ET]_7DI[8KNF-+RPL<E$PS21EV:;(H$:B[,W(:-?
MSX3VXD1\X_?<GMLOZM;J77-^<CS;*UY7;W6I6DVY"F0&@-!:3"7FJ58$&%EJ
M2MNM&HI2928RC*/DB-Y%,[ELFJH;K4GPUM^\5J7##>'+ZCZ\Y,[WINIK+7.-
MVSJIJD^V7&Q=<MM?;DV5/4B;U;OO1=^%[3=:6F\U1[47#>08!/M)))5!BFF(
M=YRY):KF(TA+KAK[O_7_`!`VO+W/2+6C5O4UIXQ:,UE),*7ZT;N]I;/H$[?9
M29W1;V*BK^%-(3%?LK))H\2?/WKL5W0N51*1$RE9F<PV5X0P..W/>\K_T.Y;
MCO\`X_Z+^QW67]%0F:O\K>Z5^,>S,695&7F;3D+[Q5WU67NV;?HR+<:WL$G.
M;5HC6.?V:IURMMPLED6:L)5A(M)"/E(*(<,9!N"95UX]TNF@J@N9-9,L;M!'
MNUWU&E>2O%J`NMR]Z)<Y[3D!9=?Z9#DY5^/NO>.U9N+WBQ7KK(1D5"TZ]S6Q
M0DY3CO=64E!PSHKUTWC7R2[CJ+1PJC(:MM.SJ1RL-)^OK!NG6?)6XTZ!V1MQ
MQL*Z\Y[5,V_0,AI&OO-/63CC>7:3U'<JNX4=4)6Y!Q3]1MXYO'R@W9**2F(,
ME=/'+N`*48UX9DMN^]8P^_F_(*QP=WM^E-Q\1%:-K*5@]37VY!8[+5=K6U]<
M=?H14+5Y219S&U(>Q0JL.T<I(DGD(I0Z/>5OUP8TQY0DH]0N^J^,6ZN(.S*G
M?'O)G<E#X81.JSLJ':K$VG)"O<0>*.E'\HC?(R)>U9D33F]-46B=F5W,DD6#
M05(^.<@.D3*%G6<^$B->K.)-_I#CJE5;JAO+5OO#M^[KV&LOKVV1T1`4"4V?
MR7O1MO.+T\A&536KFV:3L5C'QZS9\JZ?JV/R?@B*+XC<G,^C[V[N"BS,]R;O
M)JO?+[4>9G`?4E9XU*PNIKU8R[:73+R=;O-3,2-*RX3B9R1<[5B)`K67,R;J
ML)X'1U`;MW:C<<>DK$B(NQ5REWKB59X"[RG)6R\U^+>S(J5:T*VR,58JC4;)
MQ3NLAO%+8R,.>H_)[6M-UP^8/7KB33<HR-?]6D`[E9DDY'KX7QI59Q,2'#W0
MC6JW5EN7CUR\Y"['W6N\UY;(:(J=96A.6<+)[!<W5_",*K)Q.\IC:$8>(.R>
MN'$VA/G<@D8C5^+83YGQAN?RLH;<LOGMP@_63!?M\Y$X6/*9.$,!@,!@8AWW
MJ.'WMI^_:HFO#3;V^!<,V3M3NZ1DZU.G(UV7^"4YQ]4SK-NX$``>\J8E$!`1
M#+$XF)28S$P@%[K+;TN\H=VXSWT19;!X_P!AE(M"-=*]SX:LO,/$'3,1$3BY
M&K6@KEJ<Y3"1-LX:)E`"@41W^R-8M&TLTG28G>&UO.;9@,!@,!@,!@,#7%S$
MY#Q*\4^U'2I`'KQPZ*C=I5F?JT:-FB@G/6V[@O\`[WBSI,@NQ(/AIID%`1,8
MZA4^M*?]2Y7M_P`PL7@F6@N;A/MIB*17O;=FG)562>&!9)".1ZH2R4<W.7PV
M\HF98AQ5#N4,@8P%[`*?OO[,XC@_7C,\MJ^<74P&`P&`P&`P+*V+1HG9-+L%
M+F2@#2;8G03<@3O4CWR8@O'2:!>XG<M'ODTU2EZ@!^WM-U*80&Q.)B4F,QA%
M#B/>I:%<6;C]>#F0M%">OQ@BK'[O,Q";D?/,6ZQAZN$F+A4'#80Z][1P'9_+
M2#-WC.+1M+%)WK.Z<F<W0P&`P&`P&`P&`P&`P(N;^Y&L-8@G3ZBW)9]H3`HM
M8Z$;D4=DAU'X`1DZDD&Y3*.'C@ZA!;,2""JW<!C=I!*)]UIG6=F+6QI&ZV-#
M\<G\3*FVQN5P>S;/E5//HM))5*10K:QNWPEU5`,JW=32"12E3%/_`([$H`1$
M.I2G"VO_`,UV*U\VW3*SFV8#`8#`8$-N$WS)WA^LGF'^X.]X6?"9.$,!@:N^
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MNO-/CKN:O\-Y:BZS?5-GH*C[#M=BY-PEZ9;!U#Q";MKKM5WJ+:KTL`6FUB)8
M&U(VM<T@YLTJX\,//.2**^'&YVG5T@96'XN6Z+MNNU<$\1NY15;KI]QB=Z*Q
M#)JD[B&*<O<0PAU`0$/]!P*?`P,+5H*%K%;BH^!KM<B8Z!@(.):HL(J&A8AF
MC'Q45&L6Y$V[./CF+=-%%),I2)ID`I0``#`JV!X92,8349(P\JU2?1<LQ=QD
MDR7`11>,'[=1J\:K`42B*3ANJ8AN@@/0<!%QD="1D=#0[%I%Q$0Q:1D7&,&Z
M31C'1S!NFU8L635`I$6S1HV2*FFF0`*0A0````P/=@,!@0VY9?/;A!^LF"_;
MYR)PL>4R<(8#`8#`8&DSEJW=<.N;6K.6D(DX;ZZVNJ-2VRW8H#Y<'!6[2/L`
MK)(%*5121@TFLNU1'X:\E$K*&,/40#K7\JS7RYV_&T6\-UK=P@[00=-5T7+5
MRBFX;.6ZA%D'""Q"J(KH+)F,FJBJF8#%,41*8H@(#TSDZ/VP&`P&`P&!\*JI
MH)J++*$111(=5554Y4TTDTRB=1110X@4A"%`1$1$```P(`;/WG<-S6-;3G'D
MJRZ"WB(6>^H*&;M2,@,*;L8^2)W>KX1,!$IW@!X[L_\`+;%$!**W6M8K':SG
M-IM^-4BM,\?J7I^!\DV:MIVPODTQG;+(,TC.'RA!$P-V2"HKEC8Q$YO@(D,(
MFZ`90QS``ABUIM/HU6L1#-B$='M3^*V8LVZG:)?$0;((G[1Z")>],A3=HB`>
MC,M/9@,!@,!@,!@,!@00Y84^8IM@JG(VCI"G-5-\P:6M-,#=CN/\0K:.>O`(
M8HF:J)K&CG73J8Z+A(`Z`01SI28F)K+G>,3%H3%H]PB+_4H&XP2GB1L]'HO4
M2B8IE6JH]4W;!P)?@@ZCWB:B"H!Z`43'IU#TYB8Q,PW$YB)75D4P&`P&`P&`
MP&`P(>;YY'.8"3)JO4;<;-M*7<#%',R2!VC6EUT^@%`H@+9W-IE,)NPPB@T`
MACN.G:*8[K3_`*M\6+6QI&ZM:!XY-]<F4N]X<_*C:<T4[F1E'JQI%.$5=F,J
MZ18.G'>JZDU^_HY>F$3G'J1,0()A46OG2-BM<:SNE3F&S`8#`8#`8$-N$WS)
MWA^LGF'^X.]X6?"9.$6_7+95KBQ5DZC9:_:HUN]7CEY&N3,=.,49!J"8NF"K
MN,<NFZ;UL"I!42$P'(!@Z@'4,"X,#6SS7WE=]'[LXONM8<%''+':-X2VU3M?
M7ICLK76J'FNWP5Z)L]EI)+EL-F2*9&V%5ZVN](U._:E?^H#`0BRJ)`*6(WU8
MVX7WS:=SYN<G7FX.#=8X:W>=X_\`'NW33A*W:\V??-J+KWK>=7;6.T;+U9(N
M:H_8Q\=5T6#2.<)!+M?*'575.V79$2BSM&K;?E9,#CMSWO*__]+N6X[_`./^
MB_L=UE_14)FK_*WNE?C'LS%F56+M%O97>L]BM:9(R,/<'-%MS>J2\.P8RDO%
MV5:OR"<%(Q<9)N&D;(R+&4,DJ@@X52065*4BARE$1`-!GNO:3>HO;>L93:FC
M/>E06UF%*FX[:>S>0W)+^Y/'ESL0*F=.WN):JFV*[65=3TRHJ>,15AQ49.UT
M3&(04_&+(;MMO#HMRL-:6O>1^TG?+"RZWVYL0-95D^X+U0]5ZQLW$7=%5C-L
M5Z)J#J4JKNE\L+)+--/VBR2`M7,H:/C$W;M=M'K(D1)U%1.-8T97W-=-_6[=
M[O1.@;S1M92=0T<CN:;LERH;G8(6.=M-NGZCKBG!'%LE90B*FH\I$NM.N4E%
M))1([9-H=J;O5-4C&\H<PW-_?NV-)73EYK^6H=,U5H^H<<+5;M1RU(>V*;V*
MGL[CWH/E%M)$;L:SQBU5/#:SWXSCZX5JT7`LRQ46?'<H*@V2BXC9F.L\B=^R
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MK5,;17;&P:\KT)";LE]6W5OL%6RJNK+9)P=/-RV!HYCD&2(3AP9E)Y`#O*F(
MUY;.<(AMRR^>W"#]9,%^WSD3A8\IDX0P&`P&`P(T\N]%-N16@KWK@$$5+`JP
M&>I#A4Y4O)W6"(J[@C`N<#$;HR)^]@X.(#VM7:O3H/00U6<3$LVC,3".7NPM
MZK;2T`EKZQ.%`ONC7:5&F&3LR@2!JT0JWR.>KI*B)TRMVC1>+[1^$!XP1$`[
M@ZV\8G/B4I.8QYALCS#9@,!@,"FS$Q%5^,>S4W(-(J)C4#NGT@^7(W:M4"=.
MY15500*4!$0``_B8P@``(B`8&O&T7O8?+:QN]?ZN\W6=31ZQ$[/:G22B)I5$
M>IR&?D`4E_!7\(WE8PAP.MZ%'(E*'1'K$12,SNY3,WG$;)MZRU;4=35Q&N5)
M@""8]BDC)K@FI*S3LO=_S)1V1-,RYR^(8$R``)HD'M(4H9SF9M.9=(B(C$,B
MY%,!@,!@,!@,!@,!@4R;AHVQ0\I`S#4CV*F6#J,D6BG4".&;U$[=PD)BB!R"
M9,X]#%$#%'T@("`#C;4W0+X\3,EI#;=KX[6QTL:)E'RLO09!UT!-RJJD*R'A
MG`/#(6>BD2B8A3=B3YL=(H>(H;.MX[5BT.=9ZS-9;!\Y.A@,!@,!@,!@>-[(
MQ\:FBK(OF<>DX=M&""KUR@U37?/UR-6+)$ZYTRJ.WCE0J:291$ZBA@*4!$0#
M`A/NSD'/6"?_`+*Z#(><N<FHXC9JQQQOY4'V")'K6*>F,1LDZ:I@873\3>"R
M+U`AA6ZF1Z5K&.UMG.UL_C7=EO0W'R!T[&GD7:A)^_RZ0'G[*N`JBD=7^8O'
M0IEB`N@P\4W510W\YV<.]3H'8FG+6[>S5:]?=(G,-&`P&`P&`P&!K7X5O=]A
M8]SLT*UJ$VBAYA\Q1=V-6[W,FVB./[R;"4*5M2R:^/3E41M`)(B8T^0P,!,M
MT\4`0,6<:<I$<V9>JPO$'DPYNYI].I/M(['KM@6JTHU@)]M&VRKR-77>1EC?
ME-'5=9F$QXHRKD!:Q9"&=+?RD3X(WA$/W>:%MK6WN25.VD&DY3:ZU(XV6J7L
MO%M5JCQ_<4L*M<*548MO7$XR.DZMLU"7J$RXD3//$3E(9>*.R\!JV*Q9R%MX
M;7,K+`/)G?3'C=J60V6O4YF_2RUIUYKZET.`?PT1*7/86U[[7-:4&M)3MC>1
MU<KS:3MEJ:$<R#]PDU9-O$5.(]@$,6(RPYQ>YJQ_(VQ0U-?:ZD=>6Z3T'5][
M.XE:S1EK;1+>:V;L?5<S4W4C&LF!#R,#8->&53<@F#=^V>%,ET%)4H"8PG#A
M#`X[<][RO__3[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q9E5C;/@WMGUKL.M1
MMM<T"1L-&MD&PO;(Y4GE*>RT!(,&MM:*'<-2)N:VNX*\3,*J8`=$!$Y?X@'+
M_P"ZAKD;)\JZUK>H;*X$,*7Q^VAL#>*<%QLW5)WZ[[-L$]Q`UQQ)LA:K79:O
MPKU'7D_,U%2^V-\LX>.#V!VT1-XG@BZ4D.EMO+JYRN:)LYQSN%JV7`7B_P"]
M;OL&CZ]OLAM;7FFE:MK.K1#.YD9V!I5&D_<:_56%GL5>HJ5@.$0W.LV6%=!N
MO)N)(Z1A4+GT8_7XI[:MD7KJ[S?(ZY:XWZ.G7FJMT7'7T%0IIA<(:QS)+<[C
M89*T4\S:*D]=3[M\WJTTDT1.@U>.#N6:YU@!(9]-'@<^[^J#-5[5:1L^]4+0
MUJC=.1VR]%Q#"J/H*[HZ-JU/H5223MLM"N[C7&EAU_KV"@;&1LY,I*1<4@FB
MHS4%=589_P`J_$\.U*C<4;)'[/NMKUS2-J[,Y#ZOX]2#>G0=6B-R['/>YB6%
M]>F-;-;9"FMK/LB:?1$6X.=M$O'R:AO,ILF2*`RMF6X6WV]0<:]M_)"^5V^;
M%X]TK0O*V2I$#1`9[EAZZ6W/'C^ON)6KJNM<6,CW95C9M9>-(5P2,?IE\,KA
MHT<(#/HN5;A%"EN\BXB=IW6"TA.[8UQO2>X]1T54`JC[9VJD=?J5-=G;%X16
MZQ-*6L&KX2:DH1%V"<A+-5#'6*U=O6C@9_R]^O\`AHTHU^J<TOMV]676&KMC
M[-VSIO3$C%T]G7M?WC:Y-@-IQPO98R#;6RV0-7C-IS[*MQKUSY>*;2``IYI1
MHP4:#/HFIA$-N67SVX0?K)@OV^<B<+'E,G"&`P&`P&`P-(VP1-PB]XM7]BI^
M+':7Y1$796@Q030BHZP2\@V;V!PJ/3PBG@K8LQFUE>T#E9R2Z9!'J?KUC\J8
M\PYS^-\^);N<Y.A@,!@6I=+O6->UY[9[;*(Q40Q*'>JIW*+N%SCT19LFR8&7
M>/%S>@B9"B/\1'H4#"%B)G2(29B(S*`:#?9/,ZQ$=/?6%%T3"OA%)`AQ*ZG%
MD#"0PI")#-9>;[BB453%,TC2F$I045[@6Z:?KC_Z<];S_P#+8)4ZC7:-`L*S
M58MO$0L<02-VC<##U.<1.LX<+'$RSETX4$3**J&,<YAZB.<YG,YETB(C2%QY
M%,!@,!@,!@,#65RG]Y-!\8=L.M5OM3RUP<-(*%FSS+6VLX9$P3*2JQ&Q62T#
M)'ZH%3])Q4^$(_P#IZ>E:=HSEBU^LXPNKA]S^AN6]VL]+CM9R=(6K56&T&?O
M;.UG4GB02T=$F:%00AHLZ"G?(E.!Q,8!`HAT_P!<EJ=8SE:V[>&PO,-&`P(?
M\N]8O;%5&&RZJ"K>ZZR4]<(.F8=KQ:";+%>N_#,4.XRT*ND#U'KU`A2K``")
M\W2<3B=I8O&F8WAF?26SF6V]=PEM0%,DB9/U;8F2?H\A8&1$RR"(%_\`%%QW
MD<(^D?Y"Q.OPNH!+1UF8:K.8RRSF5,!@,!@,#'.P=L:_U>Q\[<[&RBU#IF4:
M1A3"ZF9#IU``913?Q'BQ!.':*@E*B01^&<H>G+%9G:$F8C>6J'D5R5?;H<Q<
M7#1SNNU.!>JOV:*[L#R4K(]OA-I1^5N`(,U&B`F*BBF=7PQ4.85#"(`7O2G7
MW<;6[;;)J<)&>OQUBK)5ID"5O%^LPO#IVHBXDS.DSBM'D04*1,Z,$LR.0Z"8
M%*4%04`PJ*$,<>?[,YUV=/UXQINFAG-LP&`P&`P&`P&!#;A-\R=X?K)YA_N#
MO>%GPF,HFFLFHBLF15)4ADU4E"E.FHF<HE.FH0P"4Y#E$0$!`0$!PBWJO3:A
M1X\\32ZI6ZA%*.#NU(RKP<77X]1TH4I%')V42U:-C.%"D*!CB7N$`#J/HP+D
MP(/>\9DQBN(VPU'NG(O>E0>3VK8O:-$EJ38-E)):@D]JTMGM:YQ^OZG+U^T6
MNPZ^H:K^;BT8]^T=-I%@@[(I_P`<2F+&^Z$'NJEN*S+=7)6"X%Z&-6.*84C4
M,D;?,U2.056MUTW&:6V&WM&M'5AY&S;^W7FO4J!%D]:`S8Q;6%<23E%1)7S"
M#A20MLZ9G5O`RLF!QVY[WE?_U.Y;CO\`X_Z+^QW67]%0F:O\K>Z5^,>S,695
MCK<$1`V#4FTH&U.X./K$WKJ[1%C?V=TY8UIE`R59DV<P[L+UE(1+QG!MH]90
M[M5)TV53;E.8JJ9@`X!R/\3G>Q=P[IXCTCC5S9X07#:O%FC["KVE%67`OE-1
MXV=A'VO#TVTS=GV&YK5'J5I.%/;.3H"E*H1\@Z<F=^`Z=`V53CI.F<Q+L=:`
MZ*U;%?*-U7Q6Z(/%6B*C=JHZ!,H.%&R"R[E9!N=;J)"'44,4H@`F,(=1KFLZ
M:V;KRN7BDZSGKK68C86R&UF>T&E2$PR;6:X,Z8R;2-L=UZ&56*^E&U<8O457
MBB1#$0(J43B'<'4+2V]R(T?H)&&7W+L^I:[)8"R2T0%DDR-5G;&$(T4GYGRY
M"JKH5ZN)/T#R4DJ4C".373,Y62*<HB7$RI]IY/<>Z3=:MKJU;AH4)=+HE7%Z
MU!/)]IX\@C<I$T/2UE'"1E&4>E=9@HLX4SI5$)=V`HM/&5`28,2]#'DGH63V
MRXT5'[8I3S;C59\S5HK>904F1E(N(^4,K`H]O_$<V:(KP^L'<6FJ>0:L!!RJ
MB1$>_!B<9QH;7Y)Z%T9)0,1M[;%*U[)V5%P\B6=EF4&"QXMHZ;,7D\^`>X(>
MLLG[U!!>4>"A'HKK)IG6*<Y2B(B9V@FN2>A:YM2+TC.;8I47M:96C6C"DNYE
M!.6-)3319_!0KD?2SCY^P,&YUXZ/<*I/7Z(=[=)0O0<)B2#Y)Z%LNTY/24#M
MBE2VU8<\L@^I3*905E2OJ^F@K8XEJ8/^'(SE:1<D/)L&ZJKR.(;N<I)!Z<&)
M9NP(;<LOGMP@_63!?M\Y$X6/*9.$,#"/(#;#;4&N92P)J)#8)`#0]5:*`!_&
MFG:2@INE$OXG:12)3.%>O0IO#!/J!E"]=5KVGT9M/6&O#1'+J6UA#NJQ:81_
M<HI>5>R[:0)+>%,1II$YG<JGV.FSA.11<O3*.?AJHF*JJJ83&`P`7K:F=8ES
MK?$8F$WJGS`T;:!326L3NJNU`#HUM4<LP*`CT`0/(LS2$.F!1'_S<EZAZ?\`
MKTYS^NT>&XO64BHB=A+`U!]`S$5-LC=.UY$2#22:F[@ZEZ.&:RR0]0_AZ<PV
MJN!"/W@>@/[_`/&^V1D4R*ZNU'*:^T@2E_Y"\C!MUCRL*D(=#*&GX`[ELDF)
MBIB\,@<WH3#-4MB?1FT9A\>[ZW^&_N.%4D)1Z1U=Z(1.@W8IE1.Z7?0;9$D1
M..._HH<]A@3-W"JG3L,[\<I?_6(`O&)G@I.8A-_,M&!C#:NW*?J"NFGK2['Q
M5O$2AX5H*9Y:;=I@3N08H'.0`21\0HK+'$J2)1#J/<8I36M9M.B3,1&J&E-U
MK?\`E/8V>S=QBY@M;M3F5JE*;'<MO63,_9Z&G4R3AK'._"*9=^8`</`#HCV)
M=AT^DS%(Q7=SB)O.;;-AL;&Q\.P:1<4R:QT:P03:LF+)!-LU:MTB@5-%!!(I
M4TTR%#T``9R=7MP&`P&`P&`P/X(@4!,80*4H")C"(````=1$1'T``!@:Z.1'
MO*=*:==KT^@@MNW:!G(1J%8IC@RL(RDE!%))O*VANU?M%W/F/@"TCTWSD%`[
M%"I"(&S=:3.LZ0Q-XC;66H3=W'+GWRAO*VYKCH209R%FBX\K"-8*URO)1<*R
M*JA&QZL--V8+`P<()]>\L@!78]>XP``E#.D6I6,9<YBTSF87'QYX^^\4XN66
M<V=KK3)BN&\"+&P0$XO4IY*TP1G[-XK%-8J.L99YTY3=,TU@".60>""8E()@
M,*9DVI;296(O&L0V6Z2]Z1J*X2*5)WC"RV@-BMU_5\DA:4G/R0+(D["F26F7
M#9I(5E501$YDY5LW0;EZ%%T<>@CSFDQK&L-Q>)WTELVCI*.F&+64B)!E*QCY
M$KAE(QSI!\Q>('_V+M7;915NX1/T]!B&$H_]<PV]N!\G(10ATU"%434*8BB9
MR@8AR&`2F(<I@$IBF*/00'T"&!KJJQC\7>1KRH.1.VU5MHZ2T&LJ(^4BGJKA
M0D:4%!*)4QAY)R=@L`F`09N$5U1'M+G6?SIGS#G'XVQXEL7SDZ&`P&!8E\V9
M1]:1@RMTL+&&1,0YFK513QI.1,3T>%&QB`*/7I^[H`B0@D)UZG$I>HA8B9VA
M)F(WE#)_R%W3O!XYK_'VE/(*$\4S5Y>IQ-OXS8AN@'4,Z6\6"A501.(BD07S
MTP!W)=I@Z9TZUKK:=6.UK:5A?6ON'%7CGWRGVQ,O=G6UPH5T[+(KNQ@P=>@1
M,N5PJ>1G3D$.G>Z4*D<OH,@&2?V3M72%BD;SK*3!M::Y,(F-0*281_B)JK!"
M(]/1Z1%AU_AF,SS+6(X5V'KM?KJ:Z5?@H:#2<G*HY3AXQE&)N%"%$I#KD9((
M%5.0HB`"8!$`'$S,[RJLY`P&`P&`P&`P&!#;A-\R=X?K)YA_N#O>%GPF3A#`
M8&L/WH<(^JN@KSOV.NG*YD-2KU'H4W2^-&YKMK><-4[AOK5"]FO]1@Z9`SKJ
M7VO6(I@HBS6'RI589S(,E7+=NY55)):KOA9?NQ+!H";E=R%TIR&]X1O-PWCZ
M.:PM^<,QO*8CZVBJYM01JVN3;<IU89M7LJ<BQ9,&1U55"-VWB`!2E$4%LZ9P
MVX963`X[<][RO__5[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q9E6,MUL7LIIK
M;<9&QT),2,CK*^L8^)LL+*6.N2CUW595NUCI^O0;5]-3T(]74*DZ9,T%G3I`
MQDDB'4,4HB'/Y[HN^[13LO'S6-SWU[P^3)7=.E@I32>[^&K76^BJX]KE$*T&
M!1W&\JJT^6)JCEIV01W,J#A^"#=%4>Y0R`R&[>T.E#*PTP3^N^5K+G]IC;-R
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MRYF3=5A/`Z.H#=N[4;CCTE8D1%V*N4N]<2K/`7>4Y*V7FOQ;V9%2K6A6V1BK
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M6O#^VS0VG[MXQK!0*\JY7$3*R$<T]229U!'KXBDC"G8/%C@;T_S#F`?X"`AU
M#$6M'DFM9\(ZS'""!8NSRVL=B6^B2H`)D1.MZP12$!`02;NX]6#E6Z1NT/2=
M9<P#Z?3Z`S4?L^T98Z<2I7J3FYK/H,7.P&V8AL7N*U?JM7KPZ1`$/^2>4"O6
M%=80#TD1>KB/^@B(CES^N?0_](]7H:\S)RJ+HQ^X].6FI.#&%,S^/2<)IN#`
M`B)FL7/HQP'3``Z]2/ENXOI#_O/Z\_&QWQ\JH'<;KG#Z%YOWOY$F>^SAOU4Z
MPN'#=.*CZ19'IEIV()*,U#%(P95V;=/HI%4#"W*P?IJ&4$4S`75JS-(SO#-9
MB+3C:6]QNZ:NVZ;MHY;NFBQ/$2=-UDUVZJ?I^&FLF8R9R>C^("(9Q=D>-M\F
M:#K>L-I2)DHZY3LXBN-8AX600=HO?!<J,E'[YXT,N5I&-WB)TQ-Z5%E4S)I@
M(E.8FZTF9UV9FT1#"VJ-!6K9MC3W+R),I(OW8I.:_1GB14V;5H0?$8A+QH@9
M)G&H%-W)1W3N.(][H3',H0^IM$1UJS%9F>UD]BE*0I2$*4A"%`I"%`"E*4H=
M"E*4.@%*4`Z``?PSDZ/K`8#`8#`8#`A)R0Y]Z!XXIO8J3G0O-_;@JDG0*6Y9
MR$FT=E*(%3LLEXHQE82*H)?$*N8SP"&[DVRO\,U%)GV9FT1[H)A5>>OO!#`K
M<WAN,G'>2\$PU])&18RMFB%3BIU&,.+2R6\RR'AF[Y%2-A50[54$3&`P#O\`
M"GK+/Y6WTAL7X[<+=#<:6R#BCU<DK<`2,1UL.U%:R]P6%5+P7";%]Y9!M`,U
MR")3(,$FY%"_^WQ!#NS$VFV\M16(V2PS+1@8&W;QETAR&CBL=JT*)GGB"!D(
MZR-P4B;9$E^$8A8ZR1IVTH1LFJ;O\LHHHT4.`>(D</1EBTUVE)B)WAK(D^%7
M+KB2[>VCAEM^0NE0*Z._>:BMIV!'3E`.AU$PCI$24ZPNCHE,"CEN$-(B42E0
M`Q^G3IVK;Y1JQUM7XSHR=JCWI-82G3:[Y5:]G]`[`CQ(VD'[B,F7-75==.@J
MNXMRT&TUA)R<0\$#DD6W9\,SHI>F2?U^:SF%B_BT8EM&K=GKEQA6%DJ4]#V>
MORB(+QLW`23.7BGR(B(>(U?L%EVJY0,`@/:8>@@(#Z0SFVPOR6U(3;6MG[)B
MW!6U5[Q9RK'*``JJ\12Z/(D#=.HI3#0HI@7J!?,%1.;T$S=+=9]&;1F/53>+
M>VC[/UVBUEUE#7"F"A`V0K@1\TZ!-,Y8R76`P`?OD&Z!BJB;X0N451]`"&+U
MZSZ%)S'JDMF&EFW;8-,UU%#,W2PQ\"Q'N*AYI0QW;U0A>XR$='H%5?2"X%](
MD13.8`](@`=1RQ$SM"3,1O*%\MR4VIN20<U;CI2G[5H4_@/;S.(-NK-,0]*@
M`X%6#A1,3X1/'4<N52#_`"T2'#.G2M=;RQVFVE8731.'48,F6W;JLK_95K74
M(X<,UG;TT&58H]Q4W;IT8)2;32,`=I3BW0[>I#(F+DF_BL8A8IYM.93.81["
M*9MHZ+9-(V/9I%1:,&#9%FS:HE_VI-FK<B:""1>OH*4H`&<VWKP&`P&`P&`P
M&!#R6Y^\/X.5DX24W=`-I.'D'L7(M@AK<X!N^CW*C1V@"[6O+-EP2<(F+WIG
M.0W3J4P@(#FNEN&>U>6?-7;<USNJL#<M7VEG;JR62=Q!I5DWD&J1))B1NJZ:
M'0DV;%V15%-TF8>J8`)3@("(9)B8TE8F)V9'R*8&M?A7M.93L>Y]8!I?;RT.
MXYA\Q5C;C294(=2M3%W)L*;\!R]/L`EZ!8SA`(X.R`.7SZA0Z^!W+E+/A*'E
MOM2PZ/XO<@=OU%LB\MFN=0WZV59!TU(]9_*6(KC]S`JOF2CIBF\CVTL5%1PD
M*Z(*(D,7Q"=>X!$9F(85X@69S'6S96H[M&\HH+:T/6Z!L29:\F=BT#9#RRU>
MTN[A6XR[U)SJF[7;7=,-+3U.D$9:OQ9HYDP<H)&;-?+JD54$IXX1I;]Z9K+?
M>S-FZ`;5;3'*+=^B(.B[A>6FK\6N04'Q^L<7NI[,ZP0U=<[+-2=LK;B<:5.M
M-[">-;@59%*0<@H<#D!1(\EJN-==4E/=T[6Y:W33]9H?+OCALK46R-7:UUM7
M[!L^^7'7-F;[KN#:(<1-IL4>UIECFI-@^4=0Y'KL[PA"JJ/^I1`0$N()B/$M
MB&5DP..W/>\K_];N6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F58[VY\JCZNV$
MTH4]%5C8,E2[/$Z\GII5LE&1E_E(5ZQI;MV+LBK=1)&R+MC"F8BGB=.WL-U[
M1#0-P(U]N6H<I=!,(/4'O"-/S<34[XISKL?+_=[.^ZJW/(I:X<Q<9(:K9K;-
MO+2^V5MNUY&/D)V$8Q#9G#>924()'12$C<S&)V='N5A^+ENB[;KM7!/$;N45
M6ZZ?<8G>BL0R:I.XABG+W$,(=0$!#_0<"GP,#"U:"A:Q6XJ/@:[7(F.@8"#B
M6J+"*AH6(9HQ\5%1K%N1-NSCXYBW31123*4B:9`*4```P*M@>&4C&$U&2,/*
MM4GT7+,7<9),EP$47C!^W4:O&JP%$HBDX;JF(;H(#T'`1<9'0D9'0T.Q:1<1
M$,6D9%QC!NDT8QT<P;IM6+%DU0*1%LT:-DBIIID`"D(4````,#W8#`8$-N67
MSVX0?K)@OV^<B<+'E,G"&`P&`P&`P/P<M6SU!5J\;H.VJY>Q9LY23706(/01
M(JBJ4Z:A1$/X"`A@:Y.>.A&;31=JV3INM0=<N^OS$N$FA$0[9!K8:E')+A:&
M#B/;ID:E.S8+#(@JF0BXBR$@'Z*&`>E+3F(F='.]8QF(U0;IEH@U=!ZYVAK[
M9]FC+3=AE*_>:)'NEFB,7,P3<K.T'<O(UZU`D<],Y:K-&KA!4ZK)\3N5$4S]
M>FLS,3&C&T1,3JSEPR4H8[<;L[?&I/)ETS,:CNW8^(Q8S[,3.U.YL8/",_69
MIF%JJ<1!)5/H4/$.0Q9^S/71:8SJW*9P=C`8#`8#`8$8N0?+_17&EBH.Q;8D
MI93M1=1M#KQ4Y>Y2@"3O0[8Q-5)&*;N?_!S(+-&QN@@"@CZ,U%9MLS-HC=K7
M/LOG?S^.=GJF&6XV<?9!;P%;FZ>/6,S.Q@@`*G2L*:3*>L1728FZ(PJ#5AU$
M6[ET<`$X[Q2F^LLYM;;2$U^-WN]=#<>3,;`>,'96RFP@NI?;DU1<'9ON[O,Y
MK5>,HZBZ\<I_21;JY?DZB'F1`1#,VO-O9JM(CW3NS#1@,!@,!@8HVQHS4F\H
M0U?VK0X"XL@242:.)!IX4S%>)_N5A)]F9M-PBXB/I.U<)"8/0/4!$!L3,;2D
MQ$[PU;V+W>F^^.\VYO7!S=4VR(*IWCW6-TDVB2,H)2@8&A72S4*=8P5[2I))
MRK-J9`A0,+PQ_A!T[Q;2T,=)C6LJ[KOWG<Q0IU+6_-+4=DU';T%"MSVV'@Y,
MT`Z(4P$&1?5QVHXE46'9T-YN*7ED'`G`R:2:?3)/Z\ZUG0B_BT/-.\@-9:_Y
M!2FP-`76K;"A[)"(2-QK<(]<&CFKB?13>F25=HM0:)J.G()/B`F=19LZ\=NL
M1+H)!W$3:N+0S,Q6V:[)$R_*;8FUY!2I\<J-(K.BI(C)VF<;,SFBBNN\J2P-
MU%SPD4GXB*GAK/EE?'[3`5`#%S/2*ZWEKO,Z5A<-)X@#*2H7'?5K?;$LBX%4
M/$%?OQB&Y@-WD1<R2AT)"010$>A44BM6Q/27M4)DG]GBL8@BGFTYE-")AXF!
MCVT3"1C"'BV9/#:1T8T08LFR?\>U%LV3313`1'J/0`ZCZ<Y[[NBHX#`8&KFX
M>]MXX4JVVFFRE+W8YDZE8YNLR+F.K=%5CW#Z!DW44[78J.MCLW2C-5PT,9(R
MB*2@D$!,0H]2ATC]=IC.88_LCU2ET#R[U#R&U]*;)KKJ2I5?B+4_J#I/92U:
MK;\TE'Q4#+K.$2LK)-,3QYVUB0*0XN"G%4#E$@``";,UF)PL6B8RJ]@Y=\7:
MN)B3&_\`4R:Q!`%&S"[P4T\2$>SH"S.%>2#I$1!0!#N('P?3_`!''6W"]J\L
M$V'WGO#&![B(;/?V-P3IWMZ]1[JOT[O`$O:\DH*+C5>I%A,/8N;M[#%'H?H4
M;_7;A.]>6#YOWQ?'Y%8K.IZ\V_:7ISE30*I%5B':N5#B0"$;G^4\E(G./<8.
M@M"CW``!U`>H7^N?,PS_`&1PH/\`\EV_K@():IX,;,FRJ"4$)-V>W3#?M4%`
M"*.&L)KU%NV0*#E,QE#/NP"J`(B4!`1=(\W.\SM4'?OO7[T/AU+B_1J4T6`#
M$=3Z*,?)-DU0`0.L>Y;(C6YQ137((D!AXG>0P=H]!(#'ZX_Z,W^KGNN1IDUO
MM1K$1%.P&LDX:=(W%,4"3(R;H9,B`HF.D*)7O>!>T1+V].@B&=G)TJ>Z$_Q1
MD?M:N'_]+4\X_L^7\.WZ_BVEYS;,"&W";YD[P_63S#_<'>\+/A*BW5.MWVJ6
M>C7*&8V.H7.O353M5>E$O'C9VMV*-<P\Y#2*`B`+,92,>*H+$ZAW)G$,(Q1I
M?CAK'0ZUBD*22ZRM@M;*NQ,];]E;,V%MJYO:]3BRI*?5BVK95EM$VSJU6">?
M'91Z"R35-P^=.1(9RZ<+*ESEGC"(C\YM\7'C5QINNW:*QK:L["S>NH16PW>-
ML$Q0-<0-UV-5*7:-M;"B*DX:6F3HNJJ[/NI^518*)+G9L#]54$_$73+$9E$C
MW</O`K)S*LDC5SV+5FR8VB:#U_9=DWO5%>L43$0.[9[9>UZT^JCI](VBQPJK
M2RT*I1<TPCVX^;C0,X%PX7*X0(WBS&&V_*R8'';GO>5__]?N6X[_`./^B_L=
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MPC:(R7H<JO/"U3),.RN&I&;IF*:IU!&,9E"R!YH\@]P:&O7,BFVR`H%"T33>
M-=LG])#2XN=1V8&Q>-_'KE7MEK-VN45<6"!.C0-_H0U9"*=M0:2L<9R_.]04
M\$L7&N&::OOO?KZP:IWE(WZ$=:?VQR[V7QL'1K>E1#=*NT.!N.Y-5Z_O<9>A
M*%M=;'D+;KF,EIQ%TNK"ECI%VR:-BK-T'BPQ&WE=G(O9_(61OG(>`TCLFO:Q
M:<7N.%3W.1M+4>,N*6U=BW0=SR#"GW5:6`[J`UE$PVIFI55(,[2;=.9A8Q7*
M)&29'52,:98G2Y3[UN=?E^5-7N<57=,U'D9HS3A-!NJ="R:MGU]L&QZ3I6P;
M58KVL4ME:;*B)O:TB\@THY=K"BVB6B#M)8SE=PE%Q&R[-<;[W[*6'CENBP7Z
M$E-2\F]_[/TV32S:E1#)'7-1CH+><QJBUP-T("=KG+NL?4,>G94Y%PI%JA,.
MS,&[<6C<BXQ&L-HV5E#;EE\]N$'ZR8+]OG(G"QY3)PA@,!@,!@,!@?BX;H.T
M%VKI!%RU<HJ-W+9PF19!P@L0R:R"Z*A3)JHJIF$IBF`2F*(@(=,#23Q51)Q'
MYN[1XG61+NUWM0XVS4CB5(@HV(Y%NYDH(K8[H!*)Y"%1=0[E4HE,XD8E$@$'
MJ';UM^58MY<X_&TUG9NN2BXQ!0JJ$<Q15((B15)HW34((@(")3D3`Q1$!Z>@
M<Y.F(>[`8#`8%@6[:^KM?D44O>QZ)3"I`45/E3;8"`,7O]"9>R4?M3B=4?00
MH`(F'T``CEQ,[0F8CRTC\Z?>,W:O[)K$?Q0WG#KU`E1*-H4A*O3[,Q&T^NI0
MINR3M=4E55!]4@W]#546_3T_[A-G6E(Q^4:N=KZ_C*/.FN67O#>4%U1TY2MV
M-TI:QQK]1Q(.:WKFI$B(ID5-61E"3T!2F\\R5;I"``++O=?#_EEZ_"+9K2L9
MF$BU[3B);4>/GNRM.ZO>)W3;#E?>^SG*H2+^5N*(N:HSE53>.X<,:Z]4>&F7
M7F##W.Y55V902@H1)N<1#.=OV3.D:0W%(C?66RHA"IE*0A2D(0H$(0@`4I"E
M``*4I0``*4H!T``]`!F&WU@,!@,!@,!@,!@6)L/6&O-LU]:K;)IT!=(%81.#
M">CT7@-EA+V^;CW!@!W&/B%]!5VRB2Q/_$P98F8VE)B)W<W._7.EN*&]=HZ@
MJ-;M3*-B):"D")I+MITB2,_4*_86C-*5EY5I*.&S-&7[2$6*<Z1A,45%1ZJG
M]%9S6)EPM&+3$,A\8&._^0;_`&/(\1=G-M.NHI"B1NU%[B5-D>PQST]S/4%H
M,T37[LN+Z#\"5!3JHP[@<I`!S=.J<O-8QVA:1:<XE+?V4?>:?G/@?_S['_\`
MI>8[?K^K?6_V?P.%WO"'8>9?\Z))L\6$3+H1\K=O)IFZB``W!((U,""4`'H5
M!,`$1]'^HSM3Z'6_V/83YRR8@G,<_+NQ12`3I*0LSL4BQU1$"]BP-;1!B9+L
MZC\)0_0?_'T]0=Z_0ZV^P/N]N7ZP"BY]X;MD[=4!37*,OL]8#(J!VJE%%3:!
M"*@)!$.TP@!OX"..]?I!UM]G]_\`C(WM_P#Z![:^C]Q_'#'>OT@Z3]FDS8/&
M[?$'?;M#'UKMRV&B;;8XT;6;75R.:S^2F'C<+$)Q92(J>NP3\UW>87[O%Z^(
M?_</6+1B-8<YB<[-C'"#W:M-W5K:;NV_&6XZ/865YDZ_$5@B32FH/Z^SK]?>
M(S2[6QU)[,N06E99RB15%5%'N:"7H80.&8M?$XC#=:1,9EL?K_NO^&,$)5'&
MLY*QK$$1(K8+Q<U0*(]_7N:Q<W%,%@[3].BB)P#M`?\`=Z1Q_9;EOI7AG6O<
M0.+57$IX?0&J"JICW)N)*EPDZ[2-UZ]R3N=:R3E(_P#W*<!Z>C)VMS*]:\,X
M0E5K%93%&MUN!KZ0E[!2A(>/BDQ+\#X(D8-VY1+_`"R^CIT^"'_0,RJO8#`L
MAQK/7#M==TZU_2'+IRLHX<N7%4@5EW"ZQS*++KK*,#**K*J&$QC&$3&,(B(]
M<N9Y3$<+CB(2%K[3U?`Q$7",/%.OY*(CVD:T\93M!1;RS-)%'Q5`*'<;MZCT
M#KD55,!@0VX3?,G>'ZR>8?[@[WA9\)DX0P&!!WWC\C=(/ASM:RZ]W90./-OJ
MKS7%FB-J;7N4U1-81(0NTJ6\D8._3M<@K)/+UF[Q2:\(M'-&AUY<\@1B0Z0N
M/%(6-XT1L]UORKL7(4=N5R1N/N];!!TI*J2L5$\$7VX%D(J1LSBPIR[W8++9
ME#I<:V-)EB&_D5&'CK*F2<>/V@5(1D+:,<MNN5DP..W/>\K_T.Y;CO\`X_Z+
M^QW67]%0F:O\K>Z5^,>S,695%7E_5]MS^J7$SJCEB]X>#05I*^7S9S346N]R
M)N:#7JW-NIV)>U_8["1C8YFV$$Y`[QJF+LH,O#+U(H<!+'LU+\`^6&U=E\GZ
M?3+ASIY7[RK<RTMC)K2]M>[@UQQGU_9I5OJZ)V?%F)M:)K\-.LY5&@VR&L[&
M/2$J[^)DV3@Z?E'2:AHU,:;.A+*PBO)\:I.:VK7=G6K=^UM@PVO+I8=G:PTU
M9@U=#Z]JM^FZU;JHU=*V&J:KC-ES4)7H.ZR#>*:2<M)),A<^,J1VHW9>6+GT
M8[<<0;O;(/6]CM')#:M&WHPU)(:KV_L'5`Z_7;[$@K3+-[58(-!+8VMK6$4V
MJME.Z)5I5HV8R\8Q<JE.<YUC]HSZ:/X_X!ZY"16C*IL+:%"TW/L=0L=AZ"K+
MNF*:^V$EHV"K%3H)96:G:9,[-A$G%/I,-#S98J>9>N8R(:(*B0`<BZ&?\JO%
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MM=I&(MK=8"N&2-,?467BV:K0R!R/`0F9GS")C'*"(@J7M."PB3K^O_J/#G^S
MQ/E[]/>^)B[5>Z]`;9UY!:VI;MO+'L5\:6*P3_J=2/K\E(LCMZVPJKJ2>A+2
M[-%F1),YU""Y`W4W:/5/Z]-)U(_9KK&C-MP][QQ=@041K$=LJ_.Q#HU-$5EI
M#1JJHB``5=S9Y:(DD"&`1Z"1DL;KT#M]/4)_799_95CP?>,<H-C"*>C>$=T?
M-E#I^4L-D3MLU$J)*`84U'?JJM5R*8"H)1[0&4.40*(@8?2!72L;W3O:=JOY
MXWOA=I=.U#5^BF+LYQ[^E-'L;J@40`2+*;4L+(B7<(%^"1R`E'K_`*"+_P`X
M]3_TD#W=O*S8Q0'>/-ZWN&JQ3%>U^L+6^;AUDSB`'103D;%4XIMXI?\`<?U8
M?KV@`E$.@A>]8VJ=+3O9?]1]T)QCA1(XM4ULZ^O3!W.RRECCX:,76$1%11)M
M7H:/E$04,/40.^5'_ODG]EE_KA;N[_=%:HV!,P+O4EL;:-A(F$]6OX%"J3.P
M#3,@#URX"9<3,[L2.D$U_*K$0%,PJ@()`;NZB(8C]DQOJD_KB=M%V<3/=J%X
MN[>:[6-N@UZ%I7YN#)!!KL*N!C3*:"0NSR8WFQ#VMR)#_+!N`G$P?##IT%:_
M:,86M.LYRVDYS;,!@,!@,!@,!@,!@,"TY2A46<>K2<U2ZG+R3@$P7D)2N0\@
M]7!%(B*(+.W;-9=0$D4RD+W&'M*4`#T`&7,\F(X>Z$JM8K/FODW7(&O^=\'S
MOJ2'CXKS?EO%\OYKR#=OYCR_F%.SOZ]G>;ITZCD%>P&`P&`P&`P&`P&`P&`P
M&`P&!K7X5\@]"(6/<^@U]WZA1WJ\YA\Q7+32RNRJ8GMITW+N385J,NVUR>:"
MXKHEJ[562$Q68E!@F9QU\(HG`LQ.DXT;$+#8(2IP$Y:;-*L8*MUJ'D[!8)N4
M<)M(V&A(9DO(RLK(NUA*DU8Q[!LHLLH80*1,@B/H#"(B</\`DAL3D,^WP>^4
M*/UXPH^PJPTUS#>%+MK8OK&^:NI>SZ3([&82RG=#7R0@K>BO(1I$6XQ2BGDE
M2F7054.68PFGA$%/>-RVIJUQ?DKEN)>])0%"VUQYOM8;ZSJ:-\ODUM"G;WUY
M8-756MTIXHC&6EW<KRP91*C-V=-LHW>J"91(2E5(6-T0_=>5%\7;G(2]/M>\
MY-9Q85NM4S7%5Y9Z.UUIF#KVM'NS]P[1CJ56)BCWNZ2VW9BEV+8$BD$I-`W=
M1T8Z013\07"YS19\-T^5DP..W/>\K__1[EN._P#C_HO['=9?T5"9J_RM[I7X
MQ[,Q9E4;>85Y:ZXXO[QMC_4EWWM'M=?345(ZEUW")V*TW6.M"9*L_CT8E25A
M!7A&K.:.ZEU$W)5F\0@Y62*JHF1(Y8WAI3X1D2VQRCXA[3K/"'GCK%*)U2QE
M-IWGD1)?)+CS`VBN<5&6D*GN'7L,C:;`YVIM>WU!FSIYI*1;QKI:MK@\.@"J
M!REC4[3&8='V5A@QCR4TC([;_L:SOC179QE9=HV@31%B182,I7F!Y6PP$1;%
MX=.G3-GK\6D=R_BFD@M(LVY#*+($(4P@7$[OO<G)#2F@"Q`[;O32J*SK29DX
MYF2)L-ADC05;!B-FM#R+JT1-R,73JN64;#*3+I)&+C0<I"Y<)`H3J(B9V4FT
M\K^.],N59H5BVI7FEDMJ507ATVJ<K+PJ:.PY(L-KU:=M<-'2%4JB5_ESE:P1
MI5ZR"8<&!-GXQA`!&)>N/Y0:%E=MGT9';'B7>S@DY6!2@DF4WZO>V>`@W-FL
M%.B[::++39:\5ZNLEW\A!M9!:68LT%5EVZ::1S%&)W-O<H-"Z%DHN)VWL>)I
MS^5C',\"+EE-R98:L,W2;%W<;>X@XN4;4:CM7J@(J3DT=A$D6`Q!<`8I@`8F
M2<Y/Z%K>UF&DYO8\2QV3(2<+`DA#,II:/8V6RL$Y6L5*<M;:+6J%<N5HC%TG
M$7#R#]M*22"Z)VR"I5DA.,3N0')_0MHVJ]TI`['B9'9#%[8HH85)E-)QTA.4
M\##<:S`VQ>+2I]DME-!-3UQ$Q[]U)17@J^:01\)7L&)W9[PB&W++Y[<(/UDP
M7[?.1.%CRF3A#`8#`8#`8#`8&I?WH_&3=_(P-&CIJE!<1IH[,"QE^4E2KPQX
M6(-?^J!#Y4ST&5V#KU$ZZ^`*@I^'\/M[B]>GZ[17.98O$SC$(/\`$[W;V^(;
M?]!E.0>CXU74+,;.>V)2]QUY/QZAE*;84*^5Q$0%ODI1X`6=5D8`31.4I@`Q
M^A`,.:M>,3B=6*TG,9C1T!T_4&J-?`G\A-94"FF3(!"JU>GU^"7$H"!NIW$;
M'MEU#F.'<8QC"8QO2(B/ISE,S.\NN(C:&1<BF`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#;A-\R=X?K)YA_N#O>%GPD?LW6E)W'0
M;3K#9$(6R46ZQ:L+9X(TA*Q192,6.FHJU-(0CZ-EFI3G2+U,@ND?T=.O01PF
MS`W'GA[KGC9?]W7JBRMR=CN>9J4DM$VB][%N:=>:56E5^J$8D>WJ[6M:8<O'
MD,J\\\J5-VBFY!F4XMD$B@69SA+/"-#_`+V9'C/8M@MZKRAW9RBU5K>M\5-C
M;SFX74?)+^U-#V!_:38U,/7*C'ZG=PTE&[5V[+6:RH+,EC*MS1WD&8_",=(Z
M4EJN?#T>Z,LFQHC8>VM:[S:<P*[LRU:7TOR%IE5Y-<PI;EM'):3OT]L2%K4E
M%KOZG4PUE?TIB#<-)^-42.JY\%N8.SP#ID06\3&S>QE9,#CMSWO*_]+N6X[_
M`./^B_L=UE_14)FK_*WNE?C'LS%F58?WM/C$ZSLL'%;(J6KM@[$BIG6VF[)<
M)R,A&JNX[=`2[37L=$A)*`::GCS:95T&#9-P[<E;G\-%3M$,$-%O`7CCNC7G
M)C1,K7>*'*CC2O4:W=&W.;9V\>4KK;]`Y%SCS6DA#0"53@5=GWR/M]A7V\NT
MGD)V/CH1LPCFCA$Y.YTFD$;F8Q.KHRRL-;4AM!7;?.FF4RU4+>-0I'&JP6)]
MK*2D.-'(9:H[3W=:=86>F2>Q";O8:V>:/KFJJ/J^^3T''F>SZ+J;GI5R(D02
M9QYI(OA;<_O6HQV\8[DLXUYMK8FFMV\1T:5K5Y3-);!V:M+6:I[1M\R_ISN*
MIE7M+J"2W-`6^,<P[B0(UB9=I$F4.OVIIY%QIA#&C:SV7J3C+N;AC>]=[2G-
M^;KH?#V#UK9(36ESMM2=O*WQ`XJ\?K-)2>X(:)E->U<^F-L:;L5BDC2LZR,R
M1=H.FYCK/FXK%TSGPD%06<\\>:7XZ*:\V;&[0U+[P#>^]K_;)'5EUA=?QVMI
M+:7([9#/:[/;DE`Q^O)Y+;=>V-'QJ;>-EG<PN[G7B"[8R;*4,@3F?1_=G[5B
M9^8Y%[%C-7[=V/5.;/`_3];XZ+5O2UZN#>\RC=+DLG_:NQ2$+6YB$H!9(NW8
MF707LKJ,A#Q\RZ>'<$;M'RJ8QMZ2LF'J%UJ]*NO#^;HVT)S=]DYE\8]GPU[9
MZOO4A0INB4RT\7;_`#FZE]REA%-?1Q=90.M9&.,1_-MYGUQ!MF+9,RKN.\8>
MJ]],L;#)O^(>@0UUL^'V7QMY9[YV;MZSS&JKM7:1#5`8'E77F]^B-HRT!&42
MV_WV?[6BQ8H0\H^DGS.;>K.40*RDBI"?,MR>5E#;EE\]N$'ZR8+]OG(G"QY3
M)PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@0VX3?,G>'ZR>8?[@[WA9\)DX0P&!A_:W'S1.]EJ@YW3IS66
MV'&OY@\_1U]ATBNV]:IS"IV:CA]7U9V/?'BU79XUL*X(B4JXMDA4`WA$[1F8
M\KLC-=46&O-JV9%U2$8[!N\/6J_;;@@R2+/S\'3C2YZM$2$B("NK'0:D\].W
M1Z@0AW*ANG<81P+TP&!QVY[WE?_3[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q
M9E4`O>&<5+WR[H&BZ'1+O-ZV5I?*74FU[3>JC9RU"_U>ET]M:FT[,ZWG%J_9
MV;:^L!FDE([S#0R'BE$3CT#H)8G#[T'P1E-$[*B]C.><G/K>*,8QEV)M>;\W
M;3[MK63&58+,2O92OQ&JZL^</HH5?':'*\3!)P0IA`X`)1&?2$^L(_%RV;O&
MZ[1V@BZ:.D56SIJY2(NW<MUR&270705*9-9%9,PE,4P"4Q1$!#I@>6)B8J!B
MHV#@XV/A82%CV<3#P\2S;1T5$Q4<V39Q\;&Q[--%HPCV#1$B2**1")I)D`I0
M`H`&!4,#Q2,='S$>_B)=@RE8J59.HZ3C)%J@^CY&/?(';/6#]DY(JV>,GC94
MR:J2A3$4(82F`0$0P/T9,F<:S:1T<T;,(]@V09,&#)!)JS9,VJ1$&K1HU0(F
M@V;-D$RD33(4I"$*````&!Z<!@,"&W++Y[<(/UDP7[?.1.%CRF3A#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`AMPF^9.\/UD\P_P!P=[PL^$L+'*/82O3TU&U^6MLC$0TI*,*K`+0K>=LS
MU@Q7=M:_"N+)+0%=0EIE=(K9L=^_9,BK*%%==%(#*%(PEHO>LCMF4V?4+;K2
M>U-L74EA@H>U5*8G:W:VRL=;*TPME4GX:S5-Z^B'S23C'ITEFY_!=M';54IT
MQ1,W<+EF$AL(8#`8#`X[<][RO__4[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q
M9E3`8#`B*UV+N1IS82U/89*C?V?L7'Z][#J$#"04H-O:35+OFHJPI,6JW/Y/
MRCWUJ6]/2HQK*-;(LDD$SG<O%%>B!?"W=RV3>]^WN]T-I#:,3II>FZ':[CE+
M0\I,+>7EFM%QN-DI^NZN[:6%!VPC:(R7H<JO/"U3),.RN&I&;IF*:IU!&,9E
M"R!YH\@]P:&O7,BFVR`H%"T33>-=LG])#2XN=1V8&Q>-_'KE7MEK-VN45<6"
M!.C0-_H0U9"*=M0:2L<9R_.]04\$L7&N&::OOO?KZP:IWE(WZ$=:?VQR[V7Q
ML'1K>E1#=*NT.!N.Y-5Z_O<9>A*%M=;'D+;KF,EIQ%TNK"ECI%VR:-BK-T'B
MPQ&WE=G(O9_(61OG(>`TCLFO:Q:<7N.%3W.1M+4>,N*6U=BW0=SR#"GW5:6`
M[J`UE$PVIFI55(,[2;=.9A8Q7*)&29'52,:98G2Y3[UN=?E^5-7N<57=,U'D
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MK!B>I"S`5T_6#='0ZF:"/PN_KX@`<"SXA/\`O+FXLJ3<'FNXJ#G=@-*M8'-&
M@[/*.H.M3-Q0B7:M9BK#-,&,H^AX.1FB((NW2+9PJW;G.H1)0Q0()$6.%>O=
MSZ]I]V)OJFUV*VC=K>.P;_L&$V:.PE]I7F<C6T;,RAX\-?45&B5JIPT%%PM>
MATSR(,H)DV;F<**H*+N"SCQLFAA#`8#`8'';GO>5_]7N6X[_`./^B_L=UE_1
M4)FK_*WNE?C'LS%F5,!@,")\OQBFGG(QCR8;<BMX^NX*LS5/A-1BUX\M=2!3
MYUU69F9I+EZ;CM)[7)#3MEIT>^7?#8UYALJF8C=RFV,9L8N=,86&XX@W>V0>
MM[':.2&U:-O1AJ20U7M_8.J!U^NWV)!6F6;VJP0:"6QM;6L(IM5;*=T2K2K1
MLQEXQBY5*<YSK'[1GTT?Q_P#UR$BM&5386T*%IN?8ZA8[#T%67=,4U]L)+1L
M%6*G02RLU.TR9V;").*?28:'FRQ4\R]<QD0T05$@`Y%T,_Y5>*X;1U4NWRRA
M-E[%L=7JVR]E;[UAQ]LTG38G4=7W?LPMW>S\^>PP.N%-H.*^O/[#FGK6->R<
MK&Q3R77<I,UCMXY-D,K6E>#TO=X"$4O'(K;T;=K9H&FZ#Y/2M!/0V4;R"K5=
M"TOWJ<@M9Z%8;#27)Y38-B;M)2ONXF9;Q,PHD#@'*31VU&?1=CGA+3U=@/[`
MRV7L^'U;-;2U[N^P<>(M2BHZNF-KZK;44E(L1I%6D+[+BX9E+:T@IAU#,I]M
M&OYF-3763,DN^;O!EZZ#PSK=$V%7;47:>T['1M>[!V9M74FE9Q:BDU]K'8&W
M"WI"W3<0_A:/$;`GFC"-V98&<''R\T_CX9I,+D31.*+`S$93(PB&W++Y[<(/
MUDP7[?.1.%CRF3A#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`AMPF^9.\/UD\P_W!WO"SX3)PA@,!@,!@,#
MCMSWO*__UNY;CO\`X_Z+^QW67]%0F:O\K>Z5^,>S,694P&`P&`P&`P&`P&`P
M(;<LOGMP@_63!?M\Y$X6/*9.$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"&W";YD[P_63S#_<'>\+/A+.?
MGH.JP4U:+-,1E>K=;B9&>L$_-/FT9#0<'#LUI"6F):2>*(LX^,C&#=19==4Y
M$TDB&,80*`CA&,-0<@=0[Y;V!?5=P)8U*JYCFUBC7<)8ZM/0X3+51]!/GM<M
M\/`SZ<-862*BT:_\L+*122.9LJJ4AQ*7$PS+A#`8#`8'';GO>5__U^Y;CO\`
MX_Z+^QW67]%0F:O\K>Z5^,>S,694P&`P&`P&`P&!C+:#3<KN-B":7G]95^8)
M,)GGG&T*C:KA&N(#RZX+-HAG5+M1W3.8%T*9BK++KH@F!BBD(B!BADW`8&!]
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MN:XK?@I@S'#\-`\5MB:*GW+P>5NT=@U&8O.QMBVFA6>@Z+C8JR6O9LC.V"??
M.)NJZT@[5&(I6J=-(((,GK=$AT2(B46XG2,)F)\+HYO5*S7CB;O:MU"`?6Z?
M=45X_:4V+:IOI2ZMH%VSGY6DQD>J((R,C<8F+7C$&RG\MPJZ*F?X)AP1O#'F
MA9]+;_*;=.^JC6=@0.LWNAM!ZC9SNP-:7K4[Z[W>FWOD!<K"W8UG8]?J5MD(
M[7D5L1@V]8*,!8B_E7K1NL*S1\0HG2,)UX0P&`P&!QVY[WE?_]#N6X[_`./^
MB_L=UE_14)FK_*WNE?C'LS%F5,!@,!@,!@,!@,!@,!@,!@4,EGK2M@7J2=A@
MU+4VCTI9S622S`]@;Q:R@I(R2\,5P,BE'JJAVE6,F"9C>@!ZX"-L]:F).9A8
MBPP<K,5Q9%M88F-EF#Z3@G#A/QFZ$RP:N%746LNC\(A5R$,8OI`!#`I[*^T6
M2B%[!'72IR$"VD%HEQ-LK'#NHAO*MC@FXC5Y)!XHS2D$#F`IT3'!0HCT$`P*
MW%S$1.-A>PLI'2[,%3("[BWS:0;`L0"F.B*[159(%2%.41+UZ@`A_P!<"HX#
M`HE@LM<J<<,O:;!"5J)!PV:#*6"580T<#IXJ5!HV%[(KMFP.'2Y@(F3N[CG$
M`*`C@?$M:JQ`*0Z4[8X&%5L+Y.,@$Y:8CXU2<DEB"JE'0Y'CA$TF^53`3%11
M`ZAB^D`Z8'TO9ZTUGV%4=6&#;6B49.)&,K:\LP1GY&/:"<'3]A#J."R+MDV%
M,WB*IIF(3M'J(=,#\V=LJTC/2M6C[+7W]G@D6[F;KC.9CG4]#MW92':+RL0@
MY/(1Z+HBA13,LF0IP,`@(]0P+@P&`P*'-V>M5KU=\H[#!U_UQ((Q,3Z[EF$5
MZTE7/7R\9'>?<(>>D%^@]B*7<H;_`$`<`_L]:BY>)K\G88..GI_S'J*$?RS!
MI+S7E">([]4QKAPF\DO*ICW*>"0_8'I'I@"6>M*V!>I)V&#4M3:/2EG-9)+,
M#V!O%K*"DC)+PQ7`R*4>JJ':58R8)F-Z`'K@(:SUJQ+2S>OV&#G7$#('B9U"
M&EF$FM"RB90.I&RR3)PN>.D"$,`BBL!%``>HA@5S`8#`H<E9ZU#R<-"R]A@X
MJ8L:RS:O1,E+,&,G.N&Z?C.$(9@Z<).I19!'X1RH$.8I?2(`&`/9ZTE8$*DI
M88-.U.8]66;5D\LP)8'$6BH"2TDA#&<!(JQZ2H]IEBIBF4WH$>N!5B.6ZBZS
M4BZ)W+<B*CAN14AET$W'B@W461`PJ)$7%$_8)@`#=ANG7H.!28*SUJTHO'%9
ML,'8F\=(.8F07@I9A+HL91D;L>1KQ6/<."-9!H?T*HG$JB8^@P!@5S`8#`H;
MRSUJ/FXNM/[#!L;'-HNG,+7WDLP;3<NW9``O5XN*6<$?R"+0!`53))G*GU^$
M(8`EGK2M@7J2=A@U+4VCTI9S622S`]@;Q:R@I(R2\,5P,BE'JJAVE6,F"9C>
M@!ZX%63<MUE7""2Z*JS0Y$W2*:I#JME%$B+IIN$RF$Z)U$%2G*!@`1(8!#T"
M&`0<MW1#*M5T7*95G+8RB"I%B%<,W"K1V@8Z9C%!9J[0.DH7_<10ABF`!`0P
M/VP&`P*&A9ZTZGW]4:V&#<VB+9-Y&3K:$LP6GXZ/=B0&K]_#IN#2+1DY%0OA
MJJ)E(?N#H(]<!%6>M3SV:C8.PP<S(UMZ6.L3"*EF$B]@9`Y3'*PFFK-PLO%O
M3%(8027*F<0`?1Z,#]WD["1\6^FW\Q%,86,*]-)2[R0:-HN/+&K+-I$SY^LL
M1HT*P<-U$UQ4.7PCD,4W00$`#]XR4C)J/9RT-(L9:*D6Z;N/DXQVW?Q[YJL4
M#HN6;UJHJV=-U2#U*<AC%,'I`<#W8#`8%#0L]:=3[^J-;#!N;1%LF\C)UM"6
M8+3\='NQ(#5^_ATW!I%HR<BH7PU5$RD/W!T$>N`BK/6IY[-1L'88.9D:V]+'
M6)A%2S"1>P,@<ICE8335FX67BWIBD,()+E3.(`/H]&!^DA88")B7\_*3D/&P
M445X:4FI"39,XF-+'.%6D@9_).%TV;,K%T@=)85#E\)0ABFZ"`A@>U@_8RK)
MI)1;UI)1S]ND[8R#!RB\9/6JY`40<M'3<ZB#ANLF8#$.0PE,`]0'I@>O`8#`
M8#`8#`8#`X[<][RO_]'N6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F5,!@,!@,
M!@,!@,!@,!@>9ZX,T9NW1$3N#MFJ[@C=(JQU%S(I'4*BF1NBY<'.J)>T`(FH
M<1'X)3#T`0C)Q5Y#SW(NI6:R3^J;9JI:`N5GK+=A:8RP1YI5O#V>P1+=PT-.
M0$((O8]I&)-I9M_]U&S:;MFX10,@452S&$,;):./.P.>E=J6F5]$T_;?'F:V
M9=M@V5M):^K&S-L[VV!I:VT>'TDUC/-1UTV''15;NORIM3Q0CB.9R$/"MBJ*
MNFSPD;%\:M>EE6U&'%_CK+Z"5K`[#;^[SW,[Y?2%`43_`+F$U^_@=).=ZN=V
MO:X(6Y/8"^Q&\DX.>9.6<4F$)8S<3+E?@)=<SGE/1NMPMK^SN9-ZC*GH2V\2
M-<\5>/%VVA#U&JT"VZC5V32IGD;-QR<7"1K%[1WVS$-8GATS(-R^L3LG<&0Y
M1(JQZDUTCREMP#T0?0O'.#92],KFOK]M:QV;>^TJ;4X2-KL!4[YM9\6?<4:+
MB(B.B6#6/UG7?5M7;B5N0ZC:%3.H)U#'.:I,YE-/"&!`SG]M#0&KM9P#K;].
MTO?[]<):5H6A*KNPM*;59Y?+)"N$9)_+V2])C"TNDPE?15>6*4,HF<L6B=L@
M5R]<M&;DL-=5XJ_&6GU#<NM]XWC6NUHBB^ZDX[T/CC?[C*0-@?[!B(.$Y`U:
MW6[2T@N^DUY+8EQNT-6UGBM=55F'+OU!\)10(XPQK728Y?F@%/>0%\;[--2%
MO>`(\^N'K>'];>J5MWIKLY7BO)0IZPFL52W)Z[1TR:8>296)`A211IY1R4H>
ML\'^L*AQ"D%"<H]%;`5'64UJO<]]YOGT.A29F+7Y&TZ9VA9++O.\+<L&Z44@
M\G*VB%*D8Y`4%TU*U..XB.F_6<FX;/&HG:6_S*P8#`U;>\VLO'%6EQ&E]C-=
M&$WAR'J.P-3ZNM^XST2*;:FHMB0AF>T]P.+9=%F'J6$UZBO'R#=BT=HOIRP(
MQS-J'B&,X;1J,[^$7^0)M-R"W/QO992BS_)(FP.+B7$"6L3^&G-K2==4TQQV
M?\?935CY<SFPOV+[E"G<G1%H@!16?@]56`2^(81KIPIT=%ZNM#?5\9`3])J_
M-62]X7RT9W^V0XPZV\:G"J3W*."ND]9E4URVQ/7M?T.XBR19GZR<(2++`IMU
M"%]6"!?]896X05YM7.3VN:C2*UQ781.K.$EBHF[+7Q3V,ML")N5P5V%H]32<
MKLPA-7T!M6K#(L(/8<I%LUGLX_\`"E'QU7)RF(LX).W\MTF5DP&!JBY[V?C)
M,;5U7HFS.M'57D%?WFJ+K*;;V%(T&HVS4.A]6[;&X,K'`W2SN(V>-:9^Y1<E
M#TR-C'!W!9E\]DO#\K'OA&-1G&?#`\Q_:A]9+05;Y"*\V&_O9-9>JBJ^J5]V
M)4./WSK59SZO`_CVY.DI\!5Y`Y_#Z1:<*JX$>T14P?ZPI>R+=IRO67WOE9T'
ML.HO=A67B=5K&^CZ;LU*U;.FKE"0')XNTWL:NC9)6[/;I2XI=NV*B@H9S!E3
M8-$$VZ:31$KD^N4ON-C?0A.7M]6XHDU:34H<3]+,[L.E$ZZ6@C94+]LE;5*#
MH]/)\G`M+6B.90QB"8)`L4LQ%</+F9#@G.-6RO*R8#`U1<K+/QDM/*O2^C2N
MM'5'?+?9FB=Y[+VO99*@U/855J6K[U'6?6-!K<_,N(ZV6RZ[KL%;^3:4+'J.
M`;51[*JNP2(Z8HR,:C.,^&!]=?VH?6G02T1\@S\S4O>8\EE]C'8>J5]TH0#2
MY\F8R\!;3H>/;R:W0T(:,:1QGP^I21)H%-L8`]68.>,,V\3K+Q1:[/\`>-T"
ME;8UQ\C'-PKUSM#N`W@DXL`4\G&G4D1L[9<ML1I=%;PW+$S[I=&3M!Y,KF.D
M`^&\273*)1.<0RE[L*S:?D..MIIVGK1K^8@*'RBYOL64!0;'`S;.JU&8YO<D
M)37*?E(1\\]60DW3#-G40<X%2>1QDUD!.D)3#82V[8MA#`8&FJU6C1>Q>9%H
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MY1.=<\KPXJ6CBG)<-)^AQ-WXDNJ[4.9/,B,UU`[,FZ3:-65U\_YL\GK-J9NI
M!!8&R0'E=:,EI*M@FLFHX8ID>-1.D3OP3G*4ONUW+)7B766D>W@4T(G:'(V+
M4>4F2)+:MF'Z/(G:2TK+Z4>D81H$T>[E7"P5!IX0^K(`C5D"SHK8':]2=T\<
M(8#`8#`8#`8#`X[<][RO_]+N6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F5,!@
M,!@,!@,!@,!@,!@,!@4$M5K!97UZ6N0)9L53+C,EAX\)7QCD%(ZWK`&_F_%,
MD82B;OZB4>G\,!&56L0KN<?PU<@8E]9G8/[(]C(>/8.["^`ATP>SCAJW26EG
M8)J&+XC@5#]#"'7H.!\0]1JE>B30$!6*]!P1G"[LT+#PL;&1)G3EQYIRY-&L
MFR#,7#AU_,.?L[CJ?"$1'TX%PX#`8%)EH""GTT49V%B9I)N<RB"4M',Y%-!0
MQ>TRB)'B*Q4SF+Z!$``1#`\+NFU!^I7E7U4K;Q6HN`=U11W!1;A2L.@(1,'-
M>.LU.:%<`FF4O>V%(W:4`Z]`#`]!ZQ6E;`A;5*]!J6IM'JQ+:S'B6![`WBUE
M`56C4)DS<9%*/55#N,B50$S&](AUP/)&4BF0L]+VJ'J-8B;/8"]L]8XR`BF$
M]-E[R*=LO,-6B4A)%\1(INBRA_24!_B`8%SX#`8%$EZU7)\R!YVOPDT=L4Y6
MQI>*821FY51**I4#/$%A2*H)"B8"].O0.O\`#`_)>IU9U+Q%@<UJON)ZOMEV
M4!-KPT<M+P;-T0J;EI$22C8SR-;."$`%$T3D(<``!`<#Z2JM80G9&T(5R!1L
MTNQ1BY:Q)0\>G.R<8V[?+QTC+D;A(/6+?L#L144,F3H'0`Z8"NU6L5!@>*J5
M<@:O&*NW#]2-KL/'PC!1\[$HNGIV<:W;-SNW(D`5%!+WG$`ZB/3`KV`P&!09
M.JUB:=)/IFN0,L^02(@B\DX>/?ND44E%%DT4G#INJLFDFLJ8Y2@(`!C"(>D1
MP/KY,5KY0?*WY/0?RJ]7^J?E-ZI8?*#U5XGB^K/7/E_67J_Q?A>#XGA]WIZ=
M<#Y9U6L1T@I+1]<@6,JL9<RTFSAX]K(*F<F$[DRCU!N1R<S@P]3B)A[Q_CUP
M/JOUBM5-DK&U6O0=9CEWKF1785^)80S):0>F*=X_5:QS=L@H]=F*`JJB43J"
M`=PC@5S`8#`H+RJUB1D$Y:0KD"^E43(&1DWD/'NI!(S8P';&3>KMSN2&;F#J
M00,'8/\`#I@?2%8K36??VMK7H-M:)1DWCI.R(1+!&?D8]H)!:L'\PFW+(NV3
M84R^&DHH8A.T.@!TP/.UIE/8F>'952MLSR+1PPD#-8*+;F?L78E%VR>&1:D%
MTT="0!43/W$/T#J`],#V1%>@(`JY(*#AX4CDR9G)8B,91I7!D@,"1ERLT$05
M,F!S`43=>G4>G\<"L8#`8%!1JM8;RHSJ%<@4)LRJZYIE&'CTY4RSDBB3E89`
MC<KL57"2IBG-W]3E,(#U`1P/RCZ?4HDDZ2*JU<C"6ERX>V8D?"1C,EC>.T1;
MNG<Z5LU3"7<N6X]BBCCQ#G)\$1$/1@?"5*IJ#)U&H5*LHQSXZ"CU@E`Q2;)X
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M4VS5HU;)E1;MFS=$I$4&Z")`(0A``I2@````&!Z,!@,!@,!@,!@,#CMSWO*_
M_]/N6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F5,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@:^N8_.^)X07S53_<M319\;MBU;;*4ONA
MM,G*\I.UM=TN2V/6:#)UU=@1J_\`[JUBO232",B\\RXFFY6W@]%"F$L1G.-U
M!C?>0:VUSJ?2]CY<1<II7;^R]1(;SNNIZ/4=I[J-I+5S]\HDWNNV)NCZ]>&H
M%1B$UVS.1E9MO&LDI4KM%,RA&CA1.97&NC-:G.'CRANJM:(<S=Z96NZ6%2ET
MZTO]/;;8:=MM]3KCRX_(.K[N>4I#5%@M:M48+/TF[276(LDF*9%#./Y.5,3C
M*L<;>9''OEU\N%^/MOF;W$:\>Q498K(MK[8E1K"DK*KSS;U5`3UWJM<CK3(1
M+BN."2*<<=T,<<R17'ABLD!A,3&Z4&$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,#CMSWO*__4[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q9E3`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$.N<_%!'F;H
MI+3*MCBZH*6T-0[#+,2]9+;&O@ZVV'`6Z2BPBS2,7VJV"&C7+#Q?%Z$*Y,!R
MG(8Q1+$X1/YC>[7G=_\`)-7D;2YG3,PI;=$L./VP]9<@*CLNSTE>"BK/8+%'
M7.#/K+9VNY1W*%;69U'O(5^<\7(-3`83HJ]QS18G$86<W]USM!3E'1=SSN]*
MA.T75O)&N[XH<:_JVSW=\AZI"Z[E*%':!@!D=PO]74755+)*KN(HD;73OG!U
MBBNL04U1>,';39.[@MQB=<..+]`X[/;DWO[FDS>U9<]K:P:E;0D2[(V_?=HI
M(%AE96:4:FB4;H5D8PN5/&,W%4`(!P(6I,YG*7&$,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,#CMSWO*__U>Y;CO\`X_Z+^QW67]%0F:O\K>Z5
M^,>S,694P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!QVY[WE?__6
M[EN._P#C_HO['=9?T5"9J_RM[I7XQ[,Q9E3`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8'';GO>5__]?N6X[_`./^B_L=UE_14)FK_*WNE?C'LS%F
M5,!@,!@,!@,!@,!@,!@,!@,!@4V8F8BNQ4C.V"5C8.#B&;B1EIF8?-8R*BX]
MHF99T^D9%ZJ@T9,VR)!.HJJ<I"%`1$0#`PS[4_&+\QVA_O?U]_\`L.7K;ZRG
M:O,,W,7S*49,Y.,>-9&-D6K=]'R#%PB[9/F3M$CAH\9NVYU$'35T@H4Z:A#&
M(<A@$!$!`<BO+-SD)6HI[.V.8BX"$C4@7D9B;D&D5%,$1.1(%GL@^60:-4A5
M4*4#'.4.XP!_$<#Q/+=5(YK'/I"SUYBRF&X.XAX\FHULUE&HIH+`YCG"[DB+
MYN*+E,_>D)B]JA1Z]#!U#XE[E3Z^\A8Z>M=;A)"R./*5UC+SL7&O)]T/A]&T
M*V>ND5I5P/BE^`@50WP@]'I#`J,K-0T$W([G):,AFBBQ6R;J5?M8YNHX.114
MB!%W:J*9EC)HG,!0'N$I1'IT`<!%34-.MSNX.6C)EHFL9LHZBG[61;IN"$35
M.@==HJLF58J:Q#"41[@*8!Z=!#`J>!3)>:AJ^Q-)STM&0D:5S'LC2$N_:QK$
MKR6D&L3%-#.WJJ*`.9.5?(MFZ?=WK.%B)D`3G*`A_)N<A*U%/9VQS$7`0D:D
M"\C,3<@TBHI@B)R)`L]D'RR#1JD*JA2@8YRAW&`/XC@>QH[:OVK9\Q<MWK)Z
MW1=LWC19-RU=M7*95F[ELX1,=%=NNB<#D.01*8H@("(#@>C`8#`QVZVWK)K!
MT^SC>ZPZKFP;)"5"CSL7+-9F(MEDL;I=E"Q,#(Q*CUI).'SAJJ!12.8A02.8
MQBE(80"ZXJQUZ==3[&$GH:9>U.9+7+2SBI1C(.JU830T18BP,^W:+K+0TR:O
MV%@_!JY!-<6;YNMV^&LF8P5G`8#`\[IVT8H&<O7+=FV(9(AW#I9-N@4ZZI$$
M2&55,1,IEEU2D*`CU,<P`'I$,#T8#`M!ML*@O&AG[.\5!VQ)8VU/,];66%7:
M%MKU^C%LZL9RD],B%C=R;A-LDQZ^947.5,I!.8`$+OP&`P&!XG<C'L#L4G[]
MDR4DWI8Z-3=ND&QY"0,W<NRL&)%CD,[>F:,UE023[CBFD<W3H4P@'MP&!X59
M2,0;2#Q>18HM(@JYI5TJ[;IMHPK5N5XY-(+G4!)D5NT."J@J"7L3$##T*/7`
M\D78Z].0B%EA9Z&F*XZ;*O6U@BY1C(0CAF@*@+.T)5HNLP6;(BB<#*%4$A>T
M>H^@<"WZ_LW75J1IZ]<O53F2[!JS"[T9)C/QBSJW4Z38)2;"SUYD#D'DM!NH
M]<BQ7**9TO#,`]W3`O,'+<7!F8+HB[(BFY.U!4@N"-U3J))+F0[O%*BHJB<I
M3B':)B"`#U`<#]L!@,!@,!@,!@,!@,!@,!@,!@,#CMSWO*__T.Y;CO\`X_Z+
M^QW67]%0F:O\K>Z5^,>S,694P&`P&`P&`P&`P&`P&`P&`P,(<AU]ZM]72ZO'
M)G67^T0>Q`1K>TG;IL#1HOT0ES-A>N6D<+\K/J)`<*%3[._IU4[`&UQG\MDG
M.--VH[?$I[TY73&ST]IUS6;;7!Z3/ENZ\8O1S2"-:%@L$LHR!C/+O!<E:]PD
M\(AC]?X`(YTC^O,8G5SGOB<[-#F=G-T#ZUE?>SDUS0"4RLZM5IY*552U-5XO
M0P=JUHL$P""4=`YL"3@'!XL$A/XA2G[A'N`!ZAG&?Z\SF=76.^(9-O;R06V3
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M\?SM+'8RHV1D^%E;&$\\D"`\*4CM,RRH`<.\W6^$_P"M.6#&"M7U#4.#.EZ?
ML6O<)]1;ET9==F7_`&/K:"TU0WUQVY2:%H1M5J-ZYOM)L5.96&[5JS3M@>/3
M,5)=ZUI/@`KY?QPR+OF=V--4[;O5KW9Q7W#M3E1?:U%SW#3D7.-X>"B-+QM.
MWVSUCN[7L#`WZ&J,KJR9L<D^W#0Y"-MAF5??I.414:(Q9VK)=V@^$[3B/+'$
MIR)MNU*WMFGKWF_W37KFL^[7W?5PVK.:&L5YCY39?,F*9O)-=70+9M6ZLRM=
M<@(IR>`<&5".72$[0J"#@2'+C;EL'Y9K:J#DYP\;<C%:6EHA6!Y%.(PNSU(I
M/7#CDTW2TXEIEO,_*00JR]A_M:[V2K#)/.IQ=)&.V#S":8A68VG&[#^RMM:T
MC[K#ZVU;RVHW#OC7"<>[[M[7]\U`.@@IEYV%%[7L<)L4C)]>:I<*;(US2\G'
M$>3,)#D;*R+RPB5TJ4B`IGB_QJP2_P!^\Q;]0Y[;RN[+/I"TT^H^[:?ETY&:
M\U?)U&'N_*4-;QNZXV]I6RER%XGVD8>ZNTH]BE+19XYXAXHJ'$$R)%Q&V%];
M(W;N#4\Q8--V;EY::S6HKGEI_2;KD'?(#0S>^Q^L=N\3!VK(5AY(#K""U2RD
M_P"YKH$X65-7TU&0+MT5BND4C)+$QYPD)K'<6QYW@[R=ND-L1YN":UB?EM6M
M+;C(2O$EMFPFL5;DSU_8U7M(CH*K3,M&2<?ZF/)QC1JWE%HKSA2`=8QAJ3OL
MAYR7BN,^K:1HN^2D]Q#VNAJCA90*]`<0^3Y:Q(V"_P"JD6AEZQ+\;'+\964K
M>U;^[K0P*0-ZU,M[(Z9QS4PLSM$SGC6NONV.ZD>J!S2Y5Q\>@^904OHSASL2
M7CWAB`=ELZRR/)FG65!TW045;-Y=+76M*<1R!3JF$A$OYAB`F!:SXA,["&!"
M:>>\WBSDP$)$48T,$F^"),16![31H.E08F#STDF]]+;M_P#:4JG_`-0`/HSI
M']?+'Y^B&.^=P[PD3O-7;+D(5LI%OHZ0DX^O%8``NB-_-,FSU]&.'"2Q4`<D
M6%'NZ$6*0Q@[R!TZ5K7>'.TVVEF356X>6>S(EP%%6J4XG7`8QL@:1+!-I4HF
M;?\`%=O"/GS==?SI4#_S@+VJ*$/_`*@(9F:TC=J)O.S-1$MYS-'W!%<EYZLZ
MVU1(:CO;.P[`AY^%K<K2F+J#<MY:UM[$VD%64`E7(%5V].]="1-H9`BO<`$-
MUQ;IC\9U;KVSJUE&=1Q]9'XV:^D=`Q5AU1R1]VU&L.4/%&L45&MWB)N.XVT/
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M3%<0AVMNNC43:`0Z++63B:HS34R-H?515]=B3S)H^B0EGZ*AVTF5R,:XQHV/
M\6)#:+JA;(;[ENU>M2,/L><84^8C-AUBZ62$UVK2Z9+EAMBW&BT_7$"E;8.R
M2<N5NH@Q2=%K_JQ9TNL\.NN>I*"''':/!2@:H]X(VFKKI.S\?=?<DI38EC@S
M6.!V['O:N.KN/B\=:I&,5D+9+WA]9=FLC@@^<`]=R]D[@\59\8W6+.<QRHU2
MD(.=X;S^OM5SM"A;/[P#D_9-=L:+I:YT^T0N@(+<$:E.[5JT=-ZV>6"J16Q-
M=\5ZC-6Z6\@<K,+BZ6.BMX+E%XH//LOGE*RTC5-[\>&U$:\8`FZER?XL5*YT
MNG*0$-R\C;"]/"56DHUUXP-(OTZ14]<V*"DYZ&<,FRBVN6DL9-TF@HF!A&<2
MR%JVS<>*_P"\XWM7*7L#7BVP[YQYUD2S0Q-DQUCO$[L6O[4Y"2EFKBC*2L,I
M82R-+K"21QA$2D2@HHA"IMFS4I0!Y->K9_E9,!@,!@,!@,!@,!@,!@,!@,!@
M<=N>]Y7_T>Y;CO\`X_Z+^QW67]%0F:O\K>Z5^,>S,694P&`P&`P&`P&`P&`P
M&`P&`P&!2)^`A+3"2M;LD4PG("<8.HN8AY1JD]CI*.>I&0=,WC5<ITET%TCB
M4Q3`("`X$?\`V-.*/Y>M2_0J%^+9KM;[2SUKPD5&QL?#1S"(B63:-BHIDUC8
MV.9(IMF;"/8H)M6;)HW2*5)!LU;)%(F0H`4I"@`!T#,M/)/5Z`M,4Z@K/!P]
MCA'Q2%>P\]&,I>*>%3.55,KJ/D$'#1P4BA`,`'(/0P`(>D,#S/*C5)%K',9"
ML5Y\RAVX-(AF\A8URUBVH)H(@VCFZ[8Z+%N"+9,G8D!2]J90Z="AT#XDZ;4)
MJ3@YJ9JE;EIFL*BM6Y:3@HM_)UY81((JP;]TU5=1*HBF7X3<Z8_!#_H&!<*B
M::R:B*R9%4E2&3524*4Z:B9RB4Z:A#`)3D.41`0$!`0'`H4]4ZM:8@*_9ZU7
M['`@=JH$)/0T=+Q`*,3E49*!&R#9PS`[,Y`%(>SJF(`)>G3`]#VO0$D[AI"1
M@X=^_KCA5W7GKV,9.G<"Z7:G8KN89RN@HM%N%F2AD3G0,0QDC"01[1$,#PQ%
M*IM?9JQT#4JS"1Z[DSU9C$0,5&LUGAW@2!W:K5DU104<G?@"XJ"43BL'?U[O
M3@>Z>KT!:8IU!6>#A['"/BD*]AYZ,92\4\*F<JJ974?((.&C@I%"`8`.0>A@
M`0](8'ADJ73IEI",)>IUF585ITQ>UQE)0,6^:5]Y%E(2,=PC9TU51BG4<0A0
M040*F=$``""'3`K*L;'K"N*S!DJ+H[51T*K5!07*C$Y%&2BXF((K'9J)E,D)
MNHIB4!+T$,#&^QM-4;:;NBN[8P.O\@K^CL=@U;D8E934XE2+=KWREH;.F+LD
MU#*UJZO$CH&[!,)4@$_842&#(C2'B&$2A`L8J.90;5B2+;0S1BV;Q+>,31\L
MG'(1R*1&:+$C</#!$I`3`GP>G3T8&)J1Q]U=0X#2]>BX-Q(M^/E>5JNHW]AD
MW\S+5*"5@4*J5HB^<K`9^JA6&J4>FX<E6<E;)]/$$YCG.7.Z[:IK:L4ZT;*N
M42B[4L>V+)$6:WR+]T+I55Q7Z=7:-"1<:`D(6-@8N$K:1DFB?\L'CETY'JLZ
M6.<B_<!@,"PY+5FL9E\ZE)C7-#E9-ZJ*SR1DJA7WSYVL(``JNG;J/5<+JB``
M'<<PCZ,O:>93$<*M7J73JD+HU4J=9K)GP)%>FKT#%PHO`0$XH`Z&-:MA<`B*
MINSOZ]O</3^(XF9G>2(B-H7(8I3E,0Y2G(<HE,4P`8IBF#H8IBCU`Q3`/00'
M^.15O0E/J59BT(.N5:N5^$;/1DFT/"0D9%1;>0,X!X9^A'L&J#1)Z9V'BBJ4
M@'%3X77N].!]3%1JEA;>2L%8KTXS]:MISRDQ"QLFV]=L@(5G,>`];+I>M6A4
MR@DXZ>,F!0[3!T#`JR#!@U."K9DT;J`W3:`H@V11.#5)155)L!TR%,#=)5<Y
MBD_VE,<P@'41P*/#4^I5Q],2=>JU<@9*Q.0>V"1AH2,BWTZ\`3B#N8=L6J#B
M3<@*AA\1<QS]3#Z?2.!8^O\`2.OM;S5PLL#$D<6.ZW6WWF2GY=".>S3&0NZT
M:YGXF&E2,&[Z/KCAQ$H*`T\0Y>\G<8QA`!`N63BQL>1-JB1@R(DQ6%RR2*U0
M*FS<"58HKM2`0"MUA*X4#O(`&Z'-Z?A#U(I+:GU)F>QJM*M7&JEP.92VJ-H2
M,0/:5#MSM#J6,Z34IILYVBIDA%SXHBF82_P$0P/W@*Q6JI$)5^KUZ#K<"W\;
MP(2`B6$/$(^8.91QX4;'-V[-/QU#B8_0@=PB(CUZX'C;TBEM$'C9K4*NV;2"
M1$'[=O`12*#Y%)0JR:+Q)-H5-RDFL4#E*<#`!@`0].!;JFGM9GN-,OQ*?%M;
M1KUI<F=.>1_F8QC"A?V]?96QXG`Q[AM`/)B385AHV*^<-5GK5J"R+=5))TZ(
ML,KL-5:P>PI6X]<@3VM!BI%HV<T/'FL*,8L8IE8Y*:%N,DFQ5,0HF1!4$S"`
M=0]&`1JM8;RHSJ%<@4)LRJZYIE&'CTY4RSDBB3E89`C<KL57"2IBG-W]3E,(
M#U`1P*]@,!@,!@,!@,!@,!@,!@,!@,!@<=N>]Y7_TNY;CO\`X_Z+^QW67]%0
MF:O\K>Z5^,>S,694P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!QV
MY[WE?__3G-GO>4P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!_
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g716112pc_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g716112pc_001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)R`P$1``(1`0,1`?_$`+L``0`"`@,!`0$!````
M```````&!P4)`P0(`@$*"P$!`0$!``````````````````$"`Q```00#``$#
M`@(#"@P#!``7!0(#!`8``0<($1(3%`D5%B$BUC&3%U>W&%B8&0I!(R14U9:7
MB#EY&CI1)5EA,C0W,[4F-G:V=W%"='7!4F)R0].452>X*=<1`0`"``4"!@("
M`@$%`0$````!$2$Q40(202)A<8&A`Q,R,_!2L<&1T>%"@D/Q8O_:``P#`0`"
M$0,1`#\`_OXP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&!$X-\HQ,X]6!MSJ9"RQG);4BO0;$'EG([L#>TSFGA+$QR>T
MY"4G>G4J;UMO>OUO3`EF!"C?2N=5H@X)L=^I0`JTVT\Z,-VH$*(-M/I][#KD
M*=/8DH;>1^E"MIUI6OTZQ0Q/\-''?XV.:?Z]U;_2N6I'?E=4YA"BC9TSH]#B
M0C++\@1,E6^O,12L>+)7#E/C9#I%#,YF-+;4TXIK:DH<3M.]Z5KTR"=I4E:4
MJ2K2DJUI25)WK:5)WKUTI.]>NMZWK?Z-X%;;[/Q[6]ZWU?FNMZWO6];O57UO
M6];]-ZWK93UUO6\4/S^&CCO\;'-/]>ZM_I7+4C.L7^AR@4RTQ;M49-9'OZBS
M[$Q9`SP*#)VJ.C4:87;FJ'QG]KEM:]BW$J]7$:]/UM>L&3`66N6J$LE5[`$L
M@YN0Y$7/`%8!B$B4TAMQV,N4.?D,)D-MO(4I&U>[6E:WO7Z=8&&.=(YW69ZA
M5DOM+KQ1#33ZQIRT@Q,]+#^E;9>5#GSH\A+3VD[]JMI]%>F_3`QK/8N1R7FH
M\?J?.7Y#[K;+##-WK+KSSSJM(::::034MQUQ:M:2G6M[WO?IK`E9:RUP`["8
M.V`(%?)*>2.9+%8`YV>J.E"I"83<Q]E<I3"7$[7I&E>W2M>OIZX&:UO6]:WK
M>MZWKUUO7Z=;UO\`<WK?^'6\#]P&`P&`P&`P&`P&`P&`P&`P&`P&`P/+GDQY
M7T/Q48IIGIPD^BG6Z-U#2KB-T,6)!&^:\JM?8&JV4;F3XDM1:[5:B&&A"64.
M)?GQ$QU;2M]GW%B+R>>A7W%='CT(*(\;>L*8.WVS\)JIHK8N8!AAOR;H_,#/
M4[CQ*2W,N/XF!4&'50V*389<=L*^;#2&$N:97$DR37'Q?/C_`/<;&]YZ=Q#E
MZ.'W"@ENW^/]6\E@TBS7?G,[8SF5]5?]TE]V%7#Q:02.$HW/WWID./O:AJ)+
M6G5;5\FD"=M1=H-O[N7'(!OR%9LG+^H!:5XP]$?J/7.A1ORM8Q-8J4+JO0N*
MD^F3J_7SLZX)`A[Y0M+EQ&H#T]D*28([;VTW(0T.$X>*RO('[BU=\;.>\ONO
M1.#]I4>Z9RN7U1OEX2%5B/0ZVQ"Z9X^\RD4LL)W8F8LF]M$_(@:ZJ##?D)VH
M?+82XI[X$NDC;>2OWONI5*<31,I7#KY?.9/!?)^T0NJ`KES!H&4JWB<_"3T<
MZ)#SK2P>(1B<(Z*DAT)9TY,:G_KZ:VR[K1>$^O\`U1$9]XKF$BP\.K1'C=\8
M(]TYI(ZD!9"6WFMCE#Z]J3U-IE:QL:S1"1I`J%R0G-.NCVI"`,/:'I'JC3BD
M#AXN`']YKC%N#\JFU3E'2'C/3Y_'@3M<M!2DU"=0K;U:E]NNDJG7E^>>DLC+
M#2HW"B,:4VU\[4UTA`=AN/1I'SIEG"7LKBWENST?^<+/Z1SF5X_57QSZ%)YI
M;KIT?HG-7ZS,/C@@.RE)+1,)8I<8.%@@K8)=W)(*C:6[,VUK7O9<RI,558VD
M/2_-+QDX[<Q-`Z7U434[.=50-AXL\987H)"'TYKH#E,,1S<$1+"JKY%7+S3;
MQ'<C4&"]&:;E.LKEQ$ODC;,Q<*SA_<N\+B&X4>'UY]XL1"O'8-:USWIB+9*C
MMW^N<R9'-5=RG(.[L9"W6P>B(*^#1*7"D?7,L+@H<D(+PW)KSOSO\4.LGI-9
MYQUT;;C<.!(+2(8H#;5);#1.;57K$DY]4^`8AJ",4VZC5+EZ<W'21?4-VO1%
ME^*V)V[HS5K!^Z/X13Q8PNCK)J+$+!)]JBH)<B[.,(-TZ#3*5T)J[3Q,[GS!
M073350Z,#E"BDEEJ&6638CPW'Y*MLZ'#<SA3[D?AZ#;@Z-]*-AR4^N],LZ*V
M2Y9UB);8HSB2SR.V()55ZDI/C"7'DUYURS1'X[<D0S*@.OH2V2'JE#AN98E]
MPWP\#/V-DKV<7`;JTD@R3G2*]<$BI$4-OJZ#IP$537U#[-5P#W#K6W.*#G)0
M^(Z'<0X\E3L?3PX;D*+?<Z\4`-@2".&>D`V8U/NMJL9L_P`?Z17A]((4>[\V
MY]-Y_>!YZN#;16.DFK+UNOMC!$D>EZ<V4B+1OTFPOJ1PW+:D^;?C-'J?+KRW
MT?1"I]AI]RZ+33@BL6XM";YUSB'`F=%Z#;G!X&1^0*30?Q6(P8)G/P^(/ERV
M8[JTON(;V3C.2M9WW,O#P8X'AD+W=XAPS.;&MU1WA?=-W,7,FDN:AP35EIS?
M.5V6JZMQ+LU1:"J(Q8J2^[)`W$VZE_6]%X;GL#FO1J;U_G]-ZESPRBPT:_UP
M5:ZH;1$G0/Q(&:B-S8$EP>4C0B8]]3#NM.1Y++,AAS6T.(2M*DZ,S%34IO@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?YCW?>G]7\?/NL>5GD5P]N
M7%O/#O+CM70G2D*&\_`B@F^M$*^6C6[4325;IMEW8&PY'3F]-K;(Z1O>E*3O
M6^B/]$KP_P#*3G?F;XZ\T\B>92=?@-^!MR"05V0T^3I]L@*W!M=+-Z:]/B+5
MDXP]&7O:4Z>0E#R-;:=;5O$X*_BN^\UR$)WG[ZU:XN=)NUT7UUWQ2YL4LL.%
M!FD0(^Y,P@$HO#CD-HAR)(UB=MUM#RDM*4G6E;UKUS<9#8K_`-*OXX_TQNE?
MZA\S_P#XV3D-6'WRO%&L^&`G[=WC!6K-/Z$"Y;P_LL<7;3HH6/*&$6WNTN\/
M+?@"M+'L?3RK*MA'Q;]%MMI5O];>\L8C:K]U3[J/3>IVJK?;+^W'*G7/KE[:
M'\^ZUT/G\M#\^,1F#FV"/*^?V.,[]`->B04/N6FPH>TR'AMN,H>;=1*<CR(Z
MR(OS[^ZCT%^DU=_J'E1;!G0WPT-ZX#*'S^IS*>-..MZ<FCJ]./JT9(#H*U?$
MB3(2TY(]FW/B:TK3:7(:0?M;?;1H?W"?)KM'`[5T:P\U%\LHUEMT"QUFMU\P
M2,/@>C!:.U#FPS'I$C,R(Q54A2F][5IQ&DZ_5WO+."-BGW2^'`/MK>'/(OM3
M\6Z-9>L&O)_R%G>05U>,!A`8T[7HK=-I%(I:Q(%*XDD?9NCB(\J.O?\`C7'@
MZT[_`%=>FT8S:K[_`+NUT>X^*_F!Y9_;7Z[N.(/.$"]F#"&96G!;'4>4/-U^
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M:2E"=)2G7Z-)2G7IK6M?X-:UK,CZP&`P&`P&`P&`P&`P&`P&`P&`P&`P/,WD
MO5."]/#5?EGD!SN/TNM$#"NIA09"'N4-B6/A3X[H0HPXMHB.DMSA\^(RN.WK
M:V97Z[$C6V''$+-;;SA2-;&^!;_4@/D'##A`O5.C6,E^%DB2KM%@;Z'8:_5N
M>6JQ1:MN6_S41?Y@FQ#*P7M,.*B8^N8@8\0<4]\*RSRJNCBKXCPWY9VZD0ZW
M3[70K=R"C0?'0";@2^P@J2)I/,8-'=I=(."XY1%.NE6",^1R/P\P8BSH8Z9*
M>UN6T\IE2AW3#`M\W^WDQ5NS]$$TX+9:SW"P3*'VHPV7NY-AYCI%DF=5L+7T
MUB/MN4VD60[;7K/+37VX<$DN;]<VW(4M"]CNP6#TZW^&74;35K%U,6X=,\]#
M(+5:Q&ZET@8V`5OK_,[&R"C-M#A\ARU.]/Y-62K8MR.Y.<9%LR$M[AK<4X\4
MCE&$(15*#]N`*'A52GU2CCJJ1=\BPH]D0+O3-,W$\D+57=^1"HIEIK59A5B_
MW$N-BRIB9#8QB<ZB)#=97K;6BWOS=:B\=^W[T-T;0ZG2B=^0`H(`J-,&B7;K
M=)#U+F-E,E:H"9NUO-$;#$E!)74YKXX9J5IZ0%-;0TVX.?0VH7N=6A^/GV[.
MBG:X>HW/':U=[7!Y/?Q1(`1[3RBY;F<WX8NB\[BR;`"-UB;&N%;X%>=P90C<
MS\0D`9VG)K#["D.X)G=&:[:-U+Q1@U[HUB!15`0W0S@WK'6&;%1;RTS+.WF+
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M"<MTH5S_`,'_``%Y+R%`E'5^A&JZ.H!#B]K,6I@%9+4?#$:1SZL6*G'8!?E9
M2S1I[@#D(*,P&9::>!/"FXX]F&^E:%%Y;IQ3.S>%/A]0GX"XO6NA5'J-8CDQ
M5%M1475.A=%"V3JD*Z$"$UL99^5V$]?BW2I=^)J/19R)^[8^XU#)ZEKBPF8Y
M.4H%1O%7P,KM3YC0HEQZ+8*[PKCIKQAHYRRTFDE'I_-^S`.?)MU("LN\1>E]
M$>Z,JU#HQ3XV)A",2ER&-[8=D2$N%Y;L^LS:9A/"OP4Z(\%YT)Z-TVV3'*_>
M34-R9.9G$;#%NJ^67VZRK+T0OSC<^X6]F8'IACVEBDPV"DCQ<B/J&Y&84@G+
M=&+L->//A=:/R<T1[)V$J0#QH-7KL280_']3XEVJ=.J1OG4>;_!E+@]%J]G`
M.!&[,"VHD*(.ZBS2T9<C:)&"Y\&.YKXN>#*U"G*O?.O##(]$>T,RKH,87;$_
ME2Z#+Z"GG[%=N63BY.0+.^)HZ>)8(3'WFQ5/C,QV]#V],K$SN_G\\7LCFG1^
M`<'H/.>,\^)6$E4JV*-5:G$U5HU^6&H%*;0\1A2;S%K(JEZ0&3*^CVMMSVIE
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MF"X/D_))'(E1$IB2%?+[6'MH%3DBHKRNX?/4Y&E76`.*?5'688GXYA6669%V
MHQ6!2PJ@L0@P9)6](G4X4,BJ=*3(4AMQN.I._7!4NTSY1<;7/)"I1FQBR8TN
M3"[&E>?7^$1G3!4BGP']#!ZZUN=.U)+WP5`BI2W\LR?+3'80X]K:-"I=IGR:
MXI-7\8V\C)?M4)V]*?8*"Q++1)VI?,E1TF.BA5$A$.\#'YL'3_UL-$I'SM-;
M]?05+L73R'YK2>;?PGD)QA\),%6`I7H"*M:8QZR(KM?*V:9^&@I@5@NW!V'#
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M3[HY4`>[-4X,^*K?I[FG=-N>]IU/HXR\A#B-I6A.]:G(3K[??2KM]EK[E?0_
MMZ=\-SE^-7?[,+E\IO)Q?TPEDJ??4,Y/TMJ0Y[($6/;XS.JM:/B]K;!N&RXK
M:6HRMK3C%CS+]XGE8[NGWX*?Q0P6+`1'79WB9S8H;`(CN'1`^YI@@)9(,B6A
MV*LG"9G;<8TZE3>W$Z]VMZRQD-J2O[K;XX*UO7\[/R=_6UO7KZ\\]?TZ]/7_
M`.M?]W)RD:O?[QIRD=PBQ_;SXH#+E;$+Y-XHD.<B3AS<71HU"IYVM5^$2*JB
M-1X>B,]J"EQ[;:$-_(K?IK6OT98%4^6_VL?);[2W/?%CS@Y9TV59+;6R8,EU
M6Q5:"IL/R'IY&6F956(.M):EGN766#+4`GO3DI3+E[VVZE#1%IAI$V/[,?MT
M^=%!^X'XSU+MU45!$VUE+=9Z]08\A3LGGW2AT2.X;"J0^I4EP(02\B<)DJVK
MZD=(:WM7RI=0C,Q0_EG_`+M1_P`1CR[_`/N+]#_E_J&:G(>.O(+SH'=4^\U8
M/,4ERN[>1?+/'SJ#0KG'/:#N4I9*M\;24`\\,*F+!V:,+"D>AM.61SW1?22M
MW;:-I4KW:5A2(1Y$_<&FD?N<<R^Y)2O'KI?CL^,LG.3%VJ%S<EO[NDJI0]U.
M_P"QA3\LU>.M%OY4IL?(CZ0Z[IU*WE*_QFM:5A0](_>.BN=X^\MQ>%RR_+JS
MO9:=X=1N<=1#+F+<KJ^A%745&^BG!DR!/4H5^+1Y["H[[+V]HU['$*]%:D9*
M]=>:OV9?N14WQ@[!=SWW*NC>2E9HE0*7BV<;M!KK`T?;:O4HCQT\F/\`C?2K
M:%)$QHV$Y*CPI43XI:V?C]Z5[1ZK@;&?[MEV?F/1O""RT*D\OK/,[=R'I3HG
MI#]9=*2F^E$K+7Q94'TXS+-3")+\P&QD94&4QM]<9A0W6HR68ZFF&F[,?T.Y
MD,!@,!@,!@,!@,!@,!@,!@,!@,!@,"ANZB^,$X%9;Z]8=UC6R1&'72<.VFJ:
M65HH*D#[+`25`3Q\_0"<!?<03VXO41EGVO.*:6VTZ@L7T456*_XK.)@^0VQ[
MM4:C7BX5P?;K,<T)BL0N8_B@N9!_#29),6-3XS/*=.18R8^YB&(3"U)0VA?Q
MEQR9$I=?%,Q=[S*-E6WFRM:KEDLM@(FR\>K/KMA6,&:##1ZIK3NCF_YN33IA
MEB,G4%@&M4KX_P#*]8*FG$J3X55ZC.<E>N%4U38UDEHC`6K,3>^E+5U:*]H.
M.GC'OKY3`5]G0R.UIY[>Y+>XR=K?3M&H=V;ZZ7$\1)I+35I+)?,FB<`C$:$&
M;"YJ47,!'NAURRLO-O*`QXBP_/Y3D,J^XV+:1]2PX\G3[J%4CDS!4CX=-#B`
MHY9::B`-E3094;+LLUQGYRUPD]1+P%QXTYR-/AHM%)F2IBF/EB14#)C#BFV&
M)#:1W)R"J7`^$ZA2XQ\?4F:947AVUF+8ZB)$IMFD220_9C4V7IB9#:30I6H$
MN3[WFV84C6G=Z^7>R7,L3S6E>.8+=9OU'.ZDPHTUZLUIV=<SQ`2Q9AE633W=
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MBNBL+YC=:\.L;\DQ9RHPI;K'T]CG,WI<^`-L\YV:2C7$XO\`%RI2/'EJ'H=E
M(;=BM[<T(Y='H5=?X1WGIO35Z&&9?0>2;K/,#]HB3K`!V+DLR0/6P2JF1A$&
M(4@C73KC"USV&_FCS&7X2UJ1I]G9,8CP5GSQSQ2(@P5_CQB-2K\&XLB*P0N5
ML?2,>M%,E@G?S!(7#MAR.*)EIM4'_5+-KASY[T5OZAG;CN_E+BQU+8\:*GUM
M5RK_`$R*`$5VLB@8^EO-W(2!7/ZI7@:HMJF$+*5D!SA*?4N;(VJ5#B150X32
MW9KRM;]^";JDP$UOQ"O$0'S&M6(.1:+#BT00%"7$[M\P$?F#%%H+,O4]3DF$
M4>XZE32T.Z==2%D.Q5_XE]S0N<T<DQO'>3OH]5MM;Z'SH95;O(!F[79KGNN1
M5E7:I9+4L?4RXB_2SJPTJC]:F-(8CLMJU#-)8]J5M>D<8LH,A^',\<.CB[V,
M=KCMKFQ0H%N_6!(*"6M;3VC@L<,>(:U!`'BLS;TUO?M@)+)]N]MR$[;T,69F
M5+Q,YZ6L->.'Q\`U%JL6ND8!V[V.9-#4M\A5Y`&CB]R"CJH`\;);&*&B(V_J
M&&Y:%M-^V7M3H[IQ<%NH/BXYS*EP+-(>)\ZO_03]F#V'5F-N0B-IN--O!:Q&
M"QID@Q]%`*UAHJR[O?QH9?=U[4MR=Z<2+W6ZUPJOAY/D2:@?M0D01$5BP`2;
M`WHEB`DHM0B2NC?FNMDR@PU&D,#R#LJQ)E15O(>DZA/;3K?T"5,#NS2#L>^&
M&:C%[`<&VNR@"<D"-EW7G!DI"(@!L)5MJ*WY6QU@"%8\-E%Z+"B,.$T^3<7,
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MNVJ#=:&:(SV=VA9:(>(`I/.U3$3$ZF/_``Q6=*<6EYIMQ)<89:F<[\2U-RBU
M1DUF6.KU]A^Q,6QRMB@EKM=Q!3Q@R*UJ6VTZ-L%VB1?HV5_/#>D*6PQ_B]K:
MT+W=6!HE!\,&#`<=0B]7<GAQ-0KX^%`N1*?LFW6"R;15G_Q"81DRCYL-/7[G
MI*)+LGV/I:F*4E;2,'<MKQZ%\T#BNAL\ZMXFZ2#G4K;>[P4"N.+',VV_.QK-
M^'1V]SB;,)J%7ID!M#")#GM;TE>](VY[=$GQ>@\(8#`8#`8#`8#`8#`8#`8#
M`T6^(/VD.@^-/W+/(+SM-=GIUJJO9Y7<7QO/1=3-C;`"UUGH`2Y#TSCDLO)'
M3-AHPI3#WQL(^5:]*3[=:],MX4+G^[-]K6M?<KYA2QXFSB>8]MYD>^MHO32`
M:47CHK)AQANW4\Y%&3!Q*6+(MQV9D12'M+AD8K;B/1+CZ5HFAJ/\@O[OCYE>
M2?2*EV#H7FQR[?3ZSS;FG/I=V'<\OT0^?E\N%J#!+O,(1[='E0K9.@ML+E/L
M+2I<MI3Z5:4YO6K8A?\`TYGGA_ZFD_\`_F.Z?_\`3L7&@LGM?]W>\A^S\=\6
M^?'O,*GE[7P()V$18;I;:E?+/,M^ND=3>OP?<642MT@M&8KXQ:86T2'WM;VG
M6V_8C6DXO$?TY]%X[1.P\?LW$.J`8-OH-WICU(MP28WOZ8H+ECT0I"FE?I=B
M2V7$)?C/HWIZ-(0AUM25H2K61HH^VQ]FWR6^V_Y+G^B4CRKI%TX+=]$Z[?N5
M%*/9!YNSU&+*(2:$9<)MG90:)T2H./HW]8B-\+[3\QC6D-R-;;LS8B/AE]D+
MR)\.;7YA7ZJ>3G-)ES\B>#=+Y+S\K&H-JA:YS8;]=!EBAW$AI5B=<*[KT&*Y
M\3+.V5+E_&KW:1I6MV9L>Q_M`?:H7]LNF=?CVOH%=ZKTCK%D`.2K;7ZY.K\4
M92*F*<8`5IILL0)SW'MFBQ*9)7IQ+;NWFM>W>V];R3-BV?NN?;R3]R#QP$<A
M$W`'SR]5'HM?Z!3+N>!2K!!'+AQ202Q"9,*!-'SMQ3M?,O(]6W=>DAIE2M;T
MGTQ$T-/U-_N^ODM$[UXE]EZ#Y:<NM2/%[7"`$:'%YS;HY6PT7A5T<L%=#ZG2
M;*ZS%GLU]Q`MAQ:7$(:C-*5K?Z=8L?U!=,I4;I/-^@\ZF27(<._4BUTJ7,:U
MO;L2-:0,\&_);TE25;<8:G[5KTWK?KK]W(-0WV=?M<]5^V.-[C6[KV2C=9KG
M6)-",#$UBJ'*Q/`G*A"/"ISLK94F4;G1#`XI']-)4C;*XOZ-;TO>]69L;L,@
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8%!=SJ_(+&W6V^IW1BE+G(L50&.*MPZJ2
M+4#N,*'#N-&5^(JW^)BK%"A1MRTQTHEL:80ZT\PI/OPL7T1`M%\8+/7!//)7
M2*>^+$V&Z6H=!B='$(EMDY<R[";6I4ALBIQ<4;.LA:.IO>_;&<86G]&XR](&
M.;X(<MX#:FBIP7T#\/D*F6JU2+-6.A#$OB6XA/I+]ZF,2G5SQ\$8Q_#D9BD'
M%M[3$9GL;TMEUJ,Z@MS#JB*YXLUF'7M"[Q60XT2Q7"=<97?XD:*D?-Z24LE5
M^BU+G:7,B3+Q:E18FM;<4\IYB/K:E*;TH7N5=4N5>*,I5\G5"Y&IL`"6J]#L
M5DA78/)$CVYE8)MMA&;*]M29XO=:Z!*:?^I?D/PXTA+</;+3,9+8F9ZLQ*HO
MB5618&Z2;UJ;3;,9M_.:F>1?(4NFU#5NK/4"%MKPTO'?:C#1A-!@N^M<EZ2^
MU,^E0VM#+++;8O=ZI%VRD^/UXC%X%A[&-I91FKP>;K8W?0XX>DBJNWAJA2C@
MJ3+BS"$X!&N!>=$;:DQD2-?(X]\FHR%,"+T9$<!X78&[;RH;TPU/L=4ME>O]
MOO<6XAG;)%OES*6#G0M@B<9CJ#,6*;JO2`?X?]$U\;>FVFT:D^BDC'-@G:[X
ML"I7-Z!"Z$Q!D%QYJ90B`WH`V8W*;A=$IKL^"T3?E3HTR<;MH]F"RVI#JY/P
M3&4;TZVK:1CFG@V'XV;H;/%1O0:J^`M9D@,'AV>@"WS90RR:@DIPX:^F>J<_
M)9*2(R?C1I6_\H:1KU^9OW$QNTJ,D..UD[9+/-ZB%IYJZSA@TO+5=J_!W*G5
M9@]3HL&/%*KD,,NBYVI:'T)1ZHF0E?+_`/0748,4("<+X6,+5VY/65-GG\S(
M63HRBADO4R+J;)9"-C9+WXY.&AH<Z,[N;&(1VV([L0,AZ$K>HGU$;2VRW+K3
MPGBSJ(6BR[M2F1EEM$'KEEB:ME?3'M)>R6T39J^6/.IWN46'RR4-,8>PXXII
MV%(<82E;:D^TF+N<S@^.''$/1:=U$-&1&B/"CR2_2!YR24D4H7K10G9IQ29)
M(RS(UN0Y*(2W74K7)E*<?WM2TZPLW*E[?SKQ/YU_!T$MG1S;38PE&Z)11,LR
M`<AQ1%GZASEJ"?7[J_'@R08N_NAO2?)<=)+CONQW7Y$1Y]A8CE.271.">+DY
M(V.U?H!G^#X4+N:VYMNI)\<+`.1+#*?-D`Y$5.KHVKG:]<]LK0U%C#(@Q$+4
M%N(AME6Q>Y94$!XZTZ962*+S7(+]1(`ZR&W-OXY262W.(%WH,<-(;>G^KY$)
MJ^DXLUE?^,;D>WYM)4S^@F+"0U>-O509SI:+=!_#(O0!][M$I^V1ARJY=(0"
MN\Z@13D9,Q>@[KT&HQ(Z(;F];>E)5[=;<7O6%QA!R%+\0BERAS2UP!P+9R_8
MIJ0S8S]>FQHH<_>;U,'#2+-IB%P#D*S6D(2?UMGV$6-#T*TY&]BO48_\K)O-
M$X%"Z$];;S>8X$Q&,UWK6ZX7NP\,"C6D&NJ507T%H9*4Q*V0D0J\."J_QRH;
MC;GL2SJ1(4XLESDC)\+XW75?.N)ZO+A=EH->KM70=8N`Z:E,(Y6)^I%R,SHB
MY!%*886^O/B7O?J-[IJ'5(<_Q&]%QC%4[`GP\NW*G"!&S&K3`Z.T/ODL:1M@
MV?T`ZQ=SMS`";F^!$S/;'AS"'8I<YM"&6F(K3L?W,-I8TPDO=:U(\#QZN-.Y
MB%']@;JT+F,D;U6*(@V7GU4G)F/@"EY:)]#J:`K=>T\-@R91MU"H$=,*6QN?
MKXWHZ7D$Q?J!?C;XX%9?2:Q<(]*'VZ3-9.5T$<W81=\)4SFUNO0X#!BD))5H
M*Z)J+Q$TVQ`<@)F+4RIQ:T[;0L8S%,?"Y)X\7AJ1`B=F-6.;U2V7"^CW8W1Z
MZ_8BJSHLU4KV"#3H(]!8A7)%6><"NQ7%R71L`8PU#<BJ@MK:%R[=YI7B!TB!
M;Z_?3=4TL\ZNP&`\CH;((V`]:G7N2_5BT@S\6<%CSZZ+@0TMH7M+^WT^J=J>
M]NW^2.49+%19?'GID^I@Y5]J5O*4[H-PFUT"8.BGISEJ#;M/-C@_\$((9>,P
M:Z[<9(QC?PNH2_\`!Z...I2I1,7G.3R#PGILN$/E7MB;,)HHPD`%1?XA&7IB
MK"A?1*\`ASH>T3&A5@JO-][7'GS/H7@KTB*U\,2:IMPM[DI+4#QH!\>['R.J
M]3Y_2XEZDR:D:)$+'46B]&*'$DWX,"%/$20!W9ZIMLD9@54Z;)EP)D):_FVW
M%=2@7,S;)E.5^-`>.*/,]&(U\=$Z`S0:!*K]OB.#*)TFX'P\4T`IVF!Q&/"-
M70X.9:GLS/JFV5J=^'47WN;P7*_^)C.6!*9^#<AL(VR5883D17)8VS,6I$<F
MW&AH?B223,F5O4C49++GM6KW*0XES]*7-*V2;ZK>PA@,!@,!@,!@,!@,!@,!
M@,#5%6_N_P#C;9W[XQ"K728R^?>3_4/&TIN>.KT9)$?R3DG5^S6GNX3_`.J%
M:I_&%U;BEB:C3M:3-=G0=L[C)]?=HWPW>R,Q/O+<*%<@X=V[IW.;WS>E^15Y
M8I7*66+7Q[J]D/OO<?.=<UK=<XMT3H)1BTN:'0*ZQ6/8JS2+(;@Q$0=Z<6XB
M6?7-U'1;S_G[?8?8^$\-(>$G?!=Y[QS,SUX9")WCQTB;H=&J!:F"^@S>CL*[
M"J4`(4-?0Q&ID9I$K<J3(<CP52W&'-:IQBKO!"V_N[>/I#C?D%VH'3>DD:_P
M_L'*>15^!/;IM6E]Q_ATL-.K''.D\O(VFVB0+?*^CD+?I\:8-2A+3@R$].4E
M,?XUK'";B-5Q5GST`W3PZZ!YA5?C/3)X7F,SJ<2V\\EF.6#;!ICB=J-UGI=A
MKET?Z`KDMPI@IFM3R4`P,/RH)@>QI4-;KBTMX3CW<5)B_NY\5%C(L_MO/KGX
MZR2?B-8O-0,%ZI<.-LF#/(!ZQB:I!'Q0'1S&G^@=!0_/4/!Z5N8QL3(1+U'<
M4RAPO">F.-$7[M/,I)3N"'>/]`'UKQJXLUV;NA\G>.&03%&C?S<*QY(SJHWS
M-_J*>HV,P("W06"ERQX=\0Q8)7TZI?L:==2.$N2O_=MY(5X#V;MA3C7:!)OC
M]PI?.8O(Q?\`!E?KAUSHW2*,`Z%2J-QJQ<[Z':.<W:Q2:_8FU%HZ3#+E=7$F
M?B:8R(CJ]+.$W$:N[U?[M?!^4FN%PWZ+TRX5_M?&N(]W<M%47SY35%Y_Y%=(
MK/)^1RBM>/7D':;>7LMRLR4;'5F&9GMPX<J1IE:&O38C9,WX.#G7W7^9]+KJ
M;N"Y)>G*(=\AZ%XT<[/PKUPVPE+W?K_VXEQD=)W2:ST\Q=:*$B,@Y]F6Y8X(
MI]ZNPUOL-.N^C6#A.7@R_5?N<A*"<+B*;XX=F[#'&>7T'P?C%Z>>XV#AF^\%
M*I2;/!%!V+YTJK3Y0)+MMDPI<_;26![X,@N3MIEM#C@C9XQE;I`?NBA;];IO
M(^2^,_;^G=\'73K]5(\G#%>1B$!!/!)M-JW5+]8NBV'H@WGPFFB.HVU=1'KU
M/>FF3HR9J)&<BLKE)'"L9F*75X]>;</R,[=V3CE7XU>:\UX_%V:/UVVV>V<F
M954>J+K-6M3E(?H(J^E.D2A;\"S[;'V1L7NOEWA\O<*4\PAI]TD[:B]7N7#)
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@><^\<QKO0"=!DVSH":,`B:NE/(14RP(^
M7=(_2@+5<E5"+.L$6:TRHM`;>1O41"".][TJ.ZTI.][+$TH5/+O%&[#J]!C=
M8>C5ZTL$:DU3?S;6!JK&5J-2OT8M'GL3!&K*.-!N?VPTB;&:?B)U#6F0ZUIY
MM+^RXLY3.&<5%?PFA)E_'RZUUZH<^Y33(C=HA(>15*[3(842_52\A#,0O:CC
M"X?U+D%N0S);%C]O:>>T]M8F92DQP?D46\QNL]'ZP;,V`._%:40N%II0H5'(
M#Y5#9D,:8B`P[`EATC61:E08RH\9F;,>=;;0_,VK9+G*'/%\>N-5ZD&>?F>@
M&)HBVFJ;#;>.V:I0B#3E+!B.;U"K!UP0HN,ZF+!K3,/:'&9$V5,2Y[W%.;VE
M(N;M,7Z#QE^8[6'+?#T6=OA4]L/JU`M%F[9/Y#+YQ-%M0-M[E-N,4$FJ4F-I
M'S(5M+^]_%^KL7*FQ'C[XSQ"!RP_PM/&W3E&L,;<PET2G3_H:&X-OE1)D(L_
M4'4IX0`9O1*(S+D.O,0$,L1M;2U'^+9;W,H"YGX\[E=5Y:/ZI/(2+K3JY2G!
MJ+55DOT<:6M/5[)4AM%+01##Z;E!M!PS.B;FNDB3'TL5>];0VG;@N<W<C<`\
M:J1NX1'+C'#(D.+%GH1*[UZ%JMQ[5(H!N-7VD/LL/`X9,IS5!&-'<WI3DDB2
M>1[MR-?$+F4?JG'O%WEL^P@(ES:BSN95>MVJVS9)*L1=U6G<]MU0ME=_.9D:
M%AZ]0;W-(+*G"3BI[@UI?O7O7M<0+F7:B>.O+^C7'K=J1T=ITS>##9A,?GUA
M`$':YS>X<W8JL\$]$*C330Z!TN--(&Y#[3#*]S9NI$5_W)6XZ+IG0?,^%#0%
MQKP'MK[0V^"*W6ANQ_0Z:V_6:_"O5U.U\'5I4&&R_-B3[9;BD)6R*B+Q!G7T
M3BW--J3L7*.U[D/!.<O`ZE5N\RJO+#V`Q?P0K5IYG)?@7+GU2CTB^V;X"-:D
M-IW"HA]L>8@.)T.@L2$/M1XLCVOZ%S/1S1/%#@=?%5H>.NFA$`Q(-+K,AQWF
M;TRVAC%?E1V:H^7(55^??J:.%S79"1TIV8Q*3IIR5\^F6U)'*5D*YYR297N<
M6B1U*85JW+!H6NQK43O%>,#CSE:N='L8I^W6F='D(F&XUMHD'3CK,B*MUQQU
MI>M[6C2"8^J$<OXWXU4E^^2@E@A2(U@K=TK-F%7(A6TS88&O21_,^CDVI<X8
M/LL6M$YW.8S4Y>W]B7'HB76TI3MOVEN95J*\<_#N6S\D#K,$X_5"$!@J0-7Z
MBV5ITA5^?R!%ZW88I@9*#SY=YK5V_%+2ZXSO<B9*:E^K'Z-;+>[1;`CC'&1M
M8MW/8'2IU@<N=9I%?90Z4H=@L-:I$>UEC5$2!'Q:Y].@>/L71I,B"8EQ94QK
M<IEU,KW,1W$$N;MBIOC'P:XBQ4C^$(C8!$*40GMRYMFIUN'EYXZ?U-%KF&7C
M(8M$/.2XW9SL$KJ1MU&DOM+7I,AOY5BYAW;50O'FR]@K%_*=162MK$R,]3J<
M,M]=)#6)7-3]&688`B&H,XJQ#"EXXE96''D(8CNR%/N-H=<^1(N:IWN?\MX+
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M)6RGW"YNX=N!RGQ]&]5?[&NUCXEL8B_FTN,LQ:J[:B0VYEA'!K,N`;'_`(Q5
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M0AO1MM(D!(D402&S1,Q0D$)@`X@08$+[%;V02B-]1,DRY4M;WU;VWM$O&TCY
M/QX!R*`4AABQ\Z^5U7XSY*Q/#')C8FI5T=4ZL'90&%!H.HH8"+::TZIE4J0Y
MM;CSKBE:]HF;6UA#`8#`8#`8#`8#`8#`8#`^'4K6TXAMS;+BFUI0[I*5[:6I
M.])<TA>MH7M"M^OIO]&_3].!I&L?V5/'!8\5'_ATZS5R-=\(>B>(94LT4HK#
MI89U!^[1+)Y`6"),KGTBNLN"NF6H6S/VE$!,0[);^'>TH]IT^R?>TTN'VT/'
M#IU%HM,ZMW9%@US'G?=*=1S-."<-XZ[4+?UTGS`H$[36A?,*G7`8'KG&?X+1
MVJX58CI6VMUUR4F1M>M:)&^8RA>/7/!BJ=S,V.XV?R(Z3&MMQ\5JWX8V&W5*
M92`A-VD$K^/O_6R0-V($=9K5Z[Q#C1A9%Z'I&H$%#3@UN/(0V\D1NKIUM4,O
M[0WA]2CBSD,O9ZIQ75N\9KE:.*72VJZ!R@Y*\7AG4Z]S0&9F=CE7$VS37V>F
MPFG@VIZ!J=5P:W&993\Z7ASW3AU_ZKSC^&/-&/`Y[[;T?M-N332?%3'"H-LT
M5J:NHL\M,QIT!@4/9_#OPIQ(ZAROP>.]]"K7T#25[UM>MJPG*>7)6_=/MX^*
MWD*[Y)R+K=ASJ^T<IXKXVO/:;YJ6D<.HO'Y]RGIJ7-IAP,3D50Q>?SJ2036Z
MI4GT^)3&FU,(WHL;MT4AM@^V%RB8[Y<U6U>1!W5>\R+79;I=JW)J/"Q5P!0[
M9>J3:[%5P70]4IKHQ"@RJ;S]NKI%SYLJ$R&<6K2/J&VW4#G.%1DY@OVKO$N?
M8M2C71;A:..4?HW=.O\`-.$U7H7\%?.>-=`\E"\>9<;!6R7%2%$MD5F+`>+B
MP<-\C]#!'V,JTEIS<K:D#G/K_P!$ZX']M'Q[X":$2Y%H=Z;U&K^/7&?'OBMS
MZB#YR<Z!QJB<'#7X95C'+):ZZR1!GI;EYDR24QCTU)=A1]*UI+6];$[IGR5W
MS_[5].Y]X]<=X=5/)>U0CG%NF\RZ_P"/W6!/-?'P/:Q9_DE)-TH5NVBP//1X
M+ML<I6[8462EG&I9%R1.^I1*:=0A>0G?-W2_Z3]O+FU.C>-C;]^Z';)OC_Y!
M=7\JSABRN5ITEV_R"[#6^FA;-T/I/X:`&P6'AQ#K)2<,AB6!\2`IN(PVCZ>,
ME&ZD[IF_&%;TS[88CD9[F70.(>1O7.9=:I<?M8*\]!2!YC;]]JIO?.]FO(Z[
M@.@5BUT\@!;)#.CG9#H0J.1#G#H[KC*]R&W%(PO.\X7=R+PS30/*"_\`EM>N
MR7#KO5;;S9?%P3I6H\SHHRL<HU>57Z'72#/.:E6Y-]-"RJ&(\0J9=DR(D%G;
M3"&U2);D@D[KBJP>V\,F`P&`P&`P&`P&`P&`P&`P&`P&`P&!278^)">Q(#Z(
M'"(-8T;;*[)7!A"2&IU7O8^&+M0]IHO#F-C"\B)`:^C)L:3*@JTOV^Y#KB%%
MB:4X/\,PHF(M`KI-O%E6&9@D*?&C:P-*!JY($]2'L06'APJ)\QV-)ZV1>48W
MZ3WM,L)4KW)<<<+R=NL>%W/JVA:M'K`0EK3-5J3)9#JW#?(7VE]"E.#5/0),
MN(C1>CQ66]*>=<3&5O2G%N)2[H<GQ9?%%JX=2Z%TJ;95`))F?7I%)B088JRC
MPKJ**:H]_,SP5A"?A6Y_0!)F.Q)8_P`I0VX`'R_EVO;T?!&["F=IOB=4J?:*
M@=393QP9SN:_+HE=-0@$J.$^LU=7YCDPHH7LL8(J*7N8^U*<=0ZSIME*?TZ<
M6Z)W,1>/"[FE\/S3A0@:9T;F7V38H<5;<1!+\]D`1=R6RZ/W!VP>KQ2MPW!\
MY],M3:&4H<0Y\;.VB<I?!3P]K]FE-OV^Y$#;+LD$7+08U4IH>&5L%9`3:<'E
M;8BB7$0@/Y2FJCR@S.DCGY7K(2VU[W6G"\G**\00`6Y0;B-NYR)+$V0`6"JB
MA:Y#*"`@.W=`N<BLQ[!#@QRDR-9YO1R$`L],5*W,$^QKV)D>Z6H<L';+^(U4
ML?1K1T:RW"UGY]A;.18HXKH7.A!8!NLW6L:@0]38<I"8X2%>Y>H"6T,I9;;;
M2YIY6WG'ARPIWJCXIU6I[O\`';LYXD*O-%/\]3"E0*ZW+$!+38K7;#DA9E@2
M@D>)O'KE,6PY.6ZVPQIM&F]K^5UXD[K<E=\6ZZ)5:4%+6=,1;12>@TIUJ+`!
MUZ3#C=:F""W1"""8J`@C,E3C(1ET5J0XXD,QM4=GW-^WVEY(P>\-*A;$C)=H
ML4@N;AS`.B,QJOAP(L^"!U6S4G5<+`ZUH,TL;+KEKDIVVV\AAF5O;C;26G'6
M%CDQDCPCK<V-9$D.DWHD3M)664+'2"X$DQ)<]*7)%K=(;:1,U+CE^>BI$I;3
MC+4MM#\=+3##R4,CDEUQ\3JU<*MS6F+MECK]8YY$2WH#7E)CAS)!!P%8FS+T
M*>\1VV2;)!5H2I]<O2(L^2A.DN+2^@1N=VT>*E)L5&?H\<J5$0M76K7J"J$B
M/&AQB=7Y\!YJT/DC17X0F8$)5X)M3[.G6E_52%.(6GV(UHEH$OP6YRT:GFQE
M@/07GW8!40P\U%)Q*Q8P5GGV2N3PHZ=M898>$W/5`E#ID66W.@^Y*G$+<=<<
M4O*4S)^*H(P4,6&=:9:K)/GP#HLFU6ZTAD)8HIKDMHES&H3L)[ZT44LW'AS[
MT)UWV[CNNL^_U2RZT2V#B>%'-HP1@(LW9EIV:DG21"/H(.(DI9&)SN.19U('
MB8ZAT%QWG,9R,S&^-,'3VVV/8VS'2T7E*;E_&X':*'SBB6NRDR,?G!P=-B$Q
M`H!6I!^NCXKPQVF'88R!J!H$=$+;9(IA-Q-R%,H6WIGT2E)+005X95<;%BQG
M+M8)2F(0L`[(_!ZM#<?JU=CT9BN#/9"$L,,EH:N=CERB24?/.WMU"TI:^!N.
M7DC=G\,(3,ZC*Y\68'QQD[FP^SO&T!EQT4_G,WC,QF,$!,T^8UL\8_@9A>Z4
MS+&K8<=4K2EI0PE@<M5NV7QAHUILMWM1*3*D$KQ.K4Z<S.'!","-JM20,I`Y
MMB4.4\^(,_E]IJ?'6[O4AAQ:/5/KK:26B4?P\JJAZQYJXV0_[ZD1K>IQ*$"D
ME(LPI2+3SQTS`)31\V:TH=4[+J)!:><D+8:B(TXZ_P"][;A>4NQ#\48L1RW3
M%]$-SB?0$IG7&;/KE6?3+L@Z\FN@5PL%CI@-I!P!!DZ\T[`TI]F9&0W[U:D?
M+(=);JP/#6D0S0H@]9#L\4)N`;H3(28.KCNI%R%/U/3DF84V*_$)%>EC:=%9
M_"MJ^F:>4J0G?RI8^$O*4Q-^,U1,U"J5'9DS%9I88\*`3DQPLAQE9>R5RUQI
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MHAY1^*?EF#N'*HMV@]-D54>,A<OZ+X<^,G2:!<ZZ"YH-<IRZ3/#N/AB)Z`4M
MU@+3I+S#+[2\CK>VN,3E/_ZL&M_:AY^%HGVA.'%?$ODAD7RF3%Z1YF=$D<XY
MG-EDK/0?&NP#$U6]$WX>RUPA]'[O;X;[T?TG19#8-/S_`.+::]5$[YO=-^3R
M_P`@\+_,+FW9:1=;#P+I[?(NM7GJWW%.YU[GACG3]UYIY.46!Y/<\XKQSGU:
M/V5BGHL<Z@]1YQ)$M+5^`PYU#_RA:6]>W99W1EUJO\-C7W2N(=%Z'QGQNHO,
M^5=@\D>S\DLHN\<T_.U,X]U#@/1+R!J3G.)=<\V@5U/U"LKK5ZK]S(37C0T:
MEP&1CK)#OBE,18DBL[)QFYJ/YD\4%?#GRGOEV^ZU;:;QLUS3NW0@_4JUXGVD
MGRWBU9%CZ74N><TX%S<5P_RJA6:;U;FDR[\SJA=J",;'AA8S1I<MYQIU"M*+
MRBHO)A_*SPLM/>N7\B'^%_V^H/C'7N.<E\E.G6CEW8>"<(D+ZYV2F<HK_*N)
M\HL(;=S-A[?;3X?K=T77K@9?*-C3(_\`$=_+[T+>$;JF]TVNSQ-\+YM:\RNZ
M&NI>-_0#O)Z9S?GO'>"H[AQ3A_78UBXCPGQFYWRNJML>0%GMYKIH*]W>R&+5
MHH'8$QH!3W..RGMI>VC(3NO;AG_.CR/.^VGY9V7PEH/BKS;Q7Y+S39;@EU\A
M_+,G8+".Y+,Z[Y1]/?ZK;.%<0%E^6U>WD[E'\1;E:_QK<`EN%7/Q""`A19R8
MS$M&%YQRN_+^>+T"OPX\IN_^<G&O++NG("HVFM=:\+*H=K[X#GR>O\[#<$\:
M#'>OX4JSU5%B+':AS5WS(N4VG7.OB&T2+0/:UMQW<%.].U.41MXQX_S_`(>[
M_MQ>$L[B5CZ]T[IH:SQRE8Z[Y!\C\0*A<9@B;!X-X=RNPG[16P5`@"')$<;K
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M8C#)+L2.O>G9+4=Q;:5)0K>AQW:)R5\@N%`A39PWV/F(@*]8#E4;+$[Q6X(Y
M=GK"77+)7]3))%J/^,U]N.XJ;&]WRQ4MJVZE.D[]!4L:?\FO'6K6Y%!LG<^3
M@[NN68@:J12_5F%84S*\+&&S\9P0^21-:>""#4.3+TI&OIF932W/;IQ.]BIS
M8RN^6OBW;@[UAJWD7Q*Q`XPG9V05"].II*"R'2>%U91%R1$,.MHBZLIR"/\`
M=O?_`,9/C,__`$20RE8X[M)3$WW'C%:Z-7N/V+K'.0?5[;%3-K'-BUSKP^\G
MXCGUGP/B:O*(-&9S<O0V5\'QLJ^?Z5_X_=\+OL%35]$3;\K?&5[FDGLS7?\`
MD#O)(E@8J;_2V^@UA='19Y3L-B)7]6=)+8=PQ+>(,):CI=VZXIY&DZW[M>HJ
M;JL78LGE%XW4ZNM6^U]YY%7*L^NSM,V$UT&KC0[CE),CJ[<TI(2B;4;>ZD>+
MQ81/];_(94AMM_V+6G6QQF<H=D1Y+^/!X`W:@O<>3E*T[,@#FST*_5A\2J>5
MK,RZ#(7UR"6X^I9"GCWRC#>U>]T>RN0G6VD[7H5+"@O+GQ9M'Y"_+/D5Q6P[
MZD8(5[G"`?2JB6<NYX0^&BE0]8;@%I"S!,9(L8]$AEG2G&53H^EZU\S?N'&=
M'W9O+7Q;I9:\`;?Y%<3K!WFCX>-T((=Z;3A9>ER+`^)BA&+,,FEV9H=TK)/0
M6V$OH1MQR:PG7KMUO2AQW3T97^<UXY[L]=I2.\<@>M]NJ;%[JE9C]&J4DY9Z
M9+%2CT*T5\9'+.2S(,@"@2)T:3&0XU)AQGGVMK::<6D5+[9\E?'>0IM+'=.1
M/:>J[EV9<;Z)4UL.U!FFQ.BNV5N1HKMA81KGL]@\J3I6VDAGD3=[U&4EW8J=
M&6*=WXF#)K"F^M\W#&&^7$^WN"2UTKPTDUQL*MMLSU1V#,(,RFN>B7'D)E%U
M)U`CJ5K2W4[W@J6"+>3WC@!$QSIGO'(1@>7S(7VF*2F]#JL>))X^;*#08?J;
M#KA327N>$S)F)%8,I]1[LB2VVEW:EIUL5.B*L>:_A_*CJF1O)[A#\1%-?Z(Y
M*:ZE35QFZ%&D3HCUR=?27VTU64R1DEO4U6]1U+87I*M[3OT+QW:)<UY->.3U
M/*]":[SQYRA@@5=LYNZ(Z14-U4-7;<?*U2K&RI_1?\+'#+#:04X;#>>=0B1/
MAO1T;VZTM"25-U6+/6WM_&Z"*NIR[]4Y]4P_-R(8/T`E8;<"$Q*88L<`44KH
MBRO39S*0Y4^./07H49_V/RVYC"FDKTZCW"I61!G0B<*&2'2H\X>0BQYT";$=
M0_%F0I;*)$65&?:4IMZ/(8<2M"T[VE2=ZWK?IA':P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P."5*CPHTB;,>;C1(C#TJ5(>7IMF/'CMJ=?>=<5O24-M-(VI6]
M_HUK6!_//6/NQ^1'E)9_,G7@W5./];`\KY-P>R^/%*%*C6SL-JD=([99Z/=N
MEWNO3.H\_#Q`P/F]0E6.!5')0@LF-.$MSI<>805#C1UX1$1R6+5/N`>0=JN'
M@43A7JIJ\7_+*OU*(+\G'/%0]&&=![M>[G?"(;Q[D4)?DX[:>"&H7,J$]$6:
MELVL:Z?>UO:FVM:;54XQ%ZQTMV_*/[J/2/'?SX+\/8IE0L_!*]RJ%3XT./",
M_P`+?1?-F^5,KT3D/%*86;+;`,Q[C6-B(OP.C77VY!74E;R([2_01LO;?7_3
MSMR'[G'W'.M<727J')>,]'Z^'\5I7D1=P_,J7:RT>.+O/FI9N)\Y+\XJQ?J`
MF3?'Q?CIR&Y7"*!=+0)5LGI'L1Y,1+GQNQ9V;8G.:O\`T]1C_.WM.NB>#,XC
MU;FDCQ'\E.2!KM7_`"L@>.UL17^_].DLW?HQ/BJP$CM2"/BX;?X%4ME@\PPS
M8F"91F>SO;"X>H;]3C%3_:'FRI_=%\R^I^-/9?(`/+\:.-P_%/Q"Y[Y6]61T
M>BWBP,]2L_<:?;NZ<DXK68<+J%8D\\KZ>)L5^#.L3CAN<2M!C;<&`A$5QITO
M#;=8XS206+[N?D1KN]^Y6,YSS>L#>C7+QSXCXD(L\"Q3;#.\@)EG\7AGE[1^
MA:C6$=$,;Y*$\E_JH*(3<!Q'Y7([?VYI"M)$;(J_YX+U\QON&>0'(/-^A^._
M%Z]3"=$CS/$>L="-7+GEF,5QSH7E5W.R4(;2C_7`W0Z]`XY/C\UJSY,$X\`L
MBC9V7#@*99;>T[A-NV)VW/C[*T$_=CZ-WOR*\H^1^+)SQS/5^I^//D;8O&-1
MR<1-VJW]I\5K-0@-T*]/9%VX9"`\>Z>8N\H=5G6TL2I$&O2#/SN19+#21PJ(
MG=>;U%0_.KK5A\&O(#[BESH03G/'?X#2G;/%CE%@A2U=+)TL'S.39`EFZZ5A
M')8I!+L-L=:V&"C66EC@:H:I$AV;+>9B$G;'*-G5Y"X/]QWS<ZT2I_CJ7`<@
MI_D9TKR4.<0BW&\\DO-#:Y&`Y9XL4?R-[R4O_`'>NV8N5N0F;>(0JDQ6K9"C
MV,;.9,2TPV&'F'BSMVQCTK_:V_'#[DG6N@=0K7.>B2.02JSS-/W&C7>>QU,,
M<"56^<N\*^B\VY+4.I\V@$[B=CU.#9[?>9S)MEZ<;BL3*],;C2--*;7H;MD1
M%QX>['\#^Y?W&T^/OE-W[K]8YX%%>-?@OQ'R")"@P6Q"U2>W=AY+T7R-7SV5
M((V$DI`ZO<E*\^A+C:2F8HH4DN;=TAQIIJ$[(Y1$=98E'W&?(WQSYWXN]?\`
M,V*+"T_K4_M0GK==G>.%OX1?J9;J#XY$^K4VA4"NV'L_2Y5S(W6^U(F&$27=
M1G3CDF(PS#9=]5KIQB9F-N:."/NP=A!^3WB1XO=.7X\B^CGK?SFE>9U0%3B^
M[12.F>3-9O-JX_QKCT!=FD;+$N&PQH-B_G)6IL22^<@)BLQ5R7$1QPBIF+KH
MI:O?>"\N+<)\G[Q3Z9S$O4ZI4KE-XX$LG*[U2"T*P]1\NU^+?@81%'Y_4):?
M)"C=T4*-$;`0!"04,)+%)A(EJ>>^/4MKZXPB?YJVL>*_D;WZ]WSS<X3T='*.
MH]#\2K+10-:Z3RP0?YO1NDE.C<HC='@46R5VPVOI*Z3>Z7,E,13/P&)[&H9&
M%(^)AQ;C.JYS$83&4O#O%/N"^776('"N(K*\IK?E[W;MW4^7=7`WC@]OJ%=\
M)B7`.15[J?<*.0K3';[$]Y%V),:Z@/R44@G`@PV)--%'_:RP]'V:G;$7/_C'
MNG'CC]R_J-_OH&G=&>Y$_5.65;[C5T[[UVHB#8>JW_G'ACV*C\6H74^71"EO
M-M58/=C9HRX78?F&H[$D#(;C2OAVAS!.R*P\/="J-YQ^;EBLGCS/N5V\>N?5
M"R?;LE_<.\BP#_"KL3.<WJ`DI3%P:*)L3_=AD9LA>Q)LRA$N6/5L.Y7WE[9F
M^_:$"=NW&,;NEP^"GW">[>5'5/'SEMYY&5Y@5F^#^_)OR*5<.96.C-O7.^VV
MB5WDHOCKA6V&-S*(ZE-N^IF2D/NS%"V%-[9]7$9$W;8B)GQ;ELK!@,!@,!@,
M!@,!@,!@>'/,[@#'9"7CS>/X5ZYRZ7X[]0,]9;W9V;GL=9H$B@6:B%1BYO/>
MJ\AMD#4.-;M2=*;(R(;ZT(CS(<F.ZMI1K;-6\\!?MS=/%VW@1U?>J3.!^.O9
MO(7HU(%1N9=.J94I5?(_ISG3[16[2>H_D36MEC=?(.?307U1_P`"E,__`!X:
M5Z)UHO*,<,UB\\\$+=3.4<,X64['63?-_&7MW*^G<=DCN3+KUWEU;FI:SD]5
M3IQ9F_SJ]:K06;.QVG;`/%AU//1GI<B&\_+7\9)W8WUE1/,_M,E.(GZ]?^7]
M]AO]&IM\`=.JQ'I_-2G0JS&M407Y,U&R!9`=WIP@[!YN3I?D:\L2"%%AL>MV
M.#)*0U;26G0U&IWWA,8*Z7]EVEUZ?0G!/D?,K]H;-\JA3I;U##-*Z96>9UBV
M'S_/9(1FT0HK(E_HLM-K!-0D_P#U*Q8#T!A+\:1(=W*/L>P_$SQUWX=R3847
MY`<WM'(KHU!LAT58*2V+Z'OHW-N9<QX;;287HD7H^Q.Z+!=YY'6X*FA)TT*_
M)^A20^G;9;169GET>2A_V@K1)J/,77_)>M%[9RD#XZ4WG9H+RJYTFKS.9>/F
MNO2JY&M:^>]^KO1CMRLLKL,AYTT/M`J/#CQ4QHD)#,F9]0:YQ>6"\9OVU9]W
M)V,-TGKU7M''#?6/*WIR*>#YB1#6M3GEES7IO.;U72MUF]+L`Z9'K+W1%S!<
MI@1%E(7"2E[:W%?*B4G/_E"P_P!JNX#'><F2?DDU<+Q`XQY"\T[5>CW/K6**
M];N/D99I-JMO5-AZ5V6L5IDA`E.M1(P:PQ+2(;@Q6$H:;=9:=13GX)!QC[5O
M**1KB$K^$!GID/@ODP3[:"-6`5//6HVN+Q,+R`]S2X72=<RA:U0*WV7GP:T#
M5%5SU!550**2SO\`!H<IH3OGV6UU7P-F=![;=NAL=8&@>:=5ZAXT=JZK39G.
MHQ:]NW;Q1E`9W/V.?=6W:AR*/4CCE2&?B\5\,3D(2U-^BDQ5$Y"D$C=A3"@/
MMX<Z>\1>!^*(_J%B*5[AG3^.6^VVR#9;VHQ;;#Q0L+D6$*&(1^CN63D:#TX/
M\;<0*598`>[:(K&D^J=EYSRG=JC4_P"VF7*D.Q#I_<8JJ!<*%YTU+EX-CFSO
MYIHY/SX-A+)T@O=K?,ODUGHT.D&`N]`X[(\+(=C2EIG29+J$/8.67I[.'I_V
MU2]_N=DE-=W'@^?7B34;8<JLCE[9.TN=5H'BO:_%VMD@]N5>H(Z/1WZR:CF9
MX=T1)G.S1FVVB#,>2[IL1O\`#'^2BW&OM<+X-USB5OI_=F3$3E!CHAE0.Y">
MD2KO:J]T8;XV0K,V:OE?[C7#-QDU\MPO3`=5J8LHJ"&)PACT%]`F&ZH3ON,4
MJZ9]I[EW5;EU;H=BO]SC7GIGD?4^T0+2".7:O%N;4D0YPN3:N<\T6#O8Z-1[
M%>I_"AK\ZVBFH19:FXJ7$NMPT(6(WS&'2D<Y]]KBR\ZB4:MB>YTYVDUJX>,W
M7S@QO@\(583'9O$WE=,Y=S6?7[&)Z!%C4OF5B9YP$(G@#,"3*<=T3C0B,.,6
M>0R7G?\`-6!J_P!J[D5"XE+\>;MUZN6^G!_)#CGEY)=M-*#`C8VR*.AF>X@I
MGX+:!D1GEWD&@$<`0!:VM0@%>-R@"$SQ<2-%;)SF[7'Y??;>KWE/VP5VTOUF
M=0&AO.*5R2S!X%7A3T67C8ZW]#L78^>%C<HW!U&K/8Z[=(XV=Z,[^A_"FI&O
MEVKV(&W?QBE"T/[5,6"2H]Z'>7A:QVRG<,J?!(:1=+I7\'L[QFUXNR>$#ZUH
M1#(RK@SH_9E/WN/,18U!72R$I2.<^+ZG99W]*PMGC?VNOSRQ9="/(,<Y2NJ^
M(GCUX\SGQU?O39-T=P^![!5_K#U8[<#HDAJV,3T.)=E@YY45I25#2D?:U;6.
M?AC:'6_[3_/0-.-5;J'E9*J'!;`8JL>[(E@J2"LUS!TCH7E=T;GP>\='Z<1N
M==M-G?M'DNQ,.F28>60L1.LM3U_%,F.NLB-\WA&*6A?MW=!M'+.FU%CRAY;U
M85TV/PDM%Z>7Y7>G;]6>U>./.N:<CK'9*O?N9>2-+F#KE!8Y8P8;<AN,2(MB
M<6K;[D7WQ5CE%Y8MN5#KY:IT:F54_;"M\.UFJ5VOFKR>8A13ES+!A$,<1MAF
M,-:8'1RMBF1ES)"([:&$//*TA.DZUK#G.:5X'5<G0VI#$1V7';E25J;CQEO-
MI??<2P[)4AIK:M+6K4=A:_36O7V(5O\`<UO`^Y$F/$;T[*?9C-*>C1TN/N(:
M1N1,D-1(C.E+VE.W9,I]#;:?W5K7I.O7>]:P.?`X9$AB*P]*E/-1XT9ER1(D
M/N):98890IQUYYU>TH;::;3M2E;WK6M:]=X'0$G`I^.N6#+#C$5MYR.Y(&3(
M\YA$AE6T.L+=C..(2ZVK6]*3O?KK?[N!E<!@,!@,!@,!@,!@,!@,!@,#\WK6
M];UO6MZWK>MZWKUUO6_T;UO6_P!&];U@:QFO[.3RN_G&-R>;C[-3Q%CEVCN7
M7BO,>DT#D=OLO`HIGDQ^7$[I(#5>DW]WDT4(1!DFQA:7'AM,26W4J;TZK9OO
MVTKNG]&^T0-1X=>7%3"<O"[[C>:]XS>'UR3S>Y!_IKK`BV'EP"HU&C3J_&C\
MJFBQM6F@M$9`L3N-$UJ,N0EI]"7!6_';/3-<ETM?V\T42Q^9-II]0/`J7Y)%
ME/\`1V.66FTW"9Y-`2NO"!1*EA!M<(W*U7KZN,FDC)0B))4^PA.HBE-:T[A*
MW7Q\/^[S02-?9^.V*E^-=FXTU4"]KC>-G-QE1L?CQWGF<.MR'1'1J?XN<FO5
M@>I=?@<U.E:_(L<6O5T[,'2)D.>]KX%IF)^4UWYVL`HC[1;-U\J;7-I_'5V;
MP9Y-&K7D-*BTBPO!N0<SF\F/U+02LBX0M55DR8G*:\0K<A-68D$8<=ET.[MM
MW:HNY@G?4>*,7BX_9M*+Y3U^V4OD=GG5KBGBU:..NP.16ZSESG-^F%;1`\1J
MC5J&"J\^;T.U.%:0575JSL<1-@]P7Y+<6(A"W<JQ]G\]T@L/=_M?U\Y2;!<^
M72:[U2C=!5Y&<\I5I\8^O#>Y">U^2O1+URR-9*MSLA0$WR1UOLUTK9UF/&CQ
M')Y&)#=G)1]"VF0DG'<[M\.?;-M?D8%N%HX&5Z/Y47ZC\^MU@4(\7^UWSK/-
MJ;;!DZA\[M'9A(.AE"/")R12ID$>_8&@Y:''1*6S[&FWW$B.55$]J3<[[!]M
M#KUZY)X_4.NU8DY4*IV7A_CC/:X_>:]Q\[6*W6&J/W;EO`>L2ZH+YA>HP2IU
MS4,Q!`E9FE0QSBV_D1$>6T)C?$7*[/*$[X<<BX54O'KO-2&%^3],B"N)<X\<
MJOSNU=*-=&@U8*T0'T&B<CYV%L%LL`RK5VN(D/ZBP]Q!L**ER0XTUK6]DCE,
MW&;SR1K'VKI@SQD\0;%R"AU*1Y"E[=V'@_%;#R2[<]O7YN`5LE.M]ZL#$H`#
MNG-;Q/KS$R"[,/R!I$RTT_`0N3I#K*2]^,OOR(JOVJ*Y<^`>*_<N.\MV1J0>
MM@>44H?QVQSJ)RNG]?NL7GM.KUU-TFMNTCG5![/TH.R&A#K)*BB;*9C:;VU(
M<:VI(CG5P@?8R_V9(-[\V+%V,-Q=5FY-2JC#\T[&3JMMF`F@G0PZ*A4Z;9IP
MP<_6[M:B87GS0IL(+T0+QD0&X:F&UITU@CGA5^"QXAK[;"7?'KQW&\CW;(%9
M_@K\R>25R'P;K5^JO&)'0"-M?Y?VZZVC=1.`>,3Y,Z"9>CRK)-&NP]1WUK2T
MEOUT._&?1/\`QRM?@%Y65^YTSBM*"FP@/H=(\HS@:R<EO'/GK#;>G6@EU/F'
MDP#_`#_6:V1N8[H=FJDHL"M4)4J/-4.WME[V-(3HDQNVXRMD_P"!/AK9ZH-H
MQWQQY=.J0>ATCF`L%NOMQX,"@<UN#G0>?U6*F(XPXT*IUY>66'(TKW12"U/H
MWIQ6]['+=JL.N^,7CW4..G?'ZI<>H56XQ9XAR'8^>5L!$!5\\FS(VBQ2S#(M
M,5\B6.>ONESG7%S)"]:4MW:M:WA+F9N<U9S/M_\`AA/Y<&XQ*\<^;.<YK]R(
M]$#A4BGV9T&_F8K\`W=V[0S+;MKEL.C)3D.>17.5+G05[C/N.,?XO"\MUW>+
MMW;P+\,>BU[F52N7C/Q\Q5>-A9-8YG6M4T8.`U*ISG1T@E38(@4W!@2*46DB
M8KLT-(;>%S'8[:WV'%IUO0Y;HZK2M'CSP^ZS>@$;7RZG'IW5.4QN%]$E$!#+
MKUMX[$<LKT;FQ=>O;MZH-.W$HKZ)/M:WN<[ZZW[L)<I(`Y1S:K7`GT"N4FNA
MKJ9I=/YR3LP\<S'+2Z'S^58)M*J*Y*-:4@!69=J(NQ(R?:VTN8ZK6O56"YRZ
M+!PA@,!@,!@,!@,!@,!@>=.^<&;[<]3-2IXZ/`J\B=(DPR$*7*U-7)+U,K'4
MRY$F1%QU1U5M6O7UWZJ<3O\`<3O6S432LNB<,Z;?.L7<U"L#[//8S%$+`Z59
MS)J)4[G;),9T;T>`35632R\:H-U^LUAV"VJ,A+9QH@O;+S,I[:Q$U'BSE(X%
MTX1$*5FY]8EV:N/<ZNU.BGX\RS1KM.-7N/1OJ++/>D%GX0Z55)-7EZ&+96])
M]D[:U.H7ISY27%VJM_Q*[9+&/:-=O:M1*2M1-T>1D7D17&;3;:Z;7T"Q1&A5
MD7/9:$]+*LG*M`2M+(J+";A)6VK34I@O*-&:*>+G7C:DH+]:A$V0"GT5YZ8J
MT[(6&/(+=4*$_P`URF"C'X.[:1O0F`D_8S7O;&Q'-M+]%LQXXN'9D>-!=WFU
M"KC=_J]=<KKO514M\3LR^#>5U7K86TM589,*&724F(.3`4%VU*<<7,<6G6VT
M^NV<%LOS+QFZ!2+[S6Q6#JY>W!^?4YNL>S18F+E&R$1=W3)LUA&28IM@T0O#
M-LB.F([4P=!:G!8KT9G3"(\2()F*<'/O%RVT*\5(L.M@<?5*P?/%&8`E^T-3
M6!!&R=1-R:W"&O$%`%P+H[?84HRN0AUQN8)3\7RZ^D7!$S"+$_#WH#AAP@-Z
MV81&>!D?GAN6.SQ8DRP$;?=+'8(1AO7XB8)U7H0JSQ1I)I@E`7!:&1UQT.Z8
MC-,#E#D@>+'81E<75!71JR#`2#Q^YOBQ<CH&HK4TQ*NKBN;Q7%6!N>F@$8=E
M99G3/G215M+KC3;;GQ*0.4)97O%^RH1W&):K:F<(ZS0#-*%5^.8)S:O51Q^O
MP1+8'0%\2-?G#*4N(XP*F;FI>7"DO)W'8<=<4H7E*&FO#BW/5_<6LWMBI33!
M@B9NP8`4L,$-:FGR(MX&!V2GMG=C852ALR%0I*!BW%2=-J4WKW.;P<M5F7_Q
M_O%D-RIPZV0BH]RH\["1$6XQ:?Q-C\D6%DK:*W)EAEMQIE>[".;U%.3$LLSD
M[3ZK1-8VF,T2)5?&\/KU\\%PY<Q5G;%RAA.$J><N<0_%+/<NZ-S,R]7+EI<X
M_48`@3=HK(F/M1/:-C=RU.-R)3Z=EY+5G>/-NLH'D82WWB'+A4FL_@EU$!&3
M=?"6]UI<-R#Z0PI46TB/"W";TKW-H;?4G:M,LH7\*26@R?'GL0(+-;;Z?6WC
MTV,="%.AG"=W:,GQ]RK;U?8EF8J2WTK1CG<]UEH`AB0AF2QKW.?3R=J<=+<,
M=9/$`\1B)AA.H$8YI&J_)/,:M-GBR3D-X[V4J?=?G$)%LV%>+%[P*GQ930]Q
M:9E2B-)VAIEC<8<G;B^)-S17.\!9]U"EY_4:8!J(RPEG;C/+%W@-YZ);T6"^
M/Z-Q5LSY\"Z1AKJ`ZHOQMP=N-N)2IB/%'(YYQJ^!KW?@)SH,=52:YI9=#JXF
MPRB`JOW^_EC6Y>@X^8??-?DGF_-'``J*@A%B(6MU<AE"=O>UH3,>JOZOX56>
M!*J,ZF]EB.\M%A^9P:I7ZA*D5]F%6JT&>?;>#VB$W96B0T,?*$'J[';:81&$
M%W86I"&V67-EY:YI+!\.N@@ZM6A$*^UJPV,%SXOS&;=K$/*I/&:B8LG,K#)A
M_&]^/!14O4.H313+C,)46)%^C=8BH4EQK0Y1:V`OC69B\'O7+K!=-6BY7UIK
M9N\FDF2R)<R,,"BHK[L`N6GNLLL1Q'ZK+#C36E+VOV^]2U*)RQOH@]X\1+.7
M4;?J'0Y%;39[K;K;;Q0\B9#L6]H];#1D!`F3UIL4<,]3QYO:XCT<<YZSHK2O
M8G6_<@1NA#^E^)W9W:YMFA=-=D31XSK)'W2B]@AVRT6?H>^C,[C%[<HDP6<'
M/#K$`9UID@-9'*!*6PUOYX_T)8W0RX_Q,ZX/LDBS,=;=C:;87/J]5@V"RQJK
M3)+%M/61JAQDNPI1P[S\O'*1V9*ERX3L=Z(VXB,ZTS&C,$Y0R3_BET9Z2=-M
MWROP[+:MAREMG0G+I';M;XJ?T%[=$,OLFFB6Z-+#VJ*,W(:>1-:BMN[;;2K3
M6M0Y0L8-PF]P`W2Q$6T"ZK%N5EYI8Z]$"SSYI^L.50L&(6D>Q8)C80LJO&8`
MAN"/&[2ML>UIST<4P^F)&I;C%^-$^#SQOG4FY2Y@=5SI5GFMN$;4KZZ(`H58
M`607)F+/J*O-VJY!91J1I;^VGGIB]O)<<6XM9+QN%8D?$CJJ-5<57.Q)$U\!
M'>D)<4JQ/V!HX4YH&IEJE?C,PA/,SX-ML$*06>9U.AZ9ER''G/JWGO<T7E'5
MG8'B7;HTAM]?4Y;*AA"04K2AJK!$17",ZW<X/32<(>DXD6[/6)J92)K;K2T;
M_&'M*UMMV0AX6G'B?SN^<\`7V+=XLF"@I;A#E>9F%"!"9/@!.>4NL%K1/BSK
M-:TB"-OM`6<0D,-2O:MY]3RM+<=6^\-TV]7X9,!@,!@,!@,!@,!@,!@,#AD:
MD;COZB*93*VR[J,J0A;D=,CV*^%3Z&EMN+9TYZ>[25)5M/KZ;UO].!HJU]JW
MO]VA>0%5N/=.;<0Y9Y:]1YU</('E'BY5K9#J<D516+E8+P<Y[`ZP5N%=JO0/
M)Z_E0B;_`+V)<$3:Z#7%=C3IA"7.5'3G$5UF-?YT=8Q]GGH5@K5CI5C\CHUI
M%@27G/T/AMK/4^,S=JAW'RHN?*NC\VZA96:NU6*8\0X[>*I8)>V@XP6S*2;2
MAAN-IM>ECG&FCT%.^VE(LOASX;^(%YZ"-L=8XSUKF_6O)$HQ"L()SNA>J2KA
MTBV,@7`QR"7J+EP[^=AG_GW+6['CQEMI5MU25IJ<^Z=RFC/VG+W7^]FO)_C_
M`$WGPOK,3J5F,<]'=(#]!OW.:WRT'XD@O'SQT"EJB5M\R`;Z-P[H`#5KCV13
M:2TEHA/@:EM-R5.:+SPJ<O\`NC`S[+EJI44U4*MY5VV]\_Z1RGDO,>OM]EKM
M8(6NQ(IGEX,\FNC%QQ3G]?I39"1U>)9;S"G.'MER&IMETZN8ZPUME0GY+QK'
M_L_:9]H7K/(K$7ZIS'NG/IW4>>>92.\>,HB_4,[/YO5?'@70.P\XJ_C+=V!1
M^.;VBL`_(*TNC;`,]'!\I452(CB$NMJ'.)SC"DW[[]N+R([LGR=L%GLOB]9;
MMY4AO'FJE56NJ=;0)X7`X'SH\FJW3B)FMV\3<1O0ZAW:]G;0'E[EPG4LN,-;
MD1W=..[$;HBL\%Y<N\+O(?BG;^D6>L]PIO2.9>2-'X<"\B3/3:Y9(/?$W7C'
M#AO"YO0>>6^L&?R])E]&"UZ`2DPRD738DQN7)8<?3)4RDD[HF,L7G*B?;[\S
M.2U/Q0$C^C>.M^1]OFI_P?\`B35(=,NM'`VPY:@D#AY#O_DA+=M163)-\ZX&
M:/OL5FM:CM&;`0?>60:2XPW'+RVS?CF]P^4OC7V2_=K\;/)KQ]NW-@?6?'@5
MV2E[JO8ZY8C?.+O1.YC:7'M*%3*F5@V2H6X"6YZ+E#Y\9,I#T?ZJ&^W\<CY&
MS,3%3$Y2\J%OMD=ING?@?EO>_*B=*[=&\H^,]=(T@)4P4?A8[C/%%VZI5;D5
M58)!9W61I!OFG1K*X[+38FADRS6"7,D#W$;2G1KG$1QB,*3KRJ^W(9\J_*[G
M_7C%LKW,.>TE[E1H\:YT9Z=#[)U.=Q.P62_\FI]V"/69KADRK<XZU8=V441(
M`316.\VY%9TPB2X[HD;N.VNJDJ;]H"[\YX7YW<9KOE-8;7ORXI_/>15BR=$J
M-0?+T[E=<K^Q%O)7`E2JY3R%TZM<IMXNLR27VME,F87:ER4/3ES94@O/&)K)
M9G?_`+='6NP^2D3LG->A\C\754GG%QH]!['R&GW"7Y''QYGA=MY12:-T^06L
M\3G)OEW,[9='K1"@;A2G'9PR"ECZ!W4B2\2-\1%3C_A9WVS?`HOX)TOK(8R9
MHCLCJ%PJ!Z'3^:1+H]3*(,I7-*MSQF")LO3[!:NC'%V>=7Y!R4S,FI'C9A)U
MB!':;^1Q\;]W)LTPP8#`8#`8#`8#`8#`8#`8#`8#`8'F#R'I75KN6YT-YL0G
MB(C;=\_'3#%UL=.@@"<JOQHM-LTUFMH>?MDBMG'-S(XF4CZ"8II2'G&];2K"
MQ49JC)>.7D(C;4<'V4@Q)D!YB7K<0Z/TB1.#%R<2^-F=0ZLZB2%,1I1VQB"\
M5UYZ/]#^"-CVFD1/C4DMPR-`YAW^0+[)7#?2SJH[G-Q--YK;7+%8D[E7VR5*
M$[T6_P`0@MUXK^%*L,*%,"R&=)4*>FD8T77PMMJ4)F'4MGCIWQ@2<$\WZP[`
M9-DB<IN39>@]+(E@&HUNZ@7I$D`2(+L.H6J^`/UN!,B[96U/C"'&]JTY\4G8
MN.K"QO%[LNB+L0)UPJ`Y^ZDY^%CZOTZZQU)AG^G7RUG52'W!4HJ^[;JS;8.O
MGBDXLH1-%-MQI"XVM>\7'JRIOQS[V;ML%<CI`M%#$3UR(HN+9K6P1G08_5!'
M0Z^B4U,$E8C-IK#8]UJ$82YM3.E,(4P[\;CS@N*\4T)A_("N^.%FK4=++?5Z
M-`$/<VLPZSDC\:YV`:8C&P#%R>G:&$45YU:8PJSRI"F69<?9"4U&BQ=LLZ&%
M^#`P.'>1%8+,S@G2_P`PI"RB6UR+7TF^;=Z9`G.QX]=9LHU00P(H3_/Q.WV]
M+%-3='WEZ=E?"YK2T"X2JR<K[D_&"Z'6D.=(Q>.U*D.SB]XOH".(N@]PBST&
MUQA06*_%M,WH(0@W'C3B2M2`DJ`S(0U(2](:V2X=?D?#^UTU<`C<.OS[`=56
MC=?*S';':+$/3IRF<]#U27"!&VX8%V:!LU>+3W9/TL:1+426I:M[>=0DLS"N
M)_`/(J0,$0(G3T5(JJH1:ZZ>C]AZ@7D,69D=>6;89@PR`N.DY*ZC+,C9>WI2
MDRJQL;[H/S+;:WH7#N7'QV\A7ILZ-1NK28%;=?E(W$,=(OKQ-ZK,]&=M`FH!
M"#@PE+K,I^N2G81(L^^6?DM,Q(K*&&$.K6(F.J01_&SI#<NG$3/1"]UD@;N"
MMY=-EZ%>/4L_7+\D@"E(;@,Q@<.4*H<N3'>C1A\0>2F:2EYG2-H=9%OP_P`"
MZPKHEG/4BZL`PM@Z6[=5_'T.^QI(:9/@<>8>/2*VS&EASDF((HYD:V!D/-AW
M8YA+_JVI3S>"XJG[?.&=FL'1)!NJ]P,UN,1M-F./CH-U-)?K\1T7S:'2I8^M
M$AIP!+&U_5>--3`J68<2>FP./*D:?5[T")A'8OCSWQXL,DE>I3*^!9KM5%2`
MPSJMVL$9!>$<F;NDB1,LU:_%C2K\B:V0CR=R8<T9.89CI4Y'1O3@N'=:\<_(
M.>PX[9>W3)A500BPB0'MMY!,;L`41T6O<[*.)&?2.JC1(Q&N%"D=6UL23<::
M_MMW2F_>+A]T&B]^;=\AQFRQ%R44%5\!5+-=[/>UA;+8DW3IQ&VV,0"EJ2NA
M?)1SX8>PL,TZ,^:&PI&Y#<?;*!<8..B^,U]`#K[OHMZ!'R]^Y0?YU*+N&#JB
M<DD8J]*K4*40/+A!R,KZ>/5MH7):TU*<U[%I2E>]Z2)F.CO2?'KK<K\K5R39
M!,FB4`[53U:A)Z!T&'/G*"6SCQB-`G-1QZ=Q(U3#4LY'@Z=ED$3EDT:>1'2M
M[:1<,$1X-Y*&ASFS/86AU@B@@@6OCA'1[XV/,.AV^+0[21*N?A(]*2%X"T>S
MM[>W"FN!E613S7RO_*]A;AF[AR#OQ,WS8#6[W9(T:L\H##BG02_1;`TY%NL"
MV!916?)"`1`X/T0R?JT*8,<D$H<),=F7]2C6W?<WLD3#`%?&SR.U'*"*AV\C
M6=K!01@B[3>A]'M!IC<>#SY,1N36C6GQ;TD"2KAMS<Y<QR082>7N5I.]+2H7
M'6$G!<R[N:YQV83+M1P:=F76.+XTT7NEE@LBZ74S#1R"JR&50B]D*P9]G*E1
MTE[V,3S]5@CT+=C.N?*T,+0>R^+?<38\A3X-T`!:223W9XK'@7[J#<NQRNP*
MZN15&+_,B9,CBHABW@%1FXTQ#HO\'DK0Y*^=EIHO*.N;*N^.7=C+UV02[;81
MZS!*[D@$`/U&X188E1(%?FN<_$R)#AC`Y_GDZSA8[VOK),,FT$8EN1]2/U%$
MN'=?\<>X:NLUYWMUA:Y\Z0BQZ^&C=$N$&8+JFNA%BLZED77H,PP;=+TN>PPV
M3;*Q24>5$;CZ<7%1K;@N-'-$X#V2FV-JWUT\W9"44W3#4]@CTV](9M(>H0K&
M$75C`@I&E0R<]=7D0VATYR?$1HJKZD@F6VRM,D7#/=:YSWKHE^;?J9J9SZ`K
ME58:;.QNCVR$.JEU=,71RU015:!1$AKA-*B94*"Z0G-1G(#.FI<72WVTMI$3
M$(:>\?\`O.IA$#3^U+K,AWZ^6#+D>G]'L!\S7H-AJ9$,-FULIMYL0U6ZZ.FU
M641BRY,B<Q8UEWE))Q8R%BXZK_\`'D!T40&NDOHQ0W-7,OEB'4.$<GD)<\9R
MZN37A%)_%$$777EV`G$:=E2Y:]_/-0ZRX[I*]>Q))KH]"80P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*5Z
MP"Z65+T*?1GT21`8@7D6.N[MQ6DZ(D7XL1-3+D2H6)(GF*W7YS3^R`?3C*)[
M4E*][=W'2PZ6*>7P?&O*K0F40M?02I26B>(W&IH/JMGK[4FO2BQ<I;!*+/N"
M4)0"6I[T#<":])G/M#(CD%+K29#F\+>U*^<<L\AZ+QVV4-PJ+)&&:[RT%3ID
MR[65R3"2*`A`718P*:)_+C`05`@P7%UI3+0V4],5O9'?I_E#@N+1X?QCRMB`
MP<HUU.=8#VD@V+R)A=#.AHU@!A1_(&G1%8),`XR*H;)SZ_9GGRC#3$N3^(^Q
MU[27D[B"X9`CR+R9%\W\?*)0[4"K<WG_`#<4"NAN-:SVW95HA`Q@:<PY[AC`
MRR!G8R9*XTJ2+W*^NTA_2(OZ?47&++3>(^0+2S*`77SS"(#,&+1'"M[L1'Z9
M!%,K5JEVI+XQ]=@E;7-7N!N5N5]'I#?T^F=MM^T7'5#KWRCRVZ,IV%+,UFO5
MLRF[)(@57DV61H)8ZD<K\>KG$,A(00DU&+Z%D(CK,!;T9>YG^4ITEMM\7MA8
M_5N5=_L'0=V2C]/-`:Q+L];0^#'V*3'_``VM#:NN-N>+$/LL!-S8]QE/3)T>
M3N2V4BZ:0[I:&=1G!$QU5'4>:^7A*O@BDVU'@S\X/#VH(>ZB7?,!>B.Z@NZZ
M>8>16])G4Z/&;<9>H:M:@*=WM>]^Y6U(+,[;3`=Q'O=8/58V+NEAL154'BBK
MG,L76+9*`&"-7,=#>Z5&(A%:CKCB)L*X,21R!:8K;\J%&8EQW(;2FG"7%4Z'
M2>)>3MONG0S%?ZH/'M-'IYGE>ITMQP#6-2.=SP`'>P^HLY\19JX7(2=J?CM(
M;EQR2I#RGW68[3`B=L1BYQ_&>_2(6HMLLUKLWT9_E]JK,C^%\_7'`XFI]+KU
MHLG/#H\!Z,V:=)&0Y6F#4Z60>G1-M0I:T^Q;KXN"%Q'R8CN5H0_U2POQVVZ'
MNVVU?3S[D@@!9"U]KI-3@`U`4ZB60Q>&R1>%867([\88\V,93'92A#8N&2C<
MN\G`,]^8S9AUNCH#VF)78$V_60"B)9]5L`*I5EOA`.,@&KV+89$OQI,9Z5MY
M#[^I6OF=7\D47"HYW%/*2E09G1!MCCF^ILQI0*J[;GFCT\G^/]`J\,"'N\O\
M*F[<`B:&RYHC-?D/ICR(33JWW4HV\HMQ/D]*WKF?=Y-I!;I'0(LBE"`-$GR(
M5L*R]D2]\I5G',/I*_2@IB%5BU4Z5+E$%-+3(T9@15M(3I:W$&8F%>JY=Y72
MN,M5Z1T38V[N]3>L$]\/:"CY9GGDZJR(JJT%LY1QV>U(#=!EH*1D2IDA#HV(
MF(\ZMMQ4;"W%^"9W#C7<;*;:E/=F.*@18@:)%_+)@MS9#L9*>C*.)*":^X0C
M3RK[A"NZU.2\SM6H;WPM1=>Y+XN%9/<4\IK389;UVMU6DUM9>B3EAT'C$Z`_
M*JT\R].+BH\\7+6'=+P?PIR2Q&^@BK(QWO9'0UI+CXN.B?6_E?D'8^H%I@_H
M1$)SXC:Z].E.B;T8%O2>?1I_.'I=)#5V&)VW5K!'<`'G9!F+*3*GQB>H^W4Z
M=U]`+BG7Z3P+HUGZS9;U6[,6#M+&Z,5*8ST.SP&1MLB<WL=1%#T5YIF5`%B-
M6%^'/()C^D8FW^B2T_[%-N")BJ<`GCOD#.YWT4!=N@:/VXUTFCV.NRYA)S5=
MA#ZITX7<)9`)\;$LF$:*`(+4?0O:4PX[\1*6FTI=>?>%Q?@AA;@7DM%BC9(3
MIQHD=@U?8/9(CTVVN/;;*?S>2][9VTI$&,].M,^A6^*-FZVR^%V:85%7%9WM
M$87&B6#N(>0S,)N1,[/:9YQCZLA%D3KC.BQ5%(`GE,"I-E`H<4T&?'1G0=D=
M)1$:7&(2".G'_G]R/IQ<:.?D?)^^U*SU2W]'MI?H1@4,Z$!+Q'[Z2@5Q,FR;
MY:XS8!@1#<B&2%$)M2*RF(TYO3P=<Y+,1MB.I2&Q,Q50^.S>/]\+=2.]2Y3'
MK84L?I]2K16>*+[H=X*S@\;K[:)TB["Z\2)LBA1JT5J;)B^]:2T83\#Z'&X[
M4:0(G"I9/J'.?(LQ8(TRGWV)"BM\[#1"QDG(E.P!]Z".RG?Q^G40:-GQ%R2C
MTE;T[ZQE^1[6(K4)U&OJ&G!$PB'%J1WLQ-9NIBP7ZL`1U^A*K%+NU^MIJ6JD
M-&SC-M_'8]CKXDR=_&1<B/L7HPPF1$^+6V_BUI#K@F8<_2ZEY23#\*"*E%)]
M5=NUMC-?E;J!"H$BH0^OJ=IK<XL4AU5V54Q-)8F`ABD)=?<FOPTM:_Q2]?*6
M.*1W;BO6IM@!7F!8GS5DB\SYO1;J@->3W/9=PT!*6<M<D`9XZ))BTM9LX1&S
MOJHS3<F2Q"7"6MMMS2M$N,ER<+I71J95R#75KK*O5U+&/KB!;\2ER@[4=@8.
M'1HP$6]#'104)2H:WG&66$?(^ZMQ>]J5Z))-=%UX0P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/._=PW<S!
M#FZ.06!(`.P?FJO;\6"&(E4LJ;@[`S-0CQD!"(5^&XB6DA&1(5(=^5E3;+WL
M4G"Q75YQHG/?+ZL?A`BPG24FC@I%,"2:O22--A$I-)%U1J$.34[<?,)E1C5?
M/QF-'FY42!^+1-O+C3'%Z;9669VNVWS;RP!@7XXRX]`):ASY@V,->O=&F&YC
M6Y?6B4&SQ[#8`TK:H;UC*59<EB8]MY(.$N,U&TK3\:66]K)3:%YB,Q8TI5PB
MGRSC[Y<WMF=4X:X4C9CIL$H,YHZ0K>VJVHE0YP2.,<F:>1'G:2Y+4KTEK=)>
MU]=OH'D]9RM/?Y;-*CV*_70!6L?FFR5%<"OW0?5.H0S3_2(C;).?;CDLJ6KF
MH+D!]V`V[&D..+2WI:9@B8ZL"+YGY=@I)6WAC,&?:9HQGX46EVL0)I'W$JN'
MB@+"J#*N49G\O55R?)^JBSW-DI@R*I_?N=5I([1=;\PZV(N5BMO3#4MJG0^C
M'P\0*)JRF+@;!_4.<U:U%%QK38)]:LXWZ>.0&-01,B/-:6M"7OEVXH=O1)K:
M2\GC?/N.0@0^\`NBE"=Z:O.XCU(@1()Z-4+%,KDXI/FP28[^#(5?5Q4,M)U'
M)DA<=O:FGE+<C/"*OP0>%SOS1K$.T!Q1B*\)7#=@UH>"F`F(4*&:-"B$LO#)
M$[.(+ZN`(HLM)U'=;9A3!TUIE<[WQVXV%O:E(&M^:[ELIB3]E^BJ\:R02=P*
MQTTXF3)29#-&?)0-`6SP@7#YR-BPSXV,]&7LI(7.8ENB]/QTOK)VUXNE9^,>
M0P]=_%4<J1<&]"M/1#_RR;/7=BV'K9;Y31+5W;GC4GR0>;RA,4;7V!SBW1!!
MK>WMH:TR\R+CJZ@OG7F!38CD"G3V4;#S;+8J^.D6.M.4@J*W.NMK313S$P;(
MLS-KN=V?&-*+,[W#'@9#J$J;?94U(BWMG-/HU`\F9]'(CKQ<"ID\#ZAS22!<
MJ)\)69ULH(*T0+);)IB3%@"(++A6&?F")0MQ2&94`#'7K?R2G-+J7%HO1.8>
M65++\<K6[W*D<UJT.IQK&XM57/FUOCJSS!FPCBBY,FJ_+49<N!9H4149N;,A
M.2VI"(ZTHC[8$SM]69,T'RE98N$T);R4-R2=ML>O``$BD?0-U:=^8S8F1&@S
MXE=TFQ$K$L>Q*E.%8\AB"[(4TYI[T4H7M?M=I7DY7R1:P/%[9.:BV"+8DTIR
M^U>Q##FK!?Z>:M8,(3L`R!.9&@*"P1%"6I3PJ.F5MQSV)^5E]`FD:D4#RPL%
M=CJMQ.SKN@\H'(--5R\4Z!0B(29RPX!77R@E,,>X9EA>@F$RS:9L9<,E'92Y
M%4O26H;8[7;_`"+YE3YA2,NZS0D1ENU27)$,Q2DP2U@CC>B+YRFFQT5Z9-K]
M%C+<K;!:'.TB5(E,+WKWL:E.S1>U)+$*\L_X,[>(K?O?O,GJ1N36+03/UV*5
M8IKH*46!S70D,GJM,#(%T1'%;B?6>]X+I4YV'N0I8]8[;QR5>`YSYDUH(X'#
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M)=%NQ2$(C'6Z_M;"8S0P?!P#YA6`R5(P&_PB$3_'IX,8?,4)^-0U0K<0ETQN
M"@8V:CGK#-!2&=SE26E,C=Q6]1ITKY7V]#M=><WY&5#J_-ZQ)M5XL]?GW@(D
M6N$^`FI12&I16?T6?U22FGM,SXK\61$C"-QG8CT)3&T[VG;C?U`PITGN/>4@
M27T"Q4"ZFHMKE;L@>LN7FV![,$*#9%S\D[-7YTZ.X.ES$PPL.^59@='<6PJ%
MN,ZUMO;#:OE%PFJ^:>1!=CB;DJ\6,=*&PN@">EF$3JX#M,>NV.]40P#%(CPY
MMX`D"PVLUQZ'LFU(?E[1I2].-O2'/07"`[H/FK#*M.B[L3C:*NK/'ITLC5+/
M`;MSW->1C_I1@PF3#,@J%JQ!;0PN+'C2=1ILYJ:U$>UM*V2WM2*U\\\O!T!W
M=,Z.8,KVNNBYK)LE4I!&35X`/CRC\H'\(RIQ&+R7L$>X;3)=F0V/BD-ITIA&
MHFXY+VK\X/5NDU6#=X_33]@M!<M:AIJ"<-D1K\63$D4*F0R;(,&-G3F*>/8L
M\`AM0QM:X[3RUK8<=;<TO9)KHOG"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!Y^[X1[C#B4R/Q$&HB0D6:
M(_8B*IM91"AAX4N`J0+*#;$AMV2/.#WI7NDPY,>1$7'1[?>IQ*<+%=7F^VU[
MS'(A`U=GD;";AD44J<5(`/X*111JS.2.3D[0'./(T(U$YN)^FM:4+&^\TISZ
M=M+\A'Q:<+'%>/6CGD(6"4"Q<)"NQ$'1<XC9:]<85>$G0FX<<3=P<4C!.R4K
MB3[2S7IE/DL)=4L;)L;4Y>D:@+6D1751C]=\UJV-L!D&3=GEKG9F#UC#[W0)
M:*F-=&\59G-T!N:TXEXQ%;;L\5+<QY^$\F(EY#*7ULJD#M6_55^2H`5;S/0#
M;)MU//K[/A,Q0=6A#1-L`S6DTM0(2'W,.K8L093TJ5'G3"6T/(0TE;>_5+@P
M5+6)GF49KXVQ3I]UC`%BZC)6*4&XC%ZB4BF$TQV]S-1%1W:G".`I2#&@D;W,
ML*&O)W)U(F-L)4Q.UF8D?S4B"F+18K"EHG`@?7$Z@.&\W?KSGX?+Y"QIE;S(
M^4?>=F`IUSES$QIOZT^+&1%4AE#3<L=N2`AY?FV8K%>N<.3>%3"%/88CB3L7
MD(Z=K9A_Q]+6LT:KXMK0INQP8T>],U76E*0VWMAN<TI3B%NE[;I9W/G?(T7U
MFK'.P0K?8Q#%9/U!R35PU,ATE)*WSN*?EHZV"$F)5NA38B0ECD'WB+DB".VW
MM$-6FW8Z'R358))<!OE,U;>@$J!*'Q`S!$?)HX6:U45A;.\0A#1A.3:94M$B
MRQ8H5ME;S*(K\%:G$:VK3R?\6H=N"M*2'\I`UCF%B4+HCE0L5^@SCTZ>[QM_
MK.@&JXY";1%&0ITN@C@F[3`B:FMQF42TC%K=83I];BTEPJF,=7YSS=3K+N&?
M#3MN6,>)J31'EA."-"E37!RL]^8XW%C,G++714:\0JY-4VTR\M#.Y4?:'VU.
MD[5I=%I7?K4+XS&8MEJ8)*JD&#TB94VJ=7@Z;<W?^+6+\T$P1ETI(8ECZW7K
M&F,U$D2XB9#WP.LO,O\`M4(I#"C?F63-P!4I%F$U<(Q5W3!NM$.4J-VQ5?ZG
MSDH[.&)>AL-CB%DH.K!$*C]HU%>3'TIE47<AEG!VI9T2T^1$KKEPJ-!=G2.?
MU>#0;*9(U,=27;JB%<UN"2=(K&[LC5<79:PBG/G7'9OO^2!9&VT)4XQ'2H15
M8YI9R<YY,JE-P^JU-A;XJFVF:3F0)5/A5^P6R2CGTFE!@DJ"3G%V'(S>K`P0
M>>BMQ&I'MVE;S?P+V2:Z/,)+HGF:)>KP(PX4$W2W%UQ^?UN#`Y(<<DPW&",R
MQO=*UI*9B!59^6*P+GBFX3:]L.N$=(0XU[C7;GT30ZUYZ0YYV`'/QI8J'9(8
MN$9>J_/9Y:35_P``)?@EO&MQGP0Z9/>LK41-F&/QF-[:==V-<C-(2I9.U;/5
M(?D!!O[I6E$;Y-J1&GTB"4B4YOF#^AA(4[U%VQS:@(Z#M+#-C+&R551)5/>D
M15@VIFF=IE,M[P158NATE'EQL-6"%.FPXA6-S^@-W8-7X=,E1I=S(V*#KID^
MNNVAB5+<E5X!'=V+94XW#>1(<VO3[Z&4:$<>J&O/^:ZGJY$1*>8)?FN5%NII
M-:YV_3-!6]MIID^G@?QE=HV`+0=.KM#,R?LI#)*0W`=U#3MQ0[6,EM^=T:"!
M%"T!`HX6]5QTHI&'TD\2D,&*7++RY:Q#I*.AT/0KSN("FM(>CS"4!MR2P[K:
MMR$#M65U_?E6_=34'E;SX\')@CXX`HW$YY*K8\4_6S:+"6FILFW+,]TJ!<E0
M%#8ZD+`K&Z5\R''-O>P1QKQ=CMTWRFB6FOC.(BE$`4*IS=F;`7F41<<V4D`[
M<TI.QY-@5)&V@27'!G82TKT*FO$5(>9:C,2'-"*K%`['+\O7(\IJG*N<)Q=I
MK[<`A9Q'(2&XO.':)+VR2DC!;D)R=T%'4?A188OO8A_@WN_#OC5Z/X.U/N:S
M/)9OI,")?(Q8K1_K[Z.G%78E!KP]R$UMDE5K:D:,DF3S#+LEQ02,&U(6^EMC
M\4>F/(?W%9$U6&:MFH_ERV546G2^D2("6Y(`AH*GC+$L@`@7O<Z3;ZS4BZ'1
M5>NI,&28AQ(LZ63CI&09CFW%2E1-*':Z\2!YCDB7.3-I@STV&KWH?.O4,+*H
M$>G/<WFT0J+(_P`':=3DS2G0734MO\09/*<&LOZ>W`TEI,1_8[7,)`>7U'KE
M;K@X@=.L1*S%>B2__P"V)"=$O[S$9,&L6B47W&><X^/6S(_$I<94FR[4XU\$
MES6U:0.WJKUZJ>;(-ZJ(`QCONIM<_!M*_%>>$0;%6):XVR0DAUDR#]@L75D)
M'6G:OQ5$@4A"6]LZTM<?3Y;VO</$X77(U=+2.RGDFK-,.N[@LQ!`$()'@XL"
M!$B?AL$.J9+:T4DM/2WD3ILV0TZ]MM*TM(0G1F:Z+EPA@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@4;V,UU
M43.I+?.QLN4-FS#:3\L<+@%Y*3$>%&72PA=N<]I0:DV`BI]LN5CL/RH"&VO9
M\*75R&BQ75YYKQ?S(LBX3,A^;5A#4VLLNF"M"IL>R$/Q@USH=>TRPZSLX>,@
M4F*3LCH=YM#FYJ(,9U[<QI'_`)@7M]7<&E?-&2W`.361T62Y%AKDTO\`+%8:
M':FHG\L#NLNF56"01:CRH5ALY-[>G?5#@J,AM26T.-S1VN?\W>5UF3.+P*M.
MKPD>.KK<2M&*X$@D[40(Q^=A[<B7)_,KA$-#!RR%CFPU,+C/.[B,[^1;.DHD
M#M8_5W\K6&:L.:IMCU8Y71!,"T-;#UW=&KM$C6$*-2V++O(+&;(]8**1D%Y$
MUZ?'_#R8YV,M2%+8AR16U'@U@\R@8RKQ$A3MA(:@U^/++GP%;^KMMSA"^<0+
M!!O#<0Q`&4RG;VY8WFB8F-'^H>B,KU[U*0T0+VK1Y\>\FXEVY^+Z##E'*Z31
M)U:9D"L@06AKT_FE3L2R9,A'D$X*0U=O[I4)''QW(Y-[:V'E.S6F'UJ)A6"E
MR%B\XW5OV5=;CL$!I*U@Y`@7&>VS70A.\4!N03&0W!D@?>G(54@//!7FXA=]
MM+A#Y5..*;BI+VI86.>7LN$S.;>/#+H)(W*%+KH"@UJ1S(GN3RRZHYH8@D3<
MO=H*!)URC#)9-IV?"D#YSR8CR&64_(X3M9A\OY>R;"6KH]<R*/BDKBQ,M,ZE
MU#3$:*"BW=WFKE17^+(C'T=$@C`[QUR0QO0J?,5'8TQI:D1!VNC(NOE3`A6C
MZNE66&2?A;73H-6%`B@C3YR_%V35AL9HONYDHTVH!7(KL01'B[1+A*VII+BU
M*1!%;4)!6GRGI]CK$H\*?CENQ6.C4Z77R\N*:B5DB;>Z%:+A;*T,W8G]LB>=
M"H/^5Q6E*2_&DQ=>[:8WKHLT]#3)/D,UU(LL7%;C<[A7.L?3PU#AT[\T`#1"
MJ!K)+>)3C;L\0U6`KD^<RW$9C?)(8U[DN:VIMTSA7BAZU^05,N]S;%#K'9QO
M2.JRG1A:0."$(]/KVCG%0D1:%[)PV!E:%\__`#/)9^9EQQV;$]5)<?<;;D%P
MI':U9_+9RO4.DO"[$FQ.(H3%MZ78J?5-JB!I`GF`NZ%),:,6'A9%KB6ARUNM
MLL0U,?21X[^VW&EM:D##-V&NJ>35-X;?>C]"KX5^]5NUU]8;GD0=N),/LOE!
M8P[1`124D4,+.&),Y35=F1UREOO;;;=>?6K?M%1=0C;]X\XQ:#42741YPO'N
MD(8.=`AH\</L:(GV#>IZG9PUYN;6.A5V*.=WIJ7]4((O/I?FQ$_%&T.U=W+;
M!WJ%;H(WJ<,K8!):@ABLJ>(JX@"+J%T)6!#4RO3?B>F/'&FAQ'U:DQ)KJ8<4
M:Y]8S\SS+SQ,*>I\(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8'YM*=[TK>M;4GUTE6]:]=:5Z>NM;_`'=>OI^G`_<!@,#\VE*O3W:TKTWI
M6O76M^BD[]=;UZ_N;UO]S`_<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#P-
MY^=/\FN*TJA=)\;JO8NDR4V6P<\MO,:Q2X]O)%"'3Z2>K'';X_\`'#DF!E>Y
MSW)==>//,K1%9K<XC*EZVW%2I!K;$3A+R;7>A>=)'OG\$!_HO:H9;?4K_P`Y
MMJ!?CO31O,Z[XW5OA!(CS[RMI77BO,"]0*=6O781H[3P5XD4'_4&IPK0",@9
MJ8V:K;5_RWYXI]3\UYG>?%.I=YOW6R52OGAARWK?0F+7R,)38TWR`NR.O3NA
M48K,I7BX\#"_D%@.#0V)GVNES1R-M;<V8>DK9V@W1MJ:U_G53S7D9]SANP><
MIT!`NEE;X'>+3<.-<\M/"Y4"G=%K=2\ANKTUGC4:U0./5*RRM7CAB`)@7*K\
MR[2]R8T<B^5BMRGP[HK9A?5[+[I'^X*)Z%X6<IXCTN*<F.46[G_);K-FI-3%
M<[LAJCW'QUBRI%C@1>=V5\6FV5FRW!`.M@9]<G/R%-/[)_",?^0D<<9EXTK_
M`)*_<UG@.9O=@K]TY51#O,/%@QU7I?+^1O\`3.FTH1<+)Y&L=7O2:"2X?&C`
M.FO2:I219NO1A-LAU$.4650RO:E.(+6WIGBZ(+R>^ZA"MM'?-4B^'^;6HUXD
M\Z=E_P`WV.$N(:'>/+?I\(YWBVA4@=[KT2^^+5%@Q[P&6EO\B%[`.F-,#=+?
M0U%K9_G_``]Q^!79?)^W^(@GH'8Z]>^M=ZDVH3!M5+.BQ7(C-=T0A59)R*S!
MN?%/'0./AU;<Z5+=B,(LB-[0MB,<(K]$M&=T;>51DM:^7;R=J/EXY"JX4QU/
MA9+Q>/6,1S0+5ZU5&(780/8.95_3\WL]FGMP'S!>C6TK+9$/R(#.H8EQ33,A
M_?R)J17'QMJ&A^5_W2G)75&"0KLT&*/Z7>F:#-@^,L<F](M(V%V!?&N'F8>^
M5,(`U+HQT%7HMAGQG+%$#09$.2U=]+,.-#S=;/#_`)>F.>>3'W'5\L\IS&^+
M7OI?1@'.CA:HP#M%`\]$\D[Y#A]PD&.5TL7.$U<WWSFM?CURE;$3QFC\TJ^9
M=]2$E+FD1HDQMN-%!&_)[[J+0NA$>8UZ]W69*Y)U]]X)8N6.OD3B:%_.5@K[
M:>C2?&CDGK*OI4+SZ5SP`ARLDG8RY$(B`GJGM$-5:V=?Y_.JZNC>3/W`0WBA
M#-4B@=1,RM=HMHH;Y#E:&+&=*N'`!MWZNU03<KB`?CMUM=*O]Z`UJLP%$9'-
M5C4(/(F[@Q-*4Y%8I6V\?Y_/-5%P\FON<0[;UUI<'I]<YE$(C9B[94>%,=#M
M?*#)VJ=AM7,N552M*X>TBZ$'RHJE5GH$]O\`.0V,3(/S!Y`5$G,ZB3%8C9ZO
M?WA[UCR=O?D7W:O]?U;E<["<NXH7&PBM!=!U>E=L,IL[78N=UJWSN7<SDF(E
M:DPH28\:-/OL1<)3,_\`'T.3/H45G=&V(BLVR_#!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@>=.\]2-\LE5`DT^B!528[H<0P2="32[3=HB519*@#O?!8D
MO1Y!@Q%=98:]G^6O>R.CU=<;0LU$7YJ&#^5G6&C-/I)3ET0A9Y=E%URT$MD8
MX.OPW5CZ5MP4@[/EL"-=`*?F`C.4'UZ2A^A#L14=[3K$Q8J,UF]5\B+;3^KP
MN7TVAKL\F:'$;>(D8Y<<.$%SY>-%'$7Y<)@C**5F-!6[N4[&AZ:9DHTSN3IW
M:FTB(PN67Y+W:W7WH,SG-AH*:Z2!TY-S.EF9!58I0L@;?IU:4-_$!4)S<FPV
MRHVG>H[BM.Q1XN,\K:_K$>TDQA:DD^6?6`;*8ASG@&RG8,>YK(#:U&N0Z<56
M%.]9C:E`1\D68T@928'/X#1W;[VWUR"R%,(1[HC4TO&&>+^2M_M\N>'YN'!!
M'$V*N1Z@7/LV"5KI(=_NZ^?$S%6;0#U'>JPJL!US"\EOZAYN*2:>C[;:^"6\
M*B,TCM/D'U414:1:XG+'F5*+6"%;1TUE^2U<7@_.>JFH@+FK@Z<]8Q90K=J.
M/ALNFA#2'4$V6HZ93KFMZ%1DC;7E)U14`V:'\K%W<%5&FT/SZ7(MB]]*DD_S
M:T+>YB@A7=-+@02%>;B35RUK]9"W--;4C33CHJ%@0NT='-<+`=-CA*@!-3>B
MT<'/^IFO6:NO48OU*O5,_8HRZX2D/#)**T1D/Z1(D.)'O,J5(]4(4G"5C3SY
MKS#[0\+AW57(U"QDF++%JK\LH*=@5XG.+4;;<KH)/ZEEZI%*;LI,#38TN3"T
M]+>1(VTTWKVH-<82!KRA[1<3$<=3J958,P/;[E&L8[4VR6","BTD?U8;)J%W
M*PZPF.V:LQ*J19PI\2M;*]-;0IQ;2V]R"5'5*&/*#J9XJH/6^7B&B$^430W"
M.2+>B708X=HU(B:Z*B%65M?6]`'B-3@*(2_:J(YO;JOT(4["H63Q'NEUZ[8;
MZ,)<XU1A]<BQ%"=F3$9PZW.DJ?;BLG0"7&BS4`U$;01A2OIXS2XCFD:]Z];5
ME28I"^(^1G0[R>Y]5K?5:\DD=JX=VSO5]BTP94(F[S<?=#-UCC"\"1$@<^BV
MR2]4?B?FJGM'XRT*WO25MMEF(Z.D1\B^J5V9TAHU6:M*&TXW=H,8D-&VAN1&
M^2_5JG\O&%X4Y^**0F:-/_BI@JZ2A0V('L>0A+.W'$"H8=GRPZDJK1KJ2Y+!
M``B0L<48BSYE@<L(IB)ODZ[*Q(%R0XAL^?EIZ3(;#B8;J)DUT0ZEO;[[FHZ!
M4,H[Y#]J]SS\WET&&$FR84<8X$?M#]DAI,R.C*&.$8Y>G;&H^@B<W_R[T;5^
MN;C)1[-LZ7)%0E\KOEUIW`1/5[=6A5E/Q[?.J5M$5*.<&-PYLRYFN?UID:*(
MME2^Y2K>Z'ASDN[]K#,B3)UOV-:1L5%TKI7F)<1"K(JS<QCQF@C5E1(V,DV>
M7NOV0,*Z<H/S^PJW6?\`*;;:RM"AJ@ZA)<;>C&F--I6I<1<XO&%V+[+=`_&K
M3UVR4+?I6[98U/U*O(/%;#KFM7O+]:)G6H*A#1`K:-5H;*,M0(T=3<C7QQV7
M'-JT\HS6-*:<\F.Q/F(0-ZBU*J3HMMJ8V[1R.[:;=H0=[H%+II=-@DL#1`Y,
MB]0;4\1K,QEQV+J%`=<?0Y^O\1>,.2-Y,==9!"R1'FPX7`,LCXD4X?7:EZJR
MH.N;M6"R=%8&U6`AH;(?OCB(Z(+36D.P5;<VVTIU405'JL"3W.]$Z#X^W*K4
MZ/+*]EJ-/-2QRI)1ZLUN==G>=1T.$YS=:6;>%@D7*1)3O:![K[4)6G$M^Y6V
M25C2LW?*7JKLJ$RFD5L.\-EU"99!\EBT%TR0ANG75^4/9+1&8:JM:"U_K\6`
M,B$8>UKA2F9&M2/J/8P6H9@GY578$RR#,4$2U<F8@:59),9ZV.U&GBC@CC<S
M5U-2%UMLAJFA2/2R3#[BM,NO?EZ2K7PZ1*5#%0QLCR3ZB%(FXQ@?2GXS%LL`
M6/:VHML'\^JM=9CUPG63US<;%FSDAZQ12'P0WXC[41YPA&W[/;[EZ%0[3OE/
MU"$(B68[R1BM!2LJ*MD=->L,NV@1T`]6PE@B3PK@<2W8[9.79-*&"Q[R9;[<
M1_;:)#J4QE"H65W7R+E<;FFAS-3_`!V7$IC%N"MK>+QVS*(H?J9>SM_./"%4
M1HE8:HHWZI[]?XM&FO<G2U,(?)$6[=9[P4G<J(]&-!!2XH?H0*JR#8)\WNI&
M*F1MM6"%^A!9!01&*I`UL6?E.2E/,Z:2^)D[V[IC7R)%8TJ"3Y-=D+5N39`7
M/:]7!<AD<X+)6:)=YWT4>-'Y18[`:/#FQ`-U@(NMWLBRQ[7$.LR1FW7/<GY6
M6BU%K^X7=;A=D7Z;:HQ"''@VJ+!KL4A`;B+9%:K05Y]3,AL6)_$69!1Q]U+F
MV][3\GQ^N_9Z[),1T7UA#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`J?K]HM51#5`G55B=*G=7Y15[`T5%3
MBJI%6N=^`U$XD7N$4&Z&E6(YK3S4I[4EAE+2O<RKUTI)85H4Z/U!L!Y"QX9+
MF4*T4RYVVO\`-R%F>EU("T.B\9J71*^Z:_$B!%H])&E#KVB<I$@?%3#9=>TA
MO3*D*$1"GZ!Y'=1L?4.,5Q,<:=J%^8-#R+S$:GJ+K8K43J3-FZ%(>`WR?(B5
MAJV4@9""3(0V8$,P"J7TS$R'4,1RS$5XH;`[SVBNQ7^B3:E1FF;'VM,"QJ_+
M<=B[%^-477<OS:38AUZX&B#L2OU7G41ZOSR:(TB9,^OC+'MZ6PXLM1*ZZ3Y`
M76R<B\@[Z1BU^$>ISG0[)RH#J!.BS)G.X'.*U>>>DK$,EDMSB$XA'L4=9!;'
MTS3;K_TVM(<;VI1)C&%;-^:LNN`Z6/DBA?1+(5H4JUV$M'LU4KT`7,2BQ%6T
MNR*_.MM-("6@M:F:^047(/;EMM1%H3+D(:V.+FD^;5D%D3`USEXVU.1V[_8A
M2ZY:Y`7<FGUR&HA76WHMN`CIZK7+%[9($X26DOPADV*^TS(4]IG0XO05/ZQ=
M[C;K#0"=1%TJ:P*N<45:!MADVZ.U8Z6QSM@T\X+GU>LM.BM$>DL_AZMO?),;
M'/J=;8]Z$Z),4\^`/)[JU<HU:G6"M0^FVPQRZ+T\HXUK?-`L*$V,ZL>)!Q\-
M@7=9CA=4?GK<2.EYW3:W9;2UJ:2E?O+,1:TZ/Y.F[7UEWD\[ELH9.#QK"FR&
M8EEC2XB9@`K>!"Y]6@%!8$E::O)GTKZ;ZIEM$EJ809;7&2VT\]H3&%J_IGEY
M+*IAL@>1AV1;K$.YV.2$N:Y$,5#N5AY[HB)]D6E--R>L"BO4U2+`)=W';BOQ
MU[7,6N3K:!Q3JS>4D:E]&Z)5B\,22"`9(<15I<,DB%((6QUOFS9.DK>7J<R2
MM"]]#U,;B,H1(9BPE^]M6E;<;)6"-0?+^RNV3GM6G<:?:*7]RND(ZH=TB['0
MZ]9AU!(Q(Z"9T#7HLZ\#XMY6_($HWI+D<5)W'D/+VAO1>+#=.\F[M5S?D5$Y
MX0`]&:YU780P;`$TL_9"7/.F/BR9::BT!*21+VJRTFM@HS$LG)3"@M[)2XXY
MF5IU<I4(1&5K'ZIWS83QY$=&KUVJE:NQUJIB042Q#XZH,WI-C"QRD#GQX:9.
MUURHNR'Y"5DU3Y$=\.-;??>TCXMK2(C&E7S_`".ZTE_IK0B;0YY"KS'GY`5F
MN%2&Z!%`]RA<W9#G7H]DB2R,SK%$^8\%E/MP]1V]?4)8E1-H3L5"Z.<=Q/VS
MNW7.>6,'-J5;JXJE_D%%@IMOK1(]/F67JU>/SOS*?C1:Q96#^J*W-#QA6W5I
M%HW(6MQ3CC<4DQA;S];?*>RBV69G1N2#I``1-[:3JTPRZ-:%VNX<F[J`I7/'
M@[\0C9)M3?9KLF3*5*,P8;3A%#3C#C7IZ9&N,=$M1YL$)9^M5\=Q:P.2C!V+
M7R3D^RCP\:`8E-A#S(`?-*CH0TK89O.[D#L$5C;[#<AB:\QIS3T5?NJ<69Z'
MYB;H]LN=,30&%D:$5='V(O8;AJNUAGZNIG;_`%")',)KA3YS=[J0!W4",EO>
MD$W$15KVK];8C:SM2\J]WN[4^C5JAJT3-EEP[8@U9=09O/X<:;UYJ4R?&1`)
M)YNSJ@\J2ZT-=7'WM15KWO(:;^5T<<+5O<?*UFP/7.ER>.!^@B0YWI,`L,'7
M99:0P*Y&1ZTDLQ9A#%/=V(N=EUR)4@$'^1Y,UN>G;DEE+"U."-O5R[\UQM67
MH7(YV'<JU5!V,P>N%`MWX_SD33^>QQY"PR:H3CU$<@ZXQ3'IL\3!;9C;GZJM
MACIVTH8UN8.*S;#Y/ZK3(9X]6P]6W/Y*'ZA)AV>SS8Q-]^S228X14ZP/&U<B
M]8R0,A#8W87M;CM!8TZ.\O3C;FUH%*1L/FW<9?.IEH!\]K]05/$2OR^8MMYW
MMM\^+J]'/%PXV"S47X)L[*D7UEH#"1*]330Z>]M49+2$N18VQ=+^/]^/`>JE
MZ%%I"S(@5::J++'Y)O8U8\?:I'&*_#6#&1Z[.T:=8,=6W*D:D2XVFX\!_27-
M[VVA%9J*5G;?+&T<O8Z-)N-0&E8PZT](B<X=C&)HUT]#H9H-%D@CG_U-/CJ]
M-DCBJU#I3DI]F:N*M+FV7'&$.%XVCW2/+\U'HMK7(Y=7H$(\`OGY;GW6V*15
MEB0+/71;Z+^B53)$(:0L4GF?Q#Q:/KV9ZRS+#CK>TJTX7CBL6U>5<^B'*Q4"
M/-C5@+%Z[1##I(;-U$B[1T2*JLTMQ<30F2F(_8NRJCUI4?Y-_1)F-SG%;92I
MO"<4"">8-]"P.;@;ERM)NX6T8!*OSP-FC#0\T66CCE(1%?.A0T!B\R-2GY+8
M7Y?B<C0W=MRU+U[-%XP]0<1ZH7ZJ`GE#M2:IY*"JLO\`X=%-OGXKH^W46K7P
M8O1"2#KSNIL*':$PY;>H^VTR8R]H<4E6O0S,4NG"&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!2'9^XA^*)
MJKANOG3:+F0F@`"`:8STDA;&&XI&%5XT9YUMQXD3KC!8BUZ?J:8#/ZWOWJ;U
MLL1:HJMYCTZS3(X4G7-#24XA1!L-#%HKIX.4WT>P<P!AXX<O&=98,$1\+J\)
M\I%90I413+K6MNH6P\\7B[%X\MJI05V^3)KD5UBIW57/FH+9UINXF70(QTY;
M)D>L0@I!8@0%$)5)@.$)41DBS_C-+CMN,./"-ML."\J9HCBMPZG>X`6:3!VL
M960H4-HD+_,$B5SRGW-X=%<1%LK^B'_FQ%YO:VTL:883IQ;:=+=P<<:AC;'Y
MIMP0$\H.YZJ*Z5'6N;0"-DM]?$!2<*HHZ%HP0M4]SW1:FG3W/'M0HZW7]SER
M6$*<C[VZIH<64LO?KT,*<QKU?Y_3SCMSIG*K*\J58V0CQ)^\R;*V?#1!;XZ6
MV+%B=!FI?UWSS=Z4Y\.XZE+0YL5JPD+S<&6#ZZ95^/6HI%C2)>X!0I.'5^(Z
M\&YY8[Y8FYLN9$>;AD4`:N\@<B,J:D@VI#BW(S._=H<4[O7D/8*ET4>/C``T
MVF&^?T8E7G2UD'U7<BVWLA>IZ-VDZ4C/CJP#$U?G4A+#FMOJF$IK4;2/<MM2
M24J,)YQO^XV7+5=B57WA,RVUZ,[*BU$I!J@>9T2>8CDWR\Z=$*79=<KL!`\3
M'TVJ?,U*5IUMAM3C9KBN7F?E76>I=!CT$52K$./?3&'%/E%#$HAIJB)8OIK#
MGQ/.2FM\]Z&T/KA)/MUM1`BPI&E-I5M))B8A4(GS4/B`1&VW?F4",`>B5-@<
MS3;,V?=A7:T!"QEP"16D5'ER1;:A+KLXEJ*VL?M6T*C/[0XXD<<:M<QGR$F0
M(')94/FQ95@ZK`G/BJ<9E#@3PXVFR4^N)>*G9/S+A0$-V=Q_3B(+TB1%]%?&
MVYO3*B4K`GYKH6F'.&<Q;F0FA,FT/BC%Q&"[:Z'E<I(]#I4\+!6,DUZ0[;9X
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MU4K2$)3Z[_3Z:UK_``8&.%!A0..]$#CXHZ-((E2S[,5I+2'B1LE+,%ISFM?^
M_(($YSS[BM_I4XYO>!U3]9!6@%/K)X:P0`%(_P!(1%.;<:B38>UI<<AR$1UL
M[=AR/;[76M[^-YM2D+TI"E)V&87'8=TG3K+3FD:6E&EMH7I"7$;:6E.E)W[=
M+:5M.]:_=3OT_<P/K;;:O9I2$*^-6E-^J=;]BDZWI*D>NOU5:UO>M;U@?>!\
MK0AS7M<0E:?<A7M6G2M>YM25H5Z;UO7N0M.MZW_@WK6\`I"%Z]JTI6G2D+UI
M2=*U[FU)6A7IO6]>Y"TZWK?^#>M;P/K`^%M-N>SY&T.>Q:7$>]"5>QQ'KM#B
M/=K?M6CU_1O7Z=8'W@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@1XQ501\I63!>%N;.IY*49KNW)4M,4>
M7F"IP-PG]`V^B#+G-"2<EAEQ]MQ3"9#FV_:I6]X'VS5JQ&^A^GK@&/\`A<N7
M/&?"('M?ATZ>O;LZ9!]D=/TDN8YO:G7&_:MQ6_56][P/V55ZS.F.$9M=!3"#
MSD%UZ=*$#Y$QUT9IW0UUR2['6\MP?I]S3"MJWMKWJ]OIZ[P.S)"!9L-P=,$"
MY8]YUE]Z#)'Q'X;K\93*X[SD5UI;"W6%QV]H5M.]IVVG>O3VZ]`^9@$&0BK@
MSPPF="<VC:X<P=#DQ5[:E:FM[7'>96TK;<U.GD^NOT.Z]^OUOTX'86,&N28T
MQP?!<EPF5QX<I<2.J3$CNJ:4ZQ&?4WMUAEQ3"-J2C>D[VA/KK]&L#K-5\"Q*
MDSF`@AF;,:CL2YC0V&W*E,0XSD*(S)D(9TZ^U%AO+9;2K>](:5M*?1.]ZP.6
M>&#E8KT$F)&D84EIAB1$GP8LR*^Q&>U(C,O1Y#3C3K4=_7O0E6MZ0O\`3KTW
M^G`^)0('.]FIH85,TU,C$6_JAT21\9"&ZX_#G(^5E?LF1'WEK;=U^NVM>]IW
MK>]X';:@06'?G9AQ67_\I_QS4=EMW_+7TRIG^,0C2_\`*Y*$N._I_P`8YK2E
M>N]>N!T]`0>HTB'H,)U#EJF+EQ-#H>HTI9#4A,]<ACX?B>5.3,>T]M6M[=TZ
MOW>ON5ZASL"A<5B%&C#8$>,-:0P.CL0X[+`]AKX]-LPFFVTMQ6F],H]J6])U
MKV:]/W-8'216*TVIQ2*\#0IV:V3=4@3`2ITBU#4.:(.;U'UM<UH>K;"7=^KB
M6=[1K?M_1@?DBKUF7^):EUT%*_&7HDDO]0('O?BLB!ME4%\E\D=7UST)4=O;
M2W?<IO;:?;O7MUZ!R*KE>7MI2P(96V"GXXSM0N"K;)O3K[WXPUO;&]ME/FE.
MK^HUZ/>YQ6_=ZJWZA]/U\#*=C/R0@B0_":>8AO/C83KL1F3&5"D,QG'&5+8:
MD0U[96E.]:6UO:=^J=^F!EDI2A*4I3I*4ZTE*4ZUI*4ZUZ:2G6O36M:UK]&L
M#]P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!XT\QO,$-X:@Z1>+O4G2_.;1)Z
M"`*V:,=9'20-W`<OM?1><U5L6\-E:*2.L$J7*KL!>GF5-FYD!C2'E2M)2:V[
M>7F\Z!?N$]5L%N&UB'X^4D;JQ]EOWBQ7UFNYR4&HWDKR_B9GL=R&6RN">5%9
M87CB-U4L*B6**X0)N?!#(.B&H)%IQHO&-7<\8_/[J7?^G\+H!C@%>J`_KGB]
MSKRH+V2OWSI/0(%.J77'>FIHE:F$X/`Q%0A63;7.O\L_&RX..\]+VR-60<85
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M`7S_`/+T;CLC8]=E19MROX6?'SE/=](^H0%"_!^!)Z=H9O?L5]3N%\^OCT[\
M2#.[;Q>V,,F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!YH\
MA[5S"&1X]SWKW-`/1*;T;HD/Y)5L%U\Y5J"?HK:+I2+P8%6&++8]XZ^#!;$&
M8TE+PTC(CRM*0EI2TEB\X>=ZCVCQ&(7J/W"=PT%6N[WYZV5,59(?.ZP=Z];P
MXF^R.7`(L@J#B.VII^]B1<*4RS+VAML9[([[_P#DNT(+4Y=%G<='^,%XJM1\
MD*YQ&@@S'':65H-4LX+G@V4=HE4H+)T88Y[SHP+`1RLH!4Y$@F,U!%-_2MSM
MRXS*%+^36Q-Y*WCW#P;!(ZF88X=1V8O6M"37;RU9XV%/ZM(J\Z#'11?LD\`#
ME13K5ELUQ>TA*GRK;LS<AYQ27/J/86MVJW>DWGQDNE#1T'LG/@-A!B"TWG<R
M!T_GX,@<`?B9&KVXJ,="6EEV0L;)=J80V^Q$U(6]^'Q']-+>C(TV2(W749JG
M-=&\1AE;MC5=X"&-2[C,K=V/5;^!V$(U;Q8N^P#U9ZM8E/`7$OUP/T.V;)02
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M<9[ROY'6!<(^=F'1]<*F3P8(<=#KW'/JKFEM3R@$:V^NPF`KI-'T;$F/"6AZ
M0M&T_P")<;=4.,NS6_)&L6BTO`X5=M@L1`H]YN!6R6@/(K<"+*H!:HA['7&5
M$DMQ7B@.;9ELD?>^RF')BJ;_`%];4ML4P8SS$XV8CL2AKENF1Y,R.!BOQJF2
ME19=XG3)<`9SN#.B_/`GW$I+@/)8:8=<B+TCW;D:2I&U#C+\_G;<_%T^KVNW
MBK36E6IFV2HHQP+-?=&,UKHHWF,6,?FR&1\$&7/6NPC(4>-)6WOZJ9O7NVRP
M\^@<9G)V*YY<<GL0JPG_`&VH."!N,.Q2I>N2VF;$'D)YVVT?",1%3)BAVY_3
M1L?:)#<>3I?RJVUI#>U8*EE@'DWSZRLF5085O%O"*67NRM6NJ&Z['=@!*U5;
M<2A_*]#DR4$8-?O(>2^REE;J$3?8E*WV9#+0J7"UY,5+\HAKD0K]N$03=]M?
M/1PN8%E2;"8,U@X6K;+M?%!VRGU\2P&!FDPU2'(6_A=TIW3:DJ;P5C3I6WR@
MKM?AT*:'I=[M+-_B-3H"QP9+'X9IGJ7-N6%PI6-(?T18M$,QT9OXHJ6%,NN0
MW4./LHWIW"\7T`\N^(V9%U<$'2LG7/Z.9OUG0BOE'),(16A8<O9X"8+##T]V
MP5^/8(2'X7Q:==??^*/\RVGTM$XRZ)#S%XZ)2:V3U=H+M7EK$6R.]2S*GJI9
MW&RCXJIV#X6W6H)T_#$/28?ZRHNXJFGG7VFGV%.#C+XF>8O(P<5V?;]6.G#_
M`,TV2JPIAF"/DZ+.UL"-/.%Q,0"6,D"0,LT4;CPI##+FG97ZBM(]S:ECC+L"
M?,;A9"SN4XG89U-L,%\A!/P;T-754U4I`6:]@RR2R3K<,<Z2BUZ6_$D:<7!D
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M7F5/.>D;T>V7C+)S?-[@P]C4J63L\:-()_ET5)F50J-C'+@Q!`DBM*%22B(,
M=VS@(=B95.8<4TVPIJ2CY-KB24M#C*:F_*3C%>=#-%;'.C[L`B!8`ZMUX[[)
MH(K2S5Z%%D^X>E;,,F+`2(L?;ND*<+?'`UKZMUMI1.,I5R/MW/NWBRQCGI.2
M3@!YT:')>D07X>G6R$".5%SXORZVEV$3'24.M^NTO(UOVNMMKUM&A,3&:V\(
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8'FWOYWD,.34ZQV*DMVRN7,/T03,F2`$^QC@=?37XJ;:LY!'0)[
MT:OSPDI6IDMS3<>,TU[EKUZIPL7T53.NG@]7[9<;:6U5`=LH=I00M,R4%LC#
MD*V,'42V#J83,18XD;;(ET.)F,-NR6HSZ=*4AC>M:+W9)4,MWC%3!0&]UM\@
M!`7L7?!3,:HB[TR%4Q7WA0WHMALH&O0U1`!.GZJ;<>>;FMQY$%##J=/Z]Z_<
M,<E,3Q_A-:I-!8B.2J[66;:*TEI-%M8@!=;0;)CIU9&W"WGJS]5,4?=!-FFT
M29B/Q&#K\26O;+VWW1W0SEV[;X@EAPE%A"#S-<F7DK.,&6`]NB!:WN?3KJ+W
M8+*6;"P6F'KE6*5+'MB77-K*Q5H1IM]MQK3HK<SP^P>)W5[?S^GUNC0K<F9H
M@$0<C`[$)`UEWFXV/9_R0;*JB0ALV>&D)B//@7WU[8=2Q(=8WME"D#%E([?B
M#VCH,1I%558[]<8!*R07W:IT,4\]7%C:]J7?H<W<$>.!UFXC8PR(DTVN,Q8$
MH1%^63[%M)'=#`Q^S>'M&/L6*IP#/YP:6]$'B:E5K_%+F&21TH"3&B5]]D7`
M,"GI@\J1A-N-KC;99FD8FM_.MY\5N]'&EOPXI$$2P>C?FF>6=NW2I,U=&M9E
MXWKH-SL=NL9VS!JM6TAGAJKF0D_0LSHNT0YKK*8R4R'$*6,99RTR?'*F<A,P
MQ52/LU+N$"Q<ULS%;!V6;T4@J22)T8]%(BSL*8=?,5TS8YK4W9#>G(FTN[WI
MWVZ;V,;\GU;'?%&CDK9S:U44N,V$16+,6)M5>\E5F]DQ?1"SIN):@GXE8S2Z
M[7&CNSLQ;NTQQTU<:0XMN1\&QW,=:_YM_+^AURQ/5%BL2.8NA;G6W`$`"P!.
M-].`WNNS^CLOQMN$IFJ%11EH40TE2%['[3OXY*]#DH&,HL=N?@Y#,'56VI3@
MVA7_`)F7>LM0OPL+%+VPQ:CYJJ[`36VM12P]_GLZR3A>H"(\=I"2B$[6[MW9
M8Y,U?[[XT4GL5AI]CYBHH_T3G0I%JL82*]:_Q.O=<FG1[`QF@!I!&RN![@9H
M,>-.(#AWQ2#$P:AY2WGOD;)$33+LVKPT2-FUQL0RJ&XLCT69IZIWO<YT3&;,
MQ"G:U&I8_17=7@O/S=+MWU'T[<Q7O3*^=;2E#N<07H_AA8P0RC@8L2<*&;$T
MT<+A5JXL2PT^VW2.=%BD$-0V"0H[-N-9:*HD?.B4W+B-R-.I=VWM0K<Z+MK\
M.;0W&*E:[-.DY+L.8Q$CU;J5D7:30T135DX@!ML4K?1)5;A5@)*(_`S*^!<"
M/,?2EYKY$"MR]YSG"AE5K=P;KT4@&Z2-0%JK06K'"QBV#KW3@OS#(`""/>-.
M()T6CQ')2%L(VP/%^][XT,KWHF*#<^M_CI?BC%3$5I++\;I5O*UEL@',/5Z5
M=@;[Y6<3KIS;;]:B&C0:)JPL#V9")3@R2F<IC7RN[PN,8JJY[Y'>,?1H8$B0
MI!&NS*6:*/TT=&$%+7IER>7H=K=>1^1D%HD8E.NQRNMZ@3DZ<<L;T-F+I^1I
M"M"8W0D).S^(B!%PY\/T3`2.S4HW5RM4J]<NK9RPL37G.<V(<.I+8R8UJ]AI
M2?HB*5#_`,18U'W]3ZM1U[;$7F@(;HGB#,K`RYCZ`89+N4Z<;C0!@SJ#MR*6
M)ZMD;8=@#)T$<DE<K%5A5D*?46!EV3($:<EMH>:]7D:+6[J?G7P&V('S"08'
M4W9=<'_AS$NIVMVNZ&M!2(21)",RQ#E)MP.BZI<Y$MYIF5"A/P77G-)7)TM\
M5N6>JM\L\32?//H*N9+EK_9+`.L?32Q[\$#0W3)>2?ES[\01N/7GOD)V1]H,
MB8PI;?N6TV^E2E*<)CN5])`>.-`X[TGH1'A=JL&N.]#.U0H*GR19>]V:6F\"
MG5;%*AV5`B56#!BPL%XH5;S$?;WM<7#1.UZ8,;JW>_A.\*JK?.C4HE6@M?AS
M*C3ZS.L<J([/IEQJ]]A3#)017HT.81T-``OIX;YV5]+!B?B)%I2W')/RJ2*W
M3"1E^B>&4NBR=6<4[/HAV*R-(3;C2.AS&3"[7SQJ7H65(6<4X6GFYW(8;9-U
MB0M<UL`EN2O26]M[V.Y&B/7/"AXX>A'H$>`$+)#7L-9Y@Z[0PAPA9S]Q:+73
MGC:8S#8L?`+U),V18POPQGYLUI]+^WE)=67NSA\F`7BK2:?&Z<,YB:M5=Z:P
M<L=-=&)E"9<8]2J(#DURM4:-,)5Z=5[3>!O+6$#IC6V)LV;'TF3*TE;>M"]V
M5I80ZWXGVR:!M70:Y`B29VJ55JS8[4#>,NSUU9BD]T#A]31OXPZS^2;+-BR'
MMR=I2R5&R?<K:65*43NZ/47+A?/QU60[S)A$>I$2163":C/EE"T/1Y[XR6D'
M$*O+0-")DP%:BLPT-0/BUI<=/QK2I1)OJL7"&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!YW[E;.7@#/-0'
M0JZH]/Z00L_/J\IPW70$&+$.A$;M34Z=9;75H[S<X3&2A,:)N62?VGTCL*WI
M6]%B^CS"*E_;_FN%@\D0(CBA910:$4L"KRX,D0^BT>D5M1*)*G/NN5^DRJ[;
M0HR`1E?1B4+>CK@O:6I#NR]T+!)&?$?HK?/69736Y(:A.6>L0`$RTVX<^7=M
M=',VPD(MSI&1$L9B`1HE*)SE19[CD,C`2K;B'FULZ4,77GK\&[-"5&G2@LT.
M5KVZRX*W+Z!'!3*O*K92CM7)P2VXP,_`X=6+RQ3-V^/4>)&=4P@FW[$I2.YV
M!=.\2>OR^C/CJ/\`C@BA0AI4_(CR[6(K=AV:K=MEC2T(/LJ)'6!T>`/3]BBB
MF%LM,D$N#Y&DZ0M`O="'T_L7B@/D4OJ0:L]$C$R5,`F`<DL]9)\QNU7T*4JH
MB@&:W.MTZ.ONEGC<\?`:^JBN2)+XUF%J:KWQDN"MV2XX;/'.&7$G'!<RNS-H
M$\0LM[CS8*YED^6AU8A6H$[FE8D&K9*0U)"OMC=0`[&F1,%IS7P.,Z==]XQG
M_E6EC)\#![FF'>*='6*)>.Y+I396JF(*?QSGE/0(L[<100=TR&;BVX*1NNFQ
M<R9%CJ;D:>U'FI:8TM(B]>J?5>F<47U`E18G)K-'G':#NX,VLI9-&J[)J.[$
M!FPP\.+N_%K!4X;MCG+6.@K&P(BUCYVX^O8TKWCI=KU-<AYW8!;(<I7$.08Q
M*RF8FHY$O`DPB]N,R+%8"D*?`GQIT2?-.2ERDNMN)4P]O6VMH]J?0ERQUUX9
MS#H1.29M=?E3B<T?$%3)<2QV<,N4,B1#X[Z!](0R/;<BSA5I(0YB-Z])L23M
ME_Y&T-I0(F89*T\@YG=B`LG::<),30M3MM&%N/I?:;AU.\PH`ZTA&XT9]B+N
M*4@#&6?52-N,-Z6EE3>G'/>+E#G?&;C+SL64[62;I*+-042;=N=W=L$@PV\9
M<2;GGW+$LP1-:8L9"+]6^\Y(^@FO1/=],KXL'*5DSZ!3RA`H5GA&)!`TFEI)
MRMOS$+EZYV=E6:EZ5IJ2A"/P$[-=D->S2?>M>].>]/HG0N5:;\8N([?=DZIK
MB7GH4X,I2;-;=)352FYJR=";;V=VTUS<@Z1?<=K:=:!J=<]_TNEI0I(N2;XR
M<:)PX(\G7C).".K\JIPXI"]7R:RW6B!<>;*`UIDV5SYQI>>(A[F-N>_4I$-E
M#GN2VG6A<NC;O&7G!NH-5>LCFJ3*'_B.@%@%N&72E;_''!>CSX60T='S(4\G
M$$M,[>2_KT;]R%)6RX\TZ+GJDH_A5'A4.N\\DOVLH'J4Z.1JQ.3;S\"T5N5!
M@20XW=>LM?FA2P%H:"F.P&6X;C"/HG'&5Z6AQW2Q<YN[6^'\NJ)L38*Y5T"Y
MX$?#'!F6BQUT0-3`K`^E1B,4!()O`T6'5/%1A:B?T^R+@]E+"G]M^J=BY8`7
MXS\4#0IL"!3G=(G#60RY<NT7`B6B"81($8#C1!LB?EF`<&ME:U!DB6H;["!+
M\?2X>F%*7M0N6,8\3^"Q"#A>)2I,0PN4^3T:B6^[Q3+)Z:\&?)VF,78L;9&-
M;C+M?A[G%D.I(3=-;T^\YIQW3@Y2R#GC'P]0`566:0F`*!CYHD/^$V&UB"0P
M:3ANCBL.$<&'(AR,T6&2'8LK:)&E2(SSC2]J0XO6Q<H=7_$#E(:XSK?)AR)2
MX[PE-&#CIYT$,YZ.%3+.0<A5[4(ZM]C\=EW"?LFEI4>'/2YKY8VW/>XX.4K>
M)\FJM@JP"GVF3:K2'!+8<=29N-F^6SN,*^12;MH:3'1KC!DOZTMV$0:?@.;U
MI.V/9KV8+9=WG-)>'&Q+H"*L=8[5%NQN*IZ9\9"TPB0@Q%,.[^I]Z7FB0&([
MI"-I:WMG6MIWK:M;):N87B_PD8^#EB:!"#RZWM_0:6)*V`;*B1IAVPV6>.W(
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M!RBWX08D)*]'-R(R);;K411!:64H;2A"1RE;W/N?A.:5^/5JW),K`CXP0>''
MEBCY-@")KU7`U(6&#)?UKZ$8R.KS3RV]>NW9KTB0O:G'E[V2[3G`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8%>7?F5<OQ*HES+QJ*1I1*:1#20I>4+VX@K`6,+BRC+.]QR@<L/7MJ1'>0I
M*D_N;3O].%MYTL/A)S,H@=`%3S@P*^1KZ+I%(G+;8)ULI-6?I;@/FFI<FV18
M`^EQHM$A151GH<WW,;=4G:'WY#SQ>4I<CP[X)N$)@R:I*EH"B(H&"ZLV3AO?
MA,"X`KM`C2_PJ0/9G/1"M=88U)>0N6Z/<D1'77&)4E#HY2[:_$SC:W77E#[+
MM3PAZH.:_.%BTVKF<A]R5(Y%MO4[V?P7/R75+4)]/CWZZ3[O9I*=$Y2D-0\?
M:31II5ROD;>V'-UM^J$ZQ/LQ`J#="M0A8FN08K9!4B:+B4P'`>A#&8KS+3;4
MZ0MU+SRD.H%OD'XV\@KA$F4#UN3$EF9_*"I+_P`^.O1Y!3BL=$7GY#41\BY&
M9ECF&6]25MH1LAMM*I/RJU[MBY6,9HE9/F=GRD%Q\INGV*B;?3,ELI_+-KE!
MYIR#\++R&?DE2`496GO;\K?Q[TA6M*5ZDM'6^-<^:'GA>A#ZX=DYN&Y(22Z4
M).N?D`!!.#QP*&\N5MV`E+-CF*<>9VA]]US2W%J4VWM);EF1_.ZV*+$SHU!*
M&6,,TZ%/G-%B&W71-$3)U70:-.ON(8"L*GRUNQV])0^Y,?6Y[E.JWA$YP&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&!XZ[[T/K7/;O]74K!"W46>566UD`T^C+-Q`\X3<N>5%^
MSSRHR=&,RPU:#7F8=F0&=-O26@_QMO-I6YO#41$NI`[I;!',;OT1ZQ@.C4SD
MW4(,(WT.OUR1J)?.0-`ZS.O%EK\(%/(P913GLZR34OR!VY$2;^7GVFVD/.+0
MT*Q0@1W#M9*V#*N=L-3JUX,6VMU#7((U2=F6F)5KI08ET?ZI$G2R[CLJ/SN8
M5=B2751E!7=@9,5U6ITA&F144Y>&=XZ"2NM6#=<OM=8&SO'OF'4)RYHVET74
MJR]#F65LC"_#B=C59U0P;T"'%C[B1W64K<]LIWYG&TY"8CHZ_;_)+L_/K1WJ
MJUD$&(2(H,,SP>=(JYPA$8M(.@-="ZBFZN0B++1.!!J4O9`6EM4+;[T%^'M:
MW%-Y2(CJB=V\JNYR)MX&42DF_4Q<`F^(N_P>R8TRUTH.6+5>[I%DKB:"U6T$
M24T5`-CGTNQ$;#V!IE*5R&-N+$1"VN(>0/0NBG^@1+6S7P\.OABA#GB!@$[J
M)U>#&$5HB1N`$D0?2N&'JI8K^&+$NH_%U_4-RI"6678VG1,0HGDWF?U$S29D
M^THJ!.SKY/T&UTZ"B+%:7=KI7:KR*R0`(==:L)0;:'X$F[%6I0P.MTFVS$1'
M>0W/9D)V6=L+)#]_M\^SLU"1VOGNN>_B3^HODDS5AT>L6(XD!53+7)X+DBP/
M4F)9/<;E2=S?J'M+AQ]0$,[(-2'TDJ&(,>3O5HXKJQ4Y*K%`9YWTZT!H(:8+
MC(M=WY+6ND7JMZOG/)=F+0JA9K46T"B#(P#Y4RODB2G%[2^1&-(%0_/(OR@Z
MOS;J-FKM,:$N`8/"95Y&0282)(*MG':+W*RLEY0]XX.L;<(>9Y\(COO.14AX
M;<EUJ8^U(?C;2(B)SU9E'DW9/PHT"7>Z1#*1SW(X2KK._+)A58H=V#C7;-TP
MJ/J]AE5<N''6.9^%-$HTC\#@RY#2Y3BVV7D*+4(<]Y==8KZ42R<4%8ZO7/Q;
MIIFWAJ:>^"Z>.M!MMGYK=+/6(T8G)8:M),M^!'X"&ER6)(R4_N,AUA3+VA4+
M-OG:_(*GVCB-:B5D$9*G*S6;/U()&KY21+E;8KU].7^O4Z4P61&A'6&:PE(A
M$C;Z9$MM##G_`,3IQLE1C*!&_*SJ*1OB*?"("2(?:J3!MMDA_@.VWC'XM;>4
M!F4!09(Q"MJEQZW=YTY,,>Q+GL+90_*;3$8D8*C&-$J@^6)DK6*S+$&*,7LM
MNYSXT&:T,&I6158;Q=KX3!]R`AHL$J\^0D4.O-19$J$TI4D(AW3\S_%*UZ#C
M_MV:GWN\F?&ODO1"MUK04K?[/7`U\Z/,@U4Q6^70#8::3F3)<*K6&?7X&DFH
M\4-'44F)V.D$V7""-[:6TL3$73'<;\@>T7/LX"NGV!4CF)&$1"P[A%JZA8:Y
M$H$6\D@-B`J4;FGQ,^^UZL,&H;$AAT-^%?4H;EKD_3:=$Q%>*)\;\Q+=/LS$
M?KYRE`:C(L=SBOG9#8R"S#_"Q]BE0*R@F,/D1\8]%=K^]Z$RTHL&FEI7(CI3
M(C*46=L=&6K'D[U&R)@@K\N-X_.$[<2)2KM?J`4KT<#0K'7OS3S&M*CV\C'!
MMVJ5-CE@4PK*=U!DRJW)^".AV=$2V2HZ+/HO=>BV&P][&6.`+KVN<:Z:GF(]
M8,BM_IP2IE9$5B^QBOUFQRAP68VT)DBV/6=\ZOK'MM1IH_2A,1@\W/\`F-Y(
M"A8)M7.0]KM-F+6<U30H<`8$,W"GANL<SYP[7MDIY*5$!W()+L\SZA3GJB5#
MFCY3#2MZ?:27C#T/T_R#N]2Y1R\_SN%)Z[<;.EVV''*IS:URXTRETE""_08<
M2ILR]G:@7+2EQZV/22<<>&$B"');;JHS[>R1&.+%3?(2\/TCR>)UDJ'M5KH0
MUBQ\YW6AXHS4FJ]:'C3=%@+E-E&B&[VD>.0LX)-?0NPIJDNHU^'R&%X*BXO)
M`+OY)]CHK%P5(-5M=RJ&C@17(357BN6Y\$(XO*Z$OLY*=73KD58F/8F-I>7"
M2H#N(TH>E[\3WI:2U"QK3Y/(E$[@"K72.<!QD?J%#K\2_)<'V.'4>7V3F8*Q
M3>ASHS9E(^>+F=!E[KL8J^ML3"FSVOJ/DVPMMPG'715SWF!U2O-19Y@4(L%>
MKS,GJ-BL0>G6.*BY<`%GK%R;1VIPM3IFX-FLUU8&6B(WM<I&J_)<;0AU*FY.
M1>,/0/%>LWPQ=[7S[I9JG$+B%D5?<N/5G8#56%Q2E?L,ET*.EQ9A@POHS)2O
MO*)A"NXJF8;:ID1QV-O2<J3'6,GK;#)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?FM:3K24ZTE*=
M:TE.M:UK6M:]-:UK7Z-:UK`>FO72O37KK6]:WZ?IUK?IO>M;_=UK>TZ]?_O8
M'5FCX!)G4<C"B3X^GHTC3$V,S*9T_#E,38;^FGT.(T]%FQFWFU>GN0ZVE:=Z
M4G6]!V\!@,#\VE._3U3K?MW[D^NM;]-_IUZZ_P##?IO`_-H1M.T[0G:=[]VT
M[3K:=J]WO]V];UZ>OO\`T^O_`(_IP/W:4J_0K6E:UO2M:WK6_12=Z4G?Z?\`
M"E6O77_AO`_<#X^-OT]/C1Z>W:/3VI]/9O\`=1Z>G_N[_P##]S`^\!@,#YTA
M.OTZ2G6_7:OT:UK]97_O*_<_=5Z_IW_AP'L1M*D[0GVK]WO3[=>U7O\`_>]V
MO3T5[O7]/K^[@?6!^;2G?IK:4[UI7NUZZUOT5K?KI6O_`-;U_3ZX!24KUM*T
MZ4G?[J5:TK6__OZWZZW@?N`P&!^:2E/K[4ZU[M^Y7IK6O<KTUKW;]/W=^FM?
MIP'IKU]WIKW>GI[O37KZ>OKZ>O[OIZX'Q\37IM/QM^FT;;WKV)]-HW^ZC>O3
MT]F_7]S]S`Y,#\TE.M[WI.M;5OW*WK6M;4KTTGW;]/W=^W6M>O\`X:P/W`8#
M`8#`8#`8#`8#`8'DU_RZIK4TJ'U5+<Y8!WD2(\=F`FDA$R2)$R4BBX_0HKFR
MWQ)YZR\Y(2[)7O4E#\-V/\&WO8A9KC_AQ"_*C3EDKU?L_.Y]+BF+=>*A+MQN
MT@=TB"0HL^LA9[$>S1]*@32DVQGY`Z/"=W%>=F"9C:/?M"/>2M$8;\YJ)*L%
M6!0:;;7E6ZY6>IA%/R*_$(&60$RN1X1L"'<*JFD8YZ!:8A1F,[]+,;$[4ZMO
MY]:C;+QE(T^7U,:XXUU(C"&"33Q&O#5<W*7>LBK,(>L5LJ=21NU*,/#4UC0*
M7<H;Q3ZEO7T3*];_`%]+:VL<9NF/!>8,.ROR!HKEMPBV6=.JPRETRS3PU5MU
MM?LE?9LSQ!`LP\S'&UH.-^?3Q'ZA]A3\?X=:TXXTE8H,>7B!T-PQ!Y59R]=D
MT[F=\$G(I@.MA%:ZH1^BKL^VPXOUI"H--QXA"3(6XW)::9'/;4I.MM[4.*44
M_P`KN?6WH!?GOO'AR;$";,K<LA;JDIBTK&EJX`>:8C1RKA`4R=+VT=NO/26D
MHL4%_P"KA^]K6O<2II&ZQY@!S]MK]&G4N17[&>GF&X_U]MKCX22(@GYM,#%@
MYV*XN*4W<+N'(#!+*]1OK'("UMKVEZ)]2)AGQ'DF4,IHJHO*#2]7+H=MYBYM
MJUU9Y,*R4QVR?C,X8ZF3J/9:M%AU68\[/C+3IKX5M;;^9/LV6F`HGF72+Y::
MC3(@C8TY8)A:*4=G6$1L$+3"M-AI8M0HTU[FK$_9[)5YT<>SIN*X\N*XG]#O
MQ-NDI['PA@,!@,!@,!@>>BWD_P`E&[--1")NQ3*];DT$Q`K==*DWX5V<LY"J
M,59][X&(#9M^<*D2$QU/:7H>A$M6DL/QUNEJ71*^5G*@C<Z451<8@T=<+/2Y
M17=0+OP&Y]'0<7=R>UQ6GWTU^H[KDM,V7MO2-;;UMK3B5)WL5*3F^^4BMWR?
MS\_#M@F<-U2-R;!,K,]%._\`[C'GJO3=(LJ=+@[V9L,21$3Z^GQ.1G-N>Q&M
M*4*PMTQ'DCRNQ6H;2JV4*6"Q$S)D.U"%@R3C3*:Z0D"CQ=^<^S'@["B9[&D.
MO-N.;4EQ+B$K;]RTBIS=(WY.\O!6TY1)&[9,MPDLH`.!"Z>=(R[@=CCZ\5*B
M*9N-%4P=E`!UJ@OD%:6VS#8>4ZXO33+ZVQQG/HP+WE_QQ#Q&-&7=",H76Y=C
MEQ(%&L3DUO\`"HI"<=KSD)Z&Q+C6NNP!$MV</>0T_'^E=;WK;R?CP5+N[\K^
M4(B?4N(N[;\2"HU8Q>J)99!:EUAH#6;-)M=OA1(,A8:OQ@MP'O*>WM:UZ=<T
MVA>XTK3(XRE=8\AN2W+1/=<LRB/X.[U=DGI(HLTJ(OBI\-7+[MQ+\)M2FHDR
MPP7H2T^Y!2#+:E1-O1UI<V*F$;%^4_+2C%=EI1<8<(_`K9600FTXT@?5!EV*
MOA*-/ND^.Q)B5J/<"492(?SK]R&_1Z3IAG>G,'&65J?DGRNXT>3T0<2,0:M`
M.5H$4G'*\6$J$.6^+7B%=*%6Y4;7T-?GB[6/EN3U[U&AQI'OE*9^)[38J8FF
M.7Y3\B1O<A,VS/@6D,;FV]BFV1VH#9!*.].KD$B?T.^CBS;<+2S+%IWO:9<:
M?`7I6OQ"%I\<9<]A\G^15DT$`D2IE<XXT`EM*A5HU,C0!ME;#J$%"C[4/:8D
M%YRP0FU[UI:VER->]*4I6I`XR^;EY/\`*Z+:+33SLBR?CE3C#W)S4"L%9\:=
M.)ZJJXH03-89W&F&-M786M3>U(1I$O7Z_JV[IL5+*2/(2@0_S`],9MD<94!+
M$^X'-U0N^&K).2(%'(U/G38C$C4Z[/P#D/21D!,Q_;\EMC_Z.M+>Q4HXOROY
M)%+"@!=RW`#L^=,&DPQJF'H1*IS8TBIQ8K=KB_2.+%M&7KV(^A>3\S$E$Y#B
M5_&EU:!QG-W*YY0<QM+U3'BVKFBP72:+8"58G3#@BPN#3`5RQP;.[!)QXK?Y
M6=`L.R?K6W'&]ZCOMZ]7H\AIH<9>B<(8#`8#`\F]?\B.N<VNK]6IWA3Y$]S"
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MK:?*]2=[3O\`1OTWO6&N,?VCW>A9'8>@L\-C]8;\9^PRKV\TPXYXZLFN+IZQ
M%6[8?P9QAXP_U5KD*G(P[_S1?LLZT[A?JIVJ3_B,,U%U>#STKS&\ADI5O7VR
M/,=6]:WO24W;PK]5;UKUTG7N\K])]=_^W>M8:XQ_:/=Z$[+V'H7,@53+4OQG
M[#WF?8GG6R]<YB:XN*+4I#<!J6E^Q/=3ZMSL/);>D.;C)T-E3U?,C>]ZTWZ+
MV9B(G.:5'2_*CN-HM]9K9O[?'E10`YTU`%D[Q:+;XERZW4H4M[33Y\[%JGDI
M8[-(%CD;^1Y$`?-E[3K_`!;*U?HPU.V*SA-NT=_ZKR^V1:[2?#GO_?1$@)%*
MNW7E]B\=Q-=ASI$N='=K\B-U;N'.;(HK"9B-ON+;@+B;;DMZ0\I>G$H)$1.<
MQ#XXSY`]7Z=;GJW=?#7R!X(';#32B+QTZQ^.I6MOS8LB$RP`;B\K[ET6S:*3
MVY2W6EJ'IBZ1'7I;R%;;2L3$1E,2A]X\INX52X66M`OM]^4W0PP,O*&C+U5+
M;XFPZU;8<=6M-'`46W>25:M$<;-UOU;3/'PI6M:_7:3@C;$QG'NMGBW8>A=1
M$VLC=O&;L7`9=>=BMB0O437%BQ&Z(D1),EUZNN<IZMT<;&;AO,)8<T2?@*VX
MZG:-*1I:TDF(C*;>?->8WD+_`.F3YC:_]GYU\*__`,WE=AKC']H]WH.#V+H4
MOATWJS_C-V(=>HK4UQCQXEFN++ZN05%.;%,,Q2\/JTKD2')\'_S%KY;,VG43
M]5>T2/\`$X9J+JWGM7F/Y#)2I6OMD>8Z]I3O>D)NWA5[E;UKUTE/N\KTI]5?
MN:]=ZUAKC']H]WH7J78>@T"B5"VU7QH[#V(]9'!R#'.:`:XN.MM&3-#.DY+M
MDF=#ZK2*?*0*FMZ@/_A90@I4I>E-:<8]7M&8B)G.E+UKRQ[N<L=?"$_MU>6-
M2&F#0L60M1RX>(4@)68,^:Q%E6`PP!\G#)U\6'8=5(D(A0Y<M33:M,LNN>U"
MBSMC6/=9G;N[=/Y581`:C>(W=O(4<2#;)S+/RJP<!$!@<W4Z1%T!),=;[1S0
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MZVQ1-(UK_*-L[PS,1=6\^[\QO(76M_\`^LGS&W_[-77PK]=_^S]/E=K6&N,?
MVCW>A;YV#H-1Y55.@@/&GL'2+98=U_\`%N,U$UQB'T&E_C(J00([L)*X]5JW
M.9/Y8ELIA3/PT[/]\AU.XWSLZ4ZDS$1=6HD7Y==^(%!8^5]MOR[#Q9Y*!!E&
M"%R\-W!X>-,ELQI!:>V.\I)Q!R",9=4^\F.P^^IMM6FVUK]J-FN,:Q[KD[CV
M[I7*"=?@T3Q3[=Y$13,&?+(EN4'N$B(-8?B2([+`XRWUWL/,B#\LBV\IUE4)
MF6SI#2M.+0K:4J,Q$3G-(?ROR2['T&]!ZG;/!KR3XT!)-DES.B]!L_C$1J8)
M4$=)FQFB</G7D#>;>ZLK)83%8^E&2$I?>3MW;;6EN)+.V(C.)?G4_)/L=`O1
MJIU3P8\E.Q@1:1VX71:!:/&$=4S^YHV).DI%P^A^05(N#6Q<J0N(]]6+C:4^
MRO;7R-;0XH1$3G,0F/#NW=*ZN3L$"]^*?;O'>*&@098XOU<]PDO`LTB7(?9?
M&AF^1=AZ:08ECFV4NNJFL1&=H=3IM:U:4E))B(RF)4V5\NN^CRI0?$^VWY=F
M8D`F0@Q3(^Y>'#8\Q%AS'HT<O`;(^4D$BW!)LM)?93(88D):<3IQMM?N1HUQ
MC6%[4+L'0;?RJV=!L'C3V#FULKOYA_".,V\UQB;T&Z_@PB.1'?ETE3>JVGG4
M;\T3'E087XD=@>R2TI4GX&=I=49F(B:MYZUYC>0N]:__`-9/F-K_`-F[KX5^
MNO\`V?H\KMZPUQC^T>[T#9>Q]"!\9`=.&>,G8[9=3"`:B'!`9OBL?I]:456I
M,YLP5/=7#<K>57DZ]TOZ*QR]+UO_`"?;V_T89J+JXI0C'F%Y!NOL-.?;0\PH
M[;K[+3DAVZ>&&VH[;KJ6UR'4M>5;CRFF$JVM6D)4O:=;]J=[]-;-<8_M'NOK
MN?9.A\FW6=4/QB[)Y%Z.Z+;**Y,;XH'U4=COP_Z31W77^L<QW(V:^L<^G_#]
M3?;]*Y\WQ>K?R&8B)SFE;<X\G.TW:[UZJV7P+\G.5`C,I^.1Z%=K5XL3ZK5V
MFH,N6W,-1*+Y$W"VOQY+\=$9&H(R6YIYY&U)2WI:TEG;$1G#*]<\C.O<YN\V
MJU#PD\C.W`HL`;+8Z%SBS>-(RJSY$YC;LD;%A]+[W0;:B6)<U\;ZG1C;*E[_
M`,4MQ/ZV"(B<YB&<XCW;J'5;"7"WGQ&[MX]#AH;12':.JV#@!<*<F[G1XGX`
M-8Y)VCI1MHIIAY4CWR8D>)\32M?-\FTH4)B(RF)>5K3>#0;I!TH/^UEY.V\F
M"LAJ.,Z&#NWBG'&V5N/T^%TMFS!F#WE0%,,C35Y`Q349$Z#$E-ZWIMQEE*W6
M-Q8C#\H7?S>'%Z9RV7(NGB/V?D,7F$TI)JO$.@WGG9%?1Y49J+<(Q%8CG?;+
MOS>UO$+3ZIC+MDU+C19"Y*]-I5J0JI.$X2\IC['(%DT&P7V?/*NJS%G(5GFQ
M:K?/#ZJBBIL<1%&A,NP@:WY?C@-@4!.!(DV`B8Q(:@36-/Q]-N;4I4:K_P#J
M/YZ/6+#;-?X!$Z3$\1.R6"^SK#7KJ0X<5N7,['WW\TC+?7MCB)OH=L[3*HY.
M6!34QA'V[N+[&AT!B,WI6VTQ-5G.:O!YPL_4[[<"A(]9/M:^<14U/3%3')*[
M;XR1IU=3#D0I:4T>3#\THJZ!]7*',KE;"['[F[1K4C;J?T9&JB/_`"C^>CTA
MV9">3TX;`YIXF]NZVST'\&A6L)P*_<]YY8:@.IE8"!*U!,G;CV_DCL<*R('M
MCF8@2?)9]6GE.-ZT\MUVLQCG*H>:WBP&+T("$OMJ^47.A5IB@Z',O-TZ!XT&
M*ES6G#(Z(X]`P77/*.VV"HUP1J*VY\-9&?4;?2VZEI3C:5(BS$1'Y1[N3K(2
M#R4_7Z+1?!/RD[Y5Z[5`D<1<N=]JY['K<*'"E/J"TV0WU[RAH-OGN4&6/:GB
MDOP7H8:8^F2-=:E;=6FD8XS,1*7>.)2?8"P&AE_!_P`D/'FMT*A6@/2[SUKI
MG)+4/"C#C]9@SZ;72'/_`",ZG?!I.="&,*AO_3M-0HT%Q#4EC;GL=).'6)5I
M8["6H-_FP:U]M7RWZ(U2;9*>%='"];\?I`/I,T:<?.";N68OGEF%LMSW',OK
MG"G;2.5/&/*][+49>M:T6(N,9A[&XUV+H73@=M+73QF[%P6=776FQ%=Z<:XL
M5+79#D%Z6MZNO<LZMT41&;8D-)C*T2DP%;><3M.MM^Y>C,Q$93;SXGS&\AMI
MUO?VR/,=.]ZUO:=W;PK]4[W_`(-^GE?O7KK_`-F\C7&/[1[O0D;L/07^&R>L
M.^,_88E[8:D.->.SYKBZNL2ULV#\&;88,1^K/<A2Y*'?^9HVY9T)U#_55M,G
M_$96:QJ\'GI?F/Y#)2I6OMD>8Z]I3O>D)NWA5I2]ZUO>DIVKRO2G6U;_`$:]
M=ZUAKC']H]WH7JW8>@\]I=0M%3\9^P]H-V1V&V8H//37%QMHHR9(A9)YZR2^
MC]5HM4E-P)B-07?PPB05N2K2D:6SZNZ,Q$3UI3E3\K>Z6*TUP`7^WAY6TH4;
M.#!1*XV*W^(TD!58,^8U&E6$W'K?DP>L+XH0RYM]]$&#,EJ:1O33+B_1&RSM
MC6/=8?;>\]1Y991@*C^(7>?(,9/!ME95MY78?'X0"$3ESID15>GQ^L]JYJ?<
M*M,1425+CPGXGPR$:T]MS3B$"(B<YB&+Y!Y$]<Z3=6*O<?"GR)X:$=&$9SE_
MZ39?&TI5HTJ$EG<80]$YCWCH%KW.*;=5IE2!JHZ=M[^5QO\`5]1,1&4Q+QOU
MRNF@=SZ/4ZIX*^9%SKQ3IZ^DDKE0;7X42^=]"O2["[<6;Y#IO9NPL/;EQ5E%
MA]N$`,23('Q&&WTO*AP9#4:C&,X]UR^.O-Q_1+!8+-TGQ<[3QQ^J=+*=8K(S
MO"/%<W#L-TOR;BZ>*A'>&V6\DB#U;D&G5,/6"4F5!^HCMPG=LMN(169FLI5Q
M?.I]'Z";*$K5]L+S,--D/X-HLX>]=?""4`)Q>1WDY>ZKI\61\G7T/Q9ALZ]N
M4AW7J]'TVG6FUIVK"Q$=-T>Z;U/E,5?&IW3(GCCY"<^/U^^;Z5!\8WS'C9_"
M`?.TNW$K-5X%4.!K>8Y[3ATZ>7?^F1"M@9:QCBX<QU#3BVE$F<:O!4Q.\]'D
MEK':P_VSO-VJ7ZQ=`@=,<Z%7+EX%MW"%8QM58I4:*Q,*^2!."3KRJNA^&H>2
M8FQOCFO[3I*E(4W&JC6*]5O6SD0?FM`"=:JWC;Y#=4ZGT`,[7KY4*K:N"Q.R
MCQ/2*<?<O<2_V6XWRF4$I#8M!'4XA'%&9D9-C1'D#VMPT.:W6;N:N*4NQ.Z'
M8K,ZRWX%^?/.&>@11?/K[8HO2/"!8N50YH"C4*5%L36N_6<O%"AP=/;E+E!H
MZ#K&Y$[<-W2I"6M&JC6/=<W4:8G@5]&E.4^*/DOW=-FY;TJCG"'(KMP`-50H
MR^7YJW2HAL7UOJW,B;UL'/>K`F;"8DM,"-:C2''%-,:;)&.<Q"'<C"&+G<:Q
MSR9X5>6GC7S257JF'MDT[:?$!/*CL7DSDVR4]FZ"^:]:OW0&2!DIOZ20Z`BP
MTDM/):(;W&3ZH$X1=Q,^K(V'9?A0SJ/CKS7P*\INJ\FM%?AUPA:Z%:O$H92[
M&V6YF#IMB+UX9>NW4*QQ"Q6'%UHPY.#LMS3+<B6EM>GU./#/&9B)2[DM5)]R
M/VV%T3QS\GO'"D::HIDO2>FV_P`=R'/^IV"K"H]9!RVFN0=%Z=;QI&NB:R*7
M*9U+#CI6X,%7L>6T\E0G#*8F7FV=%N+1E+QC[>GGET(Y4Y[42H="*7WP.T3%
MIJ<BJQ:78JDIKO8'\*E!6:/&>@2G(31!YN;*3/\`E^H<:27/K'N]&2N5B>XT
M7K'<;EXQ]UY9U<OLBB7S$R3\;RO3^@C*@%Y_.KM;&2H=PZ'R2?63QWGXUV!`
ML!AN,V48?7)3'C27?E)=343%*3<O'7W!=J`)^WOY^1:S=(<%P]6A]W^WX+&?
MFL8*`C!U^"K'>0$8A5K-#768,M#`Q^*'3.CZ=U"UM3NG(M1G<>ZX+ORAECG=
M<[^1\?O)/KG=#4L.4(4J)8?&T?W2F3CNZ>DDITM+MM/XL'37@5$BA9[0$NMB
M8,ERVM)F*DO/;J7C5Q2A1TSIL@6$JQ7P(^X)-BME.81I=C/WS[?SY%L!RYS3
M-%$ZDBNY-.5D14WIDJ9]57XT`VX[*DK^I<<=],BX9W'NW097,P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&!KO\`)3R9\B^0^3G"..T2A<2L//\`M-6Z
MI9M62WW.]AKB";X@"$6F^Q?P4-32X.8HL&.QVQ*MS&]?4H<^HTA'MWLU$1,7
M-V\:<Y^\L5Z=*\?HH'Q_-#WNN<[\'K38&KA"Z%0?P^Q>6G6R7-#8R@2;O1@,
M+H]3J+,%,@98(#BQ99U?LVZTC7OPW/QU>.JUJ[]R?H:?!3RP\H+US2EUSN'C
M&%,F;EXQRG^G5FU<L*HJ06UAN?=?<NE&#&732X97Y6S@`?/`'8'QRQ+LAES6
M\,SMCE$1E*BAOW?^Y([)X_<GLWB\#KTOK1JJAY"2I;L=:GW`7</)D[P,'?\`
MFGYPXS7XM4K1>L`WK<-B="_*4TTPRL:/W)F.Q-R(O"*N_P"4LJN?<T[R?J?/
M.B?P+\4@T_RAXIY%=E\5V9W8RX\H+8\?035V2!\D"1"HQ:]1HM[HJEOOEQKT
MR)4RNM0)R)'N3)W3A%UI+I#/NU="L_C]S#RTH_C!.M_%.^=-N?#^0U>!:U,]
MK%]9GR1M)\?`O8:K^%2!%!@]9[,/+@"ZOJGW:DQ*#RY6GDR);<0<(NKQA[/Z
MYY$=X"=BX;XP\HHW(RG<>B<<N_;[]8.AW&VA.5U.K<R-<UI]E%U!L'5R=NNQ
MTY<NEQFH25-P&X`UAR5+WM:F8SIF(BKG)X>Z9]YP)4.@>?G/JO2:!:B'B7Q[
MHE\YAMGJ,=\OU2X<#>J@+R&JMNIXH3.LU`'4NY7\7"%2?AEO'68A-YAK28F]
M;-1\>4ZND%^ZMY#VRH@[)4/'SC9%P/S3SE[!>MV;K'0N?";-0_"+IG-.<GW*
M(NT\A8M5"L5RFWF:A(^\APKP>8(6W,]K+[<C!PCK.GN])=X^X+T"I#.32^!^
M/AOLQ3M?AW<O*BF53;QN/=F&@5U\:0$01*IM<!V(\=T'JG>YALG`%-RC+^@*
MH4"/(DR4>V)&V.LY2E93SU&57@7B;Y(F)W,K;Q?LG0PW/^T=:II6VAJ7RYFS
M"+F&"W.!`NU?%62,'A=C`CJP7@G&1I$1()+T^G3T9QI53C<S'5YDY1]X%JY^
M0_`.!77G5$I1;M/$0UW*QM]5B.7>C==ZA0;GWKB7))M!("1YPBR:\?J;]:<+
MMZ3'&6(L.&)2XN2E6&IV83,.QT/[JO0ZMP7QDZH"XI4)MF\C?#`-Y-QP)FZG
M882M6NP];\1.7#:>X1@UB61(UUK?D\[-=G(CHE;2*;0AC?U&]MDC9C7BNN7]
MPJVU'QV\L.@7[D-:UV?Q,[?7/'2Q4RG=*46Y;=.B=#_@;_@V-">F%*J+(5RF
MSV^[`W#_`->)V0KFV9S;C,G<=M;XXXQI*C^@?=+Z]P/I$#CW:^'4$O:Z9WVC
MT?NMLY/>K(3I5:X->.`7SO,OM=8AV"IQ+$^8YB&H<]RQ5Z8A+J1$)9&-)<3(
M98T6-D3%Q.%,IS?[I'2>C\;ZCV0+P>O%A?%N'>-'DE>`E>N\\H3+<EZG=.YC
M^PR:0ZH$Q%-6/G/.N,O'@D16TIL+RU0M+CJ4RZH3LB*\;7R?\[+;1O%GC'EU
MT3E@NF<PZ?V*DQ;+'*V.6V9YAXT]=L1(!RGJ]K3H8J,Q<ID<M6)IL+M26!.B
MTB/N2X[#]SI.,7QZT\64O[S]^-T:J6.T>-;`&S5\YR0+Y%T@%8+7=K'S*5WW
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M`[I'+N0&^PS#'*>"=9Y7V?KUDZ..MM[Y;5:EW2=4*=QHH_!>J;KPHVZ.G1T.
M1WVFD."-D3EHYN8_=9Z3U[I%+`T[D5,E4`MPSI'=3EQ%O]=NL*37JCW;R?Y%
M7&Q5GI7-C%!J`^TA_'V,58)VHD'@2G"ZHL1;[C.O>)V1$9X__CTAX1><G1_(
M0\%HO;>84/GEOM_B;PSS,IY/F?0"]WJS_+.X+-0HM>MS5EJ5/,T^\50N#<;6
MG:9H\I&7MZ,^E3$AEN)NVQ&6M/%H3[X#E]Y9VN]<BXK5NJ6CGWD=PRF<[Y]3
M^L#3)KIWCGWWH1:DT7I2U#1<Q53ZL8:I-@<;J,IM2V9"!S3TA'UR5)6OUUGH
MDTK[N_1;8/LEYX?R'C_0>847F/FEY`G#E@Z^?IKUPXCXE=AJ?/HTJBE$4`Z%
MAW.^U:T?BK;!?Z6!$E,_2NR$)4I]M9PQJ<\'I?R3\\>H\Y+<X>XER:@WFMGO
M#?M'FU;F^L=`/<I,L\XXX]R!V94`<R!2[F&$7(R+ZI\B'C.XPV*_#^-]Y"5[
M=14C;$YZTJB/]V2)T;RJK_BWQ>M<U;,]#X96;/SXUU?H;H`XSW^T\L"^1L'D
MUVYK6QARXB:NUX\E_P`2</1FY"$GD;%Z9VYK:\+PPY3E:,\`^Y?Y+=@N_A=4
MS7$>5AX_E7PMCR2)D*;([YT=NC\ZGW&FU>""(RZQR.8-K9]#5CD.R#%A>$5A
MIUEMKZSU<]="=D1?A*\?!?S]Z=Y*63E=3Z_R2AT*=WCQ5:\O>5$^;=#+W1AB
MA,W*M4HW4>B@[%4*J5J]J'3KF,>A3(RYXLPTN6EEQIR$M+A-VV(RUIM2PP8#
M`8#`\;=@Y3T&U]K'V>L`7--IKO)(5>Z/JW)$-<ZF5+I5PLG1/<"8FI*EE6^G
ME(D#Z9J*[$)>GP37&F6]*PU$Q5*1JWC5U0;SOC$F'40HSK_-Z]>!BS5EEU]B
M/&N9FHC15;N4I54,G&+8-#VUQTHM^7M!69].I;C33[NL+RBYT3KFW$^J4HS0
MA/2*NQU:F\_<*5VB+&WF9/U4&'K1!M%<OA:!T`U'G60@$$$5`E3'I,PQ&;`H
M=C-.))R/8)F)RS9CE?+?)3G8@S.*6R%=;,CQ^KM2IL`S)CQA`/I`TQ;I>VBK
M\=U]X\.805@JD$W4_5268ZDZUM>_3"3,2I.5XV^58(#*&`;#`*$J10>KU"DR
M6>CVJ,,O`;KQ.A$C`>R_C\@D5BV6MSXQF:&+OJ=5`=C08[*VXKTI&RW"S>9\
M/ZX"JG5!NQ#E,G'^3WZH[0N]K++Z%TXT8LDL%T9.H4V=$JZ88V<AC4Q2VB<O
MZKVR66TP8_N),HCSCQ<Z16KB'#WP3&NU)@4&\5-HFA5:57VYE@+'C<)]@!//
M,F:%$W`,1A[C`9F<F1+ANNN*;8=1Z/\`"S-PX=>/'=07/4\NJPQ4&.4J%")J
ML<#H'T@NO6:L\5*U*U5MZ.[+2=DD+-?],S$2X[;D)_4MR3(=;=9]CPN+MBQ_
MB[Y%5+W+KMBU/=%.T2G[A(N,VNUBST25WHWT"UFQ%7B2)0^D'J769X[<*,W[
MVY:8Q&`ES3,UI30N)7IT?Q\N);KYGHG.GA]-)&"G"GU6Z.\B7.;C54[T:5T=
M3X"6^W`F_BHD@#86A7IJ9IA'KZ[C(PS$])5WS_A/=JI:J*=LNI%U-!^AZDR"
M)JPB2-(BT\G`J\"V6.2!E%&2]?OB&1<AT"\&:E(9=<=ARDIARENMEN*=\WXV
M]`;NURZ(4CS.A@+'V,J7.\9'V&("AW3FS@.9%KKIB<6+Q1-D-UFT?0SH<">^
M.@QX+#S/^,<VW[X6K=GQ([5.;N\NT/1#35LY);J&+K3UQFR9%>)O<[`KYVLA
M<9#J25I&TRSB5"TZ?;:=1.0V:0M3CC^L+<)E8/';IT(W<8P:GZ-`R+2H'$Y`
M_HKM?A\'LR0E,AL]%2.=FLO+C:GCU.ZU`1+GL_A2F$1]LE)"M5(G5(.:\/\`
M(JI3[.%D6Q384GR/MK51M,ZW3RI2I=8ZET5)^+$=@J3*<DUP&B$@J*D)4XL6
MB?(&MH3'CQM;$S$H#*\>NYN3QUGYM5Y'($4^O$)P+G9#K$DX(M/3V*%80!<M
M9I0Z<3BR*YTEDXR*=DN[600_";./1VI[;:5%N.J<<_X;V&0/YX"N2K?7=5N[
M%(G1235_&%1G1^3F(IJXQ@#*XI.8<9E".A!045]U;,&3L9*(QF7%Q9;V$F8Z
M-A.&3`8#`8&+-'`M;%S#EB,"P`4<U\Y`P:(1!0N"S[DH^:80G/,1(S7O5K7N
M6M.O7>M8%5_SD?'?^/OB_P#M2HW^G<+4Z'\Y'QW_`(^^+_[4J/\`Z=P5.A_.
M1\=_X^^+_P"U*C_Z=P5.A_.1\=_X^^+_`.U*C_Z=P5.A_.1\=_X^^+_[4J/_
M`*=P5.A_.1\=_P"/OB_^U*C_`.G<%3H?SD?'?^/OB_\`M2H_^G<%3H?SD?'?
M^/OB_P#M2H_^G<%3H?SD?'?^/OB_^U*C_P"G<%3H?SD?'?\`C[XO_M2H_P#I
MW!4Z'\Y'QW_C[XO_`+4J/_IW!4Z'\Y'QW_C[XO\`[4J/_IW!4Z'\Y'QW_C[X
MO_M2H_\`IW!4Z'\Y'QW_`(^^+_[4J/\`Z=P5.A_.1\=_X^^+_P"U*C_Z=P5.
MA_.1\=_X^^+_`.U*C_Z=P5.A_.1\=_X^^+_[4J/_`*=P5.A_.1\=_P"/OB_^
MU*C_`.G<%3H?SD?'?^/OB_\`M2H_^G<%3H?SD?'?^/OB_P#M2H_^G<%3H?SD
M?'?^/OB_^U*C_P"G<%3H@5FZ!X:7*SU.Z6KI?CV>M=%'W`53SQ'HU$?)5T;?
MQL,/=(0N0H[[H\>RBQ[#$M.O_HK;2=;_`',%;O%6+57^V\Q^1-LSO%AO?,:S
MR^F<^VB[T'6ZC5>*GGK1R<$#WH_ZPAU`L,A<P8A/_P`.^K:M8I>_Q=*L4C[;
M%/YIT3CX`GXRQ^<]<>>D=0K<WI53-(Z`X\/A"$ZMQ,W:2)H\S$$#8\.,W(DN
M-Q(C#;#*6VD)1H=UWC::7J9X%=,/3+3?K?XV6JQSP](`2CA;H5%>)N".:]#C
M]9H$),Q-@0\TBG]+BMG!ZD;2N,10EY"M*U@[LL:5.UQ?[5C$[I!!L;XE:?ZX
M.-AN@M*N]'7`/!+38HUNMX%`MRR*&!@%VM$-H@<@P&8L0W+1IV<W(7^G"WO\
M5HNK\`7GCSZ[/XS>^S]=JG?#Z$7VA-L%.T4?\M_E7ILB*V>1&_.(==/%K1-2
MA+JW(32W-K6GW;)W>+C[-_,$\A457^&2X^.UXET8E++4PQ.ZA4Q]CJDTC';B
M%E5VSA;0,L0>,:B,H9GL1Y3;$YIM")"'$H3K0CE&5H07YG]K\]405$,1?$8A
M4ZUN]["!Y%LYYMJ%_"@R<8Z-K<E)Q,V3J\(LD[933SKFIKDE2W?<OT5H7O\`
M%C+OQO[5O2CGYCOPKQ#MQ9=IN-TDN';?0)\,A9>ANU.1?2)84]8-B3";G+HH
M=\HQ*8>C3I`]EUYM;B?=L1.^,K6ATI_P+Z^ME_HEX\?+#,BTLYSJ"3_A4JPD
MP+I-E.5"RG:X(,@[2,*AQY(]0`LIS45YI?S#6-Z5KV8(Y1E;&%A7V[#O`7?%
M@R4\5R?CI(!1JU)XY,N7.WZ)*"Q"K)UJ'+"K-;9E;V=CIG..N>YYV;ZOK6IU
M2E['==XV3Q7V[":2WUY3Q7E.'.FU_LQ24[<N=[GRNI51NN,5J\?B&C6IS!T%
M$J(R/%<;<1IF+":83K3*?9@[O%40KQR^TD%J1&B#07B;'IY2NDZC)KRNAU62
M.:JQ@M13Q&O#6I5M>V'#/FN8U^5J-$VPTV^(C+0E*F];Q1>_/%<U>C?;SJG(
M#G`:^5\41G%[1&/QK3S1FT\R<J=I3:U.+L\BSC'RKK=B(6%UU2YLJ9\\F4YO
MWN.*5K6\'==XVB]'HGVTN<C`XBGR_%P9$!V:S7."N3T&EFB+MKN5$(\NL]@+
M&#ME)ESY0SS8J^`==G/R5?@Z]1$^C"4(2)YSJBX/AWVJ*S+KTVN0/%("Y5>6
M)X@"9#]!J(V!#Y&V%M5=8Y\X+B6ID;.K,4)=R\9F/(:=2PV0>^/V[7O>#NJL
M:7/=RW@CTKC4_P`>+]<?&JW</*5471R'+SM]H$^GRZD$;@-B`#XETYME8X:@
M7'^%'_[O;*-ZWZIUO!W1-Q=HUL)]N?=AN5KT2\5D63H=RX_T*\&FKESQF?:+
MMX_Z$:XI9C#[1M"I97F7X##_``AQ7_PGTZ/;K]&_4=WBP)#G_P!M$G=ZUTF5
M.\9$WRH72W]#KMJA=*J@PP.N?0+:*OEW.?5#;5$W+?M5R!0R4YM_3K$F5&;6
MM&]IU@[\L:2BA0OMY\NM=<O7/#?BY3KC4>5_P'UJR@KMSZ"9#<AU9_SFCG4.
M<V<^=%4:M>]ST1=[VVW)4I:?3:E>HGE.=HE5.;_;(I11\Y7W?%MHW*MT^]23
M1/H5.L)>192-.N'/9,IXG8K.5G.0$T;H)P4S`VYL?&@EY;3+"$ON:4+WSJQ_
M-N1?:XY"1AE>;M^+%6(#3P"QB),/H=1DJ!$JI7[Q5:LW7T$;3,:`!ZU7.EV"
M$/'0DL#H4<Q+0RPC3R_4M[YU=*O<2^U542'/2=3@>*%8E<IJ<VA\]U7;_3PL
M6L4D@;MMDEU.&/&VB,/?KKAZ]F9>H;[3K"'R3ZDI3M>\47O\4MY/3/MK<*IE
MPY]R"3XK<]J700K-;NXVMWBAPGK378H6371X$T6_,"S,X,'!3'HD"*N1MB`P
MZM$=+6E*]5),[YFYNW9W5OMM?BU$.M/^)L4OS$-2Z]09T&V<X'O5<'SFQA[?
M018S4(S'0B%3K,!B3AJ%Z7J)(9TIOV^Y7N'?XJ[G^/GVD2B:RR0J?AC,@TXQ
M>CM=$2+%SAP#`(]-NL?H]_4Y7]G/P2?#ME\B-%IL63'>BNSFD._'[D)]"WO\
M5C]FK?VX?(@U4;#W$AXL=3*T2"5%59ZYW>@F8PX.=FA2)H(Z.DGMC28(M/K<
M!Z1!ELOQ'G(;*E-[VA/H2.496R&H'V\=269J3'BRDA'Z[KO;!)%SYV@HSV32
MUJ3T5HFDWJ>BRI:7MC3VG/347?T^M?!_B\'=XHJCG?VS62W&3L29XQ#R_CS7
MA]1XM.%])J8I[GM4%$8!<?6@?X;:HJ/P",3&1W]0W]/1]N,IWM&_3!>_QQ8_
MG7)/M;<C&S17-(?B72XA`Q1CLU0*ZT6+.D3N9V9FY<]:64_,2R>A-,M+.IXT
M?I[4"))VM;;.MK7[BS.^<[>LOYR/CO\`Q]\7_P!J5'_T[AFIT/YR/CO_`!]\
M7_VI4?\`T[@J=#^<CX[_`,??%_\`:E1_].X*G0_G(^._\??%_P#:E1_].X*G
M0_G(^._\??%_]J5'_P!.X*G0_G(^._\`'WQ?_:E1_P#3N"IT/YR/CO\`Q]\7
M_P!J5'_T[@J=#^<CX[_Q]\7_`-J5'_T[@J=#^<CX[_Q]\7_VI4?_`$[@J=#^
M<CX[_P`??%_]J5'_`-.X*G0_G(^._P#'WQ?_`&I4?_3N"IT/YR/CO_'WQ?\`
MVI4?_3N"IT/YR/CO_'WQ?_:E1_\`3N"IT/YR/CO_`!]\7_VI4?\`T[@J=#^<
MCX[_`,??%_\`:E1_].X*G0_G(^._\??%_P#:E1_].X*G0_G(^._\??%_]J5'
M_P!.X*G0_G(^._\`'WQ?_:E1_P#3N"IT/YR/CO\`Q]\7_P!J5'_T[@J=#^<C
MX[_Q]\7_`-J5'_T[@J=#^<CX[_Q]\7_VI4?_`$[@J=$SJ/2N==`W,U0[]2KM
ML=\?XAJHVH%9-P/E]?B^LT&GS?I?E]/U??[?=_@PE3&::X#`8#`8'\UWD7PJ
ME?<M^]C<?$;RN<L5V\4/$/PRYSVZL>/T*T'ZY0>@]>ZQ?"@:7<NE1*_/&S+)
MJO@828T.*MY+:-H2K6](7(;?CK$\/CY1^4RMLY]J#^[V5NWVV@'_`!A\4!%V
MHD[GXVY56<:/L'*S-ZO$-3^;,&!RK5I^#N[0Z[/6.VO6DR=1'?;OU0K6K1S^
M764,$?;?_NWYT`"LXOQU\5'PEIBCYU6ENOW:&[9X9>TU^E!Y5<@SC<8@>8-6
MNU#H,)41I[4Q^8WIGWZWZZF!S^;*Y<52^W/_`';>];$)J_C[XFD%'^J#^'`D
MO3KB*69["4@G"4+F@M!<]`5/N;D.M3U*@-:6^TJ,M"TI7Z)VP.?S:RD==^US
M_=W;<KJS56\8_%NPRN'MEW^JP`\FXD"E-C`3%@KIB80%1C[A*3!'V*J$Q[C\
M9I]G4\?(C:5MYEQ"6!S^766(IGVV/[N'T*MKM]-\=O$\[64#`)O9J-/MS,%8
M6TW-/.ZT8:<EV"/M\4?O"]"X<E&E,R)GJA"E;UOT8$[_`)HFIF;8"5X`?W:.
M"Q#ED.$^)`T>0MYVB02I.=<QH>79ZM(:B6:%',3CD<6[$KLN0AJ=-T]N#$=6
ME#KR%;UK&"\_FUE.[9]K/^[O4975F[5XS^*0B1PTQSVO=>@N%+-))<]/=82-
M5S,+91D*S22$$I>_Q>-H6QMK;LQ3R=-Z5O?IEP3[/EGK.+#`_MJ?W<6SEW`E
M;\=O$T_,:_@[2J0&)6LF&V]UN538?,X;=BA6)ZOO$+O(Z&#2.C(E*D2-%(^T
MH]KFMY,#G\NLL+8OMZ?W:^IV>73K'X_^*`FQP(M_G3A\E^\>D2#RDH9"=-FR
M9K9IP>Q$H!BORXIAQ3ND#Y#7L?VA2V]*M'/YM99*Q_;>_NX%3*W`&>\=?%.(
M5H1$2$MD)F3="+@JQG)$.*-J:5##DQLA<WG2#.UAHJGRC+:_>['0C6U:8'/Y
M=9>GV/L%_9JE,,R6/`/AKC$AIM]EQ+-MUIQIY&G&UZUNS:WZ+0K6_P!.O7"?
M;\FKF_L!/LW_`-`#A_[S;/VGP?;\FI_8"?9O_H`</_>;9^T^#[?DU/[`3[-_
M]`#A_P"\VS]I\'V_)J?V`GV;_P"@!P_]YMG[3X/M^34_L!/LW_T`.'_O-L_:
M?!]OR:G]@)]F_P#H`</_`'FV?M/@^WY-3^P$^S?_`$`.'_O-L_:?!]OR:G]@
M)]F_^@!P_P#>;9^T^#[?DU/[`3[-_P#0`X?^\VS]I\'V_)J?V`GV;_Z`'#_W
MFV?M/@^WY-3^P$^S?_0`X?\`O-L_:?!]OR:G]@)]F_\`H`</_>;9^T^#[?DU
M/[`3[-_]`#A_[S;/VGP?;\FI_8"?9O\`Z`'#_P!YMG[3X/M^34_L!/LW_P!`
M#A_[S;/VGP?;\FI_8"?9O_H`</\`WFV?M/@^WY-3^P$^S?\`T`.'_O-L_:?!
M]OR:G]@)]F_^@!P_]YMG[3X/M^34_L!/LW_T`.'_`+S;/VGP?;\FI_8"?9O_
M`*`'#_WFV?M/@^WY-3^P$^S?_0`X?^\VS]I\'V_)J?V`GV;_`.@!P_\`>;9^
MT^#[?DU/[`3[-_\`0`X?^\VS]I\'V_)J?V`GV;_Z`'#_`-YMG[3X/M^34_L!
M/LW_`-`#A_[S;/VGP?;\FI_8"?9O_H`</_>;9^T^#[?DU/[`3[-_]`#A_P"\
MVS]I\'V_)J?V`GV;_P"@!P_]YMG[3X/M^34_L!/LW_T`.'_O-L_:?!]OR:G]
M@)]F_P#H`</_`'FV?M/@^WY-3^P$^S?_`$`.'_O-L_:?!]OR:G]@)]F_^@!P
M_P#>;9^T^#[?DU/[`3[-_P#0`X?^\VS]I\'V_)J?V`GV;_Z`'#_WFV?M/@^W
MY-3^P$^S?_0`X?\`O-L_:?!]OR:G]@)]F_\`H`</_>;9^T^#[?DU/[`3[-_]
M`#A_[S;/VGP?;\FI_8"?9O\`Z`'#_P!YMG[3X/M^34_L!/LW_P!`#A_[S;/V
MGP?;\FI_8"?9O_H`</\`WFV?M/@^WY-3^P$^S?\`T`.'_O-L_:?!]OR:G]@)
M]F_^@!P_]YMG[3X/M^34_L!/LW_T`.'_`+S;/VGP?;\FI_8"?9O_`*`'#_WF
MV?M/@^WY-3^P$^S?_0`X?^\VS]I\'V_)J?V`GV;_`.@!P_\`>;9^T^#[?DU/
M[`3[-_\`0`X?^\VS]I\'V_)J?V`GV;_Z`'#_`-YMG[3X/M^34_L!/LW_`-`#
MA_[S;/VGP?;\FI_8"?9O_H`</_>;9^T^#[?DU/[`3[-_]`#A_P"\VS]I\'V_
M)J?V`GV;_P"@!P_]YMG[3X/M^34_L!/LW_T`.'_O-L_:?!]OR:G]@)]F_P#H
M`</_`'FV?M/@^WY-3^P$^S?_`$`.'_O-L_:?!]OR:G]@)]F_^@!P_P#>;9^T
M^#[?DU/[`3[-_P#0`X?^\VS]I\'V_)J?V`GV;_Z`'#_WFV?M/@^WY-3^P$^S
M?_0`X?\`O-L_:?!]OR:G]@)]F_\`H`</_>;9^T^#[?DU/[`3[-_]`#A_[S;/
MVGP?;\FK61]SG[?OBQ]JRB\'^X']OGF<;Q>[3QWRBX)4[+"YQ8+7"I_9.4]7
MOXNA7?F_1:S/-D!1481A&$N-O:;2ZW[%:W[M[;4U&]F_=OO;NQBG]7.5P,!@
M,!@:%>'_`/<8^<__`"Y/%_\`E*L63JZ3^J/.7JCN/VP*/VKOY+R(<ZI;*?<#
M/3>>74Q&!A`S\0W4:!RQ-`C\Q.+EN_(3`/6:`/L\62K29(TG$6VSZLRI*7*D
M;YB*5WS_`.TJ.H9#Q1M\/N\]KI/AM57JAR&T!^>HBA7A10]6E6S=OJ5DO5P:
M.R+K0AA(%.4W+C?2**_7#-#I$9K6XL_)=^*1]5^U17.L3IL\CY#=9JSPR^]]
MZ_S?\EQ0`C\D=>[AV.N=FBW6<J2R17:$<]-TL1&&Q%;A^^.S*][NOK7=)J1O
MKHO7Q:\%Z[XM]1ZMU(!?S5H)=I9L$R]C30IOZ7=H-=T['VAHU57Y!0D_314=
MKL4@2^%'_$+E_AT<@II,YR4Z^3=NY16CS_/^T;RLT%Y)!/\`1K08,<6XGP?C
ME)L+HQ,.1"_@/[<WV=JUNCX!J,-FSK6XR@6_$E-R(T2.G3K/^,]=;E+SGW0A
M_P"S;42U4%U*P=N,R(E/NW<.@4&:%IL@1*A67L5DK5LCRKU"FWTX`Z&.K)6L
MML/B'84(`;&O.1Y@_:M_-E7FDTO[1E6)VVS7,OY&=B)$NK7H5?.ZP-/-!Q-]
M(UKRBJ/D]3H]2=K1`'9^6?E`C7YU>'2H!.1.BABR]-/(<8:5A.>%4D?]EE4:
M]8>QS.4]"'\KJU^+>/ELYU5@G.-$$\AM_C/*X00YLW#7-NZ*[;*&LCP>&Z3%
MR!$8G-V1DZ_%6]^S:1SRU3&3]N>`4YU-IAOM-DGFK#Q7SPY=<+3&J@4<R9L7
MGYT2O=/Z3>!U<9FN0@<6HV4(M`</IV0U]&ZEN1(=<:^9P<L?6/9'[9]M\V9Y
M-TK@P'O407RNU=)M'8.;I.<BBF>F<,Z9>KN:Z)9KIS[JE=O]'/,60-;[.3FU
M@DII!,&Y)2T])(16_IECGC<QBV8UP0[7Z\!`OF"UA?"!18AX^??9E'3CHV"Q
M#<,&I,=B+'D%B:V=OR5H:;0MY:MI2G6]:T89K`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`T,?WCW_AM?[UGA]_+[3<DNGQ?EZ2WSY7,P&`P&!H5X?_`-QCYS_\
MN3Q?_E*L63JZ3^J/.6^K*YO,?EUY!G?&#C)#L`;F$CK#`6Q5$*9KL*XAZ7,B
MPKC8A]1'EHY`Y#F0I>F+&;@M.L?XM>F'ENZ5OXO8LNV+FGE81]UK@H/73Q?=
MQ5DXO<>:]%MG/&J\Z+L5O'7R?4KC6J&1_@]MT&LBJ_:R4&RVR"S.AQ7%K'HD
MMN/+TCY%-FN$]$T\L?N*4#QGY)PSM`*DV#M%.[TN41J+M4G-`I+M1A\GL79/
MQ]E@Z/T\J22JE=4B)&EI@M:E/MZF2(3*77FQMV3,UHRQS[F/B3715^-DKC96
MQ?/&2<X@010[7]!9@M<N!/GUSL7.2+@QL=T<!1KP$F"RLD*[-0Q*C_J?(AZ,
MMXG#<@'5?NL>.U*%&_R(/O\`U.T";E"J#8H90.@A*S+0QTOF?,K;9OS_`#*=
M+K;-3J!OJXAE\C[EPW)LMJ+IQ*]NJ9+&R?1ZAZOY;\8XU?1O-;C/M3MK(#:F
M3DLUNBVRS":\WT:S%Z/RJ+;;$'%2@%6G]9O@&8"K;,Z2PHH584PCTWZ;V9C;
M,Q?10`CSRL!GQ(\8/)4?P$W+MGE7:N>5BB\<=N40#.$N]3<.$*H^?MMHKP6,
MPA%8$HE2%I@[94\]I,=;S&T2%FN/=,7DA=+^[?XRG!"S]SU:>=CM"91.1`EU
MRTV^P5;\I56TVGK>^A-4FLFZK61'+XM-(_4E(I@H,F,Q_D:?3MQEMT<)Z)"9
M^ZSXN,\\M_0J5%Z[U:/0*U`LEX`\ZY99"IFG)+]!G<R"!+1(GM"Z^%L9VT!B
M'T,-V;\LN&.>DLZ6QME;HX2G4K[D?BS%/?E?9SH4JP3+LSSZLB!_'^G$9M]L
MB;98Z`9;Y\Q"J[Z[D-J5^J)(,9F0?EBBYT7?SK0RXRZX3C*>#?-OQ_+^-S_E
MA`.V25QALI`#QBL.DV@C9B1`Q=A?/0<(=1!@R;<9!$U:S<2*Q"W"3/2X_I+K
M#:TK2DG&;KJK6K?<W\0[M:M46IW:RG[HNZJH[=6'<^N;QE4R`JVMVDZ[&_!]
M)A5&A/T`XV>)R5,QA:QB_EWK3\3<DO#<P$S[K7AI!'#B3]JZ-MHK%C'($5CB
M76Y)5^BDX59*U[J"0\>GN%-<SM0BWP)(LSMGZ6:AQ;;>]OM.M(+PW/DQ]UOP
M\!-,.3CO4U^X#*/$D0>%]<(KK?X9`Z@7.A+1]#47T@++7`O$KA-(0)&T/Q8M
M;F.+UZ::^4<-SG)?=8\*X+EN8@]!LMIE4VRF*P0B4GFE_N,LA(K@+J=ALQ8%
M'KU?GN%:[6QW$K5N=.1K3+&P[BM[VV]%6_+3AN1NP_=>\;:_TO\`*ZF[B0YL
MFJGB#/98=/N**D?N8CKO.^-HIU+<EUF,-M<!FUWEZ.3-M3VQ@>6-7'D+TIYM
M65>$UXO875/)?D?%[AR&C]"/2A!ON%HA4VA?"*G$8DFPE20D($AE'X#3ZQ31
MH\>AP8[[J/@^ID)TXM"?56C,1,Q<(+UCSA\;N(6VRT;IEVGUVU50<)-%`VJC
M;"DQX$=JMQM0@Z(9$!YSAP//312`QM^)IY&SNF!G_P`;*CLNB-LSDHPI]U;Q
M9!FS`PVCJH4:`I\$\:L9GF5B%#A=RG]A+<,1QDE!(-1CP[K3'0`<EAP?(B-1
M=1V]OIDJ9]5Z-<)>GBG?9)6F\/Z'Q;FEI[K1^UD:;(CV*I3@@!FH\_N4&,3B
M=)/0KC+"$G`T$?+0X_#9:413Z[1\.EZVG1FNDYM>]0^[O`OG/&;Y4O&RZGG(
MG-^P=\M-?C7JLC)E9\?>*3*L-M%Q5.M(^N#CMY)DK-\8VOP%OQ'TQ'5NE64J
M:^0WPK.4JYS]T]OM%X[K0N*>,?3>L&^,O-R(T:JVND1)=E`N72;38I4A$M,V
MN_E"29V/>(CHKRY6Y4"-(][C$AE4?<M)V5%S+V=VGR_X)X]7'E5!ZW<ORO;>
MQS/I:>)T+)DU::2?JM3=*&9`V+)CAPS-KO`@<J2\I*$OSTKWZ,-R'6:S&V9R
M>;;=]T[QO@\]ZA9^=ZM_3;IS*A]UO)+G0RIV<?+A0.#T41>;`1N%B2#*!J53
MRL6U@V(AF1MYA]XNTAE#SK4AIHU&R;B)R>Q^%]UHWD)2Y-UHOX]&9$V8]2;.
M"M5;.U&SU6Y5>2F(>KIT!8QXPI"F0UNMN(4IK2'H[S;J-[2O6&9BII<N$,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#!V:`
M8*5NP#*\;W6CY$&6@`['J`P4V`,2X$B.,-Z&2E)BD=BIKB'_`('-Z;>^/V*W
MZ;W@:/6O`'[SB&FTN??-DNN);0EQS^8)X_H^1>DZTI?MT9]$^]6O7TU^YAOE
MLT]WW_,#^\S_`.N5)_J#<`_TS@O9H?S`_O,_^N5)_J#<`_TS@O9H@?AK=?N`
M<>^[?9O"/RG\WGO+KG^O`]_R0&27.$<OXTD9:R7;`O/X#'P4N%)*2E"Q@^8K
MW+(;8=U.]%,Z4TE>%F-L[.414W3^A?#FT,?WCW_AM?[UGA]_+[3<DNGQ?EZ2
MWSY7,P&`P&!H5X?_`-QCYS_\N3Q?_E*L63JZ3^J/.6^K*YO)WF3TSDW.N5A8
M'8^8VGL=<Z9T>F\]"\XJ`L"5*6.YJ?F7BL)6U9K13@D2*,FTC<S<B1/90RY'
M1O?KKUPNV)F<&L8[Y7?;&Z>B&3WXTWR](ZC8G=\\/":<"&E^C]0ZET_QE-7<
M72IDCI5?LE.NPGI/4J).)%2/X!%^=EQP?.D(CN^\W6^.KHWSSB\%/),1Q*DW
M;QOZ/>**(%A)U%YI;JM`3?YLCI<#QWYKR757^@ZJBL2ZS?:YY0M"B\4\31]1
M#5(1,9^#2OG''=&-XH&8\H_L^69%SGD/%BY$56'=0/V5UCF"V8T#I-[G08D/
MDS1(==6P_/[%82/;9'XHW&?'5`T^4);>G3'7'_DB\=^K-]8Z[X8-WW@`F1XA
M,G.66+F8OR,IX7^#V]J[DBT7TQT^]V6F1.8#"L!V?8I9SQF$$&H$I4R(^<'Q
MW&T*<;BR$TB-U3CBF-P^X3X.]`ZT!ZITKQAO-HL-.WR*/Q;HM=9H?2RMVU:>
M?V_N.D,5VBW\C$(N<;C`",N(Q+V3E1C:GOPEI)#;B=Q(V[HBHD+>47C'VKFU
MNY#`\>XC/BIX]U'PUL?$T6U@B&>)NW[RBZAXN5\_40](NN[-6JM7M<]UH*N>
M\*-(4Z]N;"0SI*7*1&Z)S[I8`]Y%>$BN$F>I<-\)ACQ85(\:^(BN>='H[U=&
MF>1>6`B%R*C3A%8XR-[:8+TTMSF;,@:"0@;YA]J.IE<%/RMN+BUNNIEUJ_Y!
M>`DVKNBNI>$79^?'!O++)S3MU=L*X)]BG44%OE]F[&#MUAG]9'V+I@3AMN\D
M`32'MP)=B@33+JP<)*V9R8]2MW262K_E]]LFJV>5>@/BST<;?U_B?D&)D.56
MGNG9E&YNKO4JY]UKTN=UI\/7@%=*TB[320Q4@?83)22N<D3.DS-2%1>.^>N"
MP!_F=]O2J\WG\?KW'K&-KMC\AW()BA68:(;M3G46^B<W,4SM_4*D:O\`*[+$
MJ]SZ?9*O,%GBD%<V5'?A2MM)BKC[63CNN[QIE.;)XI<[;X".E?$>C"X_FK09
M?ER4Z`#Z(='1^9]XB<O8ZH:$42FLJ_$&QMG9Z"9V9DQY(H>2;FK1-C3URG](
MJ3=3CE@IL/Y'_:@!I,`ZSXK6.>/&E[?'L1"O5.I6`$%YY#;\>W)?0&+"SU&5
M%(<:V#N-.6%A!'9JHD&#MB`-90VEMTM;]4UY?8N'^3<KR;C<#\%Z3;HM7H7$
M;[SX/T0^*YV0[,'\E2/E91[Q9B)*"8N<&L5N=SRSVR2/:FLQ3$A-@GQY<.(X
MXU[1C%7*M074J&=Z=>>4@?!CC8&T6WRRZ+P2GR[UT'J%<XV_T(7P/MY;N=G*
M69OF)&D#Y9^E$K.%0+I[1&:4G''WR.HRMN/Y%J8B[Z*4Y'VWQZ\E>NG^8\T^
MW#SJ9.[5Q-YYV`3[!;JB-MZFZ#S7JMUYY).ZI\+E%AY_8S4R&F7#$$GB%DBH
M:/$`RQTM]]!9B8QF7KWRQ\BZ7SSR*XS*[?X-0[Z6X?XQ4;R4ZA<:*6M%FL?C
MM7H)WHET.K&.!J9"YE9:IR&Y^/L>7#4=.A7R4^1'6%BO2&GFMUG;$S$U/5)>
MD^9'@MT*]2S/5O%'I=AZ?<*V<\1!*+70^82K3=XASL?%:3TG@D9]?4W(09JJ
M=6ZW5E$GR[XP9\SCD@=.E)CNKP1&ZL)PS4<OR=^U0:H(XT-\5.IV&I!`%FIX
M@F%IFI1YZZP)%-\E^C42;*A=/_.S_0:!-L<>Y$KB0]P>#(:(38MA6[\ZGH5O
MU_F3TE8_NM<-I!&D\VXK2[/?A=;,4P438J+8OI"#W*'N8=:.*=XG/Y];KCKH
ME\!V3E38-8V0\TZ])?5M*W=ZVO53A.<L#;ROB=U9'V[:%5O&[BG4./==#V,7
M0ZDOH+:>D\OY6T"DF+X5U7*6Q9J39^$5V96AH^X0B=FT)EE)$""J/*FICQUB
M+B\9M?12W<RX#YT<FH8CAW.:Z*[-S/OEC8[O!,GP),7+?(Z[7U`&0=(59GGQ
MN/:2X!LRX/CGEE(B$.DOI6H7S+4*F=MO.MS^X7X`=PL=!L]_XUT^SD^?%R,7
M5T<KE<>A<RK5CNOC[44F;&7K/2MJMO-;\<[A1Y28`Q-AC$6'$27H:OHM[07C
MNAY`)]\\$*KXX>4'7QGA16`U-Y*SSZM\'H]MM;E%/]C'^3GBG0+:S7^E6P-:
M[L#K'-+%RP2,2Y!(29D:&#!Q4+'))18T71:W7$7_`")?T"^.FN:%>6@>B<N!
M5T"'[3&'=H-MUF8@C!(VKHH$,;+%GR#>_9-G2FELI<=TEOY--IW[$^OIASF[
MJ5YX0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P-$H_P#[DBP?\H,5_P#Y5*PZ?_+_`-O]-[6'-H8_O'O_``VO]ZSP
M^_E]IN273XOR]);Y\KF8#`8#`T*\/_[C'SG_`.7)XO\`\I5BR=72?U1YRWU9
M7-@SM8K5H0-;LM>!V)L,48."$'!,`L@4;BQY42,8&IGQY"8)2/%G/MHD->UU
M#;RTZ5K2U:V%<C?'?@`8LZ>$<.Y`*./0J>-=,#N:TV$3<'\]E!IM"A+G1@S4
ME46DS*X.=$M^[VCG!\54?3>X[.T%N79B\#X7!D#ID+B_)XDL.V%9$RHO.JA'
MD"V:V]7)-=:'/M!T.PFP,BG"'(26MIU%6+B*:]NXS.T"Y=%WQP\>W]SE/<*X
M^YLG6U4XEM7-:;OZ^I+GI**K,S7X-Z20/XFC4CZ1?JQI_7OTGW?IP7+(D.$\
M1+1A<,KQ[EY**#`1*H$8GT&JRT!ZQ`B%H$&O"M2!3GX<%A0C\YIF*S[&6VYK
MZ4IUIYSW"Y821XQ^-\IN$U)X!Q9]H8-K0<<AWE])6F`(ICQ.141<+6PG^2CJ
MP\;FJ@,(]K43<Q_XDI^9SW"YU947X_\`!PCUND!N*<E$R+^6&GKV^,YQ3X+U
MT.!C[UK#F+8Y%#M+L105:9+A.-(F;>=8(.+DH4EY2E[%RR\#C_)1;,>,,Y=S
MH='B/TZ3%8@4FM1&8TGG;NW^?R([4<8VAE^C/[]X=:=:4,5^F-MO>"Y=$WPS
MB=FFP"-CX_RX^0%7-SHXR<:H%4*2Q_0G68$=V]0I,T2^]&N+C`J*A1-&]3=I
MBLZVY_BD>T7,9*DY]X.>)G-Z!$YJ&X'RXO6F+&U<I6[A2*Q;BYNXQIA69!MU
MB,G1,R>>M`Y1N4W'GREN2F&'UMH7I"E:V)W3,VG[GC-XXND4F'N`\6>+IL)"
MVI*O<NI#Q+5I*RH$XE8]3W`:I7XY.F"8CKLKW_.MR(PK:O5EOVBYU6'$H5&'
MZIVH%,JD+7/!S@>@:B5T1&U1Q+PMD&\+I^F8:-5H<Z%C-PU,0OA:5%;2UM/L
M3I.B7*!"O&[QW!,38P3@W&0\<DV1:(L#.84F"S/:+O"9)5J8W&"-(DM$7P$!
M;Z5Z4EU4&/M6M_"U[2W,YI-1N1\IYC,LQ#FW,N?<^(70AHM<9U(IE<JLRV%4
MRB4Y)*RR@0Z`^=GHF&);NG92G7-.2GE:WZN+WL3,SFZ=GXCQFZUHU3+CR3F=
MKJ%DL;UQL-6L=$JYNNG;=)?3*D6HP%)"Y(XE9'Y*=.+G/-KE*7K2MK]?TX+E
MWQW)^6AR(LN)YK0194'+AD`I,;3Z]!(")PZG_P`'@^:,F11S4B!*@T#_`,C9
M<:4A;8?_`"-.]1_\7@N64,T*C6)RPO6"F50Z];:LFC6MTS71!-RS4E#A=U-/
ML"YL-]1FK)=/SU:'R=N1-*FO[^/U><]Q%+=/\/?&CL&R[MXXUS^=/LUEYK9[
MD8B50"/-WM_DUMK]TI@>]EXPY$^X5B(9J\+3PT@X_$D1F=,K1MO6M:+&[='5
M(9'B_P"-4O;ZI/CYQ)Y4FG"N>2%KY71MK>H`/Z'\&HZU?@?NW416AD;4<;Z_
M1LZC-:2WK3:-)%SJY$^,GC<A\G)1X_\`%&Y)G:5%I+?+:.W()*3`E"D*FOH!
MI=D*0-GOL)VK>_:T^XG7Z'%ZV.4ZL5:?$KQ>N@\2,LWCWQLFQ7::2YY5W]\Z
MJT,I4*.88F1R-6IAN`,BF:>&D((/;^$8_$2AQS;B/:O];!RG5-87$>-#;4Q>
MX/)^<1;Q&J,>@,7-FDUM-M:HL2.B)'IR+)^&_C.JPU%;2WJ#\WTWL2E.T>FM
M:T+EB@7CGX^5:,F'6>%<=KT1&XJD10?,J6*CI5!,5JPPE)9@A&&];AGZ8'G-
M;]/\7+$PWD^CD5A2!<LG4N&\5H("SU2B\@Y?3*O=MRU7.MU2@U6O`;=N?!4,
MF_F80)%1!Y[4L8O<9SZIMWWQ_P#%;]4?JX+E,:W4JI384@;4*S7ZJ.ESY!24
M/K88<#A22<O3299%^*,C16'9TE+*-..J3MQ>D)]=[]-81(<!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:)1__<D6
M#_E!BO\`_*I6'3_Y?^W^F]K#FT,?WCW_`(;7^]9X??R^TW)+I\7Y>DM\^5S,
M!@,!@:%>'_\`<8^<_P#RY/%_^4JQ9.KI/ZH\Y;ZLKF\A^;'/^V73CD*P>-:H
M<CR!Y#?Z;UWE->-VR;3:A>C-9G/#K#SR\F(B'D)JMXH9TN.<^=IYEB2^Q)]G
MO80I)K;,7CDUE%O%;[H`.@=$XI4^U6^34@?+&1]+N83I],K)RYFPB.+'@,>H
MG9U4F]'IO4++;!E^U:2ITG(!S(AB$S&TAK6DCS5[,^KU%SVH?<VCT_S._-/0
MZU^?;`,L>O$]!P=0GZS62SAN_O4Z8V7!*)3/>Q1)-;@$F387<1JP07Y;:9T=
M]Y3Q.S#1"^?\Z^Z,FZ<]L%FZ<2@T.NW.D.N42QG>+G+$9YJ1[V=CWT9V4W6^
M>QX-CO@'Q\DM.0I%:DCH:B&HR=KE2F'WWQ,[%,=H\-_-&U]H\H;5S$2S7MW>
MT=I/`[]9>WRC-2ZKS&V^+%8YGSC@DSAL_9JI0&PG<X2K(X4+0XS8IN`OZ7<E
M1*2VDL;MM1:R"G+ON\1KE7"-;[E7U"2<SO).9"L8GF)RL50M)Z5T:-QL'8X0
MX54#LOFZ^-HJ?L=@*-FX)])%V4AU#B$IA>Q'G^/?<N'EXUN#6_O,J)9>2<'#
M7ZK%.Y>/$BXCC])MO;]=@B<_=D<\=Y+7[Q=G;-32<$TD;J$_6QY,?(U$G_AZ
M6J7L6-5><_=.'V'EEEOO5XENGM]YY:WTZBUF1RZM\@D<3&\;Y5`Z.<B&=U2%
MTX:5=Z[)N1&/`CM$OQ?3,&&MH7#<U*CB]F-:-ON',P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&!H^@5NQZ_O%)ZV;KE@U4U?:7%@TVO80IJL*.)\H535`TV+<3\&
M4:3"_P`=N)I_ZC3/Z_L]OZ<.G_R_]O\`3>#AS:&/[Q[_`,-K_>L\/OY?:;DE
MT^+\O26^?*YF`P&`P-"O#_\`N,?.?_ER>+_\I5BR=72?U1YRWU97-$;U>JQS
M:L$+C<9[XRNBUP6YTZ.++&7&%$B$49$5N`$@D2"F=S)C>G'--;;8;VIUU2&D
M+6D5:78'7ER$PXLF6MN0\B+'>D+9B1W9<IU+#:G5-QHK"5OR9"])]$-H3M:U
M;UK6M[W@5=SKM_-^H-1M5DXY&)S-%'(=9M`XA3[C+A!B$@22*QZ?9HXNR.AH
MY6&_&^LU%^F4\PXE*][1O"T[<KLW+89)0V1>ZLVEB$?F$"NSPG\"#KK)>L`R
MPXT:^L_#A)ADG<(#28C[B'U[=WZ)_5W@J7=WUCF.K8+HB;_47KF:ED(`VKQC
MXV4;DS10G9XA$_#XTAV0S)BAM?5*0XE"OA_6UK>L%2C8?R%XH>+$@PSIM->D
MBAQ,G)==L`N+#7&`G+M7;+]+)E2F42EU8ISTJDE[/74)N-\CF]-J2K8J4H3U
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M,#6,.3B-2+$N.W7V'),*8^RAXZY+:3#1M7ND[=1IO2O<GU)4H^9[/RL`D*\4
MOM58B6)T9&"SD'1<B&1F';!"JH&'%>CRG-/2#MAFZB1/;K:'7FG4^[6VU>A:
MEU1W=.2$Z`,Z>S?ZRW2"DFKCVSCY>"F-#,W*2&@U\`3VV^[^&GIL^PPV-Q'?
M:\VZ^G2TZ_=P5-TR\CK7*H>E;E],Y]%TB07B*W(N=<8TF57_`*31Z,KY22?2
M0$W/8^K1O]:-\S?R:3[T^HJ79#].YM8783`#H-(.ODICX\<R&M8$F[/GQ83)
M*3"AMPI[ZI,N..D-R%MHTI:&7$KWK25:WL5+J!NN<ML,Q@<%Z'32!*58+/5(
M8UFQ"]$IUCI9%\1:PT`>Y)1,G3Z^1BK:E(90O;2D^N_T;UO8J65<Z!0V9I`:
M]=JBT1$2=0BL!RR!D31DQ49V:F(0BJFZ?A250V5NZ;<2E6VD*5Z>W6]X1AVN
MO<M?:9F1^ATF2+?D+@I-Q[77W@B"FIH,>R&<*-DE14&)DNR0D,1O=\KJI"-)
MUZK1I1:EE]=!H2@+]I3=JBJL1IBA\FQIL@;8*//0^F*N$^7U,V/:EHDKTWMM
M3FEZ7O2?3UWZ82I1>5W/D<0%^9%]`K+@95W*<T8FQR<=YN5T(-,)#R%+B[0K
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M@,!@,!@,!@,!@,!@,!@,!@,!@:&/[Q[_`,-K_>L\/OY?:;DET^+\O26^?*YF
M`P&`P-"O#_\`N,?.?_ER>+_\I5BR=72?U1YRWU97-$+]2QG1*;8:0:?G115D
M'K&SGQCK3$]IAQ;:U*C.OL264.>K>M>JFU:]/\&!(X<>1'U)^HGOS_FF2)#.
MWVHC7T<=U6MM0&?I(\?3C$76O1*W/>\KU_66K`[F!KRYMKQOKQ^!=X71K4$'
MA^MVY@=7KG"&0&#O18E;,5UR[P)B`.CTJER^<7_4F"^B4T%<'2HY!:4KVMQ1
MK'+P1,1X^>(\\))@`NL.:W391:;&+:GB4RH8RKO"I6TFWI8IO\X`ZU!#O0T2
MW=N,[9=DI^14AK;C9;W+;HH+DM(MHNKTRYV.4/Y%+['=H=4C":^R.I,6*R(:
MO=)F:>#CCSD4C-Z=%(B%+VM28\?3;4K<;6D+)-UBIE<WQ1O8@$V9N-[8&]\Y
MT8[(/=*!1D!ZM5%^[75&J8>:2$E28EHFW3R5,CH@EQN9.E/07F->Y45S;Y<8
M]'6MO._#`C8I9AWI'X\4LG0"UA'L"8\&T0E_PCAN@6JW5>=.0)D"IW/CT2RE
M77%S7T0@\AUIIV0U[OB<%[EB]`8\7;5:#G0K#VM\-!$64/9K#7A[@)V`W<J_
M7)]2_%6R&ZP5L$N((KM$FQY[(^8L=$6*EO/?&ME]6B8Y([=N2^+W*YB;2_T<
MJ%L%;HU1Z'4$C(@&P'!.N7T,")"'JW#=`21CKELI/'VV-"7$)9++A278B$O,
M_(P6)F?)U^@U7BK;TQ%ZL?3H`GH7,#G;KX.9&4F1'@T<`;L'6/BV\H5^;"DZ
MM7FTDI*XM98GRU-266"+?T.XZEBY_P!+(E0?'*8-[-7?X7"(Z-TD=4A4@("T
MT(GU0^-B-P`-HH02-75/3^IC"CD-V;+1&G2XLH;":FLHW%]NR8WDJZF`?%4?
M.J"ZO=+359=P-&BU9<DN5Z<,IT^J=`X*6U0)*61<Z$)@LV>(.=8C/+6W&<-$
M-//-2'XR4%GEU6$-+>-`"LR:+6^E3F`\^)SXDS9(?X:00*(\.7QJN4.-#'_@
M^WBTBTI0(DQ=,09,8M&1)<CK2UI/H3&U<<PK?AA7Z]6C</I+,+ZT-0)`UD^^
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MGP^H[/%'>&P+1;A-<E$$2"Q42Z(@F[)`9J+="BC;4M`M4"P(C5:+$;2M]C],
MD?%=VG:64M;)RF[6`YP4&JG_`)+:L=A9'1N@2>@"97L".SALH@0DDB8?W.B%
M1YPV6\3G)TM]M<EI$G6DNZVTWO0M#H7B)S,=?:KT"+(,.$*M'K<-@60T*FA)
M,:G@Z2(K"]0=C6DP2(>308,UJ2QM#FI&U_\`X.F-,BYR<Q?QCCFBMT.R^HWO
M1ZUW-5O'GT0*(HS4V5U:UT3\IAI;]1>;E5.#2KG/A0HLUN3N&\\J:E6YKLB0
M\+2M?CS1OPTV#8D'(P&PKY8R5"MS(KD*2$Y*@6R#K2]R(+TA8,S$$M1RC:UJ
M7+C+<;]Z$N*P6O?"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P-#']X]_X;7^]9X??R^TW)+I\7Y>DM\^5S,!
M@,!@:%>'_P#<8^<__+D\7_Y2K%DZND_JCSEOJRN9@,#I$H2"8Z>-<?EQ6R$*
M5"7)'R7(4^.B6PXPI^%,9WIZ)+92Y[FW4;TIM>M*U^G6!Y\"^)G":PJ<FJ4[
M\K0B53539PJODR`X5*%J#N5[<IZ$W(VVLUL$I$/<S?\`CU1V&4*5O33?M+<N
MR:\8>8&H\..K\U#$Q`C=6<<$6<C"?G57W'US*U->]SJU"RJK&_N3\>VWU>QO
MVN(TC](N7W1O&+E?/95DF@89I<RUBK"#,22!J1)>D"[+'KD,@PI:$L;>E?2U
M2$C4Q[Y9SJFU.//.O...*%S*,D/#+@Y"-(8<`%&UN3X!6))V;F35"B8N/2$#
MI8V&6_$133<6?0XT_P"E<CN0G2$PA(=96Y/E;<+REW!WB+QL.@VT&&3PS1XD
MR6E(#+$B5L2W($\:<1"E#@\::P.M,4K)^MA;<5"0M]2XK49>DJ22Y8[H?B?4
M;-5DAJ<2GTNP1X9X2)MNIQZ>1KXRW2KL_:'!3<0X(VHA.1T$FA.WG%MZ;=2G
MVZVVTXV6-R8G_&WG%FE09)?\PN-QZN#JQ`?%.2((L_'JXL^*JY,S#C)1\QBN
M,VB<Y$>:4UK3SJ%N)<5'C?"2Y9^^\2I_2EUUJU2;!)$5B&2CCJ_%+;A"5RR5
M?*U?9B2IB.DJHK$"');#2T2FVMZ>WMQMS>D^T7,(<CQ>Y^V3&G6C=^;/UXD3
M-5`TBTKU,IANSRU3[Z5K;&X6QL=_H\UYYPTT^Q(C2/J'$M-,H5[="Y=D+XN<
M@KXEX`+#E6`#S=@1H&H^4=%QW+=9ZO=+>_"B./J1#<M5KJ$0A/2W[6WY:Y#O
MMTN5(4X+EB8OB5RN$Y#FPY-UCG@\<5`K-F3:YBSM4$5[8MNLA0,AYIR*T-KD
M$9N+&2^S(6MB7*^=;RWUKV.4N:C>)G'><36)U3&$X#\-<:1`=>FL3ID,@U3I
M](ED=F)D)XZ2=,"2"W9C,V5*B/3=:?\`A2OUWL7,K+YAS$?RD,Y6P9P\0KK/
MQ:"AS#H]V,`1MV7-(H&[A#X.VFBA8@_(VSKTBQ&]MQHC4>*RTRD3-K,PA@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,#0Q_>/?^&U_O6>'W\OM-R2Z?%^7I+?/E<S`8#`8&A7A
M_P#W&/G/_P`N3Q?_`)2K%DZND_JCSEOJRN9@,!@?*5H7Z>Q:%>J$KU[5:5ZH
M7Z^Q>O3>_5"_3?IO]S?I@?CCC;+:W75H:::0IQQQQ24-MMH3M2UK6K>DH0A.
MM[WO>_36L#CC28TV-'F0Y#$N'+8:DQ)<9UM^-)C/MI=8D1WVE+:>8>:7I2%I
MWM*D[UO6_3`Y\!@,!@,!@,!@,!@,!@,!@,!@,!@,#&F3(>N""E@L)4:"`@Q\
MPL:-F9T46($"AT=R60)E"4UUB&/'P8K2W7GG5H;:;3M2MZUK>\#'U.WU*_5T
M9;Z+:*[=*F;:<?#6BIFQMCKI=AF0]$>>&&@\F8-GM-2X[C2E-.KTEQ"D[_2G
M>M#+-GW'$-(6ZZM#;;:%....*TA#:$:VI:UK5O24H2G7KO>_T:U@8BN66NW$
M")M-1/A;36#\%@H"L=<*P3@$T,E(TY%(B2XQ^4/(P9+>]*;>9<6VM/Z=;WK`
M_5V(`BPL5)9D8FT2@TNQ1J\J;'T9?`09T(9-,M#MN?5.#(I$C'8<>TGXT.O(
M3O?JK6MAD7Y<6,J,B3)CQUS)&HD1#[S;2I4K;3K^HT9+BD[?D;88<7[$^JO8
MA6_3TUO`Q5DM%9IHA^P6^Q`JJ!C2!T.2;LA<>#$1Y9@E$#"8KY(G(BPVI!0O
M/8B1D*7I3\E]MI&E+6E.PX@%NJUJ?LD6M6$.>DT^Q2*C:V!)"-/=KMIB#A9B
M37C*(SCBAQB.*-PY"X[OM=2S*:7O7M6G>P[[YH1&@DR;Y0>T."IFK+SES(^H
M@M(UI3Y'9!_Y/CB?0LHVI[3FT[;3KU5Z8'(**#3@L:;#3XA4.8@0R@HH/D-2
MX!(:0CMRX,^%*94MF3$F17D.-N(WM*T*UO6]ZW@=_`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&AC^\>_P##:_WK/#[^7VFY)=/B
M_+TEOGRN9@,!@,#0KP__`+C'SG_Y<GB__*58LG5TG]4><M]65S,!@8.S#I1>
MMV`3!<;9FE`98=#=>4M#34J;`D1H[CJVT.+2VAUW6U;TE6]:U^C6\#^>[EOV
MP_/3@]3AU'FW>ZKJL@.(^.'*ZX%#=:Z;SRW-(H5"\B)UN`/=5'T.QG8E'Y[Y
M']JC6:OL-1%N'JS!2$(I89CH1(.L[]LS<P]$/^%WW#7[9*M1#S!*FY,FQ:(3
M1#W0[@,Y\6':ZG1U28J^8M56;6A@DEQ--IA*%(V]$06)15[4XJ+&E19BG+;H
MB['A%]R<)3-CZQY;M"3#E."5&<$C]!ND>HM5ZIUCP[@P`-"'0:D.C\U+&R7-
MNI-.'1C4>?&9M<12=[UK2(%.6R\OYC_V"OAO]T!R)?$I\R;&8ES^340%0MM=
M-G5)ANU@AW)M3QEYV&YLM]*566I'WR=DKB@M@.B3S\?<B*_N.[#'+9HV[\9`
M7>N4O0_HBV';6X</SR#\*[V>^#)'UY-^2W(#D;@/@'`@5]+GNB!G%2TB&-IB
MIE2=-_,LQ*UL(8#`8#`8#`8#`8#`8#`8#`8#`I#R8Y'([_XZ=WX7$-1ZY*['
MR#HW,(]@F07"<4&]>JD6K+9:0.9DPG9S(]9/3JFDO-*<TCVZ6G>_71=LU-M:
M/6/M<=0MAJQ1.<^4]QH=.)42)5`1*=8^PG>GUX0US>70R/+F[3KJD(9*Y>;L
M\Y5V>E[A)LS-E;;2U-2PAK;)N-_@V,=SXJ:Z!XUWCQ]Y7<E<D=M?/D<I$7-$
M258R5+IY.+$K!Z8%1/((DRK1$I+DML7*E/NZ9);9D/Z>2A:%F(G&Y::SOVT/
M*KDEKX/S_A?49MQY/2>GCB%+/SX(OG0;QJYRGOE6[O;6(]2H74N>`+9-/.K-
M5QL3%IY`9*J[8T9ZBT-R)+DITY[9B9G/_*TZ9]J7M+/Y0']+\J9MIJ`VV.G;
M710J.B5T`<"$K#RRRV&J0%";Z,<%A#9>CE7UQVT(81H\\U[%-_+\Y)WQIBRM
M(^UIU0-=>67>^=X!]5G\IZ=XM]/@:OH^^V4D<M/&>/V?CO2;"FS$KFHW6OSH
M-L3!04&0N>*'&!FY"_>DC,;U2=\9/9/GAX:SO..ATWCQ7I\KG/+H=F+6KH<8
M-5J_9K#;Y4:H'@5%'0_S=$+U@="K5EL"3_ROCY4ELH)'O15QWF=.Z,[=W&;Z
MM>A/[3/DH;F=6L93RL`,7;J,%!:Q6*IA^G5!JX]!56?'2OQRG0Z\ST4M4K%3
MZ^8X5+/(#_ANDEI%BE#YKNX2GE2#7.-,$KE?:F[0,LTUWGWD54:#6)7<.B=O
M?E5:D6\#<"M@Z@[4W[>R7FQ;])B_A\Z$.)B&X493$5`Z2TMW3[VE:T.<=7J'
MQ)\%[UXW].9Z38^Z&NC22%(OE0M\&=,N[L:R.%G>$_P<SOH+!<SX4;_!S'YM
M8T,:CQ6W'56N0KWZ5\VWHF[=$Q5-D^5@P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P-#']X]_X;7^]9X??R^TW)+I\7Y>DM\^5S,!@
M,!@:%>'_`/<8^<__`"Y/%_\`E*L63JZ3^J/.6^K*YF`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&!H8_O'O\`PVO]ZSP^_E]IN273XOR]);Y\
MKF8#`8#`T*\/_P"XQ\Y_^7)XO_RE6+)U=)_5'G+?5E<S`8#`\<"_*E(>10*]
M?A@95KN74NG4$@W59)1$``*J/8+3RVN6=Q!2$\TZ-GR@S#<Q<B9$6E[YG&&G
M$)VT@U6CV(VXVZVAUI:'&G$)<;<;5I;;C:]:4A:%IWM*T+3OUUO7Z-ZPR\<6
MCRWAU#HUWHTJK:L#-5MH@*S+"G!4*=*'E!/(XFHHR&7EM,V:WQ[OTW<>1`8<
MC)AP&$N/.:><::>-<>J(PO.X(2??B0.;')#X[\IB#TMPU&&U^LW.W6P34HX"
MP6$V,%CX`\.4+:C3IWZZD$6'HS,=_2=/*'%8/&O)B=T^W2A,ZG_@U=+E"P^I
M&VS(^8O4ZK4/GUBLPN?'C+<;GC]$K/+7`+L.)8G1$LJ2PE*DNN"8_P"7;,>0
MY:!XWW?M@NOC[18*H[=G1U0KTIN6NQPJ]T<_4*^R+4\1C-NSK8*#H7#6N0U%
M>E.ZVES3/Z="L:0M/EU(@PH)`E6(9H<P-'V"Q&*<29D#X#94;UZPSJBU!-O#
MCR#?.JYRF8HY)EQH;BY\=49$%EQ;B8HXL?9?-,9)K:7J2(;BV(@04\&8L,J#
M,:DU-MWDY*#:'1@TBT2;'VFK]:@2(6]^GQ+WZ.?I]$J'%*N=>7U:O!+AP!(9
M]LOV$.J:_&U(4T5I\E06ZEA;=K"IBR8H&47WSDPRZ.>(?BHV7'VP_'VI#RFA
MQS>QL,F`P&`P&`P&`P&`P&`P&!H2DGN[[\3BOGFGRG[\WTJ'Y!FF&.9(,T?7
M`4U(7YH3.&QZ,KG.Z'N2NN+YK%U&<>V2V35+WN;J7J3Z+T=<.7&HJO\`3?;A
MR,#P!Y7KOMX\A?%#Q\KO7NE\=IG30OD+=KP:Y"0``+R8D<H#<X15`B+,<KMF
M6*KRIE\DR)C45EE^4ZQ'2I[327&W36VHB9ZL[X9$[P./>6/'K?TN[]9&<&\A
MAE&H=OZ9(!DK^JI6?Q^X=UIT39#P`%6XM@_"[3T4FB')>B:E)@;99<<=^'2]
MC=TGP>XL,L6;FNC0I<BQI"GH`N?-92[K>V]NQ8CK[>G-)4E6T;6C7KK6];]/
M\.!I$YW*[A4^'_;V\MIGE3Y"W6[>2=^\1V>LT"[&J(0XV3&>3,$2N]"`5%&<
M^#N54>$DV/;@%4*:W('_`$K"5NR$;>2\=,)F8J,+;S\.9@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#0Q_>/?^&U_O6>'W\OM-R2
MZ?%^7I+?/E<S`8#`8&A7A_\`W&/G/_RY/%_^4JQ9.KI/ZH\Y;ZLKF8#`8&(D
MU\#,>C29801*D0MSE0WY(V&^]$445[R>XSKK*EL;(K_2_P"W>OFW^E?K@95"
M$-(0VVA+;;:4H;;0G2$(0C6DH0A"=:2E*4Z]-:U^C6L#"[K-;4XP\JO`U/1B
M$XM&=V)@;<CE2FG$DR;"]Q_<T0(I>7I]Y.]./:7OW[WZ[P,$5YESLW`C"R=)
MK$D?#;$L18F@T%AIB&#/0;.,&MZC,L[T)CGAK,E43U^F=6CT<;4E2M;+<I4P
M+&1FVF8PZ!':8:TPRTQ#CM-LLIC,PDLM(;;2EMK4..VUI.M:UIIM*?\`W4ZU
MHCCC!`T.*F##$#(L),6)!3#C0(K$5,(>G:($-,=II+6HL)&_1EOT]C>OT)UK
M`^TB12-O*0,'H5)>=D2-IA1D[D/OH?;>?>WIO6W7GFY3J5*5ZJ4EQ6M[]%;]
M0ZR:Y7DRG)R0(9,UZ+&@.S$BX.I3L&%O2H<-R1ICY5Q8BM:VTWO>T-[_`/=U
MK`^T@`22#19(42DJPEY#)-(Z'H@RB3I&I"6INF?J6TR--I]^M*UI?MUZ^OIK
M`RV`P&`P&`P&`P&`P&`P&`P/#+OV[O&]XX[-7_#'JFO]#7U-_B:/('M*/'YV
M[.73^$IXBOBB;OKGVQK_`$?>SS@SZ'\+63WMS<?:=[1AKG+W-ADP*![EXU<T
M\@G*60NCU\`6CG,\S/HU[Y;TN]\EOU9_,@]L59AX^W\]/UXTH)9![#3<Z"\Z
M[$D[896MO;C+2T%B9AE>'\"YWX^5^P`:`BU2WKA:YEYNMJOMXM_2KY=;=-%B
M`*SUKN]Z,GK(:F1J]7AXZ,EV1MJ+`@L,,H0VVE."9F5TX1\.-MO-N,O-H=:=
M0MMUIQ*5MN-K3M*VUH5K:5H6G>];UO\`1O6!X>HWV\O'3GY[GY,.[V@G7>2G
MH%EY5RNW>0O:[EQGG)@&Q*BU214N4V:\$Z6/9I$:8ML$PJ(XP'UIO<5#2F65
M-FN4O<F&3`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8&AC^\>_P##:_WK/#[^7VFY)=/B_+TEOGRN9@,!@,#0KP__`+C'SG_Y<GB_
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ML(8'FJG^9GB1T'H#?**+Y,\)N'2WYY85&HE;ZI2S-IFE`.I*C0V`&@&7YL\@
M)1"?5(890MUI+#JE)UIM>TEX[HQF,'I7"&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P-#']X]_X;7^]9X??R^TW)+I\7Y>DM\^5S
M,!@,!@:%>'_]QCYS_P#+D\7_`.4JQ9.KI/ZH\Y;ZLKF8#`8'@./RWR!J5UH<
MRHOV58V!8>K1R,N9<P-B&?E>T>43=V&Q[KNZ2R5M*Q'N*RIK(_\`#'52H$Y3
M#"_C0A"V35Q7\T>\X;STF'$D2(;P^1(C,//P)+D9V1!>=:2MV'(=A/RH;CT9
M:MH6IEUQK:D[VE2D^F]F7@>P<Q\JH=NDV,!<9DJM?PE=0*HJPV2%CV*#1K/8
M:IN-^!&K"<D`2)]VJQ2J1$4C$9AC)DAOWK;TA*]FKC)V1L#SJCE`J))`--`Z
M>@(G[GRZ$P9_"+(I,J8DI('A7HB;/SF)1V8:WH;3D(E*NLEY"'6AC&DCM]71
M!`O-.6,F$;87LD!IHD&::J56)<A19I%=*EY\^T?0&C#)4.JR`MIA18+\D@Q&
M=$_4*VTF8XUIH=K]LW&?(.52N&@*\4*#IL+BU+$]3=CWE(YX5TCBHX9=><-0
M783S,<I$MO2$/#3[T=*69@A.VW]+CJTC0N+F4[M?+^O7KQR$4)]]=>Z47N5%
MLURGE":;"(A.E[X#Z-T&''2,L@:4?J5;=)3A+,#ZN`J7%@:;:UIA3.UBXN^B
MEI-`\P)0BFAR.KNH95Y_.Y1J,,NW+2)ET359?.$1-TBQ'FX\XK>6HL:Q+L$J
MP*;B$U.MJC;TM;&HPP6[SRK>6$4J"*WBP0F?IRM%?/A@FZ4T"L#9!J5$Z21+
MI9":*NSX<1N*N)J-(BM_4H4IM"F]^S!VO:V&3`8#`8#`8#`8#`8#`8#`_G`E
M]/YNGP=->%RXAW^=I(\I#T-GCG\&-Z5<7CD[[@4WIL$XW,U5-AUCGJ2^W8$F
M]3/H=#M_6[DZ;UMS4\'6(GER_P#&O]/Z/\KD8&M?S&NE/X_Y3>%7;.JIFB.2
MU(!Y15(]>MU.PV@#5K??*[RU=+AF':\%./`9%DAU<LS$E/-M,N*97'^72WD-
MN&]L3,3$9X,_X(G@-]M7FUUNB1ISO+NK>4HJP\YLS]8.5,;=18'QC\=J%8[$
M`@6$2$(3QC5YJ10<N=J/\,J7`>VVXZE/OV3=A43G383AEB+`Q(E`3<6(E2Y4
MD028C(0K2%KD/0WFV4I7M2=(4IQ6M:WO>M:W_AP/Y^>8]9Y5>O&O[7/BW2(Y
MF=Y%<=Z9X1IZ5S!'*KZ%LW-9?$18M/:I=K>*TX8.K35,0'(M$)CTEMF0K>VV
MG'MR6DO'6IB9F<JE_0[AR,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@:&/[Q[_PVO]ZSP^_E]IN273XOR]);Y\KF8#`8#`T*\/\`
M^XQ\Y_\`ER>+_P#*58LG5TG]4><M]65S,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,#0Q_>/?^&U_O6>'W\OM-R2Z?%^7I+?/E<S`8#`8&A7
MA_\`W&/G/_RY/%_^4JQ9.KI/ZH\Y;ZLKF8#`8%=5OK/.K9#"S!%J'(_,ANVU
MROP3.I%;-&35%.DZW:H(T#8F19N6X(+AWT+VB/M*FTI=3M33B%J+4K%PBFH7
M?N5R[#8*U(L+P276WK*Q,)V<,:K%8EN4R;#&V[0:VG8$"M&-UN>09:EICRG%
M-;7[O3:-*5HM2DC_`%KE49))4CI=`82&B#B!=3UQKK:1<$Q]+^$S"&UD=:AQ
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M'J*EDPW0:%8YD0=7KO43Q"?"G$H,$-9`Q29,'#)B1Q$A%BPIK[\B#`(.)8>>
M0G;;3RM(5O2MZUA*2_`8#`8#`8#`8#`8#`8#`8&K=[[A736JG+[JGQ56YXI0
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M-9U"\^>L6$7X[=.NOBCNC^//D]:>:USF_18?=*Q;KV/8[=%U*Y`8NG*HE0%L
M!V+#]7";),PCY-\.N7^LE]+3RD&^,8Q>,-G6&#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&AC^\>_\`#:_WK/#[^7VFY)=/B_+T
MEOGRN9@,!@,#0KP__N,?.?\`Y<GB_P#RE6+)U=)_5'G+?5E<S`8#`HH?PH:`
MLS%LJUNLX$MZ=*9([2S7"L<E#Z7?3G2YL=318'+^A4!MYYUV$N/MO:XZ4LR]
M2=)0I!;7IK6]:UK>][WK6M;WOT]=[_\`'?IK6O7>$>3+1XA4^XO'5'[I>I<.
M7<#-^J@EM^NPQU'MYVV!+J0-#?H:_&GFWEF@2&T(*2)C;4!]]AO2?EVYAKDR
MP'Q,Y?7'*BL9HE$13K"NSC841L+$&**.R.;2UZ<@LB-);B(D\N'*:0A25->Y
MS6E__0OC)<N[SKQEJ/+[,`L=8L-J:T"!O@W!SCXEIFP17`X@+$:LTF")ARS,
M`.P'3(@Q7%?##FO//-:3MUQ*A>%)KSOE.J+18'."-M,WFIBJPU3(`^R#*O&W
MJM18#(F'`F.U\&'W/6T):^G<<<_2]I6U+UM>_7!,WBIP+X6\R"P1\%%CZ`1W
M"H-<H;\LH8$2I9;\O]$B=+?MY9Q`!E,NZ6$Y`88(3/1*'83*&D--^W2L'*4;
MO/AH(,2@$.J&90H#.<H@CHGUTZ#M\G1N?;Y1^&5T*/CU-[Z:81;Y1%2J;&G"
MWXKLA;NMO)0RPT6-RY.*^.=(X<N3*K+TZ<2FUT'5II,BP*;F3AE:>G?@[TYT
M>/AKE%&X,MN,\]O>DNM16?1"?9A)FU_X0P&`P&`P&`P&`P&`P&`P-.C_`(@^
M8B^)S_#IMOQNWPJ=V\E=?X:UW_IB>JM<_*>3DCR*>B_P.)Y3NIKNC$>2H*G_
M`.K#4!3NM3=[TGUAX;Y;;Y8W7^FXO#!@>,?)7DG<#W6?'OO'`X_++#;N*Q.O
MUDI1>N6:V4:OV*M]@$5"-+*#;G3Z;T(@+.ULE1XBFXSH=^/,C27];=8<0VI1
MJ)BIB69\5N2]8H$KO_0.V;YY!Z%Y!=FC]0(53EIFR6>G4P:%Y)RWD(0)%MEL
MKE.-64C+'<R01F2%"1[+<B<IAIM2&=/.DF8Z9/6N$=$G"23&D!JW%-((09<)
M;J-:4IM,MAQA3B4J_0I2-.>NM;_1OTP-2]!\5O,G^#WP[\<NB1?&@5R#Q.N7
M`S;O4Z7T'J!_HG00WC9"C,5!ICEQSE5=KE3+WN0'A**>^T$F!2')&H_U>]-*
MPW>W&<;EMVPP8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`T,?WCW_AM?[UGA]_+[3<DNGQ?EZ2WSY7,P&`P&!H5X?_W&/G/_`,N3
MQ?\`Y2K%DZND_JCSEOJRN9@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@:&/[Q[_PVO\`>L\/OY?:;DET^+\O26^?*YF`P&`P-"O#_P#N,?.?
M_ER>+_\`*58LG5TG]4><M]65S1BQ72I5&55H5HL@:OR[Q96:;3V"Y"-`<LML
MDB2YV-7`VI#C?UYF0'`39+<=OU=6U%<4G6_;O`PL#K',"E'8Z;!Z%3'N=26&
MI4>]*L@AFI.Q9!58.+*18'Y;0O<669;W%9<^7V//_J(VK>]:V6IR3]*T+VM*
M%H4II>D.I2K2MMKVA#ND+UK>]H7MMQ*O3?Z?:K6_W-ZPCX2^RO36T/-+T^G2
MV=I<0K3R-I]^EM;UO>G$[1^G6]>NO3].!2,GR=\=871+'R6=W#ED'I-0#$;#
M:J9.N]?AG*\'#"&+":F&(LF<U^'Z"5V6R1FH=VEV&.>;E/)0PM#FRU-7T3>F
M=/Y_T/5N52;8(LC=#LS]/MSPY]3D<)8XP0+9'ALF0M#;#F]`K%"E:=:4XPIJ
M0G:5[_3Z"IAWKW?:5S"H6*_]#M`2F4JHBI!RSVBQ$(XL*"$1=:W((DYTE:&8
ML1KUUZK5O6O7>M?N[PD1,X1FXZ/T2A],J8>^<]N-:NM+L#+SX6T5DS`,`R2(
MTQP;+3&(P7WHRWH))E<:0W[M.,26U-.)2XE2="8F,)2U3[*-.;6\TC3+?RO;
M4XA.FFO\9_C7-[WKV-_XI7ZV_37ZN_\`PW@?+DJ,TI2'9##:T):6M+CS:%)0
M^[MEE:DJ5K:4O/:VA.]_H4K7IK].!$*9T>C="0?<IEE''TU>XVOGY[Z-3J5#
MKE1R6Q%M`.HD-,+<F`B2?A?VC2V]*_<5O6];P4FV`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*C[KVZ
M@^.G+[!U_ILHK$IM;F5<;.6#"D;$7?)7.V@J-6H`\.*9?FS)).SV2'&U[4^U
MOY?>M24)4K18BYJ$0;\N/&=N$1D&^Z<JJ$T`%JARWU^Y7^I5BRT6/=FAJZW$
MO`,J88G58H1?,18Z(TM+;NY,AIK6MK<;TH<96#U[KE$X9RZZ]CZ.5D"J)0:]
M*LAZ</%DSY)V''2A,>"#`@XL\U83IB6\U%'P(3#\N?,?:88;6ZXA.Q$3,U&:
M$#?*WQK*)IJ&^Y\MA$>@<]%=6J``S=J^#M!KGAJMD;@.MD:L%Y\,]H2]6`\V
M=MQ4?7LCPI"U>B6'=H%3HP"_,_Q>BS%MENY<K`!'QM/)`+B>Z/0Q=1N&KH[;
MFAD*J%Y-D3LL0AJI!#ZMOXT?#II7IM?QO_$.,LW%\L?&N?TRI\<%]LYX8Z9>
M"-^#U:H@[#$-D"ICEK,!_H0?3HE4R##+5-!)K4N-(=:?0Y[T:3M;3J4#C-7T
M97LWD9R/@$SE0_J=F<K\OM'3@'(J`TP)+%]D+E9?F2-T2V(A3=`*^F0VVQ(*
MS?@&Q)$J.V\\A<AK2Q$3.717U!\XO%CH0HJ0@=IH`"<"Z+9.5&JK;K?5P%R$
M7BN7J[<^T%(UA\RX4B2;`8YZ5?%H6C3DV!&5(2G24.:0.,NN.\[/%*P\^:Z3
M2^T4B[A9U>M%H!#0%A"QK+9`M+.3JY:)@,#92%?ER60Q<9);>6Y\3>DL+7[O
MCU[L+QFZ7C0>Q\DZK+L\#F/3^?=$G4DB@1<8=(N-?M,JJE'79K#8^PL!"$YT
M/,7(&2FM-R--JV[%>1Z>]IS225,9M,']X]_X;7^]9X??R^TW)+?Q?EZ2WSY7
M,P&`P&!H5X?_`-QCYS_\N3Q?_E*L63JZ3^J/.6^K*YO-GEIX\N>3O$SO,!=^
M*<DN:#52NG->N@`\$]8>6]&HED&VBJ74()(R(D(A*@31VV7H[CK:),.0\RI6
MDN*PNV:FVN:R_9?YT8;O@,;U!B#2#M'B56G5XYRT3;)X=T3!X+&JHKH9PA:8
MVNJ<NH,O@D657ZVN*)6+?,D5HGJ6ZA:#?V4MFA_;"'4OFGE[SS^'2X2I/E<B
M<U,M\$<5'%ZRU+MEZN33!,;*NY>OVMAF5>GA+NV8HB1-K49H=)>=2AIUHG/&
M)K)A.;?:EKE"Z+0^K/\`6MR[?0[S3+H"8KW.8=4JU.@@NH>0?1K5S;DH%NVE
MG>9<JN,3NZ0VP[,F9J-`"M:<=E:?VAH3ON*9'I_VMPO6)?3:O9NP..\/OW2?
M(+N`_FZ^95Z;9P79/(OB]VXQ:C)'H\TR\FT4>OP^C%RHH(Z'CR&Y[D9I\@_"
MA,1DB-]>:IS'V8ZN6&&'(O:6JE:[*_)DVLC0N40ZE5[;&85XH.UNEV2J1+R_
M*)\MKSWC&]IL$LEZ;:M4U+<AE2-KD%YKN!?:^HH+Q_\`)7B+'1"ZRODC7^=5
M(ITY8DG+M]3J?..4<SYF%K0DH:N9FS3A,230I9:'\Q9,B'*,N^CKCK>I#A.>
M,3HAW0/M"\@-';8?YX>"5!9R?298L!?*!*[35=,!`W:XMXBWZ);+[!L'3G.C
M7+M3UQERIY1F9JYA!920[-<BI1D(WSU452OLZVU=AZ0:N?;8;247W;M#V8IV
MNCD>NTP+*\:"0:/Y;$IEFK:NSTTM*X"ZEZH?&,8B.'2+Z9[BI.D(+S2J9]FB
M1^3;K1P_E&7'A.A4/G%*N+)/DPRT.6-V@B20N.8E$#UYEG*VR*9FQFZ\,K4R
MOC0T85#1(:)NID/R*<\;IZ'X)]M]/"N^5'NL/M9*R3P4;K4:S02-);V5O;'4
M"T\ZU")G"MM/#P$:M'"#D[4H2,A&BDC?QS2#T/6HFB3NN*;/,,&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&!4G<.)T3R&YU.Y7TN$^3IA2R<^LQ08SN$IHG)YOT*K=*"#24<C"(P9X,@
M>J,9DA%=96B7!6ZSOV_)[M%B9B;C-Y.?^V5XUR.D"NBK5?4(J_4_X8Z'0F#H
M:/SSGMW(=)YKUBWR:J$8K39!(N]77D@.1/A3IDZ-$:BJ:&)'MN+ULO.:IZ=[
M]X^\_P#)6F">=]0599%+'WFFWX@"KED)59%E)4$RS9:P,/$@KD4TH)!M,&$3
M^*))B/*F#XZOE]B5H62)K&&LF7]G*CP^C5.#0NJ]`YYXZ5^&;)S:,$MIZ7T)
MRTO\X[9R*F1JO=B"G7*C7^;\_P"V21PM6MS7G!PV-#E-R/<[)4;^R:\5OCOM
M$>*`^$4A?5]3F),4SIU'G/2;4":7L7UL%WFOV^7%8'5*#`'$MP_(VQJB*C,M
M,Q%[BZ0U[&-H63GN7#S'P`X[R3I@CJ]/L_3HED#=%ZAT2*-4;K$:F:<[!6*_
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MRO*VKWQ=1F_32FE+<).Z9S:MO[Q[_P`-K_>L\/OY?:;DEKXOR]);Y\KF8#`8
M#`T*\/\`^XQ\Y_\`ER>+_P#*58LG5TG]4><M]65S,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,#\4I*$J4I6DI3K:E*5O6DI3K7KM2M[]-:UK6OT[P/.O/O+[Q2
MZS<]<YY=Y*<)Z+?E-E'6J92.KT>T6:0T$TK9AV(%"FYA"8V+0C:I"FFUZ91K
M:E>B=;WA9B8SAZ+PA@4EUSR5\>.`O!(W<>Y\DY#*LC4U^O1.D]"JM,F'8XU3
M"",D1$L!2!((QH"Y+27G&DK0TIU&E;UM2=;+$3.2S:I;*M>ZV$N5(L@&XU&R
MCHQBNVFKEQY^NGA,QO3L0F&-"I$L<3@2F]Z4V\RXMM>OTZWO"99I!@=`H4&`
MQA$T:(P`X81!EE"Q8I+CCQ@L9`CN2YY$C/EN,Q84&%%:6Z\\ZM+;;:=J5O6M
M;W@4AR?RL\8N\&I]:XGY"\6ZU8A8S\;(`><]-IUR,Q`OU#,39AX8`,3YJ129
M<AMI4GV?"EQU"=JUM:=;+,3&<+^PC0Q_>/?^&U_O6>'W\OM-R2Z?%^7I+?/E
M<S`8#`8&A7A__<8^<_\`RY/%_P#E*L63JZ3^J/.6^K*YO/ODW^9WN3%AE-!7
M\Q9CLZ`$$SN=&"@4S3I)%3K7Y]FN!+#6RY,33DZW-4.8>6HE(;9C+1IMU;K1
M8717WGW149N2@M\\-"8#LDW'BQB!%R&A+"R;K4-6X^M$%(V[KVI;U^M_[B?W
M-$9.5';F1I$1[;VF93#L=W<>1(AR--OMJ:7MB7$=8E17M)5OVN-+0XA7HI*M
M;UK>!X<X()\AJ7:154LT:YRZDJPVZ44D6\VF[0OR8^/-201K\^6&U'+GJ]:M
MS4$:T&1_Y8T`_P`I^/4G;CJC4TITIV?S1A%S[#E1+!'8H*Q7:LA"5<IYN%H9
M!E\__$Q-\LL%T(I@=6(DZPMP'1T5M\E*B,[T]):^+<TM;4[!6CS"*CHE@EJM
MT6E[CU;T<C\^YMKJ1*"<$2IEE-)J[Y5\(P0KEPALCH<36M(6!F+EK^ID-H7L
M=OJ[8^R^=SY^EP3P&H`!K1<8,M1*`/'FHI.7*77[.[/^A'S"Y2#2V0MEFUU]
MU"X\AHU7E2M2-1)+>Y!.U+KB<\L2_5[2!IHF;4N<1VYK0ZQR8%*//JD":D0(
MB)8+Z]F(E,*X65R/%D-2OQ-V(EE7ZT3;GHD=M>+L]1M/E8H_0A7-ZDY`CD*@
M(=NYIQFL%0@\T;'GDFECX!!34QDK2BT"!\:7"*X\QHAZ)C/Z9>>:$5U0TN3\
MX`Q.OC1BQIT7-F3))"RE:U7=.PIT>VV04"KL\/6M+=<K!FEB8A"=-;^ED,$I
MJ?;)CQU;BLCM8"UR/-=<$4)VT=*2&97,SXTB"`T.&@O88T_E]HNX"[NLGAJ@
M=-KSR3,:']$KYR3;;D:0Y*UI&Y9>UF['-\WZ_"CH#SFK.F<7F0RA>75:@Q.K
M(B$+KD@,7&"0;4YPVX:M!>9%(,[CNJ:$P?<QIA]*I3Q.VTRJFO*A5ZYM*OI4
MENL+L,J;<8%9`4V(&;02@=H%1P4K2ED;!JI"?PJJSFY&GUS]2Y^]O.J:VIF,
M3"G5JI+RE&]*9"%$60W3_P"$FS>PD<!TA`B71B/0.CS):BAH4Y`+#DU:A+K"
M:VF,QMR8\Z^S,^=2'50RX5XL+/O7F&*.6I;-&)'1*4W^'#AQP50TB#9E?GIG
ME352E_F&"^;I$R#&!2#$XEM+\:;(VC>VVE2&(([6:N`SOLZH<.E6*7:2!C7;
MS!?IT.GPIX[\/H;HCHC%8#/CN?WNDDR00?/<"^YUPC,3M_VR)<9]M*F4"*Q0
MZP63S!IP&!8#A0D09)F^6A#`\+1Z%.*5]JZD*3%MC];ALS_4L4!&"DP8/3*6
M\QI"MO/)D[2A>A6UA81GS-#L6(@20NMOEY(P\-,GQU2G4N)%:!5X7;2_2W';
M$X_0!]>J`9!5B&'WJ._87I[2MN,Z;2HO:Q<;I/GI9QC%N&U(;70EJ&U.V#ZY
ML+`GGJS1+BW7S6XT:5^'E(TKIM&42E#"D23J4U*C1MR(L/Y-)<=%;5H]H%^0
MK\@!/I4VZRKB0X@7$FGJ>S^#5*EW1BLV0BNZU.)8+`[6C%G-6?<04D*>%%5I
MBNQI,65!7%F*E$BNN5L2NS^6\VRO#BH6VP:'.FG8QLJ$J]%78@T]9*S,4@54
M6WB+RR%%-5I(Q\X5DL+)CR#FD,_`AR3H8.VO%W-T[R:NO`^,TXV0)T;J4.X!
MQG3BXPZ8CC0X&#SZS1U%1!FHW0%:+8(B'G1C\=4J>W)FDD:W/CZ9T]'T(J_!
MQR['YE/H:@B@Q"*FG5>9'.E9M:HSDSH%K&F[2.<>KS3]A;B:8FU18TI%]$0X
M\HDVF,IQAM<C38[6)G2/+2I5ZWDZ>Q=[FY<C%NFUQBQCZ(/.TM;&Z,JGDY@]
M4*9I^+9U*+,3QR(S;47>VUM:'-M.O+':S=&MGF01Z56!=J!1A=%;.3E6"P2P
M(M,0TTZ[&F30D<.+3,-5<>`$/_2C)DF<ZF>2:=D+DR8RV(VA6VO%$2-*\J:;
M8['T$66N=G_,%N[(/%5"#8')\6F@2?59C=%N\F';B]P%SWFJ)+9^G$B1;$5D
M?";3N-J8MU[1>W)=O(+1Y"Q2=6>[<+E^R]0)\"0%!UP2L?0[9`?7*',ND@4X
ME);"%J["FO29<]]YA,MN.RTIM;R6G2371&QER\II'87FI]-,0^6?PAPA48;N
M/5'I[M==G7$03,KM*(#,>+6!`L8(.:BJ97/F?B2HK)/<B.N&L85XL%8+!YFF
M[GT6)5@\BGU$8LU)ILLD+I%AE$"`A=L@"1++KZ@Z'*Y:&X0@EO:DORF$35QO
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MVF!S[3<+Y5:3L?IQ*&U0[78>UY<`..<D35T%%6@=1ILOI$0Y`JY*SS3<V_4"
M%O;CKLRS18IT-SXK8B;$.$B?'>(0V&/5UM"8TFG;;%?C_F+&GM$2\6UG-"(A
MB`ZW2Z_3:W63A&QUFO\`X?+T&M`@];H4?G4N+/F+D>X@@K*=0PTRE2_HF"]K
M`#SWG[&<@.(',/E#;<(U.BV@-77:L*.IH',(\*FLJK+2R<*KF3\:TO3Y2Y+3
ML`I]/OZE$5:8\@=JY>6SNPSZ=W&O'%]-A]#.-F+)0++;*S60C\%J;SBJUD,B
M$V,E&**.GQ;\%)KCP=ZU[F6DRY+/MDI=?)->C'TDOY.SAUP@6(2>E[;Y-;_P
MO5E#U4)\EQ8&U]GE^A)&OE(DXB;M<-TI(L[;_P!/'&%&FV8VXS/MV\,&*2:\
MP!LL7HO$)R0A1LF0G/URLT>:6KIQ!R_0JG3VXDDB[\U)(A1P5\L2<U+(L/2-
M;;=9;?=W"':A<^T^>80;:HB0B;29BC@\2N2H0:JCDR"JZJ.-Q3KNOPZ4)4.)
MVJ//!EAVGUOQ?J8DAN1"CQWYDD=JPN?V7RY(=5!"[<*8'\WC$S2"-BG`![#=
MNCI?L+\I#`@:PZ7H\<1%<$1Q'ULMSZMYJ<MR00:=C*:';6"$D8/F;79/2+)3
M)Q^WF6IAD&``W>'2(H4L.3?O(PL(+#5CU0-,Z`U`I4&X*D(97,5[(\WY]H5]
M,7M6';K5Y6#N=<G_`"=7&[-T(F6ERK81F0Q80$R)CVD;'%A;D()#(A&#*(TP
MD])F3H.Q+3,L6[MM"?J(T)PD5?@\QL^17DU+CZ;"'9AB80MX.I<_2JH\NE.W
M*U.#>8.]"&%V!%C^.11*A(/EMCRH9:E(<:<;GOJ3%TJ1%J$OZ%TGS'YN$NY2
MT'(<```40'##T.J4R59C<IFFV";0R=:&D7!-9++MEGAQ&3PI#LLA'4YM$+49
MO2GM4K:S$ZU><9242L<"LV$$S"679!4]V-1)<:0Z3@K;EZ,3/PMJ7(8K4$.[
M."K:2ZATI.9B27IK:MI03M7@8E>4JZUS:4"D#)%@8J4@E<FD5X5"AV"RNW:@
M#Q0DJT?>B3P3**(1-RYGT;496YT5*D;:0E,1X8(A`,^7ES(1'4LD^;`V7J+`
MD:DU6ARBTY4Y/-AO1B>VR!<TB)'!/2K+*&^C?HZN.RM2),?2&9`[850.,>=H
MJ,\U`!DV7B]F,%+I(L(BLD85/069A3:POF:1Q*RE[0%G'7I+)R));6X,@H2F
M']-OVO;+VKX/$O*43R6KSM?5%>B$;7;Y%O35JQ49,P$+W#MKE""`01<JV,D5
MU\]&#19\N1+?()@R'G5.,;VI^(3"_!AEB/(>G\6A[@MG+#TRQ]@O1:Z!87X`
M\0GURTVBWH'C`=FD-Z#UH$"$NC7HDJ0UI[8V(F)\L1]U+[(POP0,F4\WZE7Z
MO3JL(GVDL+"L,KO!F%2I$4KJ7R^LI?C&!2'8[WXG4.A2)RH[ZR$/ZYAI#+GU
MRM/2,':F=5.^7L*_PXEN9V9J$;J#M<E01M;"09Y&D_BM@@"[PNV?0)K\4)^4
MFQA<B/:;V0>)+DQH\J+O34!8GC3L38'D?<^I`1YS5A%4&N=@78C;<.#4QP.1
M6P)RU_D`<%*,RI)NS`#=92,)'=24HDPS:&FV=H;V[':&%8/JV6CRG9-V!L`&
MLNUQ[-=V0T&)5J),JDA,0C'1Q>`DU.+-%=TBY5[;\BX$E.?B0@BAMF,B,UOU
M<$<76'H\S-.`$3SWR(/%*+`L+K=4H#/Y-%F!U#*WLN)UJ6Y];+KI*2;&PDR4
MRV],-H<<:EN)2XX.U@%G?.(4V$CK':L,YX+62+$ANN4>,.GW0E`H[]KJ=R^`
MRV[7:+7VWSFX<Z%M<YV6TE"WWM(9:F#M64HCY,A^7/O3=SK#?8-UH;C+<"O5
M2(6M%7)5&FD[D#B;8W.K%87"N9`M`8(2X[[;,2&A+RM[7^(Z)A?@J.&<\TP8
MT:+1#MMCF#Y,:`?*%JSS=;S]&:<FHN%U#28L\:P4ZT,-:VR`#J90(GB$,/NM
MNNNN*27M7_X\:[%&F])A=1B&D!GK>6-<T(%$C')1*H&#)::V]8U1IFY8FWID
MN[2Z+;B11L(:F'J-[G%26V233TWA%2]]#F+#PGM0"NPI9*P'.2]'#@A\#U^N
MGF"5.,PAD*%Z*1OZN5->0AO];7ZZM?IUA8SAINYUV?AO7Z]]J/C?')*3_6^-
M](Y`<Z13A//+6#/<NKU!\4>M4R_2KCLE5Q+--B@[$8C"93<MR.I4V2W%2E;C
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MO&PS#Z!$Y55O)8OT<Q5J;8Q8^D5JUT6IU^N,V,N2KHB&+38+(AEF+`<=T_(>
MC*6EG>HSBFBU,;9OP;<L,-#']X]_X;7^]9X??R^TW)+I\7Y>DM\^5S,!@,!@
M:%>'_P#<8^<__+D\7_Y2K%DZND_JCSEOJRN9@,#I$G)[0Z>Z*C1YA1N%*<&P
MY<E<*+*GH8<5#C29C;$I<2._(TE*W4M.;;3O:M)5Z>FPU["`'G6R*DH*3H\J
M(1W.GK';/5F/9@*4RQXML"-G1YC[1-$B#<")9EUXU'<4]5(<94B*@@YIHUVL
M%!Y]YN#8;9-.P"KM9$<X19CT`W7X\=ERJS+-+,,3PC/X2,G"SJ;*_J9(1N3)
M2I#6FX[^MZ<CCM1X-Q[S2#"JA^"FB`75<IH.BNJ)FJ-:[Q!BM5RLIL#X%UF;
M5:N1!JOX2/.AM39D>7L5'E,N>SZEN)J+>U>?3N8]]8Z#8KWSDT6E2K%4Z+6W
MG1QFI"9#1:J@^BNBYD:'9A\^,)I;-W/0IIR"R\](GLJ_Q*7M-.1WZD3%5+MV
M6D>3;?,*?H?9Y)[J,,A=#5KG,.TYE;TDE)>?!5JO29D>OQP=4=92W`4]'>;)
MPQZU._))E(]'1A?@P<)KS2%MG&6Q"#SDLRS*`R35PI4!MN+`/N'2\8_N%#(.
M#H!L5-T#'+&M/K4Q!U.?C#'G]L)':P(RF>;R*_+(2[E,_&XQ78T8`<*4>.J1
M0'7^A323CCRH-EBL])=B+`1!\R21GQ(LAO2W5+9^K4Z+VIY5J]Y5LM]GD$;"
M19W(JT]CCH8UJES%L3=1(CU4V3L<$X6VW:1K+3T,QMZ!L?+FO?4-R7VD)]!@
MPA*M^8A;=FLL,\0K[\ZQD&`%'V;H*_PWG4N5T.:^PB4P&G#V^B?1?E^-`E.S
M)4.'(UOWK<9U)<>':A7/^7>8T`SH61NIZK41^]2C*(J)U`.'_P`AGNH.6LP,
M/V?Y9'P]#W"F3=RI$`0_%>A2TQV9C;S2%I$SM6'<.3=ZD=ANEYIMLLD&,PLC
M/HJ2ML$2ZFO\;@^.L)VL*K\B#,(C:VW(Y_9)4^,C3'S.RVG67MO.JVV+BJE@
MOP_RP$<FI8NRE[M8.B'>IJCV5-+USL"5@5O7*K+)E('60C*M%<9JS_31C4YB
M3,T-EIBR$0=,-?XMAP=M^#"5WGGF=%.UX#,-Q*]5G2Y23T"PU<\#>2;9M75&
M[I9C%?C&(\J97#*H!(E%88:'^C4%QM2):7_:Q&+,[6<OM#\F7)',;&+LQ0'9
M17(?RM>KP+)U&4*$'DVZHD;!8++5)@9YZV-JIL`JN&V)8UO\46WK;*$*0]')
M%+`"USKO3^-<3LMZCR0_2U=-YYUJR5U@U.!Q:F#7;&RY*G.-04BMG&`%(FKA
M+B$67=R)2%+<1I[2-H)A$X*7OW)^S]!O3U]BT0^D`;.UJUV6OE[J($E[=R1-
M?YO#E>/$P(FQ;&##,.T@RIE[3[K0AWYE1U3-J(S4M%PR8RA\=\C:1^)H(1CB
M[98:+;J0F_C[HD^RF1<@-%'\OC$&I11LG$'\$="%/K":H^GGMN?/"U*D$Y:&
MRW#`D_'7R!G13;=/KLSGRRK`M/*&W>H:?WP2.-@2F>G#94D:7GN$5=SD+5IE
MX=]=N%M_3TC<=;6M8+CJMDOR[N['&%U>AB9]7<-7J]KA\QD6>N.CJSS>UBB(
MB`!L%M_%"+D%L)*EN%HT8/\`BL?YW&X*DZCZW(CDPO%TK)1?,P>Z*J-$M,Y%
M<%-38$:\$+!3YUBD!C%,=B3&B<:>+8'-&ZW<$M2`\C0L@E;2U-O;8:8TF6,,
MY2>AUGRV$7T-,N%E(6:K,=!L$,F'>53AE?\`R2MXXT&MS5@@'I=L)2V`/X6T
MT(<$1V79Z)+CR6EK1,T)XU@A1+DOE=6/S&%YA:"@R.>LO1+$,/O'J-+C#]7/
MH_6#AR39&#%>DE2]IDU@K64UQQ#+\08[%6W)]K+;C<LM[>KT:1&]P:[ES]L,
MZO\`@8"UQ4"VDYI<;,G65]^O6UM3Q"`ZY%F0SP^S10;C;T6(XB2P_*VI]C2-
MQWC.%>+S(GEOES^5EU)5LZ1K4)IUO1W72J@J>4K@QJ5,4+BF-QM65/13]W8;
MD1"+[S(Y%:>3"D;8>TXUAJ]J:U*F^5DVQ=5MEG7$!$)/-^GA>2,;.@R[M7M5
MH;I<T+';?]Q2*2"PCE>6[&DSFF_:GUTN&PASX=$PR8`E2O-T9-L>Z_>IIQV!
M97(=*BGM4ABK%P*D%XE<LEMLD0JS:&'J^*?B/%H,6OZ;*EHZDZ;7'>W(8%[7
M;`T;S69',$Y'19KA5U=5K[8*PHHL2&&!V.;;QE_L\I(?=K4>M%%1/$F1+BR2
M6B#,#Z)49G;KWN':DU>K?E>QRAIBXV(X:NSU^'2[1!J[U!K=B74FZUN.<B<[
MLA`H;K_T)"]Z:(1U$FQDIH3\\1++"_A3@[;P1DAQKL4/QYO]4.UIOI_4NI]$
M_&;-/B6(#&2"T<%A!I2\5Q16;38;[],;&N.@Q;DJ/\<E$9.G&F$?XL7'*^C[
MZYROJUX-0+'S,#<P]B;Y[9.53RG1#U.;'QJ]7VK^,:+@2PPI.OX/H5](%6?B
M+Q/\B?&.-O2](=9:1H175%Z)R?L_/[_!O4FA6'\O#K42/54`(N@@P3HW*IHW
MH8AK@Z0V['^%394ZU6,2<4XP\\'B,,>S<O6Q4%#I;BJ1M7COY!;]4LAI<>1L
M%H&Q/WTA#Z8O?=$X\A?EVII9;WO#5CT*:_#-I_%E?_0]P=-K4K0N/Y_A:5+Y
MCY`TSEUSC`HI0#;GR_-I(ZOM6P(:U<+#6A@N-TRTD+`4+^VM5_K)AA;LA]AS
M9AEI"IBX2Y3SD-PDS$RP+?.?,6CUFFU2A&-S68C=3+329>S5R?\`@!ADGIFW
M59$5^"$;FTB377E_2N*00D,3&&_:QO;ZY$87MED1E,\T0IA*YEU-6L:(+4#<
M,9(<H$.!<!+8ZL_F'=EML8F)-UV6,+[-/3?PT"M$[:XK;:)$9&V$%O:]_P`)
MY^3#B2)4-T=)?CLO2(#[L=]Z$\XVE;L5UZ(Z_%=<CKWM"E-K6VK>O5.]Z]-X
M8=K`8#`8'SI*=>GHE.O;K>M>FM:]-;]-[UK_`,-;WK`_=ZUO]W6M^F];_3KU
M_3K?KK?Z?\.MZ_1@?N`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P-#']
MX]_X;7^]9X??R^TW)+I\7Y>DM\^5S,!@,!@:%>'_`/<8^<__`"Y/%_\`E*L6
M3JZ3^J/.6^K*YHQ<+C7J&"E66TS)$`+!]NYDR,*+F-Q6]Z4MR2_%"P2,QJ'&
M:;4X^_MO3+#25..*2A.U:&;/0YD0C$BD($J/-@SHS$R%,B/-R(LN)):2]&E1
MI#2EM/QWV5I6A:=[2I.];UOTW@?LN2S"BR9DC;FF(D=Z2_MIEZ0[IEAM3KNV
MX\9MV0^YI"-^B&TJ6K?Z$ZWO>M8$&Y_U.@]1%H,T:PM&H+KA!MK;D$H'EO?A
M,W0TD^R-.01A)V'")>L9Q]+.V4R$J:]WO0I.A5,T4NU-!Q)I`U;:T)@C8\B8
M1F$CHN#%@1(<IJ%+DS'Y,IMJ,Q&FOH9<6O>DH=6E&]Z5O6MAT!/1::<L9RIB
MS3,D]6A8\R>@[9E1]BX!6:7@#G9;LEAEE"Y;H.0M"/=M>V-(>]/B>96L#O2*
M$S9VJ8NW`?S2Y*D0-A$$8[DY@A&A!2*QLUMM:TCR;H^Q07V8S^VWY#,E"VDK
M3Z[T$D69#MQ9<Y94:B%`DNPYTQ<Z*F+#EL/:C/19<C;NFH\EF0K3:D+WI25[
M]N]>OZ,#$2[M4H!1H-,L`Q@B[$.SOB7)3\4>-65!$GESIFO6&.4,_,<';B)#
MC:_22G>M;UZ[T*?A>\TX%,8&EK.#A%92G6X0=PC&6:(/,"9QUR,-#-..%",O
M\&&2)266&G'5L,K6E.])WO`RJCH1/R>XP*3\))L,[[B$37Q%W?B^(4YZO?J$
MG/G1[6-^CN_>GT3^G6!B;=>:C1`QP_;#XX*,K@&=9S#LI].Y$0"-]-2R6H+7
MR3I#"'%);3\;:U+>6EM.MK4E.Q5N@KI-,;LZ*:\66Q8_RU#M\J`Z,+(9%5X@
MLFU`GG"OT.PX+ZUT+,2RU,D,O.JC.:0E7LWA:2%5BKZ=.*4=#)2S(CQ'E*)P
MM::ERVM2(L5S>W_1$B2QOWMHWZ*6C].M;U^G"(>8[!S`$*J1TE>*^@)>W83=
M0+Q)FB8P^V1W%U$GP9PQ,R,H0YN<QI4U2DPV]OM>]U/R(]Q:EE2G1*.%*R09
M>SB1QB(]66'QLR1IB9IRXR2<2L[0RO6EO-%WPDW3:T>Y"=0I"E;2EEW:14I*
M@J,=BMSFR,!R$ZPB4U,1,CKBN176-RFI+<A+FV5L.1D[<2O6]IVC7NUOT_3A
M'&P;#2GHD:,7&2)!""DG`CL3XKKTT:OT]I"(TVZI<F"KU_0ZC2F]_P#C@0I[
MK_,HXB8>=N@70B!4CU[E34/K=;:J-8F*'GSVD--K=<A#)R-LN;0E2OD_5UK>
M]ZP4SE?O50M`478`A\?*$F9TH4.D.N*'NOEX,R6.GA50B*(D^.;@$(#\>1"=
M:1*8?9<;<;2M"M:%,Q^-AOI&B'XN+^@?E(@L3OKXGTCTUR5N$W$:D_+\+DI<
MW7PZ;TK:]N_J>GN_1@=ATA`84TA^=#94\^W&92[)9;4[)><<9:CM:6O6W'W7
M6E)2C7JI2D[UK7KK>!U&CX5UQ3.B41J0C1-:HTIW4.5\(:8Y`)RM19?PR%0H
MLIK>MOZ3ME2=I6E6T*2K88H+>J=883I$/9!$V$R\>97)3,::;]*P;E5P[(1N
M1MK;L`<;AN1U24ZW'4O6MI6I*D[V&6</@FFUO.FA+;+8YDPXZX2AH;;$2%*1
M'*+6I[24CGU(WI#^]_$K>M^BM^F!BIUYIXTU&KT^QBHIB6&(V)J&]*0G:`8E
MT6S/*2G_`-,:##:=,QM)6\MO3OR_J>[VJ]HIVB%NJHEYF.5LP`;(D%10)AB<
M8'Q'GC9Q3B`HAII^0AQ9,NME>HK&M?*_M"O8E7IO`R*BXI$I,%9,>B:M]$5,
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M0A[K/.V$D=JM$)Q8FR,5`BQ&9FRY<6Q2FOFBCEPXL5Z6I4MO]++B4;9=WK>D
M+WO7IA:E+UG0C31%]XN,99#^S1AQ^=&92)VMEN0A)3;KJ/P]:F'4K]'O9OVJ
MUO\`<WA'X\>!QW'67S(EAZ.H<A]IXC#;<967<4R)0ZA;R5-J*.IVF/K>M;?5
MK>D>[>!V&"@R4A;D4C!DMMOR(KCC$N.\A$F)(3$EQUJ;<4E+\64K33B-_K(<
MWI.]:W^C`PC]XI\>;`&+LP590IJ:H:+C$(\PG/;%DA8@L_#'1%OS9$8,2-1&
MIKJ$;;A[D(V]M&M^N!DDV`"O47:#8A>ILUX;#VDE#5J61C;6F1`B[T]OZB:Q
MMM6EM(]5IVG?KK7IO`C\'H]+(G[36HAV.LI2Y,>#9_>U)9'AR$H:',-C91=Y
MEL7HAH98(+ZF=/;<TB4C]'K[M)"2130:<^Y%A%ADN4RE];L:+/BR'VDQGM1I
M*G&6G5N(3'D;^->]ZU[%_J[]-_HP(W5ND4>Z!(UCKEE&3PTV*2(0IJGTQ$2Q
M0DI)#3#4=N9\#S@3Z^*I+<S2?IW4[2I"]I4G>Q07Z5S\"9'UXO<:]`-DUCDQ
M!;Y2+J;[#$*PD!$J2REQ2H,`K'J9'Z:2_P#&P^Y$6VA:G/1.Q4LE8+C5JJ#M
M%D/G1HT)2QDPQ:YSLA"T`1T`>HK*D$6F/ED,;0.3\R4;1\BT;UM*=^NO4/R%
M<JS-'(*?B\6#&5!43<287L+*BP$2EP5S)L(KJ)*B14S&U-?(XA+:EZ_55OUU
MO8I^[N56T:AUY)R`Z8GL'9,>&P]]1OXJSL/^/:D/L:<C0WAFC\/;C;RVW/:^
MG>D[UK>]!E7RXJ*Y\4DF/CNZC2IFVWYL9ISZ2$VP]-E>QQU*OIHC,IM;J_3V
MMI<3M6]:5KU#\:+B7T..,E!SS;4)@FZMJ;&<0V-DMK=C$'%(=VE$*0TVI2'=
M^C:TIWO6]ZUO`X?Q\#[5J_&Q'M;&:-.*_$H?M0&4G2TEE[^;T2,4C>MZ?W_B
MMZWZ^[`P]=OM/M<&&2`'X4Z$1EOP1LA7S0DE)49"G'VQ:9[45PEIM"%;VIC3
MB/1*OT_J[]"U3JV?I=%IU=5;#UDA,@$EH(),^`B4<V^;)$&A4$3$A@HY*=,(
MR"+Z6M,M-+<TK?Z=:UK>]"IEWPUXIMA#PK`$M($D%(!?S'$)12L-<5T#I2D+
M+;7M[7QP&74*0XXO24M.)4A?M4G>M$9/=@`Z2I>S8C2$/08ZU;)0_:B03::?
M&L*5\WHEX@P^A;"=_K.H6G:-;UO6!BH-[IQ,Q/`0+()E%Q@D>=EPVI:-[2&*
M:F;A%&'M^D>9!<U`=]SC*W$M^W]?:?5/J*ED)%D!QX$LG^)1Y42"*2<?_#/>
M7DJ$N,N/L38T`4B9.G-2VFE;8^!MQ3^]>C>E;_1@1:M]:YQ;R04-7;:+(F;"
M`L%G%!M;D1C#P2J6")4[/+D"IC$>>.<K]HFMCIC$EMF1&F^YEQ"7&UI26I?-
MHZYSFDF%`;;:(E>))KY.SI24C$8T)\0&C2)I1<0JN'^%32$.#%=?7"9?7-^!
MM3FFMHUM6"I?M>ZYS:U$!0D!<!,\L:JYBYP!7O>BD]UJO'8U8/DY8^:S'F#4
MA+'+1`EM24,OQIGN:<0E:%I2*F$@IMRJW0JP'NE).C[-5+#%^N"'A3WU`XI#
M^5QC4F&_K6M/,*=95K2M?HWZ>NOT83+"4FP&`P(W<[6)HE/M=X/;DI!TVMG;
M695#8W)EZ$UX7*+D=Q8VE(W(DZAPU^Q'KKWJ]->NO7!F\!\X\X.N'2OCF3ZK
MXHRN5<J\IC0>N<NO<'MM0Z$=@F[=SJR]3I$2]T057A#@%DY5JI*;D/02)9$`
M@IMI7R,J5)0:G;'2<8;(,,F!XS[#Y+=4K7;-<$X3X]([?=1'+0'7KO./=;K_
M`"&LUFKW*V6ZF4R)!GD:];BEC.F"]`,K?9:A,L0H\5M2WU+D-MX:C;%7,U"V
MO'#MD?R%Y!7NHMU0K19T\O>:G9*89GBR\ZKW7F-^L_,;T#T:"/R!)V`.N-/G
M-Q)\=6FIT33;^D-_)\:23%32\L(J+OO8P/CWQ3J7<+.-+&0/*Z/8+L2#`415
MFC#((>],0)%:G2(<%,\F\VEAI;[S3"%N:4XM*-*5HL1<T\Z\_P#*CLN^U<WX
MOY"^,C?$IW8@%[)\XL5<[56NP"YIGG`X2<LE;LT4;6*C/KLA8$IN1$DM)GQ7
MEQG6EK:5MG;I9VQ5Q+W/AEH8_O'O_#:_WK/#[^7VFY)=/B_+TEOGRN9@,!@,
M#0KP_P#[C'SG_P"7)XO_`,I5BR=72?U1YRWU97-5G9^</=;YU8>=Z*#!,&TQ
ME##,@J"EV!I8IY"]2$1(D.PUIV.3:=^-Z-(4^XTTZUKY&'D;4C98FIM-:V(E
M`0\0/)*++MC6684&6_&;C3-CXD=F-$1/4RO;$N?[&?<Z^A#"'%JWM+2-?HPC
M/8'E*C>+(VD7X+=(]ND$FPQPQ9T1I=>'(//&"P6V5S8S5L;D_6,45H7;79&P
MVF-H6793-^9.U.-*+>%($8\'0!-`6`Q=G(M?`5&Q`1U?<J(I\9LY9XEX;,60
MA"9G0QI91<I<6R$YN5'>E2)8YE3<MA*G$J+R=NQ>(K4FP58D',,>Z9T@19>B
M%%#A@U\E2QQ3H5F-T;X68LJ85"7$G;XT!Z.[(1J/$A-N:6I3?L6.2>7#Q;J]
MSNEON)`C#9>L_P!?-BH9JP=PF$L!*JT6I/6",;>4N0]/A#^?PUPE_&V_$<>D
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M(2RUK;:%[=<=')+^H>*`#J=OLMB,6/X1]HA+U.&N5D42*-$=4`[SEB-'L,YU
M3FJ3H4>7.=!KC+9=,-)E:>1[G6W!&ZF4Z1XS".D7ZP6TF7')#6N@4J@'JY-K
M2RBW1M(MYZW140I;A^,$2.,NGE1I\66*G;<9:3IIUGW+THD344C\SQ#K>K#`
MLH$^R`)QKINX29<>K#')3CDCI'0[Z4C1MMRX@]3Q4;T:8!=<(1B3.A?K[6-/
M[0ZT7DQE]\/F[GSCC]!@=&E5"1Q>O/@ZC80-5AM.""#<(.+!W@`&V72*%7L`
M)$N16),A,^`IDG/UN%[GFE1QRQM8_6/'&L]:D5PD6(;@G*O1;;2QA-`R.2WO
M5I?J,E<R8T3?D.3XC&ZJJ.]$>=<U+@$ID=;FDR'%*)$TJI/A="=:DC9_0-R*
MX9L$VY62N1Z6+CC)EG(-W*))BAF'B<U@#1&QMR=99#?')4CX$*7*<TIQ*R\G
M:!>,1"J=YJ%UKZ@/Y+!V"UW@C)("@^CT4D>`]+K0VETUV)`3,K]1%Q.@)=5#
M2XF*IR+MQ&M+>6C!>&+A7XC6!\-/J\KK41RM$^=],Y-+C,\]5&+[HO13'XY[
M&##=V]C%F#3E*UJ>F-\+[6]:U&:7KY,%K`Z;XR@[S6:12:Y8)-"J%0/KL,@`
M.@+)L'B*SH^Q_B4^<^3B%7C>RL60X[)DORVY:B,ER2R^_MEYDD3JC!;Q+8+<
MOJ7-W[RE350(WA0IV73X)0!`K]X%6`"H$*K90M+?CR*@%._&#(RI\Z9#6SK;
MJI#:W&5%Y8V[U+\41-7O-8N!6W2+9'HDUY^DB2U?'J>%-+D=8EL2B1E^5-E%
MK*P]UN8G\10B*I3<9K6FDK6^XX)EB[1X9U"SOW">_9)T<O;3QPVHLD((?FP6
M#+G792J]MYY/RSJUN;UEU4F&XK34UF'IIS7H\YO0C=,*M+>!#:-E3`BY!2-B
M+G1I_P"C,U&1$I@4DOKI/H)?\"IXZR[KZ:NH/9)T586;&G;FOI0\J8P^XM[0
MY)?7O!2F"+(U8"MD=LJ-'*_:'1A(,^D=&+"SM:.$0H4-JP.549SZ<]5XZ88=
MP9)<%[_69E[]-:P<D?G_`&_@,G\.0QT68RR$AC_PM;E5BZ*3)\3^"1+T2T'1
M1L.9.4O;7)(R8P9EZ"F)]4KTD+U'C::')9@;P\I=<567P)")#EUFPC[$P[+K
M4(KJ9)&W\5=(*9\F?-=-SI`J!`=&0)<B:_+BLO\`R?(XK2TN"=UL??\`POIM
M[MLRW2#L^'(+V"X'3\6"U,%223MIC<]:BRHI@`:"3(UDK"^;0DCI\Q)%EJ.Z
MZRN*XC:?01NI!>>^&YR-ZV*RGJY4K,B^UZSBH=/J@I$,&(K`BLU]"(D6`Z+`
MM62S!P+\<@Z[&(P5QR#NMQUN>Q30Y,[6_!.EA30XD1/M'8(IWGKH\2_7GHT*
M&CG<ZB+'#(PI-C?JOX(3'\Z'JDL."W74E5R)S#S.W=,('*70JW@;7:FNH.0;
MLN6]6C5,G3IIBMO'B9F%0;ASRW5^1'EV"T%VJS<YR^=1H98L.:8:(1W=J3#8
M>:9=0.21*\3S$WI5RZ:Y=`X`U)Z/,NU)T+J,><MM,MSE[SB+[,_$!,RWQT_P
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M]Q)O<NBZ+F=I>W/3)<]D:/\`'&^`<F:B>%M1%H!LA3Z!3`@<%%J^GJ@5$G<4
M-!X>RIP9*C.15"996?PV$_+<TEU+R9TA&T^NFW$CE*$G_"Q`HGSI//GPZH(@
M]S-1Q1P.$;&`@?.2/$"4DC61<>"X]`N-EWQI&ES8^TJVY,]KGIIIE]F+RU7;
M9_%VF6J]2+L0DM;W.O8^^DPJ@`9^`5(BT\5W"8)*<9]\[4:3Q6*\VZ[I;C;D
MUS:?3;:,J<IJG'S#Q8I/*CU=L-?D,HG@AL(9(=CU\,-D&F(O.:IS]S1.9!9;
MDO)EKJJ2;B%*4E4V0O>_7TTK"3NF5;/^#%,D,CQ#MA855H>@$B0(W2P'UTZ2
M"#.UQ09XJE:6M<\,"Y"WY@#<54=XJM4SY=;6XTLO*5L]$\;*IT>\-6XLL1J+
MJNB@;X5^I!B7S.@`760`.7HA,]WLC#X_7IKVHRF7$ZD0XRVUM^U>EDM$*AX@
MU>K5CLU6DV*=8FNQ5HY5B!DU&GD#,498'+--E()-$SY*MFMCRMJDKA*0.A+9
MCI0PZI_VZ<PO+JQYCP_A2K7NU!KG$%;0:G6+8.=289ZOGBLB^V"Y"V+J)EFV
M(1L+5(EGF0A;$%`E]E2FI+TA]R-%2P2T@YWXPLT>]VCH1J[$;Z3LT.RPIXPF
M)BCX$Z-8'8ZEMRVM3IT1#Z8<5N(OZ5J)#6PVWK4=&T[VHLS:DZ?X)3H0T.;-
M]++1>@[J;XDD33HB:4()-NW2#7G1$J.;K8Z8D-0[@BM3U21[NR4`;'>8W!DI
MT_HO);%=\/:M7N/](Y7'LQ'4KI3`YDI<X@]J"=C-!H`N&&&?4)FO%"%>';&>
MU,21.6K<:0\U\NMN*=V2=V-L4UX4T^*,CM#S4:`:8L4.TK()KGXB/(38,.@[
M:`&(ATZ6/&*&^<H3<QX1)*N(4F6XRVZUI#2T#DQX'P9IPD6U!FVR?/F,0($2
M(2@5X&`D!'(]@YN>G/U+4-#VJJJ;_!RU&;^FW_DS$G>M;5\2/4<G)S;QCN`3
MFIRN3#M8I=AD=EHG3ZR^"JHX@+&Q^;U/F=1#Q;`$%R*Y!)DCC//%/S'6)#?Z
MTM.]*UI'PI$S%NB]X+5]1V=9?SZ4(FYKXJQ;F602Z6CKO,2SLVPW/G5^!8`E
M2(4>X%-/*(5]8[2$JDK7%E1EZ0I`Y.1_P3I)27=)=A/H,NW"1?Y6U/`7WD#G
M.B`[^.G,LCB]C-`$Q:R0Z)+=!_30HDB##::B./2$IVYL<G3M_@96+43M3S-X
MEUX39EDI344'51`\X"DR)_69H\8&L\*7$FQ:6UKK4IN8(2UI$UN*A.G6-.R-
M.CDNWFGCP(Y57;[`J\P,BQWYJ,H@=EUV?-ALR(X1D9J,Y%FVF39I]>^MW)EM
MP'3?^3*F.ML.M(VGT),WY.G4^`SN<UVD1J1:(.K'SZH=1K-?<,A'U59+_5+I
M5KC.D+#QBVRS0FL.USZ4;#V0=>W%6E#\IUQ*GEEM^]0X"9ZC<YQ\IT-,6O(I
M6Z[4ZUJIMRY-*LBR31F3=A)A5@8B32),@,'-26I@]_?X?$<BL.QT3):GB1-0
M^$^-(V>&8&6&ZV*3)EU_L@FS$:ZVS6'2\[M_1ZGTNV3A[>G2J@P]@E5]PH\)
M:Y:%CI2VI#CZO<M9;6)QSF"^/TH;0V+88MPD/^(K@$+%&'H.[?+V(]8)RILL
M4Q`'OQT?C#<>.TW$8TRU&UZ[7M?ZI)FUK80P&!".F4W71>;]!Y\J>H4F]TBU
MTU11,?4M0W5G`SPFYZ8JG6=250]3ODTWM:-+]OI[M>OK@C";:X:!X]^9!U'A
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M(X%5KP(=!E25.Z62E2GULMZ;:0EQ:BWMC;47BV$89:&/[Q[_`,-K_>L\/OY?
M:;DET^+\O26^?*YF`P&`P-"O#_\`N,?.?_ER>+_\I5BR=72?U1YRWU97,P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P-#']X]_X;7^]9X??R
M^TW)+I\7Y>DM\^5S,!@,!@:%>'_]QCYS_P#+D\7_`.4JQ9.KI/ZH\Y;ZLKFH
M#R;ZQ8.,<=MEVJ8"6>L\067T#]*M:[:"#3H8`P<T=MXVEQ91[5:@,"%Z7\7P
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MO!Q?=?\`.&18Q\`A`YL#>A2*^%LA$Y'ZG#F5,%"M#_)QP6,5L<>GK88(!"?5
MV%69.VM-`!T!Z7\DKWLLK'&G"1\[TPHBTQ^1%B)=B?&B/HCVN&FKJ@&9!8=3
M;+$N"P?T4JK=`,4VR10LS;+:9*Q+2G$LHF-[;'%?DSR#&Q.P<SY`JO24F.@`
MFRY'3\[;9*G/3:O<K2+C$X;0^0')L2F*(0C..PB3RH\I+>E-_&XAQ1*PM4)+
MS+E!V$/%N:11NY8LI:A6YM^9CQR-6%R;I$0.8E.U9"'.HV!ZD/\`X376M.MS
MDN:W]<WMI[2"\7)8/+"Q-\KZ7;(W."=?.`.<%;]57_J7+($BC-#+])"S.A2_
MPH0Q2UKE4"0F2VKZQAC3[6M/N+VM"!6,.&'Y@DYLXPB!SR.69!LGI1F1!N<=
MZM_A%,*VF"?.TJQ-5E;UT:*L!$;@(<C0&G'O<VXZS[%KV.+`!_,6S&[Y*$C:
M>$GPB+//H%9KL6X1G9HPO<KU,IKK72BC-?D2:8=&)E19$X0W%G/04LN(TX^I
MQ/H.*P^7^6D?HM_%4J33(U901K-A-O*EV]J;9H#]6KW/3Q20NHH`19$BG3%7
MWZ4>71)UN6\/=]8S7O1K!.VHM4DKSL(62-'9Y_1PSI+=TI`N%LQ=$#]7D39[
M7S^/!'<[@E*S!GG;"5KUR1N>Q(:@N@/E;><2_P"ND8..J0R/.@/'A[MS%)+3
M:*7%/%ZK.6288*'8.Q-IGUE8H#&%3##DF[OUMW3>Y"6H`UC2'94IKYFFUCBR
M,CS4='0K.;G<TCSJM2I`,)8+35+XW91)*TW*PW"H4:%176ZK!3:P%AM]>@B7
M"*U0=PR)9+6V'-1I"TCBEO5/*0US*V*K'\$\NQ:V0J0.-,A6^%"W,L=AJ5MN
M<T.VB:%0/B_3#:MJ+!>DS&$$2,M#6]1VD./I)$*WL?FY*2$M<413A@RU!!Q<
M>_$DVQDL1&VI]RX0`K8$/'!LC^CQ:NJML$;.Z,(?1"QLYIQJ1+WIU+9>+,V'
MS'=2B/&KE=";>&+-,WQPI:FV25<=AU[R.?'C!HU@1+CO6N<:X.WMN%.<BI6P
M40G]*O:K8XN)WS8DN/%8PCENBCPN#:K!(;W=VH\@37:9#Z5,,0+=&:J\MRL]
M'DM\U=5%`J^="T3F5N3&DMO>P<4YZ[Y1D^7VMZNP^7R[5$W+IXJ`39M4,,N>
M<M-;OUM4,5'FB'H`Y+`FB;CQGY,UMN83GL,;^%M+LA`B+5P[YYAX;[T<A1XC
M4O9*E:B@X5VT2LT<-:[+;JV2CV<9'JVH53Z!4W*RT_+`R9:OD1-0AF6M;:]8
M.+J3/,FU/F^<0W*6#JC5@D5^2?![N<6PW%X9;*2*N(66)!NUX/MRNQ8UCAQY
MI9+BV6RL>7!;0O329*QQS9??FQ-BZJC9GE\`)+L<BAON-D.BLL1=BNAO\=:#
MP:]->J+*;)>X3/7VWI0=*([>FAC^VI;FEM[V.*=6+RT#UCIQ*@EJRS&'#;9`
MJ4LZ_:8<6>'^>5SAF5;;57Y(UI-<HCJ.C-)'DG)CB9TB(MK:&=.M+V..%NN+
M\L5D^/W7LR>=O-5VOEN<!:]&19DRI5@=Z`,Y[,48*.,@/@K=8K[_`$2/]1+U
MN:M42')D_"A*6T.#CC2O)GG>[%EZ#_P*6'\?5+J,-H>];@+<";*L]*.75^$.
ML+460%E3`J0"A4CU>;8;,38;#CK27EN-)./BG8SS`%3XX9QVMB(4RW3HH^HA
MEWF(Z<V3F]+IG-M5FVC$A$/5V[B7[BW.)BH^R3D".RI*EJ5OU2)VJYB>=$L1
M381ZS\WDFCI.E0[=''48T@J%?E!N2TKIG21(@E*$Q):XM.@6QE>WI32777''
M&=)UN/O:B\=%QR_)QV!5><V`A16QLV]Q[\0V.FV^#])N#SZ5IEZ#42L(9-3<
M;?=XCB)5<#_#`DSX_P`NW]Q%QW6]&:Q08/Y@V*S2X@RK\K`G):YU3@S2D3J:
M7J@EZ\D*(.`I#V.%19JCBQ4F^-H-I3&9V.<@R&VOJU_%IPO%$G_N`0DQ4RH?
M+UD53YK(P;!B7N`[/#SMQ:3,6OI+35?=:Y\,*)NB&1$AQ<S\1D1U(VEC2T*V
M.*=+\PWQJQTNU<T_*5?(GVH#A0G<F)D\(&;OEOYT2GF@8>O3Y4@PQ8ZNVAF`
M(660XS.2^[(889?=2.*&P_."8:>D%AU(B;IXYDBYM8H[**W"T2A]AY'N(W4:
M^0K@9,^`1J74F79*'E1Y\.8C;6VO36EJ'%8-2\LIUIL4(*QS\3)',F::'L-J
MKG0V;+7&W+\3KXH`[32+%5A,W)`Z;8VFB^U*')@/QI32-R%M)TX..#(1?)Q,
M+J5=YJ5%LSR-UZ7=:E&BPWI,*?2PM=E6H)7"1&.^-<AG6K5,Y_/FJVW,9D1(
M\Z/O;*FMH<<%86F'1NM6;B[^S_0&ZE-Y^>Z`$KP<H,>+"R=-K4\4Y\Y&R0OB
ML)*X%Y%A:3'CL"(3:6VY"7)&VF6GGTDB+\U447S7&W0N-"L\SLKTPPJU3`Z:
MU+=LSAJO4>"W.MAL1#_!A)"0H/NR59A41UIB2J19&D>W7T[N]EG;3HR?-64N
M88@A^6?B4@6W;BKD=Z[-PI8<%28G499B%=H;=7FO5'H$QOE[JH(16I.GFYS2
MW)3.FG_8.*57?S!!TBW*!%*A,&B80@49+2[,5<`6Y0TJ<N@+\:K'/60A@U;J
MR&_)RYY"='=1\`Q[YVVG]HVVH1MMCN?^51WLDQ^BTJF0ZKT8A6KI8@<ZRD7[
M!2XXBH6<SS]ZR25#(P,D5&.WX5J%J*WN-*4P]I_]72=IP3MK&<D_[+Y"O<,:
MK4.Q4^?;3%@JEA,0ORL]\$<F7HHU@_=QT:-,:DNP&H-41+*1E/.KV^U$<9_0
MO6E;)$6I`QYN&0DP@XOG=7-BF-#@@M^M](42AG;6]9[&)(D1-E=J405,YU%@
MB8S'XKII+C1V6@>\RW[TO87B]5\BZ!,O(P[HRTU"-![*;@Z@K7#1.V'3,VX.
M7*BPY,ICZD.MUP-->96Y%=*"Y7Q+VG7IHDK=PA@,!@,!@,!@,!@,!@,!@,!@
M,"M>S6PI0N/]6O(/451JE\UO5L$)G-*?A**5VKE#`_4QE#C2WHNY<-'R)TM.
MU(]=:WK]W"QC--6E#WW'EHO[=_9B'E;WOJT_RAOO,ZAUZA]/WR:;S>9`ZGX\
M=(Z>7E58)4^5U$U3R`.Y5>&X+5&);;8B)7&=0^VYO>HU-3<5&#<KE8,#73U,
M1TKN'F?8^'P/(7L_$.><X\8>6=6BPN(R>?`BUFN?3^J]LJ!65:SMSY]>YLH<
M'!\KA)'Q(OT;3;LJ4X[\RE-?$;BHVW75;7@M>;ST#QO`E.CVJ=>;;7ND>07,
M9=R+00XXW9QG'?(/J')ZR;L,:O#@X+=D(5BEPW"+L.'$CR)NW74,M)7IM)G=
M5X/7F$>5_.'I]SXOX@^1W5.=D8X>]T?DEP.U$Q)'Q"S0<_'%NH&%OPR>AT>0
M<&2G4OMLR$.1W'&])<0M&U)V7;%[HB<GG,;7.I>-WEKXP4!'DUWGMM([T"[N
M*NM=[I,YE86($_G%/`V^KV.J3Z5S+GY($71+<DQY+>W7H4J-)WK;"5M,K0:P
MG;,U&#9IAAH8_O'O_#:_WK/#[^7VFY)=/B_+TEOGRN9@,!@,#0KP_P#[C'SG
M_P"7)XO_`,I5BR=72?U1YRWU97,WK6];UO7KK?Z-ZW^G6];_`'=;U@?*4)1Z
M^U*4^Y6UJ]NM:]RE?NJWZ:UZJW_AW^[@?6!PZC1]/ZDZ89U)TTIC4C32-/Z8
M6YIU3.G?;\FFE.ZTK:?7TVK7K^[@8AVL5YXO!/N!AZC(R*7AP"/TS>I,2.?E
M#)IE+*M:UI"R4L/&<=7Z>]2F=?I_3OU#[#5P#7@D"MA1,`:!&#F1,$5&CMIA
MQQL>.W$:B::WI6EM:C-)1OW>[:M:_6]<#(N0H;T?<1Z)&=B;;;9W%<8:7'VT
MUO6VFMLJ1MO;;>]?JI]/37^#`^_IV/F3(^!GZA#2F4/_`!H^9#*E)4II+OM]
MZ6E*3K>TZWZ;WK6!^.1HSVD:>CL.Z;=:>;TXTVO3;S"_D8=1I2=^QUES?N0K
M7Z4J_3K].!R^Q'IO7L3Z*U[5:]NO3:?T_J[UZ?IU^MO]'_MP.-J-'9;0RRPR
MTRTVEEMIII#;;;2=>B6D-I3I*&TZ_1I.M>FL#\;C1FMN;:CL-;==4^[MMIM&
MW'U[3M;SFTIU[W5[3KU5O]._36!&6Z-5F[BY?M"_DMJQ"@+9:3.(R_HA#KD1
MV3"%0)4MX8';FNP&%2=Q&65R5,HV[M>TZ]!X)$B!!;^';<*(WN,MYR/M$=E/
MP.2/7YUL^U&OB6_[M^_:?3:O7]/K@<BHL9;K#ZX["GHWO^F>4RVIV/\`(C;3
MGP.;3M;7O;W[=^W>O5/Z-_HP,(7J==.PQ@XH*CR1X@N&.#X"5/1H31.O36R0
M20Y%B.L,2FQA)EN2RTZE;*)#2'/9[T(4D,V_%C24;;DQV)#>UM.;;?:;=1MQ
MAQ+K*]I<2I.ULNHTI._W4JUK>OTX'$@?`:^'XX,-OZ?ZGZ?V1F4?!]8OY)GP
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MKZ:W^G`C-EHM5N#P%ZR"_P`4U6BT4Z(BNS2+(YLM`?C2A\V8+BRV!I9T=+AM
M/1]2VGTQWFTN-Z2O6E8$D=A0W]O[?B1GMRF$19.W6&G-R(R-NJ1'?VM&_E80
MIY>](5ZIUM:OT?IW@<BV&7&G&'&6G&'D*;=96VA33K:T?&MMQM6MH6A:/U=Z
MWK>MZ_1@<*X$%R.B(N%$7%;]FD1EQF51T::<;>:]C.T;;3\;S25I]-?H4G6]
M?IUK`)@04N_.F%$2]]0N7\R8S.G?JG&4QW)/R:1[_J'(Z--J7Z^[:-:3O?I^
MC`Y6X\=E&FVF&6F];7O2&VD(1K;F]J<WI*4Z3K;BM^JO_'?[N!PI'P$L1XJ8
M,-,:&XT[$CIC,Z8BNL*][#D=K2/C8<97^E&TZUM._P!.L#E9C1HZ--,1V&6T
MJ6O3;+3;:-+==4^XO2$)2G2G'U[6K?[NU[WO?Z=X&&'52M"4&&QX,;&18",D
ML<0B*TI)4C,7\DB5.TXE>GUN+_3Z*_5U_@UK`S#D2*[MG;L:.[N.ZEZ/MQEM
M>V'D>[V.L^Y._B=3[]^BD^F]>N__`!P/EN#"9^+XH<5KX-N[8^..TCX=OJTM
M_;7M1KX]O+UZK]/3W;_3O`^V8L:,VEF/'88:1M6TM,M-M-IVIQ3RMI0A*4ZV
MIU>U;]-?I5O>_P!W>!P,BQL>5(G,#X+,V6\N3*EM16&Y,B0Y&A0W'WWTMZ==
M>7$'1VMJ5O>]ML-IW^A"=:#L.QX[ZF5/L,O*CNZ?CJ=:0XIA[2%-Z>9VM.]M
M.Z0M6O<GTWZ;WK_#@81JJ5YD_'M#(MALY#!R*W"F(4\E,$),GQRDZ#!AZ=^A
MA)(3X;#DE;32')&XS.G%*2RUI`9M,>.A3RT,,H7(<^60I+2$J?=^%$?Y7E:3
MK;KGP-I1[E>N_8G6OW-:U@8S\N@_QU^S_A4+=@D"H81XLIA*YJA(^03EPX&G
M5>NT1V9!F4OT3Z>NWE>OKKT]!?3HZ\*J5T>>F6:$+CL')P<97WYR5/;4@((?
MFRAXN&PMQ44?"9DD7G%(CH:TZM6E.>[:4[2$@WK6]ZWO6M[U^G6]Z_3KUUZ;
M]-_X/76\#I;%C%,(BJ'051D,*BHC[B1]L(C+6VXN.AG;?QI86XRA6T:U[=[1
MK?IZZU@?4(</&M?`/@Q(+/O?<^*'&9C-_)*DOS93GL90A.UR9DEQYS?[JW7%
M+WZJ5O>P[F`P&`P&`P&`P&`P&`P&`P&`P&!C3(<78@Y6OG($8J%.#9P<P,FM
M)>AD19.*["(0);*OU78TR(^MMQ._T*2K>L#QCS/[?_$>86CF]B@VCOMQ'\:D
M_7<AH?3_`"`ZGT7F_-9[%:*4L.0J]+M%CGB4SZS33DP6+>EIE.08DE?Q;TYZ
M.:-3NF8K![@PR8'EGLWB+S?M-['=/F6SM',^B0:DU0I=OXAV.^<F*V*EPS!"
MP":W:DU(M#@6(>`.&)TH?N2RMZ&[/D_$M*7W4J+&Z8BNBVN/<BHW"><UWEG.
M8$\?4ZUHJ]%T7-F+,<)%;";)6>SV&PV2PS21RP62T6<U,)$9TM]U^5-E.NK5
MO:L$S,S<K,PB$])YU3.O<_N?+>B@V++1.@UHQ4+<!D/RXK94`>@O#B4/ZP?(
MB$(3KL9]7QOQW6I#"_1QM:%I2K0B:FX>>>6>%G,.7]%"=6>NW>^K7>I@C]>I
M)/NG=>C=<8I$&UI'-6A^JC+>;FC1ABP0Q,:-)G[:<FJC-[:2ZE#KVG#4[IF*
MPIZ\PRT,?WCW_AM?[UGA]_+[3<DNGQ?EZ2WSY7,P&`P&!H5X?_W&/G/_`,N3
MQ?\`Y2K%DZND_JCSEOJRN9@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@>>ZIY;>*][OO\%=)\D^#6_INYA8<GGU9ZY0CMT<(@4R%'![59
M&'I1AZ<&3$>W*92SMR/IES;FDZ0KT+QW9U-/0F$,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:&/[Q[_`,-K_>L\/OY?:;DET^+\
MO26^?*YF`P&`P-"O#_\`N,?.?_ER>+_\I5BR=72?U1YRWU97-0G?>8'.K0.;
M!!4N'$'!NJ!+1;-SXL0G$D5H57+8RN*\&GJ3",:?-386DM.>OQ*UJ0G6ULIP
ML32L.:5'R<5?`$SH=L+Q*8*<FS[2/09J$Q%JN*6#<9R2#2-!_B`SD\QF9`<'
MBW78I*/)B+W(]4[5N06>-8*BN-.\N[\STX5(D+U5#IFP#@]9JMZJ4>0)(R%O
M0ARR9\L@K+E<\CAFD.SA^FX)-<J8CXH;:6EJ6.U\(YKY=J/=`-B[D1$6UZDC
M=;:GVNCE(=HM8V66C,R1(B&&9EUSG\R&8,+`1I,B(^R02RJ8YI#"DX6]N71,
M!P/RQ!%Z\\4L)>P"$6;EDF:]8RE$J+,J&^_/#V6H3(P2S6%[4`7#FQYFIS#L
MDD6-M)B+8EPWM2(Q.UF>@<T\@K=;31&"?L0>57+A:['S\X*LU7BU;0-[DUP!
MT8+#!2!THO&*1[H8C_CJIS+C<M&MJ;D*C[^F:%PQ,"N^7UCL%T*2+.U7`#,V
MPDZB(`66M$H3UJ#SB0X2)DD9<,W.DTZ2F#%7,B+2+6B5N0PN.WI.W'AVJ^`-
M>8=JMY""&N%O'5L#9`T"VGYHZJ$6)EN0Z54=+\]'G(]$;7S&.RVAIX9)>G2&
M''H^T-.J;>3A>U;Q"'Y42N/<\&UC<9V]Q[@1>/6F;:`LDC*KHLL0=KI,U#C$
MG*VXFT0M-_BL*'-),CO?\<9J4G6M,DPOP5M=Z!Y26.D3A`FV%.C02M>COD(0
MJ]4`1+5TF5%#OS8$\VY7F(;'+XC464TL?&0J9MV<PZCW(2I38N+T2"+S#RNA
MRDAX5Q+B8YLR--V>Q"K%55!H@:UR`%@Z.&K(PT%+'(E[@WLB=6.GNH<',5O4
M:*U_CDM-,C!8O2!?>9MWM;%3)V*9766J$L9$J=MI(>8U3MOQDW<-]+86FYT#
MI9J=$>D02LA2ARQ25QVGH4K2G%B*I#1?/O,1,8><,],DOVEEB.Y+"Q"-2;IS
M\J+-Y)$C-+A(J$9]Q*P"KFN7M+C;<B>ZPXE*$HAHCB]K#'.;^90L,VBM=,.&
MY$IT6T?26)4V:80)8$<K?(?E+XQ]+'QSLBVOVUS:Y$V.UL=IEA*T:3$TT+VI
M%-YIY-O*"S"?1;B7>8MD4X8373M1K:]MC+<>&B="@>H,8/\`@[E**QIQ$1,F
MRHTJ3$TVIQU:=;=%PD$HOWN+X]D@LFN76)UBO3Z(%49$SZU,,7""5OH5DP1!
M393UE%#"RZ/*5L@N1I^`)G.O-LRI#,7ZS8POP5:-Y[YEA;/$/C#<1(\H6GGB
MPV:0KA$L4DBA5)'4P+?RB)(J"W#DU`+,"E)PB,16R5>428AO[TRX@M[71U5?
M.U`=MADS*<D2VGVB'UA:HHG!JZUT6*33!K?T]F?T7O1FFR'X:W2)!J/!CQ6E
M,$]/O.MZ)VK6ZGSOO-S$"*HH\>(PIO*ZL)F'P).HT],3IT(K]1=+/;@CR22G
MVRHQJ(H*R,?G1!\]F1IUI;;C+R1$PB16F>9C%G.)A76=,I@]+<,#$@/T_1VP
MTABZR&B`N18RTR"D-UB;2TH>@E%"WH2G-H9?DQ7-N/)%[4EK/,>[Q^=^2E2*
MERH^5>8_0B7%B(6UCAIRL;MGYFE#1Q<K$9DRX5^9/342Y)AJ7*@[8D,-L(85
M$<V^+BX1U7)?(H3$G_EJSV*%#.'NGVUV)*(4>Q6"ID;`5ZK)JR:JP5;'"6R;
MT&SC/Q#U*-MKD:=VB4WK6UJ+<,A=Z/Y/$[%SJVTI3-7N6N.U^MGI*K<(,48%
M=F;*,*V-FYC2@K9^YAG02IT>#)'ZT]J<M*W$:UM,AHD3%8LOSFO>5<2^4N99
M3!%OET2::U::]:+!2C=VE,S*J*9`OO%J\#;@OQ@]\C')<EMB0TN2,*"6T:;W
M`E1E">->+"#*IYAECEI)%[#NJC631:P5&OCSX`A`62T8J"!P8C.DPBY0I1U"
M(A1:6E*&/+5(]%1XZM-Z2.U^T^C>4%>KG8;+\SLWJA%WEI"MLVBU5F4$N1BG
M1TJO8J*X&#_%4:!;WWY3`UMY'XA#9?2XK3.T):0,/1]A.:^6,Q<%J\=(<)QP
M<@8`83"?J<.-9AU?Z)SR&CHQN/&JZ7X5PL-"$&B^H\5QN,-)S&VVD;<:96V)
MG;T9+AE$\EQ))\7T^X6#\IQ.4`:J&8ED0!XFZ=CTNDBII@K<HQMT\NYQ;G!L
M$U4S0UQF;"(QMN2/E83':$S'3-5HSC_EQ5:AIZI6X^T>-_DMJZ#;):Z]9C,J
M%7J#P2JGR`8FZL:PN\'9E3LRD37BD=#C4AM3CC+JFE,"]MXK:K7/O*&*>`'+
M#U`T7^F*AG3(M;E-%5\D.C6WG\"?MRO#@DYR`Y*YZNRON1V23Z?Q1QA275[:
MCJ0+A[1PR8&(L#,B0!-QX:5KEOB"3,5#:O8XJ0[#>0PEM7N3[5J=5K6M^NO3
M?^'`_GIY;U7A5U\;/M9^-O/G1I'R5Y3T_P`(T]%Y<+H)X=T+G4_CHH:GN$FW
MQ'ZS!D57\G,BBC9F7+<8;<WMQOY'524)>.M3<S.52_HMPY&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P(C<K[3.>P@Y*\6435AQ^U5BCAYYJ4B%#G6Z
MZF(M=J-?:DN^C*25C/SF(,-M2D_/+?;91ZN.(3L5>3JU+I?/KY66;G3;G7+'
M4Y")CL>Q"BT22'?C0"Y(%(F,STNZCN0/Q8/*9;D:5MEY3"MMJ4G7KA:F,TXU
MO6]:WK?KK?Z=;U^G6];_`'-ZWA#`IDCY$\+$7L[S`GU>C0>B5DCS`38*7)/P
M6[('(]J($A/)HI`5MSZN.YT(F'E1Q6U)]LMYA:$;VI.]86IJ^BWXTF-,93(B
M2&)3"E.(2_&=;?94IEQ;+J4N-*4C:FGFU(5KU_54G>M_IUA'/@,!@,#0Q_>/
M?^&U_O6>'W\OM-R2Z?%^7I+?/E<S`8#`8&A7A_\`W&/G/_RY/%_^4JQ9.KI/
MZH\Y;ZLKFIWM53NUOKH6%29^V7H-C01.B$W.R<[790OY?L`YD4FZU*"1L`+8
M^QD1Y7>V&E:E:';C.;TV^O>%A551X=U6"`MHF[]1(VZ;=N;W6JV`@_9;8F.]
M9C!.:W6SX09IYF/3(XZN35,.I$[BN:<]N_5U3;;J2S,=%2+\8.Y!ZOJ/1NBO
M50F9)((7,-$Z3>I,8K!B1^:0!H@/8)@]UX*18B5PNM\HS$:E3URD(D[<0\XI
M@O*+Q3^^\3[?*NP6W4"X#D&8'+>?T]VT6>ZVX>Y,-TF=T`@:W;*940H^O7$?
M?-6N,P[)V["D"EI>DPVD.I:3LD3%5.JME>-?DN5K$X`<ZE%>+N$:P7I5ME7F
MX&U<W9K'7U7K\"<K$L+%$72>3K#,6&T<DK;(#G6=-L;TAAE]9;V]%S]5YAY"
M6-ZID^7](@41\131ZRE>)66T%PS_`$"KR4[K<1XEL4Y//4XS`LA=L\_)9;FS
MW!PE>VE;0Y\9(F.JK2'B]W((/A"*#V8^-#O6NP';0UN]VAHX;48N'63$$P/)
M3QYD>!+P(UR"S9D=B-J$4GBUHDH=3O3CHN.JP^<\3[95.H5FQV;KMBM%/'@R
M"RHIZYFYZ9MF(D+Z^401#FA4J'.!D&[&(>AIC.P%"G`K<=A"8NE(?$S",IX!
MWZ)`;D(ZM*($E$8&C8A'0+T%#GJ>.1RIUVIC78,/;5/FEY57L&G"T&*F>VDS
MO_&*2XM#8N.J-T7QZ\C^?UJ&'B6RKFG(E0)"@0Y_HW21P.H6>76PHYT[+_"Q
M(V?T3Z]V-*80X15'=@.[1-:TIV2^AH7#IPO&?R-A2!$MKK,^)-FR:LJ\%QW2
M;:X;*PJ_^?AP-B(HM7I@9;]0'FA4A?OB-QSS[+FIK2O@;4_%N%Y\#Y7TWG=D
MNIJ]SQA]^W0*6-GFOSU:K,3)$*A"L*"5JT/L`*/&KD>UDC>G6P<*1N")0E26
M5KUOVY69F.CU/A#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8%+^1G$Z]Y(<%[#P2U/ZA!.N\YMM"D%M062
M4FNR;$&EP!=J&1'W6$*-U,JZP2@+TXTMF;%:<0XVM*5I+$U-M8]\^S7SZTF.
MN$P/5I]9:Z+7Z*&J,9VJ%R;?(WZ*/X_`"*J@L=T>MT\R`K3O&1TT`(+B)L$5
M->>T\F="=>A.FXWUT;D14)P:+&CG9CQ!V!`APG"$AJ(Q(G.18[;"YC[$"/$@
MLO25-[6I#+3325*WI"$I]-:.;OX&JGR6^U91_)'LEE[5*[)T'G%IM=OY>5,3
M*%"&#S#])YS3)E=<Y]HZZ\N0F-/M"!EE@$/C^I"F1+:X^E-OR4.QN-\Q%='I
M[P[\5(?B91;94(UL@6=VX7&);YC-;HHCE]$!.CJ%2.=QH--YT"(%1=;04'45
M@F7<1(<44L$^=.5IOZC3+=3=/*7KC#)@,!@:&/[Q[_PVO]ZSP^_E]IN273XO
MR]);Y\KF8#`8#`T*\/\`^XQ\Y_\`ER>+_P#*58LG5TG]4><M]65S8DP?!5YB
M+*L!H2#C32,`/"D&",,8Q++E9"(@L7%>FO,-R")*6XEJ.PC>W7G%:2A.][],
M#':N]+VN6UJW5C;D"QQ*=.;T?%;7"MT_Z;Z&K2T:E^Z/8YOUK/Q05^DISYD>
MU&_<GU"'RN\\-A+,-S>S<HB.5Z5J"?;E=$J$=8.;N8\.U#,)=,(4,E;(1G&/
MC?\`8OYFU(]/<G>M%J4C%](YV;E3(`6^TLO.'&8]=(0Q=I!D)4"P2VI+\4%,
MCQ)SKT4S)8A/+;BKTE]:&E[TG>DJ]"5++0K55R6X"1UD`D%%))B$,3",#Y6R
M,RO2'H9^)`TQ(<W+D@Y<=QJ8VW[E1G$*2YI*D[UH,`KJO+TUHG<U=(H2:<%)
MR0IBV*N%>U6A)B'+1`EB29W9'\+@$XL]Q+#C#KJ'4/*TA2=*WK6"I?1+J7,@
MP%5J,=&H@JKHF1!R[(2M]?@@4D"$)@G`@*,2B#0],R:.E-2&6MN>]QAQ*TZV
ME6M[+4L78.V\8J1.0$M77>85DS$CPY<H38+]5`Q.-$(L*DCY4B`2+1I3,>=&
M3MQE:D:2ZC6U)WO7Z<%2R^NG<UW^6M:Z%1][N9)\/3]:M@#_`.JLO%]/JA5:
M_P#,/_/24;W:^1B+\KJ/7]*=82I9H9::P:<8:#6,"6=E-EGHK8PN/GN260)1
M(,ZZPB+(=4\V%-+U#EJ3K>HTK>FG/:Y^K@9[`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8$+N'1:)S_875WMH&J_F(CL4$4=(QQR",]#*I#C##DA:$?X
MEA&UN+5O2&T^FU;UZZ]2U,Y,\).ASHH6<$D8TT2:@#28N<TYZ-38!B.U*%R6
MM.:0OV3F'T*;UO6E*]VOT>N$9)+S*U>U#K:E>KFO:E:5*]65)0[KTUO>_5I:
MM:5_^CO>M;P.M%(PIC'U,>0E3/H^K:G-+84E$9YR.\M3;Z6G$-H>95KW;UI.
M_3UUO>O3>!BP%LKEH&I+@"T4D,<D/16IS6W&X[S\=OY7T,K?0U\VFF_7:MH]
M4Z]JOT^J5>@9%@L*E2ID&*3'R9H]41$^&Q-C/2H*I['U4%,R.VXIV,J;&_QC
M6EZ3\B/UD^NOTX&(_.=:W:&:7HHA5H?@$RK8A,::I[0T.H,V0G.NIC;BL16G
M;!$0A;CB4O..;0WM:FW-(%=4EVM&EI;VI.G%)4M*-JU[U(1M"5J2GU]=I1MQ
M.M[_`'-;5K_QU@%+2C6MK4E.MJ2C6U;TG6U+5I"$ZWO>O52U;UK6O\.]X&'"
M6,%9!$,\#*0R0B?$:G1)\=W7P/0WMKTU)UM>D*2TYMM7MVK6O7V[_P##`[:R
MHMN<H6X2@()H@;*+'+F1TSD#-/;C;(JB;<U(3`U(U\?S;3\?O_5]?7]&!]SB
M(\7%DSB4Z&.A0XDJ?,ESI+,2+$@PFMO3)LF1(6VTQ$B,Z][KBMZ0VG]*MZU@
M<<$L*)Z>V-)CR&HTM^!(W!FQI>F)\5*%283VX[CGQ2XZ7$[<;5Z+1I6O76O7
M`ZQ&Q`Q#@9DD3B1';$3;#!$..>NR9-V+*FMPXOLTKWN*BPG5^OZ$^B/W?7>O
M4,>S=JE*E&(4.P#9TL`._%3$<?(3/=@P=$3PA;CB(>G]K<9*U<A&<:1[G6WX
MCB%)TK7IL)+IYK:=JTZWM*7-M*5I:=IT[I?Q;;WOU]-.:<_5]/W?=^C]W`:>
M:WZ>CK>_<EQ:?1:=^J&E)2ZK7Z?TI;4K6E;_`'-;WKUP,4BP@W"#PIHK!?(1
M4J5,BQY"'W(&DQ(L_6B/P[6D<IV#-:>;2_MO;C3FEHTI/Z<#+Z6C:U-Z4G:T
MI2M2-*U[TH7M:4*4GU]=)7MM6M;_`'-[3O\`\-X'U@,!@,!@,"-W&U":+4;5
M=SRI"`5.K9RU&EQ&%2I2!->&2BY%4:,G:52)"8<->T(UO6UJ]-?X<&;P+S?S
MDZH?+>.Y#J7B>:Y/RORC,B*[ROH#79*'?BT<W;.>63J-(AWJC`H4.97FS]4J
MLI#[L.:5;@$-MLKVMI:I"#4[8QJ<8;'L,F!XT[%Y,].J_:4\&X9X[RNZ7<5R
M\%UV[RR75*IR:LU>JW"UVRFTR/&)'1U@(V(X;,4(RIUAB$AF%'B(6X][GVF]
MFHB*N<EM^.?;(GD+R&O=2CU8Q1Y9`M=ZK8Z:=F"B9*K77F=\LW,[V!66!RI@
M8W$%W*H3FHLZ,YMF=%2V^G2-.>Q))BII>&$,!@,#0Q_>/?\`AM?[UGA]_+[3
M<DNGQ?EZ2WSY7,P&`P&!H5X?_P!QCYS_`/+D\7_Y2K%DZND_JCSEOJRN;7%]
MT+Q_3Y%>.]?K4Z<)#URC=<IO7;/8C)NNUR)5QW/1UD)#+2T;M!@&(&$*Q:GQ
MY&,^X^G33T5*OT:UZZ-;)J6J"3]J[RWLE-LU8-6-H&<N'5RGE]:KQ4Q7+2A:
MQ>:A+D'/*>%ZDH98+VW$`5>I].%V:Q!EQ77"D!N0);:WIR$M61OG%^WHMSM'
MACV+HMPM4H3R+F8?L'2O)#COEE-!#+)4*A&G@^2^.0'A'0@KMNKC]@L`Z&=Z
M62>-0GWXSR7VY*D.(W)W)<12-T1Y4KB!X$]^YY;[?Y!T!NCQS1+L=HZRQ8+3
M8Z`1KM"OD#M/EB>K]8#3*_88KDVL#ROD%`8,QB/U$YNP5V1IAYN-+^G9ARC*
M?YDE7*_"+R=\-'*!8`;=%MW(.)6KHU^E2^X62@\IV("]DX[5^>]UF3B='M9:
MNPI!FT5)=NW,=VSN>8.E7ICB''4.8)W;=R4$O#CR,`>!1?QN)4VL!*[4^^\P
M[)R^*OI-0:H?,>.<IN/-[:'Y1(ZDWM'1K=*6FF3?H["2%3RL5!*/$6N<B$A]
MX7MY6J?H7$NW7(:9KD1CQT347_)*A^=X2/OOP089<$"O'L-Q$T&(FQJ2D9JK
M.?1?B`\U&8>D2V%):>B,_)M:4V1,>.5+&7X_63H%>[!P37-_'*[[[9U[?DQS
M_H4TQS<QW4W'*^0M3[Q8*W<]S#$\/<0-6JD&56A)2`02[H(R,8?'QFH[WN%Q
M=XY(%U#PRO@NT=FBS1/&`<'I\/ILVS?P@&.?*N/C5S2Z^55Z[K7.B>/VX=S3
M!K/1]-W]L4[]2H;&?.`1$Z+(>1`5$6I8W1A_.CT!]O?Q;L/C[Y71#DFVUU54
M/<4[W/\`X/6;!631:!TOR$[_`%KMM@Z`$0'L1*>*K-[I5.#*G09,9GY+#%FD
M&=[1-<TFL[MU[6]<B1@B1\\J2E-0QXN')($9;RO1J)"AL+E2I+V]:WM+;,=M
M2U?H_<UAS(9&"0AQ"$*4Q(ASF8TB'(;7KXY#,QAN3%6WO?IO?SL.I6G7IZ[2
MK6_3`[:EH3[O<M*?8GWK]RM:]B/UOUU>N_U4_J;_`$[_`$?HW@?BG&T?^^M"
M?_VE:3_^"M7^'>O_`,%M6_\`[R=_^&!CF38A\D\&;(Q-EV$/.N#%/);G[8CH
M@+D2FHCFT/R(;'XI'TMYM*FDK>2G:M*WZ8&1TXWM7MTXC:M+^/:=+3[M.:1\
MNT>GKZ^_X]^[T_=]OZ?W,!\K7HK?R(]$)VI>_>GT0G6UIVI7Z?U4Z4VK7KO_
M``IW_P"&`^1O7NUMQ'JA24KU[D_J*7Z>Q*OT_JJ5[M>FM_N^N!UV)T22TX\R
M\G;33TUAQ:]*:TEP=*=AS?73J4;]C$EA2=K_`/=WZ>NM[UO6]A\N$AS4U`UT
MA";(N0I!)N`Y*81-<'1'6&)4]$53FGU0HSTII#CND^Q"G$ZWO6U:]0[:EI3M
M.E*2G:U>Q&E;UK:U>FU>U/KO]97M3O?IK]/IK`:6A7M]JT;]Z-K1Z*UOWHU[
M?5:?3?ZR->_7Z=?H_3K_`,<#&"#8D_&?F!I\<C%C$BP=]^,K:VVR8(G*#EX>
M][UK_&P"<)UE?I^CWHWZ;WK].!E-*2KU]JM*]N]I5Z;UOVJUZ>J=^G[F]>O[
MF!^X#`8#`8#`8#`8#`8#`IGJ?$ZWUTU0YUKD2W@U,D69^76F9)2&/M35C";#
M+&GUBRPS9`$VG?OD#Y2)4&=KT0^TI.M>A8FGDEWP&((#6(-![-/:7861\*48
MF5F5-(K&1:ZZ*8AK:_-K$%AVL&FXI`#)C(CRA[<74%3CD9U_Y37*-%C43Q"5
M4.I`^B3+ULH/KT\K*`5&*,-"857:E2K1,9:"E&[9))DW"DFVRE%UF5$U$$MQ
MFO5#42.E!)W7%.(AX9#9/SD&;BP]87KA^:)!$Q5&R,8\)9D5:?%YY:X^CK$L
MU0'B%72N6/\`J&FI&I"_1*%_KJ')'JYX4F:@(;@`>G@G)6ZK-J[<@QR^(3@U
M=N8+#0)$WG8F9:I,6HO%6A:X<[2MS%/#76FD+;<C:==')TAW@;!@3*H_N]L/
ML`I8&89:CUTH&G6-X.S]#%D23@FXQS;<ZM#(D9@#(<??>&M*E-[4ZB0G3(Y/
M0N^!@$=#Z'TLDINR2[O5[15Y`98N'%((!6(52(,L!$L;DW4IJ"\NF*7IOU99
M^6<I>_;M'N42\'F2N^$=PFUT!.N'5-(Z!."0"=RL2Z\LO9$76.+MD+8\98V;
M&.:9H4O\SQ]%A34=*2+@I"T/L[>]6BSNCIDL7H'C';[J+YU7Y5JK,[0RQ=TL
M5OLD^K2W/PV5UZ<?*19=#`NV9UT-8J?(L:T!B+TV4N"J*AW;:U+WI(B6'&^$
M3/YI$EK7T1NX5P,/C"6:L3I4)$0J+A#QC`P?8M),K&FV@I."],BNR(CLC3DU
MQ*UJ2AO21RP3.W^*K=DD40DW8:W.+TSG=/H<Z3<Z&BU1KHQ2RL<I"8M3*;$*
MF$*T4E+D290U<AQ/XBB))2YZQUH?')A;]X?2+\$YI5"?37Y-8Y]S)[GST0S4
MX9J>?D2Z98*65,SYZRT5<F,?@FF%RQ\O4R-_Y>WIOV+=<=P7UZHL:\%(!PR6
M)+N`D)!-1KGIT-5*F0K,$67N8S2)U@%MA[A#2LALD\ZS)1)T\U/#-1(;^E;8
M4Z\.6%)J,\01H/J]>Z$(L@>,&K]U<N(VLKI#&Y%<:0UTUMJK40O&/18E1KI!
MSIKSQ%IN"]J6]";WI+?R;]@Y84Z$SPMK\F1;9T$^(KA0X6L$L*8KM'@CB8`9
M9;5VVVEX6I+1=*I$HG,[6^S,>9^F1+9&1_E;4I6_8.20K\4AY/FSG-#]A'30
M+-[O5Q#0&JMI8T-$MU$N%0'A_83-$"AN17B]N6;9GD)<F7]8RVVA3:&F%,CE
MC:K[1X#C394S*%=))U\80%[AA1`T9/@0Z:\W(.2EQP,019A<!VN6ARP2$6`;
M(:6T4;]%>YIW274#E*2BO"6NP)L';IL1^"Z,4VP'P;55?DIM$ZM2Z+(F"CQ$
MK8R$@O6GVZ&RS!BRTR/P^/+=9UMR.EME(Y.#D/C1<.6=HAGAT\3-JH"DE06[
M><#1E6NQNV'^!R+NO1WQUH>F_E>M!^:2FAS,QF.D8],1\:9C>E^@F;A[MPR8
M#`8#`8$'Z=3?X1>;="Y]]?L5^>Z/;*;^*:CZE[&_F<#/"?7ZB[=9U)W#^N^3
MX_>CW^WT]VO7UPL83;6_0>`^8]@;\*^<=@I_CO2N>>(=LI=O(WWGW8>@W^T=
M(E\TXK>.1`1XB@'^)T&!4HUFEW!!*4[).D%CV(ZHZ$27%Z>2:O;C,7<MK&&#
M`\(]4YSY,U'RA)^1'`J=QGJ`V[\$HG%[34>H=3M_(B=<G<VZ%T^\AK&"-5SD
M_6X5A@GV.IR8LJ*_'@.PW(#+C;CR7G$-&HF.-3JM;Q"Y!<N'<'`T7H<VM3;U
M+N/8.C6Q--?*3*H,.]E[%?>OD*[7B)N"++EQ-7?O.QS,Z3$AO3D1=/JCL;<^
M%!)F)G#)Z8PA@,!@:&/[Q[_PVO\`>L\/OY?:;DET^+\O26^?*YF`P&`P-"O#
M_P#N,?.?_ER>+_\`*58LG5TG]4><M]65S4KWBC@^@TZ``ME\70:>BT@2MDEM
MKKC'X\R,D+DA:V]+MD0F!9AS;2F`\\V_$E:EMQ]QM(U\VUI+$TIRH<%9YK`N
M5,-]K:0KJO.`_+`4Z0S`#7XD3KE5D4H5<TF9IE^66N<2J_0,N,#6H8]<N)N:
MF*U(E/[46[8_D5$Y3S+H,6RHZ'RTK=;6"ME?`5F@@Q(D=&&PCO/!I^!1@\6P
M6(S""!3;$.28B-R'6T%B\B4Y\7R>W0F9F$9@^/8^P.M`$]WI1B)8[,?NYX"&
M$L291FVQ2?1%6@<`9_/LM,6I#)/1E-R(KC,R8P_#:V])]7-I2\B_!D>9"Z/#
MYA>O'6U]4`N=*Z*_U2M$HTDV*L!*HH<%UNL4:B$-M3DP)=QH7)K148SL73R'
MB<AIV6WI6G'%Z'6^BZ)9\A8:_8^74KL7,J]T$R'*L<I+B?@N!B!6*I"J==L]
MD*5A1T<@D;!V@E):5IAW42#N1#T]IU:'4.$\7GQ?CM7&?PX(-[/SH#$I=PH%
MG@5^%`5*4'[?4ZF&H]7AE)!/H4DM,K!D;4]/20LI?XR0(*D/?B/NWO6BWX+3
MHM'C5I(6UUWJU!NA[\.D!*TN:\S%I[!;J77S=XZV9"L"#I.7*EVIZ/\`0AH7
MSK5&V!2PJ0[\DI:1>K%>0'&H72"DT\STJO\`/@MBJ#0DJ1B0[$VS:'*H5_'A
M2[R?$7VNB%@ZO,3MV!)81`.09#KJ(I)EIU]ET1-,ARLQ7J=?KJ(A=@H!8007
MSNS7N'*CSURV;Q<Z&%JU49KO0#%^)J)1;6%H3$]B$0;)DOC<UM,UY#S>F1.*
M!VWC=`7)L4<3W3GE3;NECN9#H/UFA+Y<M)D]BB]'2RR_JZ"TL%0#T=JNRG);
M<O\`\O0VVAN/M"6]PO\`Y1,3P3G_`#.VB2+_`'BM2;?%ZVR9&2"SKI>USEUV
M);;W8*&U4UV]^O$+5^3B$V#'E+&.$AP-EI<?2'8["TU;F>F#GZ3X_".D="ZO
M:B?8^?TV*4Z:`CB-0%P))LW.@4WB8QWFO2":K3#3/K$TSSR3Z5O4=F1\TK4G
MWJWO;;HB:Z)1KQ(Y'7'Z\+LUA#/2&#$`O\MK%_7[.27[IQ64.$2#ME.3992:
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MX`D\RN-9Y]9;F'<-IV\9'C[DB5!E2X+<MU4%*W'5O[^5H771\D_%JFSR]G*S
M._5X]./.3Z:*58B;R_RY?UGR15L-'CC;U!8-:CR3K<IVO3TR&GRK3;[S+B'/
MA0.4]$_\@:=S>19*(NZ=3YN$O06B`Z_-9M]6$S7[0&>ZAS<I#F6`3!,A71_,
MCUMJGT!6+O:1V_KDZTXW\/L=B1,TRUB\>(%WH?.^6UWLD>%8>95,R#)6X4VP
M4M\2N]`J\@.M8(.JP2(-6C$(BD_ADM]N5-@Q8[>H4I"M...TO&^BC8G`N'.4
M;\4;[W2PKYR#6F8]@0O49N`-N[=_J@>NPQ]BMOXR#I-^M'5HFUATN18LIQA$
M=O2=NMN,%N=%F6/E(*)QVH<R"=+HL"=&[E;+*<-U:>"I%>`U6R7BUG^Y5`4!
M?L91^-%A<VO)2O-LM/NR($N7%G+0SIKT;)>-H?+X75*:&>EZ\D.;50>4J0>L
MR2/X=$B0C--MA:."&]$+)3T*.@QU6['9D*$[95+U!(+2TWJ+M>D>@N^C99AD
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&!H8_O'O_``VO]ZSP^_E]IN273XOR]);Y\KF8#`8#`T*\/_[C'SG_
M`.7)XO\`\I5BR=72?U1YRWU97-YL\IZS6+GS1NJ6^XV6G`SYE\=/=K#6GWRP
M]VJ6A9N(4C^]I;H<+76YAMST7Z-N"6UK:DH2J(^7;A*IC9CQC[CK4V;TEJ(B
M@TD`);ERI`T02?JM@G\*ZX-L8=R?&_&HKA9+5?BZ4TB/*2_/TC36GMQE;+C#
M"RO''FE3IH2TO7.X6\`4550S<^@4\45?,5:4OD@ZI*$QZ4(=4-1'9Y8(=FFX
MJ=?(TY(<5\3.HZ8HN91;FX[QW`=%`6J9TR=-+<9:MO'76K35Y%1&B)/`R)6G
MPI.FH;@@(V>^'L2HS4YN*^S9$2VMPVFEI6E19NJ34R)\<[E>N@6-?5X"W%2(
M=C)$(2*S$'4U=@K?$;TT8'V8G$^,PT8"<2$2F78JI?P?4OI=W^EK31,7)S.K
M<FXR2+WH1U6P]1L8(4:.VX7`$_G.\&!O0A/'`K)!(84U-M>R#:>?"9TOXM+U
MIPD\M;+#+L9MH3<X.M5O%6D7PST:7;[`0FDAE\[6'<#C`8(%NO0>MO\`3[*E
MS<_0MV:6.JK'<VIL(F]ZO1%_J)]=KE;=%TK2]<6X^^Y:R7\.M>%]J9J74F!S
MQ.;0Z:)K4N8VJN3+PT%KX@PV#D5(OR(8:&*0G<MF96YWL^'1`TA98F=,%Z$H
M'C?:!7/Z`_T8;#C\6/U"D1ALU,."V3/Z"T"Z"11!H\-3')+)B%#)#ZV/<C2Y
MWL<6E[?MT3'/55MYYYXWP!<2,CKB8LVPVV1SAH;`BT\L7EO724QS4Y7X@(C!
M9U!FPFNDPDQI^T?*.0^QMK3K4K;$D1,I=<>*>,O-66A=MMPP3.%TTP88%SV*
MS+L,L(&%>0DXF7:AK%N$)Y*2SV,[(TOTV]-D#-+3\BT2MJ%[I1-/%>."J:/Z
MK=^VFJX)ZF.%OC"_2IM3;FMUXQSOKT1H$N5)D2Q31(92^K$7%/PUHBPX8=EQ
M3?Q,RG7A<Y4[+'$/'3;"B;_5V;`P>HU]JE)2WNF15,U1YJ^##"F)LJ)'C'+M
M69ER+*>(RG43U)C[T\G>VY2W1<I]=7^,=EL5!N3W3U<[M*B`(13VYDFO0;4J
M2/+@CKFZ\RY-D3@Q8BFV1!3[CVG&7(Q;4=R.ZF:S\@QC`Z!S[CWD0<.]+8[T
MXX!YU7R0F=JMV`')"\X.)J5N0Q=F94C<D<(GPH%Q8-M29#+J7718^0A[Z5+C
M;PB9C"E>3N`>.[5NG#RO?]_71*B:K,&N3+)6OE``QE:G4VP17-2/DC,N#Y(<
ME+^)+,9W4E$YQ[3^T/+;+<Z,]-\3N?(=MG13/9[`8A2B-HA7DT2AUP^Z\-38
M*XDZ,24D02!`!:AA*C1X:YH_<=<9;:T-QFE(:TT2Y6!RKD/'O'XC_"1%Z`P2
M']`@`P54+'2*)CL]TZ(JR'8U7EQ)^QY*!9H]+A3FX\2%[FFV%KT[N,C6FQ,S
M."F(O,/%4/`D3C7?*O*B1*]-XZ"(29U"'("AAS<24.TI]F"E!:W"X[VW)%@=
M_P`;.:?;4XKVI1O8N=%L=1-^/UOM=?O,WI`4W-K-;`V!=*`?EH^5L(@/=05Y
MKLIF',]9S"HQ0"ZXMC6TK<80ZYI*%1MK2(B<D7XS7_&G@UWG20O7AILH=!6(
M5#68GNSG`L:B`:-_"`A9J$_^71(I40`(EZ8=CQOTZTF.ZZTE#;8F9F'9#^/?
M#JM3*J=%=*;;@SC8/\K6R6W69Z3UB03XT^$@J::'LK-R&IG"(*%14[T\VA4K
M6_C^).V1<Y(70^$^+8DP"Y^*Z1#M=G.(L5/`I2VS8BQ$?1B?,+>1&&RDIL["
MV0%"N>#X[[WN@1R$9Q?M84M"=H+<YNA?N6>.7,SG1#<SI3LBSLS:O+=J<;88
MY8JM:[)T.E-UQ8,!+)C:_#$29LX)$EPY,=*68TIN0N3'U(2M0B9ELUPP8&B2
M3>/(S?BF5\\$>5?:&[M#\@#,!CC*!W'/YOOY+%>9<OA#-&75E<H5>EB7>;Q=
M-.3?S)^*[(JW-U)TOT1J.D1'+C6%?Z;V\KF8#`8#`8#`8#`K#I/8*-R5`1Z[
M3B4%@Z^11'D0`)HVQ!AAX.R1DR9<#P9N@X(1#UI<F6_[&6DJUO>__`L1;Z%]
MEY<5",GDWJKCXB@M;/3F"YX2,(`Q]NB19H#=@A29J'@KQ!B:W[$2-(WO:M>G
MK@J6:C='Y]-G0AD.\U"42)$B08=`CV0.]-(%PWL_%QD&*W,4]+GB_D3J0TVE
M2V-JUI>M;WK"5+&3^N\R%)G2"5\J$`:*5.8+&YEF!10HJ<.(014P62(OD&V(
M9)B>1::4ROT4AS?M5Z*]$[+4LH*Z+SXZHP@)>J>877H39(^D790Q#80<\TZ^
MU/+?237?PZ&XRPM:77O8C:4*WZ^FMX*EU$]4YBX/66;Z)1W!C<)1)R>W:P2X
MC8]&V4KFK?3.VVB*A4AO2G-[TG6UIUO?KO6"I1BV^07&J7MV.9Z'6%E41R;S
M(`67@ECTQ8FIDKS*B114%]Z2N:JJ"7YK32M)4\RG6T>OO1[A4IQ*OM'A"I1V
M7<JM&"0F!DJ87>L`IL9$C&D-NAY,J>J7J*Q'*-.I7'6M6D/(5I2-[UOUPCDC
M7>F3&GWXEMK4EB,6E@7WF#HQUEDW`A/DIP=QU$I3:2<(?%=?>8]?E:::6I2=
M:0K>@Z$#IG."BR2!M_I1!8=3R"R85I!R=C51X,DI(U.TS.7]+\`Z$^^OW^W2
M&6'%[]$H7O0J7%*ZGS*$+<-S.B4:*%:/S*HX7D6P"R,;M`_;Z2%<7/<GIBI.
M#]Q7?GB;7\[/Q+]Z4^Q7H*EQE.L\L!KEMF^DT(.Y`*?@DY!6W`!RXAC3.I.Q
M<A,P@SMD@F/OW[95Z.:1Z[]/36\%2ZDWL7,HL:*_'NM;,/$8P.8*&@30LP5+
MP[(:B5T),&#X4MR1+@$#,YIA,A.O@2K>]J6E*5;T6I=P5U"AFU&EC;,)DP`(
M6!9)AMN?#<K[M>(OF8;)J$;:?<&RQS,^O3H[SB7/1EV,K2O36T[4*==SL7)&
MMR=.]1YVWN$*@G)>EW2MIW&"D]C=#2S^MDM;:&S]F8>F7U>C;NY;'MWOY6_<
M*EV5=5Y@EF5)WT:C?3P@P^QS)&K8"4Q%KY94=(LX^ZF?MMH00W+9^&3O>F7?
ME1[5;]Z?4E2QSG9^6H-J`)O=6?F1]OM$GHYX2]`#3VIXH8P&,SD3=QQITE-,
M-(B0G-ZE2/:YM"-I;7O1:EP-]LYM]91X$VR0PTOHC-BU6&#SK(9R64JAL)6S
MM:6D@ZQM%GAGCS,3Z'7N>6^AU*=;VC](J60=[#R5E&W'NG\]:1K1=7JNY5U/
MZH!V&P<5K6R.M[2'>)1D2=_N,+D-:7Z;<1[A4OJ7U[D\#1/<[IO/H>@K`V47
MW)N5=8T+CF6VG@[T_;A%.HC95I]M4;:_;\Z7$[1[M*3ZBI9*Q]`J-3B@YYTR
MQ$'6-R>T'(MMOS($O8VJG;M*5J9":D,-L_EBM393;BE:0ZEGVHVI:D)417-=
M\F.*6DS4`8J[P$3;W3PEUJWXNU)KS1498V@4@(.9V>:&N_F>?&LD-S\*]GU[
M.GDZ=:;5M*5%J4ZB=5Y@0F"A\'HU%FSSLV8-"08ML`R)A@@/6EN="&1FIZWI
M\F&M:4N(:2I2-J3K>M>[7J2I?)#JG.!+A'1*[U2#'"K(L'2$NQ!8P\%.%S`@
M^4,,2GY[:1Y+4VP16M,N>B_D<TC?HM24J+4NLCL/+I&W$C^@TPLJ.P*FSM";
M57Y_X:*-,,RAQHAMDEO40/)AR&WTR%;]BF7$+3ZI6G>Q4NS$ZSRR>_7HL+I-
M"F2;<]*CU2/&M]??>LLB#(=AS(X!IL@I9>1%EQW&G$1].*0XVI.]:VE6M"I9
M%/0:(HOL`FYU51W1;8#89)\6HKHVF,J8H3L?J5N7^(IBHVYMGV?)I&M[]/T;
MPE(M;>[<;HBWVK=TRF@GHLPJ/EQYAR%]3#G`ZL:NQ6),C,N.OQ)$*JUV;-4A
MQ*=[:C+UKU5Z)V6(F<F19[#R>0G>V^F4+U2JO-K;7;03+[3UL0TY5XST=Z<A
M]F784/H^B:6E+DG:]:;2K>]8*E^M=AY*_#BD&>G\]=@394^##G-W.NKARI@N
M*Q.)1H\E)';+KT"%):>>2E6]MM.H6KT2M.]DJ4E(VZJ"!)$\5LU?&A!$IR"6
M,3C`^(,&3F92(3L*?.?D(BQ)C<UQ+*FG%)<TZK2/3W;UK`Q:^D\Z;7&;7?J6
MER9/BBXB%6D'I<HG.DSH4(='3]=[GITN8+DM--)]7%N1G4IUO;:]:%2ZCO5^
M8LA35B5T&G+!UQN4Z<)L6,5)B#$PMS42=2W(TIWXW&W!LA'L_2M3C"TZUM25
M:T6I=.-VCD,N.U*8Z?0?A=@UHBG;ML!QW$P[EJ!NIO.L2)K3[&[)^*Q=0DK2
ME<E4EI*-*VXC6Q4K,PC0Q_>/?^&U_O6>'W\OM-R2Z?%^7I+?/E<S`8#`8&A7
MA_\`W&/G/_RY/%_^4JQ9.KI/ZH\Y;ZLKFI7N!'GX4)5CW0CTVO0PMNU,$2QX
MDP<E2YCE3M<(^+T,!#R9)V/.H$LSIYUMO7T;.E2?<GX=;PL/(-Q%>(7\',&3
M8;=T`U!B1#)X),2!.R;81,\HIG.#+GTH&11V!\^T0JIQ$1.ACY<#XR4=MQY+
M#[$CUW%CD]!"/(OQXHH*-1P-M@MO4L<NNPZS%K908_'_`"N!LDN<RN"(K,,2
M*'A(]&*-DY++#(T3)@/L/[8<;^+5*F<5`W8-XI-]2&RI1ZZA[M7REX8F'0CQ
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M.>.@7HECHIACH`\C-N%F79#\VLSBU8'V`C4;#993^FRU3.UXS5_P3R3G_/(D
M,2!$%>D(F*2EM/R%Q8&74?%>76X=Z%6VY]*@<NNW-JG*:WINYDOJ;F[R?DT5
MYP<?IQ0O9Q]FB5<!.U+@-OO2G1GR"7VE+=TX6+NF*"57PRK##9F)V.Y084$@
M#MEEM!.5+ABS::O-Y)9605WLDNCQAC4ZN/T<"0.,J?B'X[+LJ06=^)Z4O!W+
MHZQ_`08Z)`E70MTD=/LM`J%C<'!:Y9'*_;X0NR%P?.8KS$2JD3SM\$6/H<F1
M!$0EL37=JTY+C/-1DZ;)%]''V*Y\(D4SF04TFZ6FN'J20FTPC41)TE$F5"U1
MZMP,M+EF(0F8ULQL3W%A<6$I.ITE[2M--*>2EI8B[\44C47Q/ZGTOYAW0K`5
MM2Q]GNJ:U^(S8L")^8F[*7LLB*@O7420AF+!ZXXL@*8E1Y#;+T)<Z*I3#"TC
M&(8:`0\0F(31./8K+*AV%L"H.G<6W.ODAAF5P(H`(E8:JNU+J8(^8`U.-'F$
M]1(DG4WU2[M,C6T/$[GUXQ$*-("&*@+,&+04[;2'"5=JUCI]P_*M#HM$YIS8
M"!H-H,SQ`IUQA59OHI]#CNTJ*19:W&7I&_\`*'BS>:*\NY7P6PTV8`+F[^W5
M><C.0T(W;B)&9%#]&Z9<.=MA1/34S9U;>F3K`MOKJ4;(-$71S\^5\LQC>XS;
MRA,RNP47\=KG1$\='=7LY2-;+=,LS%C<1,B$KA9RE\C=!.,02LJH1:59HB+$
M=99*"F(C\"+$EMQ)4=MMQ*-DF[MFYKGC]7:QX^5YCI,^I,T2!S77'C4:2C\3
M(A+8`(<\JL:4LQ7B0@D.MH5+T65MZ,A496T/;5$<^%S!CBJ&-$\/ZWI<.9T6
MWD'XM,K=8&LSXEDE31'*U5Q^UT\<,CC*;'>>H]=K%/GRM%7T2%,LMRE3YBU:
MUM([GPY3>&NR"O1K#8>IN46Z]I-TL/6WZT8&#J]T@'.Z73+1=C3\@'LPP%2_
M(/:;+NOLA&ASS2W$*=0V\@8Y>#FA\J\1U\KFL0;':8E%?L35&E,,5^4,L+DO
MHD*J,4JJ$!">?QK<8BQDR`9('+GQY4G;&F77);\!QY#D+FTI=O/BC9^31>?#
M.F.MU"IIU:IYNJUMH:2!,"'6+9JV$9@F@M#:+NS/F&Y8XQ#C"I!)^6E8J0IY
MSW;IW6P7,IGB+S'>CM5Z(BO#**3*G&Y$O\/A>\,8'1:W,K=AUJH0#4R%4)Q)
M#/PD7'C@MUK7U$A#*G$*$\I2XD(\:Y<21WZ;>K&BG&;J[(;6E11BNUF^ILM0
MC6.=)'HK:;)79TLURZ'%)H*.ZAP_C?TEN,J0XM8QR>VL,F!X&=^W%P-XP]M5
MF[UKG$CHKG4W^`([KT%/`7;<]>M]1D*5S/17\,_`)'25;-N"=.:%JFJVG<?Z
M?>V<-<I\+>^<,F`P&`P&`P&`P*/[!7>12BW,KIUKZ#;%*MCB*CLX,8)UR/;+
M5#V"'32?U0HC&&28RE^D.:XY%1'D+U_C?56M;+%]&OUJB^%TAB\5.+UN[!1Q
M!X4$DEVU1'I%AB'ZG60QF$)GZJLTB8J=G_'J_)WJ0RH8Z=>%/0MN>Z(UAKNA
M9U=I/BL$Z(`O3/39)<PR267K5?GNUN14EPG-52WA/PH)#!L#*!J):34*2W)>
M4,DRC\]:GMK?DLX3NT1B^P.$L((VJI]<)B;D7G=+N%2,DH:T\PHLA,JJUSHD
M<-L+SFRTU;^I-R1&=CI1(V8-D)2DN;(;4\U%QZIRQ6_%FG5B5Q:RWP]MXCS'
MI7);>\L85"HBB2HK\\W4L1E(KJ6*V[)C-.."WY#RF).T[CL[E/(5K*F.;ZJG
M`/'3H)DA%HG4K2NZMT>`/M3E42)!.KI\GHIRR/![@"U4F($*4:Z3`+O$8DM#
M)*5(W*9DI4RWIIL7,9N8#0_'&(/$<3!]PL3L&+;3E7JU3:4"E%OQFTTOHU.N
MX\42U3-SSP\JSLW(?G^^1'%D!KS34AAJ,N*@MSG3`SZEPP%0[QQFW=5/PC-S
M[@5)6`9SI)0FIJ1?[$W4:YS*,I58F0BU,I`BRB!DAIQE44+*U$7*TQZM(6,<
MV"<8\=;7Q%NM@.S/5L-U:WT.\(;M<MD#,Y^+&LT<[86`(X2`C"@,RTUDPQ%E
MSW?CA&YMAV[N4^Y-3I\8V[MNYGP`;KG4H9=>F:%=?"7@5S\J!9JPP+5N3F1%
MR-VL.U-L%,;B1A)9SIKR($DGMPHE3T;Z=_VM/?.(M:(R5XSW<22Y?"MDM`+F
M?YU/Z+./0(40@CKX:ZUZSSQLF4*2DG`BQ.IN*:FLL:C.[GQ7$/24+<]Y,<T*
M@\U\88\Z\6PKTVY6*(7&?AQ>T'Y<4E"8!'[+8&H;[,QRL*(3*[&E[DQV#;OR
MA]#VD-)D[;85Z"9G)F*UR#QIMG02MOH/1FR-U(=%DEQ[<Q$`ND?T849)V$O.
MK[4L9`(*'30M7(B928TC8^1#COI]VY"7%J$S-8N!\3Q#G,>Z\R<[%9G#3J:I
MSJ3H5-&@2W.0\BYQ;=*@09NHHVM0JH"UTX?N<+C(^,7678K'PI9<2IP8SBJ9
MCEO`P0"%)">1,L2!BWBJ7;F#TX"*<;!%>=HY-`M;LG;]':=,="G#^=/MP0DC
M6V/@E-.M#G/8ES1;G3%/P_C9XPRG>G":_P!9/P2(Z$^>Z/,62!0B8I,EH2B^
M$)TXC6XT9FNGG*?'2>&(3L5"GPOB6Q'6PEALERYA]7\82(6)6:QU^77`H,$7
M5-*O/"Q=PCR@-Q*]`64A2S`F`8J-NJ#DLFXU.0/9EJB$?<TXKXMX.ZTRL*^$
MRN03+MJS&.C0:O-L%/)RJ8SIN>6MO<.L<[OD_34)0^7(%QC]P2*DPY"5*BMA
MIOSH6\TII_0B[57,XWXO52+4>?!C%H-S+JS0H5?L5;<JCT\2-%=.Y;%YQ./S
M'!L5TTQ#-@!S*77T2-RQXZ0AQ.W$-;T6YS2%JG>,?,[I$&2++=6$<>O40,#J
M4:L-M`JE<.DO\LF3FP$(336S%F$V`A;`+[KD=R?!`[7MM*X;7M;T,9A9U='\
M,[OS&M<.C7.P+;!!^?684!^N#P+O70%+:J*F0KQ$>*<%RD3@S\>&>:1M^4D=
M8-MN*83+C*T3&)MC*ARWQJM1RS5:M7"P'#YHYT2QG0VENLDJ^S8+_P`WM)4)
M(:76H4BJ`!93F@J&&CR-L*4/^3X%/_J/-C'-BN9<K\6*0(;E5WH"%P@[E%C?
MCQ"0&%KDC^<]'`JISL\JH`.0;B,V#G\82LG[E-2X\12$NZVC3B!,S**O5WDO
M1.E6;^#B\V-CK#I8?T7G<4ZPBI4."9L\B#:))6MBW:$5C;)DH//Y$N7];!=D
MFTMO3-Z=VCZUH8UX.P7XEX^<RK5*Y'TFVVEDB.Y^1FR#<&'$:BV!V?$YG2S^
MX@Z`&*3WI\MRCPY#$)IE]3$-$EQ:MM->K8N9FX8&YN\1$]%CWT'UB$)`AS:>
MP=.&PEM76?:!O*-=`LU4B5P;7*F70PV[^''9D1$8I%(2X\63KZ67\&_A+C5+
M%*\UX)S6_BND6CL]N#V6R'('1XT\_.A))_@`DS82L0//-KK*3U>IA";?5B)#
M$R1'01BZB"_52VFT;)C.%,`9JGB\,.7:S&N]GIQ:SV^Q"CGJ<'6&>T^-K'26
MC],B-1*T1*N1@-6[_-4C?JX[`@-P?8M#,9SY!CE3[C#?%6KVL.7/]W<,$:#8
M+23!09\BNI@C3]JA'[3T<U&?"5.,\:@3YE9($9<G<B3"!O#GF&7(B&G&-#NT
M=3H_%O&BCB`/0R\DJ7=$<I,E05)L<)IX==*-ROG=!=>BF`4VK?,`CBXO.`C[
MQ!QJ&N',?TC>TJ=CM-B)EU:Y7.$L\+JW&+[W]9O0F>%O(VRO1%A#(BU4M3Y&
MQD;3),"W?JR5FZ#5[&14R;:CRIJ7'X\9K>XFG$C&[0Z^<R\/>>E;N5.';`K\
MEM,6JQ`(C-=)5VU/#ZM8J>6I$"LQPFF(/X)0>+01LK24PX(R(-A/J>0^]/?D
M%B9G!=Y;E7&ZN;J//[/V6X;(!*8$BC:<XBM+)EZ-SZ-<B-$#SG1%+63?E`1Z
MCBXR8[K),TB&^M?U6XCFT$N<U5$Q7C977J59X?7[99)0\S#GTPRP!%V*OTN^
M6ZKP3SEM/0PE4&2"<XNYSV!.D`G)&Y4':O5J/$C+TIDN+94$>1)#")#95L\A
M\9`>0<9U%2R90[$:6DJTF%K4-+9'2OF3IG6FM:7^K^KZ88:*_P"\>_\`#:_W
MK/#[^7VFY)=/B_+TEOGRN9@,!@,#0KP__N,?.?\`Y<GB_P#RE6+)U=)_5'G+
M?5E<U2=>?H[8RLQ;H",6=\O9I`2I5X`S+?,%K`8IMO'DF(B(\T<PAMBBOF7I
M#DE]IAF,TXY[M.I;PL/&-@.^&\XPNTSZ)T,B4(5Z6492-$WE[9[GQ*O6:EQN
MBPX$4JE+U7E!296'"?TEN8M;NW$Q]N?3.:-=SZE6;QBK,4^@;0KF]++6"8)/
M:M.[*'#1KK?(UB#]%KT^P+DRVV;?)KI>Q%"*&OFC.R&7G$/)>6PI1,4(A7#P
M@D"K&X(J5[54K?732#5JCE2\43/B62V4&`/HL>7,MK+B%=`D]2@/Q]:2AEF/
M(>3,?B/M.MM%K=U>F.F='\>XM#YQ/MQ6XCJT2KIKKG/;E!)VJOG:_"A!?F6X
M-LSA,98(9B<&N.Q[`A#CS[D*0XR['U#:=4V2I0V+,\9>O5[H)\S3K;"J_)8B
M^@D+T<D$M*V1,,1#%H+5]\:=*E9YP/,YJTQ,7IE3<E;>]1528\I:GAC$ONA"
MN/7CK3M:"<ONPS?-QI;I;$T^:/BIO..D6"V;:,UNGA63BX]:)V-F(X3)_2N:
M'D8A32$^]F5+;6,8BV*UU#CUDH<GL=OYI=I%QOHN-$-\Z#RR4H@E5GI%3-HA
M,HE&A%9:+O\`,_P14^2T\RESZ-*$*4XC6E#K3(EK5XI\YH$JC?1W(13"[R.D
M/-@&K=#<I\6B&[)8X1UHZ.EQ)]9%56P\BD*C-HD>W3K;#"$.(D(;4,;8@A7O
M$%CFU>NDBB7*Q4F]S;0#_*#*KA8XD\O7`1V1TDS9:RD[)#$ITRN<TFL&B;BI
M*#T9A3*7)GU_ME%CE==68-=&\;+QL,_(']9G-5,6BL@K@,1>XLAF..M1.!2S
M$8TP5:-DREEN/,B$4"2<2[)FNM/)<7I@BWN62I2_GMF\8NJ-\W&4-!.2/H5/
M_,-"88U:A4%7.HB^57H#9GM2)#+IJM61_5;*BY4[Y7"+L5:M;4MJ6G0J4"H7
M2O%NK2[?=ZO3KO5'"E361+[.#)H&%9HTH3SLGIP?NS&HT)=G(5.^UMU.E/1W
MG(LIJ/\`_%,/L-";5!<K;XIV&54'??<.<!XAL&ZJ0R.L$DGTCGG/@W#SM9DQ
M=C;DN5^0Y[D*MP=LS!DZ:MU#SBHT7TDS-%B_5;S_`&+@?--"[<%JYT'=(XJS
M":I7)Y8P'(2]C.042?'K-T$D)DB2.T1JM*#M-.[B3HD:4.2IQ]N4IU"B5,X=
M&0O;W*)_C3=@//JI8ORGT^V!^$GA<"/,G6]G964!XO+F"Q$TUH@(L`<!#9^D
M^L>@2(+C")<A#:D+]PQOQ?-=:\2+S!L5MK2;<TS4*M.Z#*<%SNA`I'.QT'88
MQ/*5P9&F17*@;N+-?C2'&X+33Y=J(ZK:5Z4_\@[LF`N=P\0[!2-,=!Y_=!5=
MY3SJQ<Z&#K+&L%9(1:1,;K5>MP@+(<LT&2<*5Z"-%N;>2^\582OWP5K?5(UH
M8]$\Y+SG@/1K)UTJ$H26=(,G:U/*MV:TNQ#<.U1+BQ8T01<I0S0.+(?N)A'Q
MMM[TE4K:F5Z;;C^P3<0YP5NX3T*R;X<$K5ML$!WH_1;&7EL%$2ZM6[4%<%6X
MVB24C6>0ZJOWA=W?TW!C:D17-29<>2S'TKV8,8Q1\=T7QFID`M5X]=Z.14-N
M;MH6V2'V^QG;$_S#=AK,NW0B!8I**&*G0H/(Y<'VNN:2N,/92RQ(W+C[E"I<
M5AH'BG2A[50:J=O+5Y7/`[!"!5)MHGA9%"Z`5D5SEU2-?`7B[-?CMHA+C55C
M?U,N%-;4ZER,A;CJQ')'EO>*-M)UVI;Y5<KB37:?X/2[!%$N%+`D^BU0]RBW
M.6J%/LXE\B.%"Z3(%$Y<2/,B1R$?W17%S&EK;+W1BS_097CFN--Y+T2A]&D!
M>*F#$A$].BDJ,[7=T>N6+H%[D$:\<T4D4ZNANF0XA5Z4VW*2[*3J.T[KU5HF
M.<=7OS#)@,!@,!@,!@,!@,!@>5_)L1Q4RU2(_7DE)+\1VUFJL,B/EV!I'=:"
MMV<\@PY!A$([$=B(%9<^5#?XBAO3B8WN:7*0LU%]%$`S?B!2R!!^.1Z61EP4
MB409,D;U`^/36*.1C&(7Y0F-B-P)M(H[OCBXEU]C:M::$N;=4ZJ<VN47NE.K
M@'\4.2R38&VNG0<(F`KEFLQIW\[3:N("O&VB55E&K3%CR0P=PT<Y3MN(TI]+
MTEV+MKV[W(1IPD3NG%!JL8\/I1J'+!6&\2)DVT5]N6\MBUQ0,,RY(C1@]6/$
M/PN)6X\D6[PY$Q]"WMSW$"$.2'GD/,I>+/*G5#C?#>>2>'CYO1VBE_/Z+S=/
M#^A#IK,6T/QH%;.F)CP:,^*KA0OU\;)$%)CFI#DMZ,OZC?T+Z8\.YD:/U;AM
M#Z,,32"]OV(,G2<+IEFG%=S&"UUGZNT]16]190F7/<<'R6%2OG@.Q(#;)=MU
MW2&(6FVZE3,8K#EA.&<BJ+GDO6QUGM*A[,E?-A6[`_$7->NYDR.#T6C1+5-#
M"!HNZ6R[.[B?6.(CI5*9<^5$2.QIH8S-2@(*5Q3HMYMQ>NB;;(A1ZH[VVJV"
M'=9#(AG15'%.U$Y]3$*8>;!/7LR9&/$O>J0TMR&[[4(3)=2IU,:Q1)3OAT=$
MU>Z3J[:AMAAT0.-F!2P:S+D@*X1I?.P57"7&:=`S&:N+.-L5YL65WJ&^[,7\
M[;R?\L]A<?1-+/Y">-QN/3QM^A6(/71-$EN"S4E%E;&.S$.PA=EJ@::S`9:N
M<FLHK<W\1E1G'4Q=BW];UZK3[A4]':H%"\7^CG'JS3#732#_`.$/+:3*+7<0
M)E\VIUC13(M2#OF(T%J=S9FP4]+$=,3WZE?AVG%2%M/:5()-QFBK0'P^Z(T#
MJDPAU.4-937JU4E6$=T,:&17C,>6-I=+"SS`&/#EAY`7H#S@I3FW9\:&KYVY
M+6V$N(+W0SPASBC7<*%8:*?O[\X,L'PX6.JE:+/PX&K!/NG52*;R6L;KR7:]
M.<KJVTS8L-AZ&W\\=$EQN3(1'&-.M;P/C7-Z)T][HA6SW:0:Z%-&R*F^W;&Q
MXBU$ZSR2NO5.FUP5%=<.E;8D6)9?>TXRVZF6K3.O8Y)>63'"G#SSF_B1T<V#
M&TU^\.F6Z@2'BYQ*M$Z_$=:<K,S9>#(:.TT>"=M<"G=A]D^&['][S4MM<QIZ
M5$TXP69W0DE.K''J;U2[>.=-YL<=B7L';0]X,FW))4`R(9HU2.EV56!J._:9
M\FVS.FL[E,$"K&UOZD/,N)6IM+@QKDP=0Y_X^:"])(=%NIWIEHYQU:M';\7E
M[MNIK5K'DG$4:N#A+),Z4L8TBX7V-:@[>F*+;=W'=:]%(923'HE%4L?B_P`W
MJ4?CPABX#1;MLJ;(<#JE6=LM,M@0_0XPNHCIX6NL/GBE#)/!8Q/3SLI^$S[M
M3)"D,25-#NG%$ZV7\/F"PFQ12_0I4Z.NLV8,@_"Z.ANIT6*?KEPIEDV.GBXN
M@')V3):!N+/E(U'5I];;KBM,R/A&+.6Z_>-YDQ#MSB^J3K+TF!4+I5A0$39H
M!U]@A<^7TX3<P%<)QX$H:O4RNUJ8]N4TA#@V(E]#2_>\EP1;I\ZL7B;S4F8-
M5-LY#)W,>(J\I@+7[786#5F*Q*0%W6ZQ9T5ID].NDP=-`JFPX\IM+:-ZDJ:;
M6S+=:$\IS9>G5CQ>XLWRV_5\A;TQ"`BQ7"KR-1;`01%`3:]3*?:+G<H\$*S.
M$`0870:(042VU#8E+;E2FE3D[E($W+"G*GXK?E*%T\^YU&=4^KV.Q$94!(SH
M#+-\1"A%[E*F&*4%"0I4>I!PE2G%6']18;4MO:Y#BY4B6E3PQR=DGTKQMH[=
M@?U9>K7JYT9<JPR)(-NR7&\2453F%Z9C&6"`^)H2J&W1BI6*S+FN,-O2--_*
MM3^VEJ%2[?3^B^,16R2[S>+CT2I6JN^E9K9IF/<*M.`R@<JY0+KKGZMBFHLZ
M5%;@%HEB>:U+2EB'[-;UZ-;6(O)#%S_$8=6R`BDUFZG1LV=7AGX0'B7V$J2%
ML-[M7CJV6JOU\74LV/BD>H'&HJH:7D2OA2YIW2?IGE%[NJ?DK;XV=*M-+0;,
M6TQ-0Q0J^F2S#N:@EG$2"U&.T"+UU;=>AAHKCW1;'`1&C2E-J40D+:<W\+LM
MA)*F'Z;YYXN>/)((/DCK1`+S:E$CP7M3+R=BLA*Y'.\Y9*V.P)21@!72LKM"
M1TJ?-=;=FNNPW'MK0/2Y'%S*LJ%9O"VMBC5C%39%4FBQZ#%C@M(2152I-]$'
M`=N2T46(6Y8XPHL>)Z(-R5$&(Y%+FVF$Z]K>RSR3?<SQ(O(SCO#7++8'8`IT
MR&HH-Z4=@3IZTHM%+3^*EW(K9N`P3?#%XT1C3T)E_P"F>C+9^!.H^1.Z+EUK
MF/\`%8O9K'LHU<R#UFM=TKUFK0-=W?>O?0*F::AJBQJL,@O33)"I$ND39$)Y
MIR,F-I*9*4OQV&'XXBRIT+Q;Z\R8'5LYU$F2-UBPFBEPG3^@5HK<*Y8(S\V^
M0&[`2&#&GV7V.KQD%8L1MEV$J7$0TEER,G3-)F82=T)XX>1]L*V)<&P2K=+Y
MM&@$9(X(:AQ#82N;^NTW5S9JMQM%Y]-G7_X'?H%,ID)*:C3&I#*E,(&,8*LH
M1#@53Y12[H#KUR#O'B%0+M<CD6*P,QQ]OM]5J,!XZ0>(@X#4:SQN7]7'N34M
M)9@NZ]&V6U/-_+A<9FGO[F3PR3S;GT@+`>%!GZ14WA(R1*5.?'#'0,!<"`_-
M7K2YCT.*I#:G=ZUMQ2=JW^[AF<VD_P#O'O\`PVO]ZSP^_E]IN26_B_+TEOGR
MN9@,!@,#0KP__N,?.?\`Y<GB_P#RE6+)U=)_5'G+?5E<U$>05EYI5JB%(=4`
MSS0!=K@L"'QJ5(GBKBD88E578^?'(BB(PS9"<9(,<N,\AR21*L1%;TW)7O"Q
M=X/-0+I_B_`2?DJX]+KZ9]#-].9W.@5V7HSSE:B[R'X.F;-.9`1"D\%.^G!.
M;A[BO:6M4=C;R]J+4NWW8!1>272'8JMR>OW>Y];GI>WNP3F-A`)&#<>=5G9:
M&`DS0XN6\J1?),Z0O<IF:Z[MUE#R6I"T:+%S@[]V,^.E5MD3B*.2';%<!K[8
MJL58;,9@LPAMG;J=I#SPQLU;A46K5F48K/L$+2[&1$*U:2W";:=CL[<)'*<>
MB0IZ1XW=MJP,H>JI"Q5FO4#H]W%0[/$>G(@UNBC*J)L4]T%LQ,<F'-B[RRB!
M(<:>E(]7]M/-K7K;@QC!"J'VOFLVP7:H&..EQC)"7S+F=H00+UVU:_(?0QE3
M$\TU?%.W4ZFUR#]FZ5,A.ZA?B$B(/VG<W:4:1[A,2F`3JW*>9V>74:5R"RQS
M\ZP6&A5B7'DU9$CH1FKFW95P:V>.W#<V,P)(%5R/JCCL9<SU4ACY%Z;;4*F4
M-#G>/WFA$>IA_'>-,'HMG.>)UR*]8`PI\K0.AZYO51MK;9^N:A5I\=7;XPTI
MA7M*_!`0PE_2/BVV,8G-7T;NOBJU>+0+1RR$\"+4WKQJSEU"OQC9T!5:\)NY
MLD$GR";@@E3;#0.FS)\6%#WN3.D37U1([C?U4A):FEEWZZ\%-\4YO<+_`$6^
M,U2H7,YL%03KTW5E(N0JA<@ED(_&3)OE+K6HM(,DYCBV)CC,F'[OF7MC3J,)
M%W4,)8[WP^4Y5;,4X%'C\_*52R6$7=)+E?DL/59?4*C57U+H0$ZHA)T9F]H)
MS(?U+?U0A<F1_DZ'I+S&%J=<61YITSC(7I9F37^56\%8+D)YI2;)$U%YVV`H
M5).V*"2YQ`86!/*^O&V6U>1*I[S,19!V']>\E6FF(L=M1*FG)?.E^,XTJ;H$
MWCI0V:Y_+(.FQHH>!$R*DQ2*V-+-%V#$JSAE#YKG-.4BR@MN.^B9)&18>DZ1
M^OIL5.;.03GC#(K-GNH+F4QR'1^?LVIT:*BM"YA&JEI=CY!&KL85NPP(*XQ>
M/Q9,=8^=\$%:(T5Q[6GVU[:&.2$67J/C3N80/WSA$\;9H19`F2((M54@4.0(
MAN^<P/'XXX#:24`^/IA*EF8RG9&M+B#Y"7V]MMS%ZW%J>DII)Z%X]%^3&R<?
MF%C/T\SV`=&L4'6HNC:NH!Q(JWV&PSBL^U,$4&.2KKFX4QUJ7N9!(`%082'-
MQF494J;\5?4;L7`*T!ZK;PG)KU'!6VI\^?OH\I7JV&C1*!,$-<PXQ5P8A$D<
M]8ZR:;2_#9>C(G-077I*)DIM+:&TEF)+?W#Q:F"C$OI''S[&X*S9>`'F4W\,
ML[C;E."FNCQ]1]G(I)UP>'+Q_P`75Z,1I8LG&1M+[#Z]KA$3T6S'Z3R7G\.H
M]%$\PNE8F'*[U:P%Z_'9C5C\&J]//U<?T:X6``4-B1UDD#YOT*Q2HS<PC,@3
M''(#>VGWO=4J<E5A.S<"YV;J]DA<D>YS5(<(I=B-DG[@:(5ZNV&#5ZM5;8E(
MFT$H@^DRX!1R')'/[TH8W'B[1$;0A&TEJ96]8G_'H]=>9\QL_*V5GNF"]&F(
M4B!$:(U.2:$],OC86YH'$?K`Z;,PBVH>:^1R*1>5,CJT^TM[VDQSM1<?O_.^
MF7$'6[WPR#.Z&8%]&JHJN!;'$:EGJ@!Z'($<YFLS2DJI@9%:,A(!<BVY/>0J
MOV(5+BPO=)^-]XM5&$X,K2^E\0-&ZJX"X;,1,-EXXCD#.BXYPQ8&@T6C]4'V
M&,3)VB%"HCDW5H=(%(TA7UI:7%VI]R4^XAITDQ.J[.=RN$>3TFRW!'+RB]QS
M(][\<MH2<,@W!F-'D!8\Z`M$O<`O">B!$QB4%S2OD8CPT3FE)1&2@F,/7F$,
M!@,!@,!@,!@,!@,#SUWJ3RJ4FIUKI]9-7&-,</VJ.$'2Y3(L>'I4*),LMSLD
M3\P`1I$74F24=Q+:]39J9#S:H<9Q[7JDL7G#R!6C7CQ!O-S*2.;=1L)VWCP8
MW\DJ"@80ND5SHQ2*#K`B''1??P:(]TR7Y,N*7MB3I*$29#DMF"]'D+4:Q2`_
MTGQDZ5:V;B>Y]TJZ;/P:UPT569$&)JLD[B$,269=%?KBK?!&D;767.Q+W(FE
M6UB8:(KSH^;MYEQ2A$3$5#Y-=<\7OIR]4E<YN%EI`V6ABVG%VE!\46(T,Y06
M>:C)\U_H<Y_H(2V'.OQ$C_J7Y`YIW7_F&F4-)4V*E,%E/%:HURL$=\RLVQ%\
MJ3-D+**P3$PC5:(,M7-P+#UQ1:+'LPU7P%C@@8T4?`^OU&C0_=%C_1(<5LG=
M:*6<)XTCN1@51.4WVIC.O<OMYQ!%,)@]9:3S%BHC:-8K+8FSET*M1H\'GE^9
M8CQ&ED)C$1_2&XGRL;906YMF2'=^!O`&J)7.1VGJ4+EQ5<L77/=5#%8'("?D
M>K!C<,U8;F_62`J6,ZO#6':97)]FD.*2Q'7'2I)*G-]B^O>+?.B'T`OE5KJ\
M^W_CP*`+'5IIUTW3BA0H(L)H,(&6.;N-4F9_/%L)@LLLDDM1F-1(&V7&O<*W
M(T=O/`3,JDSAWC_<R!"P?DB<R%).PZ^3M%!FU?<BN&((;=^C"[J(KL/F@9[3
M9/>QXIY+.UJ9)^K.QCJR=5F>*-KN@<</YQ9D3"9<-"`W`=-M(FOUB8>+=,=J
ML$2YJXPC54)6IZD&7""A$%N/*>E;^O<W]9OWB>262.S^.5+,ZM4RFVP,1YS-
MM@2LNRWHNFG1]BO=_#]!M--K4BZK;G,[L=#+ND7DPDF5CVFW&V7(BF_05,X(
MH5ZSXMQ`S[9ODU\!5T8FM10AER&P-;ED-BYH3G<>M$!5ZT=%F28RKN:&2G-0
M50MQFW9#T1Q;"UEK=ZNV^>X'1)_(KB)Y'=U`2U"*6X<8;EV1-IY[%Y]>:.`&
MQ900Y;8S[(N<=ZO*40;@;EJ*K<6ZZU,8=<=PF+M]#M/C18>?W#R`5!*KEDI8
MVOQ[P\M\C9&)U;%1;KO5(%G;@+WISGSK<QQZ&'<CRX)0=/4PUM]EQS98NZ1=
M%ZXGQ3G]6'<VY[;[N0K-1M9V$??(H$$(^ZY1.E2-';!,_&QY.9NV/^+JH#[4
M".\M;.F5*:VAQQ"AC,XK(G^0_":I8K5T`ESV\#+;7DSHW0BB!`J:1K)H@S-K
M0JN%&H-KF1R!6XM\A:BP5#$SHJ?AB_4O1MO>NR5,X(6J[^.//*Y;JV1XW<!H
M"[3YD2UPH*XL]H<3`WT?2:Z`(OO]!>F5$HU?K+$AB7QZXXA@@[MV)+;3'>>9
M&.;MT&W^/EIZ,),5[FMIB#(]4OE\G=!O<FR_(*L?--<9FG4P`1FQEB[-KTFP
M05')[L&.\5DC$[V_/TA2]";I1RR?(ZX&J%;YSP>V6N=7*-#>*3+_`&'35@E1
MX[GCP'YR*L/Q].C0S=+-#[Z',K"+6Z(BZ%[C?11)6]_"7'K*U)5V\51PS\[S
M.76N9N/,`\J:+511-EJ3;`-*%6J)6:X+<O`XLW:*SSZBP)2B2(S3JVA[,6/,
MD2DHC[)4O07)^><&O41GHE3YD1"1AEH(#P"[!LH.9?)T&P"@WYQ"UA9^9&%R
M91.AQ&=3I$2&7F1A[:)*=L;2E9)F5H%N)\N-C*P&(U..Z*I\60.`P6"!F`PP
M(FOCI1`#.3`(QMFZV3DB(CDL;.W)@2UQ6MO-+VVCT%RQ]PX1SV[!Z#62T"='
MJ_.YTJ6%`""Y41&?CRZ98Z(X)GS1LR*6>$K!6>2VZQJ1I$E._C>TXTI:%"Y=
M07XW\1"Z-I%T`;#;L(TZ&)L(G&EQMAK+HW^-!X$9TFN.&$S-V2>K4:&F.PTN
M6XIM*%*]<%R[Y#@G)BC8O4VIZ<DA)LPD)*MG+)&/P")(H1-$R$>QQ3#)Y$XJ
M1,2URGOJ?DE)E/-N[6VXM"A<NT]Q#EL@I63#]38>FTR1+FU73I(TN""GS[0S
M<IQ(<*42V+8*3;)&;D.ROA^H<TA+2E[9UIO!<H4YXL\A_,K5E@B"(9Z*$C"H
M$`*;*CAL2=`FC"`NQJAM2_IR1P++`CWH*IJ9+,*5`8D,MH?1\FQRE(+%P/G]
MNL%-/6E@Q8?R/4WZD+&E#I9^"1B.FJF?1-LZ43&W;7,9*4N"_K1%4EE4AOYE
M(V]I*]"V,F>+G")X^0(DT%A0F3.<)+%-'[5&&-39`$G6"+T,?&.LQ(&C@(U+
MCDD,(;033)<W+T\I6U8+E)`7#.7UJWR+\$KC\*Y3I<Z:5L/YCM,DB=?GMZ97
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M,!@,#0KP_P#[C'SG_P"7)XO_`,I5BR=72?U1YRWU97-%+=3`5XB"!]C8=F#@
MUIK5P9@:>VW$EFJ<7C6*M.$&M:W]5'$60?$(--[WK7U<-E>_72=IV&+=Y1RY
M],A#_-J"^B6>W:I2'J?7G42;.I#K2K&^E8Y273JFY#B=RU>LC>G%:]_ZV_4M
MRD:ZQ6G4Q$.5X&X@>Y(=@(6)@+3"=ESF"DIV(E4?>HSDDE%:D.*1[=K?;2YO
MU6G6]$18AR>@&CULL5BK0NT3KH(JU?.,6:#".#70-,F%RE=#LC2$9Z(W!'FC
M\Z<E.TJ5]7*6YZ^ND:26Y9T=1Z6(*SSHFH5<6;*0F!I,P.`"H14B.C,18L:!
M/(1HC4N7"CQH+#:&G%J0EMEM.M:TA.M$8@9RCEH5X3(#\VH(F0`FRR0)\93J
M]`>"D2#49B?/$N11S2QTR:Q#90ZZSM"W$M(TK>](3Z"Y90Q0Z/88DH>?IM4-
MP)JY#DR$7KP@E$EN3)L0G+<DQYD-YI]<HE`8D.;5K>UOLMN;]5H3O0MR+I5-
M<B%1[E3K2X!U\?*-PE`A:HAB2)CCX@J24C;B_#/D#(HF*W'6[I:F6XK*4;UI
MM&DACH/,N;C&5QQO/Z3`8<E_7K9A54%&:7.TIA>IBFV8"$JE)5%:WIS>O=KX
MT>F_U4^A;E].<TYR\#&5AZ@TMZMA92IH>ONU8&Z$$S%_4:7+&BEP508,A6I;
MNMK:;0K>G5Z]?16_47+ZC\WYY$E:G1:)3HTW18@>U+8K(5J2DV6?@2BIA+[<
M)+B29.4+C.R'];^5YV.TM:E*0G>B7+F#\_H==BMP0%)J0.$R^F4S$$5P.-C-
M24$8A=#[3$.&RTV\@K`8DI5K6MI?8;<U^LA.]"Y8#7'>;OS+9/,5(+9I=UM0
MZY'W+2,'G]/G0H2%6P3[#1&*\S%0#!P$1XFD)UME"G-ZWM3CFU%N4CAT2D#G
M+`Z/IU6@NVU_4JU.1*^)C+LLG3TF1J0?4S$0HP]J1,><]TCY%?(\M7KZK5O9
M+<)3GE`.+8<-4>GEW(LK<Z,LI6@L]<>:J60(*F,JE0G=M2MSR\M_;B?1?S27
M5^ON<7O8N7#5.>5.G`(E<%"V7H,4X>M.W2:&B,V3:;2;+V.QV65)?;WM9LT<
M/S9+[Z=)5M<E>M>B=^W"VZ>N1\I3&APT\SH&H@Z(7'P(NJ=7OIH4"P:WH[`B
M,?AWQ1X)G6_\J91K3<C]'O2KTU@N633SVA(89BII%1U&CP9XMAC\MA_A9&E1
M<$&4'MM_1^U$(D%%QHDAK6O8]%CM-+TI#:4Z(_'N>T&2.`")-(J,@35)3$ZK
MC)%<#OP*Y.B[VJ--!1'8:V!,MA2M[0ZPEM:=[]=;P7+$VWDW/[J"DUHW61>P
M\Z.-'$8L&##@_B((=/AD-5F8['CI=<KDY4%#4F)I26GF-J;WZ:W@M)I%3JTN
MP0K;*K0"3:AL94,=99`<>\?@1%HEMJBPC#D=1"+'4W/?3[$.)3[7W->GHM7J
M&()\SYN:95',<_I!5A<%P8MDE5`4YI0UXNW8'1ZFY,!U.X+IYI,Y37I\>YB=
M/;U\FM*P7+]G<TYR41/;)4"ESVRNX*B:)E6!R4D5C&QC0U<W3T%>I2QS02$E
MA2_=ME,-C2/333?M+<LD)IM0`R'Y8.JUP-+DSIY21)%!!@^0^2*I924(.O1(
MS+BYI+4=OZAW>_>][->_>_36$23`8#`8#`8#`8#`8#`8$:L5-JEN6'<L]=#G
MG*\4:-`W2D"/,=$E64*;3.'NO(4Y%>4RM3:]HWK3C:MH7I2=[UL(`0\?>-3Z
MR]4$<[JPROR200G+@!@P\8B6X`M%>M\*))7&C(6Z/67JL#WL[W[-L1FVT^U+
M;>DEN<V<'<=Y0()1BXOG%*'E(4(0.ASH=:$QY,6&`?&20K,=QN*G;.QKX6$I
MI2?1:?HH_P"GT8:]@N731PWC;<1V`WS"C-0GGI[[D9JM"FVEN$X4<=,]4HC)
M]$.0(;#*4:_4;;CLI1I.F6O8+EG"?,^>FDU=)FF5LO\`DK;6ZFHH)AD'`'P[
MAJ:T-=EM/.,)2Z.C.^FM^FWHS+F_\8TVI(N6(L/&N:6HG121^HAB:>;02`^F
M"Y,&*X$",D%UY6U112F=Q4+A)K$5$;TUI+*$J3K7IO\`0+ER0>-<F&0"HL=S
M>E0AYR)+@&(L6N"F6B,&:D<B1"E:;C)V[$VV'AI0WO?L;1$82C24LMZ2+EWY
M/+^<RUBG)%(K"G@;\&2&D)#PFI(Q\9(*RX*X,EEIM^-]/).SEZTE6D[W,?\`
M76_E7[A<OIKF'.F"<,RU1ZL@H.%PP@R=^"#]OBP\",J%$&"U*8WH9!:B*^+X
MF--H4VE*5:WI*=:)<L"*X=RD)>-=$%TBOP[2R&%@QTY@7!:0%A"9%ID,J"LM
M1T)&RI"[D02\ZWZ+<0^I/KK2E^XMS5,J8Y'RVP;C[-\\II7<5]^2QN=7!4C;
M;LN88(3-ZVY%WO;<V=8)SSZ-^J'G)CREZ5MQ?J+EVIO,><D8+HR?1:G+'O,M
MQW8;X`8N.IEF$0',(^/<;VZ^""5DM-[UZ;;1(<TGT]V_47+C)\NYV9W5'"M,
MK9*11$Z33)9`1!GRZQK3PN3K\&DS69#L37U@.$_M.M[2I^$PXK6ULMJ22Y8`
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M.LTD-JO2+!&#06S+X33`F,L8\1^'<MV(_'`P$.I4O?S)@Q].>[3#7M)<N$+R
M;F%<A:'`>?4X1!2Y)=3$'UT7&9TN7*!S9&](;C)UI*I-8&*TG_W4:'14IUI,
M=G2"W+I2^*\DFR'Y4CG-/5)E(&H??;!P8[KB@ZU+%/\`OCM-;3+'Z5M#3^O1
MY#6]MZ5\?ZN"Y3857@0-<EP,''"E2_7ZK8^&Q$T_O<XD45MU+"$)6I9(Q*?5
MO>O53TAQ>_52][V1F,!@,!@,!@,!@,!@,!@,!@:&/[Q[_P`-K_>L\/OY?:;D
MET^+\O26^?*YF`P&`P-"O#_^XQ\Y_P#ER>+_`/*58LG5TG]4><M]65S0FWW%
MVL2:Z.A5LO9RMEG3H<"`)DA(>VDCADDK+E2I)XJ)BH90S&]NDH6MQ2UZ]$^W
M2E:+3$?G2[?Q/6W_`%DYQ^V.`_.EV_B>MO\`K)SC]L<!^=+M_$];?]9.<?MC
M@/SI=OXGK;_K)SC]L<!^=+M_$];?]9.<?MC@/SI=OXGK;_K)SC]L<!^=+M_$
M];?]9.<?MC@/SI=OXGK;_K)SC]L<!^=+M_$];?\`63G'[8X#\Z7;^)ZV_P"L
MG./VQP'YTNW\3UM_UDYQ^V.`_.EV_B>MO^LG./VQP'YTNW\3UM_UDYQ^V.`_
M.EV_B>MO^LG./VQP'YTNW\3UM_UDYQ^V.`_.EV_B>MO^LG./VQP'YTNW\3UM
M_P!9.<?MC@/SI=OXGK;_`*R<X_;'`Q+'3[/)-DZ^UR"X[)"!P<K,3NP<WTSJ
M(=?,QH&VW=73>U.[=`R/>G:4^W6D[_3[OT"F6_.EV_B>MO\`K)SC]L<!^=+M
M_$];?]9.<?MC@/SI=OXGK;_K)SC]L<#'&>DVH"(*G"/(+BD>&&SBLY3-@YPZ
MZF&.BNS).VF_SFCY'-,LJ]J?77KO]'KK!2T1LYDH.@$XVG-1R,*+.CZ=3I#N
MF9;#<AK3B=*7I+FD.:]=:WO6M_X<([N`P&`P&`P&`P&`P&!7MGO<@%9`]4%5
M$[:S)<(:L.FQ4RNP(\(8#G@QLA<J18#0G2WGY1]G3:&M.?JI7M6T^B?<5U/S
MI=OXGK;_`*R<X_;'`?G2[?Q/6W_63G'[8X#\Z7;^)ZV_ZR<X_;'`?G2[?Q/6
MW_63G'[8X#\Z7;^)ZV_ZR<X_;'`?G2[?Q/6W_63G'[8X#\Z7;^)ZV_ZR<X_;
M'`?G2[?Q/6W_`%DYQ^V.`_.EV_B>MO\`K)SC]L<!^=+M_$];?]9.<?MC@/SI
M=OXGK;_K)SC]L<!^=+M_$];?]9.<?MC@/SI=OXGK;_K)SC]L<!^=+M_$];?]
M9.<?MC@/SI=OXGK;_K)SC]L<!^=+M_$];?\`63G'[8X#\Z7;^)ZV_P"LG./V
MQP'YTNW\3UM_UDYQ^V.!AA?4K,7G6,=#Y!<MR:L8C@RVG3_-VT)GR:^#LS6H
MZM716WF=B[#&WM>])_QFU)]/U?78IF?SI=OXGK;_`*R<X_;'`?G2[?Q/6W_6
M3G'[8X#\Z7;^)ZV_ZR<X_;'`QI?IMAK\!XN<Y3;X(F(N-]?-2<Y]+W$CR)3$
M54G<:/;UR'T,;?TM2&TJ<4G6])2I7IK8I;^$,!@,!@,!@,!@,!@:&/[Q[_PV
MO]ZSP^_E]IN273XOR]);Y\KF8#`8#`T*\/\`^XQ\Y_\`ER>+_P#*58LG5TG]
M4><M]65S5A;_`/YA<C__`"I<?_M.(X6,I6?A#`8#`8#`8#`8#`8#`8#`8#`8
M#`K4+_\`-GH'_P!A/,?_`*;=-PO196$,!@03J/\`\LNB_P#V"6[_`.U\AA8S
M9>F__6A5?_L;!_\`TLBX1),!@,!@,!@,!@,!@,"I)_\`\]JI_P#<DZ!_]N/,
M\+T6WA#`8#`8#`8#`8#`8#`8#`8#`8#`JR@?_7AW#_[I87^1KE&%6GA#`8%7
M]H_^6-L__%(?_P!-8&%C-:&$,!@,!@,!@,!@,!@:&/[Q[_PVO]ZSP^_E]IN2
M73XOR]);Y\KF8#`8#`T*\/\`^XQ\Y_\`ER>+_P#*58LG5TG]4><M]65S5A;_
M`/YA<C__`"I<?_M.(X6,I6?A#`8#`8#`8#`8#`8#`8#`8#`8#`K4+_\`-GH'
M_P!A/,?_`*;=-PO196$,!@03J/\`\LNB_P#V"6[_`.U\AA8S9>F__6A5?_L;
M!_\`TLBX1),!@,!@,!@,!@,!@,"I)_\`\]JI_P#<DZ!_]N/,\+T6WA#`8#`8
M#`8#`8#`8#`8#`8#`8#`JR@?_7AW#_[I87^1KE&%6GA#`8%7]H_^6-L__%(?
M_P!-8&%C-:&$,!@,!@,!@,!@,!@:&/[Q[_PVO]ZSP^_E]IN273XOR]);Y\KF
M8#`8#`T*\/\`^XQ\Y_\`ER>+_P#*58LG5TG]4><M]65S>*/.(9>GJ)0#/..Z
MW/QYM(CI8V&Q?Z?0.1W]/T5D!'PD@/9F>WI_(%:KTZ1(95LG(<:>3-;CQ65;
M<E:;6:V^+P_/K_DX)F/0"OWFNGPID>64'O(:\(?&<M$;)"GR3;H518+R>>'_
M`#(^P*=D-"M/[(N,;2M#*DJ3M4Q:P_K[AJN>4P1D,MW[Q'9I\JP,#)042+\#
M/'*:9(,$;P*YT_MD9KDB)290&UF68Y2*M*9@W7O5(:;TC>,4PT]W=-5+R:KZ
M!SI;[U'0([10.NPPG&O"OQ@FMJ!HAR9OXJ^N!RN2F%!6U%VA#C^VTN2%M,)]
M7GFFUL=5P_K[H]=`?F)4:]7[C%^[3U2TU&P`CIQDZ.\4O"<!'AZ!WSG_`#9V
M`17=*;78`F0BU]#CM3%D),%L8W#E;D;2MO3>V)'&>GO+"P5>7A*J5.VQ?NI]
MV8AW+IL7E`N(=\1O`VJ/,V651I/0TOS)]D'C@7X8H!$6B.MF6\[/E;;3$0\V
MZVZH8:?Y=XM"\P!4RYP-?=7[M*>I%]`T$C)7X<^$0<),?/K,CF;3&L9VOC@D
M"EPK;6"U>?G$'H>]GQ;T-MM>W(RWV)AI[RRL.L>:4^F=5O43[J7;Y0GD5HLU
M3L,(?XE>"1@Y*(5*RD*J9D)$B!$Y^N06"`MY_P!YO\,VV.UJ6YI#.EJ0Q.W3
MWEB7!_F1HA,&1_NJ]EE2`T(:8M$[?B]]OP=5JQ7BH*@GH=CGW<Q&'U*:)EM]
M$B18FXDM]R=*CR?A3MAO3ZF.IVZ?Y=VK!O,2XZLK(/[JOD"^5JL7M$LF`=\)
M_#)DTXUQ*R!*X6W!B[K&VI2+MNQ0YM<=TYIF=#<WMY<9YMUE`[8Z>\L,MWRP
M5)GQ1_W7>_&7(ENJ-3A+&>%GA7\!]%R!CBH^U@Y$VNPV9%/@E2.PDR6[ME;!
MJ.\Q\:D)2ZL8:>\L9HMY9#VG$W/[JW<>>E5_CFA("T>*'@&X5LKE>Z8[R0E&
MK:0D0I&*3$7%A:$,I<TXJ/[7/37O0G;$J-/\L_SF-Y;].L+%6!?==[\/,R[.
M(K,&,>\*/#*$F?HSRLCUF/8H+L>L3$2JY&%")0R2ZCU?CF6OA6UIEQF0X)J.
MGO+!5"9YE]!FS`U$^YMY%6RRQ;*6K:*V)\2/M^KF2-@4&W31-\F\AH`":&(#
M)2]")RX9-ITA"2N,E,E*],3MCI_EV4O>8,U)%H']TWOY4D*H=5ZG-&R/#'PR
M#[9YQ<W!D:NVMR5)IS[:&3)1XD-B1=I^K<*@"3#K;#<?<C&)VZ>[UC_-$^X+
M_P"K;TW^I]XA?L!C%+VZ>Y_-$^X+_P"K;TW^I]XA?L!C$O;I[G\T3[@O_JV]
M-_J?>(7[`8Q+VZ>Y_-$^X+_ZMO3?ZGWB%^P&,2]NGN\^7[D7FMRR]S4$/N?]
M^*2YM*!V"Y6H'X?^$L@)5*6+M$T"/*&(!,&.,/QAQ"PRY$K8R%,>;B)4XM*O
M:A.%B=L]/>7Z3">3P@].KT_[R'7F9@A5FCG)&_!/QMW!!$JM/HXV2%*2/X)_
M5DT9F=%$($QD)6X65*3J+IU6TZ4Q,/Z^ZY*OXU^<UTKP>UU;[P/0S==/P&"8
M<K"\0/$14:;"DH][3R-+Y\AUM7^!2%I2XVO6TJ3I6MZTQ2]O]?=GOYHGW!?_
M`%;>F_U/O$+]@,8E[=/=T2?ACY[FAL\.4^[-TZ4,*PI0TE&3XB>(\=4D?.87
M%FQTOLT)#S"GXSJDZ6C>EH]?5.];UK!RVZ>[9X-@LBQT`9'VK;`Z%%@L[7OU
M7MF(PW';VO?^%6T-Z]?_`&Y6'=P&`P&`P&`P&`P&`P/`7FA5^HE;=PF=R3R9
MOGC-9#)2S\Z?/U7EO#^B@[%'M"ZR6B#[+.[HPZ$KTF%*K6UCF!VU%"SSJV&F
MG=H]$FMM=8MX[;%>2KBH;/\`;-=6<F3XD&1!B#_!;QS.?B4B<NJ,?A`&8%X_
M.A68Y#E7@4S)ACUR94=R:WIUM'Z?28ZM8?U]W9*UWRB%3P@S?WC^N$I9]%3E
MP4AO!?QH)LZ!W47*,`;4]*C<J5&U578,16WYZ5K8B+4A#^VUK2G;$P_K[NX<
MJODU7)?T);[TG1FI?X?!*?#%\)/&<FKZ0JBJ+$:VH7R>8C4LS^>!28<?U^HE
MN2TH90M:'-(8ZF']?=RF:#YBB(XXDU]W;JQNO$JYSZUHLP;Q`\-'0K`'J5T$
MTBC%'I4NF0T;'F)I%^8IY.]I9@#WW%?K?&A;%.W3W8E(;R86TT^U]YGJKK;R
M4;:CM>#'C<Z;>5)B#"0W46IM\C7:YD<P&+,SHDEJ$N-(A;^9MQ3?ZVF*X?U]
MW:U2_,N962EFKWW7^[69$+H@[EPH5`\(_$47/MMN+[#K&HJ\FRT8(((`94,T
MW*T55)0/U%;=<^7>F]ZVQ.W3W=$2%\I9C;[![[QG3Z-88%BL=2,U&U^'/A^V
M>"6*J!+/9C(^6X'HI<-+916Z?/G,2XDI^')8:UIIQ3JTM;8ZF']?=RZ%>1.F
M(<I[[U_0(3!">Q`A.$_"7QH%:DZD..LMEFDD>315*K"9#*VEF/3\*:>1MM<A
M*];3CU,/Z^[NA*?Y9VC\*<JWW@NOGH9$O3A,@@UX/^,`J&(WT&+)?I,T@L]R
MT6I<6S.IC(BZ9TXZMLA&D>WZ9S3N*DP_K[KT_FB?<%_]6WIO]3[Q"_8#&*7M
MT]S^:)]P7_U;>F_U/O$+]@,8E[=/<_FB?<%_]6WIO]3[Q"_8#&)>W3W/YHGW
M!?\`U;>F_P!3[Q"_8#&)>W3W/YHGW!?_`%;>F_U/O$+]@,8E[=/<_FB?<%_]
M6WIO]3[Q"_8#&)>W3W/YHGW!?_5MZ;_4^\0OV`QB7MT]S^:)]P7_`-6WIO\`
M4^\0OV`QB7MT]S^:)]P7_P!6WIO]3[Q"_8#&)>W3W>>R''?-:C=-L=2U]SSR
M!4X8.<VEW&\0_#[PGF5099.E-HY_0XLV&\"1:6OQ-VG0X"G(8QZ*S(?84XK6
MG'G&V*WMK+WET%L^1S3\]#_WF.NQX0T>S-E%W_!#QQ:&:ENV$U67*\VXKDFI
M3MJB$*]+<?&I:W+:A,JE*1].E3FF)A_7W>AAOBKY[&!T`N*^[ST0B+*0HI$:
M0A^(GA_(B3H$YAN3#F17VZ"IM^-*CNI6A:=[2I*M;U^C>,4O;I[N[_-$^X+_
M`.K;TW^I]XA?L!C$O;I[N>'X=>;DLB';O'W1>D7:G,G`<ZT4Q_Q5\6*^Q;00
MPO"(DZT^=`TB(<#,'(L545<J&ZW*80[M;2M+UK>/,Y;=&S3*P8#`8#`8#`8#
M`8#`T,?WCW_AM?[UGA]_+[3<DNGQ?EZ2WSY7,P&`P&!_./Y<7FT_;4^[07^X
M9T'CW7>J>(/DYXE5'QXZ+?>*T8IT>P<#Z;RV[S;'72-PJ%?;D&G:1;0I#3:9
MB$?JRMKUKW*:TV['7;'/9Q_\HE9'_4E?;,__`*AY/?U2>[?LAE3ZM_@AM]_O
M"/VK^D5J=4+*3\M]`2J5,%H@7QF\BZ^Z5'/-.QIP>?,#5N%,?$%(CZV9+'OT
MAUM6];_3Z;T/KWQHHIW[S7VC=WP#9(A3RH%5$`[),HY^*\4_)>,+*W!]$^,Q
M9C3JXSPV4^-@$%,QM-#V)+;;;3:I"X[:6-1KAO\`"TD<^]3]F55B(VMH7Y7P
M[`2W)><)0O'#R:BO12,LX-LCQ<?\87281/\`&`L-Y#C>M):W'3I"4Z6[\E3A
MO\#7WJ/LQ+A'A\L3Y7$H=B#RJ[-8*^.7D\2;BUY^3'F1P8=$P0Z@*,$2HC3D
M%N+IKZ-QM*F]I5KUP</D\&;)_?6^TP6518\PAY7O!:*'(AHP)WQ/[@Y$+M3+
M11+I$EE97Y*225-&6CG0Z4A33S2'O\:A]#K;FTZ'U[_!U2?WQ_M&D['/M/XU
MYKC2T^YQ.@^H;A/E(*A0;A&JTFE/FA8Z&';@CG2M5F.PIC;2$L26E[VM&U_K
M8/KW^'LQ+_WH/LK[@SH`NL^35729`S*O9YE/\7?(RJ%KI7B9#90L+O!@'7H1
M.X(+37I#DAX@[(E+5,E*T[I4E[:QP^1,Z]]^K[4-3`6FL5H[YG!0MJ(E2CD2
M%X^>3*-UZ8:)SS1-5-?6!<?JC,HJ3>?VU#4TUI:_32=)UI.A]>_P0%?WEOLM
M)"J`CQ?EN#@R!Y`*24`\?/*4/--U\P"KM<.5T\0AC&YA@&<%U6#J5'D+6E;[
M2I&O:^XZXN'#Y/#V3JL_?9^SW3K?%O=;#^38NTPZM8J4T3:\7/(YW2ZS:;IO
MH1<9)A2`+T"7I5M<<E,.NM+>BZ><:96AEQ;>Z?7O\$4#?>D^RO7VP#0BK^3T
M-%8KVZJ$UKQI\G7OI`6^C#>LZA*^H%._5;1?1+$Y#KOO>1K2F$KU'<6TJ'#Y
M/!*'/OK_`&>W623#@GR>4T7AE8!!/\U[R.U\\0W>YW2B;7KH![F_J;H2>F>J
M=I4GW_&G>FM:1JGU[_!BP/WO/LT5DU3+$$K_`).P37/C)P]4R"/&+R5<>&$+
M)1X7.C?OTZ$6T0AD*F,C,*C24O1TO1VY"4:D(2[H</DEA6/O2?9MAZ6\/7YF
MC"R"*YXVR#>'>6,&SU^.X[975`:X>C06R(.K^MR*>@V.M$/2IJE_'\J&EMCA
MO\/9\DOO2_9P>#N#`$;RGJ,M<%@,DX$\5^_NE45IJ'5A*JOM1:JDHLBO)!TT
M=&CQ'FG&(2HK<B.EN2GYMPX;_!Z,_P"I+^V9_G_D]_5)[M^R&5/JWG_4E_;,
M_P`_\GOZI/=OV0P?5O/^I+^V9_G_`)/?U2>[?LA@^K>?]27]LS_/_)[^J3W;
M]D,'U;U57/[\7VC+_9A5KM.O+*>0%CXXI4-CQL\EAH$P-AFXMC@0++7QH.((
MLD*"<AHD-LS67VO=ZZ4E2%;3LOU[XT]E=L_>.^RG&$R0C`7RO;@2Y3LN0W_-
MR\G'%N.^VH?0>]QX,XI>@LGGX23#VKU4S+&-/^NW=NK<'#?X/0H3^\9_:^KX
M<8#&S/*!N`)@QA\-"_$ONRW-,16DLM[<7^3]?(ZI*?52OW5*WO?^'"?7O\&4
M_P"I+^V9_G_D]_5)[M^R&#ZMY_U)?VS/\_\`)[^J3W;]D,'U;S_J2_MF?Y_Y
M/?U2>[?LA@^K>?\`4E_;,_S_`,GOZI/=OV0P?5O/^I+^V9_G_D]_5)[M^R&#
MZMY_U)?VS/\`/_)[^J3W;]D,'U;S_J2_MF?Y_P"3W]4GNW[(8/JWG_4E_;,_
MS_R>_JD]V_9#!]6\_P"I+^V9_G_D]_5)[M^R&#ZMY_U)?VS/\_\`)[^J3W;]
MD,'U;S_J2_MF?Y_Y/?U2>[?LA@^K>?\`4E_;,_S_`,GOZI/=OV0P?5O/^I+^
MV9_G_D]_5)[M^R&#ZMY_U)?VS/\`/_)[^J3W;]D,'U;T#OW]X$^U+TP=!#6Z
M;Y:2PL0G$)R`\+QE\C!(PTN"\W*C0[!%&5R(@T+;EL-N[C/^]E2V]>Y.]>NM
MCZ]\:*<KWWH_M)5[I$.\1BWE2D+7QS4>G4B+XJ>2[0<$66_2I1"S2MS(Q**0
M.37Z%`VIQF+"2[KY=R4R77-NY%X;_!DP_P!YW[+8&:^0$!/*N%)?_!4^YOQO
M\FU):8"?0:9B-)<#+UJ)/8'(9EH5[M28ZEM*_P`6K:<'#Y/!]Z^]']F104B%
MD0/+8@V36">D$2WCMY/%S*)-6>K[U8E1RA0/+DQWZ_JJCVXWMWI*68VFU:4A
M;NETX;_!*;+]]C[1=MDAG#F_*V3`$B:^%D!&O%SR`BAK".J)AD_4XMFAQJFU
MLU$KIA#C[$=Q7TZUON?,VZG:=))]>_P8BO?>X^S;69D0D/&^5SY6%Z(CEBWC
MCY/&2:8C(F,`'CW)Q,1*?>'"`4-J)$97M2&&D;WK]=;BUQ9^/?.C+:^^K]H-
M%5*4QAKRQB@21H!9&6HGC9Y*QIP*PU>(!B@359+,@DE*\1'*K41Y*XKS?O?2
MM:]*V\[[Z?7ON\/9&%?>@^RN^Y!D3J[Y2%)\)N"E1,IXV^3Q`F1D0.CL=9_$
M3,V2*6^7*3KXQN7+D2-N.RV'GH;NU0GG(ZAPW^#*SOO=_9LGDZR9=#^4*"U1
M:@Q01!OQ>\B]R(P^#((RM"W/FKCS<D=+?)NJ?:<2K3RM-[5OU:;VD?7O=AC[
MY?VA(MCJ]FC;\LFYE/#U>N@XB_&/R&E#8]?IC>UUL.N',J\A#D0:5;CD$JWO
MYE3XC3NU[]74N#AO\%U_]27]LS_/_)[^J3W;]D,)]6\_ZDO[9G^?^3W]4GNW
M[(8/JWG_`%)?VS/\_P#)[^J3W;]D,'U;S_J2_MF?Y_Y/?U2>[?LA@^K>?]27
M]LS_`#_R>_JD]V_9#!]6\_ZDO[9G^?\`D]_5)[M^R&#ZMY_U)?VS/\_\GOZI
M/=OV0P?5O/\`J2_MF?Y_Y/?U2>[?LA@^K>?]27]LS_/_`">_JD]V_9#!]6]3
M=J^^A]G^[6J=;K0QY9%)Y,6*%DARO'+R=B5H@D$@VV#(3:S`#Q0<LR%389>X
MDMQA3\9U:'6U)>99<;+PWU6'LA;?WD?LL-"(09D5Y8-11\C4Z*M/C?Y*J>;*
MMD72<8QZN@7&MDH3DN4TROV>UN+-D,:3\3RT;'#Y/!Z1C?WD/[8T2.Q%CS/)
MUMB,RU'9;3XD=UTEMEE"6VT:UJH?HTE"=:PGU;W/_P!27]LS_/\`R>_JD]V_
M9#!]6\_ZDO[9G^?^3W]4GNW[(8/JWG_4E_;,_P`_\GOZI/=OV0P?5O/^I+^V
M9_G_`)/?U2>[?LA@^K>?]27]LS_/_)[^J3W;]D,'U;S_`*DO[9G^?^3W]4GN
MW[(8/JWG_4E_;,_S_P`GOZI/=OV0P?5O/^I+^V9_G_D]_5)[M^R&#ZMY_P!2
M7]LS_/\`R>_JD]V_9#!]6\_ZDO[9G^?^3W]4GNW[(8/JWG_4E_;,_P`_\GOZ
MI/=OV0P?5O/^I+^V9_G_`)/?U2>[?LA@^K>?]27]LS_/_)[^J3W;]D,'U;WB
MSS6\VZ_]Z^L<?\&?`SB_D7:X]D\B^']([CW[H_%;GRGD'#^7<HO0V\'"1,]=
MH0MTQ:B2A#;,$<PUM4C:MH1M;JD(R9M;=L_'>[=63^L/*XF`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
DP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g716112pc_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g716112pc_002.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#*@)R`P$1``(1`0,1`?_$`*P``0`"`P$!`0$!````
M```````&!P4("00#`@$*`0$!`0$``````````````````0,"$```!@,```,#
M!@D,``0&`04"`P0%!@<``0@2$PD1%!75%M97EQA5E987UY@961HA(B/45K=X
MN#EY"CHQ03(D424V=C=W,W&1-28G$0$``@$"!`4#!0$!`0$!`0```1$"(1(Q
M05%A@9$B`Q/P<:&QP>$R,]%2\4)R@O_:``P#`0`"$0,1`#\`_P!_&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!\CCB4Q)JA08`D@@HPX\XT6@%E$E
M`V,PPP8MZ"$!8`[WO>_Y-:U@1B"3N%V?#HW85<RI@G$%F#2D?HI+XLZ(WN.R
M)E7%^:B=69V0&GHG!`J+WXBS2AB`+7\NMX.&DI9@,#&KGIG:U+2B<W9M;EC^
MO,:V)(N7)4BEZ<RF]:[&MS20H-+-<EY;6VJ5(B2=#,TG3F&;UX`"WH,E@8U:
M\L[:L:&]Q=FU`OD"P]N84*U<E2K'MP3-RQW4H6A,>:6<Y+$[2W*%0RB0C&!.
M089O6@`$+05^\WA3D=L!35+]:,#9K-25RXV\I@#G*6=%+R:L9W$QH=K"''U"
MLMS^9[:Z%"3GN'E^[%&AV$0];PM35\DSBDJC4[B\;FT,?FF4P^8,+1*(K)F%
M<G=&.11Q_0)W5D?&9R2&&I'!J=FU44>G/*$(LTHP(@[WK>MX3AHBR^WZS;9%
M#XF?,F@Z03V62:"Q9O;3#GCW^8PUA=9-*8XI5-)*U$SNK$RLBHY04M,3;`(G
M9?\`_+L(-EJ5D8125V]*<_<UM3"^]!7/6E+LLH=3V...MES%CAR![=TR$YS4
MMK8J?%B,E8K3-J8Q08`&][`26(8O8'6]Z+$3/!:D<D<>F#`S2N)/S-*8O(VQ
M$]1Z21QT0O;`_,SDG+5MSLS/#8>J;G1L7I30FDGD&#*-+%H01;UO6\(S.`P*
M(LWIJBZ;D)\3LJPFV+R1/6D@N(UF4-[ZO7:K2*RJ(PF0RP!30U.'G(6N4SQH
M1F%@V)1LQ:`02]@T,02Q$SP7OA#`J=YO6H6"75Y`W.P(\"6VO,I?7D`94BH;
MHHD,X@,6?)I,XL`UK*6)6YYC48C:Y6K)5F)Q%!3"!O\`I/8#9:F=>BV,(KFS
M+?JJEV=GD-NV-"JR89#+8Y`F)YG4E:(NV/$VEZ[3;%HHVK7E6C3K)!(%^_*2
M)0"$<>/6]!#OV;PL1,\%C81#)W84.K-D32.<O1;"RK)'$XBF7&I'!:$V13F2
MM4/BK;HEM2+5`1NTD>TJ8)FP:)*V;XS1@+"(81$6QU7VQ7=T1<^:5?*4,PBZ
M:53B$GO#<4M)3%RJMY@]P"<,VP+TJ0_:B/3"-KD)PM`V6(U.+98A@V$6RS$Q
MI/%BHI>E33AALV31.:-[XQTW,IY7MF+T:5TV")S.L=:W/(^M)-0EJ5*V.>W7
MF[3`.+'O^0L0]X*E7D?[*YGE+TCCL?M5J<WQ>Z4VS)VPAGE`5>G/H&$N5C4Z
ME4EFL1?N.YO"FA2O($?Y8""RM@4;)-V$&QMF&Q+.],TA0`=&!V;'QL,4+DA;
MBSKTKF@,5-BY2UN28"Q$:>G$H;W-&<G/!H7B)/*&6/6AA%K1&3P*??;\J2.7
M1!^>'67%@N:Q8M(IQ%8*B9I"[N!\-BI@$[U*7I<T-*YFB3`4M,"E(5NZE"2M
M6[]V3"-/_H\+4U?)@F7JKFB1W(]\[L5^5"ZWQ'#%)+Y3J*P(P=93:<A;DSPN
M(40T+E\>\]"T+251X`D;&2F-":/00"T+!4U=:+]PA@>5<M1MJ)8XN"DA$@;T
MJA:N6*3`$IDB-*4,]2I4'&;"`H@@DL0QB%O6@AUO>\#6_?:/(P:ABW0&^EJ0
MU1\XE26#0ZVOSEQ/\WTGF:UT7LB2*,4J^*?!W.0J'=J4I@(RC1'[.3F!\/M`
M+V%VS=5JV25JTJ!*I7+E*=$B1)SE:Q8K.+3I4B5.6(Y0I4J#A`*(3D%`V(8Q
M;T$(=;WO>M:PCYMSBWN[>A=FE<C=&IT1IG%L<VY20M;W%O6D`4HUR%8F&:F5
MHU:8T)A1I8A`,`+0@[WK>MX$6D-BPR*RF`PI_>RVZ46@XOK3!&H2-Q/&_N$9
MCJZ5OB8I2E2'HD6T$?;3U.Q*C"`#T7X0;$/>@[%,?/K:KJKEU<ML^E*&-+K;
ML)NJFN4ZTI::.56&[,4BDS=%T.T:52`I<J88FXJ0C/V43H"46MCT+8="+$3/
M!81II9)9AQQ@"B2@#---,$$!9998=B&88,6]!```=;WO>]^S6M814M'7O572
M-=-5M4K*=S:N7Y2XIV"6%,4D8FU_+;%9B(YS8=2=G95+W'E9I6QHG-*6:W.!
M&PG)3SB1!'LLQ,34\5NX14SA>M0M<ZKJM55@1X4WMEPL9IKQA1*3',Z2NM1H
M]+K+;$RMM*5MR1PA9'MTN)4G$&%&A$7X=F!$#1:GBMG"*[L.W:LJ,N('6E8D
M+KLJP)PP5G!S)G)&F.`EUARH2@$:A,=$[*DH7>4/HDANDJ(CQJ#_`"Q>`._9
MO"Q$SP6)A#`8%=(K:KIPM>04<BE2%1:\6@D8LV00L!2W3DV029/DFC48DAYX
MDH6X2-W?(<YIRP@.$=H:0>Q`"'8=B+4U?)6X.O\`E8RO[5M8'15,BK2C).Z0
MJYIYJQ8M\U*LE[(K0H':,SU[^)>X19\;USFG)-3+!E'!-/`'P^(6M;%3=5JO
M:/O[)*V%DE$9=F]^C<D:&U_C[ZTJB5S4],CPC)<6IV;%R<9B=8WN*!26<2:6
M(0#"QZ$'>];UA'[>7MFCK><[R!W:V)J3F)"3W-Y7I&QO(.7JR&]"4<M6FD)B
MS%B]4404$0M;,.,"`/M$+6MA'HC8D,G;A.&N)O9;NOK:7G0*;)RT;BEVQRU.
MR,DC.9S!KDB4I88!ED:(_P`U,(XC>C]!T/QA&$(I-<!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,##R%*>N8'Q$E!YBE8SN:5.7X@@\P]0B/*)!XQ["
M`/C,'K7MWO6M?^>"'^6BLO3;[K:J6J:-NR6YH/)JFI#TFX#"V*O>I7*#,<3=
M8)<\Y1]Z#0L\%LULBRIW%13X2D4KCR3Q.2<S0&P9BHO0@1MOQOS_`(1"Z*1Z
MCB%IUMRNKB'4EIH%,*]7U_I&HZU[!>8/)2J\-Z*IH/&<ZD=C/EQQM1(F:L&N
M8I1(R'E[5O+(F4Z,$E4^ZC2"I$Q5Z<N7FV3CW*WJ:(KJK-TL,^VIU<S79_$3
MVV=61_H\IGYX@G/E=UO533V#4LVH4<[:%4PEEFR]DF(M##$W,+^IDB!PVXM^
MV[P)R;L*TX:Z?H\D7].6]66'>FU;]JUS>%UWI477UA6+TDT.74TA>Y6P0J4,
M-TP:L7B+&/ER-,`+BT`^)PX]Q0,R@*XYC)6%#(7B/7I50W1K$<*5BS<D>J7+
M$]Y:=8E:U1%7*U<V*)>P0GHLYI:FVT(EW9#9;=CS4TG<.EK3G*9E,YI/=2R)
M`8=&%C^A+]SVSI3"DB;<7=AI]<ER[]/Z^V*W>:IE)ZNMJU:ZYE]3KHN35NPE
M](.KI,X?R#;%4K&NL),VNDJN%J6/D8AERNNEJ]N<7)1(BF`*E$!,I0'&H#ZF
MZ*F.<PL[U"^%^D[CZQLSJ>@8:T+;&K'A^$Q#GE[>)0PLS7/+$_.5?*:[.?)"
M4J7@7-T<M:E;&`D]_5E$MR5W&W*_/T8@%H),<HB*GA;6ECXN]16)HZ0BS7%;
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ME&N/$F,(\`%1=<1E$7;GM47$G?\`%IEQBA,BEHT'7=7TMQC#HM$J7FD5FL1Y
MWF=0RQW+ZA89:C>.JZ[9GF"W0E)+6*7,<?L5Q>8TN"WZ+1+T98!G<Y8S?.=6
MM]&O/5R^]I94M8*W^]>I(UR;ZB`N@=)^X7.T*7N6YI!>M91>JY0H9H!;Y!?.
M;DDB!CJVQUL7FP![3'I#6XD*0E`8Z:BS57/"XY-UJ$XB[@>)'2T/M4=\PWG^
M-=A7]9"QD57\IC3N@HQ]Y-KTRHHY+6R`W_9$@%$M]4-3@I.BI$G>@I!B-T:9
M[@H,"(YG+&M*NFKT7X+]2(+%.)$35E\1OHL/`%MTE-[GE/6[!*U%P=82GJ>B
M;`<+`II5NV7-WJZ(S6!PYQ5EF:)C*<"8HEN,0DC2E[4%G+'POIV;H._'G>+1
M<,VNV%3&R8C.9%V!WR:EETKZ#>'VLH?RE8/,,_;^<59U6+9RYPM%$V/H4J/N
MQ2)*S;>VQ2`1Y@`)@B!JINQF*GI'\H5Z*LN?Y9T?;S6UNE@N,%@G$O)<=L(;
MKUM][Z`./3SE*[D<;8FK#/F&Q;*A+1(+"3$)',]"E7)W'W$:92K0-VU):;0]
MR*CO:.UCZ6=AI[?AT"D])V;&Z<B_J7]G7K.YRV]&O29+-J%N>F+S0TRZQ)]:
M+@/MIH4%N<T:V23IRBVEW7+3!FK!+B/.59"<]+YU#$PKD+U33I5QRLMJ77X4
MHA%&\E1D,MA$\BDX<ZFLNLK)DJR_@VMIXZBJV-R5):<'^$IWE[$P6.I?&8)J
M(!*=625M15W8:U7&?KZIN9ZHW$73_J!VK`JHB!%61+G.MZ2MQ]5S2W$KQ*6J
M1=!W$RNU411?%(E")K&94SS2@8*>Y/C0^+`B0)W1\($46H.3B\DYPRC&+YJM
MKF@/4\EUR<WNEJ$2N'UM:<8YTMSM(HN]6Y0&`]%\9M4S8%4&@C9')&K\=6]F
M2!'"7AX):"AHRV]H<"W$KSEQI1D69PJ:XQP\?^*+JGF+U2=K[`>G6$6/5@;`
M=N(9=*H<V7R2=&$5HUQW4P37I11`USQTO<DI<86KYX$J3C<U:MC-F+23[H<S
M$#"0D$)G#]?T^R*VSQSZEK;4L<KFGZAD;#(HO/\`LRX*XGM>7,V1Y_C]E61W
ME8-LPE/*-`Z%KF%,D6>:.7H'%(KVP3-P4JUIS.K);2=GZ.+&6%W/;]$Z;.*^
MX8UTK<4BKJK+AK]?-.S>Z+G<+I1],,A%.3CF*UJ1G,?KNL$5,MEH"&U67*;M
M7L3PD5J8XD4-)J#;B:Z`W[$I=-V-:](\TIJ7BKO-CFU=O\G9IH@'()]Z3P[W
MD"2Z6TB02Z%4;Q?8U7=2%RY\9YL6_P`J*;K.?492H`SE!SPJ$%:E]XT5YX(D
MY8\N_P"K3]50W37%U*\L<_5`?,*5Z0N&].P^*'FNE]_JI4FL*INII6\2:,]M
MU#%F^R)@X%(.76%J:74U<:W,SFWJ5#D)86`Q4-0J<'5QE,S/"HGRY.U?=]!7
M`\(.06"O8;=%Z<TU(MF+-T!1E57NIJBY;+0@JW48I"3*+#=K+JE;,&^"31-M
M8[HCY0B/6*51#@,*L2+9(JSQF-;JU!<,<-=-5[U?07174P'V66%&?3H;*EL.
MRSKE?)2$RZB[@=SFV&/[:5)TZ2<.4<I=:D3.#R-I&UNKTF-<]#$X&:4;+EEC
M,3&/"T'?/3&N:;V/Z@=ZR1^GK5)$W0/0UZ\-U7&GJKF.//\`:4[X:B7/D2N9
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MTHKGE$=>)T-8F+)`N)E*<8QC`44+0SJ,JCA#CB3Z/O;Y'/$9YT,J=F.JBMZ0
MI/I"`1`F?P72M%WM-HKSY4=[0DU,;(0,Y+/6K/!)S+4CH`WW!8Z3$84QQAH=
MZU'?R8W?/AX-W+#X\[TO#I/I/<DKB3PNH;BK_N^II42@N]S(JV=-4F9&@/&T
MD)";T3,9>J7*S68"EWVCB4,2QI2L5-9:94@./,,KF,L8B/#^5>UCQ9WRRR7C
M-(F8NBJ;K2MJ6Y(A\:8HW842GKC05F599#XKZ?\`G\F<.P8G%'&"W0WZ(-"K
M*;+$VKAYP6A.WM)R5.D%%G+'7A>OUP7U!.2>^JQBM$SF.)K*FES[M?U$)Q=L
M6LGJ23K(0[-#]7W3$9XNA3@:1/U29E@&SY)%"R4["5I2T*#M+U/DJTVSR*DY
M8SI/#3EYJ8I3B[OL;C`A3F!V:RP&+=J<XW_&H_(;.ARR15TQ-_('1U<7L_0E
MND'0-_G1Y83;DG8_<DBB3.(UYZ@IS,*!L:[14)RQY<:;\>GESG?T8X^O^A>D
MH;-R$;\^2Z-U])[#L=WUT'<D)>*WC[0KG=TJ(E?5RL%?V4\2L*]*<;%I0B1+
M2TX'(")M.4C+RN<IC=$PYK"X![LK3FCFVJXA6MZNSQ$O3KBU:U<SU7U\.NT/
M+'J,&O+HZ26\+04*[;:$LVKY,0L:@H@M?SH:VE&R+6Q&RA3N0?''>[&9OOYP
M[%\1<W7'`K(Z_M+H]^G\@FUBW>],U:G.=JR%[K\%%:KRJ#`KJ_K9)*5T7KDF
M16DCD2O8?<TKR4#82][+3:*!NN,IB8B(X4Y&U9Z5-LHI/65=/M)6A$*\J_I3
MU19A+9BU]*O"(B=13H-FD2[F20PF1L%R&6DV-JI"Z-J![3;"SK3GY`:J=2U6
MC#E:B.YSCCSJ$VK+D_U/S;QY(F%VS*]=&1>J.#TRZ7PN9Q.7H(#):RBK>AZY
M@UQ)G+INNF)Q36F_%+#'MW1P^P5,C1+BM)#TRI$1H)-V&M5S_AL+ZH'"W6W?
MUT)XM!M5/!:2IWG*:E5O-+93/,C.=>G[C<?=4UC5XT02:L+Y$YMSS'8$WC9W
MIX)-1A5R=5HE,IT6;L-3#+'&->-_A63[S'ZAEQR=ZZ/FT>MBOKP1-OI1/M?0
M./=*;:Z^ATZ@UGJ@^H$4EA$4LL%9/S:OKY0H(/VZ)%)3VU'@*2`&I\80Q;PC
M2.&O\(R?PCWZB:):\0Z07(VV?<5>>L?!)\\2#J&1.;"U`M2:O[EZ=VF9H5V$
MZ,\*)CJ)42>TK(^C3KHZ$\X*P96Q;+T-V-Z\-.7F]$AJ;U(;)2W`[R3G2UFV
M!VF_\)1C\WDGON,R&P(G"JNIRT6>[IS#(S7W4E8PL<@<K@4L)2]$OER5.X-)
M^W8Y.O4I@HBZ7AUZMG?34YLZ^JZUH[8W5+*["D>O3PYWH65R^03R.SI^=;4K
M&_\`IY^=&=U=VQ^>G-^5-U>S2/';=CAFEK?>/9L\Q0`_03G*<9BL>KF*N])S
MLD]KL6M$U7,H:7ZFEG5=U=-1XV<0P*M;:E,75U5/N+D1*(#[M$ZHK]2VM!!N
MYOB%IL3PPDM?L@7L!DIIOQ\8_BVP=?<8>HU'N@*/<5\DMN&,,*K#D1CK:1PF
M1124UK6#16W-,;@UV4]:T>=.E88UE1][MI$YKG`QM@$U4O8%B-0C7D&(@%IC
MF<L*GZYJ+3^G#W38/&U[P*[6&_K!M$IJY.E#A5TEMEG;HA;]X4[>B":7'9M9
M6-][FPW1XED^K<+FE`<[HJ^8U2@QG,`VH5[>$U)5W8QEIPU^N#<PSC#K*U+?
M9FZPT%[L',[GUQT).G&(%]/R*//#=S\_^G_44!IB'O[A`[;%*#VILZ'87`!K
M4E<3_+=R3G$W8R%(U*@F[&(Y77[_`/',KH777]/--*0+HB>V.^=426A/2\KN
MF$,.[30L=C5Q8#9=[=&>I6N6T/$+012J^':Z"T8C%4E1LLF0+&Y`HTL7-Y:`
MPT<=QMFZ_KKR?ZS*"85D?9+%(6P6>P(;E>=S/Q"&P;+W:"Z0HWJ=NR]+.(VX
M[DTH^:<$F))VES+&_-2:CZ`TM%[FD\KR0UA/[+VPA@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#"OB!Q5MR\3`J:6J3[;%R1B?7=E,?T;4L4EZV2>L:
MTSJPK7)O`I++&<E*7H]GZ!H/F@W[!:#F?#>I>D4QU,N$I9XS;'YR9_U5#SX9
M44"+@;B0AY[D,SC"!T/?+(N-Z9R0O(HAI68(:E($M0J`C"$WQ:."=S$?HNB(
M=_T;.;-A-;1T3LI-G0H:W-CN<OB"<]')9]4J"[HTQ.<(%*!6,0F-K]U2&*'4
M#08SIG!64C&I\WS?*)MFK5=:_;%D5C/.N8NKA\-$QU8QMP*$D1XGCP2NP6BF
MH9;DY@$_*^)DEA=#V*9!<6'W`2?:UN:W,(]:,1>,TL8Q,0FME=X-T0@L]F,;
MJ">2!*AC%ZN%0/2]="VF*6_).?T4C5S9C0+!2HUZC";26).B]"H=$233JU-2
MH]+H8O=BU)-J=I>I313!SKQOKR>3"TCWP)0*P:R8$UJ(<SM%44O/I@X.\T<)
MV&*.K*Q*+A:4VU@%`#E+JY!2)DYR<@:W"5SY/73'9M3WI9K[64*VJ.6MR.>.
M+,[Z>(<Z)7]!64U05[-%![1'Y,[RB&#229T(TA*?T+8<ZHQ[4I0F`+-T6)QF
M(N4:D'=5;QZ<SNNMQB1R661!9&D+8S021U=,G"4*9/<,+HQ*EVG9Y^9\RG!%
M/+`:_>4LA$U*"6\X9^P>(@\HLNV:OD@UK]UG--3VDX5W5-BK;8@-3WW-)/'#
M4D(<05.NIP]\BHW&4[^>R9NER-PF;9LQO2,:A>I<FU,>;H)0P!*&(QUUX,MU
M?TS9E-N%)L4!W%S7JR8-;<G`B=*PL>TW&72JO6."KHQ7\99*U>VMU939HXRL
MTH;H>4M)1A*!_0C$+V"$1$L^P=I&21QU%V;GZWG6=B>9Q'4\80JZW3E.KI4)
MK:WW0M:'M\G3*W[C4`DC\V-!:U;M"-W<W,@"0D1(%)Y`VL0W=S<_HU"Y5'(;
M,O.=:XBW0,A6-$/9F\W=)R=(SE$7+(#1NJ,TUG9WQQ6,ZY,;L;XG7,CC_P"S
M$F3A/,&V5L3N\)6XTU84^HV&.TH>HA8#A`DX%L=42(2Y%#[$1P:TIO%X<P/S
M<]V$FA)"1Z4(VA,K0.#\J:-I4VPB/)&,1&M2JN+]?*Q2**,8TC+9T#6<ZV#=
M;Q?C`OBE618]U@4Q;8JNBBB%6'/A.\&7(5:X2)ST\+2=-CF7LI3LC1:D*<;?
M.T72>HI$'!8T/A,!=P5.V0'IF7VS80)57[RC@"SFQ1!POR!N!'I6Z)YTWNR.
M8E&D*VHQ2`?O*8/LT+2P*4;9\7Y9._:A0,;D7"Z?F;@X,YMD/DOC5<J*<?&Q
M@:JZA\%L:8R95*HQ8IT$>SC8I/T6RR6]>L6G.I9R$P`#2_%L;9YI`^>H96,9
M:R!R2%3*+RQR?FQM88/+GVJXBXO#(\UZ;:;9*/G%(K#;H0V)5$.)V':%4YE.
M8'784>T_M%HW!ME*(WV]#9JZ-14/K:SGN+R)]8H5&IP:GA[,Q/U@RVAV3HB)
M1),@>)<CDZ/3U!GXA*-P5H$Z!&];]T/,`'0S@#:F,%Z1/>^4(%TM-X63!54N
MKR&35=#'>>5\U)&U1,"&L2%+\^9!)VF%D(E(W0LP@:I<2>(H82Q%:5[]WPDQ
MZJA6\?[YKV5HX\]1VO++=HJM9ZV>IA+D@8,:P0%-:-N3NC6`IP/!-1*9.>AL
M2O'$"T3&4Y$%MFBUI1AQ9@`B+MEE(%U,\6G>U81:,PF3L%33BO.A)4T3"3(8
M]M+87YJYO4,/9GR-&-,D<WA@;5!TL<E!*9U1(U#@@.3J0!!X#"P"<:CN_&^M
M-:ZS!2NE$`'6YBQ;4I;D6_)Q6+OHU!`2[I-8!,VGGRM08RJMFEA/]S\_3^G&
MFV/^70<%>F^;%LG>L4>H\Q/NJ;N5O53EFI"35C'%R2`:?9W&>@93\RH(\E`3
MSU0V1DM+(=AV[$NJE(<@0FEJ?"9K9@"QM2Y+VA7VXS.W]VB4^9%M95_*YY.(
MZI11Q8YM6X-9DZJ251I*I;9*K:75Y;YA7;AHHPE1M"J1[)/+/WHSPA&V5=6M
MV#&&^?OE<Q-I9`VM#Y+721N?CW>N9L3N'/71M)4]:2%0DBLM=Y1!'G22S$P2
M4;NG;U!NQA.\O8DQA01$:7/!C.G^L;0J"_8C5<&0Q5Q(>X=7+RVL#S7L^?E<
M\EE@W,&L4L/,L]@D#9!J6(&C_GHG.0)E2=6X&!(+`:/V$C$8Q,6RP?4=I54\
M2=G8V&82Y4TOA\=C22&K:]D3S-75OO&&<\.J=/'DLY"\PSW:QYX@TGW)2F;X
M@UZ.6IO,+(,T$;9JTB/[CCQ7SH:R*=MIQFU9-LS?[I@C>7`SGJJXU!Q-HUSR
MX+3)L0Q2K<D;74M<PI&54O6.B,L[?E%'%")P;7B<>UU+K(8>BK*E9M,XB_\`
M1+102R?KGJ!QQB5G+(>_R]UE$01N,N`_/K.U(&Y+L)AR1+I3YIP"M#-)\`QM
MTUG6EKW3T77U636O:RG#6D=2K7>HM#RRA22NAJ2U5@RU%7\<`HKU\E**<R-C
M721U(3K%*!K6)4A)FQF"WHLW0"1$SK#7@GU*Z60)(.:ZPF<P]NF#(PRUI1R)
M;63*])*NDLH^8D0G::(_/\;\]H7V2(UX26IH3KWDAN;#U1R0H(TI:DZV2V/O
M+IR#T$_5^S3$C1P)X_,;"2:EE<`0NZ`V22M@A+0L30U^EC1,Y2BT_P`D3:5C
M:4"W21/H9@_YV@EC.8BT!<^W:V31(V5-[(\'Z21*$2=R0222UI7FFAPF[Q.V
M0B!N3O/9S'V0%ALR^MW8M8UDGG&!$27Y8C`F:%HNV4!;^T$4GFD(=X@O$HJU
M]89-,WDF3-4>B*TB/_=DJZ^H@G12=YEI+$C">BG@#5JUS-;DR8XX:<P6B$_O
M9@VUI/%&$7J`BD4L0.\)KB63>`,E9=`/MD,,-5UQ(GF/O](2ZFTSL[-<O3SX
MJ&RAJW$K#,/0)&M:K5.IIF@!"48G/``NWKQ?(?J-0"!'2T-BJR7Q.*;V.]Q4
MV/+(@P&HZ)B!4#TDD_N$OE3"YS5\4'3+0D[6RD+7E>64=Y238R@`-&V9;2=#
M=003FU+%G.<$Z4-4B6>4H.2RF!MCLWMP7%E:SW1NBLEE3)*9F%(>^DF'$,B-
MP4%DA'O8/,$24<<Q%HS"^HG!PJF^+:L"JY+#F6C['MB*K&]N=(O*75]B562!
M8UNDQ1D-3\821M.VH3E:E(<84<`)`]%:-_F;&7;K$=6#D_=U0QD%C"&Q6$[#
MK2PU\$=BFED9S3'EL88/(9Y+K*C'O4A2!=ZXB*"$2)"M6^TM1MU8%B4E.:+W
M?9XVR2;NZH8T"Q!#8K"=1UK8KC`W<IJ9&<TQV:X]"7^=2^S8UI5(4H7>M8BA
MA<@1+%NMEJ-NK"K3$IS1>1LX;93B,=8UM+YZZ5RR-TM.D3=<*RG2//;6TA"]
M*FR#R*:NL\8U`GC8U]<MI\,>F0QP\`3=OS4>E"0(.RC3";9JU=2+NV"Q(N:O
M,CK&W&V#Q%UOZ+HIOMIBBEOF<TYO:)K(9_%HJSI9>;)#5+DQ5X\',BE8D1HW
M(UO.)V82;Y(3B[9[6SZ?KY'\7&WNM-6BS-[9.H94LOD"E17:UIA5O6,AC*Z$
MU\]::ITO6K%3D.<,*)2XH"EC2@<WI.G.4_T2TQ(-K",??-./C`Y2L#!9#9&T
M#+:2@AS>HZVM^W6:TJ&/)+/J9L1#?1KCK(BTG?3V$:018$JE[971,0I,TCV8
M,;9NF2,[8@Z@V*,3#`+*?[!F"A<QMU>)4472/;;-FZ7SV&K87(G)?*4\;9W-
M$JJ67+CE&UAB+39&EAP#3#!)25(V^2N7GU"(]'']<KD57RQ@K*/U;-95+Y2Z
MO4$3/D:LJ$70FHMQJ=:PBEWNHG$R>GA0EN@5>V4T2DA1I7I"(:H`V^:Y8OV!
M6<EI&6W>4A?=-4(E9L`>XXS&QR7O"Z>C=V)@9(M$G:*/[M#):?+'B4MB=L5)
M'3:(9B\L*@U,,M0$D;9NF(D/7R2''O*>74Y935NOXY')C=IZ-?7CXCIN*3!]
MD+-&WF0'MDU-%)='(HPL=EI#$!S4-K03LXX&C!D$'#;:(N?><>;=OBS5(W(J
MCC&QW=,3I*5JM2D*F!<VV!JM[JF)*0^PRW0"2//AZ<UL1F$`<7]&HT:C('X#
M=%C:WQ`,)@`F`WX@#"$81:_\PBUK8=_R_P`O\NMX<L><S,ZAS1O2AJ;3WEO)
M/3H'8Y"E-<T*=3K85)"->,H2I,2H"+>AA`,(1ZW_`"ZW@9+`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`I=CY_K".'0\]J9EI!D$>+9?8WLQZ=3
M])'*[7QWD5AG':.5#TL`ZNKXI&4`WQ!2!'H).@!"'6BW,L'7/,]=5(_MKS72
MZ;Q=N11^,,"^&I)D[J83(QPR"M-:QJ02)A<3%@5TF;X3'VY"-8`PH2H#>F&H
MT<:2`>A,S/%Y+,Y/H^WF*T([/(NL=&^WY?"Y[,3$TA?6IQW+:_9HI'HN\L+H
MV+TJ^-GHV:&(DQH41A(%1/GEG:,+4GA,%S##'\;TBL5RD3B@E+DQR5KM5J2P
MQ=,Y`=#8:"\2G$JVET$8PK`%1ASFFGA9YAY0MC0`6*"D'NA*@\LP;I>I3R;7
M!RM#($S]9;38"%TT[BM!HG3FBGSBH40."5N]IW=S"`3<Z-<GB]9L>G!&<D$E
M.7-Q*T!9:LL!P1NGP3ZM:3BM3.4B40QTF"5@?W%Y=R((NDJUS@T8<I(^K)/(
ME,28UFC!,@7A_<5"D9(3AIT^SAEIBR"=^7H3-JKCG%-&QAU3.B)),E0&EP`M
MBS.YSJ2+6"&$`N*)7UMJB[,):!&@;CK2A+>XF^8$Y0<65[L,T27PDA+NDGO%
M5'V$GE"5T(F[,5.D]FM<]W$;`E$7/FT8N!<!UGT/D*MJ<"59T;=70O1Y)1)A
M!R$0S0)C2BE*D!Q(RF%]+:XBCA,8/.U*)0*25TPRN-156!>L*(1M$UU&@R!.
MH1%G!2+A*M1%#X!G`&(G96_!L/C%[26JM_Y:K!Y"F/;E$WA;^BE]D31#+X+-
MWZ-2Q$XV\XZ=;);T[PE4C,TP2M:62::B$$1)!R5,>GT2H2IS2B[I1!YX^JYC
M8'-15<,8&V<)X2O@,6/E+Q*E$:*ABJND%8)*YD1*%:<Y.M6MS"VIU@6/8MIQ
MO!.W#V@7''*AEW3SX+$@]`L,`Y\@W/4;E$S866"PF)PY!,8T^'LLW4&Q@AOT
M=(S7L>W$TQZD2]$-2XC/]X]\,4G>=YGF"WLDS<VKMXX@HI[8F5@5)YJ!.TM$
MU;5:XJ=2`3Q)UL]G[3;3[)Y8Z*E*E4^2H-KL::1IU@]Z$0Y`WK0?=1"3;+NE
M[`\74F-&)$XE35[`Y'6V*8'/<YD#DIL%%>C,R,MI,\T-/5>U>S24$9;#PIT^
MDH6]0WD;1>[@!Y>QNE*2^98`I:DS9*GFPK!-1Q.R8*F>IU.'=[?BXC:[5&V6
M7LFW0`D9IQ1[?%$823C-#5$F:,-\W9IQHQDN7@?N3ZG>7)-(4(IC$9>W*(PI
M9II#Y@[L\E9!12%KZ\1$MRH9JM)M$OAKF<C7)SR#B%>]EGC!M200<4+E,RZ%
MK<MQ*=Q-SFH<R[4:KI&M4OKL<>HL5GK=OJA(^*=C5>$X(X8V%$FI]Z]W-/\`
M$>(&S1;%@N46.Y>K<ZH(12NULV#&*R>8V^UN[AEBX4O@Z^%K]JX5MDD)H##S
M"(FC\*%&6K`J#[B`)9OF[]HMBYNWG8.2J5C<:>8HW,[^8V2!+$DSR<Y3&3NS
MLX[A5J36Z6-6J>'%S4N1R_5BV"ZKE!XC-F*=*-%&;$46``1<O5`N7:MK>P$M
MC1P4QVZ,S58#!$&-TFC^YPV",-I2:.S&=LT.B:A7MG:4+Y)HLB4A]I9IB,!.
MDR41"304X1.4S%/H+E2AAH2B=U\SZ>";!!:A<V"2$-AZGH)]NRA2'Y^:#J4>
M\'280@F`]Y\D;>,2'8-HQ;(V-TOTEY<II'J`:3Q]P!JL8O5<.A^OG"]BTWL%
M,2$F45^E/T);OW\QK>"`F&FG>,Q4'7@.V,/\F"Y1.9\74E./?P.),W:TK]N=
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M+)\1(BQE^CVK>)*67H#DQZNR`NCTGES=8$K2V-)$,MM=CGJIO52^/62]HE*<
M]^9W7X4F))`5I,8U)"O=VX:,@9A8R;I6"KYLJ\UG2,S:D>XT4VVX1=S2KC;\
MO;%K1/2M#3G*&T>AFD)F9:T'GMYS=Y>T>T*@PL)8?:$01<O/,N9:RG5CEV>\
MBER=],4U6N>FUEE[VRQN5.%(38ZPZG6RAF;U!)3L.%RM4<H(*V(*91HW8511
MX0%:`+F(IY6GENLXTXUVZPQ7.(0MK>),U?H#(O,WA$"2P*//!C^RQ";E*3%A
M4F:6QV4J32!FZ"L)TM5%@/"4J/`8-TOM9W+]6VU,0S:5AE93F>T0EB?D<?ES
MU'VB6M5:SA58]?(I,B;%!.UZ>)S-P5+"`%C)`H]Z-)5Z4$;"4$1,QP8%;QU2
MYJUP>&=/,(E(G*Y)->QDGBDVD+7($L^FD550F7'-;@-8IVU,K_&7!6G,0IPE
MIR#%AZA-HA29L[!NEB5/#/.:F*$0S<6>BF1&P-D=;PES"3;6MZ-CKB`U8QJ4
MR\YS.4B<FB*5BR:)/-$8/:M'[P9XS##=C+NF[8];PI2;@)0K4.MM:>W8FQ$4
MLDJ>V9DF?ILTVX&!`LMDE*M.XED*VJ6$UFS%[+(*3;;2TOA;A(]#%[1NGP3;
M7*%4H)(@ET3',:_D:%U?UPW.#2YT8A.+7*#XPJ?(@Y)-"4MZB(J5,-;ADI`D
M@$@$2+W0PC1ZC1I-TO5<'+557>_ZD<U!+"%RF'CK^0%QB8/D72RZ$Z?29.EC
M,E`T*4YJQK0R$G:H&BAD#,V884<(U.8(K8B9A.HM3\-B1%E-Z`MT7,5JR:0R
MR3QI[<SW=@)=)>1X):4S(5>AB;&R2JS#E:M,$8B1*5)H@!`$7AT+5K">/:`K
M\^%*&"'*3!P*F'>@V/3W(I#(2U%<OSH2\O*5^+>7):"0O[DX!/$:[+-'.0PK
MU@=G>%6?H8G*9(5Q[0,!/ABAAARDP<%I5UY_9=/<BD,@+4UN^.A+R\)'XMY<
MEH9#('-P">,YW6><YF:7+`[/\*H_0Q.4SYO/%N.:.@^X:HA[7*8ZZP&FCZ)B
MK^WSJ6_.!N@JI^2252<-V4NRA4NF"EZ3&'&/A^S'4?OBL.S_``JC]#$Y3/%`
M8UPQ7?\`_P!('8SO*9L5/YOT;)B8[N625)"XRGZ&>Y@4_K8Y'=N`B6:7C@$K
M-9CEY`PA!YRLY*6G,6*!&%G*>79:TFY<K"4S=QG*T^:HE#S(6.</<:9IJ_-D
M*>+'BK.W,42LIPBZ=3IO-FT7;V1NVC4AT$K2EJ0JC"C%2),<42YJE42#AZM!
MN%1,D)9FZ*UO!KAA=W21BT[252I7S&K(C\VH4-A0C6#;"#I*<!,=*52D1@GG
M2'0E!1ZI4<J`7=//C2S'7DFEW%PGCZB:7Z-RJP+*8;><)A&92^-<D8K#C<;W
M%&Q_B"S2LXB-%B:%2\*I"05IN<#'AR&J3G;<%?FC=+"N/%E&.C6U,ZI!+]I$
M,9FL9<S03F2Z<Y7\_9HDLQ]DLI>MKQ/#A-R;.2!D:)X+/(7H7@0CB3`!]@-#
M=*>.W/L0E$&'7LYD-B3U@4,KVS.`I/-W<3DY#=WUCDB)^4+F43,--*HB[1U,
M:Q.272=6SBT(2898AB%LEZVA;IR!6,A.3*90_P!GR92I:F:/SDUVGSJ$-MQR
M,2-UE,5CUJ)&P#<@E;3&W1\6`(!Y1`CD*DU&J$H1F#($-TI.KY@IU<RND?4L
M+B8V/,'N^NG`KYP/03#HKT1+DLXM1'H\"W1I2AZD:,!Q!X=Z.0@ULL@18-[#
M@N5SLC$2Q_%=$+WE<%V>%+P(#NZJW0#<-22F(^&LX50QZ:V5.%+K9*0KV%%"
M&/8=>T6\(S>`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P-7;ANF^8!+2V*MN.;*O>.C9T3@.;Q.U.?8:U%.2A0M*5,(F>SK-B,D$K
M;R4Y1HS@I-I1A4!T`P0@F:"=1$3QFG[IVY[WL"5GL=E<>630\>*9E;@3-9;:
M?/\`,VM2YD*41*=@`T5A9DOD9:M<0I-.`>-*%*`*<01F!$(O0B3$1PFT-F70
M_3L?ELD8HUZ?]OSV/-#RN;V2;-%V\KLK7+&Q,<(M(_M[1*+D9Y(V)'$O6C`$
M+DB947K?L,+"+^3"Q$=8_*V*?LZVY\Q2MSLCFN;T4ZL9I8(_')9/Z>F2V:EB
M0&*AGMB^LIU+FAI"6K`%-O3B>E%L8]#UK9>MBT28B.$VH$/4'7.PAWOTT;Q#
MO>M;V'?0''.]AWO7\H=[#>V];WK?_P`/Y,+MQ_\`4?G_`(O\BSK:-I$^QS>;
M)NFM(LDXPKGD<_I\R9*#"Y!\**(!.29R94Y8U#/_`/--;&]!"$C^A%O2G^BP
ME1=7HH`?4'7(0"$'TT+Q&+01;"#70/'&MC%K6]Z#K8KVT'6Q;_D]N]ZUA=N/
M_J/ROZU+.MJ$Q")/T`YKF]SR-]-2@D4&C,_IZ)NL(+.:1KE!SH\6'.HO&7<*
M-P#I$+3:K5B&:+S`:$3K8\)$1/&:5!%^C.HGJ31YF?O3VN*&L;L]M;<\RYSO
M'E%U;HLUK5A*=?(5[7'KG=']Q1LZ8P1YA"),H5F@!L)18Q["'99B.L?E8=T7
M#>%=R-K::QY(L3H!E6LH'%?*H?9U#PEO9W02Y6F%'U+;:ECPU\5+`)""U.ST
MZ<U+L!X0Z,\P(PA)$1/&:8FI;OZ`G4S3QZP^+K.I&,FMSBK.GTIMGG:7M"5:
MD`4)&U&,E;VE*Y28H=!#$$LP",1!>P;\P8-;U[2S$1PFV#GO0/2L7F4BCT1X
M+MNRXRTK_=6:>L=T<OQ]HE*3W<@WXF@99C;[#*&TCSC!E>6M1ISO$7O?A\.P
M[V(B.L?E9E)V?;EC%28=H\TSCGLQF$V:8B9C8%.3@<OTL`O$N$VBJB=S0MKT
MT"2E!,]_VFV;M2'97CT`S823$1PFU#F=.];!,,`#TUKO-``PP`#0W]QX$)H`
MC$$!H0CO0(PA-#K0M:%K0M:W[-ZUO"[<>L?E?#%9]N.=-/-@NO-,XCEF-X'<
M390BVP*<7RY^&@5:(;BTDU:)VNJY$)\3_P!,5M4\$Z)#_-.V6/\`FX2HNKT4
M)OI_KG6M[UZ:5X;WK6]ZUKH#CG7MW_Y:]N[VUK7MPNW'_P!1^?\`B_[`LVVH
MK6L3F$/YMFUGS=\VQ:D-2L,^I^.R*$Z<F<]P==NDGFDY8(([_-QR+`@.^&N2
MKSSC-&)_-)T(S1(B+XZ*29^E.JW!X:$#EZ=%T,3:O=&Y$XOJN]^2%B1C0*UA
M*=:\JD;9=JQS6)FI,8)084F)-4&`+V$H`Q["'9:QZQ^5L77;=TUT[L:"K^5+
M`Z#;G)N5*W5\AUDT=!TL<6DJ0$D-2U':UAPQR7J%A`MG!-2%'D`"'PC&$>]:
MPD1$\9I%ZMO7H>:S=JC<]XBM*FXLN)<C'"PY+;W-TK9F4Q(WJ%2(A4Q5[:TG
MEBL;LL*`E+VF1&A*,-T,W8"]"'HLQ$1I-OA9=\]&0^;/D<@_#5JVW%FT:(+5
M8<=N+FB,,TB"H;DBM4-&QSRVHW+$.F]8>8E'I6B)V,P@0R_$6(`Q"(B>,UYI
MM25K7)8ZZ0IK2Y<GO/25J2MQ[,XS*Q:4G),H4*S59:U$@(J>P)HK;C6LL@L9
M@UH$Y9FCPZ+$/81Z"28B.$VIE?TQU@E7KTJ3TX+K<TB5<L3)',B^N0DY#DD3
MJ324SB0G67@0L3DKR`!.`6<66<`(]!&$(M;UHM8]8_*\H99UM2&J)/.)-S7-
MX!8+-I_VQ4J[S^GGN43#;6@)5-&FV6Q:=/-<M?SF6&"3$?$'5-[N,O8U'E%[
M"+9)B+J]%!?>?ZX]G^FE>'M_^'W@..?T[87;CUC\K\E5GVVR5%'9Y'^:IQ,[
M&=@L0GJC6RP*=:95%1.9(S'8#A,)%.FNM'+<<,#H!VT+LHTHV+6T_F!UO>B5
M%U>BBTO3769RI*0?Z;=VHTYZI.2H6&WYQ^:4C(..`6<L-*3WD:H-+2E"V8(!
M81&"T'>@AV+>M;+MQZQ^5W7=:=P5P?'"JMYBG70Q3N4Z#>E,-L.F(,"*&(AH
M0H"7`NV)["CG(3P%2:(O:$*@)6DPO-V#8B_$2(B>,TK^NK\Z0ELU8([-.%+8
MJJ+NBA24[V#(+DYDDC/&22D*I22J7,<'MR0RMP+5*R"TP0HT1XPC.",6M%A&
M()9B*X_J]]JWET+")LXQRO\`B>T;HBZ1*VGHK"C%N<XQ-F=5"Q(`]:C3L=B6
MK%I6F-:5(MD&#/1%EFC#L10A@WH6Q$1/&:2&E;=NRQ7QY;;0Y/L+GUJ;VHI<
MV2*8671<W1/S@-8`@QE2(*JL69NR)42F%L_9RH@E-L`?#H>Q^P.$F(CA-JP?
M^D>IVM^>VQH].ZYI,TMKPYM[5)$-Z<EMZ&1-J)<>F0/J-`\W6@>$*1X2E`4%
MDJR"510#-!-+`9H0=%K'K'Y7/6]G6U+Z_ELIFW-DWJ:8,0W8,=K&0SZGY,^S
M<*!F)<&X;5(8+.9'#&?3VYF"0%:<EZ39)Q>S#O+(V$S9)B+XJ`#U!USL(=[]
M-&\0[WK6]AWT!QSO8=[U_*'>PWML.]ZW_P##^3"[<>L?E?KI9]N(J6;;$0<T
MSAXL]66W"6\_)K`IU+,&H:MUTA6E*)NX3I-52D34W[]],V0\F!-*_HRMC._F
M82HNKT4)KI_KCVZU^S3O#6M[UK>_O`<=?R:WO6M[W[+U]OLUK^7"[<>L?E?=
MT6?;=>(8LIK'FJ;W^K>C%X7]NA\_IV$GPT"5.C-2&N1]J3J&I'4+D<H-*!IO
M&J$6(@6S-!"(&Q$B(GC-*M@_0G3,DF$<8)5P-;M=1MW="43U.WJZN6WUIBB`
MP!@C'AP9HE<3W)W),0(.@[*0I%"C>Q:\(-ZUOV%F(ZQ^4HM^ZK[@4OTPUQQM
M9=Z1SX0A7_/J*6MSW#FK3BI-5@5L?P:S+/B,F]Z;2R"QC.]T]V,T>'19@MA'
MH(B(GC-/53-R7I84H7,MF<A6-0;"F9%#BEF$NM"@YJVN+H4M0IR8\2U5;94Q
MD!"Q2E4FJ`GG)@)`@3""(S0Q%A$)B(X3:#2_HGIYAE<D8XYZ?EP3F/M#TXMS
M)-&F[N56=LE;6D4C)12!O:9-<K1(FQ&Z$!T:60N2IU181:"86`6MZT*CK'Y6
MU4=G6W.XY+'>Q>:YO1[TQF[+CT4E4_IZ8.$V+TV[5Z/:W*M9U+&-H");K23V
M.2A*+S-^/V>5_/PDQ$<)M0(>H.N=A#L7IHWB`6PZV(&^@>.-[#O>O;L.]AO;
M8=[#O^3^3^3"[<>L?E?X;.MK=(BL<7-DW!:>B1&:YXW/Z?W,A&:D7PD)&IT&
M<[J;0QLW_P`U\6WKPZ3_`-#O?O/]%A*BZO10`^H.N0@$(/IH7B,6@BV$&N@>
M.-;&+6M[T'6Q7MH.MBW_`">W>]:PNW'_`-1^5_6Q9UMP:+Q-ZKWFN;W8_/II
M0)##HO/Z>B+E"2QMGOIASHZV/.HK'W<)*_\`]GO3:J5BV9_/UK97\_"1$3QF
ME1Q/HKJ!]E,<99#Z?5PPE@=WMM;GJ9.EW\IN[;%&M8K*(72%P:HW<SK(7)&T
MIQB.,(0I5"LT(-A*+&/>@[+,1UC\I[<]Q7E7LE;V>LN1;%OYC5LA3BLET0L^
MA84W-;H-:M3&1\]KM.R8<_*%A"5.4HV>0F,2;`H"'1FS`C"$D1$\9IX:BNR_
M9Y,`L%C<:691L;VU+UPIW*[7YZF+2%P2C3!2,NV:M+/ELGVI<@G&"`;I)[N7
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M1_\`NB]J'DK11?\`,-V`S^9A*BZO108NH.N=!WO7IHW@+>M;WH.N@..=;%O6
MOY-:WN]M:U[=_P#QPNW'_P!1^?\`C8"Q;-MF)5W$I9"^;9M:LS?1,NI%5D?G
MU/QM_A&G%E/<7,3I))Q.8]"'?3`YEA;SOAK@KV><9HPCS"-",T2(B^*E6/I+
MJER>V9M=?3KN>.M;@[-J!SD*V]>2EZ-@;EBTA.N?%B%HNQ<[+4K0E,&H,)2D
M'*30%["46,S80[+MQZQ^5IW7;EUUT],K=5_*-@]!MCBUGK71_AUE4;!T<?7E
M*_(*9UB*UK$ACJN4J4_].$U(2<G"'^:(>A_S<)$1/&:1RJKRZ$F\V;HY8'$]
MHTO%U:5R/66%)[<YQEC.UJ$B09Z)$>QUW:LIE:DUV4!T06,A$864,6A&B`#6
MQ:+,1'";>*R+[Z/B,V?8Y">%K7MB+MAR0MIL*/7'S-&F>2%GMZ14H/1,<ZMN
M.RM`!$L/,2BTL1$"&80(8-"+$`8A$1/&8CS3RD;4N*QU4B)M+F"=\\D-)#::
MRK)E8E+3DN5&K#%H5R9`54\^FBAM&T`3E",$N"G`;I0'16Q["/023$1PFU*+
M.F>LDZQ8G3>F[=B],G6*DZ9>3??())*],0H,*3KB255XDJB2EA(`FA`:`!H`
MBUH80BUO6B[<>L?E><1L^VWZI9+.I%S5-X/8C.%^VR4@ZS^G7B4RW;8E+/:0
MMTOC4Z=JV;-R4\8B2/?W9-I.(&Q*/*!O0MDJ+J]%!_>?ZX]G^FE>'M]G_A]X
M#CG_`/M_^=L+MQZQ^5^2^S[;8*FC4ZCG-4WG5AO&F';Y233/Z>9I3$=N:0T]
MW"XR^33IHK=TW&E(`D'^X.JG2@8]"3^:#6Q:)$1=7HHU%TSUBH6HDZKTWKL;
MTJA8D3JG`Z^^03R6],>H+*4+SB$MXG*SR41(Q&B`4`9HP@WH`1"WK6R[<>L?
ME=-VVK<5<*XZ15O+\\Z&3NR=R->EL-L2EH,5%CD9B("%*O)MB?PM2Y&.P%!H
MRQ(0*`%:3BT;L&Q`T(D1$\9I!ZTOGHR839CCDXX:M6I(LY#6A=;#D5Q<T2=F
MCH4[<K5I1K&.!VU))8NTX+""TH-)$1VP&'A&9X2PC&$LQ$<)OS>BT[TZ&A,W
M=(Y`>)+2N:+(D[::@L.,V[S?%&9X.6(25*Y,F8K#M:+RQ*-I5F"3&"4(B@&C
M+V(K8R]A%L1$3QFO-):4MRZK%>7MOM#E*P>?&QN;$ZQK?IC95&SA)(5QJK9!
MS0C1538DS=$*E*G_`*81JLDE.(/\T(]C_FX28B.$VJM[Z2ZJ;7IY;FOTZKGD
M+6WNSDA;)`BO;DE"C?FY&M/3(7M(A=KL1.J)*[I2P*"R51)*DH!F@FE@'H0=
M%K'K'Y777=FVU+*YELMF?-LVJN:,6WO4=JI_GU/R203?3<RD.+6)KDD(G,A@
M[/J0N9@V\GXDXI-D'%[,/\LC83-DF(NHG1K^'J#KG8=;WZ:-X!WO6M[#OH#C
MG>P[WK^77MU>V];]F%VX]8_*_'FS[<;Z8:;#;>:9P_6:N+:AN%`I+`IU%+V4
M:U?[JX%*ILZ3I'5BL3,D_P#<F[3/)H30?S"=C,_FX2HNKT4,'I[K?8@!%Z:M
MW@"(80B'N_\`CO>@!$+6A#WH-Z[%O0-;]N]:UO>_9_)_+A=N/6/RWQ+$(18!
M#!LH8@!$(L6PB$6+>M;$#8@;$`6P;_D]NM[UO_RPY?O`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8&FT6[$99L36"&-0&0G2^SI7:,33QAS<VEOU%
M3ZX890_HG:4NI(UY:5FG21E0B:C$Y*DPPEV*-$7K1"C19UMI](YUTV*U#&IG
M40_-M$GF%.<T2S5^?U"F//29&ZSPA&BA;DFC(&J4K'*.0@+V6F$J1N(FMR3&
MEI#?Y_A&WHKE5ZAL';`M2AZ@$E:TZR&R&5.*03Q'USXU*&-VL%ETR;1MRE4S
MK%PW2OQ)#P!<0J2E3FDT40H(TI4)AME9$L["B$5@D3DH$C%(Y7(9"./N5>Q^
M9$&2!@5%-D]<AIE*%T9&J1;>5BBO5C6C0J6M&<I>QA1[V7O0S`B,9EC3>QBD
MR1],65?($#S'U\T<72'.;IIEF+57$!3.[@^3MX9GYF:@$;<FYIV-G2I#EJ9S
M-'Y85I?E'C*&UF7[J%WC3Z]-;O6`R&1AGS+#7>=%2I0LA3"B=HHOFICW*W5#
M$51\5TVQ_;68>%60%"48\IP&+2_"8()*>Z"=7Q*=+YW'P)F6,R^+$DJ6.,RN
M<,+0L?P+CYZF0M3KL033XK+4VZV<U#FU#)5*&M!Y*DS8@F[T`LXTP$&Z[)G3
MP5&4T%*8I-N)BD0F^22WX8W*5[FT/,MA[(UOVXT:VGJ'^O6H$A/"KVA7(&M1
MX_=#AIU84XIG&CI5^?28"M;ZK.+;[`K*564B/<)@F3J6EOB*-,8N5NJ%*P+S
M]Q5Q<'1N*0.:;W@Y84XDG`1^SQ@`*?&G^N(M<<L9(JSL9K,:X1](X+53RXG%
M!^<"YH4R-+&(YLMF$B?EFXLF^*&`/4MR\M`9HS:/8BE8$Q)QIMOA#`8#`8&-
M=WAHC[:L>GYU;61G;BMJ'!V=UR5M;4)&A!#LY8N6FDI4Q6A"UKQ#&'7MWK^7
M`JG[R/._U]TO]J4&^7<+4]#[R/._U]TO]J4'^7<%3T/O(\[_`%]TO]J4'^7<
M%3T/O(\[_7W2_P!J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO]?=+_:E!_EW
M!4]#[R/._P!?=+_:E!_EW!4]#[R/._U]TO\`:E!_EW!4]#[R/._U]TO]J4'^
M7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO\`7W2_VI0?Y=P5/0^\CSO]?=+_`&I0
M?Y=P5/0^\CSO]?=+_:E!_EW!4]#[R/._U]TO]J4'^7<%3T/O(\[_`%]TO]J4
M'^7<%3T/O(\[_7W2_P!J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO]?=+_:E
M!_EW!4]#[R/._P!?=+_:E!_EW!4]#[R/._U]TO\`:E!_EW!4]#[R/._U]TO]
MJ4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO\`7W2_VI0?Y=P5/0^\CSO]?=+_
M`&I0?Y=P5/0^\CSO]?=+_:E!_EW!4]#[R/._U]TO]J4'^7<%3T/O(\[_`%]T
MO]J4'^7<%3T/O(\[_7W2_P!J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO]?=
M+_:E!_EW!4]#[R/._P!?=+_:E!_EW!4]#[R/._U]TO\`:E!_EW!4]#[R/._U
M]TO]J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO\`7W2_VI0?Y=P5/0^\CSO]
M?=+_`&I0?Y=P5/0^\CSO]?=+_:E!_EW!4]#[R/._U]TO]J4'^7<%3T/O(\[_
M`%]TO]J4'^7<%3T/O(\[_7W2_P!J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CS
MO]?=+_:E!_EW!4]#[R/._P!?=+_:E!_EW!4]#[R/._U]TO\`:E!_EW!4]#[R
M/._U]TO]J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO\`7W2_VI0?Y=P5/0^\
MCSO]?=+_`&I0?Y=P5/0^\CSO]?=+_:E!_EW!4]#[R/._U]TO]J4'^7<%3T/O
M(\[_`%]TO]J4'^7<%3T/O(\[_7W2_P!J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0
M^\CSO]?=+_:E!_EW!4]#[R/._P!?=+_:E!_EW!4]#[R/._U]TO\`:E!_EW!4
M]#[R/._U]TO]J4'^7<%3T/O(\[_7W2_VI0?Y=P5/0^\CSO\`7W2_VI0?Y=P5
M/0^\CSO]?=+_`&I0?Y=P5/0^\CSO]?=+_:E!_EW!4]#[R/._U]TO]J4'^7<%
M3T/O(\[_`%]TO]J4'^7<%3T4\C<N$VY88XM\[Y[0N!K>W-0UR.T8DF6;0M+%
M-8PV$Z5$R<!X=H6"Q'I*6/0M&!*7C_G>T)>P%]7=E%\MXK=5,=.=+/HIS21)
MF+8(W'W"VXPMAS0W$MZIH)]T@ZF5&P_2\AG7'(P+!(1+`)#1$Z-T5O8,'J[H
M7\&]/(&MEII/SHW(=@</$S-%IQAFCHU;GN1[/>#(TU2M&P&2-.&7.04KH)-M
MQ0@6&`3GE!WK6AZ^ZPV*P..HVCCB%GMFCTY<4>G*2,BD^W(NXNA,A>4LB1O#
MXM>G*4*W=Y=W8B7.?O2E:>H.4#6FC,$(8O%A*R11Y5\+R-0Y+)!9]-OBYW=@
M.SBX.U[(W%P4>!.ZH_@GOZN=&K"H88B?5I(V``PL9A*LXL238#!ZV7U,\[S'
MC-]9UT?<;:I@3([25SESXUI+J96Q%(WMZ../=QRA.V3%&"4-CF(_83V]PTI;
MS2@@+$1LLL`0CU/.ND_%;HTSUE=+7IET1V:6L3S@USNYI<75[1KDBE`8VZ?E
MLS/?&QI3(EIQ*5(C4)TR,LXP*<LK0Q:V/4BKPAX)D*58C?K-J5Z)<615'W#;
MKT.8X*%[>L2.;:<<N6*[$-6*WG3*\JVXMR,&)Q):U)B$L\*08B=CU)R3/.0"
M$QY)-UU84I4Q9NA9CX"_4FI6&--3BX.R!N(F7SY^=:42=Q=#C?/*6@4B%L.A
M&;T67H`]71(*PB7-#F]HY/4:Z"R1UB20*(M5#IUJ5)6P]0D<$&WES0()`YMA
MTN7-[FK3F/*LH;NH3J3BAJ1%F#"(DWS;&80P&`P&!_F_Z&H^$^I5ZT<TY(ZK
MW()MRCQ_QO6EU1SGY)*'^.U_8EQW!/'QH436S44?7MJJ4EQF.-&DJ!&:=HDH
M?\__`-(U!9QK$SA[>Z.,RW*_8)^CK^[[H#\2O/RYDJ'/R>YUD_8)^CK^[[H#
M\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7
MW.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_
M=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES
M%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"
M?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2
MO7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.
MLG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]
MT!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0
M?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?H
MZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7
MRYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG
M[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!
M^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+
M[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_
MN^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RY
MBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!
M/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)
M7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G
M63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^
MZ`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH
M/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T
M=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7K
MY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63
M]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`
M_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<Q4'R^YUD_8)^CK^[[H#\2O7RYBH/E
M]SK)^P3]'7]WW0'XE>OES%0?+[G63]@GZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?
MW?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$KU\N8J#Y?<ZR?L$_1U_=]T!^)7KY<
MQ4'R^YUD_8)^CK^[[H#\2O7RYBH/E]SK)^P3]'7]WW0'XE>OES%0?+[G63]@
MGZ.O[ON@/Q*]?+F*@^7W.LG[!/T=?W?=`?B5Z^7,5!\ON=9/V"?HZ_N^Z`_$
MKU\N8J#Y?<ZRYH^ICP+RUZ6,#I#U!/3]K!#R[<E,=.T#&98@K%ZDS5#KIJ2V
M+'9*[G596-%5#RL9'=L<$+\$XD_R0G$&%;WH6Q;+$77>&4YS..6L3#_5)AB8
M#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P.$W_(R_TTW3_$[Q[_`)C*_P`-/:_MX.[.&9@,
M!@,#A#1?_8A[R_V\.3O[Q)KD:3_E'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`Y[>IQUS:?%'+^[EI6JV.Z[.<;=I6J8C6C^]+8\DE+M;E
MC,4#2-R5U0EFF)G=0>\A`C\8?)VI$#1G\SVX=88QE-3PISSNGUMG9AK;I.V:
M9K^NWV"U907I[W/7SW83[)&<!Q_9EV2RI)PT6DE9$JM7'-TP*,F;6DI0&+"U
MZ54G.!H16M9'<>WUXW/X?:RO6K.YOA?)=B7,IYUN"!]%//5;,IE_*3_8<F:G
M204S'(R"IJZK,N<-+*H=)_9%E2$#`LTX^[-R(T8#?/"6$P821[=S,1>BTK_Z
M^]4&B8WQRZ2"F>*6B4=66]6//[I!7:?7.Y+:EMNUR+`D3>WNL@8(\H9I7&(=
M&HHF2.2]%HLQ4[F'[2D;2A*,'2,<)NKT2=N]3:PVCO>`<E3RK83NJ##85SK;
M/1D2D#\=&&#U`YE3#G?Z"CXJA=D)0U<*7UTT>!,L6B*<=.S@D2FE@&(0<)LC
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M;G`*OD:-,/-]AVA#VVNY!,+0#TU:3#7U!M]O`F43CZ1A-@.F@;HY[2*?.6@&
M6E;U8]!\>BM#)LC;$ZZHMZ97K#3WLQ]6%6K$N>T]?MW(K)U5.[3Y[L:82Z.\
MZ.3BO(`IH7HI-+HTVIHO:>F$*YU)+1."G>T;0K$80``0&;&6$8QI=WS86`>M
M':$FXK[KZ'E_/,>KRW>:JCCG4=,52]R-Y&@M;E:Z(VJE/.]C/ROW0AU:W62I
M65R2/:9*686W+DNB]"]HO#A9]N+B+TE3[_ZZMOLU?OQP8SQRY.\8ZVYVYR7]
M)QJW;#E_%C@R7Y3%@6PN?$TV:HFGE2:7U$JAI#7)&L@+D4F.7%B\_6Q>`,/C
MB^?"?NZ6\W=T6!;'2E6\_P`C24=+&J<\$*NP%%LT?()D\0EY>Q7UJK&ME@^Y
M:W-K@LARN-'E+!*E91:OWW0P:#Y7LWNN9QK&^]-%V7U1N^[#J?T][=KJG^/4
M3-W[8"FEXVTS:8W46ZP2RVM!=CZYNCV)ACRM(L@HV:H=`(V0,;A[VLUXR]%A
MV+1ULQB9B;T6T=ZJ5\GOLQHB,T95\KZE<^_9!PG33+\^)1':F5G5_P`X0;H"
MU+HL:0J&!WDR"(0EJ?''9;>W(CG%Q`6D)+T6:::,LFR.-Z5;T](>H+V'RW8G
M,=!W&AX>K*=WFBLIZ<NBK*EMW1+DH:Z+22+,\(I6-2`^.GN[3=,X;9"<OV!Z
M7)VXA.A%[MM::8$D(C&,KF+K\NY)(MC)*&+98A#+`(0B1;&3O8@ZWO90]ZUL
M9>][_F[]G\NL,WTP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.$W_(
MR_TTW3_$[Q[_`)C*_P`-/:_MX.[.&9@,!@,#A#1?_8A[R_V\.3O[Q)KD:3_E
M'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`UGZIYDC?5L$A
M4#E$FD4410B]*+OA`XQD#8->K?J'LZ.6@PLJGXJD6D!:'ITC9298(L(3PIS!
M;*&`?L%HZQRVS?9SQFOHCT3('#N5=%+;MBNRNX9K0UB/+6R%0UU:*?EU%6ZH
MO5.LJ]M?X\O2$-<UM%Q7.SDWK@JD@5#@H\@!>C-ZPL>Y-1'1=%@>F5&NA#Z4
M/[!NN:=4?FA;>F(VO13B"5)#V>QH?TQ`&JOGJ-2AEK6&15L0AA2!J"K:%S<6
ME<"UV]'&'"&67L(C.OZZ)(A]/%"HISCJH)YT)<%GAXKZ&@%\5W/YH"*+)_+D
M]7-\P9(+`K'>$S*G(D*%JC\M]S/=0$IW9:%$2:><,\1QAA-VLS$<8:YN_H9\
MH/<>DK\N?K#%U-(N@U'3X>Q"W8)5MLUOZN(BV&9Y:8^7L-;%-\>1(R(RE3&-
M!FM1XK1.Q;-WYVCKY,O_`/-<%N0OTK*M@%C5E;T8LZP6RRZR[%Z3ZT1RI,BB
M1*E_0=7B?!7#0S^26RA`KJIU$Z)C$VM;TX)5+6E."?L9>][).<SIRIM7=G+D
M7O"YN3[I>Y-(F5ZY*L><V3$V9H+:QM,J<IW5<KJA<W242Y&H6EH$+5+#51.T
MAA!FU)0-"%L'B#LYB:B8ZM99KZ7M7S>D^RZ1761/T;-VCU"CZFF3ZE2Q83S#
M90B?Z<D`(Q$_/9C$AD=&HIE&7L2P"A5X%A_L,]OE["7=-Q/2'LB'IY/L!N[I
M&RHAU;:S16G5EB2^SK>H(<$I=QB3K)I=4[34QIC;-G"!J+/94K:VQYO6$EIG
M8H`E236C-"+,-`,;KB(K6%`J/1.J9)6;#6,,OJY*_;#>$8IZ?-KND5205$Z7
M/3D-DK0]LDAEHM1S2=%8J9G`],@7-*`/A:)&L)T#VA($6IU\DW?>W[L;T*>.
MWDNQD-)FS#F=BN'EZRN4;4CE:KBWQFF<%F[E%WN,O2DBPMRH]NDM6N\;$8RC
M2F%)]%."DHXHP!FO9*(]S+GKJVWZ>X2CG0=;\_06(67).?';FJZH/?%9S*LX
ME72]2CF\#C$JC#:-=%I?&'R&+4*PF6GGJ"QH=Z&<`/\`Y>W6ZYC*KO6U863Z
M=D^G,NJJ[(_VY>5==30*EIASS+^@HU!*+.6VW4TREI$V/9Y56KA79U;LKY&Y
M`C)4,SDS($!R(T`A#"?XQ:PL91&E>FTF8/3.I6&5MP'5$+E$]9(AZ>]G-]IU
MN%6N:GIXGKZF@-BP=QU8;HM;-"4B?S[,<'56:A+1BVO\.B]%D^TO!.<S,SU0
M&9>DY5<J56?*6NX+@@5LRSM!R[JK&X(4?$$4PHNXG6KXQ43FUQ),ZQEXCLG@
M#]#(X)(ZM+ZC7DN2=::69O7A)$6-\^%4]-^^G;<74%$BYYN[OBWY3`9DT2Z*
MWH4BI#E]H56S$)0Y(E*9I0CU5*PNM'6-M:8U"B=68(%H0*1GB$)4`@XH1E$3
M<1#IC%HVU0V,1R(,11Q#'%6%HC;,0H4G+#R6IC;T[8W%'JU(S%"HXM(E!H1A
M@A#&+6Q"WO>][PX9[`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`X3?
M\C+_`$TW3_$[Q[_F,K_#3VO[>#NSAF8#`8#`X0T7_P!B'O+_`&\.3O[Q)KD:
M3_E'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`X3?
M\C+_`$TW3_$[Q[_F,K_#3VO[>#NSAF8#`8#`X0T7_P!B'O+_`&\.3O[Q)KD:
M3_E'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#`8#`TN0>HIQ`Y7#+Z`3=+U@&Y
M8(XS)FD]?*W<]N?D;U7C4>^SAC1@<$B5,^/D69$QBQ:B0&*51"4&S1`\O6Q8
M=;<JNM'VHOU#N(>E4LP64CTW4\Y3P"&@L:9B(D0&0R.5V,!IGYP7-/)2F503
M!``)%XWC0=MI?L]@CM;WK!..4<8>*IO4<X?O5-/U-2='0&<_FP@Z^SIBC:!/
M07=+6K86H,6V&S,:UH2/,O@Q>DP@A=V<A>WF#V$`#1#&`(A..4<89>1=_<9Q
M6+Q^:O/0]>`BDHHAQZ?9'UN7K'U`IYY:5+"C<;C/,8D+D)N@"19)D10W!3HD
MGS#1!]OB*-T`;<NBY6V^J;>K+8Z=9;%C3S9<DJTN[66),ZW;HX+:D4.Z5A16
M%HU`6H0D1AT>%@$Z)2::`"TS0]$>9Y9G@)4U?)7C=VARX\]$+N4&6YHL]=!M
M7O);Q7#,!W=ES(M1QT<M4L[Z\MS8IC#)(B8P#:\3:K6DK_=?89Y/AWK>QMFK
MY(A7GJ(\16S<(Z#KCIBKI=;`G*1LK=%FE[,,+DCW#]G?.UCADB-3%1:<O<7T
MG-VXHV=<N4HM$F;.`#18]A+MRB+K1.A=A\QAI95T6*YX;JD$4T.KI59/O2KY
MN$3=/9OYFCHT,_W3WC3D7:/_`,DV'R_#[[_-]OA_G83;-U6J-S?O'D"NKM:^
M<);?4)0W@Z+HXV?FX0#=9"_,SA,#2R8HCEWS<;79#!U$E&<#:$+R<@VJ`8$1
M?B"(.]EC'*8NM%,R'U=O3=BI42/?>L:\1)Y]'F^5PE0!%,%J>6,+J%R&@6Q\
M]!&513J(\#.J%Y).QG@`G&(0-:#O>#9ET69'/42XLEUPCH*,W_$WJWR5&TBJ
M$($$G-<$"L,,+L,2-S6?`=-+8K!"C0..RE"@HS1`P^W7B%H.QMRJZT??GOU#
M>).JY-J%\^=+U;9TQ,9#9,CB;,^"1R5VC2<>BE,B86)[3-;I(6%(8+03EB$I
M0F)%O6AC#O>L$XY1K,:/5>_?_&?,5ALM4]`]$5Y4T^D$?:Y8W,,R7K&WPQ=Z
M?EL7:Y$Y.NT)C*QL:R0MQR0*I<I3D:.+V'8M?R>T1CEE%Q&B1O/:'*\>CU\2
MI]O&#-#%S%(FJ)WVL<%YZ4RL9%($3&XQIJD*`U*%QVHE:.2MXVC:<H\#M[V4
M%((X0M:PFV=.[%=%]T\F<DBB@>D+JC=1ZFZ!0Y1<R4H)(`AS2)5;<@.%[P@9
M%Q"([WYW3$A)4").,-."``1"_DPL8Y9<&2KCM/ENW`/`Z[N:+R44?JA)>3XG
M)*>$"UIJ1>]RZ.(IVX('9K0+4K(I>X$\)P"&7HP0T!F_!X?#L0G'*.*LI#ZF
MW!T6<*L:GKI2#$N5V5W"+;JQ$C2R9W43*M+)7'MD%FK:6SL*_9+!)EZ8PI,>
MH\G6Q@WH7A]F#9E/):O1_9/,7(B>&J>DKBB]3%6$K?4,*^<0'8XV1J8PWIW6
M1`;D[0VN2@865L5`4*1B"$!)._&+>@ZWO1(QF>"'6?ZA?$].0RK[!L'I.LFN
M)76R#D]2.;2[G3`VQ(L2B3N*R51)JAB20/#S%FU$K*,6.1*<2%&$P/GFE^+7
MM+&.4Z5P3J;=@\NUUSR3UG,KXK1FYJ5-<>>T=UBDR%=7R]KE;FA98ZL;WYL&
MM3.!;L[.)*<K1/F"\T6];UKPB]A-LWMK5&;^[OY!Y;W`M7_?<%K+5H,KS)("
M8^*'`\B3QR.ELYS[($"AI;W$@+&T$2!$8H5FB+3E%J0#$/0=^W0C'*>$(?9/
MJ8<#5`^Q".V5U;4$173V`1>UHDL<Y'[8Z[UE-5:U#$Y^"7)4ZB*)(?(%;<<!
M*X*%I24W9>_8/V>SVEC'*>$-M)!8L`BD"<[3DTVBC#6;+&39H[6"[2!K0PQO
MB!#?\5-DZN3*%0&<E@"V?^X][V=Y&R=Z'H6P[UO#FIX<VJ];>H]PY;T2M6<5
MYTI7<@C=(PQ19%JJ1*71G7PVN4R)8XBL%Q87UL:W\^"GHV\X9#PG2G-RG1>]
M%'#W_)AU..4<86;1G6_.?2L&D]ET=:3+8,$ABHY')9,VH7Y`W-9R=E32(WQB
M?&EK.4D!9%9:G1I(#"A%CU[!;W[=82<9C25:4AZCW"W2"IW;Z1Z@JFP'5CB*
MVP%S(V/HT;^."MI(CW&9-K"\)FUX>XLA*#[3EZ(A0E+WO6A#UO>M;+..4<81
ME\]4_P!/&,+Z[;I)UI4C`;:T!@5IP)4\NRUL:'RNK14*DE>S(Q]6-Q+(S,$N
M5(C2T1Z]0E"887L/\F_Y,&S+HL(?>W((>@C^5@WE%C^@DDA;8HMK-&BD:UY0
M2)XCB:7-;0XK$;(>R-ZM=&EA2TO1RHO0B#`[]O\`+K6#;E5UHK^1^J3Z?\5E
M\T@CIT]`CY+7:ET;YJG8$THEK;'G=C-)(?(^MD45C[U'-R9E.4!"L;"U8W!+
MO0O-)!X!^$;,N-/M#O5$]/Z?5[8UL1;J>L5]:5*E9%=@SE4J=F6,Q_4D=5S"
MP)?BKXTMJ5T=7E];3D*9$B$I5G+0>0$O9NP@V-F5U6K+M_J2\+N=+3'H5'TK
M7@JBKR4L4(G\G/.=T2N$3"4+VYMC,:ET46M2>91MZD*QW2A0IUC>28K">`96
MA`%H6#9E=5J_1WJ2<*$TJ3T/KIZKU50J9YNJTTI;G54ZJ5-GZ)VJ'6Z:*MJ%
M7,5$^+0ZVI&S@;]N($NMGB)T3KQX-F5U6K;"!SJ)V="HK8D$>2)%"YLPMDGB
MSZE)5)T[NQ/*0I<VN!1"Y.E6D`4I3@B\!Q19@?;[!!UO6]8<S%34\4MP&`P&
M`P&`P&`P&`P&`P&`P&`P&`P.$W_(R_TTW3_$[Q[_`)C*_P`-/:_MX.[.&9@,
M!@,#A#1?_8A[R_V\.3O[Q)KD:3_E'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`_P`X=>>F!:$]F_;MLW:\VP@:8QWMU[TKR?SDG+J]!`)K-YI2B:O*^O==
M)4#,KLEU$[(9`X(T;.K?4#82H3`..2?^KQFN^(J(Z1;12%>E-W"OYRDM(2YD
MFDUFUT>C#3E'5E.[4=X.S(N8+)K*<1>8V?P8];@!C8WG5E;HVQM"D?U:%W7E
M%MRA.K<CBM`\PZWXW?3+ZETV4"Z&O;JWE+J=+P+=7/D3X&YUZ;+F40EY].II
MW=4XM.NHU$8MS%1C9"9_)&^30AH=8X)R"]N:AJ9!*"$.B0@%LT0(XTC&8N[E
M6WI9<+7UR/;UCL'0E`Q62UKW91)TYDBF,:;7N%\;2#<RGDCDGI][;WJ1N:I5
M0A+);!RIC/;$^VU2^EO!9Y?EGHS-5<\HF-)UB?/NVM]'OBEZY&A?2`Y]%9LU
MS-XZ(L"L:S>[(DQ$PDH>,J.?'"(<APN/NI:YP$WUW&*\4FFMJ(8BU&CEQYIX
M-&#]@3G/+=7V_/-KLY4+TS'O4$LQ@Y`A75%-4+TI-;K>^X%UL[I];RJ[.\MI
M%3%HYT5S([I)>\72SW&]3AO8`J6XDA,WJ"$9XU:=,$LH0XMQM]57'!3U2<[]
M5RRAO2SX*=^+9E2<EX$Z&YVLFX^DG1ZJX5%?-;F90ZG/$FHJ0,$R=9W.)5TE
MHSR349S&WFHB7M?MUV'P;\TLS%SE=W"N$5-=<.GIGV3P@/B;HIKM)OZU=+H;
M)@YEU"75$JARSU+&:\RBXX_)+95R0QRU5SJ-SV2J:$H=%HE`/'YFBP&EO&,M
MU\OV=!.6V>^.-+L[%J";\BV]9S/U7VK:G0->]34X*L)+"7.#W@I:=MC5>&Y%
M/XE.H*Z4<B3;:1A^&N"4]H1DB;_,%OR17FYFLHB;C2&NG.W'O3D/YP]`R'2.
MH9&T27EB_P"8RKH5H.7QT1]71YPI3I*,HG9^&G>S4ZQ.I>IDVI0Z0#6&>):'
MVAT'0]A+.47EWC]X2SG>F^C*S]0#O!?)J^[<:J\OSI*RYS71T.4\_G\82V-/
MO,\,AB"96H4[.X[Q22O<FC!J1)\,"2GTH3-^SB=E>>+<)F)QCA<1XJ$XMY>Z
MZG+!Z,M7S?D:=\X:]-7:^6W7?UL/M6IG62&_FFFU="I.EF6"3N9RZ1QF?N,I
M3*GM:YDM+>2E:RM>`T_RPZ$SC&Z;NWK]7_D?J:[.M[5?J?ICI*Q(A:WIV1[G
M^/#IM]I9EJ>;6PFO.?2\JL>I3;0D\>?P4*L:7)*:^[8#$KF:B4&%DJ-#%X=%
MPRQC'6KOZIMU=7I_/%B^HAZ?MVNE7J2H#JKW%?VDTP%]*0T>]VWS*QQR0<;'
M3.*K%B=QF`:XL.8R0R-GF$*1@+0I`J=Z+3$AW7,95C,<^7[MI?5LIVT;XXFE
M5;4Y#W.=SI?<7+4@2QMH4-J5:H9(/TY4DVE;@$UV7MJ+1+'&(^K7&ZV;H8BT
M^]`",?A#LGMS$97/!IWTYP]T%=G?G8%JQ:;=!TU7DB].VKJWA4II=_J]I;[C
MLQDEG0*]SJR3DSB*3=>:D;$<D;Q^T@EI_FN8O8KWOVZ*+CE$8Q&G%I71O,G6
M]$W7P?-)'3W<\88(5Z5'$//<^^Z4KYS4:1V_65ARI[G%67@1;4@4".@C$V.9
M>UAD?%M4(!YFB%(A>SV1U,Q,3&G]IXM^_5TI6\K$NK@*QZEA?5$@CE0O?4X;
M(D_&SG4#7>D+3672:>%1(V-J+K<T,,`E?WX[W1:8,!IA2'SA@V69H`\KG"8J
M8FN7%JGR1076W!$UY8Z!L/BJ1VBWE^F[$>/Y-5_+J^N9)..=+`KZZ)O8S2#3
M'-K'CS4ZL5QQB3H#)2YL[TO)2RIL,$9XD0B#@EF8RB8B>=JWC_IW]XRFJ.2N
M7UE,T['*Y;[H[![WO"`W6Z+I3SM#WJX+&G*:@^0/_P#E;VFD4D=Z]9K@<Y(K
MVW!`P$.C01LL\T.B=&35=V-S//A_*(IN"_4PLR)<:5`\+[(I"U.0^5O4>Y%-
MZ5B2NNGB+SM&FW44>Y7=3=S$F3/!M<7I!(\0F6&!1HY$D,:5`Q*$)^P#&-V$
M3,\8F8_E:E6UITK1DWB$CCGI>VM+XC/O1QYRY"1<^M4AIW5>UU<$&G-N&2^I
M[3E=E6N1Y4`1II"2:8\`T^FK&Y7HS8#3QC!@F<9CC_\`J9;7SOTZ.ARO0KKK
M@EM7QFP>@:OJRAA.$75/XT,$LAVI^SX7:CY2&Y*\`"63$)"U1HZ+(E:T):;9
M'D"4:+(V9X7)(SCY-W)0G65/]2=Z2NZ;OAO&=N\^-]?>E9VKRVSQ.W5-5L]G
M=!7'T2R1OYI57'6.$V'*VPZMZW7Q,U40[N2]$D4NKF'2,OR]'':IC,8Z7$^J
M)=;N:N>K`IGC#\VDHLZY[?G+U3:,D:"XG:".CW"GX^J6N/FUK&%$*B$+;28V
MT/",8$X5>URC1QH]C6&`V'PG&4Q.5Z.''/7*O8EH57Z5M:2/CJ?T`M].6A++
M06Q<%J/]4))'8DE?N8)M2B&A:7983/9C(WV'3:225,X.[@\!:&\HAL(T$`S]
MAUJ-)RQN9N[G]VM+CZ8O>+Q0X$2:MK);-0WTEO39JF=\Z!=ZW11+K.34A8EA
MOU]<ES=_VM42J..R:&+MDHG!C>&0G:]T`$Q8I(V,`"[\;\9=,:+I_H>$>I-V
M!,'&ONZX!571=KU^_P!;.-;:Y\^ZZ-A-Y!@-;GR&]VY_?C;A02"`2MI,2DEL
M(BRPJFQ-O83BM#$.N9F)PB-+C_K83TGRKNY:I"D_3]N7CRVX-*Z89Y;&7WHJ
M*;K*1<S604UN#V_);9(F2&P2I\7([</5!4JVY='0N:=X6&Z4^PH.S\)G4S.4
M3_UIM$^+^K(QZ<7I^E'4>\R^SN+_`%`IGU987+RQ^AZ&2V370+[Z2<$1,66.
MS\5!ED[9H_:#=+6!(O<4Q"E2D`4(TE2(&M3DNZ-T])BOT0#JGE+K?L61]@=+
MPCG&VZ`17<_^F!5M>U](E57-M[R%-S1U619UF=-RN,HY1,87&EE>Q20;1L*=
MS5KURI"SC&<EV2(E,87'+'&HF;J_S#WJ^)[.@-27HS6U47;LYZ3K[U)+`Z$H
MGM7E`VE5]XV2MF=.?`JWZ!D45FTKB]6&(&V`':K>51\#,C:]C1%G%("25!JL
M!-T3,555PEWUXL5=-KN4Z(5]EHV!OZA45\T&72CC06DMK)F&_.\[VE1\]3'B
M'4:#R!.!;<8-N+7B."E%M/HO>5GE5SMX-G\(8#`8#`8#`8#`8#`8#`8#`8#`
M8#`X3?\`(R_TTW3_`!.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_]B'O+_;PY._O
M$FN1I/\`E'WEW>RLS`8#`8#`8#`8#`8#`8#`8#`8#`8#`Y:=_P#J)/G&MM\U
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M+U<JKDS)-[=M")U7`DK4P)JCL!$^,)KU+B3G%8-<D-1IRQ[`G/WKV83#&,IK
MFIA_]6%FIBS+[I3JZ/4?0=ITCR7!NBT;4X=*L9S#9\RF:JWRQ5)7;O,X77;E
M(53816R'8EQ"`Q0,YY"7[D'R@"/&RXO&YB^BK8QZQ$PGUR\ZU#&*?YWARR\.
M3^0NHE2F^NP$5/.GBZI5.R?57U2P*Z@?U%NS:&;9QZ"008W&.!IZ<'ED;-UO
M1=D1$S-Z3/+HZ"][==./&M&)K`A]5.=]6_.+!A=1T=1+(_%1EYMFSIJN-$EC
M2)^.:WLMI+;8PU.CNI/$D/"!*VF>W6O;XM'...Z:G2&F=P>LU6=8QSTV[1:Z
MU<I?1_>S.^2R7V*EDH41W-L&86>NCGR8R]CU'UHWYIA$AL4I')-Z/0":"$*I
M0+QZ*$#1U&$S<<X5O:'K@M-12R&HY7STXF0%P[JZKY'L>=-,_P#?OS8UURVH
MC!,DZ.<F8$,\;I%RD<F"XNS>`XH32UI#S]*5&@;U@CV[X3K5KZA'JD"F71,#
MH8-+A1E3?O+J_BHN6`GP5841',M%@N@FRP-6HH3I8"<!,T@TV:4@TAUOS_>C
M]?T>$G"HOM$OK*/5&VP4;V99Z"D54CG?./:;MPS3U2-DW)"\=&W"M=*PC=:M
M[2Z'1K0(FHFTELTHLXC:=QTW(T1RD1AH0["$;-8B^,6S,:]3QAF=;^F]8L;K
M!2<5WM=)E%R)B<)2%$Z4/.6"N;7DUALSL$+`?\Z76"SNI'".J$_A;?-,UM1X
M@:#HH0V:S'2%H^I5VO).".;B+PA]+GW]*G.T:XJZ/UBEF`(,K?7:Q7D3,A]T
M?1QV4!TK+/UK11&TN_/,'H/C![?;A,,=TU.C6QR]7R+.76G"/.=8U*?/H9V7
M6-?V:\V_J;$M26I$UPUW9UEU+'E49!''$<F?I5':A>SS2O?4&TA)(![T+QZ#
MA=FDS/&&NE?>N++9EQGT#V>HI#G(<<IFK5=@HZ@AG9Z":7H6O*M9-6B-HMVO
MR*8;%-/-3B3I2O*<#S7'Q:+++T3OS=F%G7Q^N,;_``MBV/5%Z6K/D];UNR<]
M<>W3`(W/6J#3,^C>_-V2SM*R6S.LZ_AA+5*&7G`;.[OADFL'?QA`,24QJ1)R
MSPB4[/\`++)&$3EMN;^W\O'T#ZN%U<TMO24?L#C^//\`=7.M.<DV4?75=7VJ
MD+-.I'UAT9+:&CL#C<O=Z@CBD"IH*8$C@%6<V:TK5+MI/**"5[R8(PB:J=)O
M\)7)O6HJ&/-5D3E'6DGE5;1+C/G+J2(*XV[HCIY/IOTG<\UH2(<]DPU>B0I(
M].&^SXN0SK3U+CL*1>>>6>25I(,0Y:1A,_>VWG)_2EXW!-;!@E[5[S/5TJAS
M0T.AL%ISK=MZ%LF(N"Y4:2Z16V8@FK*`CACJQEF)?:K3GN")2<?LLL6M!",R
MIE$1PNFIMG>J3<+.'KJU:7X_!;_*?"<]F-=7_9BNZT$*M&3/E3LC8_WHJHJI
MC(&_MDR;*>;G$?O`WB0L`GE2D4$(=;$7H8SJ,(TB9UEFX7ZIP[2[F<>5*]BW
M/I,!;6KGF2MU@V9U`DKBU[+B_0E1@MQH<:4H-96;HX62LCS2,):Q,6])1!T,
M`Q"![=AT396.Z;M85Q>H-*8=W[!>#Z_K2KE<@=ZW@UMR"77=?`*3-E<5E\\>
M8:X1[G2+?F]FJJ[;!AJ!@4.3F@"I:R2`&)B!'!$?LPL1C>.Z55-7J0=*LG27
M1=-7'RU35?U]R14\>Z#OZU&3J"0S%6RT?+FVU'9@D$/A8^>8\9*9:6@JA:->
MTG+V\I-YQ>BU9^]Z]I=D5$Q.LOO5WJ<W.K=.19?T5R&EHKGCNY_:(KS_`&,V
MW>@L.<1&336$/-BU0Q]!UX3`8TVP93:418SS$QC,^2$IJ7^!&MV`0O-"2<(U
MB)UA\85ZEW0-G\_VCVY`^18L7Q/$:LZ"M"NIM,K_`#62\+8CE+Q6;N\;EJ*G
MVFIY"QQ6'6B_0[21#[Y)1.R9O6%N`T8@^Q.(;(B=LSZD&3^LPKE_+_2?9%3\
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M3VRHA<<A+[T'6C]8*,3S8B.NI6K7M\<,9/<QF%,@!J-&>9H`/9Y>Q&/JF)Y*
M$L[UGI!5T!E*"9\T,-9=+5CV'2W(UO59;W0+)$*AA`KZA+Y8%<W<5T,@@CXV
M.%/OT8:-*`K%#&@5I_8>!002,GV&%CV[G2=*M&>@_6JG5`GP9"HI'F*>+'7C
M^7]@R9QBW<[$5")''8K:+Q7Y-<\XSE=3'PZ^;)DK>A(6-B`DEJ&L5F&HBO&,
ML)AL6/;OKQK@V5A'J92FV.UD')<#IB"Q$#+6U!VC/]]`7B74=W.4<O:$&3HT
M5(T6"O90JM,=2(0:0R<8WAK*2N^C4>A:$3L8ZYG"L=UNN&'!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@<)O^1E_IING^)WCW_,97^&GM?V\'=G#,P&`P&!PAHO\`
M[$/>7^WAR=_>)-<C2?\`*/O+N]E9F`P&`P&`P&`P&`P&`P&`P&`P&`P&!IC=
M_&,/O?J3F'I"9.K:XH.;8C?D6+J]^A;1*(_-QWDVP5O^++ESLJ$!G4Q`4)T8
M0$"-3M1M2+6Q%>'VB.HRK&8ZM2[4]+NQ'Q]ZO8*)[#DE`<_]S/CA)^DJD1U%
M%IW(B))+8<TU[:3[15E.\A:QU2OM2&LB=.XZ6M,B*1J]#5H0)S1>S18SX7%S
M'!#YUZ*%3O,HL^=UY9)M7SY4Z\+/7,LV0UXU/TGY95<-1EMAL=;XX^+)"C=Y
MA'+-BB`3:_-YA[:2<B/&69Y^_"+18]R8TGAKXVW[[3Y53=D4@DIAQG"FORTU
MLT3:HI$WL!,A,,44E;\+MHID"UJG5K``B2'P_2$9_GB$E`HV;H!NP:`(YQRV
MS:G+'].:`VC?W5U\2R0-#TMZ:Y<@G-B"/O\`7$?D(:K,A`+9""P8\\NB\Y0O
M<W05HZ$-($E$$&VTK^G'X_Z,1E,1$=):W07TEYU4EKT=:57=/PM,?5/)O)G)
MLA;+*Y4B]I'RJ/\`*QSV8CFD4>W*SF976,HFH9`?YPDH%WN(P$C",_90<.M]
MQ,3'/JVKZR]/Z&=F75S[8-O6+/TE;\[MMCNL7JJNI-,JM=7&W)VD9H^W6DIM
MNN9G%IPUJ(9"TSHV(F]'LD!NGM2,T_8/Z$1SCEMB:XRU8J?T8*VK-RJR,N-M
MOE@<]4U(^ZR(+1<PBYKL2FIWNJ+L#)+:6=YXYS%S?7UEA;JC=5J5R4DC6KP.
MXB3_``B)T>8=3[DSKST_"/\`-WHEPVC45'L<XOZ2W]&ZDM#M*=21ML:"MPEE
MNQOLBITE/O4(G#H"4+1G?->-)-;/<?*-,>AC'YA*?Q>W)1/N7RK2/PP54^B:
MZ4/5U9LM4=B34B[J+Z_M'JRG;LGU9,\[`E26G5Z>EWNIK-A:J8-PK$915LE+
M1&.Y3JT.8U!8%(/*$$0!T^2YUC2DP0>C#')&UUNSW?TE95G($'5]V]QWH7%4
M3E1ZNY>FK1C26)PB4QY^J^;-,HIR+4HTE#VS-K8N6*5!^P&'K?Y@M&#Y)Y=*
M8<GT8W"OFZ,LW/'5K_6;-5/<;YV_1""P:T4WN.MI%.*<DE9V-7[N[R^TVJ16
M$Q2J32UQDX5[@M`X)W%:<`8E&Q[.Q1\G6.5-[+KY'EO1%.\\5_;-SI76<TKT
M'SUT))["8:R1L#59+]0U@()V)C!`A2YS3P]KF(D&DA@@.+@)&`6QA"=O^;AS
M&53-<)AIG0_HOP.@YM6TQCUW2AZ%5_:\GZHCB)[B*`XY%6@J2LBCZGY@;7`,
MAV-L@E-,%EK3FUP"6,P\>Q@$E*T;L0#J<[\D`A?HMS2-\5W1PJ[=80UVJFRZ
MS6P"-2AEY)BD3M"+KE=IIK-+D$OF:2U7!3:)"4?O*$*%46A!X#PF^;K9?@&/
MD]495JVGGGI[3VXN+;#Y'MF_8*>LFUD5U.$%AU)S-&J;:6!LKRQ:UL9.PF5D
MS6"]M+PXN[C`#"#W/:]./1*X/]#OW8.C"1E66Z&+Z:]+UKZ0MR^[7/NMVAJB
M\XGQ'%C69)!T3P7%]<8=(.?0Z!P3.!TE;C',RPE3C\*.`(HC3:6#2@`E`M^5
MHL9U$17"_P`PIJ1^A[34GLGO*4*KAL-I@/;$>@(6>O8VW-C8KYPL6#6NOO\`
M!8M42Q2K<B_,77TY*)8%K/;`(T[BK4A]IA)X@:'R34::POWE/T_;#I+JJP>O
M+FZ`A=TVC.Z+8J&7J8+S;%>?@OK6Q3I7/-V!81D<FLL!,[*=UZS:=4L`4@3>
M[EE@+(`$`0Z).43%1&EJPM'TK)[)3^K*\J;L64TQRUW#.9-871U+(ZFB\NF(
M7^RV=LC]V@I:X7.0-ZFLFZY6AL\+F4L99!M"I4J#V\289WL`(SC2XUAL]0O`
M=5T+T5?5^LVF5\#;$?YLB\"B;E"VD1]),?.%4'U,T(HG+U:MR>%@9$T#*-.%
MHM&(CR=`]IWMV/"3E,Q$*R[T]/66]X/T'C\LO**0ZAHQ)*SF:J().?(O)+M:
M);7$]23@Q[J/HIUEI#K4:N8::D+<N.2,BM64B(-"2<'2DS6BXY;?NM95PM"W
M[HCL*ZYK)E<IB_9'.56\V3BK#&8MN1M,2KU);38[K4\H(=#5K@=,6NV%!(RO
M=4_N?NH1`,,V9OP$W341TEK-57I=V&QO7*<=OGL*1=!<_<.O*&2<WU(MJ&*P
M1_42**PQWKJL'R]K(:9"[#M=?5L*?5"=NTB:8Z4K6;`L7`4&A]FRSG&M1K+Q
MPCTP+AK&B;/XR@?9QQ?$\TK*_*OA%4R^A&&3VG5$:NN*S1F:XVQ78AL"-[?H
MA6CY,1+FQ.X,)CD:D2%(#%^BO8:$;XF=TQZD)4>BVU,E(=*\VU=T>_5W1G5O
M-46JFSJU*K9J>(RT7['(TQ0]SZDK9N#+&DB$O=C,#`3\Z(V5HUO=W`(%WO!2
MD(Q&Q?DUB9C6)7/<?I(4+=D_L&02!<3&8'9_"K_Q++Z_KR&,$+4'`>;+CEF(
MKD;90U&!"DF<<=HPF]Q3FMZ@D!I8#!&""'90JD9S'G;#-WIHVW/9?&9QUEV2
MZ]#/U147<](\_P#PBDXS4K?"U=[0,-:SRX;`2-$ND9MFVJNAA>D(#"S61G(*
M.5")0EF*=C`-\1IC%:JS2^E/TB'GGF&@W+O..KB>+K'YWL/FR5$<B,:`^-&\
M]0>8P)J:IRS`NX\B?%R)JDB4P\[SVX1)R`0M!,VHWLLN^+F:X]WZFOHV+9I"
M'AS>.JWN4]0S?L*GNQ[-Z#LFF8?-(W,)-14/>X)6E8):*02&)Q5@J6+QEVTG
M2MVG!4?[`FB.//&=L0!'N5R]-4S5N>CG%NCSUCST/:L7F4J4<03/D1J=H/0<
M;K-M@4N>;A-MR#]#U6R)9A(=5W-JV5E)$R-(B4?TYB<1^U9>CAD:$>Y7#K?\
M)I<7IK6ET797*THO+J*,2V*<P3"B;2;1LO-,7C5YO]H4TW-PWE:VW\*?/#U"
M8);$N0C<WUE1-AAPR%!B`*W9&]"T2,ZB:CBZXX<&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&!PF_Y&7^FFZ?XG>/?\QE?X:>U_;P=V<,S`8#`8'"&B_\`L0]Y?[>'
M)W]XDUR-)_RC[R[O969@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<)^L
M*YM0[U1>/:JCG978=?UGU'"^II_/H'!;1C31&F%SH:-TZ?"VR`I5=?N2J.L*
M]1(UICHG,.5"6#.]H1E:U[-FD3&R9J+AHK+^ENH5?$_47JD![(M*)7U1_75H
MUQ#^04RV%E\]-C%6'2@*5C/+,RJ<^+&R.26':40(+4C>A.)<@^)/290B&4G+
M`6,ZK'=&%:3#H;ZP%F7_`!X?I\0JCG^\HV[WIU,Y0::PV@K%K^J[.F["3SO;
M\U+B#98%FISX-'QH)%'$BTTU:(LHP"(181>,8-;.<(C6ZTARB@'2G;'1+AZ<
ME=H[GZRN&02WESLQQNYJYAM:C^>Y^NLVBNIXK4Y2R>2NTV=BK^3NE/LZP^.O
M"EG"01(G0.W-``Q*9[=QW..,7.G)VD]42[[PYZ0>GJIH_<[E#],.\:EK:5UW
M&9)$6"0W7$%]4W`XN-=NTCF2EIB:8I\=&)(K/.4JD1`C4FM^:#VZUNL\(B;O
MHX\W%V/W%.#+S8P.?253RYR]:KF?F]IHJ"6O3;5;,3J>:<=)9@^TS#+2VJ>Z
MD9RY9*PA?`JSG`Y*2<HT$P\`M"#HTC'&*X?UG]74KGF?WG$_4)YZYWG$SO!%
M#SO3!L"UI;6=YV#`K*FP+7)ZCA[$DD$ZFU>$BB,HE[)&GLYL*5-AXD>D.P@U
MH0@['DYN)B)QF>[FPJZ8ZDJJN;2[.:^S+8D4_8/6$L+DN+\D3U=!Y34MUU$H
MZO0U`DJ2OXB9$4\ZC<ZCD%>CG-`ZM3KLPD+2+:DHPC8O#751,[:C^MWX.K_?
M]A6D_=;^G]QI&[IF_-]6].J>BY!9=HUDO9([9<L<:2@\9?X92,$FSZTO9,-<
M)DJD*IS7'HR/BJEO93"$IA7B-%AQC$;9RXS#D);'2OJ!(G51R]SGU-*9[,J+
M]7!-S[3US33<65+;XA33Q=+>H5/,]YOK.QMC++%#!/V@,/>7DE.E6>6I(,4^
MQ20;L4:1CCQF--O[TZM^DWV2\=K3'OJRRIC*'RLFWH&JVZJX;*]$DK:>;G#E
MJEWR?U8<B`F3G-KM$;77OB5U(-V,9;J6HUK>@^S6JSSQVU'9I57O7W0:WM6N
M(>\WK*CJX>/7$[=YK6,ZMS:PQY?54.X?;IK6M0C/]S`$;2S6.(Q:W)=&Z5#<
M/:'Q#]G@PZG&-O#7;'ZJ%N'J[OJ2V:YL/-5[2)XF;-ZTW8U?P*$+%C4JB5G5
M1S=QU&+L0\LK3PHO81$Y;*8XZLY1H#/>&]U<MF",]I6PABUC''_S'ZHC)N^^
M@^F8BEEO/]R]$R&&7-ZT:"FH!%ZCG$"JNUAT8Z<%MEFG48P2JQD@(C"%,;LP
MI4>X%.I@?(<4BDC9NA;#K*NV(FIK^O[O]#<K3L\!X%`=T'?MZ<PLD2K1E?[5
MNB9VS7+C?,"1M:Q&^O[?([;86*205VE"S18F<Y8R)#S503_+;1:4C(,T9?\`
MZTAQ?+3>J1+^&Z3MR/3/I5W@,?Z!Z9N=TCTBO2N.=^P91P&&&RH_G)HL>PY-
M`'5@#9Q2PU"_*B%J!,IVV"(2KCR%'C&"-/1NK2ZCO%\W?'C&XX)>/+?.EDP.
M2S:0,EAT76=AL9UL.2%=;RR-RJ-HU;6\6)M$!.6KD2T6AA5K"2@I52H!@R=[
M!O65EE%3,=W"?H;H^_Z3NCOZT./.E;XZ#K3E'C'JF;])*+8=8=8-$U_U@J0H
MI/SU4=(I6B%,"=!+Z=:2'1QEK:C/5HT;&%$D=!"<CA;V:Q$3$1E%3,Q2>5#,
M.N0H_4'YCKWM6Q9&.M.5.0.DH+TG9[##KAL&`OUV0"R9!<L2CJ@M/&&'Q2MM
MKLAVB^EY*Y)&ANVQE)5"71!&B3&.DS'-HKV'ZHO0L4],7AV.Q7H>85+?DRX3
MI[L6WN@E;.M7RBQCSS8K&HU3T0D!<;<([J:6M+E3J[R!49I-MNC\?-!KV&.:
M?61U&$3E.FET_P!@T/E#%.(E%YI%W,IZC4NCK+)X\\$%*"279D?FU,Z-3D22
ML(3*RBER%46:$)I99@="]@@AW[=:K!(\!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,#A-_R,O]--T_Q.\>_P"8RO\`#3VO[>#NSAF8#`8#`X0T7_V(>\O]
MO#D[^\2:Y&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*_
M>ZIK>2V'!+9?X5'G>RZQ;)>RU[-US<2?(H>U3\AJ335O87$>MG($LG3L2,"P
M(-ZT<%,7K?\`Z=86YJN2C'?@[C)^O(CI5ZYCIASO9.\(9("S%L%9#Y$9*6M.
M%(U2]4,:;:-;,FE,`):1X.*,<TP`!T4>#00^P;LJJ]$XO_ESG?JE@C\6Z,IV
M"W)'HH_;E$::9VRD/21CD0FQ<S">6P)WL$C<!-+FH3[,!O0MDG##_P"`MX(F
M<=85#./3<X*LE@K:*S7DFBGN-4[&7*&U8PB@3,@:8#%7E<0Z/##%T#62A3-+
M<[.:<"E464'6E"C7FF>(>]BV7?E&MZMCY;3E63S5;:F4#C4FU3TP9;!J[XPV
MDK=P2;1QI<V%BE$:V;K>VUZ:F9Y5IB3P?SP$J!AU_(+>$N84[8_#7(%O-TW:
M;-YUJN;-UDV:R71/$K_%T:PN56Q&XD5`F&PGC>]!&JE31#"`-A"O>]&EHPZ+
MUOV86,LHX2@DE],S@*8M=<LLHY,I=\;*BC:N'UFE<(H0=J$Q9?(5<K6L#`;L
MS1Z-J4R1<<M&3H6P"4&;'[/;@W9=4LAG`?$]>VXMON&\M4@Q70X2!\EAUG)J
M_8#9F5*9*I.5R&2-[XK2*%C4_/2A28)4K2B)4'>8+0A[T+>MB<LIBIF:6M>?
M/%&],PO5=W_54)MN&%.J)^1L4W8D;R0U/S=YFF]_8U!X/?6%^0@.,"4M1FD*
MBP&#"$S01BULD3,:PB\2Y"Y>@,;J>'PFA:NBD8HJ9*[%J)D88BU-B"`S]P:'
MQB<INP%)""MD2QS:9,X$*G`>QJU(5AVS3!B&+>QNGJD<&YQH>L@6X57E2P6%
M%7W*WZ=7,7&F!$T%V5,I0A"V2*32T"(LH+J\O2$/EJ3QZ\PW7MV+>][WO!,S
M/'DJ0OT^.(B:$2<O%<N4R70+?)135!6`86V:CZ&;"5#6;FZ,6B_B*6:^>8+V
M.X#PN.@[V#1W@_FX7=E=WJFL&X_Y<K-HJ-AKZA*OAK10LAD<NIU#'HFV-A-?
M2R8,SO'I9*(]M,2`Q/(Y,RORU.X+A[&J6`5&>:,6Q[WA-T]>*!R7T[^&IA$G
MZ!R3E:E72&2>XWGH5^C)L):R6=SN^0MBAE?+1/1)2R"M3-T:51J<Y:'03!E&
M"#O?LWO"[LN-ZIY(N/\`E^7T$V<L2FC*ZD/.K,0R)FNG'B/IG""(B(V[E/[`
M60R*?,(UIH>B`*B/;[=EG`T+7\NM83=,3?-42_TQ?3^=*\;:E<.3:<5UHTS5
MVL1!"3XWH<>*F;^S-D=?7LU![QY:LU[8F9(D6%'>8G5)TX`&EB#KV87?EQM=
M=:\PU!4EMVM=4'CXVJ:V]%JC@C]H!Q0&&/P.CF%U8*Y@T$84Z=.@A\39BG]>
MIVA2A"28L6&&;UK^8$))F9BE7P3TYN%:QGSG:,`Y4I:*SY['.#'J2-,,;B5;
MP*RTKDAL'XJ2((T3B&9HWA44Y:.*'I66>,)FMZ%O"[LJJ]%DTQR/S+SM!Y96
MU'4=7-7P6=J%BF9QJ(1Q&UM\H,7-0&(T#YY81'N*8EB+"A3DF#$2D1`"00$L
MH(0:).4S-SQ9U9S=0SA127F)=4T'5<]H8DRP-)3QS&E'`T\,CGN/P*-%,.P^
MZ`:&GX8G\@G6O"#R0^S_`,,%S=\UV80P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P.$W_`",O]--T_P`3O'O^8RO\-/:_MX.[.&9@,!@,#A#1?_8A[R_V
M\.3O[Q)KD:3_`)1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P.$W_`",O]--T_P`3O'O^8RO\-/:_MX.[.&9@,!@,#A#1?_8A[R_V
M\.3O[Q)KD:3_`)1]Y=WLK,P&!H'>-_WS5,XMXAN)K![A-=T_'[;:VHB'3!5/
M7<N02N01$B,@5`GJ9D4N12N/[.+-"E*"H\\)/@*V'9VSJ(B8[VDDB[OJ.'O#
M1&9:R3*.RM0]O#-(XNX"A`GF'%L\DCL6$Z+"$LU4%2M(X+Y4C/3$1L;TO&B\
MXT2<&R#"]#;*^K#NR'UDK=T4B(?#3F6M9/:JSX6@)5@W&(DZ,C0Z%D[,6)MC
M=1*G\C9).]!`,&A[V,/A]FR5:I5/84-2J7%(97]G!/,?7V,04`V^(E[L^01N
MZVWGYV;XIHR8AVU@*L9[1``H??@Z8UM4Z7`'M.6<(LNV59Q/OV!_%R8A83(^
M1V:'3>:,3BR%EQDA?$&PJ[+.J>NT[\QFS)6_/KH]BKHT2Q3'R'=N2!$%8>:F
M1'%F:&V>29MG9L3DA:!.EB4Y@Z]TB-9SY%J=M</TN.BUH32/1F+J$D406,5(
M7<#@0_D"5JT83DC":>$E>,"P`D(A.-/TE[8A[@>WIFZJ[C6FRM/$7"LAEL\+
M+2V:S3F4.\3CKU'U1\Z**94!RMF&L/T]_"CTK6>0I,+UYFRPC:P2OU#^?VYS
M1-[GN5-H118$DD!JI)'1+8@J,B\HEP8T]QI))E4L6NQ+3$%85"EK0.+0G4&I
MBQK=>\!%H;96=6UXRN=J[_`\0-VKXRJS8Z4R,$P3-@'X07JKV6=B/>5$:D\G
M85Z?:MW\K0D:K6R=EF$&:T<4/>"8C12S;Z@4(9*U@LCM"&R^*3B4QB`/FHBI
M'`60QY2S&MG6QC9$PJWVQ"6-$SEH(RYE%H'!R(>M*R2TNTHC3BMC+MUTX,Q)
M/4*I>,D&+US!/M,QBF1:9GA6EAS"3)VJ$L4;D$[?(TWR:9LKXZD19+,FE/M%
MI(%W<5Z[29`C5&$J?))MEDH9V:S&#;$-C0Z6QS4ELFSX9#IBG:FD,+D;9"N@
M14FF=P:%*5DD942(Y^8AJU+FB0EJ=*S5*4`TY1GE#;T70X]`0]#2K7>FDBX$
M4?V]I<X^C?'6'0MR=T4@5ED,!Q*J;RB/1U.)[2'EJDI1RXM0>0:`("]G"T3A
M*UKFILGN^JU#+J7DPZTQU]IK9E8Y[\WV'X%\6D='HN@&&,$(OG3N1K7=Q@ZX
MLC1A*$:`MX&6C&IT,P(MEVRRY78\=/6*XZ145S'6&@:U,K75F!J@WSM2UXF8
M&62"L`PT4^#&!,IJ9_3(BT@'$3N-W$)'I)XP#$$;?)CRNU:_!K2M(T36:1\\
M#O)5$JC$8:VYBBM?(I!%(Z3(7O;],BG-U!I1,$I^@H$QB]0D`>:!"#9`@"EF
MV6>@'5J*72Z-P1_K270:32R877&V4#X^5\)I5-]-6!(H&M<T;D3,-;?'5U,8
M!*1,[64O=$)&QG'E!2:+5&TV\T4O/K[=.2&[XP*+.3LZ5Y55<3R&B;X98\B:
M7EWG#M8K2H;9?(8I&W>/P]N2'0U/LLY<J2?S#S3![T6#QZ$8VEH.PZZ*?&)N
M=8Y.V1BF,C=(]!IRX-\>%$Y;IAL%HJ]\?4IJ*2JWEDC[?,I`WE!/=4:`2M*M
M*5)@')]&F%DVRCP>ZZ@40,V?(FJ7>Y)F7;VL:'P<)A;NA`.7RN((&E5N;36/
M-09(^F0AT7MS<!4-6M;DWG`!_/"'9=L\!7VO$7$A<7!*XM2:KSB=[BWPMFBJ
M8B4>15#'<3XXMA#[-&-:)JB<3EK.!8(\"8:AR<BD*/2A0$_1(V]4A6=%+HS5
M7-]M2U"SI(G9[5'%5G.H0.",,-%)JB?)RUN3:F/-.V%"IF#6F:/)4CV8';B5
M_/V(._$*UF.;!\\]'3^VG2&Q.8PEAB4W2P^P)#=#&W+G-<7`W5MED=::S9$)
MRLL@PX<WC3PH<Q#/!KP!1#"#6];\6A,5KR8NY>G9C7/24#IQE:HXN9Y*BJ$P
MU,Y1R<FNKTILRPYS%'H*.P&S?YNH&*%Q:$J7DA.^:\Z0C),0(=Z4B+UL1$3%
MO$\]JA6*JI3P>J[#<%%FR"(N47:71LBY+E8U43!BFJAOFT).#.2&QB`2ZL3>
M:K!(CFQ2A;5Y1IR8(C0A`-O=EB^V(:<4%<T0^R9<-S)-/1Q%CBL?;9+&M1Z&
MN\MG":3N$AGZ!@-6QX#"K2&%DF%:VX%:3$;5>8`[8VRNBR[_`(1654-]Q.7F
MN<6=D+2Y-))3Q$(VY.B)W:C'Q-\.!/I+$$*QQ$TDC-`A+/$N-\.P@*%[!;"2
MKFE3J.WJO2$O#N?%K*#$&Y*Z:;)EIB91-,K?VNO([9^HG&V[YR?.<YY<XQ)T
MX49BI`E0'+BSDNU`#2_8(NV4EAW0KFNA'24_G,&?H>CH>3RA&;$UR=KW*A,4
M2I^"V.OTH/:)#(8X[+UZJ0J])%")8)*:FV1K?A'HS"5PCJAS-T',6-<0R6M(
M:^03-_;JKD+1!(57MAK-,338=C12"&)QV&_R-#%;&3(7*:-Z%0Y-9*`QN//"
MJ.;QEB+3C+6NCS6+TW.X/S-0=W-<-9I5(K'/I)9,8X0-R2%$1N8L2:5V2IB)
M)1BQ4>^L\92KS6=*>,P"A26428/^?L6"(B9F$YK_`*$6V'T=8-6,K2RJJSBE
M:Q:1L$]1KSU2V42]8\KD\N1(RB];;11EB;US424H`,1ICEI<4+V:(#[23%1?
M-8BVS%:*\":N.0MY;'NGGBS%#V:I&2L(5M<N:H]M"()HBT);?M&O&<,P8@["
M(&O;O0?;O!6EM6@]YLCU(4'S'KZ73>-M#7<9]@HXB?7TJ>&H=;,-.3-$^LTB
M9+)/@;O'U41LP1@BDJ]6X*5VBTQ).C`#T(NU;S+UU7+\K>](F&=A9&U/8:II
ME)[0T`9)BFJYA:Y#,%<8+"_C>3429&])2TYJQ(C`K4#$`OVZ+&+0VRB<IZU6
M'-#-(*SK":RF/JK<@-8[?5"6+)T<G<Y"_(V*3L$22*YPU.A;K%UBP9"ER<2$
MK*2>B5^P\X).MC&WKT8U1Z@E&HWEM8U:.8)UZB.!>WM&)/%1NL4<34,R7%19
MVCY,L-D+D[:^8B\DY4TI7%H3&C3;-6`*4!,T-LO#).^JS@B82Z;LLQ9%;@@3
MOZ"#N+?"F67,T830IGF[TZ.:M?99C#(%I#-($!A;8VFB=QJ5Q2(E(I/"<(L;
M9ENLYR1J:HPOERA04%D;V)3(CE2E4A:"=-B5`-R&>>M?E;4VMI?NP/:(Q8>F
M()U_*:,L.A"T<M0FGNVLWQO2N31#;$=TB<,H52]:S%05Y:H,U0^61N'O;RZO
M;;.5+0_H0K98C5$!8CG50H0><8`K8R3"M'6V4S@/1YUE7.UP=AADC:X"X0.W
MI(V3:0(&TI',UU969`ZZ$KB9[;(W%4F9A+'QP'LMT0H5:HCW120'9(Q>TE5"
M.![DIP^06+&T/OJE97GSO*-5*I)6;(UOJZ`SUGK*6MR=<_SUL#%U:":OA*1*
M&0A9]O&@&C;=+`%^W9=LHY(>V6Q[J&76?3<$F4L;(O#(U)U[^N;&'3$UO4F1
ML;ZWU^>W`F2)_?9D?'GQ./86LM4V$FK$VAK?",>P#;K4K[17]$=UG8EGR%JD
ML0;ZH52YOGS`\I&Q;(F9QAJ8*UP0IBHR[/[2]'."$\@Y#[DK/TH"I*![0&[&
M6`E:UU5&IZ6E;_;-3U='JYE<0<7.PGUBMQ)+DT%<'*),K75^[%CX2C66R%#8
MH3S).O(\M>V&/(DNT2M,:G`>'V@+6EO1;_3$N@%ANL"8:G?GP#(Z<V``_DK8
MNK(EJ>]K(E<%6L3"U&RIH<&EV9"HL8<%<Y>0W@UHX9P@EE%[4"(TMA#^_P"D
M4;ZTQQ<AEZ-V5,X'!^;S2HF-UB#L<IFR`B,N["1+37YV<OB5?.*<Y4S)G-J2
MBVG,.5ED'A.T-L\4SKSK2.V!*F2*BK"V(:8^O;;&R'>7MT,(:D[_`""KS[FC
M#2IVQS=^<?>7JN4AJP0BTYA*%2'216,E2()>Q.-:K5NJXHU1D&5SV5$C5-J1
M26E"A3OL,85ZTT2=4L,(;#)Q)XFUN*\*-$:8!&2I&L/\&]%%"]@MA)$7-0PE
M0=`PZ['67M\01/!">(EQHXU:]F,+>I<TLJ9B7YH<4D8"^*)FWLZYM4@,2K7!
MN1)7`/B$D,/``0M"8F%0._:<9^=RV#PJ#/D\D#):E:5X_EL4NJ]4WH&BR9%,
M(NDF!;F@G#BC]C2[P=<2I:%(DCP2+97F)R]"%X"[7PBO:S0[1I,_R2I+)C>T
M*98_6`!,;"G]OK&$#M"85='9E*'%#+"Q.#>^N4'<E8D[02Y+D:)O5&GD@`65
ML\;63'VE#@I4;EJL+?VT*6^;R8YT$T0THAOK^OYFQP*03]:G-G`5^F8<@>_$
MC1EE&/*Q"E/4EHMEZ+\P;9>)A[VH=^E3K&P*GQ&C:WM_:#)<;J-K8L`B,K)>
MSN;RZGLTE<W:*(!R&&G(4I3PC0+5IJQ&80080<(TH;93:O\`K6J9P%T,=%)]
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M=XTP5(SP&``-NM2NJ];^AW/<$!8$[3J0M>A'"4MQ#Y"&UZ+3H6I8]NPV]')Y
M9'RI(M;6YO-'M"U&+5QVP_T1(P^(821%JW7]E0)M6/Y"J$6<%$WN$O88NZA9
MXX)-9,KA-AQ6K7:,0M+\Z].@5ZV9S=L2H#W8AK0J@G&&:/"60:,)=LO=$.DC
MA5%=]OV+#I%'6^GIK:30NB2%J2K9GIDKL0`Z3!0H7]U:'M^<?"/:8:-=M(M`
M82(H0=#P5K$0Q#WVA"(PM>&:2U[:;/(8J&<*)NQ";8>XJ8>W0EEK-]]_<%K3
M-%[0[ZEJ6XHX2S)VI0X*U:MP$2,HD295Y(C&V5^]W"D4ICD"DL(LF+3Z3V)^
M:ANB2]JCCHJU8`HS';`)8#'>,RE\C8O>*M?%$I`I+6#2Z9F1U\1@5:(:40VS
MQY*N1>HA2X"`)#BY3)7)##VQ[<U,;9X\0:H?%-8,]M*F4,+.G#C+H\!/"WDI
M8>XKB_FZB%H:<UVV:6+VC;+9=^N]A8J\A$]TR/+\?8Z^*LL(B477Q)_=Y&_R
M\H2EK;6U\028R"'IBF\D]8>X:=_AI:%,:=H\0=!T(E*SK#H-_MJ[E<598H]Q
MVO&"J39`\*)$VQT#S^<<NU9S6$@B#B<@FZ]8W*(2\5HXIQ>[-ZQ`X&C,-+7;
M)`FVI+,5'=7<@[,DC%/75F/I.9FQN)S*[XN^Z:5,->G][9:DA$#FPYXRB'-6
MAJ:&42&4*`#1+A_$5!NDY9)6S#!A`-JUZVZZJ6U[4=JGAY[FM=6]/*#$KUXF
M(UH=5$(6,3=+$@4*%\62MB&V+I"2228\-K<0XC)4^YC/"1L0B3C,1<MHL(X3
M?\C+_33=/\3O'O\`F,K_``T]K^W@[LX9F`P&`P.$-%_]B'O+_;PY._O$FN1I
M/^4?>7=[*S,#^;$'6PAV+6A"]OA#O>M;%[->W?AU_P"._9K`IF0Q"G9W-9DP
M2!L2N\P75S#6^7IS%#VFV=7Q\OF"N(I3%"90F;P@W+&=V%KR!Z5Z&7O1N_+$
M5K9=8?Q70U7F3%//TS>\1^8%O3@\JWN-3.71I0]FOIT?,<FN0E,[ZB3/S`XJ
MHJ@'MO5%FI-&$"V66'SC_-%SP>>P*8J:^261UF[&]KP`97=G+("\SB!JG6+O
M:QH6O$:E#2VN,<7NS`L=&)`H,0N!0R]')B]^'6A#T,1,QP?5\Y_J"0-Y:-?&
MME`3'20QN7MT@D+4Z,[I*[+9K8>'1F=V]W3+VI\W9\>1.R=208!0C6)@!($6
M#VE[%R@;717/E>S&+1]F)DD?E$J:YQL+<DGME&@L1#J0R*<2TZPQBD"E'-%!
M$FM1T<"C'H9YQ9SJ?I/O1>Q`"+E,5_-M0NCI%'1S8'1Q#`V)FCT(:%DOEZB.
MQ-$PF,XV]0PL!CYMJ0.VP1]&6<L"5[RH*)\!@Q!&;H8N5(PGG"K*TM&03:7/
M+<-9LR/HJ[C29#/XY%XR1'7*Q;-;6^(DRN>3%"\.Z$A:Z*C6V/B0M2-,F&/3
M82$7\TLS<5"SHI1=`/30EFL2:5H8C.X#I$Y-J6431%#9W"I.T.ZA-N:PQ6\%
M,[^9\&ERL)9CDD$K()/`7O>@ITX"1<\.;[4I$:4:*V?9W7R:4'1"UV\F62"1
MS=YL)[D4M9&V,I(JRO*M1/G%?*0-@H0QI"V_6O*\U`$HT(=B,V,1)F;J>3`Q
MBK^;K>:&Q\@9#F7J&$0)@8Y1$9+8$*D<=2QROAFQ!N;'M&Z,[T0G_-W:0RC]
M!&(*M.X;`I\PTH/E%N8XK!<Z!JMT5M3L4WO3&\H))(Y4WR&*S>8Q=_-=)G\-
M/EY)KTPOZ%P7M$J^!I#5R`PPQ&>8D).V5HTDLP!+E5]A<8U5+XA:$69$ZF/C
MMMFL6,R%4[.TQF+:Q,-TRP$ON@<!C;K+T[/!Y%/'GVKMK6\!0$KH4F4^0:%.
M$@0C*8E>4NJB!S>.QB-NS>J1M<)=VAXAQT:?7J*.<6=F%"L8FX]A>HVX-CFV
MF$M#@I0"`6;H)B5082+6PCWK!;65RXAI!G8[4"%8YL;._P`7/01U$H?Y0KBE
M:-+1SXT4"WO>HJNDYS')WN.0YL5#*=5Q.UVBUHBA&[V66;HNZ69@7-7.LRK:
M*OS.U3PUNDC2E<44O=YQ;<:L1ZCCS&VJ+%LCH^N,F13I/#GJ*-2).!D4'A1Z
M)+)-T3I1K1V"YM/I#47.T/2%-[U$VQF06&LU6Y").9("T;B;)ER9^#'R$[:J
MV0T)%"N,E&`$#2<E.!/H`1%@WX=DN9>EXI&EF%<DF4C4.;<V16=/=N)4+_8\
ML)@3-.']X4/#A+!1IRD6HN0>&2.ZE:GT,CR$RY::84``QZ]@N4@=8=3\Y=IZ
MS/+:E5OMEQ8B+S5H<%3VRO$FAT!='="F,3MIZEN6B86ISF2D`')"`))^UH-Z
M/,#LK>A<PK>4\Y<T[+FK#*HXI=R+"B<](<8,9*9X]")B,ME;#(+*%7D+;'M2
MNB2)[FRAL7.1T>3)!A7^ZCV,&PD^$MRE+WR]1;XOD3P9$36AZD4Q:YT^/<7E
M4MB;N*2M->&5:0I3.$<?FQ0S)#ZW6GM:A(D$G2GIUAYHR]J#S#A$N7Y<.6*,
M<8R@BA<16-#.V+`KF\R-2^9QIW2:'!FRLUB,B1,4A0/P&IU@#.F:U:72GW=2
M04$8P[/"$W0N6;<JII&TJ8::D5LC#+:6$U19G9F%`]+5#*<U0!P:U<92HGAK
M=`."@ID7QI-O6PJA"'[OL)NQAV/0A<Q-\V<14W737.9=934QJ&J;SUSAKM-'
MUL?Y&@-DRJ`,JZ/1,IV2)7<IN4MS6T.)I6TGDZ2J-[",\LPP`!!%Z4\4OKZH
MY3(PF2Q$TJI3,4,02HP'/JQ`[.Z6G9>?9,2.9DZ1S2F[/A,N=1.03TH-&EF&
M!\T6R_"'0N5=[X_H':4H)4=D*?;8L85T6<4=DV*D<("7$Q/AD::Z\<TTK+50
M:.,)LC7"(;&T:=OT$[18B1%%$EEC=+PM]?\`+D/F;'6J!D1-\P-:6YA:&G2J
M8*SE#?*8!8R-,$YS-5J4JI4]0JMI$(]4H/$I.-2F''&;5'EC-%SQ36T:IIAP
MKUJ(GJ54SPNF698^M;BT2B6QIPB,=:8:\1EY$!ZBSL@D0VM3!52Y"K*V<9[R
ME,'K>A&:"((B90A96?+X*R9OC\41L$)>V1_D#7'Y*?*6-Z&C5U&;'9"`M@7+
MR)*6\(:I9A@,3`+]\1`2[/`$M07LW1;F^ZTJJKFLHA#W+4'3K7!@LQ?\]Y"Y
MRE^DDP<YFZ2-A9&0QW?W&;.+LZJSW%A:$241!H@EA+)"7HH/\H<),S*NP\Y<
M_5@WK9<O;I`%CAD?1G-Q4CG]C2MF@D5@D@8+,2M<*87>1NR>/,K4^P)M6Z1-
MY`0"`VDI]`VG+"1HMRM)N@%9.D+K%I0LZ4Z'0+<.=ZV2[5N913,*,M.FR(FD
MB.5`6J1H&P_R@EJQ&['[?8:$0\)JC\(YUIFLTK"WP&)_-%/&VM*Q,I3+(Y0D
M,3,R>;K['TT".^."4+&Y9+URE4I).$8!66:8G.T8FWLK!,S/%Z[`HBLK3D".
M2RU`^*G5#&W>$*_@TWF<9;WN(/RA*L>8E+&:,R!J:)4PN!R8&S$KB0I+\(A!
MUK01CT(1,PHB1\V\LL[S"(<[L\Y5RF?J9:A9%B&P[C<I$],XX/$8W-DTEDC;
M*3%0(*=!X.QM*L"\\+?X2DI0-:4':$,MRLR=<_<^.[(BC<I:4\?:E\DD($:=
MJFTCA"AQ=;/1GM$GBY"UAD#.O4-<W;]B3G-!9GNIP"P>62$1)8@$N6=;.>*B
M8W=0\MK*XHB0OS)+1,`)?*_F:@E\="@,02U)$3'P4<;)$(MN($J4E)RQ+-Z$
M8H\PPXX9@N45BM*\_2);*G"&H78H@@4MJJ?-#/+)ZS1V1&A/DOQQGEL?T\I&
MF3J&T^<./NRPTDX9&E6M$G:`01HH3,\W\M&KJ%B3:HM"3(9'&ED74L02Y)`I
M'8+7,C%![>P0!EBS=\R'8I^=BY*F);&[X4`)A2]0!,8,L1Y91P"Q,\'VD!M(
M)VZ8<^VG/3I,NL*&6K;T@B<[D"_<C/JM;)Q&2D]LVEVA5M40K\R3(VM&6B$6
M<VIBTWLWYNMFB)KQABP51S1%8,KDJI$:X1>PDC4U.LH>)1.I4ZRXJX91$4C<
MH<7=<\.3ZI,E<E`TZ"H\0/)T$.M"*)"/6A<II#::I6!V6^2J+I_=+`VP/QJE
MO43:1.A,8BECR\4KD/P&&N;\L9(BP2Z=1LU::)&B3%'+$I@0;T$O8`B9F8>)
MXYKJ)87(AJDDN2HWB4ZL<3:U6%8*%MCTX3/QLM5S.$,K9(2TL0D;A(5!JM6<
MU%)Q*SU)^S`CVI/T:+EKU63=Q!+W(N'UN9*"RE^PU<Z1(T=\1B,R)VA;,Z/I
M3?*T$I`U,[_,XJS,)VQKUNS74HLDDHX[?A2@T6=W-N6?6%?JV&?1-5'$*M@L
MY2^KI\SJC52E-(CY2V$LKV8L`<I&,@#DVH@$["3LH`=`]H-!%[=X2Y1F'T55
M\-<DCVT-KHY25$]+I-\Z)-+Y5,)2J=W:,)86-<Z/TE>W5S=``B3<2WI@*3#"
MDZ<K7E!"+8A;%RRKY45>2>9))^\-1ZR1`2Q%.4<!]>T[8KW`I$X3"$K5#*D<
MB6=:X1E[=UIR50,@1H2UAQ8A"*'L&"YX(.KH6C(\\EN8TRB+'3$AVA*]I33^
M5,+'86Y*HFS\<QOT>+D29JE[D$^7OBA'HXDY2F`>/1.PEDE!*%R]RNE*PD,8
M4C84KS"ESZB+?6:4M:M\8)C%7?53+*>9I8U)W_?O#))(U7KL)(0%6D_]L?H)
MII.U`/'H7*2SZF(#9S/&&>8)'I<5$%0UT>=&Z6RJ/R%$<JCSG$W/?SFCSRUO
MIX'R,/2Q"MT-0+2HA2/Q^T?A&$1,PBL'KNEZXL\]MBY+@GL(VLF1M;T#F_2U
M^(8*JCKCIK:8_%RWQ>X,T>84[L3XA(TFRC#30^8,(M!#L(F9F.ROAT5S-7<)
M?IF>UR6,1EB+8GPUR62:TD[E$VFH);(9?'$46;%KH)YCL<C;^].1R=$W)RDR
MI*M&7X#DI@`86\IE(7?F?GEG3*9,^-RII8F4YT?WTU?8DP;8F>S`EKA9!S3+
MT8Y*G8WF!L$P7JW-(UN(#FMN&H4`)*+3GGE&$N6<8JQH27M\CCS+'TKBAC*"
M6TP_H]+)*GVB;WIT:Y?*8ULY0M(//`L=#DRG:HH8Q:%_-+.UK0@Z%RB=@\D5
MW.8))JX0*'%J@EA3>.2Z;1I<]2V2QTQO;)Z79;ZV0)A62PABKU5+I.7LQ0J0
MIQ$E@/-\";>]E[++&4Q-\UT1^K89&9S*;&1$.JF:3-$A9G-X?)*_OPT[$UK7
M-W;XU'T;RYK$,=CZ-R=UBD"-`403HP\6]A]@0:`2T&C=:T+&I(D@<=8$2"00
MHN%V<D:P*Y$9IJ"U1AUI^'ONEBM8:C/$DC#`I;-$"-,WX"O--+V,031#7BD4
MUI"LYR[;D<@:W!-)=.$4<B).Q2F31:0(7"()I<U1T]M=X^\-BMM-);+`>D0_
M($7M2F<SBC?&'8=!%S"OV+F*AMQIR9(['I0P0^50YOAKE#T\MLF--"UMB[*P
MPUE>SHNM>D)J29LC%%&U*G?O)+=]E(TX]J1["6/!<IS9=$UA;S<S-\^;G5V)
M8FJ0QE,K1R^51]R5,$P:R(_+HV[N\>>FIR=FF5($Q)2],H-&%0,HL8M>8`(M
M")F."+2JI>?#5D=KV11U.6X3(RRC8RWD.$H3K#%DC<VJP9XXMSHVK@&,CIM[
M8$;FF5:/3GHU20`T0RA@_D%R_3]S57JNC;/H:/#<8^PVNBFH90[.#R_2U]<'
MJQO>=RB1.+G(7Q0].#F\*#S!BW[V7X1;]A6R]!#H(O6V32\UTP!#(T"V,*9(
M.5M<Q8I:YRJ42J4R"0-\]20I)(T[V_OCVN>%AQS77K"G2FC.\YO3-:<"01(0
M_P`HN42WS]SHVR^/,3NSN3U83EIZL=A>Y3+9Y))<<MB+]5!#I+@2]V>EBTA^
M:UK?$T!9XE(%0FY,2B*\2()Y.Q<^"6LO.-6Q@3H7#2YC"4SI'FN.KVJ&V3/X
MXT[+9X\RQ-H>PM#9)"$!,L11B-H4(7;1>G`Q.D+"8:/P:WH7+*#H>J=5DR5*
M0Q'-T+B"IN<HX!MD+^W/T;?&AQ$^H)&V2Y*ZE2A#(R70X:D:W2SW@\1QGG",
M`:8$8N;MY8=$J6JIQ4IHF0E;WEL:D<7D*@#J^R1T;V]2X3.S`+9TO5K790@-
M>7B0/+JH>'<99JY6M$(Y088:7K8UE'(_`.>YQ*;%>F(DB1NZ]0H#,#27Z2J&
M,)MKUU$2%YS(7MQ"PDDS>!IF@PXULUY9P@@-\6E`C!;&L,_$(+4]56!\%B9S
MVPO\^9Y'(4\,+E$R70\\F-J8BDE<B;XJL<UD08WPY4_M8E:@HE.J6FJ3#OZ0
MPU68,:S"\\(X3?\`(R_TTW3_`!.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_]B'O
M+_;PY._O$FN1I/\`E'WEW>RLU.7A$9=+XBSA@VVPV2Q:P:[GB-K>'9:PML@3
MPJ8-+^YQY0](&YW/;!/#8C.)*-$D4%:.$#1H/+V(02PU+CO(,\,-*EDN7P<N
MRD[K5;FQ2)J<9`\*8*4P=,7%;T_0Q-W=V9&L3?&J^LLAEV,!*;3L).-.L"!&
M$K6B[H\%$BX+ML21G%IEJYG0LD>I>+S&*Q>6@.U?#C6T8O\`C\ALB:*Y[34S
MBR"1/+Y;#8^)@+6=X6G*T!PU*\*HM&J+CK="X5/&<L8-,SS%"(U(K#07/$IB
MCG%@28R3F$0Z+P*#0A*EGZ!]@CL78+DC1,#B8EVB^!JT+DLVO0K$1RI9L53=
MY4I:1\SV4WS^O(0G9&F9S%0OB#B.W3DMI%.=71:/T[/X4Z1IMFAD+)AI\2=)
M&M"Y&$A?2EQBYX4:&U'&A3*=%B8X\DXG'!,O/;V-AB)T;35\CU'MOE<,3\AC
M"=U?MT^56S[8"5QE=7V:S)9HW.B,M4F7;;=.1^CS5>EA"XHOSB;O-.8_SO:U
M4VXCM=H@\,L-PBJFZR`2X<Y<4UM6TGNZ=UX;$TTX5.D8(9F]OJ**,QJ96I-6
M.!@D381\-3D^\'I="XF*6CTCS?/;?E[>YPR8((S'W.(EI9JG5.K^@<3YO5CN
MNGO.#VRA:$IR?W&,V:\J%KV$P98U:-.01H)P?$#1(F(CNJY+R%8/QB!S*5$5
MK.):T3&)6!(-N"YT&F;)T^0*^F.UY'"E3M&'`QO(0S:Y4J]G)"6F,/;F<HDP
M:<T!.]%W1PY+EY]YD*I>.O,0$AAX8H^TI3$!=(^SD*3&EVFD)BTGB\_DKPB7
M(BB7/<O0KFTDU8?HQ:O)1ZTJU[0`]I)FU)1KDRW(0UUW7T5W6J*"-,=YQ*D:
MI&^R!E"QN-+1=V8Y6SQ>(M\6&WN:*9N:TA64I-4H=;#M1[P1LS1>S!NA[I9S
MQ8\1Y&M*LD:-HF\ME$@I\YM9F97(R6UT1L#10\*?&]V6-R$A\1M*K<%<#%9J
M8HT1;69X]@$+0RM3DMQNODA2KC6U3]OAZ./U(VDRP;[J!L`)3(M-O'[BYS,F
M2AF-,^Z0Y,0\OKAHD#@K)3%1\)3NF)3$G;;S#QAINCZYLT1Q?<VI$69^<]G;
M8X:X.M>'#0O$K5/+=SY`'0RPN:T38F/1)D`[$A=F>,MY-$:60L9%QY05!@@%
ME[&Z&1YYXL?*_>:L>YZ4SKS*_7O#N[-!TF;I+'U\X3PB'Q)@LJ*,S'5U9M3<
M\K3VA:I5'.:9:[[/$0J,6&JO:(`G*^"16'RM-)O:<S>CVVO7!GELP<I,.Q7M
MS<5$U+@"^BCZK4\_*HUN,J$2B!.<E.,<5&MN>VX2=6<=M`)R`!0,D94E$^YQ
MDIE/<XP:OF2#`E-'*(,)I,<U29+6[(JCT<*871<L@RR%R%!+VDTK9_NY)9;0
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M1O!,A>7!U@#+:TSJF70]L:9,HAB=U=24*&`+D#D4GT@(*.=!#3Z-*V9K9=T/
M$W\7SI>]M1$C15PF9&N1-ZNP7I&]R!R=>ER"K^AMM%R2U6<^.H4Q3PR1V-K4
M1:-2I=R#U#VK2:-):PZ`>3<VUHJ)2JO&9=4CW&$`8;&"7EPC4G1NQ:IF<$$R
MLJRW1MKQJCBA(6M;6VN8#ID3"$9L*3?O>DJ4&RDNQB).NK2V/<46%'&F)QAH
MC%1LQ#"WP:.Q>6-+VY('&E1P2\)E8S]8%:,B*$IB1/MMQE^1%+TH%+:("U`!
M,N4N"#>O+.MRZ^@N7;#M6;RITATY;HM$977*X]P;#G*2I'$Z[6"/22#P1U$)
MHUHM+"W2&3I:2]C(-`N+4M#6:G+&,(Q@)&40IZ1<6S^1`=WIAC-3U6\NWY\&
MJ"M$5=CU9'/J6TZ%B]:$2:OGDJ!M(0N2R;Q,;JY(F]&TD^QT&<`PQ4`\2HL9
M0N:*<_V!#N;9Y7D50,#++YG*"'H^+/[U"I7"D#(>HB#5+8]%2V^CXI`8Z7(8
MFP+1H@'0Y:A(?%XERTA5LU07LEQ,Z\$9HWD^R*YD]9O\B?8N>BA+T-88W(W1
M:Y*D3$49V:!F84"DF(11I."QM71#"D+T0@;48`-JH)"<DH"8L8F8Y?7!';$X
MYG,^D%K)UK;6*M).5-[+S[+>71[73";1FU*JD,&AU+S:-&1PY$5!J\D3HW+B
MAZ<%R8!<<0&IT0%9R@10N%U7ES@9/&:C4<5C-?#5U*&6LS=MW(`UEQ1HEM,3
M"L@.$,.2,+F8A,9'-X0*-)2@I/,3)M^$T!A981$B=6L,SX%EHVR/1R(&QI)7
M3<CCR5WK>.OS?%$ZU]_-`AK9YL1`XRFK+,:$DU:5[:$](N^'!<S0*3585I"T
MD&CCJ,HY\6PG0_.TVL9]KQ;!=LAB]A@$UKQ[EM@2#XMHJ.RJ.FM"W:2/FPUU
M<"9LN4>483(FIS9EA&_,`J"M2B]T&2)I0UE\0V>;`)%652CK"/PR2-B#1#1K
M:1L'&9RV4PT0%IGK8X/=:S_X4:1*$!JQQ.:4Z&0N&A$'EN:<X!X#RQE%W++S
M/AV5O,G87XE>WJ$[I.[TD4^$Q25MCLETYV3:S%+:^LEJDDMJVR5/SMKB#LNV
M=.%%II6MH#O`W+RR1'!-)&2S(SS?9S?2G1E5(UD6A9%B/3^LK7:=W4/#\4C>
M4R<;RELFP&.*0Y\?TTF<"SDVEAI"]_1-*G83EZT\!?@%Q<2_M6<L.#%;47ME
M\A%50Q)')+:3S%X!%1[?4M8-\Z@%2Q#3;"78R)1Q(AT^OD$='ES*1I6]*6>[
MBT`)QHE!YHF=*1>3\H2]YM*7R\N&UB[14=XU/<["VS%R1R"5N4HBL@7[E#TD
ME9M=!=HTU$QIRT8ULRY2^`2.!(R4:EO1&:!H7IX(&S\:VNU%Q52LC%0O2"&-
M\(:Y_7ZB6R,4=ZX>8S\\-K[/MU4KA:@EMENG.1$/:,A<F?\`WIU`:0N4C3E)
M%`"[H^N38^A*`F]4VM9\X?%<9=X]9CL^/3(SDKW(:ZFTBHR/[(@<)("TH&)7
M#I`-"8N<1^2C7%.:<'M-6)#$J=K),Q,-?]</S!^+4,LN9*E6(TR@D<EDZQ8Z
M2%ROYVUT?7%QML\LID<8J4F;I/$HE$G1O1Z,4.X@+']20G.3-X-:-+NCDN7I
M7F&:6[)9).((^1*/3)LH]=$*I='\MS,(:;!,=)`,]-(BFY$<9JNYA%G]0R/&
MD^S56DJL9I).SR$XPDB::X!X#M98&?(3K'61I_?DT9(B]K1:4,A;@RM2664V
M\[:3HX;4:>0N#E6J"MS01@Y=(E[<G,(3F%)4@U:G28NZ%E2#E>S"QK'.+02A
M4+[(:=JFJ)@K2^4M&O8JTM662.0M+0;8E<V$$8;$C4E3K"%#V!Y$UN2`11^E
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M(*`J-/SXFLQ$XH$A91YX]MFR%"P`A%'`&Z-:YVQC;Q_/FZ#RR&RZ)P>T'MZB
ME5)V>U0SSX).&4=>Q"JV4RM2@3"JYZV*Z_+ET%6/&DZLI6T/12XPES:QF'*#
M#R;M>RY;2YNL*TX'2<9=I%$FIQ1PX=2]$E143Y%8[)*GF+#'A6BSUHD:TVU#
M,XKI+"6TEHV=[MI"UJ%>@F%CV$`Q$Q%JA0<4V4]!W-+,?:_D]T[AON!$W+42
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MC#`^-[*<2F3HHX!$B/6;T(LTOQB$2]4#9>1YRO7J)I-#X(&P]/\`7[]&G9M=
M)`^&P#37U_;E\S-%%W=V94!Z8]UK*P$;$-02G3?$C$IB50$"#P:V+Y1P_A16
M^$;="F;1E--6MQ3#'Z6CDN9V.3A5'=%.%:!O,N2SRPS9W4,RB:%ZDKQ:+9("
MBG!H?U![HVF%JU?M`B6$EW0M-;Q;)V1B3JXJDCLDLE%9=:2*-3"QI7\ZAMD9
M@5)P:LT+?8Y3Y7CFDLE$W.;*[*0)$B5E/`I7?$D"IM<33#0#=Y*LD/.5C,=J
M5E'PL#3/92HF5;R(NS3$5GB<ZFB,14V$=(69FF!L-U"=QU^TZ!4JDQC\E6G+
M7`XHQO5^U$;J+NA(97P--`QV%1Z*GQ4,19H_6:.:5^T/2)A2326L543:N95/
M3'*85?9C(.6%KWIM6)G)4U&.2O2<:@:DA:G3#'4W=>*VZQY5G,)Z`BUA.:2$
MNK;$W.X5ZZUW"42%WN2P&JQVJ.-T0C,G2&QI&V'@KY$R:0"4G.!P#$Z5,:D)
M3"4*R0DF8JF-DW#PGQ;*Y$4E@FIF^D]..*24*!O`G@B86?=,6G].28QRVWG*
MBW6L8FSJD214'Q'L9BHPIM]A)Z@0R[E-S[G/IJ//EAV@S.<;3VE-)?#V:NSX
M(@5F-0I$\V!83"^3F4L<0K>,DL+&U419R\)Z]_<GQ8!S0!&<X#]B;1T(F.')
ML/T5RL\3E'5S/`HE7,J8:^H^W*8:4EER21-JZ'N,\250VPFQF%4VQV1Z<G>#
MD0`\TP8]I'$)AH#$2DH[Q#RI$]7OYLYGFU1VG.9K.9$MEKDYZG25-.`R1AT9
M.VV9SE)+&HV9Q1!6+"_[D$):VXAK0'N$F?2$*7SRT($Y"H1)(F;C14=0\)OK
M(JC15LC9YPF9YZU.\\`]O[2_Q6WT#+![T9DTR>(0W59#=&39UDUHHEB_<A72
M,XT*;RQ+3=(48S2SE;*QKBJ5-RY,F=TE;JB7B(T\V6+*?-7KG:<JH+SC9-&O
MS)(D:N/%J9.V#=I*@<TQ[@L'[P1HT)A)1Q0!&PG)7"[A"SUT?@S6?J)ML>:F
M1JC;W6\+EC4PHV@U-3%5U:EG$5D4DIB9MR*2Q)=`W,YK.2M+<XI4[X,],M3*
M2A%'U=T>+8BE>:9G7E[$V$]-<#,1M++T4TN5D)'YY<+-M<RX[9@5@PQ3,6TV
M,MS<EW`XU%C&@P9K@O&'8"0(=)T>Q$!.9F)BF]^'+A-_R,O]--T_Q.\>_P"8
MRO\`#3VO[>#NSAF8#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y=WLK-0'2\MF<
M'J\F20>6Q>#N*>RJ7:W>2S%BW(&!OB,FMZ$1:7#7)MO\;*1$?-YZ4;-5F*0A
M3$:&/6P#T$TLL:RJ:BNDI=9UF)XH\:@AR-Z8K<?%D5C)+H5.J455I93+!FB-
M6N:L?7),K=9L@=S5)(](&;RU3:J+3EK4^MJ2BS&EJ\<^NK)U,G*`GHZUKKYJ
M6@JJ.Q;/G:1_/@T+DCBELB>0A48C,DD4+6)Y74L4CRDL)KLE*"YS-"5H\0RO
M=E!=L5:IS>UKL0#+?UQE>D(9\R\[?-J.JV-&C25VGGJ*W_G19C@\3"T:T32>
M$3)XKU&D8_?W!B`4<]MY0CS#]#)5#;#:JS^B997W/=:S]Z0QB)6C8J1A1IV<
M\^.3*"(96HA;Q-WAO.E:BT:WAX&#X9'%GNK@*1>`_?E%)@K%!Q)1A*UI^N5K
MCGUQ*K1=I<^1,I.:EI>40>#-K*8C?((PV-0U>SM4F?EAK\<MD[>?*GY<4F6"
M2(/&:D4EAW[`>4G&44UAJB_.B35R&8O\T@L]2((E1[+8+.AC#\VE+'V9=76_
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M07&:D3D,R23JS-)@[VW[T4>/8C'JN*/6-8L>YMB\@:5J-_G3U<B"NR':>`>7
MA&F13'I@RMANSBF0.#<ZN(8[&W39R5,%4G`9M,45LTHK>QA0FE]J_9K\[]EW
MS%&!N.D;#6:M=*WD#,VOS,R.+1'X(G;+FF%3.DAEH)W:D79G1'(`QQ&>A)-?
M6$I"XNI:,:I8$)9YY=L2PKKV-TP_M-H,S7$:UKZ60^H9`]*!*'F$S)6TO!/.
MFK<:+0BR-#<>W:Q(6OERPAF1H6YB6H/9HU2-[.]U4(]PVQX+!=.FK;:AST<1
M'6LA10>&V39[_)%A$R?FF>I*UK;F*1%ML#3HIH>VP]OFF[6<]%*"5#DC1"2D
MFA2K##E0]U*CG]<5DU1TK,9Q?X*Q>%U9@;G!'T@H/@K2E>B;4KK5)6M":^BB
MF:J3Y$X-BM+9#%)C'DK0FUJV`HQ/I)M<G\Q5L3&EJ/NSJ"VW)BO2'PZ0U['G
MX+!U)&VEA:FZ4++9J(FFF!W.8+2F`T4O:1&,UC%-Q8VH1"9IVB,D#,<0I7^T
MT(HL1&EMHKNM-_Y]C]+DD+HD3&5,BCT+G+PZEKW^1DMVT[>T(3X9#7:P6>3R
MHQ8[G%EJS"G)]>$*<S1VD3F+S1@J1%M56;L"XH\T'H)5+*;?Y3%SYJXJV]3'
MG=B?;@=$71$YK!-2M8M:"9J2&FPHG'8ZB]X,-`['&JWUJT<B*+,.4F%VQW?B
M3]8V2832EAHGN&*"GFP;!:)M"8\%])0\_,!$-F!9RWI(E/)7)[D?YN5;0`YT
M+2MC-Y"\LS>M$H2CG),*C6&9^\?=%9E2Y4Y+83)8O);3O]NA[T_I969^;EIC
M/0L+@Z283I^U(!)'.M8S&YZK<3D:),V^XM3.4$*W99AIZ<5$L6#J>R=SE2XZ
MEM?_``?WYGJG\Y1A3YOG_2(=I2)N/NDEBW+BQZ`H(2%QCR_CWNVI#K1?OXTV
MM>(5'BK>K.V[T)B_NB5GA,\#&*[F<_<G=ZDB-(KGB0]JN*:HIE!5,@L-OGCO
M`F5QBJ%H3HT48>3C49*L8EY`DP0;$XPWDJ>Z;`=+G<:?M!QKTUY_-RW35A)K
MUG4C*7ED((0=*E;\H4V+(GR#*6MYF8$J-J=6<@+F@\E>C<5`MK42$DQ%7#5>
MXNG+=EL0MB'120P*-O;FT7LU)VIB;Y2?9=+)*IM%A@*)VL$YJG32M\RT8^XG
M'MQZ0MA/;E"Q&-&8XDZ&J#%J(UEL)T6_6S")US(EJ]X>%!4?+LJ2S&`M:82U
M-;L;A$+:2%\)-VZF.3H6]&MSHJ7,)FUNC=OR5&!2<80-1XJD5-VTKBW:%S36
MLUK+&#$;VU+Z+E4V(GCJ[Q^,6,_L,LAMORMALN#END_C4G-+AHH^W(2T**+.
M)IAR=8(Y:C&G\.1UMB)\5YE=<3YL;:NL"72**P.*ZJ_H)SLNK'"(N,CL5@GD
M`15F?$H*].:^71/2JPH^DD2E<Z$I2R&QP0[/5)U(FT!3OJIMCA'%9G-G25K7
M=-&YB=$%?M\>86RS#Y@ZMB(]:X25=%[#70>,ABQK!8,QA[&D-3%!5N`P.LA`
M(TH1)`PZ,V8028B%=]!HI[%[)OAW@]EV@E<6JM>;I7$(^YV%,#*\:Y98]\6'
M#Y(8..H%0?8SJF6-("C$A(M!((`/9(2QG#'L0]9G7%X)[7CM1@B5?.CNCE3D
MR/SR>H:(0UV(D07&*`N`($1.+::7%D>HS#/+=5B1(5,5"A<K2)@E$%J"SA%J
M*MB_OL60T$T&0^(X"X2NS6*LYC,8HTL*IE1L\9NMQ=VZ%)XP^26U")1(WJ,B
M93QNVV^-.B?8"MB4[:@'$BP;8U0(GORW%49@"EF*I.8*K#C=5R?Y_1892.MH
M"\3^L+*G:VIY:IGMPPEL'+TCA`DI1"D]]:E&T#N`TQJ">620K&V.Z>V/V78W
MS*GD9CPJ_@%UM45OYS-:%0ASI?`PUC3;58S&]K6=*[-R9Y1+W!V`G)6C&6W+
MBQE'D:-+WL`GZD8Q?9-F;I67JK-=H$DD]11U&!;*WANETX<9(='K<6,K;79*
M>+UHI6S;3?$PJ!2/:Y280>\%(4:U&,A`K$8I.T2M&;3]`6'-^++EM>,R"*,]
MP0*&6B%0YHXB!VA<<G,)8E3L>G:4J"PY:RSIH0`T#29S1OAR-7O81FDE&@4(
M2Q4;JY/W7?3TNE5PL<'4NM6/;:\S^9U\=%(PF>"K#:&.(5TIF;9>RPXR4/3:
M*L[!6H20-Y&D>BBDDA:1`=%9PS"QB8BE/6+UC8]-6)T<4TJHG:!49M-]0LU*
M:,>SK71,K3QM$;>)DS4HV^^X-T`*E;08G/(+:1IQ"<3SM+PK/8C,+&,3$?7-
M;2JX;4FO''1,_4FQEMES!"K.#7LMKR0L)C>^%MU>IW=CDQ/S#L:W2(HN22-:
M>C$04_+U7@0A5ZT5[P`@N)41E""3KK&_(/8H*E+B]:2.4-\EE:$4C,VWP")S
M?;-'Z'D[3"&(5AW"PZCDI7H;F/*&J)624_V-6E!32:`XXM+5C&)BU9H^C;.T
M=6=?*)]'V3V771J$Q+*%,C_.Y:C-.NF)>V/HXJX$/9"?45C,?C`&I:E-;EP#
MTX%@#SDA8"/-A4<6TUP=(RZ`6\;"&P,&3(&G=%^YQ*1)W,RP;B_._8[G!WW5
M7GIG]M1I?S=H$`59_M;W?SSA"`I^')]`5CJ1&ELYS9<UFV:H)262BA1(I%3%
M77(R"A+;(FLID(L)SG#6KB;D>_/+L8^*FH$53G@7E`;_`![5&%B2AT6`PP3$
M1P:,JN@N@(^%>X[F4D=1U.8\<+OB%0S$F(9=U'.%3V75EL..PMX#SU:@]'7Y
M03B]@0A+G"W8R][+UL!U4?OX++8^P+D2;>F%6A@+1'X_8NJ>46)8#FPJW*MC
MF"V5-7E3&W8ZPVN*4O!4Z8V<QS(4+&Z$HT[FM2D>:I3'@583;#R4WU+=VH4W
M/QHH78T;:7J,A=C6]+,G636&HMR^+PAZ/<`D"YZ+2,[!'T48:!,Q*I$YC6(S
MA)Q&D:"2>-!,1=<WOKWMJW7MCK*8S-GJUJA,UEL-:52^,N43E,Q5'SAOB04$
M)9Z[C]Z/ST4N9I-(_AZ]W\U6YIBU"12=&B4_OAJ83C%U"!)>VYXD6R"6KYS6
MBZ02FE:#=HO#F!">LA==S64F='S25P.QA2ZX8/'6:9LK!`0(%;D<]-2Y6<D+
M)TS:/VF3&%VQP[MI*'ZW>+6L!M@DE98Q#U@(7'YJ]>>L7)A*2;>C4=FM$,,7
M,=CDFGA\>X\EF`'0HL!IA2B)GC`6`HS^8<SC6KV7)?BZN+^:&Y%)F@Z*,D`A
M^K&95[FF+9H>*Q>@ZF@B"7RDPD8#8^J(B+T[GMYBPPE,:6G.,WH111@@B(N$
M+9>LK.E:Q1)8PUUZY5TRR&O6LY.A;I*Z2&<H;&ZJN;GE"LB;Z4^I&5J`W,-?
M-CR4:8C<BG(Y4<4'W8@1*C!MCQ_A8O(O0D_OJ'OLQGS)#HVS!88;(&M2P/T7
M-6,JJ1M3HY2B%RMI9['L-:TNM?[2IBS5SG\#4K1J#`C:40TQ@1#*(AJ*USM9
M8E;36?5IU:T):3+NR(KHLJM3I7<*>I%"D$"DZ.0[4VPPMTEEU>,UH3`:9X8F
M=0G$=\*9MJ`%)R'#:1.6JG6-72BFK'8)_5T/D2<Y4S+#(!"GZ11N2/A+E,85
M\XHDVR%(AG!YYGOI+SIL5A.&>K`48I#OS]A]@\.9BI<V(I<+3+40'IIZ:DZ3
MEN>WPB8BI\XW"S&R^.Q1HIBPGDJ1NUAC4#>*MA]QVFQMPF1$N/2&"1I"M%:(
M+>](2SJNVM+OKZS[?2**1L.4K;%G"I_X9LB?O=0-#.R(QRJ>0E\HU2S/K8S%
M,S:Y$6%-4,O5$[2GJ0I$VS_+)3D;T;L0F(Y=4BY4N*6K(5T[);=<['7K*VM-
M[>7`<LKB2Q?X"Q'4U6T_<HI`8RO:&]\<XM%G)S7D-I?A/<%)/EC-$(X_"3$:
M4KVHNK+4M:RJP1GR.OX]"E%LSJ!R``8ZS#.L)$?0L&MN"I&=R8K@L-BC,E0*
M9.K*-3)G9V-5`1;V840,!Q("SC$1W6A.;#:%G8M>5W"KB5-$OC;<?([@ACK8
M#:3#OF0Y0N7E1"'(JX7*2CGF?RN1"3OWO:$OWML9F,XQ2H))5I4ZTD1HUUM&
M\;1:Y7,GB$6B=);@;G8MJ@%4Q-60O@DTJ13R&998K1C=>B$[JGQF56V)8I1O
MVU*P7G-Y#+I4/0S"%!8B/#^6P'/]EGEQKH5PB%CN]Y5S7S3'7^"3J22`$L,<
MY*IK$J436+ZE:(HG3DD0NH4BHT@.Q;;%#H<C!HDL@I,028X<I8.JNOY)*ZML
MN8NSO3LO=H_2,-M2%+Z^4/*"*O$RE=73NQ'2FU`75\?G)TE$*20;WY6-,80L
M&RN1!YK>D$`?C+.-2SL%OZYDTX1-MK*Z@(AA<\%!7MVC[#+(R:WEG<P$]*'2
M]2[2.8O+4VLD=UYK&<2:4+WH`/?Q*$F_:AU$F(Y7?\I-UI;$HJA+5\WAQHW`
MI&KL9S6M>EB\$9>4:.I)>N0+Y5\)\P]7%(VL"4\*]EA&8%,A&,K^DT#>JD:J
MUBG6TK=K.U7CS-*421EC<I*;JYV]F?%4/NU+'D=8."B%5`T@L)04GGC5\_E"
M)S\#O(-E+$(-)D:@0U)*$ZVQ5HY1G4LOOJXH,FTL))BB"2/QJ(]@+1LZ63Q:
M6TT*9QQ-,6!DL6SF]&_QU67O8B5#D2K*$8#ST*,X.P"$Q4,C:/15KUO-+[T)
MTADQ^84Q>#:VA>DC]&5D?96_C&76ZA,F8V63K5$O8)%.V$U*`Y0A+)+-"H$G
MUM0G("FA$1-?7-CI[UCT!5)-DJI&Q5E,R(>_S^%-8(O&Y3&CAN$5A5=3A//'
MLZ03YP;4D6:T4W5@<T&U).@I6K:S3F0$TPA-3;$KY:.@92V\T/MQV(ECC2\-
MSLY,;,YQ8R*RZ./H%TU)A<'D1J!AMITBS,F=%KDE^))E$TTC:=A/&J<B""C#
M"R5%TK[FKH2T+?LYI+EC_!&R+NE23)6FA;0SH].3S,Z]Z"L:JGJ8Q^2HYY*D
M*YA6,D70J#D:,UV2)-KB=@7G`&6<>68B(;_X<.$W_(R_TTW3_$[Q[_F,K_#3
MVO[>#NSAF8#`8#`X0T7_`-B'O+_;PY._O$FN1I/^4?>7=[*S4;T1<K/1%;BG
M;_$'Z<LYLM@L2<F"-)42]V^'S:7-$7<7DIL7&D@=DT:;G,UQ4(RMB5*TZ492
M<!AXRRQ%B+FD0;^J*3)?9*C<W0E@4%3,N,IGE.W+'M!)VTF*UB]I)ZL>8RWN
M:-C@H06JTH0.SN<E0`..`'SM!,![1MEA6?K:IY)%H,J>FMW/7V'/X]5RV,,,
M<=[`2QN8R;;X:T-DO=&=F,:6X($$=VH5^?X3$!9Q`CP`":6(0VRGBN_:,5O@
M8LZ.AVY0Y2Y#5P(N[U[-B9*XOKNV.LC0MQ<?<8H!W61Q8RL"]PTY:)$S>Z(%
M*C:C1:<T8!4O#;-I2R$SZI:\9:A;)RRV@]G,*%Z53AKCR=@=HZP2&;+?>6!9
M'G,U2F;H_$S#TQI(_$-7LLKPEZ_I="(N+1:N^PJ/FT"CUAC7.#(ZR-@@2PZ,
MDPR<O$I4&31L?G9B;HN@;X?I\L9K+^;KWY:]E2+4&PM:XS0P@3G[`7;-TF!/
M2U#?!Y>_LLE/?(]#2X\[3!\AL%G$K9&PN91M%/&E>K=(K%G5O4[41-U2NRH9
M9A@D2)60>J\H)Y0ADJ7D+ZAYP;G64H29VSHE+,)]52!R(CTA)95[G&VEI>'M
ML0R<IB"P2N6(F1Z1*?AB%4L=#4QY8RR1AW[="I2%@OBDG%L7+V>4-Z1,VG(!
MO*)2Q/;`ZLSA))TZ5ZE2/L?<V=O>F=[73UO5(#4JI.4K`I#O9H`A%H8A4H/&
M^NJ>D+1\Y`K'5E91J538WM;U$9LCL=TD"2PI361;<SUF5$U$C>"W1YB2KW$:
M+WE2H**-WM.6`@T82[9X+9@<[K>PMN:2$@,7D09T-:%1IL+D3$U-#Z3I2B<V
MAK<7M@:VM0],IP#DCFF1&F*&U1H:=6$DWVEX<HW<5X,=0KJX9#H^[2I[L2P(
M3$$S2Q>Y`%'F:5SF+05;8$@/7&D)T<9CC[,FTDSP[$I4JUI!!`!C'O8"Q%M;
M#>WV);7]F3!3!(<:WPVQ66L#HXX6W$_BR<4BMMQJCXY:K:8SFAJN,^<@$Y^8
MNTLT>BV+PZV(`L+MU7C/KJ:J\YU<>C@P1#-E+#7Z)^;8O6S_`!R3'2$AR,0E
MM\:A$UV6VLCPD=%*PH"4\.R$A^Q!%_)K>MX2M:1:1=9US'9;64*C[.%T:[#J
M%UMA%+!J"&.&1:,$#CY42;GX92%Q=4RR;IERT2$I,B/T5IH."=HO0B][+MFK
M>B,S_G05@!G4<>I=(YS.29LS1UP<TES2-J^`1URCNYRX0X#NV.L>B]8$OXVH
MI>^-I1#`-3I,5M2/991814\&;3]3<^IR#W5YFC`TJ=1`$AD3X2U255$R4S;7
M6K87LA=@G1=N8GAW:*]4F/06O9I;M\*\2K:(L'CT$5*SXU8D!L9C=9/'1'/9
M,,=%J1>E=XR],#^Q/R!G1O/NQS%+FEG?6E>J8WA*J3#,(*TH1K"3BA#).`,1
M*F&K5']K57;5>R.T7>*?-EGAH(?)'9VB(BKK:&O5@0\<J+&X/57-#TH9)9&V
M'0M21*J3$C9RSB!''#(5$F#+.-33:*)V554M=B4D/D,?=WB1DR]P"%K(WM4Y
MIZZ?FV%2I:J."F!L93*].R5&$PX6M'!."(C9A7\[1*EK3'^WJU<+-LZMY.U-
ML::ZWW8I+@_)Y9'Y4M3)Z\E\:@:X$M@;$`Z5PX^;OTI3E1A,80J-?_`,LD.C
MO+),+MTM=S;>U%.S`X"(DK40T,S.YF/;,[QYY8U;`UL3\3$G5O?XL],J!U8C
MFU[/*3&(5:4D\&C`"\KRAA'LE2KYMZUHK:!$[SYP0P1]1DRSWDEQ:GAY1QE"
MU/,U;0D.4Q;H\)A97&3M5?KW!,VG*"%JM*G&(HHX`/'LNV>2UEMR5(RR#2(Y
MX"2Z.TU25FL>$46D:MG!.`;9T[9%9#,6YB41UI<SE4F2)49:]:3HY6I]V)V(
M[0RPDJ52+NPZ%]WB;G#'(<N7V5(ZA9&LY%$Y@U)'%HM.RD5:1*2.4D6Q'34D
M:5YIR]4QB7'$%/Y3><%N,-#OS-%VSS6'85U"AEL595*2-(%SG9!#PX$/LDE2
M*&LQ:%B7LR1U:(L<K;G,V:3\*)V$O+8T^DYAC>D//$<`(/Y21&EOG'.@Z$FC
MTWHV25-BYX,5H&N.'+8X_-FWLJ3J'M$@<(4YO#&B32>+OBJ,+2@.C4:I:SQI
MO#Y^]B+\0J59R[LBF&EW`U(&Y_E84SI3GO;VFA4J,8#$%VRR4ULQ+8NYD1EQ
MW+W],XQM6D-;$!8UAVC=$E^+V'Z*6NV6S\(D\4FD58Y3"%:5?%W9"$QF4I4:
MAN"%*08-*-&8VK$R)<U*6]0G&0>D/))/2G%"*,+`,`@Z.9TXJ2A/1;=+3[=7
M.$6.:8[54K<88N*:U+G.K-&YLK^Y,9ILCJ.'QETE$6;WD*(#HRCV)8)Q9%9*
M[P$E#PM,PQ=$4%.)5&HLQRQMD#\\?!'"-GE1N0'M'O\`)X+NQH\E)E1[%J-M
MLE?*_$-T3(3%A3B<A`8,)6]`'K0J4,L[H2#Q"WUU2S!MA+>QM5.BLB8S&4V`
MQ1MT;H*\_G))>28I#QHU$HEA34AJY4I=1(AD`2)S"1[V(6O9HL1<7S9(JZ.:
MZ_A;,QK%6X;`R*X/FK."5U[/6)@4P>&,0'56JTX2F+)D[F[LD<:=+3D1AIKQ
MI*1[P,G80['HE3/W25#T#2CBN;D[8ZKE<CD;B\QS3$17D\W+TYT2-:D[W\[8
MT&);D\386$4J0[.7NZ5(WDE.:<SS?+4E",%2P+?TA0[E&2'14[(%2-BW`RC`
MQ^(3*6,!,NFC&QND8B4'=$,++*F$N/:9.C-3MK60)X`B5`-,2$`$+014I=&K
MPIMVE"2LH\]:3OAHCVY$RF1&3L+5MW3QU/+W*(%.3E'VZ/`FK7&5P5ZY@\_3
MPB3>8,]*7HHWP"IC5Z[/G:2KDD5#'X2.73B=/Z*NX%%F@UK8ANJ\AE?I080X
MOZX.DK#%HW&8XXN"H[8#ME$IA`3D'J322#1$7]D!GU^E50&IE-A5T:EEU@/N
MF*4$Q9X;Y&AK&&_&FMB<[`?90N;XZ>N@C3*)+'DJP1:8HXHQX+-$3Y9!XP"(
MO@E5O6@EIELA37'H:BD#]8<N51&)Q[;VS06.C<R(M*)V[*7J2.1!K>TD:8HH
MM$7H*=0>J5B++T7X1&'%"(M6D>ZQKFQW[G9FC,1>)2AO:+$6"C??)9%#57NE
M5?OT_AR20'[5J4ZF3R=LB[F!"!N,4Z`6B&>(P*<Q.,\NV8N4/D?9;6S16LI@
MMK!)%W><67<E7:26M8<'@"&#+*ID4M8GG<AFY0I1'DRN2*X6$29&E/.T88:$
M`C?$5O>",>291?J2/3+I5WH(,&\,AB6I&`;KN0QQPE3#IH8XRZJ)(_00K?SD
MB5<2]-)R$S(_&#V2\*-:+T46$98A"M+Y+,?;VB,3<;*'($3PAB55;C;7)Y8V
M1^22<"9^>6`<Q7MQK-%&%Z<D31&(@M;5ZQR-T%&4%R"`6P;+%L1*8T[J;G\A
M?*V\^PD!0H8@?W60KS&61A82PQ)`QNL@2MLD$R_-^0OC0VR%N4&-[>I5+_*5
MDB"3O0M8*E[:BM6%W4DM)X8X\,A!%9ZZ5L[FNK$YH'E^,88S&G99\;C;ZPL\
MD;%"0<C&BVWK4PC@[3[WKVA,#K!,4Q[3TQ4CW.8773(*7+)#-%\W:$A(ZWG#
M01''>NF>.2%Z:IMI\C[4JABTQEEJ!4A"X%$:5D*2S"M[`86(8J:M*)E9%25J
M^M+=,S4\:7.H7Z0M;PKA[V%@$L0,;V^OIFYFF8C8RCD9D?CZY2-,8M+<%"=.
M,02QZWKQ"IE#FCI'G%]:'=Q32]G3-K>UR"=NQ3[%Y!&U&FJ+-43EKI*1M,BC
M[6X*R?@TR:'%(I`2,2\A66<EV=H(Q`%2R4P2TA3ZI9:LU;5*92YRU/*5DV<6
M.:3?YM/1$6<(@E=SW).@D)=<QMGB;LN1Z.'MM:$)"Y7O>R]JE`C!K.CPJ>E.
M>PG3)*IE2<PUF4.C+(0;ADN/!(5[#.4U2O##'#`QDPJR71JL)T3Q\]"R[<U!
M3DL(2B+T8>4$8J4IJ>W8]:=?.=B-#8M0Q]KE=G1<H@#:[*71015<]E$'4J@L
M&F=)($[@J4Q<TS37M'[ZF.%M/L`C0_RB8J:5.3U+`CIG'(W"8V8\-TU>V1N<
M'P2==$5[=(W>9R:$/J"115^C[>_IGM@<(N/:@I860>9HP.O9H/A&(5U63+[@
MHZOY<BKJ5.K6TR5W*BCR-K!%7E>A1)99*%,/AKW)G9K8UK#&4+W,$1C>B5N:
MA*48M#HL(_'L.MBIE$&;H_FE,YO9\>?BMOLTD30<I+98!-U#Y9CLL;E<6:)!
M%D:&*&N=GM(6:O3DH79H`XMY*)J]HCPDEZ%@J6'+ZVYN1D28AW5.\8`TRRRH
MPZ-[Q5DV3G.(J<4,8+!E92!#%EAJJ#17YQ(C53V8`+>E*/",TTO6A>P5*9NG
M55`,RF0%N=@I4H(P4["7.8V&4C9%HF-Z9([($47D)3$8R31R8I!($*)>D9E"
MY2C5J`E'%@'H6M"I>DCIVCC38X2&9F$*)2XG-:9.JBLQ0JF=R(F.JZVEG*=7
M'B#JZ./G>M,Q'S@TV^\N.O=RMC,UX<%2C48ZIYFDJQC8X],$FPJ],+FQFJ()
M-&2.E))26]&1&0%/[M%&^.-S++C&9R)9W(:DI&ZJ4BDA(<<<4:6$;9?%1UMS
M(%(EDJB8A$89[^-*(5?3PR1A;&V-(Y<MD6F;40%(R8>7#G(IST\[3A:C&X>S
MP*!%!&+1=N3-1WIBFI#-'6&-QLC+EK-.'"KT245=3(TQ\5M<?ATJ=76-*V^/
MK"UU>MB":-FU+WXRVA.,\H1AP2S4YAI*E:E@.T$B4"D[A/%"%G@H&U6DD(AE
M*@E'II`=\,,0)TK26-R6N;\N<])TZ=(`:Q6K4`+)",XP(=DCCIQ5(S7MSQ$-
M,4#0NQD4+1-K62F:WB#3MA(CHU+"X+65DEC@_1I(1%I@[QYD/.2MKP<F>%Y`
M0C`2;HXK9A:GB\!?7=%NNH6!@=7^1_G!E14/9AI*^GA*5*M<*S?;29GN2;71
M<A2RPJ00IB,/1/(R1H%90_&4,912@9(VRRC9U91:L!A2V<MB-:U1W;^]GIVR
M5JXLV[35VR6FYMJ&:*(PW,3HZHJ]D*9YTA+&!S,:3=*=I``T/0!4I1)K7IR&
MIC$[^M3(VN)S1MB+@>EA[\Z,,)ERIMC[VV`?G%H85S/#2OATQ;S@."PU*C+T
MLU[3@[T/014H`P]4TTI1'N1)JZ-,B9]GT<"@>(;-&6:NDKAULE5*O2QBOBXB
M8\R=,_3-9X$IR+9JI0:<`&D^S/>/(+MEG4G3O/:]X:4::;(C7.0(&(>E0HQ*
M"T[:F?'Z71B/M\R>CH^!OA"Y?*XB]-9"%[/0*=NB)0DT5I3H1>R5*T87/HE8
MD01SN*F.;A%G1(-Q;'!9%9,RG.[:8F"H(=&IK?69M=W5K=$0P&HU)!!A*XD8
M1$","+6]BJT4^9T_SBUM:5N42;36A4?.EO51Y57LZ;U+`CB:J+H)@?,8P?$2
M5\(C[$9/&@2Y8\)D*`I.Z)SAF:)."9L5+),?0%;R>YV>H(D7MZ=R(U;+BJ?0
M-#RV-;.;5<LK^%29D8'-R84K/*2R9#+?<G`QI6GE-JUNVF4:T;OPEBIJVP^$
M<)O^1E_IING^)WCW_,97^&GM?V\'=G#,P&`P&!PAHO\`[$/>7^WAR=_>)-<C
M2?\`*/O+N]E9H+/H`SV(@C[<\J7%*3&YU")^B$VFD$F&O$"DK?*&A,IVH3*0
MC;E*]M`!0`.@F#*V+01@%[!:$:-,BN#N?J^?VV6?.'2%."=2UW1M-DME93.,
MDL<Q51%\,K.-))Q$U?P!CBX*Z(`PC1FA<6QN\\C1QA("/=SK=,Z+(B/(<"A\
M9:F.O9K,F2-I+!9+@9DB19'G9I)FXGI_?)9)VXM4RGEE"L\F4J?BP2!A3C5C
M^(I@$+S5*A0-UOC3/%M?4Q(6J4M,EE+T\LZQH4ISW!'#6P*_3!"YM`VY3(=Q
MN*LRF22%8RSM6>YNZTTYR<W``#SC?9K96Q.4RV,DT`9Y5*:WEK@I<"7&L)`]
MR-B)2&D`2*UK]#)%!U93H6:G.-.3%M4F/,+T6,H6CP`%L6PZ$`1S;6J4\0UC
M)66`MPG=Z"X5C%JRBL-<GMJADQ1)DM7-%D1YL4O$8E48<XV^GO3#:CJG7:.3
M:#K?D')M)CB0F;.MTOY-^(JWF<.%"0/K['F,^6#E2IK:62!'1H1JBHVBF#F]
M)"'2(+H2B2(8TS%JVKPMXMM#I_3)O"6$).ANF[0)-P.S2)DE\1LVP)0^P55,
MI;)8!#4.XT>VQ!:[,C7&6&5C5N<0$N=9$UM#<,W:!<)<R[6+5(C"#RC"RB92
M[JX<4V;^28(M`W)H_8BMH(9%D8:[%:JVCE5Q-EEKI7MG!N./(GQDCL0TAB;F
MDD3@(#CIO"C5.3<JV!2(1FRSPU+EEA<?1XA<!_:+&G;-+F22N4F@DE3%1,\Z
M&'N4QL68&MY3:LCA[:_-IFK6?6PX*\LXTYL5A#Y@5)1:K0W>221[G]_B5G.5
MFL5HN`'&9O47%93>.(PYN;)3&8LR2XHE+[A'VAI2BF3M(7U$)5(5853CIG;B
MV\H18-!,"2[T8V=TASET\]ZE)SP-^DT3>H`C<'^N;/D34I3[J*T13YDC#\EB
M4D3M2E(EF;2M)."I3B4%B$H"484<6$90B9A(!T&];E<OL(%T3P-B/S(3$(W*
M11^L1!@4(*E`Y4;&&9DU!0-#R%<L'HH]8[%KEFB22_)&2/S1G"^7)\_S-U6V
M4"Y4N*7JTL%C6S-R>4J']A)>4+NFDA%B/KK(7(*%.P,SBO>E.UJHH*1(E3E*
M?82203Y00EN;M#!<254(Q_'\=GGA?Y5/I,(L3NTB`SD3XEC)-B;#_P#(M";8
M;%@LN_@R'6Q:1;5J/YP_,_FC=**JN2JWW,]A<[<7I']XM5%:YD=:T591AT+?
ME"=0K0$PU.V1M,[0\R8-T%<M2%4V>4LEJ(AQ`N,-+";Y8N:94WAJ`GL8H4;.
MK"%76DJM81"_.BH4Z6;+ZA/I15."7D,8T^;6CBBLY7I`(\3;IY/&J\G8?+)`
M-T\>;:)I@#.T+[+7D*'`TRTY`GD4@`<<3LM*L3P*)5V$EJ\M.6-.F$RPU,9O
M1FS1>\F&"\7AV$`3FVEIWIV5ZMA;=#W6R[">O<&F+Q;XBZL]5J$JF&PV#RRO
MXVR+(B77A$(<G-F9YHN5)GE:W*G<ISV4=Y^RB"4X#K?K:X*%YV_-+8=Q3Q2H
MT(,VW`HM#VGXN-Z"RPNNH@W1T+L::8RLH&N1V`[IS'%X3)PG$"-*3CV<8;X_
M"29N*0MQXYK=SF\F6K[/F?SB=W>761"V)*HK]O7UX^RBQ(?83G,F,*6(%R"3
ME-4^B+:8D"_'.K:FUKR!$C\>O87=-/:Z<7L;SM:L6VO907V7'O!EK/Z,N$IU
MEDD.SU$WL*!6G'$ST$71M?S);V]+\**2F::@F%&C-/'I4$;GS3\:4G%)V;83
MFI;5:>1;^"R%LG<<KIZ`^/$@729I9`L\K>8R&619S6?/K;8`AJ7I]+@%)2]`
M\X1XE(W33'(>"ZW0&59L4UGSP&L-1!44JDX85)'U_D$-M51<9$J/D+K$#G&-
MR*5R]6,$B5,NVXUZ;RTZ4P0"TQ7L&Z4N!R#%42B#EL<^L!A88JT\_-;['T!L
M5-33W7,L@1R.K5,A7KHPK<T)FEJ313L%M-1`<DP2R_85X/$(;EAW?4;;:Z!E
M(ET[=(Y7D:=6J72F/I4<0*;WLZ'/C5+V9P72E]9%S]$RV=>Q!$:J;%:(_289
MOA-*'X#@$B:^ZHVSCV/E)(PN:[;GZA9`FN),](O@BX,N)K2&1=?IS:F%K3@B
MP6^7(G)%Y")4K==+%1Z!(F\!I:@`U)Q=S*1_E:!0QQKY%^<28*=,+97+<V-3
MZX143E+7FG)?-;#8GY6H)8$*Q4YB.G;MIR)1`)3&I1@$$HG97CV+M<%75JZ5
MD<^,Z65&NL!,#[S%8XL;487-F?'J6SB93=Y<7\@!1SMM^<):G3IT_EEDHDK8
M7[-#-./,$29O[J7L#CYGLZ6/DVF-DRIU>UQ[,E9$YL:K;<>;(HQR-3)D<-D,
M>W#=H+*9"7%5XB-2+XB)&,DLY-Y1^U!J@L94S-5<R57#(Y!$D+E+^_,L&E4.
MDC&X;=X^XDK'6LZC_,$C2+#V=G2-YA`6%`(2PI.`CP.98O!Y18?(T29E8<UH
MF&3MQM!U>C'(*ZUJA04P]'IMMOFM$90;LG8%T>.4MR@Y"]'ZM!?HTP8C21Z)
M(_HOY@_&+4=97'55R><S"V)O.I`UER!*Z)U0U0H,A`Q;DU<$5"L2(IF[1H^4
M(XWMG\"A$S;<--A+TI/5:)&8?X0Q8RG@GJFA8TDM]58$5LJ01*PY$I>WN3,Y
M!D2=BI/"74BNF=W936)Y9E:U(SHUD#0;3.*81:E(H7*0;-&$\!9=2].R`E\0
MQ-$[L$@8[$FT=?8+&J^CM?.K,W09(J9S*X:&]A9'J6:#%=DV8[;8DJIM"8]!
M4>YMCNX$)/=]J`F%%W2SCART[)5"][B5O29O?D[U*K'B"5[88DZQ2,WG,H,[
MP-\M7;6G96]U=-#22-R<"V,Y=MH`YKSC/*V5H@H@;EY6;6*.RFN/D_..11&3
M0R1I9A"IM&#&L+[&Y*F:W5A-6%I7AL=F!T0NT??E[<O1K$9R=2B6FAT$!GEF
MEDM24\X]JFUB7%UOUQ>[3>#JQ/K55(7I>FB)#3'%"]Z>']>U-T-*CS2UK7H]
MP3"6&F`.`(+.AW[-"($(8W3'!,Y?#XE<<*)IXBU$CLY1UO@SM)7+395=AR5<
MV'HCAL3Z]LDPBLJBJ);*!(A."1?IK!_3D^:GUHO6P['#5$(]Q)0,1EE6S.)L
MLGCKQ4[FB=F0IMGTT+97A:VU8=3S>?)8Z8^&1]T/3PS9)0C=)2S3AI2_-$,'
MC`,;I2V1<]D.M=O]8,5CS6&QJ92JU)!-1M"*#NCG(6ZXY-*I3,8T%3*(B^D-
M*#2V7*2T9Z8H"H@D(-",,%K8MB];1V%\DP>"6>WV*S2.4[1,+S)I+&H8H)B@
MFYF?YC'0Q5^4'2HJ-$V-(&@;,'PIFQS>5B%*9HL02]Z2H`(Q<U2-7GRE#K14
MRY;,9\LBT,E$@:I.Y-PDL26-GSN<J_-I9W5K$LX:'^+JS72*:9@-`S48E+6]
M(M*"!#$H$5A8FONR`^3:EEL*2,S=+)0N8MK)@[M#XS/C$M,)=)0U,[+\5;UY
M;0K0'J(XMC296B\0#2]+"=Z/"<7L16QNF)6+%*&2Q^`VM"G6P9])G"YW.6/4
MSFYZUE8)2D<Y?%&N'*SX@;&&5I;XP!F:&9/\-\L@TQ*:7HP1A@O;O9+U02K>
M18G4KK'7Z-2IY)=&>92.7.12*-U_'8\]!E-<PBMW5C+C,7B;,UL;<-!7#0M"
M<D"!:)>6>,P\P"DP&%G*WRM+CB!VW:!EGR63RLM88UE-Y;4E)BBD#<,F'3:#
M?_(7QXC;I)(XTJVB>K#U;>A5ITBMQ+)4&A%[#0&B,IB*82R^1FZ8RJN538X+
M"V5MM"NI_/%C@]`+6*66IH.?%F:%-K0FCQI3RS3XX*4+Z4J5IR?(3B&'0Q^4
M6$1EHL'HGF*)=(IF1#+7]]:D#2S3*/'H6]!$WA&K;9PE:$SFX)D4QCLD0LLR
M:P,I8&M\2%%N+:2I6%DC#I4/>B1-<'DD?*L+?T3*63))<SNL7=YY)HJ]HSV1
M2I9)1.KRB708WK21P953>X:8YU"TA29.>4,@QL&<0>$T0]&A%RSA'/+0&CYE
M2*R<3EP33Q98[M(IP8L94,O.>;1F+_.)(J3?"&5O8$R$MXD1Y"=%I%M-IN"!
M,:$T'CV,7K:!0#B^MZ_4,:]`]R,]<RRO4S`!.CB$>91O.Y:]3,PA)'8Q&&AH
M:6;XJ^G%EIDQ9?@3A!K8Q&>,T99RF7TMGG\J;VC)+"F=EJXI4;C7%41:81-.
MJ84;;*@UO8\^GIA,I<WUD4',3*H/DB).(]O7)E"E*-609X/:0<$1.E1Q0YVX
MJA;^SJX`NMN8.06>!M%?Q%`XH:X=7BLJD^*&JFQNC`5$2$K1OVG./)?ADI5!
M/>$9\?2#3'Z/(5&*!NGB]<KX\<WJ;"7L5PS6,0Q[9[W02I$B!%E<@,)O$VG]
M2%B;5CM$G0LYO7;@+@MTX*![<V]<I)T2,PCQEA&YG2.+H&2-K;-3"<:@L1>W
M:15O`"C(V2S0!VDDV:YY(SFUS#'MR)X)6.K<:0F+<5:K2%$XJRB]_P`J<28;
MI\7I6\95DJM)%;&CO>WWX\XO#VAD\3K^:MSL2LG:^QD"-`.4Q1R<(HI8),ZJ
MA(UK6>E6!)4;T8,PPI,:0-TU3-#Y*K91&T,47.,K<&5'#:4@IR=2XH=#<6"C
M%4I4QPI:<0V$F>>^!ERHMR&5LO9@-`\CR!!V+9-R-P3BJMX-'4\=1N:T8$<3
MFT%)<V>+5U"W1?&9G%6&'BW)C(7#V)+)Y$S-3``2=R5%;.V><;L8=@V$L*EG
M*98XCFFO9T:>HBUL.;DP1^WXO+U"=A!`W1QCM@57'H5"7%F9IT0PJ9/#URLJ
MOTB9Z`C5$K-%J%R/8BR3]E%BYY]%QGU\9:%*L\*F%D&2>1$;BR]=:<'3L#2<
M&RZXE37(TDIC[86F>8\A,C]@1<LP+>H*6$!]VVF5!._I=")=3HKMWY-12=:Y
MGRNU9Z\MTL=8W+;#CY"*%M31-;"AK"W1N+3-1I)&=N3(:VM["TC&@0J"4"E0
MS)!F%[U[V%67<SJCER*^_,CHURN7M3BQJ:_&2H`-A6@4H('6\VJ;3:H(6LAI
M?ER"%V"Y%JC0>$TM6(H\C9>R_`(;I8@[CFLE$(W`3GJ:;91&.IFS@.;4!QT)
MVY]*YQ.$6H^"B)`,B%D:6%;\O?A=/Z3?B)_H,)>MH%+^#8I81Q[A.[4L.4/#
MR_/,AE#@XM=;&D.*]X::P9O>6!F.@Q[/"71L05(V$)')M)+<R4RA:7I1O:G0
MRR[DDE?,T`;UA<G>;9D43>F^93^:UX_K%L*;P0UZE4X57C(2$)+JR>XR)$@7
MHGD9A2X)X@L*I6`P6O)+4DC=*41WE"#Q]$ZA!)9BXNLBD<`FDB?EJEBTL>IC
M`[<EMVER`]*D8D[4G%(9S-%@EJ8@@M(%'HHA.60$'MV2WMC//,6@%)6=5JJ<
M2-''9X3.W"125`>P04,-3RYCTVO2B"(8\UM<8KYM;4Y`EX`)DX2`.)JE89H0
MSS?:+N;06'<6U@QQF7MR&2/:M/9,3L-@=UD?;H'%&4+=:K16;8\+(M'X=%&J
M-LY9"&KFX:+RB3`;&<H,.V>,W0@EW2L>!\Z-$"L4N=HIQ,G-M:$UMI(?!'`,
M9!&(J7=T[CUDSXPA0@CR21NYXY3'0;;MK5QP6]$>:G"$>MA&$EZ4V*PCA-_R
M,O\`33=/\3O'O^8RO\-/:_MX.[.&9@,!@,#A#1?_`&(>\O\`;PY._O$FN1I/
M^4?>7=[*S4/T:;8.JU.1US'G1_=7:0QQK>#&)V>VM]CT74.90GN2LQ4:FM<2
M!Y7MI100Z1)'UK--+-$+9H@`$2:6.+FE)XOU`V1*#2JZ`6G\X:Y:H7.G:8GV
M#$$-4PR,0WG.7-LN.FC**7K4#M9!=QJ3%8U1!+DL/TI0#(7F)$ZL&CN*Y+**
M9NNG)O4N<<#<6YJ>UR]]<WM9-6-+6,CKM1#TJRJXI7T57OQ94<M(#LF;R5:@
MYO;C=*RG82]8-,K1[$3T]J39ZC/5-A?G0E2$5N0$HR$])**?C)DVC;&O3RU_
M9*T9*=5O;6TO:]O][;O=Y"K;$;D:>A0'J-FK"M*`D:*)I#[6#3/19IEDL$*F
M]SIHVPQ^\'2H'!-;A@GQ9-7&N^>#ZM^,/CRZJ7Q]0-]C@G!B1"\F'-9>MB)5
M$B0[2$X(F&#DM:]6H;28F-BFUHM=1-LW?OFE(27%?93ZA,4O-6/+<LG8EEN0
MQT?H8H1@D2,@+V"0I41.U`#$0=[;=Y%O'Q>!?2G0!L:C(Y:NNN6:`Y4!9$P:
MDUM*SG8N=0[HL#[+44="WRAF)1M2.K57M-;$8R6M:6@3[\HU>7L1E+CDG)-?
MW1,^7.J:NDJ"SE\@>6ZP6JMI:^S1TC%BV-MSB@%*(W21+/WM#7HR))L;666U
MKVED<"2O>24#>G4#)PEQNB>2OI#3O33&U6G+:346,Q2:PY;93@B8Y!.$RI,D
MASG4L'31@X$<<920U(K$/DD:.*)<S513H!U4F"5+@)!^,LMQS?%PK'K4<-='
M5@G-QN9K=&&`<59G-Q7Q1U*;WF^%"NSXZLCJNZ'F42B8-5))SDK`XNLP"KUI
M43LE6E7%EGD"\6:CD,ZB2/T43NCQ=TE&<\50I@TE$])X;$8O7X;,>'*Z(S<L
M/66;*7AZDY-9+?AK<X."F0.:L(&\Q,I3.):]0$:=F?H.+/U!KZ>8G:,V(?\`
M!JD9:MF6O>W>?."V7V';VW&"!<']6XN!:MGK1D32-Q<E0E8RFEN=0:!K8C2R
M1PG7S22]6SKEMLI_>Z>(?Y1#(V5&+JCC"7)XLSHYO+&I"77$DYP4A>5Z52WQ
M5_C8SI46K-\I*6_Z*WYX?8(&5(VUKQ4=8G._0#V@>VI_66A/7DZJ.E:GCDF0
M3A&D;%SC.JNHTJ-2*1,!D@;V(2-XE<3DHD1Z]"K$@7"3!,``K9(@Q8F&US@P
MW%!JLOUFCB"7SI6&?IBJH3O\[>WB4[KI^CM:`E3FADP9<R3-<JC#ZODZY`@,
M>VYP4"2%HDJI*4-*874TM1%+U%T!JPZLF=F,[TM,CTD;P+WZ1.C4:^@B4=-]
M0%HB9CL09-)L[F+4D1MJ&E#`>ZNR[7Q#V'J3SB%9@(3,5I]<$(<-=03.8W2=
M6"N[-K6:WKB8'1U6SJ/IH`Y5*B;V!&UPJHV9R>`(8U:A+J6<%G<U"!*-&I"I
M,5KMI#D@<JZ5JD*V#]BNGQ)MKMUMF'P.;NTD*BJFP9PQ/-@5,S0%%%[`@RJ0
MK'5_?WEW*MFQ4S_'%91BMR7IHNN1!5#*V3X21>//B\)<2[?>)D@DCV_3Z'FR
M.#!F[!%V<UOE$?ADJ?\`=G/LLI:7N2&TV")IE+"E=V!F1/2A@D1(3$99[:I)
M&%2(0]*]J5B-R02WV)H?E-KSF&J:<92I1)[%F3BM00^=(VZ/'+4[&(N:+62?
M*9D^*'(Y6,UA2K6,Y/LI,O$V&I$)!)JE`-/.ESM*^0O,6U;[%(86EZ.^:#DM
MM)6JW(Y/+^G45F08U0J<I4X*I-#UD#\.PMSB,+5H1JLE2FTHV'88MP.,$Z:G
M4OEC[.(I:C9#6NVZ+G37#8Q83XG]V<H?><MW+_FLO47"Z+)#'Q5FK:5ZHA.E
MCC(I"#0$[8)4G$'5-*7#?5'3"<W<YNS0CLD3/+([RPDV]L$\6-<:9`5-U`7.
M[!V4U'21.GCLG#"5Q*A&N1H/?#RBU04YY:D.O&2)T\T0C<!ZO0W9#DK],;';
MJS87GRHFN*./GA2R,,-R6V>[LEH.!EM,!*E7,*?,BZ5*[O+))5Q(-Z-(,(<R
ME>S2W%=TYN?74"N16/%:X:+`"6ZR642:&S1J>X<AC#1$#^09)$F!A3'NKV6Y
M%/H.E$Z58!$-"(LLT\E<,SW?1N@$BN?UJI^YJCZ+*CMB0IL%?L]KYTCEGM4,
M;HS;*'Y\JY[+*/K!LAJ^1RF42EM5*:[1V""8!/1+E!S8E<%R<PU$-M+)"G+$
MQ;^1ZJNMUSS*F1]FEF1I'N2Q1C$W1-1\'C"VI3[?J<251")L.U'1'$G^(4RT
MO*):6UQ=F=%9RI<8:I4GZ;SS!>+T2I@ZI:4MM)XRZ6`AC+*]64[MMF3N>-T=
M=EC&XQ:9"*8D:>6SF21V-HX426B2L<D2@9$"LY4G5.",!Z)8M/'I1FOFV\+8
M8;*DE<RF]R89&U?0@Z:3N]S(GAP631`GH$RL4+I*D,J?$\ZCR"0-<N(3IU[J
M[M0`'JDS@,TS18"A-1+/I89UX6Y3-RF#];SHV!M,PV>0R#JC6$^35GNS9,ZQ
MIQIB<*+D7Z:36^%;:$[BW,[?$E2AKTH*.\UT"'9H]/*D[CM<])Q#EVEF:#I)
M:S6:TRV5M<QC#U+HH>]DQ&V'^=,8I;*'M(K.C3W)*O,ES9+S]I#S#50VA0G(
MT:<HT6,FE]D$60SL$EF"5-C;PD2-F:+!K6,I:PL:,,,N>I5!&>*16DKQE3F5
M)6%,)JL]65(WMW2*334R94L;=.;>,D@02"^GLS4DBO5LR;U-;2V-2A^"D4SM
MUEDE`\1-+7THTZR2L'R!MT6)/?"GP\EI)3/.BBCDB;3;M(,LP6_-3"-'IXIE
MSM`KE;KY<II9C-9NCT52S&*RN6368,K]"WN>NELDR).94[`E?7)TCL/415&0
M,HDM*W(BDI:4@9&EQ*O>W,F8JH:_5"EZ7D\(J29.)'3;I5SU`:8>+I;5-F-^
M[3G4Q5PFPU[Y):G<VR;-B^/0E0_.\6/=$K8K8_>TI>@IDNC"7(I2)J^5LX?%
M.Q$K(Z(WM1=KR^J*[A3FXN;?(#M?!Y-'7"%?#*N1`AUMPMKE2.?M!:SYUR)E
M*8GUF=4ZPPIT7MRQ*F)'I[/L.&=B.@[1>);([BB+L,2E>V0B$%+IC&'9D4RV
M#.L$BC/-45\Q=:1N.1ML5LCZK8FV)OR_WI>L.7GBTD-.'I;`5`CZ#"Z743+8
MW-T6Y#7C.\1U=)YL>ZD0ZPUL=-3K*HAH#)<]1N51V++/`-/*B6QB4KA"\+AI
M<HUM5A)KDB3="+3J.A.U)^Y+9DTV3*:S#,F9U.F0WH]/+HER-`V)8\QM&I<'
M=AC+@BL1@7E?T*<HDP:0H7@&G`3@TF8Z*?=X=UZZFH_FF[7[":I<W9X`T!DC
MN"Q;BBTR4P*O4#5,'<INNN&FNU<I9DGD!Y+8L=W-J]^'HP]K&U&I0IR^GQ61
M)X%U4QGL#O$7VS)38;].NAAJ&J0RY4353`WOT\>4E2S16<TS-N;&5M@4$2-J
MA#&E#2^-SLF-/)/3E.HO?0#3P8Z/5IT9*E[8V>_='PJL0)2#7I#,K@3:LI58
M"*IK`;G]>7+8_*W5Y*@3A/%4<-1I$JXE&-V0J3B4Q34;Y9XN.UHVY0[L2>2]
M&CE<5DB=D*B$-;9@D-DA"J)R1Z8'"AY(WRT@M79:J+HI&:]L\EV<E98PV:2@
M(&%0M5^>G\R%Q6B<\WH+DCERL=+.;HX)8+7T!26],T2=[:'+X!,Y:3(*[8:=
M<R6]0I,2Q]Q0MQ\W)+V+^5<,._\`T:#K=,JXH+'&?H^RELA'&7F_&EI76C<<
M9L*3K[$:T;0Y1-O[2C[3$2J73_'3S(DIC%'1^2)#U"5`VJP(]Z+/$K7"1'`&
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M`!W&Z#(3)E9`RM+#D)FRQ,<6VMM06WIG;K$C9WF:LM2*E%3AE*F&S$,/7&H6
MMNZ6.FR,#FUKD,L0D*W5RA6E(T)A*@T(2O),UHM1L)(F*[H@_P`(Z9?ZCYU:
M44CDC/8T;8WE;8SCJ4HVX+E,6>H98F@H)ZM9CPFR)A46G\)4N:=%L12[9>PJ
M`C2#/*&(G&YZ->HM&^JXM'X')7E\N^4.J1_-%(X!*1.,788V`<<A"&:2QYG:
M._9PZOI,;7('-X:DBK;M&W,P:Q"E:$WG-ZE.73AH@D;9NOI;6E82"-.70+9!
M7V&4ROLT4JD_SOM)VGJRJK$W+YI!01RXH&[%051+G6)'*$*!Y;$1RQ.::2U^
MXA7%*(OIODNAYK:Z'Z-R=ILI-T',K`CMM4U-"93$IXHAD&F58P>V*T>?)A,0
MBEAM3+'Y:"(-2Q0[-QY`%:AU)5[`J4D#0^.II>E4M^\F2^U]MDJ(.78YC:<V
M5"763C$Y6@9:ZB[Z@L9Y6W6JN-A.?VTR1MSI7XFXM*`]$Z!,(+/);PI7`6CC
M"15(P&A9-'N2V"O0-UHJWR,7I&[(4LS+9S^=.UL<:.ID5ANA264_/!(J<=G0
M$LY46@&X!`:=X0:#Y_LUA;O*^W[*J<J8ZB@L+-35NNL!.7(I!8$AL)F!,C'<
MQ*S+^L$TO2(:Z944]A8XT\.%-2%W_F,CHS*5:4ORC%/Q32<>Q<7]=&P;C7%U
M/=3T'%3IU9K@O0.LI765(D#J.K9JO8AUC:`H.TR(YMF#^^%&-4S71T@_9+RK
M6*U*,!ZP\PL:K0B7%ST:U3.$]K1ZK543BWYT9-)7N*1=\13%78:AZE,?N--3
M187=&4!OM&N41$8D=I:$)0!6J4Q-I-*WLMH/2J`A)+Z;>B3T;>;5)Y3)*_;+
M7)G:6WNCI-"'A?93JY0<A]M>A3$U:216PN$T,:54"8YX26C5(CD6RVU3_(%)
MM/O9V"X_"11>K>CW./#4/EC]#LC,E@%TK6I`F%MMFD6G[BU4XPQ%$J;WBY[%
M>K0"D,22QS;M+I$%O"J7&@)"G`4UC*$S'984SA]^3'G^FCFV'N;!;<4':K@8
MWGS$UY=V=P54-?D$@C\<_3.421VTX/[[)&4X258ZNJIK,</(4*CPIC5&R:7V
M5N]UYT2Z202Y&@MIU/@O0T@EM>SA_F[PRZ5F3.J[WBK23)*Z26.YQE=6%83.
M0Q@K9Z!&B1NK,I,&-HV<F7'*HMQ^%9N-8]9N5,N+/*%?1,U#)(-:3$K@S&^M
MT'F;%<SK5\08(DN7RV0W;-RY=5BZ2A?S3=#<RX^F<U1!FFK;:$&B:MXVV2NV
M)]`E,\$;8,DLDP+;0[E'8FGJZ7M483QGHHHN.%Q%^LT"I]92'^O4)"0X`BC0
MN;264!7I4B4&'H]:.8K\K*J""W/'+%22*:2"9/""2%])#FJ1YF.WB*-ZG5W,
M"J@012+F+C4<:1%U:>Y`)TA(+-$F\`',1BH!6PDF8;<X1PF_Y&7^FFZ?XG>/
M?\QE?X:>U_;P=V<,S`8#`8'"&B_^Q#WE_MX<G?WB37(TG_*/O+N]E9J;O6>S
M.MX0W2*"1AAEKXLLBHH<8TR*0+(V@TUV':$1@;FM+<4+.^';<$:61[&G!LGP
M>;[!#\00[+&6(B9U:A(NS91$XL<"S:X&_N4BF5@QVM530Y&.&YB%FZ>W136C
MDD;B\->G2+)4)4D9U`#4:5]5K$0#AB3A6ATF-<G6WHN22]5*XO7%63USJ26-
MBF>K9EJ1QF1&J8N[01CK>*3::360*43TQ)WUX($Q0-4-E3Z;TJEUVK1[,`C+
M.-,()6J`1KN<;DB:3I+24XB2J7$I$]=:<?BZ!LL&2OQM<ZBL0C2^7Q&&+5[R
MX$6`8-8:0C.;T>F5>(I0J)*"<,;>C]P7MMYLCYEBB5"3)2ELR0QXBOGEX5O,
M4CCW$7V)V?.3GA0^RN$,J(<I:(Q6(SCVEIV\I?,>&\.G'PF*#$PG&N+P-/=Q
M[L^1.*I*4ESI+EI*!RL.(1HJ<R"3U:VNLQ;8@F;)&TE5:E,2S=H$L.<'9"XB
M:FU.UIO>4;FO*4)!'C:M:P>D!PZQ'JOGF-N$:3MSK5.HX^F+M@>+%;Y=8=9Q
M21.,-9G&)JHX\Q.*J)Z!"]C(=Q/J(W6_8A3@4(%IPB+BVNY7=,V)EK(8LJM0
M8W6O6=)RVEH2W/*^2JW(BQT70DW5O\L<8/`)3*8^XA@53D@.;D[4[HRE^P`)
M5F%;5JB(NV*;"6CU<VUG#JQEBR%/0UL\8628OE?NY4C:[)A4/<%430O3H[1I
MIA\G2H5,1<)>F3..GA8QMY"K^@VMT:((-U(BT**[+>C5"-OW3AA#I-'P3%4R
M918#=I-*#DUP*JA<%<Q6IX\IU`D9"DDMU*\D#R:>@.T5H`5VO=-C:^3;U!(H
M]S[%;?GS,Z*GQ38'2#<ZQ>.K(F=LQ)42/HZ1(8J:[[3Z:U113/4I*(I<E$E-
M/6!)..$$H:D`A43-0MEJZ$.*A-L2&=Q=I@<AJ9]:HXYLJB7*I`Q.;K*8K"Y3
M#$C?(F2(G/"E8_BGJ!M]V2LRM7MUV(A*4LT(@9Y*Z*DCO;NI#')U+`56Y(&2
MF81+)I=GQ*0+6IYC>HS*;6B)3+#(Z]P]H>I4X.3E4#D;O;P3%P)$QQ'G>$_2
MA.G+.-)=(^FYK"EZUOF%/MZ(R&1VO9C;!C/9A+N7$(Q:4X?X3$C(SI7#&8V>
M/J<Z*.2IS1A"WE$%)@EI%"]0:`G8I3\J[+LIWAJAPAU5$1544"K9*X/3Q/(\
MX*66!6;>PZDB[H0R',>V]Z>WL,7?52QOTK*^'(2TVRU"A<H"D*&V$Z;>S5\H
ME9D'@E7D2U^=9/&VZ"NNY>]QJ"2R(2R(7=,&><`E,GK=K5FM9B6B7(GS&9O?
M6XXQ6E$E7*2]GC)&WG/!\2NV0N$!>[38JK<%<%:E=11(!JJ0*OG6OM.Z6VK'
M*,18B(QB(RQ69'6T-OM1;B[EG&JO,"?[FW+0Z*$<-NM<T[>>J`16LH)9$PK&
M6QDN9.TYBY[&\!5,KDURZ*M4T6QQL*1RAHCCRK;;170D::/*E"%"<J$Y-^S$
MQ0U6B@#;K2D9-W$_N,1<I-6==F*)&Q5L[/RJ+3"2M;;&RYXS#IPR>0*0NK2S
M/3Z3(:N%9Y"$X2/PI5#A[R2/6]E`&`;8YK<I2_IW);!>(!/XFG2I7.>]#-4'
MER%^;U0E2*GI\WL9S*XQQ(SH1MZ1(VOQ1*->-4>H7#0G&*"$WF$^8)C2X5$G
MZVNEOD/QF35G&OFFR,?1CE+V..SDD[X?'Z<Z,:ZG;)2WNCK%$S@\2A3'-+#M
MM&M)$!YA`Q"5D",(*T*CDN:L>J!6L?90D-:3=@BL49IXZ1J>GM4@`S2$$#E;
M]"W5&8OD$/98VADBE>R[6H4B):]DFH![&>80:6:G")QI!&GLN0J6O2M!2THE
M:$:!>S1=2@DK0LF<YG;)2<9NI0VZAK*P;`B;W!A>%1&E*0Q0J$O0&%D-HBSD
MVS!M?A!V'-G&1J$;16<*ES`^`H-JK]QBEG.&RG23VVOL5%)-2%;(8$QJ&=BA
M(X"H";[6_P"+:.(,),1!4"\DH;4I4]C(CPU\W1VOUCK*[2($7#F5RE#:R-NW
M;4_=(3[L_O@4+F)H;2TK&M<1J2TBHP0"=)B2#E)A98AM1B5]9S6O'6Q#[)K]
M&UM$"LH<+8$4#EZ20G2X[7-+;<1S=(U,FBT>+:`AD#R6E3*TQJ<&@C*,4^60
M4HV:*OA]:O;(.QY+&G29QARI8!DLJIBL286LD0V2A.C[)$:[CM/S)4MB3\IB
MJ);+GM\BUQHS4:%0WM(0JT*@E0>06),H/&WFLYNZ"=WA@OI0"JW97+*=4O)*
M6ITJY<HL:7-!*A]2QI[/85T7;T:5GL`EB.4LY[4HD"9<ET8668-<0>A+%<.D
MJ8'W4SLC>Y2$ZND2FJX017Z*:S2&34EW^%.D^97-8VMT2A3A%(S)'Q''W5O+
M;7/2\AC7HU)H@Z1#$E5@(&WS2FLNMY=:3[&(>UT2^,$KD")REPOGF\26(13=
M9M"*NSW.4QY^DE:M;S+7E&XV4B;AH$C3[EI<0?\`_,?=]$*#Q.-<U,MO8$K:
MY`LGDS%(B*;;:QJB2-"5L4PQQD3P;(H1>EBR]VE3(3"$!J=PVV5<%(G*;74)
M'B*+V`H&SSA!+MTTXLO+NW;&55E/U,5HU]C-@L=07!:B11+')TC4<(B5=P:%
M/H95%%\_KV-&SAR2OMC($(T)C>C:_>T*P(W'9`4YJHFW5?\`8O2:NNG$Y`7!
MS)6V0NN(+:%KR'4D01]1'XE.9(]1=L515@/;UATS>P'1-V6*$/G-H`)TI991
MQJE02G$(BWJI_HMVM.0+V%76XHF8LBDAF<&/42]$\_.)FC4\>*^7:?RD3.3\
MU%JAT;TZE.66)R")$LUL8BSRC4^B3%-?ZSZZMUP''938M;1Y!#GVK^89#)D\
M7F(%A<&?;TL6T8$F5QPE;%TCQ-$JL]H9CE:<\U%IO2^,28:P[QEB.IQCDLJ"
M=CCF5)6;=ZBG)TR,,'K-MMJ,IEB5Z;B;"B[]&7>3L[4RO4PBT.;?G<0F:0E.
M1*7;@TH1K4HBW%26;XPDVZTCZ;MY:3))&TOM)RI%'X-)`0^PYRTJ9"ZQ"$/K
M0LA!$]7O$F7P)@B@HA%4<N4'DK"W$2]>%I4;$@3`&088-O=ASO4`2F&RM:S4
MA8C_`!>&QAWDCV]M:5Y/&E3ZK20W!#EJE25%3(0TQV70-"TC][7OR12C7OZ9
M/M(:`!R@`V]V>F'9SW7[DIB\XIPQBFRU=`V*&Q0N32A^/G#K-"V4Q>\1]5'J
MJ=0/=>P\QV&C<W%I+=71,Y)_(-:B@*D)RH;?)9R_I!Q;8K1\M=*NDD1:K5<T
M;7+%EA?&XBAJ-6K5H6M&@F!@(F\."!QD3TMTE9A.21I;5AN@`4+41RA,4<2F
ML[[W,^ML4@,_215V*J]A?&1):DM='&-J)L\&[Y,DO2[Q'FV#(F=&C,UIH&T$
M_$$2M.8)R$8`M&%"`Q3AUMY<VZ5&6P]6Y''EW?Z[D5<N#*^@9MHGI%)R&U\3
MGL+&_D/487RZ'P1X>&HL+WM"H.VV$E`<D2HHH9Y18#S#F8IKTC[G87%^110J
MN9*0_N25M84R43RR:\-OE6,E@4\J#S!:'K<FK=K<DLB7'>`1!C(:(\`?849K
M1=J#QCJ&\):Z0H,0KF-.+:_6-6;`T&.DS0LSQ/8_->,Y->RQ78"Q/"53?#71
MG?4J`6QLZ==HX)>DX"@$[&/<7;'U]UI6?U,\MU10J6UA!#'B3VA0<_O5D0OD
MD98RGBD7AD&CLE<3UJY:B=VUVDB=TF[4F3(=A*1J1C.,.5IR"1#W4B-=4$1=
MN`B#`8[SR./"I@;8_-G-RFSBI2-"60RR%Q]<\J*YKU*U1L<;6RA>F:3%I2)\
M=F4_3>=L\@Q=I,LTF+MN=$UL'K&;5:M&SS&E"`NZ1AK%:XACD_<)4WD2*ZK-
M>JOK2,(0M-<&2IY,.<X^I5O"A,T#TWI0:TE+<3QEE#)&,3S1<'7\QVY.+A,*
MO>*X@[0Q4H]&^<I7:L8+M-[(MF%R9M=X9*X6U*"HB8DK`2QM4@"E=5K>>4<$
MD@Q4$M,-O3BS:3K^9+G2(P]/1Y&K#L!JATNB+&;:37N-B@DX@5M3EH>9'+DL
M65":'M)NG7%N5MZ1`Y%:5*4QB=6I3;//(&WG>B/._?T>0DHUS'7;G*6QVJ[Y
M[M`&AW6DKT\M#"H=/-UA)5R^*):\99&%@F2<8@I9$XJ2/9H2A*048$S!M7E7
M?1I$QG3[6;[$A1*:0%KE;E:R84A2NK)`RVA;&?F@H->1M[28XM=EL#^<ZM2D
MQ,CWI(V*M'%@&7X<)6E\E:0CMECESJZM)L*6)=HM/+FW/"%Q>?F^_P`32UBH
MM%@D[0JF,,@CHL0R)I1FE`-*1&(/$$)I"M42+QZ+M08'5MW222QXV*5E%11]
MPM0F/,;0=/`(U,IA[EQPDZ'`;*W=5$'#44<VE_>DI(-MI:_2GQ%EBT`H)R@8
MJ/'^6<6]XMR:*++*3U6\K:T`6\M#8Z`E#03+W*>,]!J^@11PR'FH])$#,K8&
M\]L+<Q.@Q:<@:,$ETWB"NP;>7-^I+U3:\4EAC;NI$3T4T;L)38D;)G*=8]Q]
M3!:"K*WR8]69S=#D9$P&Y@FNR1&.(DXQK]C+*'HC9.]"H6R9U!'W&K%UI15M
M0O#4ZV`XP"JBU3J]&DVZI;%ZAL&XQ(N#0^P9,M3N"AG=3$921I7&GHVX:H6B
MTPA&EDK6GEH_IW5V.&D:."FPL#O5T3L^"(I:\KT#_.&221F*/:IS94!<4&PJ
M(K&W:6$LZ]8E=%BY"XE^%6WI0GI!*!,4JN!]GRYUAT+D4TJ9J0&:B]'/]MJH
MY.A*TD3,Z!F2Z'0/4+:W*-IG";D$F)2ECIHTUN$E(/\`*2"<5)9A.B[4WNGL
M-HIV8OL:W#E4U1L$7FB]P6QIP=]+&Z:Q&H91=I$#>CW"()H"SN4BA$8V:E"9
M(Q.(/?4QQB`*0SWG0C&WD<.P3XQ(#83-:O4M$X,EPZ\96EEF3:_,\DGZ@ZFE
MC/%F9\5-+">8J71&[$+N<(U$7[LF:7;?A,*1:/-&U[+I["9Z<F+W&MPY5-4;
M#&9FM<5L:<'C2QMFD3J&4W8F@CV>X1!-`6=RD4)B^S4H3)&)R#I:F.,0!1F>
M\Z$1:`6OUY8T=BENQUAJE"WV_7,!O&6/1(K!:5<7CK35U;UE-D\A9GQSBZ4B
M4NRG5T,(0-:M$W)@GDK0GJP$E$FJA&/DN6QNE$-8O54QM4TERI?-5-<))3IK
M.D.GF(H;-FC%7,6EBUN:X8]1U$P.,M=C"_,=W=C":%(>!'M6>6(C0VVJ*I>G
M)U^8&<6O-4&Y^]QO\Q*5K8FD++%S'1SLREZ$?%27WT913<C*53FR%:D1INMA
M(3F>6'7@+`'!,1=,ZA[#>2-.Q,SJ]JA:L!ME,45V=8BV2(Y7-ZKM:'T\^QM,
M3&*\=).$N22R<H=1[:1J<'1S+\S1K<D-"66:-J$M_9=MS!+\=@U,Q#X`H1<Q
M^[$3"?O[`_I7JXNC9E0\[:G)O^8)AJ<N/J(>>-M&860H$,.C%2<&QB2$C;$<
M6>C7<+G-5*`J)43,%R&6SUOA==R%Y5/D4B[^4?(IJQ.:]ZD<@@R)I;7%K20D
MYR]P:#9",U"H+_I0'A-(`-J4O/4,R.YYM2U8Q7+$CLFN'8#0KJ692I\:G1A5
M'*(^:2@L$8X6A61]^-8WT"TLA$2YMJL@9!R)R5I5!:C8K6N2*QWK.6QYPG:"
MSHNT)6PB<7PR5Y*3)/X"7E96L\8(NSPQ<P1V&N[ZETYJI8E;&M4E(=75U6D"
M#MO"8>G"<*Z)U1O2DQN>Q`L8JX;XK"RZV>'YQ7.#X^AF#9/XO<U@U!(8X;&W
MB(QY2%@]]@!ZA,H5EM[AX!:T>C),V(HH3%0W$PY<)O\`D9?Z:;I_B=X]_P`Q
ME?X:>U_;P=V<,S`8#`8'"&B_^Q#WE_MX<G?WB37(TG_*/O+N]E9H/9"2O'"&
MO"*U!1D,%/TC$\BF"Q"WL(!)5Z5<VGJ5KB>F3)%"-T2DG)S?,`84H+`,L6AA
M#O0B^2JG8'*$AB;YIW746YPQA2#0R!6>\PHQDCR><O[;.`A<'(*W2=B.DTI0
M(W@@P1A)JAP()5E"V<`LS1=5D-3+5HD41:&M/#UR2-_$&Z&)@GMKJ-N,`R*6
MQW3,XSCE2@2G<?<32E?A$(P28\>C/:$>_:-58L+)R;%FDQ`Q;I)O9:BE26<"
M3:>(F<@JR6GM3E%6U^`%4N/)@B\#(H5MR,0?=-%)1&D$Z"#Q`P>KS>J/-/+4
M.-EBF-G4XQ"B\C$^R_W)[C"=/#9,^H']FVL<D_O_`+M#5SN@D+F1H/A2>>%:
MIUH.]FF>T>J6+9J]Y*;G"N]L3=3Z=[WISG5;*T#RQ?'WM,<%O='>2,C@4Y;=
MI4TB*8D9YYWF*TNBT"<0OYJ<KP"\GZ9'+F>?V;-I"A10:032*M$9=G><JC61
MU0&-+:N0OJ-QCSV->L2`3Q9ZAZ`QP/3Z)TE6H4GG"V,DK8!K$=G]<J1Y+830
M15S@M.1]?9;D@7-S4>3'F-\E+C%#'=Q:=QG^F2/!VXO\Z'`:0IN$$"`MR4Z*
M"6!2;H8O)]I03R7/FJ)2>7N%&RIBC2X<6B#\\/\`#G-E1N!9S28.,('$]P,;
MU1Y2U"@.]P$,S85)"8WR]&EE""(N.#VNR#EJ2QQ`F=3:5<XS(7-;`V8P;K$-
MM[F_'2@B4+(NQ+B58-&2(,T;2G#W9(9[X4YIP'ZT$\O0M#7N\IPN:XP\LG-;
MA'JZC"=O84K_``Z#NC=%V:-K@6.IL*'JVV'M*LT@+D_O)7QLE>G2IQ&&)W(?
MCV/WD>MC7BQ=HV'S6ULCBPOX8!-`6A:L3J1^BS,ZP92M?+-6E(&QH;)!MS?F
MA(ED489HT4H#H]06Y)B&PO24`U`$Y0A$2^B6'\>IRDSJA1T4F2U^L>H(:M1N
M<1(1,:^6.#NM?X9(C$ZT"4]4_O#TO4J&YQ\P9ZU6H.$7LXTT8AZNXVUKR,B9
MPRIK8:A4,E&JW<XU]3*V9X0UPKCJH$E<D;FMTL6EL_S6<$@%Y:-2+06Q02`X
MHLHP`!:%Y(Q&EW&-V2..,K2S5)*'2$MD8>:W*5(XN(MTCKNU,=JL+W`VT9^U
M+XP-)AJ1R":%-LIO<T_G`T`\KS-%]4+)KZ&<RL+8JL&M&BH$K,C<3G!3-HL9
M&#VMN6LJ.2-&]?.-$<<D;28^VS!V2%$!.+)0)W%226`LLX8=DF9YHJ7$^-9.
M%\7I"*&>$Q%;H&Z2";'B'GMI-8,(2&]F5/B9O7_#RX]'@LI1"%>H!K2#20("
M#B_*UH)?5W3(Y5S<&)0V'+WBI%L0(2-UAP1D>'^,N[>H1UZXDS1MG4=+<URP
M3D7$71H`Z`="=F^Z')]'^:$0/%HFJ$M[KR))(0MD`2*:(JZP6QZ>2Y:X'0=H
MB$]27R(J53%8G7'+4YJM9.ER`I6[;4EDJ%BLH`Q^8,O8@%]7>UJ,H:19I>@A
MS$IK=%/V1.\NC?&43A'M31O32S29TD#H6TA4;?BP23W,I2K4;+_]WLO1A@A^
MSQ837B@,P%S55[R_-DUC<3C'SWA]IV!('5WC8=Q]_86PYGD-L$JG,:4]"<X*
MO80\+FS7L/7@).6!*.V2I,`-99FN0\^*%,R=8,FA#0^S$;6JLV.@.;6V1(WB
M9FG*"6N>P\:K2B,RA^=78_2M(J3)U:IQ.-\X)AXA[V)MCK%)YU@4/:39='(8
M@A3U,D\.+<$B1E0,S+('UJ.K]4M7/!:EN)8`)&5JVTJU03@')R"M$;_]/AT(
MN7K9HOR^PO,/VQI*>;7T$+;'*#%(5L8*7J8-&E3Q(6J0,"4"KS'!E9U;TX+2
MW,H)@2AK%)OG:\XW8AJJ^6MW$4>C=D2E1'Z9D!3U&C[!FB2+;B+U)'V--\JV
M\CDR-,C<`K0M;=.`#<`*TXR4Z9XT8J","K8S-E]2TFJ(<QOR1<_-3?4,E;7-
ME1M3FZ%JXU(VQR9FIG=JJ3EN"DU2O1+2P,2Q9'C33=C&:GV-$:(00^7HFK\C
MC?+]7MCK%5R:G88@2QJ1BD#6_+XNVG?-*<KX\VRE3(MO2H*T]DE#@@:4JLY8
M(12H9"0D8A>`D.AK+)!BG/K$RSU=HFO6IEL#3DJL%Y&\MR0I^);DRMQ</BSZ
M8X`-+0LB9R4*=%Z/+)0:4FF@"7YHQ"%RIB!5CR*W6XN>HG'H6X/RN'5O((P^
MED1E="43$\:FU>15N@SLEWM,X.CJH8WH8PB$I/&<O4F%&>U4>'99W4LB-U3R
MRZQ=`*(1ZK7*)5S*7-Z;5T<<&M:UP63-R5"0\E(W9M7F@C7N3<WIB52$!I*<
MM*04685HH`0Z)>2/*IUS"W/<(C[1'8?)"941%"(F\PYCC,AB@TP9*XU<P)R'
M=N/,0Z(9%\Q<$G@+\84R96J#K7\\P`EKJ][E3W('D-]./<2I<T#7I\?6ZMGL
MZ/*521O6,R4J1>1&')68L#&#X\E3A6)/*^&[1$DZ,+\HLOPDO+BSC_KEJP9%
M$7J0N5*RN3QII52:'+5C[$7)S1QZ.N)BU6\MVM+QF*H]'GJ/"4B-WHQ(B7(/
M.]H#B/&`:PDVG.G*_7K5NRX-#4D1CJA(XRTY9$V%FCC8YR(A4KCJYR-<$RAI
MVL?EQ*HPDTLM.,\\`MCV:/6MC67EB$5Y^1JUL-A#;6&W!.5&):OC#$9'U;BD
M1(Y(LG<)?#FE,<>K1M*"4/)SFT&>`"8A0HV8F\/BP:H]'$W*T9B4[8XRX4NV
MP56NTWV"SHI#%=Q-(K?4YI)+(^-^W$QG927%+XPDH!`()$#8M%E>S>\'J[VR
M!<7YKE3_`&(\D)*HD+Y*&V10>U?=U\>=-/:)*U(6N6L,Y;"59R)6I3L)29(Y
M!6D[4!0@)).WHD(`Z&K%?-KF5SD3$L<V"KFN6RE@?:UC;4Y*HFD=)G#&'3Q$
M#V-L943F<FE4=*9S5)*<GRU`DJ!6(K8"-C-*T-7HFL%Y?7#>Y=8+=5!HIDBC
M"=RDDJ<F,L"U(H<$1T1$VNCDN`!MVN>(RF.0FH1D#4+6TDPL0CDQ8@#U<'Z8
MT-!6U&HB(Q@CR]GKN9.L3B;%)=)0F,4I@LC7QHE*!H/7'@//VOB.E;>!1HPP
MTHDA4$&A:"((UAAWN'\IM<Q$:;$*>=+-@T82)D\62@@QDT9XV1&U<81>3'')
M>C^'IBH4_*&XM0<`KV,ZHQ+HSW8S98A<^#*-,2YQJ,^,2QK=H5`6N/L#HS1C
M1DS1M$33MEGN4=/$H2(USL!I/4/Q\`1IFX_^=L!"0Q.DV$L1H-C64B:XQSVL
MFJQM96>I%5B1^5/EH.#:UIXF?,F6929B.@TCGJU"ET-Y;G]]CB\;4K<3``.4
M)3=D&#$$7AP:UV29HJ6L6!Z2R%D@<6:7I"C86]"O;V=&E-1)8NP.T4CH$@22
MP%)C&>+/JMM(,`$)@&\\2?0O)]@-"Y>"5TA4$ZC#!"IA6L,D41BR8"&.QMT8
M4"EF9VX+4-B&U(6\1/NQ+0I8S!(CTF@^[*$@MDF@&7OPX+F'Q54332UT2/*V
MLH6K7(2'=.E]Y84)Z,LM_1+&UZ'ML-*$V&J'-L<5"4XX9(C1IE!I7B\LP81"
MY?)'0E,H8LXPE/6T3^:SLW(6AP9U#84L(4MC4[K9`S(1FJ]GJ0IV)]<3EC>$
M(]>X*1^8G\L>M;T+ED$M,U6C6LKD1`XY\0CK,SQ]F7'H`*E2)HCSN.0,*/1Z
MK9QI^F5\.,5I!F[&8G4'&C+$$1IFQ"Y?&(TA3\!WK<,K6&QH0'7;T2-I84"4
MQ*XZ97*-DFHS`D^-$4CCSRK0)B2M@)3(U1I)0`%F"#L3,SQ8M-SK0Z-U.>TU
M15\2Z'M:=E&J!%VKV@:TS8V,I:(@K:?9"4H;.RHDIGEA`(Y.B3EF;$`@K0!<
MLG$JCC45F=K3_8C'J47`M8?G2X.2%G*]D=B30>RQ2(D@;FY%[VR,*9>M&6)9
MM2J,-7G[&;L&P%EB^2,!Y:YS#'S(KJEJ[^;Q[HD>#VK<:;]IE#@@:EC`C,4>
MTK9AY*:.N![8`D8A$!;#1(]`]V%LK!<INW5)6+2]BD;9`XL@>Q$M9&G!(SHR
M#2RV6-JH:U;("67HI.:BB*TQK`8`(3/AV])][V2```BY8,//U'A=37H-40+3
MD?&10XT_YM-G@,C0X\5$!M0DWN_NGE&1`D#0(?@\T34`*/8MI@Z+T+EF9-5D
M/D0S',IG:F>7D.BN2L4V1,S0H?X],E$1#!B)<C$X(U2-8[HXP00CT%64>G.3
M)RB32S"@!!H7Y(^S<^5$S5+!*1^9;0YUU6[3&VJ)LSHC3&_#?FJB"A:W,@U*
M0DTE=_)\SS3TX2=F>><'>O+-&#8N;OFST2IZK8&\;?X9`HQ&7?4?011.L9FI
M.BVW1=L(;TR*.LY)(0IV5D*(:$@1)4@"2#/="-C"+9)>PBYGBPJ3GNCT#E&G
M='5<)3N,.4J%<75%L2/0F4\]\7R8O:(&P;*`6VR)T4KD!>P[+;E9XS4H21BV
M+!<O>\4=3TAE#C-'ZM(8\REW0J6YS>W-A0+EBY*MCZB)+M*-J23"S%"^)JAM
M1YVP^<>V[TE&,1`0EZ%R\\BI>'2:>P6>."8H"B!2]WL=`U)VIB"D<[*<8"IJ
MQ%.G=>:UFOASVQ5XYK&M-Y2HHO9"@/FA,VG3^6+>AYHZGI%*'&:/U:0QYE3L
MA4-SD]NC"@7+%J59'U,26^\;4DF%F*%T36&-1YVP^<<V[TE&,1`0EZ%R_,VH
MRG+(+4E3VLH5+2UKFK=W`#['VY>%R7N#"VQ9R,<]'$"^)$ND;94:!42?YA"I
M(C(*-`,!)>@B)F.#(2&H:NEDBC\LDT"BSY)(J%M!'WAS:$BI:V!9'4E^8O(,
M-+WH6V!\("M;]CT+:!7[3B/+,$(6Q<L@DK6O6]D51M#"8LDCZTUB/6,J9C;B
M6M4=%T+(V1PT]"6G"G-,8F^--Y"38@[V04B("#V:*!K1+EBY!3E52IO/:Y#7
MT4=4*A0]+!E*69'XP+I'(VJ8/K@F4%EEJ4CBZRQB1.9R@H8#AKTA1_B\TL(M
M%N6'%SY2'PX+075D*2M8(TGAY;>@8TC>C+C2*4!FS>U%)T($Y19#9,-;=$@@
MZT8E7C&>2(!A@Q"%RR[+3=5QUU<GMC@49;'-VD8)@M4)&P@L(I4#XN+<A3)O
M9M*@>#C9`O,-4$`*,..6GF&;$,T8A"Y?)NI6IVF)RN"H(!&B8E.A.`YFQB;B
MU"24#<T138L&^B4^<>Y"$VIRDP-FC%LE.2667X`%@"$7/%]'.F*G>684?=:\
MB2]G%IVW[FJ949O@.?E:!Q>5I1XB_>27)R<FM,J-5`&%0)4G+.\?F@"/0N7V
MC=15A#EK&XQ."1B-KHTTOS$R*F1J3-IJ!HE#W\YI$A")(`KSB7F1[$O4>9XQ
M&+33#][\PTP0A<K&PCA-_P`C+_33=/\`$[Q[_F,K_#3VO[>#NSAF8#`8#`X0
MT7_V(>\O]O#D[^\2:Y&D_P"4?>7=[*S5;;-:)K39HLS+%"(A-';-K6Q#2E[8
M6ZIUVZ[F+3+B$'NQII191ZA2U`T4?OQ^[FZ"9H(MAUK"Q--1P\52.-L[*@KV
MP&2/:1LS;'I(U(&)[B*"9LQ,_M"<K$"][A$C9Y4RDC<;%)4^)`I)/4'-HB3#
M=)UJC02[HGB]/,/+SU45J.;DZ*%JR(5[4%85Q##7!J:VU/(;.#"8E%;LM-C2
MIWU^<D;/+HY5T,2D%K!EJB5Z=WWXC0*=G&B9N$%JOBR8K6J$*K.,@#""#21<
MXL\89(:2-:\MJCJ9@Z&.W82TM]6M+R[%&PI"4WG)PZ"4J7+%QH?..\@LLY='
MAEG%]FMR.N@1IRKB2CJZ;1%/"@JH:8E4OD94="0.YI!)KH4*Y$`$G>X\&$@"
MG,;]%GB<5:QU"`2@X*0L;H^OLR[=P"M(DK@_.TO9'@F7HE[G(FQ**P8TRPB<
MCE]O3MI75Q&6.:D1YPBK6]VV:24W/1*C8"D8S-F&;6&E%C<_-A\9NVUM8QN'
MG%Z9E[C5,'FRIGC[6T,3/1,(KUQB=OPMQT-\)4EMUQ-FD:1*0A3'C3+"B3#-
M>44,T(C)L+;?/<@G\RGCPSR&-M[%;E)?F-FHG=C6JY=$&=+^<(Q#(ZR>DS@4
MD1+U9UAF[7(E9&R#S$"0T)H=EB`,D32GUW$CM,ULJD$^?:Q3O<F@TQ@8&6%5
MP:@A#,F>ZD/J=I?VYG=7Q:>!]T@6GB6B\>O&VA2-H!>6D\\X;NCXSGA!/))?
MN1)']G41YS)=HS(:^.,G$+CRF&2.O*$A#QM(KKB6QY=M\),HX!A99VA(STSC
MY(M%C3`.&-RR+QYAD-L66KEK=)86UQ^4P"OZYE8'>&*72<,K9!+/=+,`]U]*
MR'I*4T/*]0O"G+">E&6C5D$+PB,&F"08(F(CN@=7\/;@R1@1NDE;G);$I7!%
M+=+0*ITZO\@AU?E65\"1N+=*I:],,1DQ*RR52G:IE*))$K$<;Y>@FEDD"<GZ
M@W$SBTO-9N,QD\'<$E1MM91*-H8Q!#&@#]':JB]KL+#*9&%>\N1)-A'++,TK
M)-(`-,UF)3MD>,2P6R!.7Y3OG?E(-,5U+8(\.K>^.#]!(S5FYBG<)TZ+7R'0
MIB?&*-+7IAFLJDC0RNA0)&K..2->RD8C#A:]HB]%`*$Y7-JZ+X6.=(&LC;_,
MF)ID;RE@#<Z2>%Q4QO7(6Z$4(\T7Y+`M5NACDD$J1O1S@1H9@@)1'G$>PP)@
MC!#=K:;1GDGW3GZS:>?5D<*?+3TWIY2_(#YY*V-X)9H_%HH@5+&6Q)9(%:;1
M\?BY*4:!.I"C)3A+*UYO@$88-VMHG8/"J>6)Y$-AES3%W%VG-C6"4:W1M6U`
M6NDNL>G+(:FA_71U^9GI2T$JZA)1.`TZ@A2H3JM#*$480#Q",J>")<+$,%C,
M\U6KFA:TK0QY[E$8,E]QN!+'/HS*+&F)$FBREUG*@B4D/<@L0]0J2R!.H**/
MT>(O0B50DQ0W:4R<-XE4-9,+'*Y+$'A3$80V0P"1'"Q":C/@M)R:DD;PD)<W
M12-&I7,[][TH+]@_#XSTX1B+,\>#<@D-YMM6$7=!$<92LKA&ZX<)980[*F$!
M;B#54VD?.J2GD3:BD:&Q5DFD$<$[EE'F(@MK<>0@2^Z&+/"E1F*RS.C=6Z:<
M:[H8X(SOFVK_`/TFV:PM0D:]ITZ$&+*\DZ)^.1I"3%)(D9KNC)/1^=L1F@$J
M1A&`P`A`$<Q--5T_&,V0B93$<Y@P5%8&JE-8+OF:Z$.DL/67[7U^F&74XDO^
MS'U6!SKPE![PA"688I<%CH/7G&A2A+NA<[=SFX**VKZ&3"11Y[=(I?;A>[TK
M214Q.PN;DXVS+[7"R-C*X/#F<A`U+Y0`A,K.4*#=#2!4;#H8O"$EZ^#7$?IZ
MB$XR,I5,&MX8Y-$'=I3^]CG;4.#R/YM6;%(XX1R+,<R20I\8D;387@,0N207
ME;"K\L8@K`@3'6Y[I[P`"6K;:2(9%&D;#84<4:BOQ%#-52.N)6;2+#16TR>M
MVZ:--;RJ$*(RR#,,2J$B=1H"XY/H>_"2>6(RI]%W*4S7W97LH=O@^BY':3_9
M]Y&PV/I6>N5$-C<;K+=?5LWD.[ZLD:A].MNG8M(SE'NHR5!?QLLS9(5)0#";
MM*61<W(JFQ9A(K%89,VM,L73JJ9JV@/3R%F`L(K6&S6&;B[]*(>_LTK"V*RI
MTJ<$9B4T&D+B248(H\/F`&(RK1!?N#HVLXTV*R=B9FAC9JE<JZ@+@P/,CB49
ML>#/M:NDX<7=>[R<^1R>+V,U4I%VP1*@[2Y``M>IVH4'+-A`7=U?MGX7=4T]
M#::^QF]/*W%#,VYY8V6-*"82U([3F<\D<Z/A#8L>#SHW+FA#,"@,,@*\*\A8
M6X#/"8E>5:0!-VE<DWJ+E63U125AU]'YHW1VR97#&>$-EILQ\XD`@$P^'!B,
M/D:N.3V62-,S."0C8Q"1-IQ:8@O8``,'Y18PPG*YODC-?<6/L7=VB0.]@H%*
MY+8>[`6-R5%*WHDL9M@1*<FLY$BF<N?I,Z;]L9&0):L.$8::HV;HHL.M$ZI.
M3P37E"=V=;%Y.+BLA$5@4QL*/S!F>MQ;3C8CJM9^9V>IB`$OB1])))BNWAS6
ME*2%)!:L29,J3%^TAQT>2+B([LFX\:OI*\:"+O\`6+9$MOD'GB73C6IRQ^;9
M;7=,--/L<42^YR!O:QU4ZD,1*IP0>`M08C6NC=H>RG#9Z<;D!(]/!PC<7A<<
MB=HFJRZL7-JJ$G/Y,C:G:1I4$MDTJ&GL:5PV2,SXO=C#)FM`!R0^[&!/2(%!
MA)NRC2SHN[7[MAJ(YO<:1FJQ=''!@C-:GP-CCQ]>QU1,GDA]F#6UQ%H33AS<
M)N_OBEJ<F1EC)C67M&+S'="<G$X"&<A(%E<S-M?*(XIES>Q4<[6F;7;2XU>P
M5,WIH9&H0022>1`E<OD>QR\_3ZY-+C,43_+`Z3*TFAI4IQ"I45XAK]A3EG+C
M3\,'IWF-T&:HFIG*)._L!D.A(;#3CGC\^2^C6INF$3FT*>V:635T98J\S>"V
M`[D[4,^BTR5V/+7>4:$DE,47<GRKB]Y+D3\:U3&*%1>=S"/264Z5P]3N4Q1'
M">BI]?\`&FRL7-.]%HV82LR<?##QG%""C4)MN*<(C#=IPDW(Z;QE:6V="F(L
M2`I)'#(;5E=5-+FN,RQF=X`BJS5LHFVRM;2RLXA[F3DT6>).K9#PZCRI.4H3
M'A-3K!!*+NAGZ_YA?XQTJQ2=2J6+8'$F&=S1\6GM+.V-,RN.66%9*ZN'=J((
M=U[I[Y75:6U*6IT$>G)(/&I:AD#W[KLLDDSI2N)CRO/YI=K\QMB5&UUV.075
M81]CO\%8]/Q,BN&*LC5\$:Y0FG:QXEK2B6EC``H32U^0A1$)SS=Z1I-JRW%=
MV?D_`:QS//<D<X;G0QOL"7*8M&7$J91*/-E)2:-2UE:Z?4.<$ES7(O+A3C8;
MZJ1+"C0DG)'`Q$8E"$6CRR;ES1#E;=</C3)H*]1M`\1]_NA\:].$:6JBE0+1
M31E$TMK^XE/I+\\DQM)%DI9QQJH2A?H@K8A`$7K>"9OBW%PY,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,#A-_R,O]--T_Q.\>_P"8RO\`#3VO[>#N
MSAF8#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P.$W_(R_TTW3_$[Q[_`)C*_P`-/:_MX.[.
M&9@,!@,#A#1?_8A[R_V\.3O[Q)KD:3_E'WEW>RLVK_7/0ZSF2KHW8B&*)IB>
M_7KSE3@FE4[FLA:=/>]YP&GE3\!62W.@SCXTGFHEY:;RPA5#3Z)V85H>S`EQ
MBYKLU0E/JG5K5UEW[75HUY8ACA5UZ2BGZ^;ZCBL@M:3V,A@/+-3]1SV4+F)I
M:T1<4*CD6L92'8#E!I)Q3;X@';..`1AULFHF$)</6&H:"R2YEUEJP_FP:)53
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M/:OB#;5=_'MDU;>ICYY(W*NE;(.D'KD<Q`5:47L5A6G;<BGA![^6:+:79R<I
M,I1FZ,,"K+UH;)J].7Y6"R^J#S0[K^:TJI%;,50]8FQPNFWF;5ROB9#N"<OJ
MJ/5RL<V1Y6)IBV-EB+R"A-2O;8--[NL2FJ3$Q9Y8MDV3KV1B->KGR))HD"<%
M"N-EC;M7+Q:,"72>G9BP&6U%V&PZ_J9QU52->D+631VU9%H,C02E(!HQ4>N`
M81YB?^FPOQY/OZA/J/Q;B^*31EC,2DMD7HR5$7<22+H(;*7R#1*'K9PAKYCD
MMN2F/@"5#(Y(Y2:I0HSO,&8,Y$H,&$"<@TX(QPW?9Y#O5+H2".<N9+:=7K2R
M.S/KW:QVKVL;(>XS":IY#L5/`[)FEENREJ$!A+BBMU0)UJLO0D+@N5E@;?/\
MTL(ALGEV_++0;U6>7;/'#V6MT-NSVQI?-95"OS0PZNE,DL:+#@[)!I-+I7,D
M;0Y*XXPP9BC]G1Q2:Z"<S"!B>4Z8KS%FCDY0G"8X\%3PGU>ZHDC#%K+F\2FM
M)5VYL'5:Q9&+$@LM7VG(W/G:]ZSH9JU7B.))W=D?399,K$3->FD6]NIC\K+0
MI@F[2JS<A.'+FG\J]77E.&L'Q-^9+^(D;8"ZS9Y6::CYBNLRIR.=F:O95;ZN
MSHPC).U&6^*0>T61^`JT>>E<FE:`U"8I&,!0Z1AE*W>ENY*PYI.J*73.3-2:
MI9Q6MY6T]NZ:,3B2R1="*?K9ML0QSAJ:--JM$$S;<X@,.*<-%F*"AA"1KQZ'
MX21C,\.+.2[KEA3T)2M\QL@,>8+GMRA*]94E@M2]:MVCN>W(Y6J,O1%>KI,E
M*=G33WH3:KTJ.:BQFDG*30I_,WH;=9CHH".>L#R%*8XZR)J(NW__`!-</$`8
M5E+3%!)KN(M:U5E'0M/2S,J3E'3=4XVPA&S#UK:<!1GA4B%[B+2K"[,E3U;Z
MND5<TCC)KC83H.S>^])-\:KQEKVSG*[9.Y5CVRS\AU/&4$/&A4$@G\Z?)$WH
M%C`8(#@!]5^TK0$!)QP(LX=/K2VRL[]2JD*YFK56,HA5T-UH2.J7FSXQ7IT(
M0BE3XK8ZQ?K<7UH6T)9"J7H+#)AD8<#=E*2BFS:A&:G"M$?K18JYC"9UY*MK
M[UCN290DYV33<V:5'+N@*YJ.P11J;,A11%9%WEIU)JQMG3T4K"6$J?K6)3\)
M6HB%*4Q&),K5[1$*TXAEG"8M.^5O4(:>M^BY;7E?0.8,-/H.7Z<Z%@TUL:#2
MJOY18"*V;!M:.-$DC33(`E)W>KG^*P5`XM#@666I-&J.`>64(&@:)..V->-J
MQ[C]4,[E64WW6$9HZ<22:4QS;#>CP3I^9E^ZC=F>46HDKPR.Z5,1IDB4.0"=
M*MIAD%[TJ<B?<RPB,"+#K'#=$3,Z6S$L]6;GR*:*ESXMDL,@4.9.I17)%IS5
MMB-ER124\VKJ,2N+,ECJ5`H9D19Z>\&E4+:T\(52-T2'DF`**6B))LGQ3'KK
MU`/N_P#+U*='0^(Q?W&[;:J&MT`;UF*BMHM!VJU3W(`)A.9%"V2SQIFUF)0!
M,%I`0N`<`T(BS-A]F]Q,<;FE951ZPU)RVOV!YLNJ[RK2RSZZJJ:RJM6^LIK-
M@-+S>\R<(%0\$C\D3QQC^<TNOB0-HQ1%N&B0N*Y"+2E4F1E`-$75V3>E4M8O
MU4N4?>ZP9EBBT6F66_,Y15,(A#K5\E1RY9>$%L!AKN=42X-.RA?";8AZV0DN
MRUO4&`)W&25+R2><VI3U)9-DKKI+M>B^@Y>A@E:.$H<)6=$K'F#PT.<3=6<^
M&I*MN5YH.3-$U$N+++CDE.LR,.R-`@/WYRXEJ5J"M"(*V/9)QF.*ADGJU\8+
M1I4Q,LFFG173P[F)93*\DI;Q\-+N;\P)D!&B$ET(%O@M'6T&XQO?Q3R];4>7
MY&O,PZV9-:GGU59\FEK2Q1V'5K*69P<JF;#7T@$[9?`MG/JC2/@>5("VY["C
M7:/B<883%X#1%^0J?"AB*$-`,K8B[(^OM;9*Z?4:B_.O7DGHBVHG(TM4,]*<
M^6,.V(E#I1*T4*>KMNBT*?$JMER;`&M$,@"1UBK,6G6B`,[9R]2:8'W5,<:2
M<QC,Q<<5K<Z>H1S)U1:-@5!3TM<7F80!N>GX0%K0)"VR^+1J;+:WD4KAJWW@
M\2]B9YPAVWF"5`1'F;.(4$E&)%!"@P3C,1<JYWZJO)AS`R/#0OLN1.4D8XVN
M9(2P5C)7"=KI7,;@F5$Q6J?FWHDM0DM9ZLFMY(D"T'B*$G31YQ6*#"4:4P_!
MLE`57K!<V()JWM;C%+A:*T*YYNR_)Q<+Y`'9HC]8FT%8R:JK'JZ;QQ45J6-U
MA1J>Z4,JY+I*+1#SM$D+\_W\DP)=D^-H-;_K2\[L=`698=*LMA6=;<.J[HN;
M`JQ'7C[(#X"MY]C#`Z/CQ=RF&K'-#$*V+>9Y&R3G=(N6`,3O`34^QZ(5;3B/
M;F]>"T.O._9CSDKXM8H_"ZV<7?K$<I*7/EA26RFB+0LZ*P)AF0DZ9+6%76S+
M7E0]GO`DJ?>T)*8C8-#//`#>Q:&.-WV0)!ZE]G*%4;N%70\03\<S7L)ZXKC,
MW*LYS.O(,S;K3DE#M=L/%9[@P(L16S]=,8-:=-Y3^8^I&T\ES&4(/FI"ALY?
M_JK>_P!+[U,Y-ZA`YF!UJB%Q1#%:SJ.Q%,EKBPI+-V2//EK"EIFZ6G1$QK:M
MG%KM*(M$:(<U0VL+PQJ4#JG$2M\S0@;&>&UF95ZIM<NLU8:VIQG5ND\;>K>=
M*'LYBGR`;2)K@E[3>;P<FP(JI87=S3+CRG:`.))"96,A40:3K:M(4`TD1@V<
MYZ)I6OJ)1K7$_(?4]U1*1)9/U837<<CE=TQ$Y'83DXVE8<9D4F:8C&VHGS74
M:52FBRL(%*L8""=A"(\TLOQ&!)./JF(Y/VU^JYR*^`K=>RNEE.L;GL;J64/T
MS1U9+11"E$-[39SK2I4M\O9B(LFLW69V&QK6@I.I"8-(>E&<K]W2;`I&79DA
MB+UD.0%KT0TZ;K]2HSW!M*U*%U%3A-$"XZLO!7S:X3X]_&EVE)@D<NU,6PKE
MPO9O1ZDHX@L]-YAY8V9=GX;?5FH"-E-#39QLN72):]34Y\>ZOJ>QWFOX)!67
MK2><E,\LG;TZ-Y2B.(DMB1$MO<C1A&$9XQJT@#$']*`;)Y,LK]8GAE$OMAL-
ML%Z$LJI6H;P%EQ_Q:LAP1VV@H9:CK0?OV@.XT=ONR5E&-PVV%;VH`N",39XE
MP1LR6)1OJ8\N]'6C`*@J!VETIF$[KQZLHT&HT%O;(8R1^5SB!NR&6KW!Q3:&
M](9O7#NU'%-(78I.I3EC.-+(5I#CR3AE$7*E)IZG3/4EWWS$+B*C$/JZC+3M
M"-+'IM8;`E4SD,$J[B:JNK9$]-Z"/(G)N3O[8MGBI.,@X("U3>G*"GT)3L>%
MC"XB8XS_`-ID7GU=J%B\O9$$PKNYHA6;IRI(^L5MQO$8;5L09H>R3!OAB!A4
M:BSS(]N+Q(G9Q)(2&(CE!!BY:A2AV(Q7K98V3XW2N+P]:OGR,\\V/8]&,TYM
M*V8G5E]SH-:%0%^>B:[646%H;'E=>KC#U;BAAL%'*I2SI?B:-:L*4)UVU*<0
MTY"DTF6L>W-U/!MOT?V[".75M:/=J.*!G@CY1-^7C-P((U,Y-+BV"D&>KG1W
M/AY$?1JVLX+>&PM>\)58M+%FA%:1!,$`[6JYC&^'5BY/W]"1\F=@=*5["9LJ
MD'($=MLR;U%:D=>JIF">;UE6*&U447?$;HWKUK.BEL2?FE>D6EDJ=>Y.18]E
M^:$PD`V^J(GFUCHOUCJSE#,E_/G#%</<':;3J/P^?4P1/+AHBP(15];5A:%J
MW"PV"Z5Y7[DT5U4+/9ND<H7KVX")"X,J\M.I5B``(CJ?;GDN5+ZLO+ZIF;E0
M8YT(1+)!*ZPB\.JA91,V16O.";NB=@3.FY=%8:I3%*%\'L=GJY]"C<C#"2T:
MEO-)<=(C`#T$FS)[&;U9./I$*#*6%YLEVCDK;*R7RN:I*KF&X?1JNY)T[U?6
M<>OQX-0%?FQDTILE@6L@42HL9B)8GV-9[LF,*/,)LR>%1ZM7*1'/BOJ/15GF
MTLEL"3P$,GU#T"94JW#&U:[2:4$,"^1(WTMD:DC<?H2,Y.3(!G%;*`VB-V$`
MB[)NN:Z.>.H)+>37UR\-T*0/X*$OF5U?6;3$',E(XVC'FJE*CM6,*C%\L7MK
M&U2"5++(&D+&<>E0$EA)&:,O7FBT28JN\,OPSTI)NM><(U=DSKE%4LK<YI<D
M)D->-\M!.TD:=ZCN.>5,O2%RTIG84[YLY1"A'".*2ED[&9O1>Q@T$8AE&V:<
M\7'U<ID@FG5L624Y7S\Y4MTBT<F5'!T5@6$V36Q[:FUQUS3E>O<X?G6G2ZJ@
M=<N;K/\`:MP/0OKZ\H$Z3?L;S1##K1ULBH[Q;#WSZM]J\S+I+5=SU/0\1NJ"
M714,&ELJ6V_9!O.8*MNNE+QM^)VL3*&6E7ZT&U2@<*)=H\XLQL:.,3JO+6`4
M&)#-"`(PB=8NJ7O=GJ32RK>(N2>L%51PZO7_`*@F-)15RAUY6<OB\,J$FWXK
M()/M[ET]B$(F#@M:FDIE+"4,AG":H`K+$,HD>A%:)&,3E./1Y*M]8:CY9`H\
M[6+5=[UI:"JOZ:E4HJI/6$QEZIGEW0;L4Q4A5K$_D,+*5)IW<"\8SHZWB2HE
MI[<48K6D(22C=@$X3'"J3%^]7GD:.-Z-P7IKP-VEBD^FUC-[?24V7NM'1JH[
M/+I^X7&[&],C&?`]57.#-$O!9FCC/=?_`':4*I+_`$N#9DR4I]6OCB%BL5=)
M'VQFZ'P!IN!R;K*%5LN.KBU5?/[HG8KHCU.RLA$8CGK[7;VHVF7`)T409M.J
M.3FGID:LX@;,O%-';U'*#8I)S[#W]'.8N^].,[$MJ\Q^968QJ"[R]2^M\,CT
MD5L$E>C4BV2N3",HE2C+7-@/>$^SE96CRMB)MG7LA/"WJ10CKM%5L%6,3BVW
MV]\TU)T%:[-'6E5JNH$&V(NWR9D8T3Z_KR'MW]]1KM#).3)EB0OV>2>I+5:V
M3HN6.W[6L6!]1VBZ=T6#R),H#6QC$R4RKO!BFU:6!(Y6^PR.F6`BA$(CUYQY
MZ@D::HA++80F.#LQIV]P<=>[L+B`7F`*+4F$F(VW".]U]E3OD%WH52Q0NNIS
M'K9L^&5@ICK_`"V<1:P'EXF<^AT+T&#+V^NI%5S9\W6Z5B=5!LK?F%,K"E]T
M3F;/-#O0QQW+<Z*[2I7EJ753$K<42-K%;LC9XNPO[<U)7!@:'.0RJ/PEDW(3
M-N:=W+2KY-*$2?8T2-=M,`S9ZC1*<`S0DC&9X-<TWJ[\AGH9DXG:N=O31EG>
M'2.?$J8FB0VWU+!?3?S"[1ZF"1(Q&3^1)+W>VR.Z3D:+":J<TQI8QIMF'EG6
MR?KS9.E?41899S=U)TY;\6<*TAO/E_774Z*-JV=V:9^[-];O;1'(FPND4?C0
M*R;7F<D=BFDAK)%Y2IS4$%)Q"":`0A.&L1'.%S\&]-ROKKF]AN>=UPUU%-SY
MU<$`EU;-$S(L!+$I!4ML3*L7!N%+$K8SIG5289%//,&6G"3XC?Z(1A7@,&3*
M*FHX-QL.7";_`)&7^FFZ?XG>/?\`,97^&GM?V\'=G#,P&`P&!PAHO_L0]Y?[
M>')W]XDUR-)_RC[R[O96:H;VHNM.D:OD-/VVRJWR%R,]A<#RVQ[>HP^-+[$Y
M"URZ(RB-2>-KVM_CDGB<K8T3DW+D:@H],L2EC#O^3>MEB9B;AK?$_3AY=B>D
M"L#%.I))B9#<LO>IW-;1GDMG4TEM]UHV4[9$DFTE>7Q0MD+DOK1D0M"+1GA(
M:DB(@*,LC9>MX7=*,N7I9<?K&IK0MT4FD8=(^JKQ7&9A&+)F37,XR.LZ,CG-
MS"0RO^W0\].B74Y%$+4Y$#"84X#)"K-#M:`M0`;\F9E_IM\XS>269,7M7;WS
MKM*LFFE7F0(K?FJ5Q9*=;7!L=5E7Q007`1#/#)&XM!!KDEV`WWG>MZT(`1;U
ML1G,1206MZ>?+=PUM2E2R6'R-HA'/D,=:VJQ!"[!F\/7L-;R"NRZID<#.?&5
M]3O3G'Y!`B"F]7[P>8J&`H(PG!,V(0A&4Q-I=/\`C*E;!:*";U()Y$G7F-.0
MWTM-J[L:7P6>1)CW'&V(O4:%*6!T2N#U&I;&V=*E=T*[:E.OTG*,&'SBBC`$
MW3'BI9O]*WC1N$_%`A,Q5-3D%,DC,<<;3L1QC-3L0+EB?03G%*98%<B-;:PB
MLDMR#M3LY(6LL@I5I"2DWX418$P2[\GUM;B#C1E`5/)VDE<2TLM^W9$J>VBP
M;`;1/DO[8/8JVM&(.Y+*XF[<(A:+L>TDB:S"O<4:M*F.*\CRMCP1EEP^M%/Q
M'G3TVK:O*'A@CU)7BRJ'65]53>QL<WMUKBRZ1^GQ(FI1$4KYHPQ'$;#>J'?Y
MGI`J.V>M)VL7*$RKSE2<84Y;RKM_U,IOZ;]5G2;A(#>?'XOSOZ>SK(+)A<46
MI)7(+`<Y,D8EZ.-M+C/G&7"1;K9D<S$DC6HU;8X+5CW'FL8#R0$"T(;YUZR_
M,YHGT_O4RD:B9%RUZL)U24K6;-,1U;:%E5XAFE%V[[M>%-M%B-\9<X\DE\4<
M51/SA9258#!)S#3M"UH!YQ)@B<L-.ZQ)-QEQ1'I&O03:)>\N'2P>GJH61]^D
M<S<FN?!ZP?R;VOR->Y$KS$K?N2.%;?$4YVA)MM92,12(PGQZ`(F[+RK\/2S^
MG+SZP@JU8UO%V(IA3<GD$A@]EI+KGR*QTS7+4\422NO7B4('5*HD=925)!F@
M"UC7`/1GF("S]Z]YV,X8W2H>L.//3:Z+8'4%=*G>U(?)(C8-@,2$FR;.,88?
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MK:*?HRK9;#I$!X22!BF,?L-04[(G7>P+P`W[L;L2?8R=C?E:"6#P;Z<]4094
M@LA0^1]`VZ2Q_<F>[JLU=8;!*.D>MHI;$1G">4%R59-VR?R;K5I;5K'(=FZ4
M$NI(R"CM)]'E9%C+*>'UI_Q<S%Z:_,+-:#;<2I)9\IG:%T325:X3*W["DB&3
M38-(N/.CI/I<SKWT37))E(J<<MLRY8J*'H910#"P%'>,P=3=-5R:]N7,?ID<
MF6-0<:FUP(:HL!-!XY6]>16T.CG-"MMRM*_?G-NK>$RYKFDCW^<2+ULKG(F-
ME`H\0BD:E.VF&'E:))PN[/*)7+7?IC4'3;I''>H)A?4$5L*BDV0P8;ML"5#5
MTSS[*Y3-:SYT1&3%Z?3(U2;2^2DTLYI;=I=K6TO2)088G&8$8G.9XTMB_.%^
M>NE)DLG5I,LK5O;Q5?YEI,5'I]+8LT2ZND\U1V*R,<H9F-U1M[J9%YJD$X-B
MD0`J4AJD_03-@-$'"1E,14(G.>).5V)?8]UOBR1U>[+!WS/9C:B&V)%"_FG^
M>Q@J-%<<H"]JG@IFC3>IC]!1_P`8S`A1H4Z-1X0A`I4^8-V4Z(Q1=/\``=A\
M]<PUK0S_`!66TA1UG,]A\^E1>R'5?LZR:@=G61F.9;D8\;>)@H:WB0*ESDG.
M$>F,]Y\9A>BM@UH3.5S,\5I6UQ[S)8SQ9SM8S6I22?HERI!&ZOB:?R&)2/<V
MYT52&84B^5BY-CTVKXE8,"<3UCJC5,PB5A@DVS#?-**%K!&4\N2L!>EIQX>F
MBFU\2F[J_0=Y=)G%)NZVK8:^>,=JR.T66XI?=J&7*)`-X)N::S6.(-.LBT9[
M^K9TH6C8@M0C$0QOR2WD/C5%S;8/6-RO3I&'JTNN+I%9\R-A4?>8S$8ZPLK,
M0PQ&*,32_2:6.&E!QXG*0/:K2DDEPDD@<%!:<@L8`8,LKJ.40PW[,3B_YZZL
M+55*`2O76!?:NG`$QF`"PWX6V^XZ>`HPO>D88D)9[7(4=T#X&)XWM=M+[SOS
M,&_+\4_C!Z>?&J\M"]1V-+79,WO:(]*X-MD2AS1A>H-UY(^O@D"4)WT\@Q2S
M=+N3@L5$BWO80A$VFZ]V+\@(W9?7VI*[PX!YOZ'M4BX;.9INOE!C#6L2D;8R
MV=/(Q"I]#ZCL!XM2!Q*PX.POJ&,3./,]@O1CGLA:F,\\P`2C-B3[,*&(RF(J
M'Z@/.O,_#+9=%V,"Y]KFNTK#-K"FZ1[E\C>*VK2,)W!ZLVPG:*QA2:N)B[.8
MXG+')44F`,!(`^4G`40`!(1,SEIS0\KTYN-9&U6Z_1V$NS2JZ1N*(]1O\\B4
M\FS#+&VWX[XGJ%V/6<C1/1+E7*UK<W1:YDIVK:5$8L>'$PX@SW]6$T;LO)B1
M>FGQ)(VEJA?S6=GMO@4)NBG)JTAMB<.*Z;LG1SFW6C;#9>"K4F.>9G*)?-5J
M*9!7.AOQ1*\C3N"4TKVE8-^2I'CA+T^[=7L'/SE8%CS*;G4G:R]48Q="V4CF
M]B<V6Y(8_"K&B\RF,,?6LJ8U.Z2Z)-1'PPX\19"]O",`0[&IV<7=E&O=T(=N
M?:O>IQ15BN#,M-E?-[?,&NIUH'IV)(9$4[B2.$24M>@*5@1ONUD=0%%`$L`=
MLD8?,!X1[V+#FYJNK2*?\T^GY1MU-<_L1Z?XD\.$EM/KR,U`Z65:"ZE$ME1,
M3*CM7HB.4DE<E\#2SIF76BD4J%)2+V$NCSMP(3Z7&F*<.MV4Q7@V<HKB[G_F
MYW97NHHR\1Q:R4)77-183Y;)7=(YU54KK)':NF]^1NCDJ3/;_%#9>YDIG90$
M;CI&L&G$<(K0`!).4SQZJ6K?TL..ZJ<(\XQ.)3?SH@]U$\Q`AZM6P7Y#%2*&
MFTTG]1QUA0NC^I2H(O"I#8+J(E&$.PJBE/A5;/V$(M"<\IXID?1?(%7P'EVC
MU2@IJC'+MM5.11$;^>,C=7F,6>&,2N*U@W2`Y(N6O+@)TCTI<0E`>=B2J0CT
M:/>_``6A>4S,]40;O2SXZ:%$&^%0Z:MS/"TD%0+XBBM:Q4\*LU'55D/UO50F
MN6*%2(+-:95961)EKHS:=RE'D#.\DSS4H0$!&_)F@^FAR*%D^;WS%D`FOYF_
M,+90I_,Q&BC7WC/O5[2"4;>MG"/W=6_B/G^WS?=__:>+W;^BP;LE93_D3T^8
M%)(Y4$V1.S3+NID<PKV)Q,B6V4XO<U0MM_R+LB9;0`9%"\QB;&*X)XH=%;J>
M)(C1$KDS>,\!)B8@1=V4Z]/_`(\$_P"*_3S@:*?1.<N:V-Q^[+:KYK(@7YTY
M86U06\;8N!/8-<.=8L38Y&KZQF$QN@D+FVG$[)3:5:,*)T6B$<0(1EE/@V#8
MN#:(9Y]0]DKCK+ETCYL2/^ZC!,[,E4@9H_))2@EC/(IZ<RGK"V]PFKNQS=R0
MG*C0;*VD-+!HG6TZ;9)-TU,=7LDG"O/LDL62VX)LF3#9<HELRGBF9Q:P9:P/
M+7,)W1L5YU?G]@&A<PIF=;^:V%MZ1/HHO1:=02)2`.CS#!B&Z:KDJ;7I1<5:
MA\/@8H!)Q16)UM;E4*FD-DSH@B;0V[YP.TY^FGVTSX0*2.*BV!_.EN5BV4H9
MGT(%"$2?18`!+ORNT3N7TTN*U-4N2ZY'&X/FC!:MMN-6).!7;:31));2DVVW
M2JPX19CO#7=M=)I`R5441KR&PPHP"8U'KR`ZT<H`>(SRO1LW=W('//4K/&_S
MH1USDC6V5-9E4,)C=*))'_975W-\((G"'8FE>@--4.Z*!-7DJ3/_`'*3R1;*
M$#9AGB)&4QP9A\Y'HV1POJ6`.L;<CXQV6MD;A?J,N2OY!TH52NJXM3#V-K6D
MKP*XL%17\-0)0A;AI]%FE"/#[#AC'LD93$Q/1B+FI3FA8KJB47,SIU:>(1V5
M\UP1*\+'Y:QN3)TT1#*UD$%>F1&,](_@FY4>;$&C%Q8]$:V+>C"]&&"V6)GD
MY[RKTY^.GF84=4%679.8U9+?8L<O[;N;<5H6%<+_`$OR-'Y]1+16]=VLIFAK
MS6T5I*:W^G)3EIE9GNJT\\E4G4FJE!@3K=EK,\&T+3Z5O&+`;`2V."2YH9(.
MUUJVN<006I8Y$-MDRG)HZV55CS>L:U)=MMQ2*$6.^K7U*O?`*U)KBI$)2,\O
M198#G?E/%&G[TBN,I7J4K).RVH^RB>22>2*?3Y9=5DE3R;EV77#54DRCDDDZ
M!_1KED:=Z\84#:,@'E&^6C`/S=FC.,-+OR;HTM0%8\_H9LW5BSK6=-8<T*L"
M5!7/3J]#72@F"PBN`+B1NJI4)$3\U*\:B-DD^`G9A(C?#YAA@A',S,\5#(Z6
MH?CK4+L;5ES.KJ>@:^RXRD@"^7/:NMG>TNRNAHQ(E$OE:0>E[I(9:NM*2?"(
M[I4:-"SE2!24067HW0RRW.7W_P")"^<=<N/L&N"A)!&RUS#T594JZ+FL9/FT
M@22E98BB2P]\<K+A3FC>TDKARV)3)M9%B%:S')=,SEI,,D11@P>(;IN)Z(]$
M/3RYHB;BS2-0SSF=3MLM]LO)SLFSK,FU@V#,[`8JJF-(Q\Z<2>2/"U7)(S'J
MMGCHT(6,W6F9*2I$,"71PAF"&Z4T8^+*!CU4<YTHWQY_%7O*,VA4_HYK73.4
MN"R)OE=)GU!""#WA8Z'.KZRQMJD)Z-,B6FGIPI0%%[#L)0/8-TW,\Y>:R>(N
M>;6<[=?I;&G[YRW0]4M*I-*6*:RN-R5CFG.YAJFF)Q7[TR.R)=`I=!%QOO"9
M:V"3F'&Z]A_F@V(`A&4PU!?_`$=^>I)9K([N#_8FJ?(I.P:QG-<);'LQ%)[H
MDMKWFW7A:$LNRS$DV)?K/:[+>DAA;\UNH%!:W9NO":42`)&%WS7>TOC?'O!C
MC=DH;*ZE<H06D_5Q-[ABD8@=T3P4>J:(=(S!>WV5;5#,*9Y70:N%=Q3*,+"W
M%:T%AVH'I666`M.K5`/&[*NS-P_TE.)H`]5P]PZ"S)@'6&ZP6,36@M6PRV%U
MD%.RJ5S.OY9+6;<A$BE$A97Z=/)OF*PC(,TY&Z$5OPD[*$YY3Q6C5/I]\VTW
M8-/61#V>9FO?/E0[H^D6Z1V'+9''*Q@:EF8X^])XPR.KF>F+=)(U1Q&6O5*/
M/&>,L1NO"<::8,DY3,4B'[-^GV5]OV65O9O256RSIB8@FUN/D2OJPC-O+RHE
M40>WE2U-KV\.C9'%:Z-1`N-(U"(HDYDCZDY*VB2AV'>ANGLL;H7G3GWH]^CW
MYYIU+'"/0.4P5O>:C07;)(G54HF2:4QR=UHUVE7#)(&UFECY\Z0-*UL1.!>Q
MKM[3`$6>2(LO8B9C@^-]\'<Z=)62PVO:#'+54O8X]$XJ8;'+!F,2:Y!'X#9C
M?<4%:Y2T1]W0('U)$[);PNB4!H/",X8P'Z.*\)81&4Q%0K*:>G9Q(9%V>(2N
M/.#0A(B5F0J&F_G0F#+)&P$SNIKZ\DSO"G--($[T1.(W;%?II.VN",0E[06V
MB"3L"0)A>Q&67UY)USGS=R"X<U#8:W8VV\N>^BWP[HEP6VVXNMUMUM/EG*&>
M<CL-[46IM]6/)L@<4J1U)]X!H!"C03"BRMA#H(F<KUXP^G/7&M`\NV`8BH1R
M7UY&T$3GJ\?/$<D"5'`"GJYK75V#*+?=H<1H*]PDJYQ92X^S+56QI6=A;-MC
M>$D@)A>A.4S&K=?#EPF_Y&7^FFZ?XG>/?\QE?X:>U_;P=V<,S`8#`8'"&B_^
MQ#WE_MX<G?WB37(TG_*/O+N]E9M.N[JUN2WN=WNOJ2;HH\R!^EU?:E+-*7Y=
M&!N];()BT.4\;XJ_IR%K8V30]C2#^'#=$RMI$9K8%1!Q8O!LZQF(FY<XN1N(
M^WJ?O[D:=VA(T4R:JNI69U;<SS-;ND%EL*!A(D5S*JT24;&A1B*/;;9'PR6Q
M]%(GIX&>UNS(WA+"D3K$20>SJ<L9B8AZKI]-.[;?Z"M&S7F5.RF+SR_[<=P-
MB/HJZXJE'ST_<',M9U]`]Q:+/#4Q-12/KYA2256C3!![0)BUHSS1>)*)S(SB
M(KM^ZNH/P+ZA#?9=72::V$B>Y@RI*?=)/T(+HVSU2Q!7$4Y#9ZCL[DX-)F,Q
M$.DJ*=W^D72G<N-&68=\3VYF@"Z)$Y6RSEC5<OM^7@KKTR>P*[L?BEV';$X<
M8U6M3\OEVFYM70TE=9#$+^@T@5R/J67*E-FL\K4V3#.ABE9#:K(2B0FJ6U%\
M/V0B2^[G$PG+&;^OLM#U(N<.JW2TKXZ,I+YR+8FFX&Z$@+@4984E?GQKE&J9
MN$N#@Y>JF$M;=)(C<SS/I&VZ='`Y:XHGAO3DA)()<$B4>R8SC53U:HJ/3?[_
M`)?6`SFIZ=*^KQ_LR(319RZW=1SV4R%=H/-7YNY%:J:WK*CBDQDEKQ<:H$IU
M'E2?W9*H3Z<MF:=PA*V=;\;[]6SJ?A7L])(;6)>7U38$QE]H<ARR+=22#I2;
MHI4DHVI)]RZ[67SH\U>TQUKC;6O5(ZPESBH>F@"=-*CWG?O99`UJDLNN9RC]
M4!6>EMU="*N?H'SM.6>HCWPWU,W%Q`T73:B%`\G=%],U3/\`GIM.<"PN3FP+
MU%%PQVCCB^(@;<HRJ=C5:7WQ4:>H,B[\>?;\).Z\3]JR"^^<9O"X!`N?ZDJ1
M/6C:G@[#T3+)<[,%;:3VJVW35\U<76-N9EJ*I,NEZ%<WF$G-;;M"$0%GO"Q*
MEV`;L:F.;5R4\;=I<>4W7K_63NC*Z@)0>G)2M(L%=G6)+XY,I7`^5I!RCT,V
MV4*/1E.RL]=1)HFRV8MSJ_;);P'Q=,H$-,H\!8BQECE.O#7_`*ZS=+<@W>Z4
M9RS3G.5B/"?\Q3-8,8DLEEECRMED4R;%G&%[TC"W>1O2+3HX2E[/MV9Q]Y6#
M6&#V2<0->`0E"<K0JXC*+F9Y_P#6B(/35ZZA*2/LK2X'6O3[?-N6+`L"AI!U
MS=L3.MN61;E^QJKNY\66N(A]E4?-37L[Q>:!2EF>Y2`QBV:840J"4`PZW8^*
M)PWTSNYH)3-,P)V<8U8T(K*M>(HQ9G.#/T=9%=1FZ]4G&>HVBV8LBG[6PIU4
M<1?/*TH;(RCCDY14L%'?=G/16BRO$-V,S/C^S(77Z:/:G0DE[+3S$NN&"%7W
M0/3M:,<=;KHFQT(?I2\O%7O_`"$YOL8)CP7HE76C?%%S>_.2M>K*$N4J/<6X
M+8H$09",XBNT_P#UD)%Z=7?$BLJUI1![-D%#E3.CI#&:/41OH)R?F2AD+KRF
MCJ6/\]2Y,NB:N52Y@A5OIS9"DD#0I(-]]-+>="TX%#3'W4W8UX_NVDXJXOO&
MEH/WF%S@L:I-?TDV0O5/05COV<7:MA#C&.:F.IU9KY:<J9&V0$'*IZU'.*?:
M?WD"1.H"(L6C-"!HYRRB:YTJRF?3RZ[A5I4C<$MLA8X3>O[:Y#U(5^[[M%X:
M5%$5]P,PT=T9%BHHO\,5=U\\Z%;-NX_>4>SW8!)+B<H*4@"7HLY8U7W_`%>W
MM'TT;#O'IV]+,@<.BBEAZ$K+B*-O,]57%.(;)H@Z<U==M-IV>V@C+<F6IS]3
MZH"TQ3,XMYZ4YJ=647@"G-6F*QC'.(B(GK/Z*@G'IH]P"D==M$3MN5I*>K^V
M^D#:UCD0OUZ:IA345F_2C=9U)V`UR.?1R7?.(^)5:0<P'MJGWI6UIO:A2#4(
MUBKP18SQ\?X;S];^G@9V'UK"YC8\E?FKFE/RK.Z<LZ*PN3H&)_L]W>[QJ&RF
MN`RLI;$WE=^;%S;X&>:X'-+BT.NU!))0#]%&&^VN<<MN.G&VD-@^FAUUN`-8
MVEQ':,JDLT[A>)[#WGKZ]ZW;VF;V]:;FX<9WJP2]F)=CP(N8:N#\.#%$B5&F
M2'.IRI'I2M3@,&=;\?T_GS>R;<*]:M4PNFQKVOI^/H&1\VSJLY(?"K%N-1,8
M%<J#G*NX>H[]A<`@C<X*%]A6),8@N1F0=J)$0R)])W='L]S<'0K<_0W8U41K
M?U#;'E^C[DN/TXK1'V57I]D7EVO$)M/KFH>43*1P%A1%3J$MT*BE+M+PH2.#
MO4S:DKV.-0%7DH@'MKVJ6J!D^\;,WNN9F(R]/"&I#%Z?/=A[QRI<L_.AEI6W
MSY+>L8Y6)-NWK*GZ55)3]J5\S-_/`+,L."0R"HKU?*QGS(J-?S"$*)S<F9T3
MD>^K#T.SC(ZW8ZQ'"40K7TP>L4H:>E5KQ>*3(^G^W:<Z(B=9+.AI0)-%88KY
MN>ZEO0<6=FN,-3$U.9=Q+&Z8(VH1:D#D@;C4YZ_:I>MV>)SC6NC*4WZ8':29
MJ9(K=]K2V4(3^A:$D5[JB>AY,FC-YPN"&78;:EC,J6,,<?GL?DMFDS5F3.S8
MX.>@.:-.6D-T$MM(.4"<\>71&R?2U[TC50LD58+86."EQJSE+5]1-QZ%L62#
MNZP*?LV^S;(9")%.TSPD943M5TMA1"8T99"!WU&RVY<460`*C!OQ_5=T5]-O
MJE%**]F[_9\SD+_7!OIQH8>X2_HZ?KWEJB%26//E/93'(T<411N"RQZG%-RI
M+'`+SVP9L@(2A"<-.,'O`ZF^.'W_`(;1^G!15O\`&C']U)PH1H9JW)FW4EJK
M+U8K=<)9'GD$HNM*\TXQ(8C(D`Y,UR605_+#RW-,(X*1N'&1'B/6*'/QZ0F<
MQEK>K2>U_3^]0RR;;Z@E+=+8W`62XTDXC(%,#OJ=Q-')&?74U`6'4LB0-38P
M[D\,E4;H"'29H<5XG<XX#TX'IVXI*UJ`Y'498Q$?7)"NBO2S[&EL$M"J(@)F
MLJHWA-WY"J)K:6=6W'!VND]]#'UXXT';[FZI6J2.UA$5XB:Y2SG19R,5$(2'
M[V)QF)SU(2Z1GCQYZ-W/48Y.ZXORD*3JWGM1#V]?$ZZG;<]2$VQWVMY3#;@)
MKME9Z:F\:D:!AD2,R*QR2IW`QST4W_&]&"0C;SDP=*AX<X98Q-RL_D#C9]I.
MXN\W2=0=BW%>KYG!K$+G++:$M=7>2;=J/A$#LR'2"++?=C(LYME@Q]\="'=`
MLWM8C?2"2O=@(BB"8F4W$5R<HH!Z.'340JR+L#$AB5=V'2'+LFJ6H9##>A[.
M0IEMX(.L&2VHS;FU;8WMJUN8'N!-Q@@M:\"TAL5FFIMIC`G#-W6DYQ?C^SH[
MQ=R!U-3/7U\V[==D266QF8K;H-;7E)92=WA]C-$]MU'-:G*>JR7QHE[C$GIB
M`%;CR,T#C[B@2^<F2!4)E`1)SC+*)QB(:*2?TQNZ7F:W)*$"V,H[)=*O[ZA;
M5T4JZ;M-=);7?^D+KK">T&[IH$=']MM#HJGJR'[BRL#,I$+7N10"0F)=%#T=
M;\:[:?A8TTX$[863/H!Q;D:*>TC+^LXE=[G3\ZZ;FD?M7HJ#D!NPJ2UF\W/"
M6)N;X33L4>)M%7J(1I2@$H`6PG-#DM.1%HQBANQKO3$W;Z9G8LP03B51Z=/Y
MKA.>L+<GTHK-KZ+F:(2RA'VOSF.@HY#GN4(7*%Q%UHV;/+B[`0EMQ!)ZI5MP
M"H,5I496A&6/#LES5Z:_3T'Z*F%AP)^2I#;(M7@NTIK>;C=,J43R2I:*K\F$
M7M&YU"R&-NCTI=Y')V\$E+,*`F:78*C:(1",H/E:J;XF*GN@M9^FEV_\*8(Q
M/)9\UHT&0<9-U^)F7K*[IDOZ=D]17<KF/2W3/QY<D8W^KEUS5JHVU"C*`\H3
MB%0)*K-)(1(AB+.>/&._)N>?R!U(@].4SF-DFX#;*CUR2)X0-I]NSYN+G?-3
M9UD^6*Q<]*KN(3+;%AX)CS/[I#1N9>E2AMT9Y`C32`"-W'.Z-U\OX5/S1Z<E
MQQ/H3E>^K=(9@)*:5=M',D(U=%C6"XT57USRBKW?GBEF&4/&D'YRVVOT+5)?
M?U*PL"9+MQ(1$!5)$2(9-6<HF)B.R+7_`.EQ/[(Z^O.R&")Q0=9WU>'I^6_)
M)B&XIY&Y60P<YV(C6W?!#(X@)$>@=9&P(2E[0Y-BY-X=:$B`))XQC%",XB*Y
MU*!L'IN]U,5F<W*W&XI,KK2IWYR;(RDB=[.P'ZEXVP]C6?:,=6#4S^-2,VQF
M69\V/D:B+HE$,3EM$S#:##1)#`K"ZN[&8GK_``G'>_._5?0?>REFHUOEK2V-
M7+7-#E#;B6W%:E7P"B[-:^K+2?918[!'(L@60RWIZDKAI]R6,:H12DQ"M2$'
M;]Q6'""3&<8QUZHG9OIK=9J(F!P:5QMKR&5VMW1)I[!'OKR\ZR;BGJX+/>G#
MBVX627L1+J-N2\P5R>-)\U$*1(E3*'@Y6D]Y6I"1C+&<?IR\W]DWI\^HLJDU
MV/VKG1RM%87)EH45&6LV[;%B@6;IYRY1A=7(NYTZ1O1J6ICD=M3EB7M2Z-)`
M!3Q=",F0(AFO"QQ!@W8Z:<_Q?!YWGTY.V':R.K'R76Q;;TV6E"K.9XD_U-TB
MVUTOD<7FB:O"()5ZQ%)X!(U$6=JEU'592%<$S;88F]XU[=[>5H"1NQT;BR?F
MGLP[T[Z,A,+>JMA_<7/KE7ED0Q)%Y3.(_1+Q,(8_KTRV!2YP-"]/SG"Y36CZ
MN;G0HTA4B^*&^>G("22GT6<WCNG_`,RUBK7TW^UX(O311\O=RG=<5+;7*#?2
M[H[W38XIA***2="LW1/82JTS3B=C<IB^+MG1AA(&H5`/C:`I(,Y,2>,L,=3G
MCTZ_PH%J]&V]&N!R>'1UCB\">:WIWU(XY1$OBG15K-1[K=E_7S6UM\L6FH,:
M2D#W%T$,8XS[JY-ZL]P(3.S6!8,A<8HV=H;X_3^75[K;E&Z^AK#Y:=XW8KC"
MV.I8%T&;+W)IGTQC6_SSR6#P=+0LS6QJ*GM:.Q6JO['83GD:%Q-"D":25O9)
MNAB!E<8S$1+BY,.0^LN8*`@+W=\BL2?QQFN%,LL6AFZ[+]E+-:<Q)YQF4+:;
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M7.>Y)=MF7[!J5D:*FD$17KI+;#N0SS8Y@LRU48WQ>@:MAV@3F"/*,TO5*=`&
M4Q,PT%@7I==DOC&AB%JR0UIJ\$TO.;$5PT]+6`0)I/G_`!S"ZXB;8<OKYGA)
M`VINZ78UTDTW%&&I$/GEKO,5+1'[,CJ<\>7UJN+ERE.I`=TQ."6)8MA2FI:5
MI+GV_N@W5:OLO4<=>]D_.I'-[S7\:EL@1L;'8-<OD5*%83@2V;4(BY2$A2L(
M*5G^'*F4X[;CC/Z6L2R.&NI)_P!MO5B.,@3K:HE%U,4N56KJ^;.9W%FY-U0P
M:UGO$Y7/+0G20U2FFMBC5OWSB*7$C!\1VOV,#FB2@V(RQVUS_?JTJJ[T@NFX
M77%9D-3=%:SLZA.7:&IRM76&=$64%O56Y4W7SK:$UM`2AO;6O>HY8%5K31HF
MEQ3K$[<8XJ6WW8!1AA@IJZG.+OE,_LLY+Z:O=*\WI9NDUTS10OM2S(<L53!F
MO]YC,?LROM=M0BYW%U3M<>C:.?UM/X=SHV.<42;3N8$Q9*@36FV-%LA0G)NQ
MT^N3=3O[ART.A6.EX12;\NBT$JBBNI8<E9R[CLJ!';L224LSQ+F%T<'*,KS'
MB4I8)8#.2O,4N2E08C-)`J\"DWVZW7..5:SQMHI;WIK]YFUK9-459)V%SB4V
MF:.>1M;)>B+-W/H+9Q_&M;P)78C+-I,URX]J;E74+3(7]X()(4N)WOB=<VB1
M*#%'@CJ,L>//^7[LGTG+;D<EO.8**I@<_DDQZ9X0ZS;W=;T'84;5V(ZT_%:F
MCG1U9/!9:,U+$Y(\O<.D#NSR#05*<T#V0G+"A]V+\@;XJ([2]K1Z:7=BHGHA
MGE]US18ZV?9->J769,W0;['H_:$`3]K0>Y'UX2H6&-H+$KN?Q3G1L=(HE&2Y
M%D:)4[;$^QHMD*$XWXZ:?5-^NQN(UMGV)P-/JQ@K%*D7)E@21O6Q^16=,8DX
M-E;RNF956K4],KMH3T7)W."294SNBE*X^U4[HT9R<2G>CC2SJYQRJ)B>;GS"
M_2_Z]IJC8O4=?&1!\BC]SQPC"+TA#Q>=A+@O-KU`Z7$1T%+JQ5RM"^1B)+W)
MG=X6F0F&(/@ZQH:#4^VL!R='O9UOB9N>LMFN&>$+ZH'HZJ+PNUKCL_F:S@2I
M^>+;MDFYIG(Y(VV[4,RGABE6-D?VI&EGT>GD$D;(F(<AZ2*42EC/--3:.6F&
MFDRRB8J.KMEAFX3?\C+_`$TW3_$[Q[_F,K_#3VO[>#NSAF8#`8#`X0T7_P!B
M'O+_`&\.3O[Q)KD:3_E'WEW>RLVIO9O0$QYPJ:-S*`1&,368S*].>Z/C[+,I
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M8PL;Y6.GUS24]/.C%P0F-.CM?T`@Z-PD87C?W_#5QS]:6[V2JXI:$BI7G6'I
M9+2E[=/LB"7WG*F8JR*OHN>M5:"IJJG0ZNO=Y-U!8;X)6O0,Y0#T2%$H;23-
MJ#E9HDYULBZU9"6^MY-H1-+I(6T37\LCU;2'L>'-=:PVT'97TFWK^5ZU#::&
M<VC71L0-0PBMI<@$%G6*RSU8VIR-),#M2$WR`#X[KP3^)>IOTG:P:VKUKI6K
MHW([%;.L7-\LI-:HU,:3UWSQ":*EHI_6+5'T4P<%4E=07?MM+9WE4A$F<&P*
ML9VT:@O6R;(CC+U\/^HM<<X=...4IM!R9=<5D\\<Q7RXV>[2!S.%+^89?RJD
MEMB=!O0DS$%("<(^E&_YEFM@!Z2G*G=,K\T`-B*T,L8URCA:36AZJ$WADPZ>
M:FR'T2U-E*=%5IRG'&*Q[5>(U/6R46%(JD9!=,7DU)HZJ3UQR<VE6H$Q.ZD!
M7*%^TQ/M.3Z6:]W$8</M?UW4)(O6BO),QG.D0H.CY6"`QF4/MD/A=S2HJ$3T
MN']M-O&'QOG^3(J]<PR2"3ET>"GUK=UY)1:<D@](("D80'B+\<?7VMFWWUCK
MUCLNA]7F<TP:0V0UV%?\-L\MDLP3/#Y8.A>DT%`NK32<AG*:+$FR=P;W`+Z8
M0[[UM)XDR/98_?`*B1LBKO1,.W_4!M?C_O*0-;2Z0&75BBY)YJF"JCYQ8JB'
MRF6OTXZPLZJ9"=S_`!U%'G<<UMYU9U[<'W4\TM.,IL3$>'6U.SB9S3'&,L>]
MM:;_`/54ZJN;GGLQ'3E>,-$*(08N8(E:*FP`H;`@:1DZN9.:I.P2:.$)7221
MZS9*W.VG=K7IVT"%G![R0,P:HA(>IJQA$3%Z_P#Q=TC]7:?TW(+2@;G5]<2=
M'29'3]5$Q,=R25YZ.#,^0.:'Z['*Y[2C#M$@G(>?;54Q$3>W2$T\2\0'=J<#
M?.&XB2D$V7KU616GJA]!R7JJL.;9AS?`T"A\1TP?8ZR+6@)2J:4-^PB16/&Y
MC`#)D@AQDWB5=LR1"TO@4R(Q4O=2W0Q'HLIO"6H$X15Q*H>I^T^S&7JRXJ&B
M<NIB/(J]ZQ],Z/4[&6]_?XU,Y5#N@[#2-\M26:I-8WA6OK>3!">@>538D.$E
M,+`D2Z,-,,&&+&..V)[2SD3]8ZXI-8E%UH1S5%5<AD:GX9;&FZQP(D#PO1=>
MV?R+*E%$N4N3Q8E_20QPJQ3)E"=>$2]2G<$;4$DI8:`\RI/MU>OU5MANH?4%
MORH^G'NC*LJ"G97'8W)>'X,Y2.P+)E\7?54J[GL&W:NAAR!IC\$DJ$MA@+]6
MY3BYC-4:4+4)QA"8O1_A,"2,8F+GO^&N-9^LW;-A6+1L&3<S,2HV2Q^#*[63
ML]@E%N+@OE=U7#1\@=J+W*"XV"7L,!=Z@.<CTAQ1CHY!7A;RBR%9(1*3J?;B
MIFU<MGK`]4VW3D)M>#UC0U.1]YZ*XRC[M+;)G:EWC;56'2M@OT1>X%+RV_8G
M>$SZ#JV),G=WMP2H6\93F9[DGTL1F%;&S&)J;X2D*3U8KH@+$[#8:NBL]B5>
MI+=MFTI%9UQNYLVW"&OU*K6X^!&(#MCK=.T+%25ICQ;DU?$-ITR!,G`WFF*1
M>Q9L;(ZZ_P`6VCYF]3>77WU^V\]K8;333&I0X]HHT32PV<\/5_59KD*W(G41
M":]JV4QA"VP]QMTU].?V@LI<9HMI\D.O/WL1^SF<*QOGI^6O<T]:J<Q$B['X
MBF*KD*"(0SL>1PZN&NV77=TU\NXYM)EJ]:GZHBYD1]SJ=LN]0[:6QQ008J]V
M`:E)&%9[SYQ18]N-(^M>C;7N[OFR>'J#K&52V.4VOOR7,E@R5WK_`.<TN*KY
MP0U)`7*?S]MA\^=6>-DE'ID925.F4.P4BA0(\0TR!8:'W7(F.,93V4NR^J#T
M+.;%,9*^H"J'.(R^TK-Y]J`ATM*2II_(+EC?!S/VY!]RAO(A(XTSPM]"O%%E
M@TZY2O*4F%KBR_)"(H=79'77^:6#`/505V-Q!U%WG&*65.U54I%B%U<L1+RY
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M?:LVDX1;:7C[U/I5=$Y;&WH"&4U2]?SZCY3=E<S-JM5P<`(T4/Z@%RYN.3TV
M61N+LZ-ZG,J=6A0R@0*5&O.6;0B\Q1LH0SG+"N'%+.N_4J-YIZKJ2@6.,1.=
M(9&^40QV8SG.KFQV,QAZ+L:1UO`72%$N`$S)+ME.$=/4&H$`7%0(!)@%(V[0
MDQIXQPN+<U*[]42[KRN!BGKC(HHTP::U3Z=$A:*6H*YQR)77"WHOU`E%8NK+
M;Q[K`MJ&6Y6:&*"FB5,19(25Y!`DA1R$0_/#'<X1$>?Z+WB'K;R=U1DR"157
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M/JJ]!RRS87'=<Y5C#XC(K(Y6I%[3R*W7!ZGD>M;K/F`V\XOHL$2B[G"GJ%06
M3`+0+EJ5S&:[-:G2I&`!A?E&$V17'ZMFJ:]1ZZBO3&K/K&U4E&3*XYS;\6I=
MT71^3.T.I2L'J?7:CJ1-)[W>C6QW=*U8:R,<]*9$5H@TTDHHHO8RC%`C2ALC
M?472:<L>HY<73E[5I3#-5=/)FL46Z*DUN6<T6;)'V(O37SU?OW?123G0:>&A
M#8<2LE^7I'!N6N!S<0B3DK2!F*32B1GB<(B+4-9WK13.J;=OB,K:6K:P(O3M
MI]4U(EKRNK4=G/IIT5<Y<[G]#H;0>ZW-AYK>P5-)TB$<?4KPGJ1H%ZE.>'SP
MBVFPL>W$QQ8]T]96R(NU*#I#"N;GM@A%Z5;`;:Z"J:WGRSJ+;(+:]:LE@,ZV
MO6E`R-=EV;.F%XD"1A?4#(C<A,GOB-T4$^[*MITY/C^]H8?ZM_3==/$[A-B:
MXL,ENNL.X*B9'F:6Q*:MAE9P_EV);G<8:+`--C+LY&2"P&<GRF<T84PG`D[2
MS0?"'1`R[(GA=5"PV#UIY;)Y/$%1%'0F,QB2JZQAY]22JR'5/U6FD-H\C(^K
M$]K(ZQ+B9+>LY[B)+AIA<'?:@!X_<5Z_7E:3>Y&$^-&A>LU?+17K"MEO/54M
MT^LIDXAFT#5QRQY1(:XAT+[2JNYK'8P6BZ/$7ART$CC2RC5[26%(80A=%KRA
M"4>`19@38;(O2=-?PEZ7U7>IY=/()#8=S12T<.F<LY2JA6AL.ZGQ4[1NT>K.
M=)I=[2>:LK^%R>-OT$@1\'/*-4HE@SWQ$K(&FTF'H>]4V1QOK^&$K'UJ+-M.
M9U`TLG,[(G8I72%.V5/@JK%2)7Q&OMJLIM.54BKT+P!D!,*X@#Q#_ARO9"<]
MU7ZVL&4428@$0HBS[<=>:-O7JN=?/=01F6(X-RU4$D<UWI66XXO<EL&<R>O6
M7GWU#)N\Q@QFESVMAT8W'9/$'2('DNSSH(VQ,T.'O"79BM.$)M-F-UK/'\+,
M]57LGI^BI/:5<US.:IKZ`NGIF=:WW$I(%V<VJXE%QU0;"4C8IK9T6HCH^X.+
M`1*"E2=``)NQMXEJQ1X?=4X#!ACC,7/&T?MKU=>AJ5,>ZM?>>ZM?KOB-W3>L
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MUK9)DE=`X!F-ROK,@>5,853&=O\`T5-ZI^=<NB,7C+=$I&J94D73HFT@PXM*
MA3:&J`#:PP>'648Q$UQM:LG]76R&!7=D1%1,+;IMS;8#=3%]O,KGK['JMJRP
M[BZB9*8YEELIE8XFI5(:?E=*KC[*D3GLCS6IL]U2`T(2GWDLD8<.Z"R+UO5T
M%KJ?R>:U_3R1TA%)]=RF-/Z"V5FJOOFU^6KY@-,I6.BI.XQ]*JF<*LA)-=N)
M!Q!1[@B/2FIO*4EE"5"EK\=SXPWA[%[LG/+MMTQ53;5+',%74+`BB/.SDLDC
MJV%2'I,RSZ_C+A6<J"C8W$MECB.K9VJF6G((Q&B;8J\!V7K918MUSCC$Q?1S
MOMOUC+_6U9TFZT_`Z(9I=&Z/[$MBMD*Z:R6:V+1J/CRV&6KY*7UE5Z6,MY<)
MD5F-[N:[Q1*%9[II2C&B5#.*T-9HZC"+B^&GYZ-M*+]2VSK8[,)YD,J2OG:'
MM*]#"979D$L9(M+.D!G/<?O0%N09M?#FY9,J-E"QZ^!M`T2=0O,!X'(PW9&C
MR"(YG"(QMJQ"/4FZ6AG0?4E'1]HK'HZ1KNL>W8#2=;N-L+T-UQ9=27/J2]8*
MS/<);XFK3L-"/1K`=&$SKYYRI.]O2,>]&!,V1JNMD5$\-(;4*O43LZ[_`$YN
MR^WN98G$69EK>!V!(^:)!/0R%T(G:"LJJ99#8TK?HXA;4YI9T9LHN21YM0@&
M(A<LCVAJ32"#Q;+)LB,XQR:PS[U7+V?#[@IF/0:OE"F+<TOZM[O*K+(1'>YS
MA\XI?ND6B]ZE2OXT&Y;4+._!3LB<*5.L7C5DJEWCT0B/3Y%V1Q[_`+L-'O61
MNB'QNPVL^B$%BMO//+[C*)/*W^P$,?GDKG<`XMB?3/YPGME4!TJ55S9;LZB9
M23&I"M5IQF!<Q"&G$:G3TV1UUO\`=CG3U-.J+:MVFV*IBJ#,D<%N.UV:0;@M
MPR:4\PW)%G'T_9-TRPLCY.&V"'2A3+JH7")3N;>B1^$+H!(IV802>,@H;,8C
M6_J5O1;UH)),IM4X6ZG:\:8A/=<HL:NO7>T7$SI%Z=>K*!9+T06;64`310MJ
MEU%5:6_Z;7EV$I*&H`TNZL.T^F_2=0/C_?\`"&)_6>O=MJN,2B9<\U6WRVW:
MUX9MRL#(K8\GDD'AL+[3'<:)`*X7)WBT04)W6).-+GE%:0&`0N2I\0I`J2C`
M#--'QQ?'37\-R;"]0NQ8US=QO98ZUJZJ;&ZVE6H8M7WM;*5JY[I-S;:[L"PW
M!RFMKPQ&_I79OEQ5>C;HN!/M/MS6.J71AI(PC*$<QC%S'*'HX<]0&U>U+)1M
MZ"F(?7-7-?,E"7G,W1ZG#ZYST,EOTVTD4=C<.82HB@:'F%DF50K<"'Y6J1&.
M#2O1&E(PB-,T4,L8QCNZLX<.$W_(R_TTW3_$[Q[_`)C*_P`-/:_MX.[.&9@,
M!@,#A#1?_8A[R_V\.3O[Q)KD:3_E'WEW>RLU`]'7;!J$A43EU@1MVE+3)+IH
MRIFAO96UI=%B6:7%:\3K2#O1B=X7-Z8E"Q2J3)%:@\L8E*<DD1A!9AH0`$6(
MF9J&IUC>HAZ9D8J^VYP]7%2$YA=5LZ(BRF6'H&:?.!#3.)XICP&\49:D*TUX
M0.]C(#TZT(`&)BG4@>E>RS@[PZVYW52]"NSO3F.OY%<[C>=<$V+SO2LM?&AG
M66)MK@-10"7-[/*;&L5NA8E".'LDO<XG(VW;\Z>5MV2,BU.%3Y"=3[316=5R
MF7UAMV^FFY=-AGL9N6D7_I#H=IJ=JCXE<Q0O#\]H8XPV#NK380W.9QR>,J),
MP/;YI&H0A2F2`H`@@$I\H.@DK.JUJ']L+U`?3?BD6B+\_P!J4_*(TSWC`JJB
MNXXRH)DGB=H3QT6HHF]-J9N;%@&)F.VE7JBY"FT%`-.C5#(4&B*,#A8QSNN:
M_F&N>8>4CI)+M)XG7ZV^[M<%#I+)4N">Y2RV.A)FE$5$D+^]C4+$Z>;39622
MW,I1H$7OAP"B"M#&$.SFYG1#473G`L`>H%7C5:W.<0>)I))I#H!&&=;#V?3A
M(T\^4UE-6IM2MQ)"1`8YV@PFQ\X8_)*<GU)M$`1RHOR]%K*==2I&_D)RZ#7W
M#6D^89C<UJU8]Q"+$$3I0_HV6FJ#GB&!3V-5/$=JQ,T-AD;MA0G(D13:G*":
M_;*]YV(8"@@$[JJ>"HI-WGPH?TH^T\H?J8E+PEIJ_'CH&UCG*#G,%6Q"@Y#6
MC'*8):KTYE>:H:5SQ88RO($><@2K6A6F/"%2'R]%VY5;8B.7OQQ(*)=;[CD]
MI)3S[!&5<T2&P"3(XCA,%8X4N(4.3!(C5"=.5$4T4<"2CCD"PM-M"/19@BP?
MS182LKKFK.1=D^G$?`F"U)3=G-2J!`M.1LD=E#VNB:M(BMR.$@>)<<A`L2FK
M6R3,#:I+<G)PT64)(WGEK3S@)C2SA#;EPU3*ONEN2.B+[M:GX>[1">W'S,&%
M/4N.51@A<*.`D+88]QMWBDL7-YB9P+;TSSO>U+>>(*8U9L(1^T8\$QE$7/"4
M/C?8GIS2QFM6SHE='-LA;&@F!*;9EK"JBSFI<BY:X&MM:">U2%(<XR\Q^?&X
MQ"SA+TM&<Y)C$I&MJ2AE!&W+AJG";I3B-[GD,0I+3H9UL*_H*VFQ%42OBZUZ
ML>`/'Q?;$WFO82C-KF5],8G$MO0+#PZ7'(%19!1AB<\(!65=H5C3/9_(W3'0
M,^BU2CKNS-\]TK"++U?<=%&)"S,K38$HM**JXC''<A*:]-?PU'60UYIR8>D"
MY`XIQD",!O>\$XY1&O.6(AWJ->F[9\4@%[[NNG&A'84EDE>P>36,G;8G*G!;
M6LR(;G(&MR5&F>VJ,LLE7H59:Y3LAN3&.2,P1A1R@O6QMRC1=E[WKQ5S\[UZ
M1T3/:'K!Z&>\RRL]V,9%6A8A,V^,R"32Z,'N:?0V4A.^2A%\4="1$E$#6`,4
MFAT+QX(C*>%L*H[4X85QMDLY3>5+K(M*9RH@B";F+VY4VBG-=.I"<YK>'K:4
MP#$KA;H_DC">X#3$H=KRC0F`"H+&,5EPU0R!=(4Q9/3,4HA-3L7'*HX@ZM?X
MI.42JN)6@AJGG6XJWJB8HT"AA$O7Q*3R]WLXI8>B"-.N0;3&DKRP'BT'!4Q%
MH50W;7"5V,%VMXQ4]`9/&Y/=R^\JH?T\/5296TT7<TEJAYLF8L[:WF`DJ1>[
M1Y(XA$,"M6B*=D(5&@''E:&6<<H6NY==\0DQV'.+18=.293;K5/]5G%6CX*>
M_P!C#KYX<%TW9$+'[EM>EVPS8LPAS]_)()0O9OEJ=@5#\.R;<N=M?.7G_B28
MI)3ZE3;)I$*=J*-9;$M`F=6G([-WS#%;PKZ#7Y)Z[1QY.X.D<A;NJCI+*H<$
MJ$@2P*-&C)*T4C\@C<6=W].[]5)ZE_`=QVVW15H<J]C_`-X2H>>K$@\[F:&/
M1Q;>1UU26S(5%JU6M3FA)?U,KB#U7/N!R=RV(G2YT3(T^Q'CT`5)PRB+Z-CX
M!U1S+T"XP"`R%UK%PM&3*9Q)HI5"M[A]I/"%%7TVL&OMS$"V-;D#"SZ7*(([
M:3FF'$'`-3JT?MVI2JBBR3$QKR:S2[U%N46JZ[)YIL"'SBE6F.SJTZC-Z,,'
M6D6@C38\$YC9[NGKDS/S#.%-GP!7&J*D)9Z>4+6)"VEF)1)0K`F`++&6,9JX
M^M5P<[=`^G?5D7J+EJC;WJ8]$]1IP<ZXAVI]J4R&=)9"Y2J1N[^J<W96O<I7
M*+%>$;V\"-5'&+Y`9I6L(">7XQZ),93-S">P"^^"I2YU2R5G8'.#PXG`3G4V
MEB)L*-"WG3N'RRR"TD).;4^DS"[R:$1!Y>#4B<:=6>A0J3S"]@`+>"8RYVV`
M@:NHK-@L<G%>%0>7UY.8B-3&)"P-[2NCDF@\O\+L:)L4%)MI7"-2;S0J1A#X
MDZSQZ,WH?MT+9)N)UXI(C@L(;DY"1OAT50)4R<](F3(X\T)4Z=(I;$;(I2D$
MD(P%E)U#,W)T@P!UH(TI!96];+`$.B6_@()!RW8A^+AL4+?$R%"UIGH$=:`N
MR=L:RE1+8W$.(4>EA2%N)7'@()"/19(3AZ!K6AB]HN7A3UA6J1FU'4E>09+'
M]*FU=IB3Q-@)9M+696%>SK--A;>%%I4U+@:.3&>#QD&ZT,&PB_EPMR]^X+"-
MKX^Z;AT5VYQ,*X,5<=QYH]_C(70.PN88^K]S]X9@N(1;T?I,(OSM;_G^W",'
M)*@JN7H6=LDU>0YZ;H\]QN2,B)='VPQ*V/D/E;?.XNXHR=)PEE',4U:4KLFU
MK7A+<$Y:C6O-`$6BW*2.$/B3L\H)&ZQ:.N<A:B-)6M^<&1L6O+:F"N3.84Z!
MT4IC%R,@+DC)4:`68$.CR@&>SQA#O1+E3MC\M4A:1<2(D<+2($D2N"&7H!'$
M3!PQ/)K$KY_'+XFX3GYM?#3IBVMDT"G>A(EXSDJAU1)CS@&"*UA8F86INO(`
M(F5IA0>'[3SPT9\Y3[C++LF9G&$[3&'2LK:+P2(T:??E[$LT=O8/YO\`X?R8
M2Y>Q+#HBB)$G116-I$XD"]J$0E8VQ.2)K=3@*'1M$44E`#:!R/+"-03[/+.&
M'0AZWO6MX+?8,5C`#RE0(XP@4DB2#)4!9V\)Y0T#<I:$(RCM)]&%B1-*TY*3
MO6];+3FC+#[`"$'88YPKV`NS.MCSK!X@YL#DW-;0XL;A&F5:SN#2QC&8R-BU
ML4HC$2IN9QF"$E(,`(M/L6]EA#[=X+>\F)15-Y/N\9CY'NZAL5I_)9FXKR%3
M(B"VLRDGP)@^4H:&X.DZ48?8).1K0"]A#_)@?$N%PXEI>V$F)QDIBDRIU6R1
ME+86LMID"Q]WO;VK>VX*72-U5/&Q;]Z,/`8-1[?Z38L#U-48C3$%O`R1YC9@
M-#06P-0&II0-X6QB*&6:4RMX4B<G2)H+,)`(*8OPDZ$#6]!]NM8%75ESK3U0
MR.R)?!H:@;Y7;$^E5DS:2+=F.[ZODDT+9`2(I([.8E2]J8%HH\D,TV)C"T!9
MI>QA*T(0M[+,S*7IZIJY*C8V]+6\!3((P]'26-(4\/CQ*./2-08,U0_L:8MN
M"2TO1YIHA#5)PEGB$+>]BWO>\)<J\G?+-"659,'MB:UM''R:5^=+E+.L5(2=
MM[DJFT=:XJ]*I:S:!IJF2HMC9DQ*,QS*5#0^4'9&R]Z]N%N8BENGPZ(JGT$H
M516-J9*6S'1TN1'L;8<^EQ]2/9JAB`[&)1+PLR@W>Q#2Z,\@8M^W8=[PCSN$
M"@KNTN#"ZPN)N;&[-C8RNC,X1QG6M+DS,@AB9FEP;E*,Q&L;&D1@MI2#`"*3
M[%OP!#[=X+>I-$(FC]VVDB\=2[1&-9J/:9D;2/=#61"-K93$WE)@^08T-A@D
MR78?9M.0+99?A!O>L#'CKJOC%[$ZF06&C=(NA5M<9<AQAD$OCK:O+&4N;F)8
M)#M0T(5I1@@FDIQ%EF!%O0M;UO!<O2L@T)<6Q:RN$.BRYG<VEN87)I61YI5-
MC@QM&S-M+,M0'I!I5;2U[.'[NG,`(DCQ;\`0^W>"WV>H?$9()N'(HM''X;.!
M<!I&],C8Z":P.:$;8Y`;A+DI^T0'%M,$G/T5X='$"V6/VAWO6!Y'V`0.4(EC
M;)H3$9$W.+DB>'!`^QMF=T2]W;2"$S<ZK$K@B4$*G)O3)2BR#QA$:4`L(0BU
MH.M:#ZO$&A,A:':/O\.BSXPOZDM:^LCQ'VES:'I82%(`E6[-JU(<C<5)0$!&
M@F'`&(.B2]:W_,#[!<OH7#(>4]-DD*BD:+D3*SBCK,_EL36!Z:8^+>A"8FQT
M"ETN0,XA!UO:4HP!&]Z_]."WK;XW'6DY.H:F!E;#TK=\(2GM[6A1')FGWD2W
MX6G,3$%C);O?!;.\@.]%>;O8O#XOY<#^MT<CS082:TL+,UFID.VM.8W-:%$8
M0V;5&+MMQ(TQ!0BD.UIHCO)#O1?FBV/V>+>]X%/5CS95-5"N!2S-+G(W6_)H
MNG5NOMA/CE/GJ;N2ED;XJW-+LNDYSAO<2C$/:$C.TM``@;T#:G"465KQ&"&6
M9F?!8Q]<5XJ;V!I4P*%J&N*$')8LVGQ=C-;XTE4H]MRA,P(S$(D[.0>WBV0,
M"<)81$[\&];#_)A+E)5;4UKSFY0N;4"U0T*MKFD]6C3J#FM;M,>CVL;C3BQC
M1*MHU1I7F%["/RS!!]OA%O6PQ!$+AR9;)'--$XRG<ID441+W`AA:RELK)(2C
M0D$R166E">^%$HC!$@"J$;H)0M@U_-WO6!Y&ZNZ_:'5I?6F"PYL>V!@)BC$\
M-T89$3JRQ9.'0$\::7!,A*5MK`0'7L`C)&!.'7_@#6"Y8J1U5"I"EE.R6H$5
MD4MCCW%U]@0@)$3LA"WOX1;7'LDY:2")`U.(5?A4E'EG>(M46`W7\\.MX6WD
MJ"F*WHFJ(=2591M.PUO!8^"-,+`:>I=?:W[$<:M.=5SH<L7/;F\K%1ZE>J5&
M&GK52@TTX0QF"WL3,S-SQ99/5U9)%#0K2UU!$RJ/QX^(L*E/$8^2H9(HJ`:4
MJC#0<6WA,;8\I+4&!,1$[`F&$8M;!O6]X2Y0ZU>=:8N>&SN#3V`,"YJL>L9%
M3DG<FQ"0PRLVMI4TJF5YBK9+V<".2,K:<WK#`E@2J2M$BWH0/"+6MX6)F-83
M>.UQ`8DU-K+&X9%V9M:#%I[>E;V)K2@3K'-*)$[.`/(2@_\`F+PF,$!8H_\`
MY56AB\T0O%OVD>P$&A1;HU/@(?%@/3"R&1IC>`1]I"Z,T<-#H)K`U.&DFE;<
MR&!#K0DI(P$;UK^4.!^5L#@[DUK&-QAD47LC@S(HXO9UL=:%36NCS:,TQN85
MC>>C,2*69`,\8B4HP"(*V,6PAU[=X+?MPA$+=HP&$ND0B[E#`)4:$$1<&!I6
M1@")O$4-`C"P*$AC4%*A&G+V27HKP%;`'8=:]FO8+YLPE:6I"H/5HFQO1JU*
M9$C4JDJ-,G4*$C8$X#<E/.*+`8:F;P*#-$`%O82M&"T'6O%OVAD,#A-_R,O]
M--T_Q.\>_P"8RO\`#3VO[>#NSAF8#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y
M=WLK-0?1=`,?1T-B$,D#^\QQ'#[LHJ[DBQC*0&JECS0]LQ*VV1D4A<2%!(6I
M]=(B4D6"`'1P4QP]E""9H(M%B:FW/Y3Z/52GU>IK$JW;+1IQ<Q63S4@?DK?#
M@.2!+8/12+I@$\VG$RC0+'YAG+:20%,8#:-8BT,)P=F#V9AUOUNN:-R/T7ZK
MF#KT&Y2BUGUX.Z-BELDRMS/@,,%*8Q9=[PMGAEMS^!R$\"@,>:)40W*%.F'W
M4U.2->:0)0:D`0G*B_).E<FQ]@^G)6EB6?-[.<YM+4"J=VYR#;#FQMR*/D-R
M8_CY&[(8I&4:C3?IP*99:G>3M+Q:,T>FWOVI1%;WOVUS&<U7W_+7RN/1OKNJ
M*O45W![DDK,[QZ<<SRVI[*+@4'.G$1;>3YXXSVJ(K-U:E.>AM1J2+'=2G4:4
MDH"O`:,T@HA0:>::=3[DS-SW_*].H.=^C;<X)MVB':21ZYNAI^MD*F&S@"MO
MIB/5O(E-JGS:DYFS&H(])#RP\V;2L*TC0DZER?#X_L0S='JMB"3&8C*^2HEW
MI"5XJ883$VZYK!B\.54USQ3/1D49F:'KD_0C1SA8C[;\5?%,A?F=RD]=2>36
M5,7Q:_KF=2`US)=3-:T2J`4K`-\KAYN].UGYTO4FXT5WV%-V:-QKHV%UE64A
M8X0AC\`B_3%\L?1,V2:?&1C12>4.2"=M(R4:M>I'L+8,LD0-F%".-$Y7%?6C
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MYK3-#5(.K9`E97=.S'\\5^AJB$2YNF7NB>2FK%5>-29(N1J!')SE18E0?`,>
MP82<KXM0W;T7:;<:[K.#%6Q82993U%<V4U`7\;7%S-)G#F*S9[9T.G#\SI42
M!,^*9&NL1>A>$&C$Z<U(+QIQIE7A4!+OG\OZS>BU03/.87+@/Y![4ABL&8;'
M@^J\C"6+3!XKQRF[U'IG"DJ4\HRI)()VGRTY0<AVL'LPLH\@2=7YZH^4;YIL
M1QGP"1R++%\M4WM/+E6%<]T?RW$$TNBU?1A-$:;YW<9ZHK%I!N#L#*:_2!,W
MST\AQ<EHC#%HR0F!`3K?EZIEENY<VM2_T:HP=&7F'-/3MM,<?E4$O^@)<4GB
M58.+@_<I=$VDLN"64M[^\1I>%KD+-+7IT`W2],46Z!0N(BSRCS2$IY)=_9M+
MT]Z>U<=.A7$/4SEL/1*N1[BX_3HV$AF<0HH1<4EJ&1ND@+/?D3@I/?F?\SZ-
M,0$T0DYQ*L[9P!BT#>CF,ICSMKKT#Z/D)OM3;(5G0MLQ9@NN?W;/9Q$D37#G
MJ-;7W3$Z>BYZUD9WIK4-R"70PFFDH&E\/*5K4R%V<DP/!M0`XDL9S#9BE."8
M12=[FWTT3V7O;Z<JZS5#8G5*Q%,_F=;W+6]SRK6C$2$E=X8F\5LG1MO])[1I
M5)NS_,,T`6B3E<5]OPU75^CRSK-2!.+J^[T3:E!TZLJ!&QL\`C:NIG[KF]62
M]KF4[?XZQ-4BGD??7*-I6338YJO#IB4+B!'",4EFII3KY.T?_$EJ+TG&*BY4
MAF=9]"SMC?'ANNB)6P4;`ZU5,=C5Q=EFN%O.T,;V8#*F)KP46FKPL^%+FD8#
MM-ZC:=4%4,LD\NI.=\87KQ+Z?<%X;I64\[5[8,VDU/2%O:/A\8DA+&6JB<C4
MP9MB=FR"/OC8@3.6B[1>V[<A4HE(E"=L=EBG2+RDIA:8H99SE-\U+03TGXC%
M8.@AK_>M@S,YHKGABI&F0*XQ!65P2U_Z?_0#K>E,-9Y#2TEI%;@Z%K4[(]*]
MA#M40D"J*`2I&(6I1OUNNOY2*I?3`B-/W/2%N1FXIHDW2VK:$8VL\?C,8D%I
MDVO8-R6(?$;;G+&0E=9Q5<4>[F5*FF.+"3$Z)S;TJXDTLT2D)])RN)A(I;Z8
M-`S!K[P&XE$AG_>1<\;9=;WS.A"BS:WBL_IF$TVYPJ"2M2QFNNXH0AA87,*)
M6:<08O6';,"('A#HF^=.S&3#TSHK);Q.M9MN:>1N(.]J43T%+*?21Z#+(V_W
MWS/!X_`Z9FY$E4,89BP1ME;(8QGN,>1JRT3BH:2]:&02H6$J2[]*:;VSZ.#K
M&>=Y50?.-D31P<;NZ+J2\YC9LQE$>B[Y35O)]+&SI/IZ&FL,0-7O4JO:"JEC
M2JB2;W-F1GN8]H!($HC@9*6,];GH[54[69U11$4%3RA5((JS.9R6N68YAC;`
MBK6MD2-`UPRK&(J.-K=\28(0T-X$R58OVH<U!>_:H/,WK6]5Q,WJM7"&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.$
MW_(R_P!--T_Q.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_\`8A[R_P!O#D[^\2:Y
M&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.$
MW_(R_P!--T_Q.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_\`8A[R_P!O#D[^\2:Y
M&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.$
MW_(R_P!--T_Q.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_\`8A[R_P!O#D[^\2:Y
M&D_Y1]Y=WLK,P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.$
MW_(R_P!--T_Q.\>_YC*_PT]K^W@[LX9F`P&`P.$-%_\`8A[R_P!O#D[^\2:Y
M&D_Y1]Y=WLK,P&`P&!K_`'NF6NR^D(L3(I5&VV77"-FD!\.D;I%'A>THJCMF
M3$MVWME/2NB=&)\CR,XP)1I>S?(T`6]@V(.RP^OW>HY]8=]_;U:GTGP6?=ZC
MGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O
M5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9
M]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'
M??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I]
M)\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>H
MY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;
MU:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6
M?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUA
MWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?
M2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ
M.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V
M]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%
MGW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8
M=]_;U:GTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:G
MTGP6?=ZCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=Z
MCGUAWW]O5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]
MO5J?2?!9]WJ.?6'??V]6I])\%GW>HY]8=]_;U:GTGP6?=ZCGUAWW]O5J?2?!
M9]WJ.?6'??V]6I])\%JPM^L2ZYA09E&+(NTIZ9YG6`4WQ2Y+!?6P\ASLV(-#
MBC<6=Y?%S6Y(5[8X'$FE'%#`(!F__#?LWHL2W*PY,!@,!@<)O^1E_IING^)W
MCW_,97^&GM?V\'=G#,P&`P&!PAHO_L0]Y?[>')W]XDUR-)_RC[R[O969@,!@
M,"C+?_\`K+FO_P#>:[^X6\L+'-9TFF</A9;(;,97&HF5)9(SPV.&29]:V(M_
ME\A/$F8(JR#=%24+K)'Q2#9:-"1LQ4I'K82P"WKV81\7>=0U@E$0A+W)V5JE
MU@?'_F1&US@G3O$J^:K<6[R3X$A,&$]Q^!M9P5"KR]"\DH6A"]FL!%)U#9UJ
M1[ATG99-J(2MY@LIVRN"=?\``)E'1$`?8PZ^[C'[D]-`E)>E"<?L,+\>O;K7
MMP)7@0R?V/7M41=?-[1G4/KB&-8TY;E+)W)6:)1M`8L.`F1E*WM^6H&U.<K4
MF!+*`(S0C3!:"'6Q;UK!$3.D/-`+2K:UD+NZ5E.XG/VMA=DS$\.</?FV1-J!
MW61J/3%&WG+VI0J2>\*XI+&QQ*T$>]&(UY!H=[`8'>Q4QQ3S`8&)?GYCBS*Z
MR23/#7'H\Q-ZIU>WU[7I6MG:&M"2-0M<7-R7&D(T*%(06(9AIHP@`'6][WK6
M!#&2Y:ADU@22IHY:==/]I0U"!SE];LLUC;I/(LWC,2$A6R*(H7(]_94NS7!.
M'QJ4Y0=;4%>W?](#Q%J:ODLG"&`P/-I8DVK&WZ5)MKRTQ2PQ#H\K:LM(<::0
M2J&FT+S@IC3B#`!'L/A$(`M:W[=;P/3@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"@^FO_P`0.?\`]YU%_>_!
M,+'%?F$,!@,!@<)O^1E_IING^)WCW_,97^&GM?V\'=G#,P&`P&!PAHO_`+$/
M>7^WAR=_>)-<C2?\H^\N[V5F8#`8#`HRW_\`ZRYK_P#WFN_N%O+"QS:*^I)P
M9=?=CG7S'$[BA%10&JX=84KBJIUAZZ>24WI9Y`UM57SU,VF*V5LBH:D:DJ]4
MUO2=4K<D[BZ#V!)O101B.L,HQXPTZM+TRN[K7M>>6TY7%6<=GTCBUVFL]@-%
MS7R8O95MQ4G5,(04]%8@&)HV.MJ^@DHAL@1D2=E/*D)S/(??0I2G`*@LV+&6
M,17)D(]Z4W4B2'6$@9KE8J4=7QI[*D5;,%<W??4A8H!9W0%@U"\UBL?7]R:H
MPY6`&%5G%9+'#WAS1JE+9M[TH;D@Q`+\DN^+UB^#,:]-GKH">%ID=N2-*UET
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MDUXO#<Y)T$7A<9F8P<U*E\))VL9=(Q;4"1`3)VT>A%C?CT^J:M5CQ1WM:.[P
MA1,OLV)LT9.H5MDTGL.Q;_@3/UQ+8=8W43Q;LG2@M".RMTKAVES5.H<Z*SF!
MB<XB>K94:%*I5)BQ&(XZG+&/KAP;WPK@#I]NLN6)9I:3;.Z5L5/R@ELA3:5J
M2^V+4D`**W"GB=M["J_-S7L9CT&L117J=M<&8Y.M&X*'ET==*47O)C>8<[HK
M3B\^N&>LXY2DNYUC)U(K(<GZ*D]\?G(;[1LRLK(Z<ADXZ%<;BFE'WLHB=:K7
MN!KY2P/Y[8YRIH?GK3EML1EFMH$BE2G(INQN^RNVOTL.HGM1!%%K=&+965'T
M56,#DUMU\=&-2-+7[.Q=:$6%6R10W+VI7*D)JBV:];$[VZ;"\/K="]J%XTY^
MBB38;XY0P;YZ5'7TMCJU9*NFE3E9ZFLY!%02A-?W1[2W_.E%PW2-0UD\#;V8
MUM0:(C/7M=NL_4&Z1^>H"L*5&A4*QG)`W5=^/*-+_?\`XL,7IQ=;OUHV\^37
MH]^>8E9%YUI,70:"[;#C2:74RS=(0*TI!7*^&QB#M#O#G^+U#'G.%M:INE1B
M)P;EXR3B4I2DWW<F['E')5#[Z4/39#3(E;7/F&0V)(>7XM1:6PM=%7-$Y&QN
M%4=26%;%9LSPK=:^L-/856/%2REDCTB0+R"%JE,PJ$@#A?$S%Y8WQ^>CK[3[
M1,*(K1\/M-A3O$D<)2T+G0VFE-P6B1)5YL&A,><Y*@A\K`]OE=MZI]8U?EL+
M8<L:6Y$62?L\:I2K%AQ.LZ)?]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_`$<P
M5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?839_T<P5)]X2
M/?5W?7V$V?\`1S!4GWA(]]7=]?839_T<P5)]X2/?5W?7V$V?]',%2?>$CWU=
MWU]A-G_1S!4GWA(]]7=]?839_P!',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?8
M39_T<P5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_`$<P5)]X2/?5W?7V$V?]
M',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?839_T<P5)]X2/?5W?7V$V?\`1S!4
MGWA(]]7=]?839_T<P5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_1S!4GWA(]
M]7=]?839_P!',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?839_T<P5)]X2/?5W?
M7V$V?]',%2?>$CWU=WU]A-G_`$<P5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-
MG_1S!4GWA(]]7=]?839_T<P5)]X2/?5W?7V$V?\`1S!4GWA(]]7=]?839_T<
MP5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?839_P!',%2?
M>$CWU=WU]A-G_1S!4GWA(]]7=]?839_T<P5)]X2/?5W?7V$V?]',%2?>$CWU
M=WU]A-G_`$<P5)]X2/?5W?7V$V?]',%2?>$CWU=WU]A-G_1S!4GWA(]]7=]?
M839_T<P5)]X2/?5W?7V$V?\`1S!4GWA(]]7=]?839_T<P5)]X2/?5W?7V$V?
M]',%2ED-M1JFSJ:THHG9S&<4B-7;5S*LYG#VH8"C2"=D%.D@:$*$U:/9^MA)
M"/9@@!$+6O8'?L%4B/37_P"('/\`^\ZB_O?@F".*_,(8#`8#`X3?\C+_`$TW
M3_$[Q[_F,K_#3VO[>#NSAF8#`8#`X0T7_P!B'O+_`&\.3O[Q)KD:3_E'WEW>
MRLS`8#`8%&6__P#67-?_`.\UW]PMY86.:\\(8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8%!]-?_B!S_\`O.HO[WX)A8XK\PA@,!@,#A-_R,O]--T_Q.\>_P"8RO\`
M#3VO[>#NSAF8#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y=WLK,P&`P&!1EO\`
M_P!9<U__`+S7?W"WEA8YKSPA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@4'TU_P#B
M!S_^\ZB_O?@F%CBOS"&`P&`P.$W_`",O]--T_P`3O'O^8RO\-/:_MX.[.&9@
M,!@,#A#1?_8A[R_V\.3O[Q)KD:3_`)1]Y=WLK,P&`P&!1EO_`/UES7_^\UW]
MPMY86.:53&G:IL-R3O$ZKN'2YU2(@MR9QD+`W.JQ.@`<<I`C*4+"#3"TP5"@
MP>@:WX?$/>__`!W@N8X(G]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_ZG@N>
MLGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_`*G@N>LGW8.=/J1K#\C&/^IX
M+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/\`
MJ>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC
M_J>"YZR?=@YT^I&L/R,8_P"IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R
M,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_`*G@N>LGW8.=/J1K
M#\C&/^IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1
MK#\C&/\`J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3
MZD:P_(QC_J>"YZR?=@YT^I&L/R,8_P"IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@
MYT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_`*G@N>LG
MW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_ZG@N>L
MGW8.=/J1K#\C&/\`J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+
MGK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_P"IX+GK)]V#G3ZD:P_(QC_J
M>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_
M`*G@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,
M8_ZG@N>LGW8.=/J1K#\C&/\`J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#
M\C&/^IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@YT^I&L/R,8_P"IX+GK)]V#G3ZD
M:P_(QC_J>"YZR?=@YT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3Z
MD:P_(QC_`*G@N>LGW8.=/J1K#\C&/^IX+GK)]V#G3ZD:P_(QC_J>"YZR?=@Y
MT^I&L/R,8_ZG@N>LGW8.=/J1K#\C&/\`J>"YZR?=@YT^I&L/R,8_ZG@N>LGW
M8.=/J1K#\C&/^IX+GK*9PNIJQKE2N60*`Q.'*W,@E,XJ8XQ-[2<N3IS!FD$*
MC$1!0CBB3#!""$7MUK>][P7,\4%Z:_\`Q`Y__>=1?WOP3!'%?F$,!@,!@<)O
M^1E_IING^)WCW_,97^&GM?V\'=G#,P&`P&!PAHO_`+$/>7^WAR=_>)-<C2?\
MH^\N[V5F8#`8#`HRW_\`ZRYK_P#WFN_N%O+"QS7GA#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`H/IK_\0.?_`-YU%_>_!,+'%?F$,!@,!@<)O^1E_IING^)WCW_,
M97^&GM?V\'=G#,P&`P&!PAHO_L0]Y?[>')W]XDUR-)_RC[R[O969@,!@,"G;
M?B$VDNZW>8`9%=R"O;#^>04,Q4/")F=4:B!3N$*D>US(C<5R-63J9Z4E"\@T
M`MI]@%K6A^()8KFP?OG4O]G*!_+6Q/H#DU7T]SWSJ7^SE`_EK8GT!QJ>GN>^
M=2_V<H'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_V<H'\M;$^@.-3T]S
MWSJ7^SE`_EK8GT!QJ>GN>^=2_P!G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:G
MI[GOG4O]G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C
M4]/<]\ZE_LY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`
M<:GI[GOG4O\`9R@?RUL3Z`XU/3W/?.I?[.4#^6MB?0'&IZ>Y[YU+_9R@?RUL
M3Z`XU/3W/?.I?[.4#^6MB?0'&IZ>Y[YU+_9R@?RUL3Z`XU/3W/?.I?[.4#^6
MMB?0'&IZ>Y[YU+_9R@?RUL3Z`XU/3W/?.I?[.4#^6MB?0'&IZ>Y[YU+_`&<H
M'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_V<H'\M;$^@.-3T]SWSJ7^S
ME`_EK8GT!QJ>GN>^=2_V<H'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_
MV<H'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_P!G*!_+6Q/H#C4]/<]\
MZE_LY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:GI[G
MOG4O]G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C4]/
M<]\ZE_LY0/Y:V)]`<:GI[GOG4O\`9R@?RUL3Z`XU/3W/?.I?[.4#^6MB?0'&
MIZ>Y[YU+_9R@?RUL3Z`XU/3W/?.I?[.4#^6MB?0'&IZ>Y[YU+_9R@?RUL3Z`
MXU/3W/?.I?[.4#^6MB?0'&IZ>Y[YU+_9R@?RUL3Z`XU/3W/?.I?[.4#^6MB?
M0'&IZ>Y[YU+_`&<H'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_V<H'\M
M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_V<H'\M;$^@.-3T]SWSJ7^SE`_
MEK8GT!QJ>GN>^=2_V<H'\M;$^@.-3T]SWSJ7^SE`_EK8GT!QJ>GN>^=2_P!G
M*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C4]/<]\ZE_
MLY0/Y:V)]`<:GI[GOG4O]G*!_+6Q/H#C4]/<]\ZE_LY0/Y:V)]`<:GI[HC-H
MGT?8[(1$WU#2+(RJI-"'5V<VF23QU=$[=%YHP2E6!N;U<1:TBE:J)9=DE:-4
M%%A&9H0M[UK>MT],=6UF')@,!@,#A-_R,O\`33=/\3O'O^8RO\-/:_MX.[.&
M9@,!@,#A#1?_`&(>\O\`;PY._O$FN1I/^4?>7=[*S,!@,!@,!@,!@,!@,!@,
M!@8QZ4."-G=E;2C"XNJ5L7J&QO&/RP+G`A*:8C1B,]NO+"J4A"#8O;KV:%[<
M#2FE)+?$LFRA<ZORQSAR&MG(^+"?(PN9FU[E[M$Z:=$Z]W=VXQ$D6H4;^XO1
M($WNPE";_P!R6$SVD^$!U-(6V=>7;(FI'*&&E31M3PRJ':.1PR.S=<_/J%"B
MFR1_>?CK>3MB:B8I)8:7H3>848L=D3LC$F$6:<G"I+MA=[[<MJ.$!0RNOH.0
MH6+YK:J!,7((Q-!!40J!LMANT6>"V4O3.]$J;`4Q1N2I#C?`1_\`-`FE`4>T
MDDTE1:H';H[HS:U0I:JMT%.PO$F/=8I\Q)N:\J1H8W<6HE6!DA4J4[4=(ID]
M1>.*R7U`0:W)RW8M.81O1R<]06H9")7E?DQGM/L;W%$D98GB3E*7E6P129+"
MI=%1QVX-J'<UW.^(L4"0,CO'6,E:VKSSU6UBXKP*M!-3EJ"5%,@'HB^'F33A
M#&ZH$3&XDM?G!&Y22%3)&YOC2P+]MID33(T+LK2@E+B8G&>G6Z.&6)(<29MO
MUO>P;%0S)ESW/.:6F#G$H0[,]BKK%<:6B@XRTMCRJ:7N,.'S0LZR4Y$W<FF)
M*V")R-CD*ED^)*24+J2W(P#$,2T)>Q41/95RCHKHQ4Y0(Q37SA$%3>4F3SR+
M.%?39X-1F?-)M;Y?/GE\C^UD<<H+#YPX.84S8V*=.#H%CT<F5C(5`\):A^HQ
M?O4J%AB0UE>-DC!(9BL827M]C,WBHC"ME!?DJIU"X:2K(VT2@M[+0,YIB!48
M@"UF>]!5GGEE!$Q"WJLO6V)J]+V)X@J8A:&OI.\M!R*,2AI8ULSC4D6,@DBJ
M0OKE[NDBC^$243$IT2,YW)`K/-"WC3[1[),0@S585TEL<"D44?9A/7I*QRYZ
MN&-3ZNE[![A*&V.Q)6.OF%I8XU%U+$J&Z*%93<8><[Z*_GB$-=[->(M0];/T
M9?LA?)`%HIXXN-1^0*1D&O</ES0^R-@%(:P9T\?2D?%EC8RRM"FF#L<K5&'J
MTX-M.PB2E>Q1L@E0@\=ZTZ$D#^5'4%7Q-6<0Y)43ZZN#18$39(Z]*H?6\E6U
MX^'.('1T12..:F#D:)R(2+$SH0T;`0D*,,-$F+MAFFVYK>G*N-264++!J*IU
M`#(I)':-5:/;V9/V%"!R-<T"=[8I^O:*VERM]]R0NNRU:=4-C!H!I&W$&A"J
MZ3*1/=^]#:>I2R1>L6U6<T*Y^(L;M#[`V%B3PM'8RV,-+NL3')$$K=;:0Q-L
M5MRMK$2F;2W719I2DP27WDE0]JZW^H@K7%O10"(!^`J%3>L<U,-L(])(#@-=
MNOA+FQ)B'LH25``J!-#?Y8SE0CE;X$W1A>M$ISQ4,"U=%=,/ALC.*I5J84S$
M?,U^VMV;):X2`*.()I`L018U,W'E$F/$Z0MR`YL==>`C7Q'8-(%&R`B4"H6)
M5]Q6FJESS%+"9/C!#:SVF[DN<3KV3M:OWF'6C)61J9W,AS>5*-$:Z0LML&SZ
M3[6?'C=J3M&I@E@+/$Q"AFGI[HY8[KW\BJW)T(-8$1,<KH<"G+0IFYI3Q)%2
MMV8G_0GAAB+NR,2Q'MV3+ECB%5M#LI'X##0^TM1P3)RZ7Z!0MSH8S4^7-TY*
M9P=&.:L\0GC!'WI@CQS:WRQW'&9`?I];%S6Z3%KTA;#E6CWE,U/)Z<S19`1`
M)4+6=K\?F^C@3DPB+HYZW2BJXA,$!2.2R1@BZZQ);!6TQ>-L:`D/SD8EADX3
M/`6\@X1A>S0$&*/"$9V"M:4:S])]&-[P$Y[IUY4LSR2KE:@`XZ_[4Z;FN`0D
MY='8`WC$VKMN8U(%[VE;W$)JI:8LVV[-2FD'GDBH?,WJ_H4EG`?^9Y(>XK`;
M"0I2Q29#:&5"CG<@C)TNEWO+PCVV-,A;$3<H:4:8]8$XA::L$OV4E&2,;87I
M8%D=!-CFS)H="(II.;#8F[/GQ)HF$H`GDSZQ6L\/36VN;(K84QZ*/*X`W(O:
M,K1IYCZ2,7D>PHI02(A2T@Z(Z0EB>QV>#5.ZL86N)2US:75SB,D;Y(6YM,)L
M4XF*-.E2Q6QF2M;+XTV;;ERKRB!H70DPUO\`$,H)A:CJO)TN6QTL6J=W!#-(
M7.9K7LB7IUD7EZPJ+O344>)!7.TA6V]6B>Y"Z@$UII`L&6R><G$I"`TM2D),
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M084"DQ0L,4+"=@5")-3Z4BH?27],7U"&!*[R2!QEH`I;6"0`<E$/L92TF*I&
M*,%-]4C`C5F*VZ8"&ZKQ#>U'@;BA(=%&(P#,UO1=L3P22;77=,*M6R&!HC8I
M+%P2>-$MABR"SM6&"0];"*X&]V:8\-129GF4/8Y`X.@5#*@,^+F*BS=Z4%E%
M&!*)45W9F"WY=,@'/0N].*@%1FJ7&90Q0E9Y<S:LN8(`J`ZB+62^(=F,(E"5
M.WN16E/F''IY,G2%Z&J9W7!,1U?F&7;>$AD:$@R%LKC"TDAB;,MEB*$V)'!3
M)!*W`YO7/L9:Y(I]]BR&"*="+7Z<`+=JMI3#`;3DG%&!%17=@%]F]),]B352
ME9$\QC<4?9"UDPY)!Y(S*7=F<9M7#;#"&M^,<53<<_IX[)%RX]TWYJ(U,G$$
M24GPFG$BH9YDNSH![IJ.SA+5[*=-G25N:93&"T,D`+<:9X`_3!0D,:AJMK(_
M*5\E9/FT1M6K,2@5GE*C-:V9[D$5%J_UTYTB7&$KD*CDSDK<6<$F3O#.T2HU
MG;HXBDA43E!CXU&J]'H)5'5D@;7$++MP\Y:THW(T)Q>R1>2*CJ]SCT=TBQQX
M,C<*=:'E2M%(&]BA$.9YB]R1Y<FJK8[*VIQ*<5"A`W%Q1XE3HK3J%991YK>2
MF*(`4L--//2"H3207=<+?5E?2GYEMS@^2]9,VMU:XDUR9X>3"4Q#X5"G>/LY
M)AHF4IRVE3*G42A2X"9R1C\HM>$L1@16JF5_2'3B.:.'PZKQ+$)@6J.;9'>,
M3%J880ZE2"W2T@91*5)2=(]NLX;HRPZ"Y-HMHFPIW)&8C4>)-I8*BF[L1DSB
M\V/8+:2J4KHLWL4&7(Q*4AJ;3/*5Q\O;I(P)Q*$B12,D#:Q-:_P&:V(.U_FA
MWLL\OV$Y+7PA@,!@,!@,!@,!@,!@,!@,#A-_R,O]--T_Q.\>_P"8RO\`#3VO
M[>#NSAF8#`8#`X0T7_V(>\O]O#D[^\2:Y&D_Y1]Y=WLK,P&`P&`P&`P&`P&`
MP&`P&`P/D,@DTDQ.82480<`PLT@98!DFEFZ%HTLPL6M@&`S0MZ%K>MZWK>_;
M@?%`@0M2%&V-:)(VMK<E3H6]O0)B4:%"B2E!(2HT:1.`M.E2IB`!`66`(0`!
MK6M:UK6!Z\!@,!@>!L:VQE0IVMF;D#2V)`B`D;FQ(G0(4H!#$:("=(E+*3DA
M$8,0MZ"'6MBWO?\`X[P/?@,!@,!@89CCL?C*0U!&V)FCZ$]6>O/1L;8B:4AR
MY5L.U*TU.@(3DF*U&P:\PS>MC'[->W>_9@9G`8#`8#`8#`\RA&D5@"6J2IE)
M85*98$M004<`*M$>2J1J@A,"(.E*14G+,*'_`.HLP`1!WK>M;T'IP&`P&`P&
M!YU:-(O3'(ER5.M1J2]E*$BL@I2F/*%_ZBSB#@C*-+%_YZ%K>MX'HP&!AG:.
MQ]^-;#WQB9GDYE7ENC,<[-:)Q-:7,G_^%Q;#%A!PT"\KV?S3BM@,#_Y;P,S@
M,!@,!@,!@,!@?S00ZV+>M:UL6_$+>M:UL0O#H/M%O7_COPAUK_\`IK`_N`P&
M`P&`P&`P&`P&`P&`P&!PF_Y&7^FFZ?XG>/?\QE?X:>U_;P=V<,S`8#`8'"&B
M_P#L0]Y?[>')W]XDUR-)_P`H^\N[V5F8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8'";_D9?Z:;I_B=X]_S&5_AI[7]O!W9PS,!@,!@<(:+_
M`.Q#WE_MX<G?WB37(TG_`"C[R[O969@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,#@;#;DC,H[8[+.ZEZ8M*"W=S]T!'F7D;C9JOUZH>,6)32*MH1)ZR?8?6C>
M_1ANZ8>.@YVXO3<X#<`2`D"DH#4`A-LKPF&E>F*C28UEK2U^M%U"HJ99,6,7
M(]KRZ9<XT1?K>V0)JL<ECY2G%N]44Q0"CFSIK8K`=G5TF!33:"TQ*J+U&'7X
MM&70)C3[L$KV%^/&ZUXK9?\`N/LQ7:_.D1E-V\_U6U03U7+7XEO67(JS>6F`
M6]'6;F=5<M=:4D2VU%JJO%C^-^`Q$-Y;RH/6RD+<J*4&$!.:ED-N-3__`#;7
MJ*^J+U17?.A<@J6,4,TPVE^+)IV3.&*Q0W;9,IEFVKN&ZJ8<JWCLTD-OJ'MB
M(?(M#A*0.KH8\B;'#PE%)1HQ`)2U=F,S4W=U^&Z$I]6B=1>Z7ND2F.JY+9C%
MWUT)S^&F6<;R"VWSG^K.,Y5T;!)@WQ\4A5+TDEGTU:4+4E=C$0VA:G5^6E3"
M/UXPQSLTOE7[M9:\]8OK:6U!#IE(TO*T':;:L[D>().@'M=%7"L>=4O1#=:#
MI.$-R5S`NI[!E:4B'*H"A9XZZR5W@8G=T>?*7MZ`U&:4:=;,;Y\VPW%_7CO5
MGI*7?U9.+(9Y4\1[HGLI2BL)N:I+:4&6.3WV/8<+A2R,LCU/(F[*JO\`B;RB
M`W$K)(U(FQEV6)0X)DA!B@!SE%YQ':%10;U5>S;:10B!0+[K[78"NQO4#@LI
MLE^B3Y,8>Y-G']3U#:T0?8Y%:PZ`D,>+=)5JS?A;H!',GUL!HH2Q(I%K6DHJ
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MD_N8$@&=EVB;$Z$#>M4ZT?Y4=SA$SSC@[*<K]E=&V_RKU1:4B::`?9W314N,
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M0/L6A$6N:3INI[(YQG<5J>5VUT-5QD(`PM-<Z=R0)$5@NP'-^;T2A$`C85"N
MGQQ5_7!GZC[=MOISU*N*V^6634D>:D%V>I[`U/,$!4RYHN2K6BC&)\K:)#Z2
M0K)RZ-$G73-$QE2)!LUB9B41JPOW'WPK8U!<)QB,)X\FPUH^IM<\,[)E-/-X
M:)1QV%=A<W\IH.:7]NE@^KKEAM[QJ!O;]T_7+FGEZ-D35[`!S-8H"GU'')`>
MUQ9W$K=$1^BP$U(PC;>O"^S+>GQZ@O3G1=L43'KN;Z*W#>EN9.@[YA:2K(U-
MV"00%;S]T5$Z6$V/[Q*)W+$$Q23ECFJ=Q&).C;-M:Q,(D.U)8]&9#+&(B:XQ
M*FKB]3[L&$FW&^-C!1#;7+/ZB4IX*@TD.BZQ<O@R>'1)ZGZVT[1<Y_?E.5FK
M52@)*"+L[8>_1E'\44^]&+31FIVLQ:QA$_>K2-F]4+K,4LYEJ&6U13K1;?;<
M)HEVYV,BBU38T`+?6*WWZ-=NJW>4P6Q)-&9-'*ZHML0SV.:;7?\`HRG4*%4J
M6C(&:.ILC6>4?4-?6+UGNPWFJ.@+=)J:A$Z>)QP;M$81(7^--<IJJ:)^NZYY
MX25C;$4CG0<RM]])=8M-%"E<^K8C!OA+\A$2%"J3J$^2W4^WC=:_4+AO;U1.
MLN5[3Z/K"T&JB+-E]2\N2.TZFB]+198^);1E<`@E>R"T)1:"I#?<CL'G)GA+
MQ.!JB8X_1@13U&TP5".1B4C$6`D81EK%U;;WF'LGH^V>2^J;7?V?G]\L&F`S
M;5.2]/9%71:H;,TW5&QSV.'V@IKR_.BX[3)+=*G<QO=MJ9:H\+260Y;TE`HV
M657,XQ&41K3F*Y^K-:I,&BG12:,Q"RK?KGDKO]PEH`-,]@=?QNRJ/NWD>"/C
M?N*U]?UQUA9]5P75C*'1PF#8Y/1ZYJ:C-M:MKV<X$"CO9%URN/W1!@]1CH*H
M[3ZT=8S;U#WXX6IVY0])?>!A`$SES)!F5HX*9[$`LAT4L;IR`P-@>9U)8X!H
M-3&V0D;!NXEIQ1JM9LE"8LV14:5I^[_2=RI:$XNOG"E;8LJ+QN%SZ?UY'9++
MHU#9:Q3N(-SXX(@#7;BDPC3Q(&*01E<;KWA`H3+U@!)#B]><8+6Q[K+**F8C
M@V`PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<)O^1E_IING^)WCW_,97^&GM
M?V\'=G#,P&`P&!PAHO\`[$/>7^WAR=_>)-<C2?\`*/O+N]E9F`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P(\YQ**/;HSOCS&8\[O<>-VH8'AS96U>Z,9XMZWL
MYG<%:8U6V&[WKV[$2,&_;_YX'X3PV((_C/ND5C:7YQ.9;U(/=V-L(^.O!1I1
MQ3L\^4E#\3<RSB0#">?XS="`'>A>W6L#ZKHK%W-.<E<HVP."50[)7\],N9VY
M6G.?41B<Y&]'$GIS"S'9(:D*$4IWK9Q8B@;"+6PZ]@?WYK1CR34_S<8?=ST0
MVT\CX0W^2<W&*C5QC>:5[OX#$0UIXSME;ULO9HQ#WKQ;WO!9\U8QIY-D6HXP
MZD!_N?GOOP=O^,G?#B%*5O\`-<_=_?3/<4RPXLGVCWY0#1A#[-"%K88T->0`
M"&0-@(-#PMLL5B7RIN#&64*&3+AC"8-;($FD6D[RK&8'0MF*0F#V+6M^WVX+
M9GYOL/PE4P_!&CX&O*6$+F;X:B^$K"7'S/B!*IN\GW-04N\X?G!&#>C?%OQ>
MWV[P/.CBD6;BTQ3?&F!"4C+.)1E(V=N2EI25"-*W*"DP"$P`D%GMZ(D@80ZU
MH1)(`;]H0!UH/@9"H:<L;G`Z)1DU>SMY#2TKC&%J&L:VI*I(6)FQN4B2;.1-
MZ=8F+-+)*$$L!A81:UH0=;T+9%Q8F1X.:U+NSM3HH8UX75E4.+>D7'-#H`HT
M@#DUFJ231MZ\!!XP:.*V`S0!BU[?9O>!\F6-QV-EKBHZP,K`4YN*EW<BV5K0
MM1;@[+-AVL<UP$)!`5;BKV'6S#S-",,]FO$+>!\4$2BK4X+'9KC,?;75P2A0
MKW-`RMJ-P7(0J#U@4:Q:G3%J5*4*M4:;HL8A`T88(7L\0M[V'S:8;$&%E51M
MCBD;9HZMVMVM8&EB:VYE5[<M""X[5-2-*2A4;7A%O1_C+WYNM[\7MP,&\UE$
M'.&.,&;6_<+:E<6?H@VKJ_&"%/T3:9$E&F7CA3RPEI%D57`'L)Y1R/98BU!8
M#-?S@:WA;UM3G.7']/<QH9CJ%%RN62FPYBAGL\L:TY.MG]@2J3M$80PF/K%C
M\ZA"4VI(S#FTEL;4;<0B1HD@1!+*T(TX1@G*97VL@\*<0LH7"(1=<&-KQND=
M"LC[2I"P.9I@CC'%ET<D'IJ7F&BV(1Q'EF;%O>][]N$N7I3Q2+)'A7(DL:8$
MT@7G!4+GU.S-Q+PM4`1_#P'JW,M,%:I.`@_H-"&,0M$_S/;X?Y,#ZG1N/*'U
M'*%#"RGR9O0GMB"1'-:$U]0MJH>S%+>C=QD"<$R%09OQ#*`8$L>_Y=ZWO`^J
M1B9&\:4Q`SM2(Q"F4(D0TC>D3#1HUAY:I6D2B))`).F5*B@F&%@]@!F!T(6M
M[UK>!YE\6C#JV.K(Z1QA<F9^--/?&A>T-ZQL>3SQ%"/.=4"A.8D<33A$@V,1
MP![%L`?;_P"&L#T)V!B2!:`I65I3!CZ<:1A"G;D9(61*:G`E,3-&BR0Z;4YB
M4L)8@$^`.RPZ#O7LUK6!C0P>%`7O3H"(1<#G)-I!2)Q#'VD*]_$WC+,0">EF
MDFE#KM$84$1.SQ&>6(.MA]F]:P/41%HPE>G22)8XPII$]I2$+T_$-#>2].Z)
M*'04R-T="TX5R]*G#KV%EFF#`#7_`(:U@?!KAD/8V-3&62*1IGC:WWW2R/M;
M$UM[&K^):$%Q]Y:4B4E`?[_H>]'>(O?FZWOQ>WVX'[01")M2%"V-<7CK:VMC
M:K9VUO0,C:C0M[0O$`:YJ0I$Z8LA(VK!E!V:06$)1FPZV(._9K`\'YNZ_P!,
M"F*?,:'?-9:2E3+(U\V67X`K3H=%Z1$*6;W+X<>2CT4'R@C+V$OPZ\.M>S6"
MY2I*E2H4R=$B3$(T:0@I,D2)22TZ9*F(`$HA.G()"`HD@DL.@@`'6@A#K6M:
M]F!]\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<)O^1E_IING^)WCW_,97^&G
MM?V\'=G#,P&`P&!_G:ZPFTG]-OU77SU!IY3UO6GR'TYR9#.?;,GE*P5VLN0T
M%:%33ASD,8=)A#(X4J?S(%+V!YV3I:24+REFA:W[=@"`TUCU8;;BXE9O\1CZ
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MXL^WG!_$8^FG^%>G/U/>C/T?8L^+/MYPTM[3[1C_`*TD7J;A?A2F^C)6AE70
M]&V%>O0-C4?.ZCIZCZJJ:?M%@R!>X/\`8#8QJ'J8NHF(M.WMB8@0E`A["$0A
M["'#K'&?;]65/]565B8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
/8#`8#`8#`8#`8#`8'__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
